data_2ka5_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ka5 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 37.4 p90 . . . . . 0 C--O 1.237 0.418 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.64 173.26 11.72 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.77 1.228 . . . . 0.0 111.511 165.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.3 mt -119.09 147.4 22.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 174.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.5 t -125.1 -174.79 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 129.761 3.224 . . . . 0.0 104.849 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -51.75 -54.33 29.71 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.869 0.867 . . . . 0.0 113.311 -163.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -127.39 12.37 6.99 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 122.933 0.493 . . . . 0.0 110.367 163.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.47 HG12 ' CE2' ' A' ' 56' ' ' PHE . 22.0 t -119.31 163.77 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 O-C-N 121.114 -0.991 . . . . 0.0 108.585 -166.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.4 t -132.28 125.52 54.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 -170.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -107.69 103.46 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 -176.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.7 mt -90.61 104.77 17.31 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 104.886 -2.264 . . . . 0.0 104.886 -178.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 57.7 mtm -112.89 84.98 7.26 Favored Pre-proline 0 C--N 1.332 -0.172 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -171.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -70.49 156.74 60.82 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.853 1.702 . . . . 0.0 109.871 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -122.61 -92.55 0.53 Allowed 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -178.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.63 59.44 1.63 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 121.784 2.084 . . . . 0.0 111.658 -175.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -144.97 9.69 1.3 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -175.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 25.0 mt -79.26 52.93 1.4 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.429 1.013 . . . . 0.0 110.975 -176.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -85.4 169.63 13.49 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 126.598 1.959 . . . . 0.0 109.116 171.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.9 mt -57.53 -35.38 49.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 C-N-CA 124.272 1.029 . . . . 0.0 112.09 -174.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -71.61 -16.18 62.27 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 120.97 -1.081 . . . . 0.0 111.211 -176.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -120.24 56.28 0.98 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.291 1.437 . . . . 0.0 108.804 175.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -140.45 -64.1 0.47 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.405 1.082 . . . . 0.0 110.592 -177.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 28.2 t60 -58.45 -46.19 87.07 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 120.513 -1.367 . . . . 0.0 109.368 169.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.44 -30.05 70.8 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.792 178.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -52.93 -54.05 40.54 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.856 1.262 . . . . 0.0 110.017 -174.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.547 ' HE3' ' CE1' ' A' ' 44' ' ' PHE . 0.8 OUTLIER -57.43 -44.74 84.91 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 124.651 1.181 . . . . 0.0 110.866 172.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.0 -34.24 77.13 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.569 1.548 . . . . 0.0 112.372 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -69.55 -62.48 1.37 Allowed 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 171.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.7 t -47.64 -41.03 7.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 123.916 0.886 . . . . 0.0 112.763 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.547 ' CE1' ' HE3' ' A' ' 40' ' ' LYS . 1.6 m-85 -61.54 -34.76 76.09 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 123.892 0.877 . . . . 0.0 112.121 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -112.41 -12.23 13.55 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.386 1.074 . . . . 0.0 112.712 -170.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -88.38 -34.67 17.49 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.614 1.566 . . . . 0.0 109.889 171.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -130.35 -62.63 0.92 Allowed 'General case' 0 C--N 1.345 0.373 0 C-N-CA 123.095 0.558 . . . . 0.0 111.807 -169.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.6 mt -62.41 -56.08 21.63 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 119.245 -0.407 . . . . 0.0 111.447 -162.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -60.75 -35.29 76.02 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 118.676 -0.678 . . . . 0.0 110.274 175.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.14 -16.21 12.52 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 127.19 2.196 . . . . 0.0 112.965 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 118.23 -10.15 13.35 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 126.046 1.784 . . . . 0.0 111.988 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -73.62 120.26 18.98 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 118.802 1.301 . . . . 0.0 110.837 -172.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -109.72 13.0 23.91 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.83 2.052 . . . . 0.0 112.074 -176.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -150.94 107.31 3.48 Favored 'General case' 0 CA--C 1.518 -0.274 0 O-C-N 120.248 -1.533 . . . . 0.0 107.983 -173.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mp -112.02 152.0 13.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 176.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.47 ' CE2' HG12 ' A' ' 22' ' ' VAL . 23.4 m-85 -130.08 150.5 51.32 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.603 1.161 . . . . 0.0 109.492 166.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.5 tp -119.91 110.28 16.54 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.204 1.001 . . . . 0.0 108.535 176.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.3 t -84.31 134.47 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 171.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.3 mp -109.82 6.19 23.23 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.62 0.768 . . . . 0.0 111.963 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 33.4 t -51.98 -48.14 64.52 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.158 0.983 . . . . 0.0 111.458 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -87.99 7.05 32.96 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.341 -0.85 . . . . 0.0 112.195 -168.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.6 p -134.45 126.93 49.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 125.579 1.551 . . . . 0.0 108.099 -173.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -75.34 -42.56 54.06 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 120.675 -1.266 . . . . 0.0 108.944 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.496 ' HB3' ' HE2' ' A' ' 95' ' ' LYS . 1.4 p -162.05 -178.15 6.23 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.992 0.901 . . . . 0.0 111.681 -173.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 21.3 tt -139.66 160.03 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 C-N-CA 125.344 1.458 . . . . 0.0 108.586 -175.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.12 156.18 22.26 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.408 1.083 . . . . 0.0 110.421 172.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.4 m -53.51 -28.77 32.93 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.126 1.37 . . . . 0.0 113.434 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -62.01 -66.6 0.51 Allowed 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.73 1.212 . . . . 0.0 109.309 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.0 t -74.27 -24.23 59.24 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.369 -0.824 . . . . 0.0 111.659 -176.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.1 tp -49.98 -30.82 11.26 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.944 1.247 . . . . 0.0 112.407 172.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.65 -24.69 29.84 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-N 118.396 0.544 . . . . 0.0 113.448 175.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.8 t -66.16 -39.52 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 118.194 0.997 . . . . 0.0 108.605 173.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 mp -52.55 -53.25 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 123.8 0.84 . . . . 0.0 108.914 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 73.3 t -58.94 -46.29 91.5 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 175.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -55.57 -43.2 75.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 119.46 1.027 . . . . 0.0 112.501 -174.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.2 mt -59.73 -38.89 78.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 124.114 0.966 . . . . 0.0 109.013 176.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.63 -50.94 71.5 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 119.151 0.887 . . . . 0.0 109.478 172.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -53.94 -47.93 70.75 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 118.077 -0.963 . . . . 0.0 110.331 -176.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.7 m -56.33 -57.49 12.04 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 124.092 0.87 . . . . 0.0 110.358 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 50.3 mt -53.28 -46.79 57.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.859 1.264 . . . . 0.0 110.637 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.2 p -61.78 -31.13 71.32 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.972 1.309 . . . . 0.0 111.978 -175.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.31 -31.68 33.45 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.848 1.659 . . . . 0.0 111.696 175.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 39.4 m -78.69 -21.95 47.43 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 117.64 -1.171 . . . . 0.0 113.991 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 121.02 4.92 10.0 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 119.652 1.115 . . . . 0.0 114.546 -174.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -113.32 -176.28 19.38 Favored Glycine 0 N--CA 1.437 -1.261 0 CA-C-N 119.24 1.52 . . . . 0.0 112.196 -173.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -131.47 157.5 43.33 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.825 1.65 . . . . 0.0 108.68 176.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -148.96 135.45 19.47 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 175.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.11 170.84 15.1 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.36 1.464 . . . . 0.0 110.28 -176.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.27 171.58 8.2 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 122.793 0.437 . . . . 0.0 110.467 -176.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 77.9 t -146.77 143.49 20.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 124.939 1.296 . . . . 0.0 109.723 -172.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 29.1 t 43.61 63.81 7.54 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 125.914 1.685 . . . . 0.0 109.119 -176.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -78.32 91.98 1.16 Allowed 'Trans proline' 0 N--CA 1.444 -1.428 0 N-CA-C 106.168 -2.281 . . . . 0.0 106.168 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -55.39 155.19 5.41 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 122.869 1.319 . . . . 0.0 110.125 -177.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -64.69 -25.26 67.87 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 122.318 1.056 . . . . 0.0 110.99 -165.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.496 ' HE2' ' HB3' ' A' ' 64' ' ' SER . 0.0 OUTLIER -68.82 -35.7 77.29 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 126.069 1.748 . . . . 0.0 111.547 177.428 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.0 m -82.44 -38.15 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.745 0 CA-C-N 120.436 1.471 . . . . 0.0 110.429 172.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.2 -33.42 63.01 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 120.193 1.36 . . . . 0.0 109.85 -176.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.45 -31.38 72.53 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 177.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.1 p -96.54 -32.12 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 C-N-CA 124.974 1.31 . . . . 0.0 108.653 -177.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.98 -18.59 65.41 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.408 1.883 . . . . 0.0 111.341 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.1 m -80.16 -57.01 3.82 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 168.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.41 -5.43 5.26 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 130.257 3.423 . . . . 0.0 114.006 -167.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -130.76 6.93 4.74 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 125.381 1.472 . . . . 0.0 110.659 -177.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 46.71 73.95 0.17 Allowed 'General case' 0 C--N 1.342 0.262 0 C-N-CA 127.511 2.325 . . . . 0.0 109.706 -170.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.79 -63.13 1.28 Allowed 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 174.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -57.64 -31.95 66.79 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 123.344 1.545 . . . . 0.0 110.284 174.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -76.43 1.91 15.1 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 120.09 -1.631 . . . . 0.0 111.219 -175.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.4 mt -126.54 -53.12 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 126.06 1.744 . . . . 0.0 107.936 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.2 t -103.11 145.8 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 125.878 1.671 . . . . 0.0 108.186 -174.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -71.09 161.28 31.39 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.5 -0.75 . . . . 0.0 111.164 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.19 143.56 27.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.421 1.488 . . . . 0.0 107.113 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -141.23 168.43 19.8 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 128.902 2.881 . . . . 0.0 109.239 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.2 -46.47 13.71 Favored 'General case' 0 CA--C 1.515 -0.372 0 O-C-N 121.53 -0.731 . . . . 0.0 109.697 177.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 60.1 p -119.45 173.79 6.77 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.045 1.338 . . . . 0.0 108.894 -173.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 8.8 mm -66.88 -41.9 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-O 117.858 -1.068 . . . . 0.0 108.726 168.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 18.6 t -67.9 -37.85 82.24 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 119.982 1.265 . . . . 0.0 110.87 -167.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -60.82 -28.46 68.81 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 118.4 -0.809 . . . . 0.0 109.802 177.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -81.27 -54.38 5.54 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.15 -28.76 59.27 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 125.917 1.687 . . . . 0.0 114.061 -160.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -104.79 -0.69 27.0 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 125.22 1.408 . . . . 0.0 114.406 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -123.32 -35.03 3.02 Favored 'General case' 0 C--O 1.213 -0.841 0 C-N-CA 125.162 1.385 . . . . 0.0 112.924 -167.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.4 t -57.02 -27.23 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 126.036 1.734 . . . . 0.0 109.442 161.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 11.8 mtm180 -54.18 -31.65 53.38 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 121.127 -0.983 . . . . 0.0 113.061 162.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.74 23.66 5.02 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 118.326 2.713 . . . . 0.0 118.326 -177.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 21.6 mttp . . . . . 0 N--CA 1.431 -1.383 0 N-CA-C 102.66 -3.089 . . . . 0.0 102.66 -179.933 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.5 p90 . . . . . 0 N--CA 1.447 -0.61 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -126.66 178.78 5.7 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 163.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.6 mt -126.5 152.23 33.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 163.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 23.3 m -111.19 -141.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 125.612 1.565 . . . . 0.0 107.724 174.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -29.94 -79.21 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 129.043 2.937 . . . . 0.0 112.501 166.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -142.82 14.04 1.91 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.952 2.501 . . . . 0.0 109.252 177.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.8 t -115.75 140.07 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 O-C-N 121.092 -1.005 . . . . 0.0 108.712 -173.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.4 t -94.14 130.67 42.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.1 mm -106.94 94.32 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 36.1 mt -77.83 133.69 38.13 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 176.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 70.4 mtm -131.24 92.98 31.15 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 124.21 1.004 . . . . 0.0 109.064 -172.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -78.02 44.62 1.62 Allowed 'Trans proline' 0 CA--C 1.542 0.915 1 C-N-CA 125.461 4.107 . . . . 0.0 113.887 -164.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -49.12 88.77 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 128.763 2.825 . . . . 0.0 114.343 -169.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 36.94 35.41 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 128.95 2.9 . . . . 0.0 115.016 -176.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -122.78 7.43 9.38 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -167.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.0 mp -73.84 63.89 0.93 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 126.027 1.731 . . . . 0.0 109.605 -176.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -78.82 26.88 0.23 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 128.938 2.895 . . . . 0.0 113.868 -166.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.6 mm 72.86 -63.09 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 127.068 2.147 . . . . 0.0 110.643 -177.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -70.3 -18.56 63.11 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 120.916 1.689 . . . . 0.0 111.35 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -47.83 -49.58 28.8 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 123.991 0.916 . . . . 0.0 110.516 162.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.73 -37.33 87.23 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.79 0.436 . . . . 0.0 110.446 -177.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -61.89 -51.19 69.17 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.332 0.653 . . . . 0.0 110.017 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.259 0.0 OUTLIER -81.82 -15.76 53.08 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-O 117.599 -1.191 . . . . 0.0 112.608 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -44.48 -50.74 9.28 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.441 1.896 . . . . 0.0 110.661 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.501 ' HE2' ' CE1' ' A' ' 44' ' ' PHE . 13.6 tmtt? -60.65 -53.16 60.85 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 123.222 0.609 . . . . 0.0 111.19 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.41 -45.91 87.48 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.039 0.836 . . . . 0.0 109.914 -177.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -60.49 -66.98 0.44 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 117.292 -1.337 . . . . 0.0 109.705 176.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 73.5 t -52.13 -32.32 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 120.537 1.517 . . . . 0.0 111.986 -176.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.501 ' CE1' ' HE2' ' A' ' 40' ' ' LYS . 3.3 m-85 -58.19 -71.78 0.1 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.91 0.777 . . . . 0.0 109.905 172.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -65.89 -30.83 71.49 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 123.887 0.875 . . . . 0.0 112.885 -170.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -77.32 -31.81 54.85 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.011 1.325 . . . . 0.0 110.962 -175.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -138.13 -62.73 0.58 Allowed 'General case' 0 C--N 1.341 0.22 0 CA-C-N 118.522 0.601 . . . . 0.0 110.991 -170.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 46.6 mt -58.81 -59.43 5.44 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.416 0.553 . . . . 0.0 111.176 -171.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -60.68 -35.26 75.83 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.029 1.332 . . . . 0.0 109.647 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 tttm -56.5 -34.7 67.22 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.952 176.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.41 8.82 5.74 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.991 1.281 . . . . 0.0 114.173 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -77.63 159.77 28.98 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 118.941 1.37 . . . . 0.0 110.426 172.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -143.44 11.06 1.68 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.251 1.82 . . . . 0.0 111.795 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -139.34 114.73 9.79 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 119.93 1.241 . . . . 0.0 107.914 -176.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mp -121.91 152.55 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 127.381 2.272 . . . . 0.0 105.118 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -131.4 160.74 34.18 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.985 1.714 . . . . 0.0 109.37 166.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 26.5 tp -127.6 119.44 25.95 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 118.085 -0.96 . . . . 0.0 108.434 169.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.42 HG11 ' H ' ' A' ' 60' ' ' SER . 46.4 t -81.54 139.35 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 120.389 1.449 . . . . 0.0 107.685 170.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.3 mt -112.54 8.82 19.39 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.889 0.768 . . . . 0.0 112.22 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.42 ' H ' HG11 ' A' ' 58' ' ' VAL . 71.9 m -74.79 -34.1 62.36 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.297 -0.877 . . . . 0.0 113.233 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -90.76 30.6 1.15 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 122.889 1.328 . . . . 0.0 110.469 -174.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.9 p -160.8 170.7 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 129.344 3.058 . . . . 0.0 104.853 -174.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -129.94 -47.31 1.13 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 172.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.7 p -143.23 171.76 13.66 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.707 0.803 . . . . 0.0 110.648 -176.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.6 tt -138.32 157.88 31.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 C-N-CA 124.987 1.315 . . . . 0.0 108.393 -174.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -73.53 153.54 40.24 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.74 0.781 . . . . 0.0 109.808 174.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.6 m -76.21 53.23 0.8 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.629 1.172 . . . . 0.0 110.447 164.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -129.29 -69.45 0.69 Allowed 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 160.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.03 -38.84 77.0 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 128.967 2.907 . . . . 0.0 112.031 -173.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 20.9 tp -46.05 -40.39 10.62 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 125.881 1.673 . . . . 0.0 111.966 171.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.82 -31.1 40.98 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-O 119.404 -0.665 . . . . 0.0 111.762 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.2 t -70.62 -33.75 54.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 118.074 0.937 . . . . 0.0 108.659 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 22.7 mm -55.75 -46.98 79.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 O-C-N 121.367 -0.833 . . . . 0.0 109.722 174.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.4 t -60.48 -36.64 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 O-C-N 121.087 -1.008 . . . . 0.0 111.693 172.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -63.73 -28.09 69.65 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 120.873 1.67 . . . . 0.0 112.121 -178.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.4 mt -70.32 -34.95 60.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 O-C-N 121.289 -0.882 . . . . 0.0 109.091 173.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.18 -40.93 82.14 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.1 mttm -54.65 -46.48 73.98 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 117.92 -1.038 . . . . 0.0 111.607 174.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.6 t -58.23 -58.36 8.83 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.1 mt -62.07 -40.28 86.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 123.828 0.851 . . . . 0.0 111.157 -170.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.0 t -60.52 -40.87 93.03 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.68 1.592 . . . . 0.0 110.909 173.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.7 m -69.97 -35.11 74.2 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.985 -0.447 . . . . 0.0 110.613 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.1 m -73.06 -51.08 19.46 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.472 1.109 . . . . 0.0 112.844 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 132.98 18.8 1.05 Allowed Glycine 0 CA--C 1.531 1.04 0 CA-C-O 118.064 -1.409 . . . . 0.0 115.031 -170.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -116.86 -168.06 14.72 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 120.251 2.026 . . . . 0.0 111.72 -172.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -132.4 153.22 51.03 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.639 1.576 . . . . 0.0 109.901 -178.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -153.16 140.69 19.8 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 174.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.6 172.26 13.85 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.61 1.164 . . . . 0.0 111.469 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.02 165.74 13.0 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 53.7 t -142.89 134.85 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 C-N-CA 124.723 1.209 . . . . 0.0 108.034 -165.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.6 t 50.74 54.43 15.4 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 126.201 1.801 . . . . 0.0 111.821 -174.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -73.5 107.7 2.45 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 124.175 3.25 . . . . 0.0 109.154 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 32.6 p-10 -66.47 165.52 14.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 122.393 1.092 . . . . 0.0 110.6 174.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -69.09 -26.35 64.88 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.863 -1.148 . . . . 0.0 112.214 -170.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.9 -29.18 70.57 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 126.878 2.071 . . . . 0.0 109.66 177.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.3 t -84.88 -50.32 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-O 116.105 -1.902 . . . . 0.0 108.875 169.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -54.04 -34.74 60.84 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 122.782 2.537 . . . . 0.0 109.844 -177.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.73 -46.09 89.71 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 121.711 -0.618 . . . . 0.0 111.268 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.8 p -83.95 -38.8 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 -169.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.7 mp -61.28 -24.29 66.3 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.776 1.63 . . . . 0.0 112.644 177.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.81 6.86 34.27 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.376 0.989 . . . . 0.0 111.302 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 41.5 mt -108.67 -39.24 5.43 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 126.773 2.029 . . . . 0.0 110.704 171.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.2 t -94.72 0.42 55.0 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.413 1.885 . . . . 0.0 112.021 -168.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 57.96 79.86 0.19 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.296 1.838 . . . . 0.0 109.432 -168.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.28 -55.44 1.26 Allowed 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.97 1.308 . . . . 0.0 108.996 175.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -59.54 -18.41 40.34 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.642 1.977 . . . . 0.0 112.183 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.92 -9.09 24.59 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.422 1.889 . . . . 0.0 114.535 -178.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.8 mt -107.62 -38.04 3.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 126.926 2.09 . . . . 0.0 107.914 -176.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.5 t -120.78 145.44 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 123.726 0.81 . . . . 0.0 109.117 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.04 161.01 27.67 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.084 0.554 . . . . 0.0 110.742 175.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.09 144.12 25.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -144.67 167.05 23.49 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 127.363 2.265 . . . . 0.0 110.784 -176.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -84.72 -44.52 13.29 Favored 'General case' 0 C--O 1.233 0.189 0 O-C-N 121.835 -0.54 . . . . 0.0 110.008 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.6 p -128.96 177.22 7.27 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.165 0.986 . . . . 0.0 109.48 -171.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 13.7 mm -74.95 -42.59 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 174.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 10.0 t -70.82 -25.56 62.9 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 119.573 1.079 . . . . 0.0 110.313 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -65.74 -16.22 63.57 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 119.676 1.126 . . . . 0.0 111.399 170.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -107.98 -38.75 5.72 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 123.762 0.825 . . . . 0.0 109.185 -171.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 8.2 ttp -61.7 -42.75 99.36 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.245 1.018 . . . . 0.0 112.571 -160.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -92.72 -23.53 18.89 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 124.586 1.154 . . . . 0.0 111.861 175.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -81.39 -52.14 7.59 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -169.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -46.89 -34.8 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 127.182 2.193 . . . . 0.0 112.637 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 11.7 mtm180 -60.68 -32.6 71.81 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 123.595 0.758 . . . . 0.0 111.834 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.8 60.31 0.93 Allowed 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 127.008 2.123 . . . . 0.0 105.624 -178.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.259 1.59 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -174.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.5 p90 . . . . . 0 C--O 1.237 0.4 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -129.48 175.75 8.52 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 157.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.5 mt -125.41 157.54 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 163.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.1 m -117.34 -143.13 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 168.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -47.33 -66.44 0.41 Allowed 'General case' 0 C--O 1.234 0.268 0 C-N-CA 127.058 2.143 . . . . 0.0 112.134 -175.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -141.93 12.15 2.03 Favored 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 123.711 0.804 . . . . 0.0 112.574 170.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 20.5 t -105.77 139.07 28.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.9 t -90.72 149.87 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.239 1.016 . . . . 0.0 108.307 174.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.7 mp -129.88 107.81 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 176.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.49 158.43 24.51 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 120.57 1.532 . . . . 0.0 108.586 170.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 38.8 mtt -133.49 86.14 41.16 Favored Pre-proline 0 N--CA 1.465 0.296 0 C-N-CA 124.951 1.3 . . . . 0.0 107.941 -175.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -65.12 93.0 0.22 Allowed 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.372 2.714 . . . . 0.0 109.967 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -74.05 52.79 0.46 Allowed 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 125.639 1.576 . . . . 0.0 109.679 165.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.85 -2.01 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 130.048 3.339 . . . . 0.0 117.769 173.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -71.84 33.32 0.06 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 128.998 2.919 . . . . 0.0 112.485 176.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.8 mt -84.46 59.7 5.59 Favored 'General case' 0 N--CA 1.457 -0.121 0 O-C-N 120.355 -1.466 . . . . 0.0 108.098 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -73.31 172.35 11.36 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.979 1.712 . . . . 0.0 109.724 169.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.7 mt -71.98 -39.21 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 O-C-N 121.472 -0.767 . . . . 0.0 110.609 -177.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -63.97 -33.81 76.58 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 118.48 0.582 . . . . 0.0 110.117 -170.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -78.47 -21.71 48.64 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 125.267 1.427 . . . . 0.0 111.688 175.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.99 -55.9 6.6 Favored 'General case' 0 CA--C 1.521 -0.17 0 O-C-N 120.639 -1.288 . . . . 0.0 112.294 -171.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -67.11 -30.71 70.8 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 118.717 -1.193 . . . . 0.0 110.191 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.48 -23.36 60.06 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 117.785 -1.102 . . . . 0.0 110.308 176.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -49.87 -41.97 46.6 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.296 1.438 . . . . 0.0 111.295 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -58.79 -63.74 1.18 Allowed 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 172.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -44.79 -50.95 9.9 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.865 2.066 . . . . 0.0 111.447 -177.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -61.78 -65.44 0.69 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 117.304 -1.332 . . . . 0.0 109.959 177.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.7 t -53.1 -34.21 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 120.365 1.439 . . . . 0.0 111.416 -176.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -60.75 -69.43 0.23 Allowed 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 124.41 1.084 . . . . 0.0 109.115 174.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -62.81 -39.84 95.53 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.312 0.645 . . . . 0.0 112.538 -173.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -70.55 -31.42 68.46 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.793 1.237 . . . . 0.0 110.858 -175.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -137.71 -58.59 0.67 Allowed 'General case' 0 C--N 1.343 0.298 0 CA-C-N 119.021 0.828 . . . . 0.0 112.238 -171.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 43.7 mt -59.95 -53.04 62.48 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 120.54 -1.35 . . . . 0.0 111.303 -171.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -69.49 -15.65 63.3 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.553 1.941 . . . . 0.0 111.177 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -74.49 -28.89 61.21 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 118.292 -0.861 . . . . 0.0 111.068 168.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.71 1.82 8.17 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.756 1.646 . . . . 0.0 114.235 -177.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -72.83 159.8 33.17 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 120.066 1.933 . . . . 0.0 110.71 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -139.22 -8.29 1.32 Allowed 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 126.349 1.86 . . . . 0.0 111.423 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -129.25 129.25 44.72 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.029 0.931 . . . . 0.0 109.325 -175.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.5 mt -138.39 155.39 28.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 126.706 2.002 . . . . 0.0 106.433 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -134.43 156.96 47.64 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 125.708 1.603 . . . . 0.0 111.459 166.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 46.5 tp -125.97 114.94 19.14 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 117.289 -1.339 . . . . 0.0 108.584 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.7 t -92.85 119.0 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 121.137 1.789 . . . . 0.0 109.206 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.4 mp -90.78 1.38 56.95 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -173.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 73.4 p -51.26 -44.28 61.73 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.636 1.974 . . . . 0.0 114.242 -171.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -68.88 -27.86 66.18 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 120.942 -1.099 . . . . 0.0 111.098 -175.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -95.13 150.86 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 125.344 1.458 . . . . 0.0 109.103 -165.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -70.2 -59.65 2.76 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 158.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.3 t -164.33 176.83 8.75 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 122.699 1.238 . . . . 0.0 110.677 -168.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.0 tt -109.12 177.95 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 128.288 2.635 . . . . 0.0 107.666 172.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -118.88 173.88 6.62 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.247 0.931 . . . . 0.0 110.381 171.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.8 t -50.5 -41.23 53.17 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 126.583 1.953 . . . . 0.0 111.428 -175.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -65.14 -58.7 5.34 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 118.154 -0.927 . . . . 0.0 111.008 -171.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 66.0 m -69.75 -36.72 76.06 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 120.293 1.406 . . . . 0.0 113.012 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 39.8 tp -49.39 -43.48 44.36 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.867 1.667 . . . . 0.0 112.599 -172.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -94.98 11.41 69.55 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 120.739 -0.743 . . . . 0.0 113.797 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.6 t -85.03 -39.69 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 118.376 1.088 . . . . 0.0 108.44 153.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.4 mm -56.19 -62.76 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 119.454 1.024 . . . . 0.0 109.68 -177.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 9.8 p -37.13 -49.83 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 124.908 1.283 . . . . 0.0 114.289 165.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -60.61 -42.37 96.67 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 123.598 0.759 . . . . 0.0 109.306 -167.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 75.4 mt -55.85 -41.32 66.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.459 1.104 . . . . 0.0 108.221 176.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -58.89 -51.81 68.44 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 124.074 0.95 . . . . 0.0 110.13 177.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -56.57 -45.18 81.44 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 122.882 0.473 . . . . 0.0 110.331 -175.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -46.94 87.67 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 123.013 0.525 . . . . 0.0 110.711 175.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.6 mt -63.77 -41.24 91.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 123.702 0.801 . . . . 0.0 110.652 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.3 m -58.86 -51.11 71.42 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.713 1.205 . . . . 0.0 110.961 173.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.3 m -63.78 -26.53 68.67 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 176.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.9 m -74.24 -51.59 14.9 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.773 0.829 . . . . 0.0 110.967 174.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.74 37.49 0.62 Allowed Glycine 0 CA--C 1.529 0.965 0 CA-C-O 118.699 -1.056 . . . . 0.0 113.662 -165.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -133.76 -168.7 11.9 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 119.755 1.778 . . . . 0.0 111.602 177.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -142.94 119.48 11.03 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.086 1.754 . . . . 0.0 110.111 -171.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -122.77 146.12 47.8 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.173 0.897 . . . . 0.0 109.143 172.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -152.72 173.35 15.38 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.342 1.057 . . . . 0.0 111.581 -176.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.5 mt -120.36 164.6 16.1 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.833 0.853 . . . . 0.0 109.527 -176.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 55.7 t -140.87 147.19 22.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 124.164 0.986 . . . . 0.0 109.468 -175.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 52.98 57.87 14.46 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.991 1.316 . . . . 0.0 111.332 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -77.15 81.69 2.55 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.202 2.601 . . . . 0.0 110.303 177.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.65 143.82 19.32 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.085 0.554 . . . . 0.0 109.668 172.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -54.77 -36.25 64.67 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.983 1.313 . . . . 0.0 113.643 -156.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.3 -41.17 62.69 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.155 0.982 . . . . 0.0 109.204 178.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -81.2 -29.67 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 118.67 0.668 . . . . 0.0 109.676 -173.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -62.81 -26.87 68.95 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.172 0.896 . . . . 0.0 110.801 172.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.75 -44.16 93.94 Favored 'General case' 0 C--N 1.344 0.33 0 O-C-N 121.465 -0.772 . . . . 0.0 109.47 175.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.9 p -86.3 -43.6 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 -168.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.4 -24.68 60.71 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.674 1.19 . . . . 0.0 111.296 177.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 26.3 t -77.42 -52.79 8.54 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 120.271 1.396 . . . . 0.0 108.712 172.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 52.0 mt -58.26 -51.46 69.69 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.942 1.297 . . . . 0.0 111.76 -172.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.5 t -73.79 -5.29 39.96 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.383 0.538 . . . . 0.0 111.197 -178.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 64.24 76.69 0.34 Allowed 'General case' 0 C--N 1.342 0.263 0 C-N-CA 126.832 2.053 . . . . 0.0 107.583 -174.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.84 -51.86 1.45 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.751 1.22 . . . . 0.0 109.501 -171.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.59 -25.54 66.3 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 122.995 1.378 . . . . 0.0 111.436 172.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 4.7 mtm180 -75.28 -8.34 56.38 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.505 1.122 . . . . 0.0 111.34 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.9 mt -130.47 -34.74 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 125.07 1.348 . . . . 0.0 109.006 -165.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.5 t -112.68 149.14 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 126.339 1.856 . . . . 0.0 108.159 175.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.93 160.97 30.63 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.688 0.795 . . . . 0.0 110.782 172.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -146.67 144.36 20.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -176.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -148.18 174.02 12.39 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.017 1.327 . . . . 0.0 112.437 -172.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.75 -44.48 9.43 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.751 0.821 . . . . 0.0 111.526 -177.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 71.1 p -126.43 168.43 14.22 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.811 1.244 . . . . 0.0 109.063 -176.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 9.0 mm -62.66 -39.89 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 167.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.3 t -70.66 -36.28 73.28 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 119.502 1.046 . . . . 0.0 110.155 -171.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -69.14 -5.65 23.7 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 118.324 -0.846 . . . . 0.0 112.225 174.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -104.42 -44.55 4.9 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 174.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 10.0 ttm -56.7 -51.83 67.27 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 125.377 1.471 . . . . 0.0 112.593 -163.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -104.8 13.75 30.76 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 126.322 1.849 . . . . 0.0 110.933 -176.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -112.98 -58.13 2.2 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.607 1.563 . . . . 0.0 109.309 -177.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -48.75 -39.03 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.071 0 C-N-CA 126.736 2.015 . . . . 0.0 110.501 177.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 12.0 mtm180 -56.5 -30.42 62.97 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 122.692 0.397 . . . . 0.0 110.668 -176.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.71 38.69 1.36 Allowed 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.745 1.218 . . . . 0.0 111.366 -174.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.875 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 167.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 11.7 p90 . . . . . 0 CA--C 1.539 0.544 0 CA-C-O 120.386 0.136 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.9 173.7 9.39 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.481 1.112 . . . . 0.0 110.209 164.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.434 ' CD1' HG22 ' A' ' 23' ' ' VAL . 9.5 mm -121.82 135.47 61.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 169.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.5 m -115.88 -169.19 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 C-N-CA 126.185 1.794 . . . . 0.0 108.051 168.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -24.08 -61.14 0.05 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 129.397 3.079 . . . . 0.0 113.823 -170.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -145.62 19.91 1.5 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.874 0.369 . . . . 0.0 111.707 161.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.4 t -110.11 136.23 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 O-C-N 120.837 -1.165 . . . . 0.0 109.192 -175.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.434 HG22 ' CD1' ' A' ' 18' ' ' ILE . 66.0 t -85.32 125.31 40.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 106.862 -1.532 . . . . 0.0 106.862 172.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.7 mm -103.5 104.2 16.31 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 173.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 25.2 mt -78.24 123.1 26.55 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 172.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 32.9 mtt -125.34 75.94 68.61 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 124.404 1.082 . . . . 0.0 109.295 -168.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -67.0 140.49 54.71 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.298 1.998 . . . . 0.0 110.875 -177.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -130.25 66.43 1.5 Allowed 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 128.731 2.812 . . . . 0.0 109.521 171.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.23 7.33 6.18 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.956 2.102 . . . . 0.0 113.567 167.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.19 -3.34 26.06 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.217 1.807 . . . . 0.0 114.435 -177.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.6 mt -70.19 31.92 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 128.932 2.893 . . . . 0.0 115.483 -159.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -62.35 151.29 37.2 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 128.641 2.776 . . . . 0.0 112.603 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.7 mt -53.43 -40.31 40.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 124.24 1.016 . . . . 0.0 112.183 -177.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -65.83 -30.47 71.09 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.364 0.666 . . . . 0.0 110.086 -172.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.34 -28.43 14.97 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.27 -34.82 74.28 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 117.924 -1.036 . . . . 0.0 111.831 -176.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -59.71 -64.22 1.02 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 119.569 1.077 . . . . 0.0 109.606 174.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.254 0.0 OUTLIER -74.93 -8.21 55.82 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-O 117.989 -1.005 . . . . 0.0 112.858 -172.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -41.65 -42.73 2.59 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.709 2.004 . . . . 0.0 111.993 172.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -53.55 -68.73 0.15 Allowed 'General case' 0 C--N 1.343 0.298 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 170.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -52.62 -42.49 64.64 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 125.54 1.536 . . . . 0.0 111.806 -174.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 15.0 t90 -55.78 -60.63 3.18 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.834 0.854 . . . . 0.0 109.533 172.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 53.9 t -56.37 -35.91 45.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 119.927 1.24 . . . . 0.0 111.716 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -70.06 -37.64 75.57 Favored 'General case' 0 N--CA 1.441 -0.903 0 O-C-N 121.309 -0.87 . . . . 0.0 111.048 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -105.39 -9.2 17.7 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.008 1.323 . . . . 0.0 112.308 -167.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -99.35 -20.24 16.61 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.916 1.234 . . . . 0.0 112.135 165.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -135.67 -49.49 0.71 Allowed 'General case' 0 C--N 1.349 0.577 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -174.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 35.2 mt -67.93 -44.45 76.84 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 120.041 1.291 . . . . 0.0 112.314 -169.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -69.34 -24.56 63.92 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.462 0.705 . . . . 0.0 111.845 173.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.7 mttt -66.26 -6.83 15.16 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.944 1.298 . . . . 0.0 112.676 164.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.3 21.88 72.01 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-O 118.945 -0.92 . . . . 0.0 112.589 178.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -73.08 143.03 47.57 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 119.7 1.75 . . . . 0.0 107.597 163.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -127.82 0.89 6.04 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.601 1.56 . . . . 0.0 112.754 177.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.36 124.59 43.29 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 172.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.3 mt -125.13 147.19 29.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 128.448 2.699 . . . . 0.0 104.362 174.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 18.7 m-30 -126.59 158.29 36.63 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.259 1.423 . . . . 0.0 110.475 166.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 29.5 tp -126.85 111.81 14.61 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 172.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 79.6 t -78.65 135.01 26.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 170.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 mp -117.35 20.02 13.81 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.197 0.999 . . . . 0.0 111.694 176.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.63 -51.5 67.02 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.576 1.151 . . . . 0.0 112.806 172.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -86.83 -9.75 55.08 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.127 -0.983 . . . . 0.0 111.72 -164.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.6 p -108.16 155.01 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 127.212 2.205 . . . . 0.0 108.773 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -101.68 -46.73 4.85 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.792 0.837 . . . . 0.0 109.01 172.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.1 p -155.36 170.58 21.58 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 123.767 1.746 . . . . 0.0 112.643 -166.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.4 tt -137.72 177.52 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 C-N-CA 129.242 3.017 . . . . 0.0 105.592 -176.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -131.28 170.53 14.48 Favored 'General case' 0 C--O 1.238 0.486 0 O-C-N 121.471 -0.768 . . . . 0.0 110.696 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.3 m -67.5 50.63 0.05 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 128.548 2.739 . . . . 0.0 110.994 167.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -133.0 -72.73 0.51 Allowed 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 103.986 -2.598 . . . . 0.0 103.986 155.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 m -65.9 -27.34 68.12 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 124.393 1.077 . . . . 0.0 111.92 -167.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.8 mt -51.36 -35.06 36.83 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.218 1.007 . . . . 0.0 112.54 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -72.07 -34.17 61.84 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.1 t -75.54 -34.15 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 O-C-N 121.526 -0.985 . . . . 0.0 110.402 -173.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.2 mp -55.89 -45.77 80.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 170.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.7 t -63.78 -45.99 95.69 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 O-C-N 121.048 -1.033 . . . . 0.0 110.04 175.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -50.24 -39.7 45.45 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.883 1.22 . . . . 0.0 113.247 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 65.6 mt -60.88 -47.81 91.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.203 1.001 . . . . 0.0 109.715 174.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -59.57 -47.09 86.91 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.7 mttt -56.69 -46.32 81.26 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 119.063 -0.494 . . . . 0.0 110.675 -175.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.8 t -54.39 -58.41 7.55 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 174.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 81.5 mt -55.58 -48.18 77.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.619 1.167 . . . . 0.0 111.628 -174.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.5 m -69.01 -14.38 63.01 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 117.651 -1.166 . . . . 0.0 112.947 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 51.3 m -87.42 -45.07 10.86 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.474 1.034 . . . . 0.0 110.506 163.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.8 m -66.19 -17.63 64.85 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 126.112 1.765 . . . . 0.0 115.014 -175.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.94 0.2 9.81 Favored Glycine 0 C--N 1.336 0.552 0 CA-C-O 118.116 -1.38 . . . . 0.0 116.307 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -115.85 -165.31 14.36 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-N 119.859 1.829 . . . . 0.0 113.699 -163.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.403 ' HB3' ' CG2' ' A' ' 122' ' ' VAL . 1.0 OUTLIER -131.61 154.41 48.91 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.888 1.675 . . . . 0.0 108.852 173.202 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -123.76 141.48 51.99 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 168.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -144.38 167.18 23.09 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 119.468 -0.893 . . . . 0.0 112.163 167.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.4 mt -120.86 160.05 24.23 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -175.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 26.4 t -134.28 138.34 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -171.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.7 m 58.45 60.23 5.7 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 125.034 1.334 . . . . 0.0 111.952 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -82.74 101.02 1.01 Allowed 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.171 2.581 . . . . 0.0 110.001 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -65.72 170.54 5.12 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.896 1.278 . . . . 0.0 108.899 175.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -72.2 -30.04 64.55 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.167 -0.958 . . . . 0.0 111.449 -175.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.407 ' HE3' ' O ' ' A' ' 95' ' ' LYS . 0.2 OUTLIER -58.42 -45.95 87.43 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 120.804 -1.185 . . . . 0.0 108.896 176.934 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 31.3 m -79.07 -37.24 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.856 0 CA-C-O 117.355 -1.307 . . . . 0.0 111.261 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -56.36 -30.65 62.93 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 121.292 1.86 . . . . 0.0 109.329 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.62 -38.41 90.12 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.689 177.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.4 p -95.81 -28.41 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -170.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.17 -15.37 63.08 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 124.973 1.309 . . . . 0.0 110.231 177.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.52 -55.28 4.97 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 120.05 1.295 . . . . 0.0 107.881 168.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.28 -43.26 86.9 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.966 2.106 . . . . 0.0 112.191 -163.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.1 t -76.45 -6.34 51.31 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.563 0.745 . . . . 0.0 110.964 177.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.7 m120 52.63 83.56 0.06 Allowed 'General case' 0 C--N 1.346 0.425 0 C-N-CA 129.376 3.071 . . . . 0.0 107.875 -163.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.95 -72.96 0.68 Allowed 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 176.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -61.74 -24.47 66.83 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.77 1.228 . . . . 0.0 110.728 174.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -75.15 5.9 4.89 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 120.777 -1.202 . . . . 0.0 111.313 176.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.9 mt -129.45 -43.39 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 C-N-CA 127.795 2.438 . . . . 0.0 107.829 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.3 m -98.25 178.69 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 C-N-CA 127.066 2.146 . . . . 0.0 113.137 -172.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 24.7 mmtm -99.58 162.95 12.71 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 124.099 0.96 . . . . 0.0 110.086 170.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -151.18 136.47 10.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -171.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -145.03 167.1 23.47 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.41 1.084 . . . . 0.0 112.668 -169.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.14 -38.64 17.53 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.876 -0.515 . . . . 0.0 111.183 -174.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.1 p -134.64 177.21 7.96 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 15.1 mm -71.19 -40.56 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.278 174.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.4 t -70.3 -32.63 70.49 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 119.424 1.011 . . . . 0.0 110.143 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -70.7 0.57 6.76 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.617 172.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.39 -37.04 3.83 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 119.259 0.936 . . . . 0.0 109.523 175.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 20.7 ttm -63.67 -55.27 24.77 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.984 1.314 . . . . 0.0 111.788 -160.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -81.61 -18.79 43.52 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.064 0.459 . . . . 0.0 110.265 173.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -80.33 -49.02 12.09 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -162.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.403 ' CG2' ' HB3' ' A' ' 86' ' ' PHE . 4.1 p -42.26 -40.48 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 127.856 2.462 . . . . 0.0 111.461 174.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -58.01 -45.83 86.25 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 125.106 1.362 . . . . 0.0 113.423 177.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.09 34.62 3.08 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.364 1.866 . . . . 0.0 110.778 -166.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.847 0 C-N-CA 127.076 2.151 . . . . 0.0 111.67 -176.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 20.8 p90 . . . . . 0 N--CA 1.445 -0.723 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -127.62 176.74 7.28 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 120.791 -1.193 . . . . 0.0 108.451 164.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.9 mt -132.32 120.13 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 171.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.6 m -102.33 -175.93 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 166.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -26.74 -55.95 0.08 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 130.199 3.4 . . . . 0.0 113.95 -157.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -143.5 8.97 1.58 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 118.775 -0.631 . . . . 0.0 111.241 164.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.32 115.62 50.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 -172.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 38.9 t -68.3 156.4 7.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 173.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.7 mm -130.6 98.4 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 177.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.53 134.49 45.28 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 120.24 1.382 . . . . 0.0 108.25 168.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 51.6 mtm -128.83 72.7 81.53 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 123.644 0.778 . . . . 0.0 109.551 -177.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.59 145.3 57.73 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.31 2.674 . . . . 0.0 112.577 -176.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.418 ' HB2' ' HE3' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -118.87 -77.8 0.58 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 126.056 1.742 . . . . 0.0 110.452 174.689 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.418 ' HE3' ' HB2' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -135.56 13.85 3.45 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.001 1.321 . . . . 0.0 111.07 -173.571 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -108.78 18.42 20.8 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 120.967 -1.083 . . . . 0.0 112.103 -162.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 19.8 mt -92.62 68.06 4.68 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 124.146 0.978 . . . . 0.0 109.087 -176.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -81.23 144.24 31.73 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.2 tt -52.83 -37.19 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 CA-C-N 119.006 0.821 . . . . 0.0 111.82 170.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -62.62 -52.73 62.2 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.49 -0.756 . . . . 0.0 109.71 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -76.01 -16.38 59.97 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-O 118.228 -0.892 . . . . 0.0 111.96 177.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.73 -40.8 88.5 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.909 1.231 . . . . 0.0 110.518 171.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -60.6 -39.03 86.63 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 120.433 -1.417 . . . . 0.0 109.575 174.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 90.1 mt -73.04 -23.55 60.6 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.783 1.233 . . . . 0.0 113.05 178.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -53.98 -37.67 64.22 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.175 1.39 . . . . 0.0 110.97 -170.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.427 ' HE2' ' CZ ' ' A' ' 44' ' ' PHE . 0.4 OUTLIER -63.35 -52.49 61.53 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.072 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.89 -47.96 73.64 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 124.815 1.246 . . . . 0.0 109.834 178.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 17.6 t90 -58.57 -69.74 0.17 Allowed 'General case' 0 C--O 1.219 -0.549 0 O-C-N 124.593 1.183 . . . . 0.0 109.79 176.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.0 t -52.89 -32.21 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 121.153 1.797 . . . . 0.0 111.549 -175.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.427 ' CZ ' ' HE2' ' A' ' 40' ' ' LYS . 4.0 m-85 -61.43 -77.15 0.05 OUTLIER 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 123.612 0.765 . . . . 0.0 110.051 172.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.404 ' HA ' ' HB2' ' A' ' 49' ' ' ASN . 0.6 OUTLIER -64.95 -28.47 69.54 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -172.183 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.9 -30.06 61.17 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.347 1.459 . . . . 0.0 110.445 176.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -139.83 -66.71 0.45 Allowed 'General case' 0 C--N 1.348 0.508 0 CA-C-N 119.603 1.092 . . . . 0.0 111.609 -172.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.403 ' HB2' ' HA ' ' A' ' 44' ' ' PHE . 18.5 mt -57.37 -54.35 47.78 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 120.878 -1.139 . . . . 0.0 113.081 -169.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.404 ' HB2' ' HA ' ' A' ' 45' ' ' ASP . 78.4 m-20 -67.48 -34.63 77.56 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 125.864 1.665 . . . . 0.0 109.127 177.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.12 -39.07 71.65 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.106 1.362 . . . . 0.0 111.279 176.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 139.65 8.51 0.94 Allowed Glycine 0 CA--C 1.535 1.334 0 C-N-CA 125.123 1.344 . . . . 0.0 113.93 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -92.34 150.3 20.92 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 119.023 1.412 . . . . 0.0 111.392 -177.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -143.22 44.79 1.55 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.287 1.835 . . . . 0.0 108.247 -172.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 171.59 149.84 0.05 OUTLIER 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 126.015 1.726 . . . . 0.0 107.829 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -153.34 163.0 2.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 105.342 -2.095 . . . . 0.0 105.342 -174.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -136.29 148.88 48.18 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.45 1.5 . . . . 0.0 108.615 169.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 50.5 tp -124.27 110.56 14.77 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.251 1.021 . . . . 0.0 109.808 177.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.3 135.57 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 173.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 mp -123.65 43.25 3.02 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.953 0.882 . . . . 0.0 110.288 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.8 t -99.98 -49.58 4.27 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.945 0.898 . . . . 0.0 109.029 -176.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.82 -14.45 58.04 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.126 -0.984 . . . . 0.0 111.159 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.7 p -106.0 118.71 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 125.596 1.559 . . . . 0.0 107.232 174.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -68.83 -51.63 38.6 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 176.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 86.2 p -157.76 166.62 32.27 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.86 -169.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 21.3 tt -135.49 148.99 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 C-N-CA 124.882 1.273 . . . . 0.0 108.333 -168.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -71.49 155.24 40.81 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.2 p -63.97 -14.35 53.24 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 117.902 -1.047 . . . . 0.0 113.77 -174.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -68.53 -71.37 0.22 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.036 1.334 . . . . 0.0 108.934 172.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 41.0 t -63.0 -34.1 76.84 Favored 'General case' 0 C--N 1.339 0.136 0 O-C-N 121.911 -0.493 . . . . 0.0 111.029 -169.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 50.9 tp -40.66 -39.86 1.16 Allowed 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 125.595 1.558 . . . . 0.0 114.041 169.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -107.54 0.25 34.63 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 118.44 0.564 . . . . 0.0 113.246 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.0 t -75.28 -30.05 22.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 O-C-N 120.774 -1.427 . . . . 0.0 108.647 161.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.6 mt -66.87 -61.15 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 125.181 1.392 . . . . 0.0 112.542 175.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.4 p -41.77 -49.19 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 168.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -45.79 -36.79 5.42 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.567 1.547 . . . . 0.0 112.863 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 90.8 mt -64.52 -46.87 91.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.295 1.038 . . . . 0.0 108.558 175.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -52.9 -48.6 67.08 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.635 0.774 . . . . 0.0 109.728 176.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -56.49 -43.03 79.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 118.955 -0.545 . . . . 0.0 111.067 -174.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.0 m -57.7 -64.79 0.78 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 118.883 -0.58 . . . . 0.0 111.352 166.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 51.1 mt -61.52 -42.71 95.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 119.303 0.956 . . . . 0.0 111.502 -166.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.4 m -57.07 -47.55 80.71 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 119.323 0.965 . . . . 0.0 110.179 175.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.5 m -63.54 -34.28 77.44 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.975 0.807 . . . . 0.0 111.689 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 56.6 m -67.57 -38.08 83.56 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 118.604 -0.712 . . . . 0.0 111.941 173.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 105.03 59.37 0.66 Allowed Glycine 0 N--CA 1.448 -0.52 0 CA-C-O 119.162 -0.799 . . . . 0.0 111.136 -166.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -148.68 -176.45 22.07 Favored Glycine 0 N--CA 1.439 -1.149 0 CA-C-N 118.891 1.345 . . . . 0.0 111.553 177.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -130.9 92.13 3.17 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 122.084 -0.656 . . . . 0.0 112.439 -158.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -104.76 134.75 47.38 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.839 -1.163 . . . . 0.0 110.545 174.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -142.48 167.43 22.11 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.623 1.569 . . . . 0.0 112.472 175.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.1 mp -113.9 153.13 29.75 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 127.54 2.336 . . . . 0.0 108.299 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 72.8 t -141.09 135.35 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -166.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.7 t 48.46 56.14 17.66 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.691 1.196 . . . . 0.0 110.645 -170.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -72.42 0.09 7.97 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.304 2.669 . . . . 0.0 114.777 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 18.6 p30 47.63 -163.04 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.733 1.613 . . . . 0.0 112.662 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -95.91 -41.54 8.75 Favored 'General case' 0 C--O 1.225 -0.196 0 O-C-N 120.473 -1.392 . . . . 0.0 109.416 174.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.459 ' O ' ' HE3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -53.74 -50.84 65.1 Favored 'General case' 0 C--O 1.227 -0.126 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -175.548 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.3 t -68.84 -47.52 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-O 118.571 -0.728 . . . . 0.0 109.143 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -60.95 -19.74 61.33 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 120.513 1.506 . . . . 0.0 112.273 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.5 -15.52 63.27 Favored 'General case' 0 C--O 1.216 -0.664 0 O-C-N 120.785 -1.197 . . . . 0.0 111.081 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -118.59 -34.13 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 C-N-CA 125.822 1.649 . . . . 0.0 108.25 -175.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.45 -14.84 31.85 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 117.617 -1.182 . . . . 0.0 109.08 175.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.8 m -79.69 -29.66 40.83 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 117.907 -1.517 . . . . 0.0 109.813 174.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -92.05 -25.33 18.84 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 129.103 2.961 . . . . 0.0 111.421 -159.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.7 t -113.65 35.44 4.05 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.858 1.663 . . . . 0.0 108.296 174.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 35.21 62.38 0.57 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.524 1.93 . . . . 0.0 110.585 176.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.54 -51.47 2.75 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -166.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.5 -24.49 67.84 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 118.616 0.644 . . . . 0.0 111.308 173.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.6 mtt-85 -80.03 -11.25 59.79 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 118.476 -0.773 . . . . 0.0 112.97 -177.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.0 mt -128.1 -37.13 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 C-N-CA 124.49 1.116 . . . . 0.0 109.577 -167.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.6 t -104.26 141.01 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 171.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.52 158.98 34.17 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.882 1.273 . . . . 0.0 111.295 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.1 mp -130.98 146.36 34.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 124.878 1.271 . . . . 0.0 108.077 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -147.02 168.13 22.3 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 127.286 2.234 . . . . 0.0 109.849 175.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.53 -51.77 7.48 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 75.4 p -130.81 171.6 12.95 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 123.165 0.586 . . . . 0.0 109.715 -171.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 11.8 mm -66.49 -39.3 83.64 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 CA-C-O 118.074 -0.965 . . . . 0.0 108.837 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.2 t -67.27 -36.99 82.72 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 118.862 0.756 . . . . 0.0 109.771 -175.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -62.22 -9.31 7.42 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 124.321 1.049 . . . . 0.0 112.256 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.79 -34.45 4.47 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 124.676 1.19 . . . . 0.0 109.636 -175.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 12.4 ttp -61.8 -46.18 90.67 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 120.593 -1.317 . . . . 0.0 112.549 -161.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -101.52 -2.63 30.18 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.66 1.984 . . . . 0.0 112.112 176.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -91.49 -62.6 1.4 Allowed 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -42.43 -37.4 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.307 0 C-N-CA 127.534 2.334 . . . . 0.0 111.553 174.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -44.02 -35.45 2.1 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 125.446 1.498 . . . . 0.0 113.32 174.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.09 22.96 2.23 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 172.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.306 0.1 OUTLIER . . . . . 0 C--O 1.249 1.076 0 C-N-CA 129.436 3.094 . . . . 0.0 116.08 -162.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.1 p90 . . . . . 0 N--CA 1.45 -0.444 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.408 ' HE2' ' CG1' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -135.01 175.31 9.69 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 121.978 -0.451 . . . . 0.0 110.192 168.21 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 67.4 mt -130.45 119.24 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 126.303 1.841 . . . . 0.0 106.944 175.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.408 ' CG1' ' HE2' ' A' ' 17' ' ' LYS . 33.7 m -100.59 -154.35 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 127.529 2.331 . . . . 0.0 106.792 174.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -25.94 -77.41 0.01 OUTLIER 'General case' 0 C--O 1.241 0.658 0 C-N-CA 129.805 3.242 . . . . 0.0 111.467 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -148.21 28.07 0.92 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 127.961 2.504 . . . . 0.0 109.828 170.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 20.2 t -119.68 148.03 22.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.7 t -103.7 140.29 22.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 177.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.8 mp -118.22 101.54 11.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 177.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.32 146.55 45.18 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 120.416 1.462 . . . . 0.0 108.453 165.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 69.7 mtm -127.98 79.58 73.54 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 124.63 1.172 . . . . 0.0 108.267 178.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -58.05 135.66 70.02 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.813 2.342 . . . . 0.0 110.636 177.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.22 -105.36 0.22 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.339 1.856 . . . . 0.0 106.312 169.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.92 69.4 1.04 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 121.551 1.978 . . . . 0.0 111.247 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -154.9 4.93 0.23 Allowed 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 115.505 1.668 . . . . 0.0 115.505 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.01 37.63 0.55 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 120.576 1.535 . . . . 0.0 109.988 172.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -77.74 157.4 30.06 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.771 1.629 . . . . 0.0 109.599 171.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 61.1 mt -62.15 -35.82 71.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 123.938 0.895 . . . . 0.0 110.704 -174.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -73.33 -8.86 57.67 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.11 -0.994 . . . . 0.0 111.402 -177.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -113.54 28.83 8.47 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.343 1.857 . . . . 0.0 109.754 171.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.68 -54.51 2.6 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 120.733 -1.229 . . . . 0.0 111.7 -175.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 40.7 t60 -62.07 -52.24 64.73 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 120.623 1.556 . . . . 0.0 109.759 175.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.89 -24.73 64.52 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-O 118.748 -0.644 . . . . 0.0 111.167 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -51.86 -44.76 63.81 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 124.88 1.272 . . . . 0.0 110.625 -177.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -64.68 -44.71 89.46 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.82 -41.45 97.87 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 119.038 0.836 . . . . 0.0 112.205 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 15.6 t90 -58.81 -66.28 0.52 Allowed 'General case' 0 C--O 1.221 -0.401 0 CA-C-O 117.23 -1.367 . . . . 0.0 107.479 173.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.5 t -52.93 -36.11 23.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 120.585 1.539 . . . . 0.0 112.193 -177.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -57.76 -67.0 0.38 Allowed 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 124.04 0.936 . . . . 0.0 110.028 173.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.29 -45.43 66.34 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 121.441 -0.787 . . . . 0.0 111.684 -171.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -62.42 -28.75 70.01 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.939 1.696 . . . . 0.0 111.006 -175.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -136.69 -65.85 0.55 Allowed 'General case' 0 C--N 1.346 0.432 0 C-N-CA 123.19 0.596 . . . . 0.0 111.53 -172.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 44.3 mt -55.58 -53.68 53.5 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.147 0.885 . . . . 0.0 111.822 -168.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -71.5 -34.26 69.96 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.513 1.925 . . . . 0.0 109.834 176.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.03 -30.16 65.92 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 118.242 -0.885 . . . . 0.0 112.021 177.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 140.26 -0.49 2.03 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 119.25 -0.75 . . . . 0.0 113.805 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -92.51 154.81 18.23 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 119.803 1.801 . . . . 0.0 110.347 -174.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -134.85 6.72 3.44 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.806 1.242 . . . . 0.0 109.816 172.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.86 132.21 36.29 Favored 'General case' 0 CA--C 1.518 -0.288 0 O-C-N 120.583 -1.323 . . . . 0.0 107.769 -176.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.9 mt -135.71 154.02 33.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 126.094 1.758 . . . . 0.0 106.422 175.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -129.54 152.71 48.78 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.725 1.61 . . . . 0.0 109.702 163.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 54.8 tp -118.97 112.35 19.49 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 118.149 -0.929 . . . . 0.0 110.069 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.2 t -90.72 111.18 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 119.175 0.898 . . . . 0.0 109.474 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.8 mp -91.64 5.23 50.48 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.425 0.69 . . . . 0.0 112.514 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 24.3 m -51.59 -42.13 61.69 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.094 0.958 . . . . 0.0 113.221 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -85.23 -29.26 24.8 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.766 0.712 . . . . 0.0 111.09 -174.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.8 p -80.82 173.1 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 O-C-N 121.34 -0.85 . . . . 0.0 109.158 -173.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -121.56 -46.14 2.27 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 120.588 -1.32 . . . . 0.0 109.31 172.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.9 p -150.1 172.63 14.97 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.537 0.684 . . . . 0.0 112.402 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.3 tt -133.48 153.18 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 126.072 1.749 . . . . 0.0 107.323 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -85.16 162.5 19.2 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 122.579 0.352 . . . . 0.0 110.206 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.2 -36.79 66.31 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.598 0.759 . . . . 0.0 111.903 179.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -55.57 -72.93 0.06 Allowed 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.049 1.74 . . . . 0.0 109.59 -178.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 53.5 m -64.27 -30.86 71.9 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 118.249 -0.881 . . . . 0.0 112.662 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.3 tp -59.39 -16.89 25.89 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 120.521 1.509 . . . . 0.0 112.769 -177.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -90.73 -33.97 8.1 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 118.995 0.816 . . . . 0.0 112.843 167.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.6 t -64.2 -36.84 78.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 O-C-N 121.149 -1.206 . . . . 0.0 110.363 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp -52.72 -51.38 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 175.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.4 t -66.02 -35.74 75.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 O-C-N 120.95 -1.094 . . . . 0.0 110.268 177.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.69 -45.05 82.02 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 119.662 1.119 . . . . 0.0 111.268 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 71.7 mt -59.45 -33.72 52.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 123.438 0.695 . . . . 0.0 109.21 175.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -69.8 -44.9 69.1 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 120.269 1.395 . . . . 0.0 108.44 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 48.7 mttm -58.87 -47.31 85.37 Favored 'General case' 0 C--N 1.335 -0.025 0 CA-C-O 118.584 -0.722 . . . . 0.0 110.151 177.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 31.8 m -51.45 -59.55 4.12 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 123.684 0.794 . . . . 0.0 110.272 172.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 21.1 mt -53.96 -43.76 59.28 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 C-N-CA 124.278 1.031 . . . . 0.0 111.406 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 51.6 p -57.35 -48.77 78.14 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.207 0.912 . . . . 0.0 109.974 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.5 -33.87 76.66 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.762 1.625 . . . . 0.0 111.304 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.4 m -67.76 -16.58 64.19 Favored 'General case' 0 C--N 1.335 -0.056 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 170.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.86 1.09 61.79 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-N 119.196 0.907 . . . . 0.0 113.664 -172.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -92.65 -175.99 41.46 Favored Glycine 0 N--CA 1.432 -1.608 0 CA-C-N 118.892 1.346 . . . . 0.0 112.193 -175.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -136.09 155.92 49.48 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.537 1.535 . . . . 0.0 109.517 178.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -152.39 147.17 25.97 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 175.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -148.04 161.04 42.18 Favored 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 124.152 0.908 . . . . 0.0 111.638 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.3 mp -106.73 158.17 17.17 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.795 1.638 . . . . 0.0 108.186 -176.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 84.9 t -142.41 135.67 27.55 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -165.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 46.41 57.82 16.62 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 124.904 1.281 . . . . 0.0 109.656 -173.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -72.32 88.75 0.84 Allowed 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.177 2.584 . . . . 0.0 108.604 -178.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -54.46 148.98 11.05 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.657 0.741 . . . . 0.0 110.647 -175.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -54.49 -34.11 61.02 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.671 1.588 . . . . 0.0 111.582 -168.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -49.15 70.23 Favored 'General case' 0 CA--C 1.521 -0.172 0 O-C-N 120.327 -1.483 . . . . 0.0 108.645 177.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.1 t -62.05 -47.9 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 123.774 0.83 . . . . 0.0 110.386 175.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.43 -36.95 64.57 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.827 2.051 . . . . 0.0 109.846 -172.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.84 -59.07 4.18 Favored 'General case' 0 N--CA 1.424 -1.728 0 C-N-CA 126.731 2.012 . . . . 0.0 111.54 177.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.0 t -65.53 -45.58 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 CA-C-N 111.754 -2.476 . . . . 0.0 107.284 -176.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.81 -17.55 16.6 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.965 0.906 . . . . 0.0 110.222 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 65.6 m -117.0 16.7 15.06 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 124.551 1.157 . . . . 0.0 112.314 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 62.2 mt -123.23 -16.25 6.98 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 129.484 3.114 . . . . 0.0 111.435 169.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.7 t -113.61 1.13 14.84 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.837 2.055 . . . . 0.0 110.632 -177.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 44.99 81.59 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.811 1.644 . . . . 0.0 110.201 -165.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.52 -53.26 2.53 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 173.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.89 -12.04 51.57 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.372 1.069 . . . . 0.0 112.867 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.4 mtt85 -98.66 4.05 47.88 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.848 1.659 . . . . 0.0 111.199 -178.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.3 mt -132.84 -37.24 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 126.031 1.732 . . . . 0.0 110.019 -173.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.7 t -111.15 149.78 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 177.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.24 159.01 35.4 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.224 0.61 . . . . 0.0 109.888 174.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -131.99 151.47 35.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 125.041 1.337 . . . . 0.0 108.625 178.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -148.02 173.0 13.35 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 127.055 2.142 . . . . 0.0 110.639 173.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.57 -39.24 14.27 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 123.563 0.745 . . . . 0.0 109.231 177.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 25.2 p -136.86 170.48 16.02 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.043 0.937 . . . . 0.0 110.837 -173.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 19.9 mm -63.94 -45.36 97.1 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 CA-C-O 117.754 -1.117 . . . . 0.0 108.587 172.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.3 t -67.38 -36.72 81.9 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 119.228 0.922 . . . . 0.0 109.134 -169.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -70.87 -15.35 62.62 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 176.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -86.48 -49.34 7.66 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 174.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.95 -52.24 63.61 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.762 1.225 . . . . 0.0 111.316 -160.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.06 -7.98 54.49 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 127.906 2.482 . . . . 0.0 114.446 176.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -104.28 -53.25 2.76 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 118.795 0.725 . . . . 0.0 109.355 -169.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 12.8 t -50.68 -33.63 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 C-N-CA 129.336 3.054 . . . . 0.0 110.39 172.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -43.46 -36.96 2.18 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.006 0.922 . . . . 0.0 113.243 166.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.57 24.08 3.15 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 116.452 2.019 . . . . 0.0 116.452 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 31.5 mmtt . . . . . 0 C--O 1.255 1.383 0 C-N-CA 129.56 3.144 . . . . 0.0 103.174 177.666 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 25.9 p90 . . . . . 0 C--O 1.239 0.533 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.88 170.27 10.28 Favored 'General case' 0 N--CA 1.46 0.069 0 C-N-CA 123.937 0.895 . . . . 0.0 110.286 169.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.1 mt -131.49 150.57 34.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 174.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.4 m -120.27 -133.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 126.408 1.883 . . . . 0.0 107.03 176.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -46.38 -75.41 0.03 OUTLIER 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 127.565 2.346 . . . . 0.0 111.312 -177.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -143.35 27.79 1.54 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.821 1.649 . . . . 0.0 108.434 172.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.418 HG13 ' CE2' ' A' ' 56' ' ' PHE . 11.7 t -121.73 138.94 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 C-N-CA 124.172 0.989 . . . . 0.0 108.451 -175.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 72.5 t -99.21 140.44 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 125.668 1.587 . . . . 0.0 107.546 -178.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mp -119.42 95.98 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 126.402 1.881 . . . . 0.0 105.957 -178.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 31.5 mt -84.8 126.28 33.3 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 177.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 56.1 mtm -125.76 92.02 47.25 Favored Pre-proline 0 N--CA 1.464 0.274 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.76 106.53 1.68 Allowed 'Trans proline' 0 N--CA 1.45 -1.074 0 N-CA-C 108.28 -1.469 . . . . 0.0 108.28 176.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -74.79 55.53 0.68 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.264 1.026 . . . . 0.0 111.549 172.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.99 41.11 3.76 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.447 1.499 . . . . 0.0 112.866 -173.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -105.75 48.85 0.82 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-O 122.222 1.01 . . . . 0.0 110.317 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.61 68.36 8.66 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 123.483 1.611 . . . . 0.0 108.185 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -68.05 3.23 1.67 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 129.577 3.151 . . . . 0.0 114.977 -174.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 mt 65.65 -56.3 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 129.795 3.238 . . . . 0.0 111.378 -167.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -63.81 -31.98 73.34 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 118.258 0.481 . . . . 0.0 109.777 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -59.4 -60.1 4.39 Favored 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 124.147 0.979 . . . . 0.0 109.117 165.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.19 -38.91 54.96 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 120.515 1.507 . . . . 0.0 114.448 -178.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -67.86 -34.04 75.92 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.702 1.137 . . . . 0.0 111.881 178.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.17 -19.0 30.74 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-O 118.154 -0.927 . . . . 0.0 110.883 177.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -46.62 -49.96 18.26 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 127.917 2.487 . . . . 0.0 110.299 -172.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.0 -57.22 11.07 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 124.6 1.16 . . . . 0.0 109.917 175.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -56.55 -48.98 76.13 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 124.561 1.145 . . . . 0.0 112.07 178.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -56.54 -71.77 0.09 Allowed 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 117.574 -1.203 . . . . 0.0 108.055 178.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.6 t -46.39 -42.72 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.089 0.955 . . . . 0.0 109.373 -177.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 -60.22 -59.97 4.57 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 120.606 1.548 . . . . 0.0 111.643 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -68.63 -4.04 14.09 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.619 1.568 . . . . 0.0 111.991 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -107.17 -33.04 7.56 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 116.413 -1.756 . . . . 0.0 108.956 -177.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -134.57 -49.81 0.78 Allowed 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 123.603 2.91 . . . . 0.0 109.335 -174.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -69.49 -57.0 5.79 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 124.039 0.936 . . . . 0.0 110.666 -169.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -62.81 -27.22 69.17 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.571 0.748 . . . . 0.0 109.781 174.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -66.66 -20.14 65.92 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.862 1.665 . . . . 0.0 113.616 171.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.02 6.18 46.02 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.297 1.427 . . . . 0.0 114.787 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -76.57 149.81 36.58 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 119.994 1.897 . . . . 0.0 110.236 172.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -130.02 6.18 5.0 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.216 1.006 . . . . 0.0 112.791 -178.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -133.16 113.09 12.3 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 120.683 1.583 . . . . 0.0 106.856 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.0 mp -118.11 151.2 20.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 104.732 -2.321 . . . . 0.0 104.732 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.418 ' CE2' HG13 ' A' ' 22' ' ' VAL . 20.3 m-85 -132.89 160.28 37.45 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 124.525 1.13 . . . . 0.0 110.318 166.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.4 tp -137.72 86.89 2.21 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.866 1.266 . . . . 0.0 108.71 175.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.4 HG12 ' H ' ' A' ' 60' ' ' SER . 95.0 t -60.74 138.57 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 128.428 2.691 . . . . 0.0 107.2 168.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.9 mp -117.81 37.08 4.06 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.29 1.836 . . . . 0.0 109.445 173.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.4 ' H ' HG12 ' A' ' 58' ' ' VAL . 19.9 t -76.42 -38.85 54.98 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.278 1.431 . . . . 0.0 110.688 178.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.97 2.62 51.77 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.917 0.78 . . . . 0.0 111.604 -173.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.3 p -133.24 174.52 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 127.977 2.511 . . . . 0.0 107.464 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -118.4 -31.38 4.95 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.298 0.639 . . . . 0.0 111.64 177.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.1 t -159.01 158.86 34.0 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.746 0.784 . . . . 0.0 112.478 165.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -76.84 166.29 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-N 113.874 -1.512 . . . . 0.0 108.531 160.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -103.8 159.47 15.61 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.206 1.402 . . . . 0.0 110.608 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.34 6.17 0.84 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.615 1.166 . . . . 0.0 113.491 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -76.87 -78.22 0.13 Allowed 'General case' 0 CA--C 1.535 0.376 0 O-C-N 120.956 -1.09 . . . . 0.0 108.766 155.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.8 t -69.93 -13.74 62.39 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -169.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 33.1 tp -47.06 -31.31 3.26 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.054 1.342 . . . . 0.0 111.674 168.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.06 -28.14 31.97 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 121.458 -0.776 . . . . 0.0 114.466 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 45.7 t -75.27 -35.81 34.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 124.45 1.1 . . . . 0.0 109.59 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.6 mm -55.59 -49.79 71.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 123.75 0.82 . . . . 0.0 110.359 175.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 38.7 t -60.34 -41.34 86.84 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.213 0 CA-C-N 118.123 0.419 . . . . 0.0 110.13 177.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -53.25 -44.67 68.34 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.41 1.005 . . . . 0.0 112.413 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.64 -36.17 73.89 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 123.156 0.582 . . . . 0.0 109.593 177.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -64.7 -42.91 94.95 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.289 0.95 . . . . 0.0 109.479 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 55.1 mttt -60.27 -45.27 93.9 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 118.569 0.622 . . . . 0.0 111.309 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 30.0 m -54.95 -52.13 63.99 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.154 0.182 . . . . 0.0 111.434 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 59.4 mt -65.1 -41.62 92.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 122.585 0.354 . . . . 0.0 110.741 -175.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.2 t -48.38 -59.68 3.27 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.168 1.787 . . . . 0.0 108.127 173.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.7 m -64.8 -33.08 75.13 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.3 m -67.45 -20.41 65.49 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 113.834 1.049 . . . . 0.0 113.834 174.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 94.23 9.99 58.78 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-O 119.067 -0.852 . . . . 0.0 113.5 -171.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -88.03 -173.03 47.54 Favored Glycine 0 N--CA 1.434 -1.441 0 CA-C-N 119.449 1.625 . . . . 0.0 111.456 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -130.54 149.99 51.95 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 126.184 1.793 . . . . 0.0 106.692 171.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -141.06 145.34 35.73 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 174.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -149.61 163.06 38.9 Favored 'General case' 0 N--CA 1.441 -0.888 0 O-C-N 123.79 0.681 . . . . 0.0 111.755 176.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.7 mt -97.68 167.78 10.75 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 123.397 0.679 . . . . 0.0 109.429 176.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -148.59 152.08 12.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 124.702 1.201 . . . . 0.0 111.096 -175.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.6 t 39.92 63.64 4.88 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 127.15 2.18 . . . . 0.0 110.825 178.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.14 175.27 7.81 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.252 1.968 . . . . 0.0 110.341 177.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.47 ' N ' HD21 ' A' ' 93' ' ' ASN . 1.0 OUTLIER -127.34 166.53 17.65 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 173.555 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -58.02 -41.71 83.76 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 124.519 1.127 . . . . 0.0 109.305 174.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -26.08 66.77 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 126.513 1.925 . . . . 0.0 110.65 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.5 t -88.62 -49.38 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 CA-C-O 115.777 -2.059 . . . . 0.0 109.071 177.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.38 -34.85 64.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 122.547 2.431 . . . . 0.0 110.297 177.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -31.01 72.04 Favored 'General case' 0 C--O 1.219 -0.511 0 O-C-N 121.395 -0.815 . . . . 0.0 111.479 -178.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.4 p -100.0 -41.31 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -174.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.9 mp -65.84 -14.58 61.71 Favored 'General case' 0 N--CA 1.434 -1.271 0 C-N-CA 125.972 1.709 . . . . 0.0 112.617 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.74 -41.5 10.1 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 117.328 -1.749 . . . . 0.0 108.197 171.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.48 -34.57 78.6 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.747 1.619 . . . . 0.0 112.486 -172.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 9.0 t -93.25 -2.05 55.48 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 118.094 -0.955 . . . . 0.0 111.701 177.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.401 ' HB3' ' HD3' ' A' ' 107' ' ' ARG . 48.9 m-80 56.86 83.49 0.1 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.633 1.173 . . . . 0.0 109.201 -163.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.55 -58.58 1.68 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 127.876 2.47 . . . . 0.0 109.878 174.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.83 -20.14 65.57 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.698 0.799 . . . . 0.0 111.215 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.401 ' HD3' ' HB3' ' A' ' 104' ' ' ASN . 4.5 ptm85 -84.06 -15.35 47.8 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 177.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 13.9 mm -88.85 -36.79 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 C-N-CA 126.358 1.863 . . . . 0.0 106.06 -172.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.48 149.63 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 124.61 1.194 . . . . 0.0 112.297 -172.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -57.25 156.94 6.79 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.357 0.663 . . . . 0.0 110.807 168.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.12 149.22 16.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 -178.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -140.3 165.04 28.47 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 124.845 1.258 . . . . 0.0 113.389 -170.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.82 -52.35 5.16 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.136 0.974 . . . . 0.0 109.753 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 53.3 p -125.12 175.06 7.63 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.549 1.14 . . . . 0.0 109.359 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 5.6 mm -63.84 -45.08 98.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 118.441 -0.79 . . . . 0.0 109.008 167.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.4 t -71.29 -28.18 63.94 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 119.384 -0.927 . . . . 0.0 110.427 -169.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -69.14 -20.56 64.03 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 119.201 0.91 . . . . 0.0 111.181 173.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -92.51 -49.6 6.04 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 -173.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.99 -60.51 2.71 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.924 2.09 . . . . 0.0 111.539 -166.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -86.61 -16.31 37.13 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.553 0.741 . . . . 0.0 111.012 -175.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -77.54 -59.92 2.58 Favored 'General case' 0 C--O 1.216 -0.695 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -47.85 -28.7 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 126.949 2.1 . . . . 0.0 112.987 -174.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.86 -28.1 65.79 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.484 2.314 . . . . 0.0 113.45 173.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.72 39.51 0.16 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.858 2.063 . . . . 0.0 112.799 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.074 0 C-N-CA 125.776 1.63 . . . . 0.0 110.323 -174.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.3 p90 . . . . . 0 N--CA 1.448 -0.56 0 CA-C-O 120.489 0.185 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.3 pttt -135.46 170.29 16.17 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 126.073 1.749 . . . . 0.0 109.343 166.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 40.4 mt -120.65 138.28 51.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 C-N-CA 125.296 1.438 . . . . 0.0 107.626 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 76.9 t -131.8 164.67 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 C-N-CA 127.761 2.425 . . . . 0.0 106.769 -177.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -25.07 -63.31 0.06 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 129.553 3.141 . . . . 0.0 113.136 -163.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -145.75 54.01 1.17 Allowed 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 160.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.415 HG12 ' CE2' ' A' ' 56' ' ' PHE . 13.6 t -140.04 152.68 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 124.45 1.1 . . . . 0.0 109.197 170.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.9 t -111.96 138.47 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.8 mp -118.33 106.18 19.2 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.9 mp -82.17 63.13 6.23 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.831 2.052 . . . . 0.0 108.271 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.7 mmm -60.05 98.4 0.14 Allowed Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 126.219 1.808 . . . . 0.0 110.805 -175.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -68.26 -47.42 1.64 Allowed 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 122.918 2.412 . . . . 0.0 109.834 -172.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 31.21 54.67 0.22 Allowed 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 120.88 1.673 . . . . 0.0 113.231 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 78.24 22.77 0.75 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.788 2.035 . . . . 0.0 112.527 173.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -118.31 69.78 0.8 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.617 1.567 . . . . 0.0 108.327 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.4 mt -129.72 20.28 5.56 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.832 1.253 . . . . 0.0 111.581 -177.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -49.51 142.48 7.93 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 131.067 3.747 . . . . 0.0 109.533 -177.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 28.9 mt -55.2 -46.66 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 121.049 1.749 . . . . 0.0 111.551 -176.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -80.6 2.96 23.45 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.207 -0.933 . . . . 0.0 112.772 -176.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -89.42 -57.08 3.01 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 153.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.8 -32.28 19.56 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.112 1.765 . . . . 0.0 114.08 -175.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -66.98 -53.17 34.12 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.53 1.059 . . . . 0.0 110.868 175.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.252 0.0 OUTLIER -81.29 -11.27 59.4 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 120.782 -1.199 . . . . 0.0 112.385 -177.492 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -34.83 -57.4 0.54 Allowed 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 129.275 3.03 . . . . 0.0 112.054 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -60.99 -48.95 79.45 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-O 118.542 -0.742 . . . . 0.0 109.34 -176.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -57.91 -46.35 85.09 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 119.494 1.043 . . . . 0.0 110.656 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.406 ' CE3' HG22 ' A' ' 43' ' ' VAL . 5.5 t90 -56.72 -61.05 2.7 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 108.876 -0.786 . . . . 0.0 108.876 174.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.406 HG22 ' CE3' ' A' ' 42' ' ' TRP . 53.0 t -52.23 -33.01 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 124.37 1.068 . . . . 0.0 113.038 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.405 ' CD1' HD12 ' A' ' 48' ' ' LEU . 3.5 m-85 -64.23 -69.57 0.27 Allowed 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 125.19 1.396 . . . . 0.0 108.815 172.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -80.05 -11.33 59.78 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -166.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -88.51 -27.88 21.17 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.27 1.428 . . . . 0.0 110.74 174.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -135.55 -64.18 0.64 Allowed 'General case' 0 C--N 1.347 0.482 0 CA-C-N 119.513 1.051 . . . . 0.0 111.858 -170.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.405 HD12 ' CD1' ' A' ' 44' ' ' PHE . 41.3 mt -48.6 -55.12 12.08 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 118.518 0.599 . . . . 0.0 111.226 -178.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -86.25 1.71 49.86 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.394 0.678 . . . . 0.0 110.963 -173.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.5 3.63 55.12 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 127.599 2.36 . . . . 0.0 112.038 173.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.04 40.23 25.53 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 119.446 1.021 . . . . 0.0 112.564 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -110.45 165.68 11.6 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 160.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -140.81 3.75 1.86 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.557 2.343 . . . . 0.0 112.141 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.42 133.19 28.99 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 121.135 1.789 . . . . 0.0 109.239 -175.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.9 mp -133.69 149.87 31.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 128.252 2.621 . . . . 0.0 105.206 -172.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.415 ' CE2' HG12 ' A' ' 22' ' ' VAL . 23.5 m-85 -136.23 150.46 48.98 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.087 0.955 . . . . 0.0 112.563 168.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.1 tp -118.35 78.3 1.25 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.475 1.11 . . . . 0.0 110.25 175.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 99.5 t -60.11 102.34 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 C-N-CA 126.586 1.955 . . . . 0.0 109.042 172.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.6 mt -86.61 14.25 7.25 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.809 2.444 . . . . 0.0 112.11 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.8 t -63.5 -50.55 69.19 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.802 0.841 . . . . 0.0 112.052 -168.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -83.48 -10.99 58.0 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.342 1.057 . . . . 0.0 110.65 -166.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.5 p -109.61 168.0 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 128.809 2.844 . . . . 0.0 106.712 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.48 -34.53 8.2 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.527 -0.733 . . . . 0.0 110.079 173.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.8 p -153.15 167.31 29.69 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 -176.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.4 tt -102.16 151.8 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 162.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -94.89 164.96 12.69 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 124.259 1.023 . . . . 0.0 111.109 -178.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.5 m -76.48 52.65 0.8 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.321 1.848 . . . . 0.0 110.654 176.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -133.44 -68.1 0.59 Allowed 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 158.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.5 t -64.31 -24.46 67.66 Favored 'General case' 0 C--N 1.342 0.267 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 60.6 tp -55.81 -16.54 4.6 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 120.819 -1.176 . . . . 0.0 114.103 177.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -91.5 -34.14 7.61 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 119.946 1.248 . . . . 0.0 112.083 168.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.7 t -64.63 -38.31 82.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 126.295 1.838 . . . . 0.0 110.389 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.3 mm -54.96 -48.93 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 125.292 1.437 . . . . 0.0 110.662 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.9 t -63.89 -45.64 96.4 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.471 0 O-C-N 121.144 -0.972 . . . . 0.0 108.648 176.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.17 -39.26 72.06 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.857 0.753 . . . . 0.0 110.977 -177.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.6 mt -59.62 -44.43 93.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 125.642 1.577 . . . . 0.0 110.628 170.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.5 tp -60.46 -50.67 72.66 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 120.325 -1.484 . . . . 0.0 109.214 177.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 48.3 mttt -59.42 -15.17 15.37 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.52 -0.738 . . . . 0.0 111.217 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.5 t -85.91 -48.56 8.61 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.63 0.772 . . . . 0.0 109.674 172.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 30.6 mt -62.44 -41.93 93.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 O-C-N 120.3 -1.5 . . . . 0.0 110.619 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.6 m -76.53 -5.26 46.81 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 173.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 45.6 t -74.84 -48.07 27.03 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 120.949 -1.094 . . . . 0.0 108.443 159.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.8 m -66.49 -56.03 12.82 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.409 1.084 . . . . 0.0 113.495 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.31 13.49 4.8 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.32 0.962 . . . . 0.0 113.81 -167.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -86.46 -163.58 38.56 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-N 119.141 1.471 . . . . 0.0 111.508 174.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -136.31 162.14 33.84 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.459 1.504 . . . . 0.0 110.023 176.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -158.8 139.53 12.7 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 123.959 0.904 . . . . 0.0 109.192 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -145.25 171.7 14.19 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 121.171 0.51 . . . . 0.0 112.239 175.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.08 170.04 8.37 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 176.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -151.17 144.46 16.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 124.73 1.212 . . . . 0.0 110.739 -165.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.9 t 42.79 58.73 11.24 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 125.861 1.664 . . . . 0.0 111.52 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.57 166.34 26.17 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.489 2.126 . . . . 0.0 109.916 176.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -129.68 170.41 13.85 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 174.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -60.55 -42.56 96.81 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.287 1.035 . . . . 0.0 110.212 -176.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.1 -27.22 68.77 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.692 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -86.23 -47.12 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-O 118.635 -0.698 . . . . 0.0 109.607 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -53.63 -44.46 69.56 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 125.581 1.552 . . . . 0.0 108.648 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.19 -23.38 67.29 Favored 'General case' 0 C--O 1.218 -0.592 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.786 -169.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.9 t -95.84 -48.52 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 C-N-CA 126.014 1.726 . . . . 0.0 107.35 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.83 -21.63 57.04 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.108 0.963 . . . . 0.0 109.334 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.7 m -85.05 -11.83 54.45 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.865 0.866 . . . . 0.0 112.874 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 32.6 mt -119.81 -39.7 2.82 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 126.18 1.792 . . . . 0.0 111.033 -166.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.5 t -81.95 1.89 33.29 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.307 1.843 . . . . 0.0 111.095 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 51.18 78.05 0.12 Allowed 'General case' 0 C--N 1.345 0.408 0 C-N-CA 127.386 2.274 . . . . 0.0 111.03 -169.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.78 -57.75 1.61 Allowed 'General case' 0 C--O 1.227 -0.099 0 C-N-CA 123.909 0.883 . . . . 0.0 108.94 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.24 -24.8 66.62 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.548 1.139 . . . . 0.0 111.205 177.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.02 -7.62 59.35 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.6 mt -115.03 -47.63 4.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 125.651 1.58 . . . . 0.0 107.789 -174.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -100.59 143.38 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 123.14 0.576 . . . . 0.0 110.291 178.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.9 161.86 12.15 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 124.141 0.976 . . . . 0.0 112.041 176.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.67 146.14 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -177.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -143.46 172.39 12.84 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 125.722 1.609 . . . . 0.0 110.399 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.64 -40.24 10.86 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.781 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 64.0 p -134.27 167.58 20.43 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.765 1.226 . . . . 0.0 108.792 -171.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 4.7 mm -69.75 -40.55 79.28 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.0 t -78.31 -4.74 49.51 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.194 0.907 . . . . 0.0 111.957 -176.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -90.38 -10.51 43.67 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 118.329 -0.843 . . . . 0.0 110.755 166.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -99.25 -44.5 6.22 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.418 1.087 . . . . 0.0 109.606 177.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -60.26 -40.48 90.48 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 127.801 2.44 . . . . 0.0 115.828 -161.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -112.59 4.31 17.21 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 126.836 2.054 . . . . 0.0 111.31 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -99.64 -63.66 1.11 Allowed 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -46.82 -30.47 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 127.44 2.296 . . . . 0.0 113.04 -176.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 12.1 mtt180 -53.64 -20.51 5.36 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.382 -0.824 . . . . 0.0 112.358 174.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.1 24.34 1.46 Allowed 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 115.151 1.538 . . . . 0.0 115.151 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 116.71 -1.614 . . . . 0.0 110.478 -161.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.0 p90 . . . . . 0 N--CA 1.447 -0.614 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.27 173.51 11.46 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.7 1.2 . . . . 0.0 108.776 174.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 70.7 mt -133.35 104.1 6.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 174.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.7 m -77.74 -171.87 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 166.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -24.59 -68.58 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 128.835 2.854 . . . . 0.0 115.319 -167.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -142.26 19.12 2.08 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 128.279 2.632 . . . . 0.0 109.72 177.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.404 HG12 ' CE2' ' A' ' 56' ' ' PHE . 6.7 t -127.84 133.57 67.13 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 CA-C-O 123.678 1.704 . . . . 0.0 108.783 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -92.66 153.87 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.686 0 CA-C-N 112.151 -2.295 . . . . 0.0 107.044 -175.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.4 mm -138.17 91.36 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.55 118.86 10.74 Favored 'General case' 0 C--O 1.226 -0.174 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 165.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 4.9 mtm -116.65 80.65 10.75 Favored Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 104.829 -2.286 . . . . 0.0 104.829 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -74.47 168.05 25.72 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.256 2.638 . . . . 0.0 112.051 -168.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.86 -106.73 0.1 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.703 1.201 . . . . 0.0 108.853 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -103.67 3.56 34.48 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.036 1.335 . . . . 0.0 111.53 174.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -76.18 -1.77 27.91 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.244 1.017 . . . . 0.0 113.275 -174.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 17.7 mt -77.33 21.67 0.25 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.902 1.681 . . . . 0.0 113.662 -176.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -37.24 133.78 0.65 Allowed 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 127.343 2.257 . . . . 0.0 109.343 166.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.1 tt -52.07 -34.42 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 124.309 1.044 . . . . 0.0 111.987 -176.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -70.2 -37.67 75.13 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.147 -0.97 . . . . 0.0 112.081 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -67.09 -46.5 74.06 Favored 'General case' 0 C--O 1.219 -0.521 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 168.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.91 -44.1 66.71 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.97 0.804 . . . . 0.0 112.187 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 14.3 t-160 -65.34 -43.46 90.82 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 119.93 1.241 . . . . 0.0 111.144 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.26 -14.97 59.66 Favored 'General case' 0 C--O 1.218 -0.554 0 O-C-N 121.574 -0.704 . . . . 0.0 110.379 -178.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -50.25 -44.35 53.51 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 127.167 2.187 . . . . 0.0 111.015 -173.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.438 ' HE3' ' CZ ' ' A' ' 44' ' ' PHE . 0.4 OUTLIER -67.35 -41.6 84.9 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-O 117.823 -1.084 . . . . 0.0 111.266 176.061 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -58.65 -48.58 80.57 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 120.324 1.42 . . . . 0.0 110.346 174.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -58.76 -61.64 2.47 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-O 117.738 -1.125 . . . . 0.0 108.186 177.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.4 t -52.78 -37.34 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 119.943 1.247 . . . . 0.0 111.65 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.438 ' CZ ' ' HE3' ' A' ' 40' ' ' LYS . 3.3 m-85 -59.44 -65.43 0.67 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 118.885 0.766 . . . . 0.0 110.371 174.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -60.74 -50.82 71.92 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 126.504 1.922 . . . . 0.0 111.162 -173.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -67.19 -36.4 81.69 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 127.816 2.446 . . . . 0.0 111.179 -174.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -128.91 -60.34 1.09 Allowed 'General case' 0 C--N 1.347 0.498 0 CA-C-N 119.496 1.044 . . . . 0.0 112.254 -174.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 12.1 mt -64.0 -25.26 68.05 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.564 -0.71 . . . . 0.0 112.843 -165.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -99.83 -15.68 18.33 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 127.283 2.233 . . . . 0.0 111.573 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -69.91 -16.75 63.28 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.435 1.094 . . . . 0.0 110.898 164.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.04 1.64 33.88 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.61 1.576 . . . . 0.0 112.935 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -72.57 145.58 47.3 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 119.066 1.433 . . . . 0.0 110.564 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -126.74 4.5 6.7 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.681 1.192 . . . . 0.0 113.285 -177.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.6 mtmt -145.88 95.32 2.62 Favored 'General case' 0 CA--C 1.514 -0.418 0 O-C-N 119.687 -1.883 . . . . 0.0 107.124 -166.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -101.94 154.11 5.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.404 ' CE2' HG12 ' A' ' 22' ' ' VAL . 16.1 m-30 -124.37 156.15 37.56 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 117.922 0.328 . . . . 0.0 111.332 163.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 29.4 tp -130.1 107.65 9.48 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 124.89 1.276 . . . . 0.0 108.438 175.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -75.81 161.92 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-O 121.37 0.605 . . . . 0.0 110.651 176.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 30.1 mt -139.61 12.51 2.52 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.935 1.294 . . . . 0.0 109.678 -174.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 68.7 m -66.38 -64.35 0.88 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.918 1.287 . . . . 0.0 110.559 -176.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -69.74 -43.6 71.97 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.972 0.415 . . . . 0.0 111.689 -169.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.3 p -67.94 160.98 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 126.47 1.908 . . . . 0.0 110.691 -177.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -95.24 -56.17 2.81 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.795 0.838 . . . . 0.0 109.314 174.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.5 p -156.36 -165.39 1.89 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.372 0.669 . . . . 0.0 110.693 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.0 tt -139.6 145.02 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 C-N-CA 125.858 1.663 . . . . 0.0 106.914 -177.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -82.86 162.13 21.7 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.308 0.643 . . . . 0.0 109.774 175.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.0 m -54.19 -29.38 45.76 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.947 1.299 . . . . 0.0 112.843 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -56.59 -64.41 0.88 Allowed 'General case' 0 C--N 1.344 0.346 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.7 t -77.24 -22.32 52.39 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 118.839 -0.6 . . . . 0.0 111.582 -176.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 22.1 tp -54.98 -27.17 41.88 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.958 1.254 . . . . 0.0 111.887 173.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -83.93 -35.64 15.26 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.16 0.886 . . . . 0.0 112.87 171.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 45.5 t -67.89 -42.01 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 118.524 1.162 . . . . 0.0 109.462 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 12.0 mm -54.73 -49.68 66.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.206 1.002 . . . . 0.0 109.338 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 38.7 t -62.48 -42.34 95.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 O-C-N 121.397 -0.814 . . . . 0.0 110.417 174.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -52.89 -44.08 66.63 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 120.129 1.331 . . . . 0.0 112.239 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 59.8 mt -60.67 -38.44 78.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 124.06 0.944 . . . . 0.0 108.67 176.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.49 -49.23 64.42 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 120.005 1.275 . . . . 0.0 109.466 178.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -52.57 -48.25 66.3 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 118.607 0.64 . . . . 0.0 110.077 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.0 m -60.02 -54.54 44.81 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.248 1.019 . . . . 0.0 110.711 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 48.6 mt -60.17 -43.74 93.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 124.337 1.055 . . . . 0.0 110.647 -177.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.0 t -70.22 -12.52 61.65 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.397 1.079 . . . . 0.0 111.865 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.5 t -83.82 -46.75 11.84 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 119.208 0.913 . . . . 0.0 108.583 167.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 72.1 m -54.12 -53.65 50.37 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.239 0.616 . . . . 0.0 110.41 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 132.88 18.04 1.12 Allowed Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.213 -0.771 . . . . 0.0 112.589 -168.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -109.48 179.35 20.83 Favored Glycine 0 N--CA 1.44 -1.034 0 CA-C-N 119.827 1.813 . . . . 0.0 112.587 -173.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -141.87 108.49 5.35 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.914 2.086 . . . . 0.0 108.815 -172.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -106.57 139.8 40.45 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.76 1.224 . . . . 0.0 107.802 -176.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.92 172.49 12.86 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.155 0.889 . . . . 0.0 111.861 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.11 167.17 13.47 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.58 0.752 . . . . 0.0 109.903 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 92.5 t -142.39 139.13 29.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 C-N-CA 123.36 0.664 . . . . 0.0 110.122 -168.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 t 46.54 54.46 14.82 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 126.304 1.842 . . . . 0.0 111.178 -175.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -69.79 99.89 0.78 Allowed 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 123.149 2.566 . . . . 0.0 108.769 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -62.5 158.3 18.24 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 122.116 0.96 . . . . 0.0 110.954 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 -59.47 -34.77 72.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.216 -171.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.43 -44.93 89.34 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.37 1.468 . . . . 0.0 109.55 175.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.7 t -74.45 -47.22 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-O 117.2 -1.381 . . . . 0.0 109.761 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -54.66 -31.97 58.44 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 121.383 1.901 . . . . 0.0 110.233 -176.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.41 -62.57 1.63 Allowed 'General case' 0 N--CA 1.423 -1.808 0 CA-C-O 123.453 1.597 . . . . 0.0 111.724 175.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.6 p -66.87 -34.58 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 CA-C-N 113.981 -1.463 . . . . 0.0 107.651 -173.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.9 mt -63.26 -23.97 67.66 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.912 0.885 . . . . 0.0 111.36 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.7 m -78.85 -49.59 12.66 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 120.103 1.32 . . . . 0.0 107.829 170.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.71 -15.42 40.37 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.23 2.212 . . . . 0.0 113.582 -174.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.6 t -120.67 -0.18 10.27 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.914 2.086 . . . . 0.0 111.479 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 48.07 69.01 0.58 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 127.266 2.227 . . . . 0.0 112.967 -168.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.38 -49.44 3.57 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.369 1.867 . . . . 0.0 110.096 166.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -65.57 -12.29 51.69 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 119.56 1.073 . . . . 0.0 112.728 -177.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.0 5.04 25.8 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 127.255 2.222 . . . . 0.0 111.049 -174.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.7 mt -125.62 -45.55 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 128.093 2.557 . . . . 0.0 109.579 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.8 t -95.09 166.92 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.678 1.191 . . . . 0.0 107.802 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -95.95 172.64 7.88 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.737 0.815 . . . . 0.0 109.408 168.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -157.98 147.0 9.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 -163.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -148.48 162.95 38.58 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.568 1.147 . . . . 0.0 112.489 -169.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.95 -58.37 2.62 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -178.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 69.2 p -102.87 -162.53 0.92 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 14.6 mm -84.76 -34.17 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-O 118.564 -0.732 . . . . 0.0 111.133 156.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.1 t -70.22 -37.33 75.0 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.373 -156.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -67.14 -39.97 86.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 176.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.63 -41.38 96.21 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -171.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 9.8 ttt -51.39 -43.45 61.93 Favored 'General case' 0 N--CA 1.424 -1.728 0 C-N-CA 127.897 2.479 . . . . 0.0 110.804 -174.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -104.75 -15.48 15.22 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.837 1.255 . . . . 0.0 112.42 -177.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -81.65 -47.21 13.28 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 119.008 0.822 . . . . 0.0 109.096 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -55.24 -19.96 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 124.864 1.265 . . . . 0.0 114.086 176.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 7.7 mtm180 -70.39 -27.94 64.69 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 118.512 -0.756 . . . . 0.0 110.86 173.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.4 47.29 0.11 Allowed 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 120.624 1.556 . . . . 0.0 114.002 -176.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.069 0 C-N-CA 125.134 1.373 . . . . 0.0 111.444 -172.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 36.9 p90 . . . . . 0 CA--C 1.533 0.301 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -125.94 173.45 9.12 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.181 1.392 . . . . 0.0 108.938 164.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 52.1 mt -132.4 119.6 39.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.9 m -114.72 -166.11 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 170.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -45.66 -43.6 12.63 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 128.492 2.717 . . . . 0.0 115.278 -149.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -150.23 19.37 0.86 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.359 0.664 . . . . 0.0 111.163 156.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.3 t -122.15 120.72 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 124.266 1.027 . . . . 0.0 108.532 -173.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.5 t -75.5 143.78 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 176.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.1 mm -119.33 104.03 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 175.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 26.9 mt -85.72 124.64 32.47 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 177.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 65.0 mtm -126.86 76.46 75.36 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -167.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -61.56 148.44 92.99 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.507 2.805 . . . . 0.0 110.934 -170.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.88 -85.27 0.37 Allowed 'General case' 0 C--O 1.225 -0.212 0 CA-C-O 118.931 -0.557 . . . . 0.0 111.123 176.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.5 35.13 4.69 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.194 1.397 . . . . 0.0 109.275 -176.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.94 -19.36 13.43 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 120.791 -1.193 . . . . 0.0 112.385 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.9 mp -72.77 90.21 1.4 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -132.85 26.04 4.31 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.621 1.168 . . . . 0.0 110.801 -164.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.3 mt 65.24 -54.12 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 129.071 2.948 . . . . 0.0 113.558 -172.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -66.31 -32.4 73.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 120.175 1.352 . . . . 0.0 109.509 -174.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.1 -8.12 46.97 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-O 117.265 -1.35 . . . . 0.0 110.364 175.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.06 -65.99 0.77 Allowed 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 120.869 1.668 . . . . 0.0 111.794 -168.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -67.96 -17.39 64.43 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 121.421 1.919 . . . . 0.0 110.97 177.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 69.3 mt -78.04 -9.19 59.02 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.103 1.761 . . . . 0.0 112.087 170.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -69.01 -60.39 2.39 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -169.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.65 -33.43 72.79 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 116.609 -1.662 . . . . 0.0 111.253 174.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -64.63 -50.16 68.21 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 120.801 1.637 . . . . 0.0 107.904 -175.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -48.58 -62.37 1.54 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 118.134 -0.936 . . . . 0.0 108.704 166.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.7 m -57.93 -46.46 87.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 CA-C-O 123.311 1.529 . . . . 0.0 112.671 -166.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 -50.01 -44.95 51.45 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 126.771 2.028 . . . . 0.0 108.98 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.417 ' HA ' HD21 ' A' ' 49' ' ' ASN . 15.2 t0 -78.96 -9.4 59.51 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 128.063 2.545 . . . . 0.0 114.908 -176.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -123.88 -8.69 7.8 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.385 0.993 . . . . 0.0 112.652 177.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -136.16 -61.68 0.69 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.586 0.754 . . . . 0.0 111.069 -174.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.4 mt -67.29 -52.08 44.9 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 118.733 0.697 . . . . 0.0 110.935 -169.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.417 HD21 ' HA ' ' A' ' 45' ' ' ASP . 86.2 m-20 -64.97 -27.16 68.65 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.26 1.024 . . . . 0.0 110.449 173.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.25 -46.81 75.84 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 125.044 1.338 . . . . 0.0 108.74 -178.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 131.0 47.59 0.13 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 125.527 1.537 . . . . 0.0 109.768 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -123.6 133.33 53.96 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 118.32 1.06 . . . . 0.0 110.511 173.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -126.26 22.04 7.23 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 126.097 1.759 . . . . 0.0 111.336 -177.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -143.93 142.25 30.67 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.66 1.184 . . . . 0.0 108.321 162.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.1 mt -141.76 150.62 19.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 129.238 3.015 . . . . 0.0 104.421 -176.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -133.75 153.84 51.41 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 125.219 1.408 . . . . 0.0 109.969 169.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 29.7 tp -118.95 111.57 18.52 Favored 'General case' 0 C--N 1.339 0.143 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 174.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 87.6 t -86.2 103.47 12.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -78.92 -12.71 60.04 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.091 1.356 . . . . 0.0 111.747 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.75 -38.45 47.77 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.919 1.287 . . . . 0.0 111.115 173.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -84.95 -45.66 11.98 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 120.822 0.344 . . . . 0.0 110.792 -165.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.8 p -76.77 -178.75 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 126.619 1.968 . . . . 0.0 109.663 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -122.89 -41.45 2.35 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.41 1.084 . . . . 0.0 108.821 170.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.5 t -154.23 165.36 36.51 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-O 122.623 1.201 . . . . 0.0 113.766 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.7 tt -135.29 152.7 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 129.805 3.242 . . . . 0.0 105.985 176.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.447 ' C ' ' H ' ' A' ' 68' ' ' PHE . 0.5 OUTLIER -111.49 175.13 5.55 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.356 0.662 . . . . 0.0 110.468 -167.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.9 p -62.53 19.0 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 128.244 2.617 . . . . 0.0 114.312 173.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.447 ' H ' ' C ' ' A' ' 66' ' ' ASP . 4.2 t80 -112.38 -73.02 0.68 Allowed 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 166.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 74.7 m -66.05 -29.44 69.78 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 116.878 -1.534 . . . . 0.0 113.778 -172.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.3 mt -48.55 -46.77 39.38 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.606 1.548 . . . . 0.0 110.192 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.17 -33.07 82.85 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-O 119.71 -0.494 . . . . 0.0 112.025 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.2 t -75.5 -29.6 21.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 118.275 1.038 . . . . 0.0 111.087 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 mp -64.58 -40.21 88.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 174.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.1 t -60.64 -43.46 94.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 O-C-N 120.559 -1.338 . . . . 0.0 110.172 169.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -51.24 -43.33 61.45 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.854 1.262 . . . . 0.0 112.204 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.1 mt -58.56 -45.13 90.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 124.406 1.082 . . . . 0.0 109.353 175.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.01 -49.3 70.78 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -51.4 -49.42 61.62 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.018 0.527 . . . . 0.0 109.615 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 13.6 t -64.28 -47.49 79.33 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -176.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 47.7 mt -60.43 -45.17 97.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 C-N-CA 124.979 1.311 . . . . 0.0 111.747 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.5 m -75.29 -23.32 57.35 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.818 0.735 . . . . 0.0 112.143 176.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.78 -45.59 89.05 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.437 1.017 . . . . 0.0 108.543 167.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 74.8 m -63.94 -71.02 0.19 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.889 1.675 . . . . 0.0 112.008 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 141.23 33.74 0.12 Allowed Glycine 0 CA--C 1.527 0.798 0 C-N-CA 124.195 0.902 . . . . 0.0 111.198 -164.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -126.37 -173.78 13.66 Favored Glycine 0 C--N 1.336 0.578 0 O-C-N 120.517 -1.578 . . . . 0.0 109.592 169.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -131.19 164.15 26.17 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.367 1.067 . . . . 0.0 109.902 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -156.03 141.19 17.43 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.973 1.309 . . . . 0.0 109.03 175.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -147.08 178.44 8.37 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 123.727 0.811 . . . . 0.0 112.166 174.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.35 163.56 18.46 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 123.453 0.701 . . . . 0.0 109.911 -178.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 40.2 t -144.08 133.51 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 123.847 0.859 . . . . 0.0 108.837 -163.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.9 t 48.95 58.96 17.72 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 127.029 2.131 . . . . 0.0 111.778 -171.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.05 91.96 0.91 Allowed 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 123.748 2.965 . . . . 0.0 108.711 176.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -51.66 153.5 2.34 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 126.536 1.935 . . . . 0.0 112.092 171.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -54.03 -31.2 50.63 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.989 1.716 . . . . 0.0 111.204 -176.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.84 -44.71 84.72 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 126.798 2.039 . . . . 0.0 109.207 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.1 t -74.1 -44.77 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 125.634 1.574 . . . . 0.0 110.488 172.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -58.49 -23.89 59.06 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 120.496 1.498 . . . . 0.0 110.451 -176.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.91 -62.31 1.79 Allowed 'General case' 0 N--CA 1.427 -1.614 0 CA-C-O 124.804 2.24 . . . . 0.0 111.003 175.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -72.76 -46.16 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.707 0 CA-C-N 111.411 -2.631 . . . . 0.0 104.865 -167.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.5 mp -61.28 -19.83 62.2 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 124.913 1.285 . . . . 0.0 112.568 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.6 m -87.1 -54.89 4.08 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 172.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 68.1 mt -51.37 -51.3 55.82 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.546 1.538 . . . . 0.0 113.08 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.1 t -91.32 3.66 54.32 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.826 1.65 . . . . 0.0 111.987 -167.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 55.38 77.9 0.21 Allowed 'General case' 0 C--N 1.34 0.175 0 C-N-CA 126.387 1.875 . . . . 0.0 109.678 -173.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.22 -55.59 1.76 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.327 1.051 . . . . 0.0 108.636 177.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -60.18 -31.9 70.56 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.235 1.414 . . . . 0.0 110.306 169.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -74.21 1.21 11.83 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 117.556 -1.211 . . . . 0.0 112.965 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.4 mt -133.94 -39.55 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.547 1.139 . . . . 0.0 110.629 -169.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.4 t -106.12 153.92 7.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 119.647 1.112 . . . . 0.0 108.81 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.71 157.27 38.3 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.291 0.567 . . . . 0.0 111.486 174.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.0 145.29 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -172.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -149.19 169.66 20.23 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 127.093 2.157 . . . . 0.0 110.55 -175.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -88.08 -48.24 7.89 Favored 'General case' 0 CA--C 1.521 -0.173 0 O-C-N 121.763 -0.586 . . . . 0.0 109.419 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 67.5 p -121.56 173.52 7.36 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.921 0.888 . . . . 0.0 109.939 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 17.9 mm -70.7 -35.92 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.6 t -74.06 -30.11 62.23 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 119.446 1.021 . . . . 0.0 111.246 -173.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -65.19 -20.41 66.43 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 119.462 -0.304 . . . . 0.0 111.355 169.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -101.91 -39.93 7.13 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -170.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 53.1 ttm -48.72 -50.07 35.23 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 127.781 2.432 . . . . 0.0 111.089 -167.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -101.47 -0.42 35.2 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 117.985 -1.007 . . . . 0.0 112.591 -174.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -119.31 -35.49 3.58 Favored 'General case' 0 C--O 1.216 -0.687 0 C-N-CA 123.79 0.836 . . . . 0.0 111.542 -167.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -54.21 -29.02 18.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 O-C-N 121.14 -0.975 . . . . 0.0 109.559 157.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.11 118.02 17.58 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 102.467 -3.16 . . . . 0.0 102.467 163.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . 0.267 0.0 OUTLIER 85.46 23.42 0.08 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 111.968 -2.378 . . . . 0.0 116.193 165.582 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp . . . . . 0 C--O 1.25 1.111 0 C-N-CA 123.854 0.862 . . . . 0.0 111.187 176.487 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.9 p90 . . . . . 0 N--CA 1.452 -0.374 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.5 pttt -129.6 169.43 15.03 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.651 1.58 . . . . 0.0 108.631 168.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.5 mt -137.95 123.71 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 174.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.8 m -99.26 -154.18 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -24.92 -72.5 0.03 OUTLIER 'General case' 0 C--O 1.237 0.414 0 C-N-CA 130.085 3.354 . . . . 0.0 111.623 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.14 12.14 2.19 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.296 1.439 . . . . 0.0 110.646 172.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.7 t -112.41 137.45 45.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 O-C-N 120.657 -1.277 . . . . 0.0 108.749 -171.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 65.9 t -88.72 143.3 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 175.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mp -126.84 97.56 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -69.03 140.18 54.94 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 162.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 22.8 mtt -131.44 73.25 80.01 Favored Pre-proline 0 C--O 1.236 0.375 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 171.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.53 167.44 24.13 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 121.608 1.539 . . . . 0.0 110.62 174.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -161.16 -107.6 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 126.532 1.933 . . . . 0.0 105.999 -173.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.68 1.87 36.39 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -171.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -90.43 -23.56 20.98 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 120.773 -1.204 . . . . 0.0 113.726 -167.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 16.6 mt -74.9 -76.0 0.15 Allowed 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.155 -153.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . 0.258 0.1 OUTLIER 23.36 60.08 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 129.64 3.176 . . . . 0.0 113.201 153.629 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.8 mt 63.54 -45.29 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 127.908 2.483 . . . . 0.0 114.352 -172.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -63.61 -21.89 66.6 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.226 1.011 . . . . 0.0 112.906 -165.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -127.72 63.22 1.38 Allowed 'General case' 0 C--O 1.232 0.178 0 C-N-CA 125.141 1.376 . . . . 0.0 107.991 170.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.03 -67.94 0.89 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.674 0.79 . . . . 0.0 112.268 -177.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 39.7 t-80 -63.0 -37.1 85.82 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 120.71 1.595 . . . . 0.0 110.188 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.8 -15.3 60.75 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 117.747 -1.12 . . . . 0.0 111.935 173.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -52.59 -48.7 66.09 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 120.581 1.537 . . . . 0.0 110.942 -172.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -67.54 -42.43 82.72 Favored 'General case' 0 C--O 1.211 -0.922 0 CA-C-O 117.428 -1.272 . . . . 0.0 110.381 175.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.5 tttm -55.39 -45.14 76.64 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.937 1.699 . . . . 0.0 111.051 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 8.2 t90 -61.78 -63.04 1.39 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.546 1.138 . . . . 0.0 109.283 176.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.2 t -59.55 -32.39 48.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 119.655 1.116 . . . . 0.0 112.305 -176.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -56.54 -60.37 3.64 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 170.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.24 -44.15 72.57 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 -168.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -76.39 -17.26 59.46 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.228 1.811 . . . . 0.0 111.246 -170.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -141.68 -55.5 0.46 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 66.2 mt -64.9 -50.88 64.8 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.687 1.13 . . . . 0.0 111.451 -170.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -65.0 -29.6 70.53 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 127.867 2.467 . . . . 0.0 109.657 175.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.1 mttm -61.02 -46.87 89.0 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 118.638 -0.696 . . . . 0.0 109.14 169.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.97 4.38 2.66 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.193 1.377 . . . . 0.0 113.06 173.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -64.08 150.83 44.63 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 118.936 1.368 . . . . 0.0 109.593 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -122.29 -1.92 9.12 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.05 1.34 . . . . 0.0 114.409 175.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.0 mtmt -133.75 121.97 22.65 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 120.908 1.686 . . . . 0.0 108.379 -176.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.4 mt -130.39 157.21 42.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 C-N-CA 125.646 1.579 . . . . 0.0 107.366 176.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -131.92 161.4 33.15 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.389 1.476 . . . . 0.0 111.768 165.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.8 tp -128.46 81.23 2.01 Favored 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 125.068 1.347 . . . . 0.0 108.173 173.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 99.1 t -56.25 136.4 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 127.93 2.492 . . . . 0.0 107.563 166.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.59 12.6 12.35 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.182 1.793 . . . . 0.0 110.459 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 68.3 m -43.46 -46.24 6.7 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.68 1.992 . . . . 0.0 112.835 173.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.02 1.42 39.54 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.848 1.259 . . . . 0.0 111.69 -164.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.7 p -132.42 114.46 23.29 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 C-N-CA 126.082 1.753 . . . . 0.0 107.526 -177.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -64.69 -38.55 91.37 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 120.652 -1.28 . . . . 0.0 108.319 176.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 57.2 p -154.52 146.94 23.98 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -174.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 21.3 tt -100.28 151.38 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 113.82 -1.536 . . . . 0.0 107.411 163.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -92.3 168.9 11.0 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 123.083 1.42 . . . . 0.0 110.271 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.0 p -50.75 0.06 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.723 1 C-N-CA 132.565 4.346 . . . . 0.0 115.962 170.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -98.77 -70.52 0.72 Allowed 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.6 t -77.0 -19.88 56.74 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-O 118.552 -0.737 . . . . 0.0 112.082 -172.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 14.3 tp -48.57 -33.94 10.6 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.792 1.178 . . . . 0.0 111.743 170.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -76.4 -37.24 36.67 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 118.114 0.416 . . . . 0.0 113.683 173.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.9 t -65.31 -34.6 71.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 124.176 0.991 . . . . 0.0 109.62 -178.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.58 -48.13 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 123.747 0.819 . . . . 0.0 109.918 175.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.6 t -66.66 -39.85 84.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 O-C-N 121.187 -0.946 . . . . 0.0 109.851 178.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.63 -40.63 72.4 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.643 0.735 . . . . 0.0 110.996 178.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.1 mt -61.88 -39.44 83.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 126.592 1.957 . . . . 0.0 109.641 175.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.22 -41.5 90.03 Favored 'General case' 0 C--N 1.341 0.215 0 O-C-N 119.922 -1.736 . . . . 0.0 109.487 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.8 mttm -54.22 -44.11 71.41 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-O 117.841 -1.076 . . . . 0.0 110.524 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.5 t -53.6 -52.66 59.1 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.822 0.849 . . . . 0.0 110.825 176.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.0 mt -67.66 -39.85 82.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.012 0.525 . . . . 0.0 110.472 -174.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 26.6 t -66.25 -36.22 82.45 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.28 1.432 . . . . 0.0 110.932 176.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 71.8 m -65.39 -40.11 93.07 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 119.386 0.994 . . . . 0.0 109.894 172.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.5 m -73.29 -68.97 0.45 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.733 0.813 . . . . 0.0 111.642 -172.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 146.75 34.43 0.06 OUTLIER Glycine 0 C--N 1.334 0.418 0 CA-C-O 118.798 -1.001 . . . . 0.0 113.354 -166.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -127.6 -163.19 11.33 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 118.948 1.374 . . . . 0.0 111.321 -176.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -137.89 151.85 48.44 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 169.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -147.47 147.53 30.29 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 172.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -153.48 170.73 20.04 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 124.812 1.32 . . . . 0.0 111.211 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.3 mt -108.47 167.4 10.07 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -145.38 152.85 14.21 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.511 0 C-N-CA 124.89 1.276 . . . . 0.0 111.085 -173.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.1 p 41.3 58.88 8.94 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 126.32 1.848 . . . . 0.0 112.812 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -71.35 7.94 1.31 Allowed 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 124.227 3.285 . . . . 0.0 114.498 -170.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 56.26 -160.98 0.2 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.383 1.473 . . . . 0.0 108.993 -176.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -87.9 -15.67 36.01 Favored 'General case' 0 CA--C 1.552 1.044 0 O-C-N 120.706 -1.246 . . . . 0.0 110.892 164.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.62 -33.72 10.85 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 121.062 -1.024 . . . . 0.0 112.606 -160.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.268 0.9 OUTLIER -77.28 -37.67 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 116.254 -1.831 . . . . 0.0 107.615 166.421 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -52.96 -35.17 58.57 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 121.685 2.039 . . . . 0.0 110.235 171.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.06 -40.17 87.01 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.424 -175.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.4 p -92.41 -33.31 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -167.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.4 mp -65.55 -12.07 49.6 Favored 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 124.845 1.258 . . . . 0.0 112.5 178.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.7 t -87.29 -50.68 6.42 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 166.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.21 -38.59 87.16 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.261 1.824 . . . . 0.0 113.14 -168.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 10.9 t -86.47 -18.44 31.66 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 119.01 -0.519 . . . . 0.0 110.786 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 64.45 93.72 0.06 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.563 1.545 . . . . 0.0 107.215 -151.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.64 -50.94 1.73 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.576 1.551 . . . . 0.0 108.706 168.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -29.96 68.18 Favored 'General case' 0 C--N 1.346 0.426 0 N-CA-C 110.002 -0.369 . . . . 0.0 110.002 177.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -77.99 5.65 9.42 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 128.022 2.529 . . . . 0.0 112.353 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.3 mt -124.05 -34.93 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 125.232 1.413 . . . . 0.0 109.006 -177.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.501 HG11 ' H ' ' A' ' 110' ' ' LYS . 1.7 t -123.85 -159.31 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 125.028 1.331 . . . . 0.0 110.546 -177.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.501 ' H ' HG11 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -116.1 158.8 22.63 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 128.837 2.855 . . . . 0.0 108.073 169.932 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.95 154.03 17.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 -178.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -144.87 167.64 22.12 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.934 0.894 . . . . 0.0 112.7 -171.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.75 -50.52 6.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.944 -177.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 70.4 p -130.29 175.46 8.92 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.92 1.288 . . . . 0.0 107.823 -176.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 6.3 mm -68.25 -41.71 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-O 117.687 -1.149 . . . . 0.0 109.218 170.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.2 t -67.35 -35.62 79.76 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 120.102 1.319 . . . . 0.0 109.43 -175.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.69 -6.51 26.61 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-O 117.554 -1.213 . . . . 0.0 112.797 174.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -110.55 -41.06 4.43 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 119.375 0.989 . . . . 0.0 109.772 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 1.9 ttp -59.61 -53.87 53.03 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.754 1.622 . . . . 0.0 111.94 -163.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -84.88 -13.72 50.03 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.187 1.395 . . . . 0.0 111.215 175.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.8 -52.27 5.39 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -168.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -50.31 -25.58 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 128.066 2.547 . . . . 0.0 113.359 177.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.17 -41.71 84.45 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 126.72 2.008 . . . . 0.0 111.423 175.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.54 55.84 0.62 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 127.165 2.186 . . . . 0.0 106.272 -170.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.419 ' HZ3' ' C ' ' A' ' 125' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.027 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 170.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 43.9 p90 . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.7 pttt -151.06 178.51 9.12 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 126.86 2.064 . . . . 0.0 108.787 165.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.8 mp -132.07 136.37 56.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 167.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 20.4 m -99.65 -131.63 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 125.214 1.406 . . . . 0.0 107.704 172.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -44.89 -73.64 0.04 OUTLIER 'General case' 0 C--O 1.235 0.306 0 C-N-CA 127.505 2.322 . . . . 0.0 111.359 178.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -143.59 8.63 1.55 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.477 1.911 . . . . 0.0 110.309 171.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.0 t -97.62 132.22 42.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 179.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.7 t -83.44 143.64 11.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 170.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.5 mp -121.93 114.4 42.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 174.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.36 147.05 32.55 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 120.41 1.459 . . . . 0.0 108.719 163.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 8.9 mtt -140.43 77.77 23.26 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 127.834 2.453 . . . . 0.0 107.097 -178.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.99 98.62 0.62 Allowed 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 124.881 3.721 . . . . 0.0 112.858 -172.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -76.53 79.26 3.22 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.419 1.087 . . . . 0.0 113.667 -167.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.266 0.0 OUTLIER 40.7 35.61 0.33 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.607 1.963 . . . . 0.0 114.098 -179.494 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -113.43 -11.51 13.1 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 120.63 -1.294 . . . . 0.0 112.732 -164.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.41 83.11 0.26 Allowed 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 125.596 1.558 . . . . 0.0 108.403 -172.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -123.08 38.29 4.22 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.387 1.875 . . . . 0.0 108.127 -177.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.412 HG12 ' CG ' ' A' ' 68' ' ' PHE 0.304 0.3 OUTLIER 68.96 -26.89 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 130.957 3.703 . . . . 0.0 114.556 -177.833 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -40.51 -32.1 0.18 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 129.659 3.184 . . . . 0.0 115.535 -175.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -117.79 -4.34 11.16 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 127.289 2.236 . . . . 0.0 112.089 -164.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.35 -52.0 18.07 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-N 120.114 1.325 . . . . 0.0 111.755 -166.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -60.48 -41.64 94.64 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.74 -0.6 . . . . 0.0 110.123 -178.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.3 -18.53 58.91 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 118.365 -0.826 . . . . 0.0 111.89 178.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -54.49 -42.87 71.26 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.414 1.461 . . . . 0.0 111.824 -172.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -61.76 -52.67 63.28 Favored 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.7 tmtp? -49.11 -46.32 44.68 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.917 1.687 . . . . 0.0 111.255 175.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -62.71 -65.55 0.67 Allowed 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 116.973 -1.489 . . . . 0.0 110.178 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.6 t -54.94 -35.16 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 120.709 1.595 . . . . 0.0 111.284 -175.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -57.59 -67.9 0.29 Allowed 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 123.913 0.885 . . . . 0.0 109.057 173.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.86 -51.56 69.1 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.807 0.843 . . . . 0.0 112.604 -174.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.32 -30.92 70.01 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.617 1.167 . . . . 0.0 111.379 -168.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -133.7 -65.0 0.69 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 122.884 0.474 . . . . 0.0 109.843 -164.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 52.6 mt -56.71 -54.16 49.36 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.835 0.743 . . . . 0.0 111.382 -174.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -67.19 -23.84 65.79 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 126.086 1.754 . . . . 0.0 111.577 175.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.0 tttm -74.68 -6.29 47.92 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.303 1.041 . . . . 0.0 112.194 169.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.68 7.28 53.77 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 124.791 1.186 . . . . 0.0 114.352 175.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -72.32 162.81 28.95 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 120.033 1.916 . . . . 0.0 110.031 176.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -148.34 4.23 0.69 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.502 1.521 . . . . 0.0 111.652 -176.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -141.54 119.02 11.55 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 -177.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.9 mp -119.89 154.97 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 105.14 -2.171 . . . . 0.0 105.14 174.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -130.91 164.19 25.82 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.48 1.512 . . . . 0.0 110.132 160.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.6 tp -128.16 114.6 17.2 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 170.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.4 t -82.55 110.42 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 125.991 1.716 . . . . 0.0 108.711 175.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -75.38 -10.89 59.86 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.579 0.752 . . . . 0.0 111.588 170.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.9 m -55.93 -23.52 32.3 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.464 1.029 . . . . 0.0 112.347 172.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.57 -14.16 25.28 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.283 0.947 . . . . 0.0 111.824 177.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.5 p -137.39 101.53 2.19 Favored 'Isoleucine or valine' 0 C--N 1.34 0.152 0 C-N-CA 124.798 1.239 . . . . 0.0 109.643 -173.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -55.05 -48.29 73.67 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.8 m -158.97 170.48 21.99 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.8 tt -135.83 155.9 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 C-N-CA 127.059 2.144 . . . . 0.0 107.99 -165.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -91.33 158.47 16.53 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 126.168 1.787 . . . . 0.0 109.774 176.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.7 m -56.07 -24.73 41.83 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 117.594 -1.193 . . . . 0.0 113.337 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.591 ' CE1' ' HB2' ' A' ' 69' ' ' SER 0.278 0.2 OUTLIER -47.59 -64.53 0.76 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 119.686 1.13 . . . . 0.0 111.049 170.766 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.591 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . 30.1 t -92.48 -15.94 26.46 Favored 'General case' 0 CA--C 1.512 -0.486 0 O-C-N 121.52 -0.737 . . . . 0.0 111.642 -168.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 14.2 mt -52.07 -36.22 50.01 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 119.225 -0.99 . . . . 0.0 109.288 170.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -81.27 -25.14 55.64 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-O 118.203 -1.332 . . . . 0.0 114.753 175.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.2 p -72.69 -35.56 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 120.332 2.066 . . . . 0.0 110.048 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 mp -53.34 -49.97 50.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.342 1.457 . . . . 0.0 108.136 173.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 80.7 t -56.61 -52.34 54.84 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 176.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -56.0 -22.46 27.0 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 114.114 1.154 . . . . 0.0 114.114 -174.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 57.8 mt -80.37 -44.34 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.452 1.101 . . . . 0.0 109.481 172.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -54.16 -48.77 70.52 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.452 1.024 . . . . 0.0 109.485 177.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -57.45 -42.75 83.1 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.168 0.587 . . . . 0.0 110.638 -176.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.4 m -60.17 -54.25 48.12 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 118.956 -0.545 . . . . 0.0 110.574 174.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 80.0 mt -57.63 -42.19 80.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.858 0.863 . . . . 0.0 110.803 -176.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -52.07 -40.8 61.72 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.728 1.611 . . . . 0.0 111.242 175.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 t -84.33 0.85 47.64 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.766 2.427 . . . . 0.0 112.799 -174.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.7 m -128.84 -14.26 4.53 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -166.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 130.51 -18.75 5.15 Favored Glycine 0 CA--C 1.521 0.409 0 CA-C-N 117.992 0.36 . . . . 0.0 113.741 177.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -100.3 -173.06 29.86 Favored Glycine 0 N--CA 1.429 -1.781 0 CA-C-O 123.02 1.345 . . . . 0.0 113.283 -156.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -133.46 153.09 51.91 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.461 1.504 . . . . 0.0 108.256 174.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -145.23 146.98 31.93 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 171.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -156.02 173.34 16.95 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.039 1.335 . . . . 0.0 111.153 -175.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.6 mt -121.06 163.78 17.81 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.697 1.199 . . . . 0.0 110.148 -170.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.7 t -141.87 135.0 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 123.963 0.905 . . . . 0.0 111.478 -172.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.6 t 53.0 59.63 13.37 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 128.626 2.77 . . . . 0.0 113.938 175.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -73.11 -51.57 0.16 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.73 1.62 . . . . 0.0 115.808 -169.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 85.01 172.48 0.07 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 128.463 2.705 . . . . 0.0 109.638 -171.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.08 -34.19 42.69 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 125.408 1.483 . . . . 0.0 110.398 169.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.59 -48.12 73.39 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-O 117.883 -1.056 . . . . 0.0 108.619 -173.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 54.8 t -79.82 -52.48 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -176.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -63.92 -9.73 17.06 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.55 1.068 . . . . 0.0 111.23 -176.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.41 -74.53 0.09 Allowed 'General case' 0 CA--C 1.489 -1.4 0 CA-C-O 122.108 0.956 . . . . 0.0 108.547 162.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 17.7 t -70.93 -29.65 38.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 113.585 -1.643 . . . . 0.0 107.114 -156.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.03 -12.44 3.36 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 117.685 -1.15 . . . . 0.0 109.972 173.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.75 -37.03 8.89 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.1 mp -63.79 -18.53 64.18 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.887 2.475 . . . . 0.0 113.257 172.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 12.7 t -128.0 16.48 6.77 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.97 1.308 . . . . 0.0 112.623 -171.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . 0.257 0.1 OUTLIER 40.11 78.95 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.38 1.472 . . . . 0.0 110.661 -173.906 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.79 -49.02 0.82 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.114 1.366 . . . . 0.0 107.93 -178.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.9 p-10 -62.53 -25.32 67.98 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 125.747 1.619 . . . . 0.0 112.072 176.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.5 -11.92 38.78 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.744 1.218 . . . . 0.0 113.895 -178.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.6 mt -105.55 -51.04 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 -173.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.5 t -107.91 142.62 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 121.414 0.626 . . . . 0.0 109.328 -170.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.4 mtmm -69.52 163.36 25.56 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-N 114.673 -1.149 . . . . 0.0 112.261 173.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -148.87 146.0 17.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 113.312 -1.767 . . . . 0.0 108.887 -169.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -148.57 167.55 25.12 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.544 1.138 . . . . 0.0 110.625 -171.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.7 -40.72 13.06 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -177.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.2 p -127.29 172.08 10.92 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.81 0.814 . . . . 0.0 109.501 -179.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 23.8 mm -70.04 -40.71 78.79 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.553 170.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 38.8 t -66.35 -33.12 75.0 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 119.288 0.949 . . . . 0.0 109.846 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -64.66 -11.76 38.98 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.872 0.869 . . . . 0.0 111.952 175.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -113.58 -39.08 4.14 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 124.935 1.294 . . . . 0.0 109.829 -175.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 5.9 ttp -58.17 -46.79 85.12 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.865 1.266 . . . . 0.0 112.348 -164.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -90.09 -19.89 23.81 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.869 1.268 . . . . 0.0 111.623 177.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -83.62 -50.39 8.25 Favored 'General case' 0 C--O 1.219 -0.532 0 C-N-CA 123.685 0.794 . . . . 0.0 109.095 -171.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -53.36 -16.7 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 127.292 2.237 . . . . 0.0 113.173 177.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -47.36 64.07 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.299 2.24 . . . . 0.0 111.746 169.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.22 37.21 1.72 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.559 1.944 . . . . 0.0 113.199 -173.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.107 0 C-N-CA 130.886 3.675 . . . . 0.0 111.666 157.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 9.2 p90 . . . . . 0 CA--C 1.535 0.383 0 CA-C-O 119.495 -0.288 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.535 ' HG2' ' H ' ' A' ' 18' ' ' ILE . 4.9 ttmt -137.65 173.36 11.74 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.563 1.945 . . . . 0.0 109.452 173.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.535 ' H ' ' HG2' ' A' ' 17' ' ' LYS . 67.0 mt -135.53 134.81 51.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 128.866 2.866 . . . . 0.0 105.973 168.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.2 m -108.1 -169.94 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 128.289 2.635 . . . . 0.0 107.038 164.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -23.05 -75.92 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 128.153 2.581 . . . . 0.0 113.311 -171.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -134.15 36.23 3.24 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.256 0.622 . . . . 0.0 110.291 172.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.447 HG12 ' CE2' ' A' ' 56' ' ' PHE . 6.8 t -142.25 153.55 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.049 0 CA-C-O 122.785 1.278 . . . . 0.0 110.572 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -113.41 151.96 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.721 0 CA-C-N 112.67 -2.059 . . . . 0.0 107.487 -168.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.9 mp -132.33 88.54 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -179.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.59 158.26 32.51 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 120.377 1.444 . . . . 0.0 109.811 166.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -168.53 73.18 0.82 Allowed Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 123.905 0.882 . . . . 0.0 110.317 -176.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -68.65 120.86 7.76 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.881 2.387 . . . . 0.0 111.407 -168.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -76.16 66.53 2.32 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.4 -0.812 . . . . 0.0 111.749 175.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? 61.31 8.7 2.21 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.538 1.535 . . . . 0.0 113.155 -175.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.04 26.84 0.14 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.835 1.254 . . . . 0.0 112.789 -178.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.97 80.01 7.87 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 123.353 1.549 . . . . 0.0 106.842 175.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -99.63 148.95 23.79 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 127.191 2.196 . . . . 0.0 107.333 163.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.0 tt -54.37 -30.57 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.465 1.506 . . . . 0.0 112.217 174.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -58.93 -63.62 1.23 Allowed 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 175.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -51.7 -46.06 63.75 Favored 'General case' 0 C--O 1.222 -0.356 0 C-N-CA 125.252 1.421 . . . . 0.0 109.574 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.75 -40.57 63.23 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.838 1.255 . . . . 0.0 113.631 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -64.29 -47.72 78.41 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 119.795 1.18 . . . . 0.0 109.599 177.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.41 -31.77 65.79 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 118.014 -0.993 . . . . 0.0 111.03 -175.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -41.35 -40.3 1.66 Allowed 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 128.075 2.55 . . . . 0.0 110.715 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -55.46 -72.11 0.07 Allowed 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 118.989 0.813 . . . . 0.0 109.41 168.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.53 -35.48 63.24 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.869 0.868 . . . . 0.0 111.132 -172.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 20.7 t90 -59.88 -73.23 0.09 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 117.152 -1.404 . . . . 0.0 111.24 170.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 53.9 t -49.18 -36.33 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-N 120.452 1.478 . . . . 0.0 111.195 -178.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -68.52 -57.48 5.73 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 124.732 1.213 . . . . 0.0 110.538 -178.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -67.72 -31.58 71.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 118.545 0.611 . . . . 0.0 110.636 -177.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -89.24 -20.62 23.92 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 123.334 0.653 . . . . 0.0 111.728 -168.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -133.62 -53.85 0.88 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 118.619 0.645 . . . . 0.0 111.537 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 35.6 mt -64.31 -39.92 94.9 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 119.035 -0.507 . . . . 0.0 110.808 -171.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -72.97 -35.61 66.94 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 126.922 2.089 . . . . 0.0 111.356 173.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.91 -50.62 70.2 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.563 0.745 . . . . 0.0 109.46 175.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 138.21 6.08 1.48 Allowed Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.368 0.985 . . . . 0.0 112.634 -177.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -72.06 155.63 40.09 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 118.464 1.132 . . . . 0.0 109.876 177.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -131.65 15.31 4.89 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.692 1.597 . . . . 0.0 111.187 173.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -153.32 105.11 2.83 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 -163.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -116.09 155.19 17.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 103.801 -2.666 . . . . 0.0 103.801 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.447 ' CE2' HG12 ' A' ' 22' ' ' VAL . 27.4 m-85 -130.29 160.67 33.23 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 159.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 42.0 tp -126.72 103.98 7.83 Favored 'General case' 0 C--N 1.334 -0.083 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 173.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.2 t -78.88 141.27 15.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 171.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.4 mp -122.69 12.24 9.88 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.603 0.638 . . . . 0.0 112.304 -178.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.5 t -50.01 -44.72 51.35 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.655 1.582 . . . . 0.0 111.401 178.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -68.56 -36.22 78.48 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 118.684 -0.674 . . . . 0.0 111.234 -175.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 p -103.44 117.71 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 126.579 1.951 . . . . 0.0 107.753 -160.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -76.13 -39.63 54.65 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.22 -0.925 . . . . 0.0 109.17 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 78.9 p -140.29 163.17 33.47 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -175.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.0 tt -136.7 154.73 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 C-N-CA 126.407 1.883 . . . . 0.0 107.068 175.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.89 160.07 17.37 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.185 1.794 . . . . 0.0 109.847 -175.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.3 t -62.8 -12.89 27.35 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.7 1.2 . . . . 0.0 113.278 174.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -71.37 -68.29 0.46 Allowed 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 168.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.67 -30.3 66.86 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.674 1.189 . . . . 0.0 112.531 -163.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.6 mt -47.42 -42.54 22.44 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.966 0.907 . . . . 0.0 109.759 174.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -71.79 -29.84 66.84 Favored Glycine 0 CA--C 1.528 0.854 0 O-C-N 121.365 -0.834 . . . . 0.0 112.298 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.0 t -67.92 -35.26 71.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 O-C-N 121.583 -0.951 . . . . 0.0 109.314 176.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.8 -47.91 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.6 t -60.88 -39.43 81.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 O-C-N 121.535 -0.728 . . . . 0.0 110.938 174.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.41 -42.76 92.53 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 120.973 -1.08 . . . . 0.0 112.327 -176.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.3 mt -53.64 -43.52 54.83 Favored 'Isoleucine or valine' 0 C--N 1.343 0.308 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 172.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -66.44 -48.35 70.25 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -173.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 24.6 mttm -55.22 -47.59 75.1 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 122.777 0.431 . . . . 0.0 111.099 178.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.1 m -61.87 -46.55 88.95 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.974 0.91 . . . . 0.0 110.391 -177.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 29.4 mt -65.75 -48.06 83.64 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 C-N-CA 124.051 0.94 . . . . 0.0 111.328 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.52 -39.54 80.38 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 177.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 50.6 m -62.57 -41.54 98.99 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.061 176.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.7 m -61.42 -51.22 69.66 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.362 0.983 . . . . 0.0 109.982 174.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 134.75 24.24 0.6 Allowed Glycine 0 CA--C 1.525 0.671 0 C-N-CA 123.711 0.672 . . . . 0.0 112.396 -171.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -119.67 -173.12 15.23 Favored Glycine 0 N--CA 1.439 -1.131 0 CA-C-N 118.599 1.199 . . . . 0.0 111.942 -176.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -131.6 155.3 47.77 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.843 1.657 . . . . 0.0 109.246 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -150.57 135.42 17.5 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.697 0.799 . . . . 0.0 109.595 176.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -139.95 162.24 35.65 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.009 0.433 . . . . 0.0 111.982 -177.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.5 mp -103.03 151.93 21.93 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.025 1.73 . . . . 0.0 107.405 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 70.4 t -145.1 145.43 20.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -168.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 47.1 t 42.37 57.66 10.7 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 124.499 1.119 . . . . 0.0 110.124 -176.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -64.98 -77.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.947 2.431 . . . . 0.0 111.301 -165.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 25.0 p30 142.46 -175.12 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.492 1 C-N-CA 133.337 4.655 . . . . 0.0 106.01 171.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -77.84 -32.91 52.42 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 122.458 1.123 . . . . 0.0 111.849 176.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.74 -51.26 19.9 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 129.921 3.288 . . . . 0.0 110.271 -166.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.2 t -63.94 -48.12 87.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 125.668 1.587 . . . . 0.0 107.75 168.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -61.56 -26.08 67.72 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 122.746 2.521 . . . . 0.0 110.828 -175.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -46.98 85.83 Favored 'General case' 0 C--N 1.344 0.341 0 O-C-N 121.376 -0.827 . . . . 0.0 109.583 175.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.2 p -80.45 -31.31 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -172.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.3 mp -66.06 -17.48 64.72 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 118.037 -0.982 . . . . 0.0 112.462 177.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.6 m -77.86 -58.11 3.44 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 165.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.93 -68.56 0.16 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.019 2.128 . . . . 0.0 111.641 -173.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.7 t -76.92 14.59 0.81 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.671 1.589 . . . . 0.0 112.518 -175.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 42.76 85.05 0.02 OUTLIER 'General case' 0 C--N 1.34 0.194 0 C-N-CA 126.256 1.822 . . . . 0.0 112.014 -169.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . 0.334 0.1 OUTLIER -126.04 -41.47 1.94 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 125.169 1.388 . . . . 0.0 112.362 178.163 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -67.76 -21.18 65.28 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.95 1.25 . . . . 0.0 111.259 171.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.9 mtm180 -79.51 -1.94 39.94 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 118.805 -0.617 . . . . 0.0 111.227 -178.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.7 mm -127.69 -46.17 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 C-N-CA 124.97 1.308 . . . . 0.0 108.384 -164.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.6 t -110.48 149.24 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 -177.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.468 ' HE3' ' H ' ' A' ' 111' ' ' ILE . 0.0 OUTLIER -71.52 160.88 31.93 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.979 173.519 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.468 ' H ' ' HE3' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -145.27 143.29 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -177.249 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -146.55 171.4 15.14 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.349 1.459 . . . . 0.0 110.417 -177.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -87.24 -50.03 6.87 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -177.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 31.8 p -125.55 170.54 11.35 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-O 122.174 0.987 . . . . 0.0 111.141 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 12.4 mm -63.13 -36.76 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 C-N-CA 124.293 1.037 . . . . 0.0 108.379 170.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.79 -43.0 90.04 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 119.869 1.213 . . . . 0.0 110.979 -178.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -71.41 3.87 3.43 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 123.691 0.62 . . . . 0.0 112.169 178.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -114.39 -33.89 5.46 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 174.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.16 -52.31 62.94 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 120.17 -1.582 . . . . 0.0 111.79 -162.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -89.8 -13.81 35.82 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.48 0.712 . . . . 0.0 112.113 172.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.81 -52.36 6.1 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -168.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -53.31 -32.45 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 126.406 1.883 . . . . 0.0 111.322 176.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 43.8 mtm180 -62.18 -25.03 67.55 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 124.221 1.008 . . . . 0.0 111.285 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.22 56.33 1.0 Allowed 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 119.158 0.89 . . . . 0.0 109.862 169.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.199 0 CA-C-O 118.196 -0.907 . . . . 0.0 111.437 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 15.2 p90 . . . . . 0 N--CA 1.451 -0.418 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -141.32 173.14 11.78 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 127.309 2.244 . . . . 0.0 108.365 164.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.6 mt -129.8 120.65 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 167.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.3 m -88.09 -151.96 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 124.938 1.295 . . . . 0.0 108.226 172.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -25.03 -72.39 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 128.6 2.76 . . . . 0.0 113.472 -177.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -145.43 28.03 1.21 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.184 1.394 . . . . 0.0 110.49 165.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.2 t -122.42 137.22 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 O-C-N 120.824 -1.172 . . . . 0.0 110.444 -177.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.4 t -84.8 135.81 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 177.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.1 mp -117.01 103.39 14.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 173.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -76.66 95.52 3.98 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 128.194 2.598 . . . . 0.0 106.765 171.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 14.8 mtm -94.45 95.8 1.58 Allowed Pre-proline 0 CA--C 1.55 0.966 0 CA-C-N 121.539 1.972 . . . . 0.0 106.54 172.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -67.99 172.25 11.13 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 CA-C-N 122.08 1.778 . . . . 0.0 109.488 171.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.471 ' ND2' ' H ' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -152.89 -71.99 0.14 Allowed 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 169.661 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.471 ' H ' ' ND2' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -132.33 17.27 4.47 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.0 1.32 . . . . 0.0 112.488 -176.794 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -89.89 1.13 56.58 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 122.994 0.518 . . . . 0.0 111.13 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 17.9 mt -89.76 89.56 7.83 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -132.68 22.07 4.27 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.499 1.12 . . . . 0.0 113.152 -166.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.255 0.2 OUTLIER 64.12 -43.27 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 129.188 2.995 . . . . 0.0 114.444 -172.795 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -61.39 -19.01 61.42 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 120.765 -1.209 . . . . 0.0 111.061 174.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -115.25 68.77 0.71 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 126.404 1.882 . . . . 0.0 108.288 174.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -132.34 -62.61 0.83 Allowed 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 167.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -59.05 -35.29 73.07 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.238 0.927 . . . . 0.0 110.306 174.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 36.0 mt -67.11 -28.88 68.52 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 124.244 1.017 . . . . 0.0 112.929 173.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -59.13 -57.75 11.69 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 124.62 1.168 . . . . 0.0 108.745 -172.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.496 ' HE2' ' CE2' ' A' ' 44' ' ' PHE . 3.9 ttpm? -54.24 -49.06 70.37 Favored 'General case' 0 C--O 1.216 -0.682 0 CA-C-O 116.684 -1.627 . . . . 0.0 110.216 172.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -43.99 85.67 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 120.667 1.576 . . . . 0.0 111.367 -176.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -67.81 -60.89 2.17 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-O 116.709 -1.615 . . . . 0.0 109.088 177.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.444 HG12 ' CD1' ' A' ' 48' ' ' LEU . 56.7 t -52.1 -38.7 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 121.538 1.972 . . . . 0.0 109.772 -178.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.496 ' CE2' ' HE2' ' A' ' 40' ' ' LYS . 8.0 m-30 -60.26 -69.03 0.24 Allowed 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 124.362 1.065 . . . . 0.0 110.687 176.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.21 -10.13 59.17 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -171.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -90.94 -31.37 16.4 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 116.048 -1.929 . . . . 0.0 110.284 173.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -134.54 -53.42 0.82 Allowed 'General case' 0 C--N 1.357 0.906 0 CA-C-N 122.804 2.547 . . . . 0.0 109.91 -174.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.444 ' CD1' HG12 ' A' ' 43' ' ' VAL . 6.6 mp -55.8 -59.59 4.65 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.818 0.818 . . . . 0.0 110.918 -174.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -75.45 -5.48 45.26 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 124.623 1.169 . . . . 0.0 112.268 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.7 mttm -75.59 -28.8 59.06 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.12 0.873 . . . . 0.0 110.274 163.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 125.0 -6.0 8.29 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 126.143 1.83 . . . . 0.0 112.688 -176.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -71.49 174.79 6.15 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 119.44 1.62 . . . . 0.0 108.928 175.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -172.09 5.72 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.184 1.794 . . . . 0.0 109.598 -169.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.81 112.49 12.54 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 104.889 -2.263 . . . . 0.0 104.889 -176.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mp -122.94 146.38 28.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 178.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.419 ' CZ ' HG21 ' A' ' 122' ' ' VAL . 17.1 m-85 -129.34 128.96 44.17 Favored 'General case' 0 C--O 1.228 -0.051 0 C-N-CA 123.958 0.903 . . . . 0.0 109.735 166.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 47.5 tp -95.16 121.48 36.85 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.296 1.039 . . . . 0.0 109.594 -178.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.4 ' HA ' ' HB ' ' A' ' 90' ' ' VAL . 0.8 OUTLIER -89.09 152.94 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 119.59 1.086 . . . . 0.0 111.402 177.902 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.0 0.8 3.21 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.115 0.966 . . . . 0.0 112.982 175.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.44 -8.19 1.7 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 169.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -116.68 -5.66 11.61 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.563 1.145 . . . . 0.0 111.83 -168.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.4 p -143.8 148.43 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 125.012 1.325 . . . . 0.0 107.47 -170.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -78.0 -46.98 19.53 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 176.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.8 p -155.12 168.2 27.82 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.6 tt -94.13 156.43 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 125.977 1.711 . . . . 0.0 108.178 162.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -111.44 174.57 5.8 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.551 -0.718 . . . . 0.0 110.358 -176.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.5 m -57.87 -39.92 78.98 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 121.412 -0.805 . . . . 0.0 112.241 -172.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -50.36 -53.13 31.36 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.255 1.422 . . . . 0.0 111.232 176.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 p -93.51 -20.75 19.97 Favored 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 121.683 -0.635 . . . . 0.0 112.026 -169.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 31.6 tp -56.97 -17.21 8.87 Favored 'General case' 0 CA--C 1.551 0.988 0 O-C-N 120.844 -1.16 . . . . 0.0 111.468 170.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -101.07 -8.51 47.53 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 125.046 1.308 . . . . 0.0 115.216 169.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -89.16 -38.88 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 119.608 1.704 . . . . 0.0 109.157 175.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.4 mm -58.42 -41.17 80.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 O-C-N 121.127 -0.983 . . . . 0.0 110.706 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 65.8 t -61.36 -42.77 94.94 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 CA-C-N 118.264 0.484 . . . . 0.0 110.212 174.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -63.67 -30.64 71.72 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 120.82 -1.175 . . . . 0.0 111.052 -176.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.9 mt -64.17 -40.06 87.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 171.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -67.84 -49.19 63.51 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 123.931 0.892 . . . . 0.0 109.172 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.3 mttm -48.72 -55.64 10.84 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 124.451 1.1 . . . . 0.0 110.418 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 69.2 m -78.41 -26.75 46.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 118.145 -0.931 . . . . 0.0 112.699 -172.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 25.2 mt -59.04 -44.89 92.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 119.85 1.204 . . . . 0.0 109.306 165.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.2 t -74.59 -18.44 60.57 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.34 1.056 . . . . 0.0 112.135 -176.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.1 m -77.89 -43.78 29.08 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.881 0.872 . . . . 0.0 110.279 166.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.0 m -64.38 -50.9 65.84 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 118.418 -0.801 . . . . 0.0 110.741 -176.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 134.2 23.13 0.69 Allowed Glycine 0 CA--C 1.521 0.426 0 CA-C-O 119.157 -0.801 . . . . 0.0 113.565 -175.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -115.82 -171.98 16.64 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 118.84 1.32 . . . . 0.0 111.81 -170.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.16 158.4 43.75 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.466 1.507 . . . . 0.0 110.201 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -150.5 142.2 23.66 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -144.07 173.22 11.91 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.318 1.447 . . . . 0.0 110.605 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.28 168.14 10.88 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.4 ' HB ' ' HA ' ' A' ' 58' ' ' VAL . 57.7 t -139.48 129.4 30.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 124.425 1.09 . . . . 0.0 108.153 -164.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.9 t 43.84 69.98 2.12 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 127.122 2.169 . . . . 0.0 110.555 -176.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -71.09 118.82 5.89 Favored 'Trans proline' 0 N--CA 1.445 -1.365 0 N-CA-C 107.597 -1.732 . . . . 0.0 107.597 173.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 49.1 p30 -67.33 165.5 16.26 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 122.863 1.316 . . . . 0.0 109.447 163.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -69.19 -24.49 64.05 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.892 -174.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -46.41 78.79 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 126.624 1.97 . . . . 0.0 110.256 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.6 t -77.93 -38.59 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-O 118.263 -0.875 . . . . 0.0 109.982 -178.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -51.25 -39.02 55.78 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 124.744 1.218 . . . . 0.0 110.045 177.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.7 -61.27 1.91 Allowed 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 125.69 1.596 . . . . 0.0 114.222 172.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 77.9 t -71.21 -47.92 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 C-N-CA 125.889 1.676 . . . . 0.0 107.339 -169.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.39 -21.53 60.05 Favored 'General case' 0 N--CA 1.438 -1.028 0 O-C-N 124.495 1.122 . . . . 0.0 108.6 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.4 m -82.47 -52.01 7.27 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 81.1 mt -57.94 -29.0 64.81 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.578 1.951 . . . . 0.0 113.495 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.9 t -111.53 -1.81 15.71 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.917 1.287 . . . . 0.0 111.205 -171.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 53.9 78.9 0.14 Allowed 'General case' 0 C--N 1.343 0.283 0 C-N-CA 127.181 2.192 . . . . 0.0 109.931 -176.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.19 -49.39 1.94 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 126.716 2.006 . . . . 0.0 108.064 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -67.17 -12.19 59.36 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.141 1.376 . . . . 0.0 112.465 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.1 mtp180 -90.22 -0.79 57.79 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.867 1.667 . . . . 0.0 111.433 176.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.6 mm -127.46 -45.21 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 125.623 1.569 . . . . 0.0 107.431 -165.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.2 t -99.21 155.08 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 174.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.45 164.78 25.65 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 121.524 -0.735 . . . . 0.0 109.832 170.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.45 141.83 23.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -145.1 164.91 29.8 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 125.981 1.712 . . . . 0.0 110.095 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -94.94 -54.59 3.4 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 46.7 p -106.96 157.56 17.69 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 118.778 0.717 . . . . 0.0 109.365 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 9.1 mm -58.65 -36.55 60.67 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 175.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 45.0 t -60.79 -41.59 95.9 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 118.933 -0.556 . . . . 0.0 110.654 -175.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -71.92 -21.49 61.61 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 124.163 0.915 . . . . 0.0 110.639 -176.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -79.53 -54.07 6.25 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 104.12 -2.548 . . . . 0.0 104.12 176.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.97 -59.3 3.19 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 125.518 1.527 . . . . 0.0 111.774 -160.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -75.61 -19.21 59.38 Favored 'General case' 0 CA--C 1.521 -0.172 0 O-C-N 123.926 0.766 . . . . 0.0 112.299 -176.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -88.09 -51.49 5.77 Favored 'General case' 0 CA--C 1.495 -1.14 0 CA-C-O 118.568 -0.729 . . . . 0.0 110.134 -172.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.419 HG21 ' CZ ' ' A' ' 56' ' ' PHE . 40.3 t -48.65 -39.44 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 126.439 1.896 . . . . 0.0 110.062 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -47.64 -43.11 25.76 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.545 1.138 . . . . 0.0 112.639 171.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -134.06 33.82 3.37 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.377 2.671 . . . . 0.0 112.752 -172.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.235 0 C-N-CA 126.708 2.003 . . . . 0.0 113.977 -160.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 14.4 p90 . . . . . 0 CA--C 1.541 0.604 0 CA-C-O 121.468 0.651 . . . . 0.0 111.682 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.531 ' HG2' ' H ' ' A' ' 18' ' ' ILE . 3.2 ttmm -136.56 173.17 11.99 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.222 2.209 . . . . 0.0 108.076 161.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.531 ' H ' ' HG2' ' A' ' 17' ' ' LYS . 54.2 mt -135.33 144.96 32.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 129.015 2.926 . . . . 0.0 104.223 163.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.1 m -105.76 -130.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 173.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -50.59 -66.87 0.31 Allowed 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 126.917 2.087 . . . . 0.0 111.263 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -144.48 11.87 1.5 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.825 2.05 . . . . 0.0 111.82 178.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.445 HG11 ' CE2' ' A' ' 56' ' ' PHE . 8.9 t -119.26 135.44 59.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -177.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.452 HG11 ' HA ' ' A' ' 55' ' ' ILE . 0.6 OUTLIER -81.55 150.39 4.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 C-N-CA 128.337 2.655 . . . . 0.0 111.798 174.26 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.1 mp -132.33 88.95 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 175.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.421 ' CD1' ' CH2' ' A' ' 42' ' ' TRP . 4.3 mm? -58.36 140.18 54.03 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 168.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 61.6 mtt -139.2 76.54 32.17 Favored Pre-proline 0 C--N 1.328 -0.339 0 C-N-CA 125.04 1.336 . . . . 0.0 108.483 176.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -75.49 68.02 6.22 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.574 2.183 . . . . 0.0 109.02 176.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.2 93.41 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.461 1.504 . . . . 0.0 107.861 176.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.25 -21.32 0.07 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 127.911 2.484 . . . . 0.0 114.8 -170.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.88 59.0 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 129.535 3.134 . . . . 0.0 113.837 -177.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 65.0 mt -127.98 23.41 6.13 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 119.516 -1.99 . . . . 0.0 112.21 175.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -53.3 150.21 6.51 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 164.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.7 mt -58.31 -37.95 66.21 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 CA-C-O 119.33 -0.367 . . . . 0.0 111.629 -174.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -68.33 -34.56 76.34 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 118.725 0.693 . . . . 0.0 109.343 -171.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -72.66 -43.72 62.78 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 171.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.41 -33.18 65.54 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.883 0.765 . . . . 0.0 111.626 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 25.5 t60 -70.06 -47.96 59.79 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 120.495 -1.378 . . . . 0.0 110.262 174.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.0 -17.34 61.46 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 118.968 -0.539 . . . . 0.0 111.727 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -48.83 -55.78 10.62 Favored 'General case' 0 CA--C 1.513 -0.442 0 C-N-CA 127.999 2.52 . . . . 0.0 110.513 -170.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp -66.48 -28.99 69.01 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 117.86 -1.067 . . . . 0.0 111.047 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.7 ttmt -68.26 -51.99 38.97 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 121.157 1.799 . . . . 0.0 109.211 172.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.421 ' CH2' ' CD1' ' A' ' 25' ' ' LEU . 13.7 t90 -59.91 -59.45 5.4 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.229 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.0 t -50.41 -30.04 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 120.262 1.392 . . . . 0.0 112.199 176.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -72.76 -69.84 0.39 Allowed 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 173.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -61.61 -35.86 79.06 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 124.289 1.036 . . . . 0.0 112.949 -167.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -75.69 -30.94 59.51 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.247 2.219 . . . . 0.0 111.284 175.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -132.02 -67.21 0.68 Allowed 'General case' 0 C--N 1.352 0.694 0 CA-C-N 120.682 1.583 . . . . 0.0 112.286 -174.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.5 mt -59.17 -48.76 80.41 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.372 0.987 . . . . 0.0 112.694 -170.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -65.56 -34.5 78.39 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 125.428 1.491 . . . . 0.0 109.726 177.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.9 mttm -61.38 -21.64 64.25 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.802 1.241 . . . . 0.0 111.811 171.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.6 14.68 36.94 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.329 0.966 . . . . 0.0 112.485 -178.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -70.38 139.14 51.85 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 118.931 1.365 . . . . 0.0 108.085 166.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -119.42 6.02 11.13 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.592 1.157 . . . . 0.0 110.292 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt -146.87 98.05 2.99 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 120.27 1.395 . . . . 0.0 107.254 -167.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.452 ' HA ' HG11 ' A' ' 23' ' ' VAL . 1.2 mp -102.81 151.92 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.445 ' CE2' HG11 ' A' ' 22' ' ' VAL . 22.4 m-85 -123.2 160.42 26.59 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.965 0.79 . . . . 0.0 111.908 157.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.6 tp -125.3 122.48 37.01 Favored 'General case' 0 C--O 1.223 -0.324 0 C-N-CA 124.887 1.275 . . . . 0.0 109.221 171.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.6 t -95.06 141.74 14.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 173.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.3 mp -123.57 6.46 8.9 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.011 1.324 . . . . 0.0 111.133 -174.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.4 t -54.66 -36.8 64.99 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.114 1.765 . . . . 0.0 111.737 174.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -104.76 18.71 21.79 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.113 0.965 . . . . 0.0 111.101 -165.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.4 p -151.18 122.84 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 123.551 0.74 . . . . 0.0 109.386 -175.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -73.24 -43.41 61.22 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 117.995 -1.003 . . . . 0.0 108.979 177.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.4 t -150.35 175.82 11.47 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 119.169 0.895 . . . . 0.0 111.962 -171.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.8 tt -140.91 149.85 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 -175.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -81.45 155.75 25.69 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 123.804 0.842 . . . . 0.0 109.743 -174.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.2 p -54.01 -25.8 22.98 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.068 1.347 . . . . 0.0 112.619 175.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -61.94 -63.24 1.32 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.366 1.466 . . . . 0.0 110.478 169.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 26.4 t -82.46 -22.95 34.99 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.591 1.157 . . . . 0.0 111.974 -163.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 40.8 tp -60.91 -16.66 44.63 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 120.549 -1.344 . . . . 0.0 111.609 170.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -91.85 -29.95 11.08 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-O 118.849 -0.973 . . . . 0.0 112.194 167.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -66.67 -37.23 79.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 119.551 1.676 . . . . 0.0 111.23 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.4 mm -59.68 -46.58 93.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 C-N-CA 124.6 1.16 . . . . 0.0 109.826 175.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 50.8 t -60.98 -41.51 89.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 174.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -55.96 -41.01 74.06 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.408 -0.807 . . . . 0.0 111.344 -176.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 71.1 mt -64.03 -39.75 86.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.719 0.808 . . . . 0.0 110.03 174.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.17 -49.25 76.58 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 119.705 1.139 . . . . 0.0 109.075 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -50.12 -55.53 14.63 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 123.475 0.71 . . . . 0.0 109.88 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.71 -39.9 95.45 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 117.569 -1.205 . . . . 0.0 112.365 -178.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 76.4 mt -64.32 -43.98 97.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 121.023 1.738 . . . . 0.0 109.85 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.3 m -56.8 -48.07 78.79 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.393 0.677 . . . . 0.0 110.899 172.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.4 m -71.77 -10.54 59.92 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.09 1.356 . . . . 0.0 113.935 178.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.2 m -99.7 -25.54 14.36 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.687 1.195 . . . . 0.0 111.94 175.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 120.19 2.61 12.22 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 116.435 1.334 . . . . 0.0 116.435 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -99.2 -158.83 29.17 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 119.682 1.741 . . . . 0.0 112.95 -171.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.496 ' CZ ' ' HE2' ' A' ' 125' ' ' LYS . 0.3 OUTLIER -139.93 160.11 40.67 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 127.0 2.12 . . . . 0.0 109.852 170.387 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -149.31 143.82 26.07 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 176.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.27 165.56 28.89 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.09 0.956 . . . . 0.0 112.157 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.2 mp -113.72 156.39 23.87 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.753 2.021 . . . . 0.0 108.983 -175.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 57.7 t -146.79 149.39 15.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 123.432 0.693 . . . . 0.0 109.934 -159.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.2 t 49.14 54.89 16.83 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 125.029 1.332 . . . . 0.0 111.412 -175.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -82.54 81.7 2.41 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 122.344 2.029 . . . . 0.0 111.69 -164.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.0 156.54 9.13 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 122.044 0.926 . . . . 0.0 110.545 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -62.93 -33.68 75.85 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.803 -1.09 . . . . 0.0 112.241 -163.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.8 -41.59 97.88 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 123.67 0.788 . . . . 0.0 109.264 -174.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.9 t -70.63 -42.37 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-O 117.514 -1.232 . . . . 0.0 110.236 175.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -58.82 -28.65 66.23 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 120.127 1.331 . . . . 0.0 110.804 -172.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -51.08 -60.46 3.07 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-O 125.028 2.347 . . . . 0.0 111.454 173.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.7 t -71.08 -39.01 73.86 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.747 0 CA-C-N 112.508 -2.133 . . . . 0.0 107.454 -172.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.2 mt -61.79 -15.62 42.98 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 118.234 -0.888 . . . . 0.0 110.481 177.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.5 -46.1 10.49 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-O 121.32 0.581 . . . . 0.0 110.164 173.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.73 -62.53 1.8 Allowed 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.703 2.001 . . . . 0.0 108.425 -177.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.0 -5.76 43.33 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 129.129 2.972 . . . . 0.0 111.07 -169.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 49.99 77.73 0.11 Allowed 'General case' 0 C--N 1.344 0.361 0 C-N-CA 127.45 2.3 . . . . 0.0 109.437 -168.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.44 -57.08 2.17 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 173.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -65.52 -12.44 52.82 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 127.427 2.291 . . . . 0.0 112.462 175.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.4 mtt-85 -88.96 2.89 53.19 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.082 0.953 . . . . 0.0 113.08 171.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.8 mt -133.15 -43.08 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 125.098 1.359 . . . . 0.0 109.238 -173.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.1 t -114.16 141.73 29.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 125.501 1.52 . . . . 0.0 106.941 -177.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.46 159.64 23.9 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.618 0.767 . . . . 0.0 112.21 177.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -123.28 154.93 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 125.65 1.58 . . . . 0.0 106.98 169.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -147.44 162.97 37.94 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.98 1.712 . . . . 0.0 109.569 170.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -81.35 -53.24 6.49 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 119.464 -0.895 . . . . 0.0 109.361 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 67.6 p -129.44 161.58 30.06 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 125.327 1.451 . . . . 0.0 108.502 -169.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 26.7 mm -63.79 -38.89 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -173.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.9 t -74.38 -19.97 60.24 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 118.863 -1.135 . . . . 0.0 111.487 -174.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -70.22 -20.46 63.09 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 118.965 0.802 . . . . 0.0 111.173 170.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -105.42 -39.83 6.01 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.997 0.919 . . . . 0.0 109.478 -169.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 5.0 ttm -58.36 -44.12 88.7 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 124.49 1.116 . . . . 0.0 111.972 -162.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -95.16 -10.49 30.39 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.347 1.059 . . . . 0.0 111.726 178.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -93.12 -50.67 5.4 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.041 -172.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -47.98 -37.43 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 125.73 1.612 . . . . 0.0 111.059 173.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -56.49 -32.78 65.35 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-O 118.494 -0.765 . . . . 0.0 111.684 176.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.73 29.42 2.35 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -175.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.496 ' HE2' ' CZ ' ' A' ' 86' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.175 0 C-N-CA 124.317 1.047 . . . . 0.0 110.059 -171.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.6 p90 . . . . . 0 N--CA 1.442 -0.844 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.523 ' HG2' ' H ' ' A' ' 18' ' ' ILE . 3.6 ttmm -122.44 170.85 9.56 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 126.411 1.885 . . . . 0.0 108.667 167.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.523 ' H ' ' HG2' ' A' ' 17' ' ' LYS . 42.7 mt -129.1 130.52 68.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 157.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.7 m -88.87 -141.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 125.311 1.444 . . . . 0.0 108.185 171.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -40.45 -78.38 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 127.585 2.354 . . . . 0.0 111.001 168.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -135.8 9.17 3.32 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 123.308 0.643 . . . . 0.0 111.87 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.7 t -106.25 135.16 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.2 t -84.98 147.52 5.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 171.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.8 mp -130.4 91.85 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 176.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -71.25 111.94 6.99 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 121.072 1.76 . . . . 0.0 108.983 171.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 4.1 mtt -106.11 91.39 5.46 Favored Pre-proline 0 CA--C 1.548 0.869 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.33 122.95 4.78 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.187 2.591 . . . . 0.0 111.499 -171.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.406 ' C ' ' HE2' ' A' ' 29' ' ' LYS . 0.4 OUTLIER -90.63 74.87 6.69 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 122.34 1.067 . . . . 0.0 111.746 175.959 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.406 ' HE2' ' C ' ' A' ' 28' ' ' ASN . 0.0 OUTLIER 55.72 16.9 2.16 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 119.891 -1.756 . . . . 0.0 113.137 -174.036 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -99.09 13.41 32.95 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 121.421 -0.799 . . . . 0.0 112.546 -161.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.95 72.25 6.7 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 171.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -92.35 148.5 22.07 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 169.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -58.65 -34.45 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 120.345 1.43 . . . . 0.0 109.617 -177.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -64.47 -12.14 40.73 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 120.202 -1.561 . . . . 0.0 112.949 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -110.36 -26.71 9.42 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.452 1.501 . . . . 0.0 112.074 168.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.53 -37.57 80.12 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.099 -1.001 . . . . 0.0 111.194 178.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -55.49 -47.65 75.83 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.003 0.921 . . . . 0.0 109.368 168.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 73.0 mt -70.02 -24.01 63.21 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-O 118.081 -0.961 . . . . 0.0 112.496 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -55.43 -38.25 68.74 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.805 1.242 . . . . 0.0 112.151 -162.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -56.87 -65.3 0.64 Allowed 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 118.384 -0.817 . . . . 0.0 109.107 167.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.2 tmtt? -50.74 -47.16 59.43 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 124.199 1.0 . . . . 0.0 111.029 -175.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -61.67 -67.5 0.4 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.809 1.244 . . . . 0.0 109.657 176.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 54.2 t -53.79 -33.22 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 121.411 1.914 . . . . 0.0 111.867 -176.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -60.56 -75.17 0.07 Allowed 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 124.769 1.228 . . . . 0.0 109.581 171.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -70.75 -14.15 62.33 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.886 1.675 . . . . 0.0 113.871 -169.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.88 -33.43 16.46 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 120.739 -1.226 . . . . 0.0 109.865 175.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -136.67 -60.68 0.7 Allowed 'General case' 0 C--N 1.346 0.439 0 CA-C-N 118.86 0.754 . . . . 0.0 111.921 -169.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.1 mt -60.19 -55.93 27.72 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.463 1.029 . . . . 0.0 112.673 -173.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -66.41 -9.62 35.6 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.595 1.158 . . . . 0.0 110.973 174.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.13 -2.77 58.67 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.656 1.982 . . . . 0.0 111.81 171.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.85 5.45 59.82 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.913 1.244 . . . . 0.0 114.204 177.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -77.48 146.72 36.28 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 119.745 1.772 . . . . 0.0 110.017 176.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -138.45 14.48 2.77 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.525 1.93 . . . . 0.0 110.027 -172.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -149.74 116.7 5.95 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 178.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.7 mp -120.8 152.7 23.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 175.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -124.18 158.07 33.26 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.603 1.161 . . . . 0.0 110.082 161.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 54.2 tp -118.09 122.97 44.45 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.963 1.705 . . . . 0.0 107.422 173.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . 0.252 0.7 OUTLIER -95.09 157.48 3.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 119.921 1.237 . . . . 0.0 109.927 174.349 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 24.3 mt -132.24 13.69 4.64 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.226 0.611 . . . . 0.0 111.359 -168.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.1 m -81.53 -46.48 14.43 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -173.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -88.2 -23.12 23.67 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.454 1.025 . . . . 0.0 110.7 -173.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.0 p -78.74 162.66 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 125.538 1.535 . . . . 0.0 109.776 169.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -116.99 -37.51 3.57 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.443 0.697 . . . . 0.0 110.516 170.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.87 176.07 13.04 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 122.438 1.113 . . . . 0.0 110.123 177.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.4 tt -132.6 160.0 42.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 127.361 2.264 . . . . 0.0 108.05 -172.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.454 ' C ' ' H ' ' A' ' 68' ' ' PHE . 35.6 t0 -96.24 168.79 10.37 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 119.625 -1.922 . . . . 0.0 109.79 -168.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.5 m -65.25 31.26 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 128.954 2.902 . . . . 0.0 112.052 165.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.454 ' H ' ' C ' ' A' ' 66' ' ' ASP . 43.5 t80 -132.08 -67.72 0.66 Allowed 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 172.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.28 -25.01 61.43 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.443 -166.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 33.1 tp -55.3 -33.09 62.96 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 120.601 -1.312 . . . . 0.0 110.95 171.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -95.32 1.99 65.0 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 125.111 1.339 . . . . 0.0 114.709 174.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -92.63 -32.79 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 120.181 1.991 . . . . 0.0 109.544 167.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -56.69 -53.02 46.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.339 1.056 . . . . 0.0 109.13 177.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.0 t -59.33 -39.95 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 O-C-N 121.515 -0.741 . . . . 0.0 110.374 176.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -54.94 -38.68 68.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 119.207 0.912 . . . . 0.0 112.231 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 80.5 mt -69.61 -34.21 60.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -63.43 -50.33 70.22 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 119.846 1.203 . . . . 0.0 109.278 175.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -53.31 -48.13 68.67 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.056 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.4 t -58.09 -61.38 2.59 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.395 1.878 . . . . 0.0 111.264 176.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 59.7 mt -54.84 -45.87 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 119.646 1.112 . . . . 0.0 110.798 -177.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.3 t -61.88 -41.04 97.4 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.44 -23.71 65.55 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.133 0.973 . . . . 0.0 113.348 173.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.0 m -79.0 -25.4 43.32 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 118.02 -0.99 . . . . 0.0 112.388 171.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 103.67 15.78 21.69 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.5 -1.167 . . . . 0.0 113.954 -170.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -98.08 -168.28 31.86 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 120.322 2.061 . . . . 0.0 112.586 174.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -133.51 162.65 31.3 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.031 1.333 . . . . 0.0 108.501 168.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -147.88 147.1 29.39 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.298 1.039 . . . . 0.0 108.222 176.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -152.21 172.64 16.08 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.089 1.356 . . . . 0.0 110.72 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.15 171.47 7.79 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 118.588 0.631 . . . . 0.0 109.831 -178.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 86.1 t -146.69 144.06 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.821 1.248 . . . . 0.0 109.83 -168.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 44.09 60.07 12.22 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 127.815 2.446 . . . . 0.0 113.942 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -84.51 92.56 0.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 124.545 3.496 . . . . 0.0 110.141 -170.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.65 160.32 14.31 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 121.848 -0.532 . . . . 0.0 110.269 177.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -63.74 -34.89 78.89 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.779 0.832 . . . . 0.0 111.167 -167.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.446 ' HE2' ' O ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -59.34 -29.99 68.06 Favored 'General case' 0 CA--C 1.517 -0.321 0 O-C-N 121.006 -1.059 . . . . 0.0 109.439 178.903 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.2 t -92.57 -37.48 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-O 117.911 -1.042 . . . . 0.0 110.283 177.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -59.55 -33.31 71.25 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 121.806 2.094 . . . . 0.0 109.723 175.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.64 -27.33 67.6 Favored 'General case' 0 C--O 1.222 -0.349 0 O-C-N 121.234 -0.916 . . . . 0.0 112.463 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.3 p -95.39 -39.65 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -178.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.41 -15.66 18.34 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.075 1.75 . . . . 0.0 111.955 177.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.0 t -93.51 -52.85 4.3 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -53.75 -44.81 70.28 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 128.472 2.709 . . . . 0.0 111.805 -177.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 10.1 t -79.52 -17.42 54.1 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 118.843 -0.598 . . . . 0.0 111.299 -178.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.2 m120 63.67 94.21 0.05 Allowed 'General case' 0 C--N 1.34 0.153 0 C-N-CA 127.098 2.159 . . . . 0.0 108.253 -157.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.98 -57.01 1.26 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.502 1.521 . . . . 0.0 108.575 170.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -57.33 -32.56 66.83 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 122.478 1.132 . . . . 0.0 111.098 171.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 60.6 mtt180 -71.36 -1.68 13.79 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 120.499 -1.376 . . . . 0.0 111.922 178.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.7 mt -122.62 -39.06 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 125.874 1.67 . . . . 0.0 108.714 -175.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.4 t -125.7 144.77 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 124.861 1.264 . . . . 0.0 108.775 -175.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.75 160.32 28.4 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.594 0.757 . . . . 0.0 111.328 176.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.94 142.17 34.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -173.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -146.82 176.18 10.07 Favored 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 125.189 1.396 . . . . 0.0 110.98 -176.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -103.56 -43.14 5.46 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 118.365 0.53 . . . . 0.0 111.797 -175.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 30.6 p -109.22 -162.4 0.81 Allowed 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -176.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 27.1 mm -92.01 -39.89 11.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 117.371 -1.299 . . . . 0.0 111.322 160.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.0 t -68.76 -34.77 76.14 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 120.916 1.689 . . . . 0.0 111.052 -168.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -69.06 -15.73 63.52 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 118.934 0.788 . . . . 0.0 111.696 176.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -91.12 -54.24 4.03 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 176.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 6.6 ttm -54.0 -39.48 66.12 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 124.84 1.256 . . . . 0.0 112.001 -163.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -93.49 -10.61 34.34 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.985 0.914 . . . . 0.0 113.392 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -92.24 -58.24 2.45 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 118.35 -0.833 . . . . 0.0 108.775 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.1 t -41.62 -44.39 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 128.456 2.702 . . . . 0.0 110.824 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . 0.251 1.5 ptp180 -53.12 -26.13 15.59 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.09 41.64 0.44 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 127.852 2.461 . . . . 0.0 111.371 -178.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.929 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 172.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 28.2 p90 . . . . . 0 C--O 1.234 0.279 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt -131.97 171.01 14.11 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.733 0.813 . . . . 0.0 110.942 174.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.3 mt -129.61 110.55 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 104.651 -2.351 . . . . 0.0 104.651 176.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.4 m -93.38 -134.93 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 119.562 1.074 . . . . 0.0 109.172 176.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -45.83 -78.72 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 127.827 2.451 . . . . 0.0 111.785 172.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -137.76 15.3 2.9 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.281 1.832 . . . . 0.0 109.678 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.9 t -121.6 133.55 67.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -168.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 74.6 t -92.22 131.22 39.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.9 mp -112.48 103.63 15.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 176.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.7 137.35 45.92 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 161.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 13.8 mtt -139.96 79.98 21.62 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.57 -98.81 0.01 OUTLIER 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 121.452 1.435 . . . . 0.0 111.508 -170.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.51 ' CG ' ' H ' ' A' ' 29' ' ' LYS . 18.8 p-10 155.82 -106.18 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 O-C-N 119.38 -2.075 . . . . 0.0 107.688 -163.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.51 ' H ' ' CG ' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -126.94 25.68 6.25 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.205 1.802 . . . . 0.0 108.888 167.25 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -63.19 -16.99 61.9 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.869 1.268 . . . . 0.0 111.711 170.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.6 mp -74.09 67.96 1.37 Allowed 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 169.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -124.59 7.44 8.24 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.775 2.03 . . . . 0.0 113.312 -175.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 94.87 -24.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.563 1 C-N-CA 135.457 5.503 . . . . 0.0 110.113 -176.438 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -71.94 -18.69 61.99 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 120.871 -1.143 . . . . 0.0 111.778 -175.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -98.98 -31.21 11.92 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 173.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.15 -41.74 94.46 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 113.647 0.981 . . . . 0.0 113.647 -159.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -64.3 -43.79 93.66 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.981 1.264 . . . . 0.0 110.146 -177.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.01 -22.33 49.46 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.593 -178.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -41.86 -54.27 3.47 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 127.585 2.354 . . . . 0.0 111.972 -171.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.2 pttt -68.99 -41.22 78.14 Favored 'General case' 0 C--O 1.217 -0.609 0 CA-C-O 118.15 -0.929 . . . . 0.0 111.273 -178.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.72 -44.04 90.3 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 120.31 1.414 . . . . 0.0 110.939 178.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 7.1 t90 -58.13 -66.14 0.53 Allowed 'General case' 0 C--O 1.223 -0.341 0 CA-C-O 117.364 -1.303 . . . . 0.0 108.515 171.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 51.3 t -49.44 -38.28 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 120.049 1.295 . . . . 0.0 112.282 -176.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -60.73 -62.68 1.69 Allowed 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 125.106 1.362 . . . . 0.0 109.294 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -70.61 -44.16 67.83 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 118.852 0.751 . . . . 0.0 111.218 -174.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -61.07 -33.95 74.14 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.914 1.285 . . . . 0.0 110.523 -174.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -136.41 -52.56 0.72 Allowed 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -171.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 39.3 mt -63.46 -37.93 89.18 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.207 0.912 . . . . 0.0 111.075 -173.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -84.67 -9.39 58.3 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.158 1.383 . . . . 0.0 110.549 176.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.3 mttt -82.38 3.83 26.41 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.614 1.566 . . . . 0.0 111.148 156.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.95 4.33 88.52 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 125.374 1.464 . . . . 0.0 114.344 176.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -68.89 112.23 5.43 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 119.541 1.671 . . . . 0.0 109.303 176.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 -107.63 16.65 23.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.889 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.48 126.05 32.09 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 121.106 -0.996 . . . . 0.0 108.743 164.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 mt -128.44 160.19 38.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 126.303 1.841 . . . . 0.0 106.64 172.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -132.42 159.22 39.92 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.016 1.326 . . . . 0.0 111.351 161.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 56.2 tp -127.86 87.19 2.57 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.227 0.611 . . . . 0.0 109.418 171.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.43 HG11 ' H ' ' A' ' 60' ' ' SER . 91.2 t -52.1 151.8 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 126.163 1.785 . . . . 0.0 108.326 167.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.6 mt -135.68 18.68 3.3 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.619 1.968 . . . . 0.0 110.292 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.493 ' HG ' ' CB ' ' A' ' 91' ' ' SER . 67.3 m -54.1 -54.11 43.95 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 125.071 1.348 . . . . 0.0 111.281 -169.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -97.41 9.61 41.89 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 123.338 0.655 . . . . 0.0 111.339 175.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 17.6 t -98.62 100.56 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 104.312 -2.477 . . . . 0.0 104.312 -176.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -57.82 -49.87 75.19 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.6 t -152.88 164.42 37.92 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 123.1 1.429 . . . . 0.0 112.861 -175.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.4 tt -95.06 -162.77 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 126.877 2.071 . . . . 0.0 106.838 161.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -143.21 166.67 24.06 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.244 1.417 . . . . 0.0 109.737 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.6 t -53.03 -32.73 48.32 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.14 1.776 . . . . 0.0 112.171 176.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -66.14 -60.12 3.11 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 119.376 0.989 . . . . 0.0 109.697 173.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.05 -19.37 47.75 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -163.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 18.7 mt -55.21 -32.66 62.43 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.405 -0.809 . . . . 0.0 110.766 169.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -69.35 -44.23 66.26 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-O 118.832 -0.982 . . . . 0.0 111.474 170.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.57 -32.88 51.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 119.213 1.506 . . . . 0.0 110.759 -169.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -58.51 -53.18 50.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 125.069 1.348 . . . . 0.0 109.391 175.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 38.2 t -60.98 -38.76 80.16 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.618 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 173.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.1 -38.02 81.72 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 120.278 -1.514 . . . . 0.0 112.073 -176.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 70.6 mt -67.43 -36.19 75.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.288 1.035 . . . . 0.0 110.073 172.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.483 ' C ' ' H ' ' A' ' 79' ' ' SER . 20.0 tp -60.81 -50.5 73.2 Favored 'General case' 0 C--O 1.219 -0.544 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 175.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 44.2 mttt -62.35 4.48 0.14 Allowed 'General case' 0 C--O 1.234 0.257 0 C-N-CA 126.409 1.884 . . . . 0.0 114.316 178.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.483 ' H ' ' C ' ' A' ' 77' ' ' LEU . 3.5 t -103.99 -58.8 1.82 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 167.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 78.3 mt -55.59 -35.82 39.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 125.305 1.442 . . . . 0.0 111.319 -179.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.2 p -53.88 -58.35 7.59 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 126.048 1.739 . . . . 0.0 108.688 -177.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.7 t -61.93 -39.86 93.53 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 127.968 2.507 . . . . 0.0 110.899 -178.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.1 -23.47 67.16 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 175.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.29 17.58 49.63 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-O 118.637 -1.091 . . . . 0.0 112.933 -174.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -89.8 -173.78 45.49 Favored Glycine 0 N--CA 1.438 -1.195 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 172.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -131.75 148.98 52.61 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 125.547 1.539 . . . . 0.0 109.539 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -143.96 149.96 37.58 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.27 1.028 . . . . 0.0 108.425 176.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -154.18 168.4 26.67 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.972 0.909 . . . . 0.0 111.77 177.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.5 mt -113.47 171.74 7.38 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 177.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.401 ' CG2' HG21 ' A' ' 58' ' ' VAL . 0.5 OUTLIER -152.43 146.65 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 C-N-CA 123.898 0.879 . . . . 0.0 110.227 -166.327 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.493 ' CB ' ' HG ' ' A' ' 60' ' ' SER . 4.7 t 43.92 54.11 11.1 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 126.122 1.769 . . . . 0.0 110.264 177.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -61.89 -30.96 84.63 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.976 2.451 . . . . 0.0 112.335 -169.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 63.14 165.58 0.12 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 123.962 1.839 . . . . 0.0 110.755 -161.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -54.36 -33.98 60.2 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 112.343 -2.208 . . . . 0.0 110.666 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.63 -41.58 21.26 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 124.439 1.096 . . . . 0.0 112.067 -158.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.9 m -75.06 -44.33 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.732 0 CA-C-O 118.085 -0.96 . . . . 0.0 110.483 171.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.87 -29.76 63.24 Favored 'General case' 0 N--CA 1.461 0.09 0 C-N-CA 124.334 1.054 . . . . 0.0 108.79 -170.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.34 -62.74 1.14 Allowed 'General case' 0 N--CA 1.428 -1.555 0 C-N-CA 126.153 1.781 . . . . 0.0 112.342 168.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.7 t -72.66 -39.89 61.27 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 CA-C-N 112.365 -2.198 . . . . 0.0 108.295 -173.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.67 -17.51 23.11 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.755 1.222 . . . . 0.0 109.236 177.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.5 -1.89 43.11 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-O 121.607 0.718 . . . . 0.0 112.467 179.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.8 mt -119.45 -42.78 2.63 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 127.187 2.195 . . . . 0.0 109.854 -174.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.1 t -87.23 0.16 55.78 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.978 2.511 . . . . 0.0 111.341 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 42.94 84.35 0.02 OUTLIER 'General case' 0 C--N 1.344 0.351 0 C-N-CA 126.949 2.1 . . . . 0.0 111.808 -168.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.73 -64.41 1.32 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.937 1.295 . . . . 0.0 108.704 170.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -58.9 -29.03 66.75 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.537 0.735 . . . . 0.0 110.483 172.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 26.3 mtp180 -69.12 1.31 3.7 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.903 -1.123 . . . . 0.0 112.147 176.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.8 mt -130.35 -38.77 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 126.696 1.999 . . . . 0.0 109.663 -176.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.2 t -122.09 153.14 26.33 Favored 'Isoleucine or valine' 0 C--N 1.342 0.242 0 C-N-CA 125.299 1.44 . . . . 0.0 110.149 -169.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.43 155.49 35.3 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.236 1.014 . . . . 0.0 112.511 173.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -147.22 147.78 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 126.43 1.892 . . . . 0.0 107.478 -178.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -144.14 169.89 17.0 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.195 1.398 . . . . 0.0 111.571 -175.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -86.65 -37.7 17.77 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 175.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.3 p -137.3 175.91 9.19 Favored 'General case' 0 C--N 1.334 -0.079 0 C-N-CA 124.168 0.987 . . . . 0.0 111.145 -168.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 10.7 mm -72.74 -40.08 60.81 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 CA-C-O 118.479 -0.772 . . . . 0.0 109.918 176.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.3 t -73.2 -32.33 64.73 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 119.294 0.952 . . . . 0.0 109.965 -171.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -66.65 -10.08 42.47 Favored 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 123.436 0.694 . . . . 0.0 112.036 170.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -102.91 -47.62 4.32 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 -178.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -58.08 -54.39 47.47 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 126.565 1.946 . . . . 0.0 113.676 -160.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -87.47 -12.34 46.3 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.01 1.724 . . . . 0.0 111.25 179.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -91.78 -53.3 4.35 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 124.596 1.158 . . . . 0.0 107.941 -166.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -55.06 -23.73 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 128.649 2.78 . . . . 0.0 112.785 176.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 78.8 mtt180 -59.66 -28.48 67.29 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 118.46 -0.781 . . . . 0.0 111.718 169.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.34 26.22 3.81 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 126.5 1.92 . . . . 0.0 115.009 -176.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.6 mmtm . . . . . 0 C--O 1.249 1.069 0 C-N-CA 126.236 1.814 . . . . 0.0 106.724 -176.901 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 7.6 p90 . . . . . 0 C--O 1.234 0.288 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -141.85 175.96 9.31 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.437 1.495 . . . . 0.0 108.503 156.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.2 mt -127.77 138.22 55.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 167.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.0 m -114.08 -156.74 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 C-N-CA 126.356 1.862 . . . . 0.0 107.727 168.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -42.21 -63.02 0.81 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 120.978 1.717 . . . . 0.0 114.641 -162.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -133.82 19.23 3.84 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.689 1.596 . . . . 0.0 110.973 170.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.443 HG13 ' CE2' ' A' ' 56' ' ' PHE . 4.2 t -132.59 119.07 37.14 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 123.137 1.446 . . . . 0.0 109.924 -168.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.44 ' CG1' HD13 ' A' ' 55' ' ' ILE . 0.6 OUTLIER -67.06 150.3 11.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 127.425 2.29 . . . . 0.0 112.383 169.156 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.4 mm -135.68 96.38 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 174.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.452 ' CD1' ' CH2' ' A' ' 42' ' ' TRP . 4.3 mm? -59.99 132.24 53.32 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 164.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 24.8 mmm -127.79 81.32 70.5 Favored Pre-proline 0 C--O 1.234 0.245 0 C-N-CA 126.111 1.764 . . . . 0.0 106.91 178.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -61.69 143.8 96.76 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 122.267 1.978 . . . . 0.0 109.053 170.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.02 -83.11 0.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 179.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.74 1.53 14.18 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.286 1.034 . . . . 0.0 112.035 172.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -67.62 -34.78 77.66 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -171.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.6 tp -73.22 -81.28 0.06 Allowed 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -153.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 34.24 41.38 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 130.062 3.345 . . . . 0.0 114.361 154.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER 61.31 -31.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 130.54 3.536 . . . . 0.0 115.416 -170.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -54.12 -34.65 60.82 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.505 1.122 . . . . 0.0 112.332 -175.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -122.4 60.37 1.0 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -173.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.45 -65.87 1.14 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 118.769 -0.634 . . . . 0.0 111.512 -177.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -60.32 -28.38 68.09 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.073 1.306 . . . . 0.0 111.887 173.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.95 -31.15 44.97 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 117.65 -1.167 . . . . 0.0 110.206 176.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -45.37 -52.66 9.65 Favored 'General case' 0 CA--C 1.508 -0.649 0 O-C-N 124.362 1.039 . . . . 0.0 110.033 178.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.39 -45.98 90.7 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 117.544 -1.217 . . . . 0.0 110.027 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -61.4 -46.95 88.02 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 119.94 1.245 . . . . 0.0 111.38 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.452 ' CH2' ' CD1' ' A' ' 25' ' ' LEU . 15.7 t90 -62.86 -60.79 3.0 Favored 'General case' 0 C--O 1.215 -0.715 0 CA-C-O 117.436 -1.269 . . . . 0.0 108.796 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.7 t -54.16 -30.0 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 CA-C-N 121.468 1.94 . . . . 0.0 111.706 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -66.61 -65.49 0.67 Allowed 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 120.723 -1.236 . . . . 0.0 110.481 170.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -66.63 -37.4 84.77 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.353 1.461 . . . . 0.0 111.781 -171.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -73.14 -31.86 64.54 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 127.941 2.496 . . . . 0.0 111.996 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -129.38 -58.1 1.13 Allowed 'General case' 0 C--N 1.343 0.322 0 CA-C-N 119.596 1.089 . . . . 0.0 111.605 -171.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.0 mt -64.97 -31.54 72.83 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 121.674 -0.641 . . . . 0.0 111.986 -175.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -80.44 -19.44 46.1 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 118.405 -0.807 . . . . 0.0 111.031 176.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.06 -5.22 55.47 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 127.073 2.149 . . . . 0.0 114.128 167.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.03 6.26 79.37 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-O 118.68 -1.067 . . . . 0.0 114.38 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -66.02 143.18 57.52 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 119.29 1.545 . . . . 0.0 109.861 175.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.56 22.99 3.16 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.579 1.551 . . . . 0.0 109.059 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -151.84 98.82 2.51 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 174.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.44 HD13 ' CG1' ' A' ' 23' ' ' VAL . 1.3 mp -96.25 152.64 3.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 172.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.443 ' CE2' HG13 ' A' ' 22' ' ' VAL . 12.0 m-30 -125.68 164.35 20.8 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.704 -0.798 . . . . 0.0 112.524 162.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 21.9 tp -129.11 129.1 44.77 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 124.174 0.989 . . . . 0.0 109.364 167.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.8 t -99.91 139.99 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 167.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.8 mp -120.64 54.04 1.08 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.437 1.017 . . . . 0.0 110.122 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 26.0 t -109.16 -47.32 3.44 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.879 1.272 . . . . 0.0 110.77 -168.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -72.84 -49.93 27.2 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 1.8 p -68.95 141.58 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 124.581 1.153 . . . . 0.0 109.111 171.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -79.0 -36.81 40.62 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 119.153 -0.451 . . . . 0.0 110.009 167.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.498 ' CB ' ' HE2' ' A' ' 95' ' ' LYS . 10.7 t -165.36 159.73 17.43 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 122.706 1.241 . . . . 0.0 113.168 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.0 tt -79.57 169.94 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 C-N-CA 128.257 2.623 . . . . 0.0 109.219 166.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.0 164.14 12.68 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.124 1.37 . . . . 0.0 109.809 177.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 95.2 p -63.24 -24.22 67.78 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -175.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -60.56 -72.01 0.12 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.799 0.84 . . . . 0.0 108.858 171.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.0 t -70.76 -15.18 62.66 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -173.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.7 mt -46.27 -37.49 7.36 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.699 1.136 . . . . 0.0 110.844 169.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.61 -22.18 51.32 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 123.136 0.398 . . . . 0.0 113.971 -178.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 52.9 t -79.12 -35.45 17.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.515 1.126 . . . . 0.0 109.181 177.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 16.7 mm -56.53 -47.45 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 123.499 0.72 . . . . 0.0 110.667 174.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.9 t -62.43 -40.44 88.06 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.266 0 O-C-N 121.558 -0.714 . . . . 0.0 109.739 176.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -52.02 -46.85 65.13 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.466 1.03 . . . . 0.0 112.309 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.3 mt -56.65 -41.32 73.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.374 1.47 . . . . 0.0 110.097 175.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -66.67 -46.87 74.26 Favored 'General case' 0 CA--C 1.52 -0.209 0 O-C-N 121.494 -0.754 . . . . 0.0 109.621 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -55.72 -50.86 69.2 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 118.757 -0.64 . . . . 0.0 110.472 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 33.1 t -53.14 -52.05 59.97 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 124.845 1.34 . . . . 0.0 109.214 178.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 21.6 mt -63.29 -46.9 94.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 C-N-CA 123.467 0.707 . . . . 0.0 110.69 -174.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -51.45 -55.36 19.23 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.798 0.839 . . . . 0.0 110.461 171.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.6 m -65.3 -17.48 64.54 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.227 1.011 . . . . 0.0 113.504 -178.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.5 m -83.84 -47.26 11.28 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.789 0.836 . . . . 0.0 110.915 178.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 133.32 -1.0 4.42 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 118.295 -1.28 . . . . 0.0 113.75 -166.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -101.73 -169.41 27.56 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-N 120.208 2.004 . . . . 0.0 112.509 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.578 ' CZ ' ' HE2' ' A' ' 125' ' ' LYS . 0.1 OUTLIER -135.41 165.71 24.85 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 126.869 2.068 . . . . 0.0 110.8 171.615 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -155.25 141.76 18.75 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 177.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.79 168.6 23.93 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.268 0.627 . . . . 0.0 112.186 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 mt -116.16 164.17 14.88 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.502 1.121 . . . . 0.0 109.438 -171.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 79.6 t -146.13 154.87 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 126.049 1.74 . . . . 0.0 109.998 -169.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 t 46.93 58.4 17.07 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 127.772 2.429 . . . . 0.0 112.15 173.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -76.73 97.31 1.13 Allowed 'Trans proline' 0 N--CA 1.445 -1.363 0 C-N-CA 122.148 1.898 . . . . 0.0 111.23 -177.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.43 158.73 5.4 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 119.251 -0.98 . . . . 0.0 109.723 162.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -69.65 -29.45 66.92 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.339 1.056 . . . . 0.0 111.834 -167.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.498 ' HE2' ' CB ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -56.99 -51.93 67.29 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -173.177 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -78.76 -41.03 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 124.057 0.848 . . . . 0.0 110.286 -173.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.97 -33.65 18.45 Favored 'General case' 0 CA--C 1.503 -0.827 0 C-N-CA 124.456 1.103 . . . . 0.0 110.836 175.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -53.98 47.13 Favored 'General case' 0 N--CA 1.417 -2.121 0 CA-C-O 123.368 1.556 . . . . 0.0 113.107 178.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.0 t -69.69 -43.52 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.832 0 CA-C-N 111.346 -2.661 . . . . 0.0 106.58 -172.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.36 -28.87 56.76 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.933 1.293 . . . . 0.0 108.755 175.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.7 m -92.01 4.09 53.81 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.374 1.47 . . . . 0.0 112.729 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 94.1 mt -125.06 -20.76 4.83 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 127.752 2.421 . . . . 0.0 111.769 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.2 t -111.69 2.24 17.12 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.751 1.62 . . . . 0.0 112.029 -174.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 54.17 87.73 0.04 OUTLIER 'General case' 0 C--N 1.342 0.247 0 C-N-CA 126.541 1.936 . . . . 0.0 109.887 -172.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.73 -57.2 1.45 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 118.544 -0.741 . . . . 0.0 109.702 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.85 -35.29 44.18 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 123.302 1.525 . . . . 0.0 110.585 164.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -72.05 -1.68 15.62 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 120.834 -1.167 . . . . 0.0 111.832 -177.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.7 mt -126.46 -38.63 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 126.34 1.856 . . . . 0.0 109.628 -175.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.2 t -118.21 145.68 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 125.696 1.598 . . . . 0.0 109.332 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -68.14 154.38 41.81 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 123.384 0.673 . . . . 0.0 110.199 174.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -141.98 149.35 19.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -173.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -147.65 165.69 29.67 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.122 1.369 . . . . 0.0 109.434 -172.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -84.66 -46.69 11.24 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 45.3 p -119.35 170.37 9.18 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.232 1.413 . . . . 0.0 108.638 -174.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 8.9 mm -66.95 -42.02 88.24 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.81 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 167.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 48.2 t -67.98 -37.7 81.81 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.787 1.176 . . . . 0.0 110.712 -165.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -63.51 -28.02 69.66 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 118.184 0.447 . . . . 0.0 110.259 176.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -80.69 -54.99 5.14 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -54.89 -29.06 54.88 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 126.213 1.805 . . . . 0.0 112.721 -163.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.63 -23.32 14.28 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 126.5 1.92 . . . . 0.0 111.712 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -81.96 -53.73 5.9 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 120.114 1.325 . . . . 0.0 111.887 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 51.4 t -44.05 -39.91 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 129.293 3.037 . . . . 0.0 110.099 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -49.83 -23.26 1.79 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 127.414 2.286 . . . . 0.0 114.265 174.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.69 37.09 0.19 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.306 2.242 . . . . 0.0 113.274 177.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.578 ' HE2' ' CZ ' ' A' ' 86' ' ' PHE . 0.6 OUTLIER . . . . . 0 C--O 1.248 0.99 0 O-C-N 121.436 -0.79 . . . . 0.0 109.514 -174.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 37.4 p90 . . . . . 0 CA--C 1.538 0.508 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.407 ' HE2' ' CG1' ' A' ' 19' ' ' VAL . 0.7 OUTLIER -143.48 164.74 29.49 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.97 2.108 . . . . 0.0 106.823 173.689 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.2 mt -130.36 118.57 43.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 174.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.407 ' CG1' ' HE2' ' A' ' 17' ' ' LYS . 6.4 m -93.34 -162.02 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 125.677 1.591 . . . . 0.0 108.001 168.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -24.6 -70.85 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 129.651 3.181 . . . . 0.0 111.771 171.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -149.96 21.86 0.88 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.734 0.814 . . . . 0.0 110.835 -177.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 20.4 t -127.19 156.62 38.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 95.8 t -116.13 128.52 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mp -101.55 104.95 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 46.8 mt -88.97 128.84 35.71 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 103.551 -2.759 . . . . 0.0 103.551 175.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 30.2 mtm -123.48 95.48 45.1 Favored Pre-proline 0 N--CA 1.465 0.302 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -176.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -69.07 161.44 45.81 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.251 1.967 . . . . 0.0 111.088 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.593 ' ND2' ' H ' ' A' ' 29' ' ' LYS . 0.5 OUTLIER -151.92 -71.48 0.16 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 121.232 0.539 . . . . 0.0 111.964 -173.003 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.593 ' H ' ' ND2' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -147.47 6.06 0.83 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.53 1.932 . . . . 0.0 112.132 -176.238 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -79.58 -2.61 43.21 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 128.333 2.653 . . . . 0.0 112.746 177.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.6 mt -101.56 95.23 6.32 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -166.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -164.72 30.76 0.07 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.886 0.874 . . . . 0.0 112.386 -161.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER 73.7 -46.94 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 127.968 2.507 . . . . 0.0 112.287 175.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -68.85 -5.26 19.94 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 126.353 1.861 . . . . 0.0 113.189 -173.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -127.25 0.98 6.41 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 127.345 2.258 . . . . 0.0 109.127 177.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.14 -57.75 3.62 Favored 'General case' 0 C--O 1.224 -0.241 0 O-C-N 120.229 -1.545 . . . . 0.0 110.868 -173.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -65.05 -24.63 67.52 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 120.831 -1.168 . . . . 0.0 110.98 -178.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -81.54 -33.25 31.85 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 126.219 1.807 . . . . 0.0 110.863 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -42.4 -53.28 4.3 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 126.711 2.004 . . . . 0.0 111.285 176.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.39 -43.26 99.25 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.482 -178.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.13 -49.39 77.14 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.103 0.865 . . . . 0.0 110.639 174.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -58.01 -64.26 0.97 Allowed 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 118.099 -0.953 . . . . 0.0 110.014 177.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 68.8 t -49.56 -37.95 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 120.018 1.281 . . . . 0.0 112.062 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -61.12 -62.21 2.01 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.604 0.762 . . . . 0.0 110.329 175.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.11 -16.66 59.85 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 125.018 1.327 . . . . 0.0 112.867 -170.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -93.62 -31.4 14.51 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.778 1.231 . . . . 0.0 111.732 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -132.01 -54.26 0.98 Allowed 'General case' 0 C--N 1.346 0.42 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -172.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 30.7 mt -60.39 -50.95 71.54 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 118.654 0.661 . . . . 0.0 112.291 -171.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -61.28 -39.43 90.38 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.241 0.616 . . . . 0.0 109.944 177.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -60.09 -1.91 0.37 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 128.318 2.647 . . . . 0.0 114.797 172.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.49 2.75 75.93 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-O 118.304 -1.276 . . . . 0.0 113.02 176.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -72.48 119.09 16.21 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 120.024 1.912 . . . . 0.0 108.791 175.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -114.08 19.2 16.65 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.618 1.167 . . . . 0.0 109.309 -177.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -146.4 130.01 16.96 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.328 1.851 . . . . 0.0 107.353 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.2 mp -138.6 154.26 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 128.062 2.545 . . . . 0.0 105.612 177.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -130.37 156.6 44.44 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 124.633 1.173 . . . . 0.0 113.366 166.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 26.8 tp -121.69 75.83 1.22 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.907 1.283 . . . . 0.0 110.885 177.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.1 t -64.56 118.35 6.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 127.791 2.436 . . . . 0.0 107.023 173.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.7 mt -95.85 5.14 52.02 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.563 0.745 . . . . 0.0 110.643 -176.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.3 m -56.73 -23.61 43.72 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 177.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.46 -7.19 56.98 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.516 1.053 . . . . 0.0 111.272 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 p -134.17 157.23 41.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.902 1.681 . . . . 0.0 110.605 -168.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -85.72 -44.6 12.4 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.236 -0.915 . . . . 0.0 108.682 167.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 m -160.29 161.66 33.4 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 123.345 1.545 . . . . 0.0 113.703 -179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.2 tt -72.47 174.28 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 111.808 -2.451 . . . . 0.0 107.796 163.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -117.88 -144.94 0.38 Allowed 'General case' 0 C--N 1.327 -0.382 0 O-C-N 120.952 -1.093 . . . . 0.0 109.646 -160.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.6 t -50.62 -147.99 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.798 1 C-N-CA 132.111 4.165 . . . . 0.0 112.388 157.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -25.04 -39.91 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.158 1 C-N-CA 132.022 4.129 . . . . 0.0 116.421 177.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.2 t -55.07 -31.55 61.24 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.659 0.784 . . . . 0.0 111.778 -178.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.8 tp -57.49 -18.88 21.06 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.402 1.081 . . . . 0.0 112.73 173.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -98.48 -24.7 10.79 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.559 1.552 . . . . 0.0 113.204 170.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 90.1 t -65.92 -40.86 88.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 119.185 1.493 . . . . 0.0 109.551 173.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.4 mp -51.45 -48.59 34.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.552 1.141 . . . . 0.0 109.628 174.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.8 t -64.92 -46.27 92.26 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.635 0 CA-C-O 117.224 -1.37 . . . . 0.0 109.658 175.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -49.07 -51.29 32.25 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 122.469 2.395 . . . . 0.0 111.814 177.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 77.9 mt -57.85 -37.2 58.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 124.913 1.285 . . . . 0.0 110.143 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 25.7 tp -63.59 -53.6 49.09 Favored 'General case' 0 CA--C 1.52 -0.201 0 O-C-N 121.012 -1.055 . . . . 0.0 109.265 176.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -57.68 -22.82 48.24 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.388 0.675 . . . . 0.0 110.142 -177.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 67.5 m -81.43 -48.24 12.16 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.44 1.096 . . . . 0.0 111.326 177.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 21.8 mt -58.61 -43.97 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 119.983 1.265 . . . . 0.0 109.782 172.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.4 t -65.65 -10.87 39.82 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.637 1.575 . . . . 0.0 112.296 175.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.7 t -96.46 -43.21 7.73 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 120.32 1.418 . . . . 0.0 109.552 171.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.6 m -66.91 -28.01 67.96 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -178.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 110.02 38.85 1.63 Allowed Glycine 0 C--N 1.337 0.613 0 CA-C-O 118.702 -1.054 . . . . 0.0 113.428 -174.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -134.77 -175.64 13.97 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 119.93 1.865 . . . . 0.0 111.644 -177.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -127.31 154.13 45.3 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.874 1.67 . . . . 0.0 109.858 179.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -150.41 139.38 20.98 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -145.99 170.38 16.75 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 120.831 0.348 . . . . 0.0 111.477 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.21 167.34 10.63 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -177.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -148.86 150.06 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 C-N-CA 123.863 0.865 . . . . 0.0 111.541 -170.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 44.2 54.77 12.26 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 126.51 1.924 . . . . 0.0 112.064 171.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.05 167.25 26.62 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.76 2.307 . . . . 0.0 109.714 -178.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -123.06 169.57 11.06 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 173.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -66.69 -34.74 78.52 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 123.686 0.795 . . . . 0.0 110.127 -168.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.99 -35.94 80.0 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.337 1.455 . . . . 0.0 110.953 177.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -81.36 -46.03 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -176.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -57.43 -31.18 65.63 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 125.958 1.703 . . . . 0.0 110.466 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.95 -21.54 66.43 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -175.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.6 t -104.85 -42.55 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.043 0 C-N-CA 125.72 1.608 . . . . 0.0 107.164 -174.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.08 -17.23 24.18 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 116.715 -1.612 . . . . 0.0 108.868 -177.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.8 t -87.18 -50.64 6.48 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 117.62 -1.632 . . . . 0.0 108.569 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.84 -52.78 64.05 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 129.148 2.979 . . . . 0.0 111.047 -172.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -77.07 2.99 13.45 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.157 1.383 . . . . 0.0 110.891 -178.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.6 m120 47.15 75.85 0.12 Allowed 'General case' 0 C--N 1.342 0.249 0 C-N-CA 129.563 3.145 . . . . 0.0 109.816 -171.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.74 -59.86 1.9 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.295 1.438 . . . . 0.0 107.517 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.1 -26.76 67.88 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.776 0.83 . . . . 0.0 111.348 174.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.4 mtp-105 -74.99 -2.2 26.12 Favored 'General case' 0 C--N 1.339 0.112 0 O-C-N 121.751 -0.593 . . . . 0.0 111.75 -178.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.3 mt -128.0 -46.68 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 125.912 1.685 . . . . 0.0 107.272 -171.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.6 t -104.39 148.94 8.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-O 121.898 0.856 . . . . 0.0 109.917 -175.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.07 155.71 39.91 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 123.85 0.86 . . . . 0.0 111.852 173.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -146.42 146.59 18.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -174.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -141.47 163.75 32.1 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.917 0.887 . . . . 0.0 111.178 -171.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.5 -55.01 4.74 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 64.7 p -113.86 175.64 5.38 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.815 0.817 . . . . 0.0 111.048 -177.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 3.4 mm -61.74 -45.87 97.74 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 164.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.2 t -69.34 -33.14 72.66 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 118.774 -0.631 . . . . 0.0 109.855 -164.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -68.85 -24.04 64.3 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.785 0.834 . . . . 0.0 111.155 175.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -82.74 -52.59 6.63 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 6.3 tmm? -55.89 -40.1 72.53 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 125.298 1.439 . . . . 0.0 113.502 -157.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -89.39 -21.38 23.09 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 117.935 -1.031 . . . . 0.0 113.151 175.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.423 ' HG2' ' HE2' ' A' ' 125' ' ' LYS . 1.7 tt0 -84.27 -55.64 4.07 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-N 119.046 0.839 . . . . 0.0 109.76 -172.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.2 t -42.61 -44.19 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 C-N-CA 127.96 2.504 . . . . 0.0 110.586 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 17.9 mtm180 -48.11 -40.93 25.01 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 124.057 0.848 . . . . 0.0 111.083 178.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . 0.321 0.0 OUTLIER -117.83 43.48 2.39 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 125.628 1.571 . . . . 0.0 113.879 176.085 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.423 ' HE2' ' HG2' ' A' ' 121' ' ' GLU . 5.4 mmmt . . . . . 0 C--O 1.251 1.153 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 164.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 11.4 p90 . . . . . 0 N--CA 1.45 -0.474 0 CA-C-O 121.368 0.604 . . . . 0.0 109.649 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.4 173.1 12.1 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.487 2.315 . . . . 0.0 110.031 176.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.3 mt -137.8 135.31 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 127.93 2.492 . . . . 0.0 107.789 166.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.2 m -101.1 -139.36 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 127.085 2.154 . . . . 0.0 108.638 173.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -41.92 -71.19 0.09 Allowed 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 129.227 3.011 . . . . 0.0 110.524 177.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -147.88 20.94 1.13 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.602 1.961 . . . . 0.0 108.222 -173.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.3 t -131.51 147.65 32.68 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 C-N-CA 124.437 1.095 . . . . 0.0 108.109 -172.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.7 t -103.84 151.13 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.1 mp -129.89 94.71 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 124.871 1.269 . . . . 0.0 108.426 176.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.5 105.51 1.2 Allowed 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 129.677 3.191 . . . . 0.0 109.06 170.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.412 ' HA ' ' CG2' ' A' ' 58' ' ' VAL . 50.8 mtp -113.98 73.68 2.46 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 125.663 1.585 . . . . 0.0 107.943 -172.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -69.75 177.34 5.67 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 123.114 2.542 . . . . 0.0 111.532 -173.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.549 ' ND2' ' H ' ' A' ' 29' ' ' LYS . 2.1 p-10 -156.18 -79.99 0.08 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.982 1.713 . . . . 0.0 109.336 -178.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.549 ' H ' ' ND2' ' A' ' 28' ' ' ASN . 3.9 mppt? -136.58 26.36 3.11 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.972 2.509 . . . . 0.0 109.304 -174.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -91.43 -7.81 49.6 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 125.098 1.359 . . . . 0.0 112.055 177.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.18 75.97 9.9 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 120.977 1.717 . . . . 0.0 108.498 -177.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -105.82 58.51 0.66 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.186 2.195 . . . . 0.0 112.28 -173.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.3 mm 53.85 -75.78 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 127.613 2.365 . . . . 0.0 112.76 -175.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -67.31 -17.99 64.99 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.64 1.176 . . . . 0.0 112.032 -173.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -43.7 -39.43 3.65 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.455 163.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.12 -44.99 96.48 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 175.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 38.5 m170 -67.31 -44.68 78.57 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 118.902 -0.57 . . . . 0.0 109.709 -170.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.78 -19.91 47.49 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-O 116.985 -1.483 . . . . 0.0 111.69 173.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -44.85 -54.02 6.86 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 125.005 1.322 . . . . 0.0 109.785 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt -56.83 -53.8 53.71 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.85 -46.95 81.44 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 117.296 -1.335 . . . . 0.0 111.544 -176.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 6.1 t90 -62.44 -66.16 0.58 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 117.329 -1.32 . . . . 0.0 109.05 177.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 87.7 t -50.46 -37.96 15.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 120.003 1.274 . . . . 0.0 111.117 -176.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -59.51 -74.04 0.08 Allowed 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 171.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -48.92 -43.02 39.04 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.637 1.975 . . . . 0.0 113.267 -171.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.468 ' HG3' ' CE1' ' A' ' 47' ' ' PHE . 3.0 tp10 -84.7 -28.69 26.16 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 126.846 2.058 . . . . 0.0 109.727 -167.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.468 ' CE1' ' HG3' ' A' ' 46' ' ' GLU . 2.8 m-85 -128.77 -66.76 0.82 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 118.925 0.784 . . . . 0.0 110.606 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.6 mt -61.13 -53.41 57.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 118.865 0.757 . . . . 0.0 112.517 -166.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -67.89 -29.06 68.07 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 127.496 2.318 . . . . 0.0 109.572 176.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -63.49 -24.31 67.76 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 118.028 -0.987 . . . . 0.0 111.605 167.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.8 -4.43 19.07 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 126.533 2.016 . . . . 0.0 113.281 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -66.1 156.38 34.07 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 119.429 1.615 . . . . 0.0 111.085 178.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -134.25 1.09 3.17 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.332 -1.303 . . . . 0.0 111.212 -177.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.8 mtmt -138.04 123.18 19.21 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.622 1.101 . . . . 0.0 109.296 -170.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.4 mp -137.45 152.78 27.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 126.701 2.0 . . . . 0.0 106.581 -176.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -141.42 120.12 12.56 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 126.977 2.111 . . . . 0.0 110.216 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 46.2 tp -90.18 119.29 30.38 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 176.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.412 ' CG2' ' HA ' ' A' ' 26' ' ' MET . 0.8 OUTLIER -87.84 154.81 3.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 118.806 0.73 . . . . 0.0 109.963 173.011 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.9 mp -134.38 8.02 3.64 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.871 0.868 . . . . 0.0 111.482 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.03 -36.05 67.56 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.891 -1.131 . . . . 0.0 112.073 -177.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -96.33 -11.38 25.92 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.439 1.096 . . . . 0.0 112.16 178.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.4 t -109.87 113.5 44.38 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -169.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.85 -41.61 43.39 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 -178.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 93.8 p -151.99 168.65 24.53 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -171.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.5 tt -133.64 151.98 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 C-N-CA 124.504 1.122 . . . . 0.0 109.107 176.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.68 162.85 17.69 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.007 0.923 . . . . 0.0 109.006 179.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 85.8 p -66.76 1.9 1.62 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 171.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . 0.25 0.1 OUTLIER -71.03 -78.63 0.07 Allowed 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 123.955 0.902 . . . . 0.0 110.817 156.028 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.31 -24.17 57.4 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 118.901 0.773 . . . . 0.0 111.777 -158.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 35.0 tp -44.72 -38.88 4.72 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.527 1.531 . . . . 0.0 111.889 176.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.41 ' HA2' ' CG1' ' A' ' 74' ' ' VAL . . . -108.94 6.36 32.71 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-O 119.82 -0.433 . . . . 0.0 114.154 -174.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 95.0 t -75.99 -46.18 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 158.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mt -59.57 -54.23 37.29 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 CA-C-O 122.694 1.235 . . . . 0.0 111.61 -173.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.473 HG21 ' HE3' ' A' ' 78' ' ' LYS . 9.0 p -45.69 -56.32 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.835 0 O-C-N 120.404 -1.435 . . . . 0.0 113.841 163.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.409 ' H ' HG12 ' A' ' 74' ' ' VAL . 0.9 OUTLIER -49.43 -43.93 45.06 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 121.369 -0.832 . . . . 0.0 110.97 -174.356 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 56.3 mt -58.11 -41.87 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 O-C-N 124.859 1.349 . . . . 0.0 110.569 173.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.459 ' C ' ' H ' ' A' ' 79' ' ' SER . 21.7 tp -57.99 -54.06 51.26 Favored 'General case' 0 C--O 1.225 -0.196 0 O-C-N 120.278 -1.514 . . . . 0.0 109.695 170.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.473 ' HE3' HG21 ' A' ' 74' ' ' VAL . 72.2 mttt -65.13 3.23 0.63 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.276 1.43 . . . . 0.0 112.419 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.459 ' H ' ' C ' ' A' ' 77' ' ' LEU . 41.4 t -106.2 -51.08 3.03 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 126.631 1.973 . . . . 0.0 107.782 174.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 87.8 mt -59.55 -44.6 93.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.678 0.791 . . . . 0.0 110.367 175.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.58 -19.7 65.29 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.786 0.721 . . . . 0.0 112.638 176.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.9 m -80.64 -33.94 35.31 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.341 0.973 . . . . 0.0 111.405 167.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.4 m -73.12 -62.7 1.37 Allowed 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.339 1.056 . . . . 0.0 110.421 -176.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 148.5 29.03 0.06 OUTLIER Glycine 0 CA--C 1.527 0.819 0 CA-C-O 118.14 -1.367 . . . . 0.0 113.787 -168.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -134.06 -166.4 11.25 Favored Glycine 0 C--N 1.338 0.685 0 CA-C-N 120.245 2.023 . . . . 0.0 113.319 -171.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -135.1 150.18 50.18 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.305 1.442 . . . . 0.0 109.246 178.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -145.9 144.12 30.0 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 170.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -149.99 176.52 10.7 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 126.165 1.786 . . . . 0.0 111.924 -175.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.14 168.32 12.55 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.702 0.801 . . . . 0.0 111.165 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 99.4 t -147.35 141.43 19.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 124.722 1.209 . . . . 0.0 109.787 -160.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.2 t 42.98 58.19 11.6 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 124.527 1.131 . . . . 0.0 109.342 -176.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -71.57 -163.2 0.13 Allowed 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 124.275 3.317 . . . . 0.0 110.114 -177.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -155.9 151.42 27.04 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 124.508 1.123 . . . . 0.0 108.07 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -61.5 -21.53 64.3 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.201 1.0 . . . . 0.0 110.998 -176.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.62 -38.19 48.54 Favored 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 126.422 1.889 . . . . 0.0 111.451 176.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.3 t -62.18 -46.98 95.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-O 117.102 -1.428 . . . . 0.0 108.216 166.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -57.93 -30.45 65.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 119.982 1.265 . . . . 0.0 109.155 176.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.34 -30.46 69.43 Favored 'General case' 0 C--O 1.218 -0.589 0 O-C-N 120.703 -1.248 . . . . 0.0 109.934 -177.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.4 p -101.59 -42.63 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -169.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.7 mp -67.0 -19.67 65.75 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 115.95 -1.976 . . . . 0.0 111.152 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 12.0 t -79.67 -45.44 19.01 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 121.441 1.928 . . . . 0.0 107.31 172.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -67.6 -51.03 55.1 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 126.337 1.855 . . . . 0.0 110.585 -165.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 9.1 t -81.77 6.32 15.84 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.787 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 50.0 88.27 0.02 OUTLIER 'General case' 0 C--O 1.235 0.304 0 C-N-CA 127.162 2.185 . . . . 0.0 110.102 -169.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.87 -55.9 0.88 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 127.563 2.345 . . . . 0.0 110.739 -175.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.77 -27.05 68.93 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.944 1.247 . . . . 0.0 110.681 173.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 -72.44 -18.18 61.72 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.146 0.498 . . . . 0.0 110.109 -177.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.2 mm -97.54 -56.2 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 103.595 -2.742 . . . . 0.0 103.595 -174.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.507 HG12 ' H ' ' A' ' 110' ' ' LYS . 1.4 t -80.41 -165.0 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 125.518 1.527 . . . . 0.0 110.115 -177.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.507 ' H ' HG12 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -125.66 168.82 13.21 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 128.46 2.704 . . . . 0.0 108.813 169.367 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.36 145.73 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -147.02 171.14 15.73 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 126.334 1.854 . . . . 0.0 110.678 -175.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.28 -53.16 4.34 Favored 'General case' 0 CA--C 1.523 -0.067 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -175.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 71.1 p -130.17 162.88 27.89 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.568 0.747 . . . . 0.0 110.895 -175.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 29.1 mm -65.03 -36.48 77.91 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 CA-C-O 118.168 -0.92 . . . . 0.0 108.582 -172.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.9 t -69.04 -31.74 70.75 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.527 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -68.13 -9.15 44.3 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 119.056 0.844 . . . . 0.0 111.672 173.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -110.37 -38.25 5.29 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 119.529 1.059 . . . . 0.0 109.203 -179.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 2.8 ttm -64.1 -46.45 84.14 Favored 'General case' 0 N--CA 1.446 -0.649 0 O-C-N 120.667 -1.271 . . . . 0.0 113.433 -161.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -91.36 -14.68 30.27 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 117.976 -1.012 . . . . 0.0 111.057 175.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -95.22 -46.85 6.59 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 119.327 0.967 . . . . 0.0 110.574 -167.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -49.84 -31.77 7.13 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.18 0 C-N-CA 124.89 1.276 . . . . 0.0 111.002 173.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -52.63 -36.21 56.12 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.518 1.127 . . . . 0.0 111.969 174.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.88 35.34 0.76 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.884 1.274 . . . . 0.0 114.251 -174.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.242 0.679 0 C-N-CA 125.5 1.52 . . . . 0.0 112.957 178.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 tpt . . . . . 0 N--CA 1.47 0.561 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 144.82 158.19 7.53 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 124.103 0.859 . . . . 0.0 111.344 171.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.3 m 60.52 148.5 0.02 OUTLIER 'General case' 0 C--O 1.237 0.441 0 C-N-CA 127.082 2.153 . . . . 0.0 112.051 -164.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -80.72 135.11 35.94 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.432 -174.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.76 100.98 5.64 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.7 tp -137.69 98.82 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 37.6 t-80 -153.38 96.01 1.99 Allowed 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -61.38 169.84 2.05 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.774 0.829 . . . . 0.0 111.613 173.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -93.22 92.84 7.92 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -167.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 40.3 t60 -148.32 43.62 1.03 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.732 0.813 . . . . 0.0 109.89 -178.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -63.28 147.67 50.4 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 172.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -88.77 -95.65 0.1 Allowed 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 169.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 13.2 ttt -156.96 96.16 1.58 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 105.318 -2.105 . . . . 0.0 105.318 -167.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -69.51 122.0 84.19 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-O 118.269 -0.872 . . . . 0.0 109.905 -171.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -78.46 101.24 1.44 Allowed 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.494 2.129 . . . . 0.0 110.038 172.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -162.69 175.36 11.42 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 126.474 1.91 . . . . 0.0 109.74 170.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.64 173.26 11.72 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.77 1.228 . . . . 0.0 111.511 165.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.3 mt -119.09 147.4 22.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 174.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.5 t -125.1 -174.79 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 129.761 3.224 . . . . 0.0 104.849 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -51.75 -54.33 29.71 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.869 0.867 . . . . 0.0 113.311 -163.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -127.39 12.37 6.99 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 122.933 0.493 . . . . 0.0 110.367 163.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.47 HG12 ' CE2' ' A' ' 56' ' ' PHE . 22.0 t -119.31 163.77 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 O-C-N 121.114 -0.991 . . . . 0.0 108.585 -166.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.4 t -132.28 125.52 54.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 -170.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -107.69 103.46 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 -176.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.7 mt -90.61 104.77 17.31 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 104.886 -2.264 . . . . 0.0 104.886 -178.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 57.7 mtm -112.89 84.98 7.26 Favored Pre-proline 0 C--N 1.332 -0.172 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -171.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -70.49 156.74 60.82 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.853 1.702 . . . . 0.0 109.871 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -122.61 -92.55 0.53 Allowed 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -178.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.63 59.44 1.63 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 121.784 2.084 . . . . 0.0 111.658 -175.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -144.97 9.69 1.3 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -175.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 25.0 mt -79.26 52.93 1.4 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.429 1.013 . . . . 0.0 110.975 -176.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -85.4 169.63 13.49 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 126.598 1.959 . . . . 0.0 109.116 171.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.9 mt -57.53 -35.38 49.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 C-N-CA 124.272 1.029 . . . . 0.0 112.09 -174.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -71.61 -16.18 62.27 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 120.97 -1.081 . . . . 0.0 111.211 -176.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -120.24 56.28 0.98 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.291 1.437 . . . . 0.0 108.804 175.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -140.45 -64.1 0.47 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.405 1.082 . . . . 0.0 110.592 -177.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 28.2 t60 -58.45 -46.19 87.07 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 120.513 -1.367 . . . . 0.0 109.368 169.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.44 -30.05 70.8 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.792 178.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -52.93 -54.05 40.54 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.856 1.262 . . . . 0.0 110.017 -174.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.547 ' HE3' ' CE1' ' A' ' 44' ' ' PHE . 0.8 OUTLIER -57.43 -44.74 84.91 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 124.651 1.181 . . . . 0.0 110.866 172.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.0 -34.24 77.13 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.569 1.548 . . . . 0.0 112.372 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -69.55 -62.48 1.37 Allowed 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 171.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.7 t -47.64 -41.03 7.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 123.916 0.886 . . . . 0.0 112.763 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.547 ' CE1' ' HE3' ' A' ' 40' ' ' LYS . 1.6 m-85 -61.54 -34.76 76.09 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 123.892 0.877 . . . . 0.0 112.121 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -112.41 -12.23 13.55 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.386 1.074 . . . . 0.0 112.712 -170.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -88.38 -34.67 17.49 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.614 1.566 . . . . 0.0 109.889 171.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -130.35 -62.63 0.92 Allowed 'General case' 0 C--N 1.345 0.373 0 C-N-CA 123.095 0.558 . . . . 0.0 111.807 -169.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.6 mt -62.41 -56.08 21.63 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 119.245 -0.407 . . . . 0.0 111.447 -162.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -60.75 -35.29 76.02 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 118.676 -0.678 . . . . 0.0 110.274 175.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.14 -16.21 12.52 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 127.19 2.196 . . . . 0.0 112.965 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 118.23 -10.15 13.35 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 126.046 1.784 . . . . 0.0 111.988 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -73.62 120.26 18.98 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 118.802 1.301 . . . . 0.0 110.837 -172.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -109.72 13.0 23.91 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.83 2.052 . . . . 0.0 112.074 -176.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -150.94 107.31 3.48 Favored 'General case' 0 CA--C 1.518 -0.274 0 O-C-N 120.248 -1.533 . . . . 0.0 107.983 -173.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mp -112.02 152.0 13.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 176.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.47 ' CE2' HG12 ' A' ' 22' ' ' VAL . 23.4 m-85 -130.08 150.5 51.32 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.603 1.161 . . . . 0.0 109.492 166.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.5 tp -119.91 110.28 16.54 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.204 1.001 . . . . 0.0 108.535 176.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.3 t -84.31 134.47 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 171.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.3 mp -109.82 6.19 23.23 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.62 0.768 . . . . 0.0 111.963 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 33.4 t -51.98 -48.14 64.52 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.158 0.983 . . . . 0.0 111.458 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -87.99 7.05 32.96 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.341 -0.85 . . . . 0.0 112.195 -168.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.6 p -134.45 126.93 49.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 125.579 1.551 . . . . 0.0 108.099 -173.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -75.34 -42.56 54.06 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 120.675 -1.266 . . . . 0.0 108.944 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.496 ' HB3' ' HE2' ' A' ' 95' ' ' LYS . 1.4 p -162.05 -178.15 6.23 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.992 0.901 . . . . 0.0 111.681 -173.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 21.3 tt -139.66 160.03 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 C-N-CA 125.344 1.458 . . . . 0.0 108.586 -175.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.12 156.18 22.26 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.408 1.083 . . . . 0.0 110.421 172.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.4 m -53.51 -28.77 32.93 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.126 1.37 . . . . 0.0 113.434 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -62.01 -66.6 0.51 Allowed 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.73 1.212 . . . . 0.0 109.309 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.0 t -74.27 -24.23 59.24 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.369 -0.824 . . . . 0.0 111.659 -176.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.1 tp -49.98 -30.82 11.26 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.944 1.247 . . . . 0.0 112.407 172.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.65 -24.69 29.84 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-N 118.396 0.544 . . . . 0.0 113.448 175.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.8 t -66.16 -39.52 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 118.194 0.997 . . . . 0.0 108.605 173.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 mp -52.55 -53.25 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 123.8 0.84 . . . . 0.0 108.914 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 73.3 t -58.94 -46.29 91.5 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 175.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -55.57 -43.2 75.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 119.46 1.027 . . . . 0.0 112.501 -174.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.2 mt -59.73 -38.89 78.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 124.114 0.966 . . . . 0.0 109.013 176.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.63 -50.94 71.5 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 119.151 0.887 . . . . 0.0 109.478 172.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -53.94 -47.93 70.75 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 118.077 -0.963 . . . . 0.0 110.331 -176.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.7 m -56.33 -57.49 12.04 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 124.092 0.87 . . . . 0.0 110.358 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 50.3 mt -53.28 -46.79 57.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.859 1.264 . . . . 0.0 110.637 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.2 p -61.78 -31.13 71.32 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.972 1.309 . . . . 0.0 111.978 -175.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.31 -31.68 33.45 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.848 1.659 . . . . 0.0 111.696 175.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 39.4 m -78.69 -21.95 47.43 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 117.64 -1.171 . . . . 0.0 113.991 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 121.02 4.92 10.0 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 119.652 1.115 . . . . 0.0 114.546 -174.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -113.32 -176.28 19.38 Favored Glycine 0 N--CA 1.437 -1.261 0 CA-C-N 119.24 1.52 . . . . 0.0 112.196 -173.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -131.47 157.5 43.33 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.825 1.65 . . . . 0.0 108.68 176.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -148.96 135.45 19.47 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 175.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.11 170.84 15.1 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.36 1.464 . . . . 0.0 110.28 -176.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.27 171.58 8.2 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 122.793 0.437 . . . . 0.0 110.467 -176.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 77.9 t -146.77 143.49 20.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 124.939 1.296 . . . . 0.0 109.723 -172.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 29.1 t 43.61 63.81 7.54 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 125.914 1.685 . . . . 0.0 109.119 -176.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -78.32 91.98 1.16 Allowed 'Trans proline' 0 N--CA 1.444 -1.428 0 N-CA-C 106.168 -2.281 . . . . 0.0 106.168 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -55.39 155.19 5.41 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 122.869 1.319 . . . . 0.0 110.125 -177.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -64.69 -25.26 67.87 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 122.318 1.056 . . . . 0.0 110.99 -165.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.496 ' HE2' ' HB3' ' A' ' 64' ' ' SER . 0.0 OUTLIER -68.82 -35.7 77.29 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 126.069 1.748 . . . . 0.0 111.547 177.428 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.0 m -82.44 -38.15 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.745 0 CA-C-N 120.436 1.471 . . . . 0.0 110.429 172.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.2 -33.42 63.01 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 120.193 1.36 . . . . 0.0 109.85 -176.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.45 -31.38 72.53 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 177.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.1 p -96.54 -32.12 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 C-N-CA 124.974 1.31 . . . . 0.0 108.653 -177.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.98 -18.59 65.41 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.408 1.883 . . . . 0.0 111.341 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.1 m -80.16 -57.01 3.82 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 168.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.41 -5.43 5.26 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 130.257 3.423 . . . . 0.0 114.006 -167.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -130.76 6.93 4.74 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 125.381 1.472 . . . . 0.0 110.659 -177.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 46.71 73.95 0.17 Allowed 'General case' 0 C--N 1.342 0.262 0 C-N-CA 127.511 2.325 . . . . 0.0 109.706 -170.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.79 -63.13 1.28 Allowed 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 174.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -57.64 -31.95 66.79 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 123.344 1.545 . . . . 0.0 110.284 174.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -76.43 1.91 15.1 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 120.09 -1.631 . . . . 0.0 111.219 -175.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.4 mt -126.54 -53.12 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 126.06 1.744 . . . . 0.0 107.936 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.2 t -103.11 145.8 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 125.878 1.671 . . . . 0.0 108.186 -174.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -71.09 161.28 31.39 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.5 -0.75 . . . . 0.0 111.164 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.19 143.56 27.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.421 1.488 . . . . 0.0 107.113 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -141.23 168.43 19.8 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 128.902 2.881 . . . . 0.0 109.239 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.2 -46.47 13.71 Favored 'General case' 0 CA--C 1.515 -0.372 0 O-C-N 121.53 -0.731 . . . . 0.0 109.697 177.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 60.1 p -119.45 173.79 6.77 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.045 1.338 . . . . 0.0 108.894 -173.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 8.8 mm -66.88 -41.9 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-O 117.858 -1.068 . . . . 0.0 108.726 168.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 18.6 t -67.9 -37.85 82.24 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 119.982 1.265 . . . . 0.0 110.87 -167.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -60.82 -28.46 68.81 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 118.4 -0.809 . . . . 0.0 109.802 177.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -81.27 -54.38 5.54 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.15 -28.76 59.27 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 125.917 1.687 . . . . 0.0 114.061 -160.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -104.79 -0.69 27.0 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 125.22 1.408 . . . . 0.0 114.406 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -123.32 -35.03 3.02 Favored 'General case' 0 C--O 1.213 -0.841 0 C-N-CA 125.162 1.385 . . . . 0.0 112.924 -167.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.4 t -57.02 -27.23 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 126.036 1.734 . . . . 0.0 109.442 161.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 11.8 mtm180 -54.18 -31.65 53.38 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 121.127 -0.983 . . . . 0.0 113.061 162.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.74 23.66 5.02 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 118.326 2.713 . . . . 0.0 118.326 -177.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 21.6 mttp . . . . . 0 N--CA 1.431 -1.383 0 N-CA-C 102.66 -3.089 . . . . 0.0 102.66 -179.933 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mpt? . . . . . 0 N--CA 1.468 0.458 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 48.6 36.68 18.73 Favored Glycine 0 C--N 1.339 0.726 0 C-N-CA 125.446 1.498 . . . . 0.0 115.087 165.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.2 p -61.44 179.51 0.22 Allowed 'General case' 0 C--O 1.239 0.522 0 CA-C-N 118.003 0.902 . . . . 0.0 109.638 167.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -64.88 171.77 3.27 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 122.995 1.378 . . . . 0.0 111.098 163.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -67.66 129.36 39.67 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 172.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 36.3 mm -90.11 -60.8 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -177.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.2 t60 50.69 102.22 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.007 2.123 . . . . 0.0 111.958 -166.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -59.36 162.16 4.99 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 122.216 1.008 . . . . 0.0 111.809 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -75.22 166.75 23.14 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.805 0.842 . . . . 0.0 111.972 -172.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.471 ' CE1' ' HD1' ' A' ' 11' ' ' HIS . 0.0 OUTLIER -71.73 175.32 5.8 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.695 0.798 . . . . 0.0 111.173 179.457 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.471 ' HD1' ' CE1' ' A' ' 10' ' ' HIS . 3.8 m80 55.31 104.35 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.098 0 C-N-CA 128.201 2.6 . . . . 0.0 112.649 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -142.98 166.26 25.12 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.009 1.324 . . . . 0.0 107.539 174.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.8 mpt? -120.15 175.95 5.69 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 126.71 2.004 . . . . 0.0 107.598 175.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -104.71 96.86 11.24 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 124.088 0.955 . . . . 0.0 109.696 -175.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -77.65 49.22 2.84 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 124.928 3.752 . . . . 0.0 111.198 176.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -160.41 165.11 31.7 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 125.689 1.596 . . . . 0.0 107.909 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -126.66 178.78 5.7 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 163.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.6 mt -126.5 152.23 33.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 163.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 23.3 m -111.19 -141.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 125.612 1.565 . . . . 0.0 107.724 174.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -29.94 -79.21 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 129.043 2.937 . . . . 0.0 112.501 166.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -142.82 14.04 1.91 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.952 2.501 . . . . 0.0 109.252 177.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.8 t -115.75 140.07 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 O-C-N 121.092 -1.005 . . . . 0.0 108.712 -173.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.4 t -94.14 130.67 42.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.1 mm -106.94 94.32 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 36.1 mt -77.83 133.69 38.13 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 176.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 70.4 mtm -131.24 92.98 31.15 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 124.21 1.004 . . . . 0.0 109.064 -172.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -78.02 44.62 1.62 Allowed 'Trans proline' 0 CA--C 1.542 0.915 1 C-N-CA 125.461 4.107 . . . . 0.0 113.887 -164.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -49.12 88.77 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 128.763 2.825 . . . . 0.0 114.343 -169.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 36.94 35.41 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 128.95 2.9 . . . . 0.0 115.016 -176.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -122.78 7.43 9.38 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -167.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.0 mp -73.84 63.89 0.93 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 126.027 1.731 . . . . 0.0 109.605 -176.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -78.82 26.88 0.23 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 128.938 2.895 . . . . 0.0 113.868 -166.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.6 mm 72.86 -63.09 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 127.068 2.147 . . . . 0.0 110.643 -177.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -70.3 -18.56 63.11 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 120.916 1.689 . . . . 0.0 111.35 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -47.83 -49.58 28.8 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 123.991 0.916 . . . . 0.0 110.516 162.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.73 -37.33 87.23 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.79 0.436 . . . . 0.0 110.446 -177.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -61.89 -51.19 69.17 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.332 0.653 . . . . 0.0 110.017 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.259 0.0 OUTLIER -81.82 -15.76 53.08 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-O 117.599 -1.191 . . . . 0.0 112.608 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -44.48 -50.74 9.28 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.441 1.896 . . . . 0.0 110.661 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.501 ' HE2' ' CE1' ' A' ' 44' ' ' PHE . 13.6 tmtt? -60.65 -53.16 60.85 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 123.222 0.609 . . . . 0.0 111.19 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.41 -45.91 87.48 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.039 0.836 . . . . 0.0 109.914 -177.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -60.49 -66.98 0.44 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 117.292 -1.337 . . . . 0.0 109.705 176.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 73.5 t -52.13 -32.32 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 120.537 1.517 . . . . 0.0 111.986 -176.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.501 ' CE1' ' HE2' ' A' ' 40' ' ' LYS . 3.3 m-85 -58.19 -71.78 0.1 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.91 0.777 . . . . 0.0 109.905 172.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -65.89 -30.83 71.49 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 123.887 0.875 . . . . 0.0 112.885 -170.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -77.32 -31.81 54.85 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.011 1.325 . . . . 0.0 110.962 -175.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -138.13 -62.73 0.58 Allowed 'General case' 0 C--N 1.341 0.22 0 CA-C-N 118.522 0.601 . . . . 0.0 110.991 -170.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 46.6 mt -58.81 -59.43 5.44 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.416 0.553 . . . . 0.0 111.176 -171.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -60.68 -35.26 75.83 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.029 1.332 . . . . 0.0 109.647 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 tttm -56.5 -34.7 67.22 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.952 176.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.41 8.82 5.74 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.991 1.281 . . . . 0.0 114.173 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -77.63 159.77 28.98 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 118.941 1.37 . . . . 0.0 110.426 172.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -143.44 11.06 1.68 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.251 1.82 . . . . 0.0 111.795 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -139.34 114.73 9.79 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 119.93 1.241 . . . . 0.0 107.914 -176.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mp -121.91 152.55 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 127.381 2.272 . . . . 0.0 105.118 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -131.4 160.74 34.18 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.985 1.714 . . . . 0.0 109.37 166.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 26.5 tp -127.6 119.44 25.95 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 118.085 -0.96 . . . . 0.0 108.434 169.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.42 HG11 ' H ' ' A' ' 60' ' ' SER . 46.4 t -81.54 139.35 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 120.389 1.449 . . . . 0.0 107.685 170.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.3 mt -112.54 8.82 19.39 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.889 0.768 . . . . 0.0 112.22 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.42 ' H ' HG11 ' A' ' 58' ' ' VAL . 71.9 m -74.79 -34.1 62.36 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.297 -0.877 . . . . 0.0 113.233 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -90.76 30.6 1.15 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 122.889 1.328 . . . . 0.0 110.469 -174.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.9 p -160.8 170.7 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 129.344 3.058 . . . . 0.0 104.853 -174.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -129.94 -47.31 1.13 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 172.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.7 p -143.23 171.76 13.66 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.707 0.803 . . . . 0.0 110.648 -176.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.6 tt -138.32 157.88 31.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 C-N-CA 124.987 1.315 . . . . 0.0 108.393 -174.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -73.53 153.54 40.24 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.74 0.781 . . . . 0.0 109.808 174.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.6 m -76.21 53.23 0.8 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.629 1.172 . . . . 0.0 110.447 164.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -129.29 -69.45 0.69 Allowed 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 160.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.03 -38.84 77.0 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 128.967 2.907 . . . . 0.0 112.031 -173.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 20.9 tp -46.05 -40.39 10.62 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 125.881 1.673 . . . . 0.0 111.966 171.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.82 -31.1 40.98 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-O 119.404 -0.665 . . . . 0.0 111.762 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.2 t -70.62 -33.75 54.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 118.074 0.937 . . . . 0.0 108.659 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 22.7 mm -55.75 -46.98 79.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 O-C-N 121.367 -0.833 . . . . 0.0 109.722 174.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.4 t -60.48 -36.64 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 O-C-N 121.087 -1.008 . . . . 0.0 111.693 172.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -63.73 -28.09 69.65 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 120.873 1.67 . . . . 0.0 112.121 -178.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.4 mt -70.32 -34.95 60.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 O-C-N 121.289 -0.882 . . . . 0.0 109.091 173.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.18 -40.93 82.14 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.1 mttm -54.65 -46.48 73.98 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 117.92 -1.038 . . . . 0.0 111.607 174.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.6 t -58.23 -58.36 8.83 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.1 mt -62.07 -40.28 86.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 123.828 0.851 . . . . 0.0 111.157 -170.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.0 t -60.52 -40.87 93.03 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.68 1.592 . . . . 0.0 110.909 173.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.7 m -69.97 -35.11 74.2 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.985 -0.447 . . . . 0.0 110.613 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.1 m -73.06 -51.08 19.46 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.472 1.109 . . . . 0.0 112.844 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 132.98 18.8 1.05 Allowed Glycine 0 CA--C 1.531 1.04 0 CA-C-O 118.064 -1.409 . . . . 0.0 115.031 -170.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -116.86 -168.06 14.72 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 120.251 2.026 . . . . 0.0 111.72 -172.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -132.4 153.22 51.03 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.639 1.576 . . . . 0.0 109.901 -178.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -153.16 140.69 19.8 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 174.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.6 172.26 13.85 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.61 1.164 . . . . 0.0 111.469 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.02 165.74 13.0 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 53.7 t -142.89 134.85 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 C-N-CA 124.723 1.209 . . . . 0.0 108.034 -165.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.6 t 50.74 54.43 15.4 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 126.201 1.801 . . . . 0.0 111.821 -174.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -73.5 107.7 2.45 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 124.175 3.25 . . . . 0.0 109.154 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 32.6 p-10 -66.47 165.52 14.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 122.393 1.092 . . . . 0.0 110.6 174.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -69.09 -26.35 64.88 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.863 -1.148 . . . . 0.0 112.214 -170.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.9 -29.18 70.57 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 126.878 2.071 . . . . 0.0 109.66 177.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.3 t -84.88 -50.32 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-O 116.105 -1.902 . . . . 0.0 108.875 169.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -54.04 -34.74 60.84 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 122.782 2.537 . . . . 0.0 109.844 -177.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.73 -46.09 89.71 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 121.711 -0.618 . . . . 0.0 111.268 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.8 p -83.95 -38.8 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 -169.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.7 mp -61.28 -24.29 66.3 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.776 1.63 . . . . 0.0 112.644 177.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.81 6.86 34.27 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.376 0.989 . . . . 0.0 111.302 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 41.5 mt -108.67 -39.24 5.43 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 126.773 2.029 . . . . 0.0 110.704 171.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.2 t -94.72 0.42 55.0 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.413 1.885 . . . . 0.0 112.021 -168.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 57.96 79.86 0.19 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.296 1.838 . . . . 0.0 109.432 -168.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.28 -55.44 1.26 Allowed 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.97 1.308 . . . . 0.0 108.996 175.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -59.54 -18.41 40.34 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.642 1.977 . . . . 0.0 112.183 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.92 -9.09 24.59 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.422 1.889 . . . . 0.0 114.535 -178.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.8 mt -107.62 -38.04 3.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 126.926 2.09 . . . . 0.0 107.914 -176.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.5 t -120.78 145.44 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 123.726 0.81 . . . . 0.0 109.117 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.04 161.01 27.67 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.084 0.554 . . . . 0.0 110.742 175.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.09 144.12 25.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -144.67 167.05 23.49 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 127.363 2.265 . . . . 0.0 110.784 -176.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -84.72 -44.52 13.29 Favored 'General case' 0 C--O 1.233 0.189 0 O-C-N 121.835 -0.54 . . . . 0.0 110.008 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.6 p -128.96 177.22 7.27 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.165 0.986 . . . . 0.0 109.48 -171.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 13.7 mm -74.95 -42.59 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 174.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 10.0 t -70.82 -25.56 62.9 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 119.573 1.079 . . . . 0.0 110.313 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -65.74 -16.22 63.57 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 119.676 1.126 . . . . 0.0 111.399 170.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -107.98 -38.75 5.72 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 123.762 0.825 . . . . 0.0 109.185 -171.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 8.2 ttp -61.7 -42.75 99.36 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.245 1.018 . . . . 0.0 112.571 -160.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -92.72 -23.53 18.89 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 124.586 1.154 . . . . 0.0 111.861 175.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -81.39 -52.14 7.59 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -169.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -46.89 -34.8 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 127.182 2.193 . . . . 0.0 112.637 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 11.7 mtm180 -60.68 -32.6 71.81 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 123.595 0.758 . . . . 0.0 111.834 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.8 60.31 0.93 Allowed 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 127.008 2.123 . . . . 0.0 105.624 -178.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.259 1.59 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -174.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.646 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -142.65 174.33 23.54 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 177.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.3 m -161.88 -6.75 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.311 1.844 . . . . 0.0 112.253 168.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 47.99 55.82 8.12 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.886 1.274 . . . . 0.0 113.555 128.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -61.79 -68.8 0.29 Allowed 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.334 -0.853 . . . . 0.0 110.513 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.7 mp 53.31 -96.26 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 125.289 1.435 . . . . 0.0 107.862 -163.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.63 140.36 58.5 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 120.253 1.388 . . . . 0.0 109.749 172.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -123.82 166.47 15.56 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.029 0.932 . . . . 0.0 108.804 170.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 54.73 -178.81 0.03 OUTLIER 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.406 1.098 . . . . 0.0 112.436 -166.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -129.94 139.61 51.07 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 175.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -136.15 73.73 1.47 Allowed 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 -176.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -121.37 -58.46 1.78 Allowed 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 171.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.0 ptt? 53.41 -179.09 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 127.71 2.404 . . . . 0.0 113.205 -172.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -153.5 147.83 19.11 Favored Pre-proline 0 CA--C 1.539 0.525 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 168.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -74.64 132.88 16.46 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.635 2.224 . . . . 0.0 113.014 172.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -153.63 173.62 15.54 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.16 1.384 . . . . 0.0 108.951 177.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -129.48 175.75 8.52 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 157.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.5 mt -125.41 157.54 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 163.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.1 m -117.34 -143.13 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 168.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -47.33 -66.44 0.41 Allowed 'General case' 0 C--O 1.234 0.268 0 C-N-CA 127.058 2.143 . . . . 0.0 112.134 -175.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -141.93 12.15 2.03 Favored 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 123.711 0.804 . . . . 0.0 112.574 170.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 20.5 t -105.77 139.07 28.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.9 t -90.72 149.87 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.239 1.016 . . . . 0.0 108.307 174.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.7 mp -129.88 107.81 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 176.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.49 158.43 24.51 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 120.57 1.532 . . . . 0.0 108.586 170.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 38.8 mtt -133.49 86.14 41.16 Favored Pre-proline 0 N--CA 1.465 0.296 0 C-N-CA 124.951 1.3 . . . . 0.0 107.941 -175.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -65.12 93.0 0.22 Allowed 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.372 2.714 . . . . 0.0 109.967 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -74.05 52.79 0.46 Allowed 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 125.639 1.576 . . . . 0.0 109.679 165.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.85 -2.01 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 130.048 3.339 . . . . 0.0 117.769 173.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -71.84 33.32 0.06 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 128.998 2.919 . . . . 0.0 112.485 176.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.8 mt -84.46 59.7 5.59 Favored 'General case' 0 N--CA 1.457 -0.121 0 O-C-N 120.355 -1.466 . . . . 0.0 108.098 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -73.31 172.35 11.36 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.979 1.712 . . . . 0.0 109.724 169.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.7 mt -71.98 -39.21 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 O-C-N 121.472 -0.767 . . . . 0.0 110.609 -177.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -63.97 -33.81 76.58 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 118.48 0.582 . . . . 0.0 110.117 -170.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -78.47 -21.71 48.64 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 125.267 1.427 . . . . 0.0 111.688 175.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.99 -55.9 6.6 Favored 'General case' 0 CA--C 1.521 -0.17 0 O-C-N 120.639 -1.288 . . . . 0.0 112.294 -171.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -67.11 -30.71 70.8 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 118.717 -1.193 . . . . 0.0 110.191 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.48 -23.36 60.06 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 117.785 -1.102 . . . . 0.0 110.308 176.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -49.87 -41.97 46.6 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.296 1.438 . . . . 0.0 111.295 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -58.79 -63.74 1.18 Allowed 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 172.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -44.79 -50.95 9.9 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.865 2.066 . . . . 0.0 111.447 -177.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -61.78 -65.44 0.69 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 117.304 -1.332 . . . . 0.0 109.959 177.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.7 t -53.1 -34.21 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 120.365 1.439 . . . . 0.0 111.416 -176.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -60.75 -69.43 0.23 Allowed 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 124.41 1.084 . . . . 0.0 109.115 174.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -62.81 -39.84 95.53 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.312 0.645 . . . . 0.0 112.538 -173.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -70.55 -31.42 68.46 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.793 1.237 . . . . 0.0 110.858 -175.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -137.71 -58.59 0.67 Allowed 'General case' 0 C--N 1.343 0.298 0 CA-C-N 119.021 0.828 . . . . 0.0 112.238 -171.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 43.7 mt -59.95 -53.04 62.48 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 120.54 -1.35 . . . . 0.0 111.303 -171.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -69.49 -15.65 63.3 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.553 1.941 . . . . 0.0 111.177 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -74.49 -28.89 61.21 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 118.292 -0.861 . . . . 0.0 111.068 168.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.71 1.82 8.17 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.756 1.646 . . . . 0.0 114.235 -177.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -72.83 159.8 33.17 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 120.066 1.933 . . . . 0.0 110.71 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -139.22 -8.29 1.32 Allowed 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 126.349 1.86 . . . . 0.0 111.423 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -129.25 129.25 44.72 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.029 0.931 . . . . 0.0 109.325 -175.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.5 mt -138.39 155.39 28.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 126.706 2.002 . . . . 0.0 106.433 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -134.43 156.96 47.64 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 125.708 1.603 . . . . 0.0 111.459 166.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 46.5 tp -125.97 114.94 19.14 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 117.289 -1.339 . . . . 0.0 108.584 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.7 t -92.85 119.0 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 121.137 1.789 . . . . 0.0 109.206 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.4 mp -90.78 1.38 56.95 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -173.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 73.4 p -51.26 -44.28 61.73 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.636 1.974 . . . . 0.0 114.242 -171.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -68.88 -27.86 66.18 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 120.942 -1.099 . . . . 0.0 111.098 -175.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -95.13 150.86 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 125.344 1.458 . . . . 0.0 109.103 -165.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -70.2 -59.65 2.76 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 158.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.3 t -164.33 176.83 8.75 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 122.699 1.238 . . . . 0.0 110.677 -168.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.0 tt -109.12 177.95 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 128.288 2.635 . . . . 0.0 107.666 172.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -118.88 173.88 6.62 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.247 0.931 . . . . 0.0 110.381 171.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.8 t -50.5 -41.23 53.17 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 126.583 1.953 . . . . 0.0 111.428 -175.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -65.14 -58.7 5.34 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 118.154 -0.927 . . . . 0.0 111.008 -171.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 66.0 m -69.75 -36.72 76.06 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 120.293 1.406 . . . . 0.0 113.012 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 39.8 tp -49.39 -43.48 44.36 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.867 1.667 . . . . 0.0 112.599 -172.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -94.98 11.41 69.55 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 120.739 -0.743 . . . . 0.0 113.797 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.6 t -85.03 -39.69 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 118.376 1.088 . . . . 0.0 108.44 153.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.4 mm -56.19 -62.76 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 119.454 1.024 . . . . 0.0 109.68 -177.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 9.8 p -37.13 -49.83 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 124.908 1.283 . . . . 0.0 114.289 165.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -60.61 -42.37 96.67 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 123.598 0.759 . . . . 0.0 109.306 -167.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 75.4 mt -55.85 -41.32 66.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.459 1.104 . . . . 0.0 108.221 176.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -58.89 -51.81 68.44 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 124.074 0.95 . . . . 0.0 110.13 177.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -56.57 -45.18 81.44 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 122.882 0.473 . . . . 0.0 110.331 -175.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -46.94 87.67 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 123.013 0.525 . . . . 0.0 110.711 175.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.6 mt -63.77 -41.24 91.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 123.702 0.801 . . . . 0.0 110.652 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.3 m -58.86 -51.11 71.42 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.713 1.205 . . . . 0.0 110.961 173.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.3 m -63.78 -26.53 68.67 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 176.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.9 m -74.24 -51.59 14.9 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.773 0.829 . . . . 0.0 110.967 174.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.74 37.49 0.62 Allowed Glycine 0 CA--C 1.529 0.965 0 CA-C-O 118.699 -1.056 . . . . 0.0 113.662 -165.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -133.76 -168.7 11.9 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 119.755 1.778 . . . . 0.0 111.602 177.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -142.94 119.48 11.03 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.086 1.754 . . . . 0.0 110.111 -171.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -122.77 146.12 47.8 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.173 0.897 . . . . 0.0 109.143 172.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -152.72 173.35 15.38 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.342 1.057 . . . . 0.0 111.581 -176.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.5 mt -120.36 164.6 16.1 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.833 0.853 . . . . 0.0 109.527 -176.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 55.7 t -140.87 147.19 22.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 124.164 0.986 . . . . 0.0 109.468 -175.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 52.98 57.87 14.46 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.991 1.316 . . . . 0.0 111.332 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -77.15 81.69 2.55 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.202 2.601 . . . . 0.0 110.303 177.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.65 143.82 19.32 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.085 0.554 . . . . 0.0 109.668 172.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -54.77 -36.25 64.67 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.983 1.313 . . . . 0.0 113.643 -156.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.3 -41.17 62.69 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.155 0.982 . . . . 0.0 109.204 178.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -81.2 -29.67 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 118.67 0.668 . . . . 0.0 109.676 -173.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -62.81 -26.87 68.95 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.172 0.896 . . . . 0.0 110.801 172.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.75 -44.16 93.94 Favored 'General case' 0 C--N 1.344 0.33 0 O-C-N 121.465 -0.772 . . . . 0.0 109.47 175.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.9 p -86.3 -43.6 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 -168.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.4 -24.68 60.71 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.674 1.19 . . . . 0.0 111.296 177.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 26.3 t -77.42 -52.79 8.54 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 120.271 1.396 . . . . 0.0 108.712 172.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 52.0 mt -58.26 -51.46 69.69 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.942 1.297 . . . . 0.0 111.76 -172.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.5 t -73.79 -5.29 39.96 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.383 0.538 . . . . 0.0 111.197 -178.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 64.24 76.69 0.34 Allowed 'General case' 0 C--N 1.342 0.263 0 C-N-CA 126.832 2.053 . . . . 0.0 107.583 -174.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.84 -51.86 1.45 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.751 1.22 . . . . 0.0 109.501 -171.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.59 -25.54 66.3 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 122.995 1.378 . . . . 0.0 111.436 172.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 4.7 mtm180 -75.28 -8.34 56.38 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.505 1.122 . . . . 0.0 111.34 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.9 mt -130.47 -34.74 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 125.07 1.348 . . . . 0.0 109.006 -165.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.5 t -112.68 149.14 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 126.339 1.856 . . . . 0.0 108.159 175.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.93 160.97 30.63 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.688 0.795 . . . . 0.0 110.782 172.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -146.67 144.36 20.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -176.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -148.18 174.02 12.39 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.017 1.327 . . . . 0.0 112.437 -172.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.75 -44.48 9.43 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.751 0.821 . . . . 0.0 111.526 -177.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 71.1 p -126.43 168.43 14.22 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.811 1.244 . . . . 0.0 109.063 -176.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 9.0 mm -62.66 -39.89 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 167.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.3 t -70.66 -36.28 73.28 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 119.502 1.046 . . . . 0.0 110.155 -171.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -69.14 -5.65 23.7 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 118.324 -0.846 . . . . 0.0 112.225 174.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -104.42 -44.55 4.9 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 174.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 10.0 ttm -56.7 -51.83 67.27 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 125.377 1.471 . . . . 0.0 112.593 -163.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -104.8 13.75 30.76 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 126.322 1.849 . . . . 0.0 110.933 -176.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -112.98 -58.13 2.2 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.607 1.563 . . . . 0.0 109.309 -177.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -48.75 -39.03 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.071 0 C-N-CA 126.736 2.015 . . . . 0.0 110.501 177.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 12.0 mtm180 -56.5 -30.42 62.97 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 122.692 0.397 . . . . 0.0 110.668 -176.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.71 38.69 1.36 Allowed 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.745 1.218 . . . . 0.0 111.366 -174.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.875 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 167.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.419 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.28 162.42 35.78 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.684 -0.566 . . . . 0.0 111.684 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.1 p -74.2 100.59 3.73 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.699 1.2 . . . . 0.0 109.225 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 53.9 t0 59.98 -85.58 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.231 1.812 . . . . 0.0 112.707 -175.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 29.1 pttt -139.46 25.45 2.42 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.961 1.704 . . . . 0.0 113.415 -154.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 29.7 mm -57.88 136.99 20.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 123.674 0.79 . . . . 0.0 110.576 -174.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.504 ' CG ' ' H ' ' A' ' 8' ' ' HIS . 13.0 p-80 -164.94 -77.98 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.275 1.83 . . . . 0.0 108.302 161.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.504 ' H ' ' CG ' ' A' ' 7' ' ' HIS . 14.3 m80 -60.21 116.18 4.04 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 124.572 1.149 . . . . 0.0 110.393 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -144.11 17.06 1.74 Allowed 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -177.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -80.23 141.57 35.47 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.585 0.63 . . . . 0.0 110.484 169.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 18.3 m80 31.03 84.09 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 129.511 3.124 . . . . 0.0 113.587 170.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -126.13 21.3 7.43 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.825 1.25 . . . . 0.0 112.296 -176.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.3 tmm? 91.57 144.25 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 130.589 3.555 . . . . 0.0 110.242 -176.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -142.0 86.24 10.53 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 125.493 1.517 . . . . 0.0 108.622 -167.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -80.98 68.32 8.37 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.469 2.78 . . . . 0.0 110.188 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -159.26 164.64 34.77 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 120.773 -1.204 . . . . 0.0 111.088 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.9 173.7 9.39 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.481 1.112 . . . . 0.0 110.209 164.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.434 ' CD1' HG22 ' A' ' 23' ' ' VAL . 9.5 mm -121.82 135.47 61.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 169.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.5 m -115.88 -169.19 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 C-N-CA 126.185 1.794 . . . . 0.0 108.051 168.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -24.08 -61.14 0.05 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 129.397 3.079 . . . . 0.0 113.823 -170.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -145.62 19.91 1.5 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.874 0.369 . . . . 0.0 111.707 161.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.4 t -110.11 136.23 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 O-C-N 120.837 -1.165 . . . . 0.0 109.192 -175.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.434 HG22 ' CD1' ' A' ' 18' ' ' ILE . 66.0 t -85.32 125.31 40.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 106.862 -1.532 . . . . 0.0 106.862 172.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.7 mm -103.5 104.2 16.31 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 173.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 25.2 mt -78.24 123.1 26.55 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 172.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 32.9 mtt -125.34 75.94 68.61 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 124.404 1.082 . . . . 0.0 109.295 -168.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -67.0 140.49 54.71 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.298 1.998 . . . . 0.0 110.875 -177.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -130.25 66.43 1.5 Allowed 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 128.731 2.812 . . . . 0.0 109.521 171.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.23 7.33 6.18 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.956 2.102 . . . . 0.0 113.567 167.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.19 -3.34 26.06 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.217 1.807 . . . . 0.0 114.435 -177.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.6 mt -70.19 31.92 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 128.932 2.893 . . . . 0.0 115.483 -159.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -62.35 151.29 37.2 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 128.641 2.776 . . . . 0.0 112.603 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.7 mt -53.43 -40.31 40.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 124.24 1.016 . . . . 0.0 112.183 -177.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -65.83 -30.47 71.09 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.364 0.666 . . . . 0.0 110.086 -172.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.34 -28.43 14.97 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.27 -34.82 74.28 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 117.924 -1.036 . . . . 0.0 111.831 -176.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -59.71 -64.22 1.02 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 119.569 1.077 . . . . 0.0 109.606 174.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.254 0.0 OUTLIER -74.93 -8.21 55.82 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-O 117.989 -1.005 . . . . 0.0 112.858 -172.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -41.65 -42.73 2.59 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.709 2.004 . . . . 0.0 111.993 172.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -53.55 -68.73 0.15 Allowed 'General case' 0 C--N 1.343 0.298 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 170.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -52.62 -42.49 64.64 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 125.54 1.536 . . . . 0.0 111.806 -174.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 15.0 t90 -55.78 -60.63 3.18 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.834 0.854 . . . . 0.0 109.533 172.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 53.9 t -56.37 -35.91 45.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 119.927 1.24 . . . . 0.0 111.716 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -70.06 -37.64 75.57 Favored 'General case' 0 N--CA 1.441 -0.903 0 O-C-N 121.309 -0.87 . . . . 0.0 111.048 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -105.39 -9.2 17.7 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.008 1.323 . . . . 0.0 112.308 -167.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -99.35 -20.24 16.61 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.916 1.234 . . . . 0.0 112.135 165.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -135.67 -49.49 0.71 Allowed 'General case' 0 C--N 1.349 0.577 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -174.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 35.2 mt -67.93 -44.45 76.84 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 120.041 1.291 . . . . 0.0 112.314 -169.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -69.34 -24.56 63.92 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.462 0.705 . . . . 0.0 111.845 173.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.7 mttt -66.26 -6.83 15.16 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.944 1.298 . . . . 0.0 112.676 164.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.3 21.88 72.01 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-O 118.945 -0.92 . . . . 0.0 112.589 178.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -73.08 143.03 47.57 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 119.7 1.75 . . . . 0.0 107.597 163.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -127.82 0.89 6.04 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.601 1.56 . . . . 0.0 112.754 177.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.36 124.59 43.29 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 172.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.3 mt -125.13 147.19 29.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 128.448 2.699 . . . . 0.0 104.362 174.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 18.7 m-30 -126.59 158.29 36.63 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.259 1.423 . . . . 0.0 110.475 166.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 29.5 tp -126.85 111.81 14.61 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 172.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 79.6 t -78.65 135.01 26.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 170.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 mp -117.35 20.02 13.81 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.197 0.999 . . . . 0.0 111.694 176.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.63 -51.5 67.02 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.576 1.151 . . . . 0.0 112.806 172.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -86.83 -9.75 55.08 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.127 -0.983 . . . . 0.0 111.72 -164.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.6 p -108.16 155.01 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 127.212 2.205 . . . . 0.0 108.773 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -101.68 -46.73 4.85 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.792 0.837 . . . . 0.0 109.01 172.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.1 p -155.36 170.58 21.58 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 123.767 1.746 . . . . 0.0 112.643 -166.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.4 tt -137.72 177.52 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 C-N-CA 129.242 3.017 . . . . 0.0 105.592 -176.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -131.28 170.53 14.48 Favored 'General case' 0 C--O 1.238 0.486 0 O-C-N 121.471 -0.768 . . . . 0.0 110.696 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.3 m -67.5 50.63 0.05 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 128.548 2.739 . . . . 0.0 110.994 167.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -133.0 -72.73 0.51 Allowed 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 103.986 -2.598 . . . . 0.0 103.986 155.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 m -65.9 -27.34 68.12 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 124.393 1.077 . . . . 0.0 111.92 -167.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.8 mt -51.36 -35.06 36.83 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.218 1.007 . . . . 0.0 112.54 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -72.07 -34.17 61.84 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.1 t -75.54 -34.15 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 O-C-N 121.526 -0.985 . . . . 0.0 110.402 -173.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.2 mp -55.89 -45.77 80.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 170.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.7 t -63.78 -45.99 95.69 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 O-C-N 121.048 -1.033 . . . . 0.0 110.04 175.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -50.24 -39.7 45.45 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.883 1.22 . . . . 0.0 113.247 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 65.6 mt -60.88 -47.81 91.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.203 1.001 . . . . 0.0 109.715 174.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -59.57 -47.09 86.91 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.7 mttt -56.69 -46.32 81.26 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 119.063 -0.494 . . . . 0.0 110.675 -175.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.8 t -54.39 -58.41 7.55 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 174.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 81.5 mt -55.58 -48.18 77.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.619 1.167 . . . . 0.0 111.628 -174.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.5 m -69.01 -14.38 63.01 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 117.651 -1.166 . . . . 0.0 112.947 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 51.3 m -87.42 -45.07 10.86 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.474 1.034 . . . . 0.0 110.506 163.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.8 m -66.19 -17.63 64.85 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 126.112 1.765 . . . . 0.0 115.014 -175.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.94 0.2 9.81 Favored Glycine 0 C--N 1.336 0.552 0 CA-C-O 118.116 -1.38 . . . . 0.0 116.307 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -115.85 -165.31 14.36 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-N 119.859 1.829 . . . . 0.0 113.699 -163.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.403 ' HB3' ' CG2' ' A' ' 122' ' ' VAL . 1.0 OUTLIER -131.61 154.41 48.91 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.888 1.675 . . . . 0.0 108.852 173.202 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -123.76 141.48 51.99 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 168.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -144.38 167.18 23.09 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 119.468 -0.893 . . . . 0.0 112.163 167.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.4 mt -120.86 160.05 24.23 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -175.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 26.4 t -134.28 138.34 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -171.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.7 m 58.45 60.23 5.7 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 125.034 1.334 . . . . 0.0 111.952 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -82.74 101.02 1.01 Allowed 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.171 2.581 . . . . 0.0 110.001 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -65.72 170.54 5.12 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.896 1.278 . . . . 0.0 108.899 175.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -72.2 -30.04 64.55 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.167 -0.958 . . . . 0.0 111.449 -175.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.407 ' HE3' ' O ' ' A' ' 95' ' ' LYS . 0.2 OUTLIER -58.42 -45.95 87.43 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 120.804 -1.185 . . . . 0.0 108.896 176.934 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 31.3 m -79.07 -37.24 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.856 0 CA-C-O 117.355 -1.307 . . . . 0.0 111.261 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -56.36 -30.65 62.93 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 121.292 1.86 . . . . 0.0 109.329 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.62 -38.41 90.12 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.689 177.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.4 p -95.81 -28.41 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -170.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.17 -15.37 63.08 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 124.973 1.309 . . . . 0.0 110.231 177.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.52 -55.28 4.97 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 120.05 1.295 . . . . 0.0 107.881 168.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.28 -43.26 86.9 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.966 2.106 . . . . 0.0 112.191 -163.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.1 t -76.45 -6.34 51.31 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.563 0.745 . . . . 0.0 110.964 177.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.7 m120 52.63 83.56 0.06 Allowed 'General case' 0 C--N 1.346 0.425 0 C-N-CA 129.376 3.071 . . . . 0.0 107.875 -163.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.95 -72.96 0.68 Allowed 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 176.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -61.74 -24.47 66.83 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.77 1.228 . . . . 0.0 110.728 174.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -75.15 5.9 4.89 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 120.777 -1.202 . . . . 0.0 111.313 176.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.9 mt -129.45 -43.39 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 C-N-CA 127.795 2.438 . . . . 0.0 107.829 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.3 m -98.25 178.69 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 C-N-CA 127.066 2.146 . . . . 0.0 113.137 -172.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 24.7 mmtm -99.58 162.95 12.71 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 124.099 0.96 . . . . 0.0 110.086 170.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -151.18 136.47 10.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -171.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -145.03 167.1 23.47 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.41 1.084 . . . . 0.0 112.668 -169.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.14 -38.64 17.53 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.876 -0.515 . . . . 0.0 111.183 -174.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.1 p -134.64 177.21 7.96 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 15.1 mm -71.19 -40.56 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.278 174.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.4 t -70.3 -32.63 70.49 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 119.424 1.011 . . . . 0.0 110.143 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -70.7 0.57 6.76 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.617 172.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.39 -37.04 3.83 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 119.259 0.936 . . . . 0.0 109.523 175.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 20.7 ttm -63.67 -55.27 24.77 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.984 1.314 . . . . 0.0 111.788 -160.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -81.61 -18.79 43.52 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.064 0.459 . . . . 0.0 110.265 173.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -80.33 -49.02 12.09 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -162.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.403 ' CG2' ' HB3' ' A' ' 86' ' ' PHE . 4.1 p -42.26 -40.48 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 127.856 2.462 . . . . 0.0 111.461 174.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -58.01 -45.83 86.25 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 125.106 1.362 . . . . 0.0 113.423 177.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.09 34.62 3.08 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.364 1.866 . . . . 0.0 110.778 -166.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.847 0 C-N-CA 127.076 2.151 . . . . 0.0 111.67 -176.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.9 mtm . . . . . 0 N--CA 1.472 0.637 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 141.61 -79.85 0.26 Allowed Glycine 0 C--N 1.337 0.599 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 80.8 p 53.95 -167.11 0.07 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.282 1.833 . . . . 0.0 112.172 -171.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -99.25 150.04 22.5 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 165.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.5 pttt -149.73 174.82 12.18 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.032 0.933 . . . . 0.0 109.631 178.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.5 mt 70.98 -48.41 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 128.078 2.551 . . . . 0.0 111.579 177.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.5 t60 62.89 -77.72 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.625 2.37 . . . . 0.0 111.031 -178.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 28.3 m170 -61.38 140.14 58.07 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.694 1.598 . . . . 0.0 111.235 -176.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -155.87 126.07 6.63 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 172.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -140.47 145.1 36.49 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 126.335 1.854 . . . . 0.0 106.752 154.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 24.7 p-80 176.34 -50.51 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.3 2.24 . . . . 0.0 109.736 167.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -73.21 167.44 21.17 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 169.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 18.0 ttt -125.4 70.27 1.17 Allowed 'General case' 0 C--O 1.231 0.084 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 174.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 34.08 80.03 0.27 Allowed Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 127.691 2.397 . . . . 0.0 112.345 176.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -78.3 48.06 2.59 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 124.913 3.742 . . . . 0.0 112.105 -169.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -155.57 168.38 27.31 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 127.635 2.374 . . . . 0.0 106.02 -171.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -127.62 176.74 7.28 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 120.791 -1.193 . . . . 0.0 108.451 164.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.9 mt -132.32 120.13 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 171.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.6 m -102.33 -175.93 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 166.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -26.74 -55.95 0.08 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 130.199 3.4 . . . . 0.0 113.95 -157.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -143.5 8.97 1.58 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 118.775 -0.631 . . . . 0.0 111.241 164.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.32 115.62 50.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 -172.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 38.9 t -68.3 156.4 7.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 173.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.7 mm -130.6 98.4 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 177.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.53 134.49 45.28 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 120.24 1.382 . . . . 0.0 108.25 168.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 51.6 mtm -128.83 72.7 81.53 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 123.644 0.778 . . . . 0.0 109.551 -177.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.59 145.3 57.73 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.31 2.674 . . . . 0.0 112.577 -176.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.418 ' HB2' ' HE3' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -118.87 -77.8 0.58 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 126.056 1.742 . . . . 0.0 110.452 174.689 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.418 ' HE3' ' HB2' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -135.56 13.85 3.45 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.001 1.321 . . . . 0.0 111.07 -173.571 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -108.78 18.42 20.8 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 120.967 -1.083 . . . . 0.0 112.103 -162.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 19.8 mt -92.62 68.06 4.68 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 124.146 0.978 . . . . 0.0 109.087 -176.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -81.23 144.24 31.73 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.2 tt -52.83 -37.19 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 CA-C-N 119.006 0.821 . . . . 0.0 111.82 170.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -62.62 -52.73 62.2 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.49 -0.756 . . . . 0.0 109.71 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -76.01 -16.38 59.97 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-O 118.228 -0.892 . . . . 0.0 111.96 177.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.73 -40.8 88.5 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.909 1.231 . . . . 0.0 110.518 171.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -60.6 -39.03 86.63 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 120.433 -1.417 . . . . 0.0 109.575 174.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 90.1 mt -73.04 -23.55 60.6 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.783 1.233 . . . . 0.0 113.05 178.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -53.98 -37.67 64.22 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.175 1.39 . . . . 0.0 110.97 -170.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.427 ' HE2' ' CZ ' ' A' ' 44' ' ' PHE . 0.4 OUTLIER -63.35 -52.49 61.53 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.072 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.89 -47.96 73.64 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 124.815 1.246 . . . . 0.0 109.834 178.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 17.6 t90 -58.57 -69.74 0.17 Allowed 'General case' 0 C--O 1.219 -0.549 0 O-C-N 124.593 1.183 . . . . 0.0 109.79 176.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.0 t -52.89 -32.21 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 121.153 1.797 . . . . 0.0 111.549 -175.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.427 ' CZ ' ' HE2' ' A' ' 40' ' ' LYS . 4.0 m-85 -61.43 -77.15 0.05 OUTLIER 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 123.612 0.765 . . . . 0.0 110.051 172.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.404 ' HA ' ' HB2' ' A' ' 49' ' ' ASN . 0.6 OUTLIER -64.95 -28.47 69.54 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -172.183 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.9 -30.06 61.17 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.347 1.459 . . . . 0.0 110.445 176.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -139.83 -66.71 0.45 Allowed 'General case' 0 C--N 1.348 0.508 0 CA-C-N 119.603 1.092 . . . . 0.0 111.609 -172.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.403 ' HB2' ' HA ' ' A' ' 44' ' ' PHE . 18.5 mt -57.37 -54.35 47.78 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 120.878 -1.139 . . . . 0.0 113.081 -169.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.404 ' HB2' ' HA ' ' A' ' 45' ' ' ASP . 78.4 m-20 -67.48 -34.63 77.56 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 125.864 1.665 . . . . 0.0 109.127 177.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.12 -39.07 71.65 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.106 1.362 . . . . 0.0 111.279 176.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 139.65 8.51 0.94 Allowed Glycine 0 CA--C 1.535 1.334 0 C-N-CA 125.123 1.344 . . . . 0.0 113.93 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -92.34 150.3 20.92 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 119.023 1.412 . . . . 0.0 111.392 -177.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -143.22 44.79 1.55 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.287 1.835 . . . . 0.0 108.247 -172.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 171.59 149.84 0.05 OUTLIER 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 126.015 1.726 . . . . 0.0 107.829 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -153.34 163.0 2.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 105.342 -2.095 . . . . 0.0 105.342 -174.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -136.29 148.88 48.18 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.45 1.5 . . . . 0.0 108.615 169.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 50.5 tp -124.27 110.56 14.77 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.251 1.021 . . . . 0.0 109.808 177.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.3 135.57 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 173.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 mp -123.65 43.25 3.02 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.953 0.882 . . . . 0.0 110.288 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.8 t -99.98 -49.58 4.27 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.945 0.898 . . . . 0.0 109.029 -176.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.82 -14.45 58.04 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.126 -0.984 . . . . 0.0 111.159 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.7 p -106.0 118.71 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 125.596 1.559 . . . . 0.0 107.232 174.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -68.83 -51.63 38.6 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 176.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 86.2 p -157.76 166.62 32.27 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.86 -169.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 21.3 tt -135.49 148.99 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 C-N-CA 124.882 1.273 . . . . 0.0 108.333 -168.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -71.49 155.24 40.81 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.2 p -63.97 -14.35 53.24 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 117.902 -1.047 . . . . 0.0 113.77 -174.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -68.53 -71.37 0.22 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.036 1.334 . . . . 0.0 108.934 172.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 41.0 t -63.0 -34.1 76.84 Favored 'General case' 0 C--N 1.339 0.136 0 O-C-N 121.911 -0.493 . . . . 0.0 111.029 -169.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 50.9 tp -40.66 -39.86 1.16 Allowed 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 125.595 1.558 . . . . 0.0 114.041 169.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -107.54 0.25 34.63 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 118.44 0.564 . . . . 0.0 113.246 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.0 t -75.28 -30.05 22.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 O-C-N 120.774 -1.427 . . . . 0.0 108.647 161.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.6 mt -66.87 -61.15 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 125.181 1.392 . . . . 0.0 112.542 175.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.4 p -41.77 -49.19 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 168.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -45.79 -36.79 5.42 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.567 1.547 . . . . 0.0 112.863 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 90.8 mt -64.52 -46.87 91.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.295 1.038 . . . . 0.0 108.558 175.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -52.9 -48.6 67.08 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.635 0.774 . . . . 0.0 109.728 176.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -56.49 -43.03 79.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 118.955 -0.545 . . . . 0.0 111.067 -174.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.0 m -57.7 -64.79 0.78 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 118.883 -0.58 . . . . 0.0 111.352 166.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 51.1 mt -61.52 -42.71 95.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 119.303 0.956 . . . . 0.0 111.502 -166.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.4 m -57.07 -47.55 80.71 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 119.323 0.965 . . . . 0.0 110.179 175.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.5 m -63.54 -34.28 77.44 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.975 0.807 . . . . 0.0 111.689 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 56.6 m -67.57 -38.08 83.56 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 118.604 -0.712 . . . . 0.0 111.941 173.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 105.03 59.37 0.66 Allowed Glycine 0 N--CA 1.448 -0.52 0 CA-C-O 119.162 -0.799 . . . . 0.0 111.136 -166.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -148.68 -176.45 22.07 Favored Glycine 0 N--CA 1.439 -1.149 0 CA-C-N 118.891 1.345 . . . . 0.0 111.553 177.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -130.9 92.13 3.17 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 122.084 -0.656 . . . . 0.0 112.439 -158.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -104.76 134.75 47.38 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.839 -1.163 . . . . 0.0 110.545 174.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -142.48 167.43 22.11 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.623 1.569 . . . . 0.0 112.472 175.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.1 mp -113.9 153.13 29.75 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 127.54 2.336 . . . . 0.0 108.299 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 72.8 t -141.09 135.35 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -166.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.7 t 48.46 56.14 17.66 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.691 1.196 . . . . 0.0 110.645 -170.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -72.42 0.09 7.97 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.304 2.669 . . . . 0.0 114.777 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 18.6 p30 47.63 -163.04 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.733 1.613 . . . . 0.0 112.662 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -95.91 -41.54 8.75 Favored 'General case' 0 C--O 1.225 -0.196 0 O-C-N 120.473 -1.392 . . . . 0.0 109.416 174.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.459 ' O ' ' HE3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -53.74 -50.84 65.1 Favored 'General case' 0 C--O 1.227 -0.126 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -175.548 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.3 t -68.84 -47.52 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-O 118.571 -0.728 . . . . 0.0 109.143 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -60.95 -19.74 61.33 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 120.513 1.506 . . . . 0.0 112.273 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.5 -15.52 63.27 Favored 'General case' 0 C--O 1.216 -0.664 0 O-C-N 120.785 -1.197 . . . . 0.0 111.081 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -118.59 -34.13 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 C-N-CA 125.822 1.649 . . . . 0.0 108.25 -175.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.45 -14.84 31.85 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 117.617 -1.182 . . . . 0.0 109.08 175.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.8 m -79.69 -29.66 40.83 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 117.907 -1.517 . . . . 0.0 109.813 174.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -92.05 -25.33 18.84 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 129.103 2.961 . . . . 0.0 111.421 -159.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.7 t -113.65 35.44 4.05 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.858 1.663 . . . . 0.0 108.296 174.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 35.21 62.38 0.57 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.524 1.93 . . . . 0.0 110.585 176.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.54 -51.47 2.75 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -166.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.5 -24.49 67.84 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 118.616 0.644 . . . . 0.0 111.308 173.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.6 mtt-85 -80.03 -11.25 59.79 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 118.476 -0.773 . . . . 0.0 112.97 -177.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.0 mt -128.1 -37.13 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 C-N-CA 124.49 1.116 . . . . 0.0 109.577 -167.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.6 t -104.26 141.01 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 171.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.52 158.98 34.17 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.882 1.273 . . . . 0.0 111.295 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.1 mp -130.98 146.36 34.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 124.878 1.271 . . . . 0.0 108.077 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -147.02 168.13 22.3 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 127.286 2.234 . . . . 0.0 109.849 175.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.53 -51.77 7.48 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 75.4 p -130.81 171.6 12.95 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 123.165 0.586 . . . . 0.0 109.715 -171.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 11.8 mm -66.49 -39.3 83.64 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 CA-C-O 118.074 -0.965 . . . . 0.0 108.837 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.2 t -67.27 -36.99 82.72 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 118.862 0.756 . . . . 0.0 109.771 -175.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -62.22 -9.31 7.42 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 124.321 1.049 . . . . 0.0 112.256 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.79 -34.45 4.47 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 124.676 1.19 . . . . 0.0 109.636 -175.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 12.4 ttp -61.8 -46.18 90.67 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 120.593 -1.317 . . . . 0.0 112.549 -161.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -101.52 -2.63 30.18 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.66 1.984 . . . . 0.0 112.112 176.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -91.49 -62.6 1.4 Allowed 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -42.43 -37.4 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.307 0 C-N-CA 127.534 2.334 . . . . 0.0 111.553 174.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -44.02 -35.45 2.1 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 125.446 1.498 . . . . 0.0 113.32 174.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.09 22.96 2.23 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 172.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.306 0.1 OUTLIER . . . . . 0 C--O 1.249 1.076 0 C-N-CA 129.436 3.094 . . . . 0.0 116.08 -162.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.5 ptt? . . . . . 0 N--CA 1.472 0.65 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 178.47 -169.46 41.1 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.9 t -82.72 -82.88 0.14 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 175.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -147.9 148.98 31.41 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 119.694 1.134 . . . . 0.0 110.499 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -141.73 161.0 39.03 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.917 1.687 . . . . 0.0 108.671 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.46 124.86 55.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -177.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -72.67 96.55 2.02 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.85 1.26 . . . . 0.0 110.456 -175.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -78.77 170.06 17.26 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.341 -0.849 . . . . 0.0 110.454 168.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 8.1 m80 58.0 -176.21 0.07 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.695 1.598 . . . . 0.0 112.076 -175.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 71.3 m80 52.02 88.68 0.03 OUTLIER 'General case' 0 C--O 1.234 0.241 0 C-N-CA 128.539 2.735 . . . . 0.0 113.435 -177.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -40.02 102.83 0.03 OUTLIER 'General case' 0 C--O 1.24 0.598 0 C-N-CA 128.422 2.689 . . . . 0.0 110.811 -175.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 62.3 t60 -71.5 131.49 43.36 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.23 1.412 . . . . 0.0 109.094 -173.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.4 ttt -168.89 97.46 0.37 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.438 1.895 . . . . 0.0 107.285 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -62.6 165.26 9.75 Favored Pre-proline 0 CA--C 1.551 1.012 0 O-C-N 121.54 -0.725 . . . . 0.0 111.134 172.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.425 ' HG3' HD22 ' A' ' 28' ' ' ASN . 92.0 Cg_endo -74.19 89.23 1.06 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 124.807 3.672 . . . . 0.0 109.977 174.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -153.0 169.37 23.05 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.408 ' HE2' ' CG1' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -135.01 175.31 9.69 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 121.978 -0.451 . . . . 0.0 110.192 168.21 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 67.4 mt -130.45 119.24 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 126.303 1.841 . . . . 0.0 106.944 175.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.408 ' CG1' ' HE2' ' A' ' 17' ' ' LYS . 33.7 m -100.59 -154.35 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 127.529 2.331 . . . . 0.0 106.792 174.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -25.94 -77.41 0.01 OUTLIER 'General case' 0 C--O 1.241 0.658 0 C-N-CA 129.805 3.242 . . . . 0.0 111.467 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -148.21 28.07 0.92 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 127.961 2.504 . . . . 0.0 109.828 170.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 20.2 t -119.68 148.03 22.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.7 t -103.7 140.29 22.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 177.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.8 mp -118.22 101.54 11.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 177.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.32 146.55 45.18 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 120.416 1.462 . . . . 0.0 108.453 165.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 69.7 mtm -127.98 79.58 73.54 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 124.63 1.172 . . . . 0.0 108.267 178.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -58.05 135.66 70.02 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.813 2.342 . . . . 0.0 110.636 177.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.425 HD22 ' HG3' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -135.22 -105.36 0.22 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.339 1.856 . . . . 0.0 106.312 169.582 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.92 69.4 1.04 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 121.551 1.978 . . . . 0.0 111.247 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -154.9 4.93 0.23 Allowed 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 115.505 1.668 . . . . 0.0 115.505 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.01 37.63 0.55 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 120.576 1.535 . . . . 0.0 109.988 172.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -77.74 157.4 30.06 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.771 1.629 . . . . 0.0 109.599 171.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 61.1 mt -62.15 -35.82 71.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 123.938 0.895 . . . . 0.0 110.704 -174.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -73.33 -8.86 57.67 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.11 -0.994 . . . . 0.0 111.402 -177.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -113.54 28.83 8.47 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.343 1.857 . . . . 0.0 109.754 171.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.68 -54.51 2.6 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 120.733 -1.229 . . . . 0.0 111.7 -175.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 40.7 t60 -62.07 -52.24 64.73 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 120.623 1.556 . . . . 0.0 109.759 175.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.89 -24.73 64.52 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-O 118.748 -0.644 . . . . 0.0 111.167 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -51.86 -44.76 63.81 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 124.88 1.272 . . . . 0.0 110.625 -177.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -64.68 -44.71 89.46 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.82 -41.45 97.87 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 119.038 0.836 . . . . 0.0 112.205 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 15.6 t90 -58.81 -66.28 0.52 Allowed 'General case' 0 C--O 1.221 -0.401 0 CA-C-O 117.23 -1.367 . . . . 0.0 107.479 173.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.5 t -52.93 -36.11 23.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 120.585 1.539 . . . . 0.0 112.193 -177.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -57.76 -67.0 0.38 Allowed 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 124.04 0.936 . . . . 0.0 110.028 173.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.29 -45.43 66.34 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 121.441 -0.787 . . . . 0.0 111.684 -171.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -62.42 -28.75 70.01 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.939 1.696 . . . . 0.0 111.006 -175.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -136.69 -65.85 0.55 Allowed 'General case' 0 C--N 1.346 0.432 0 C-N-CA 123.19 0.596 . . . . 0.0 111.53 -172.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 44.3 mt -55.58 -53.68 53.5 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.147 0.885 . . . . 0.0 111.822 -168.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -71.5 -34.26 69.96 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.513 1.925 . . . . 0.0 109.834 176.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.03 -30.16 65.92 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 118.242 -0.885 . . . . 0.0 112.021 177.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 140.26 -0.49 2.03 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 119.25 -0.75 . . . . 0.0 113.805 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -92.51 154.81 18.23 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 119.803 1.801 . . . . 0.0 110.347 -174.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -134.85 6.72 3.44 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.806 1.242 . . . . 0.0 109.816 172.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.86 132.21 36.29 Favored 'General case' 0 CA--C 1.518 -0.288 0 O-C-N 120.583 -1.323 . . . . 0.0 107.769 -176.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.9 mt -135.71 154.02 33.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 126.094 1.758 . . . . 0.0 106.422 175.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -129.54 152.71 48.78 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.725 1.61 . . . . 0.0 109.702 163.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 54.8 tp -118.97 112.35 19.49 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 118.149 -0.929 . . . . 0.0 110.069 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.2 t -90.72 111.18 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 119.175 0.898 . . . . 0.0 109.474 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.8 mp -91.64 5.23 50.48 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.425 0.69 . . . . 0.0 112.514 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 24.3 m -51.59 -42.13 61.69 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.094 0.958 . . . . 0.0 113.221 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -85.23 -29.26 24.8 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.766 0.712 . . . . 0.0 111.09 -174.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.8 p -80.82 173.1 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 O-C-N 121.34 -0.85 . . . . 0.0 109.158 -173.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -121.56 -46.14 2.27 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 120.588 -1.32 . . . . 0.0 109.31 172.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.9 p -150.1 172.63 14.97 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.537 0.684 . . . . 0.0 112.402 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.3 tt -133.48 153.18 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 126.072 1.749 . . . . 0.0 107.323 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -85.16 162.5 19.2 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 122.579 0.352 . . . . 0.0 110.206 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.2 -36.79 66.31 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.598 0.759 . . . . 0.0 111.903 179.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -55.57 -72.93 0.06 Allowed 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.049 1.74 . . . . 0.0 109.59 -178.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 53.5 m -64.27 -30.86 71.9 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 118.249 -0.881 . . . . 0.0 112.662 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.3 tp -59.39 -16.89 25.89 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 120.521 1.509 . . . . 0.0 112.769 -177.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -90.73 -33.97 8.1 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 118.995 0.816 . . . . 0.0 112.843 167.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.6 t -64.2 -36.84 78.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 O-C-N 121.149 -1.206 . . . . 0.0 110.363 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp -52.72 -51.38 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 175.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.4 t -66.02 -35.74 75.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 O-C-N 120.95 -1.094 . . . . 0.0 110.268 177.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.69 -45.05 82.02 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 119.662 1.119 . . . . 0.0 111.268 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 71.7 mt -59.45 -33.72 52.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 123.438 0.695 . . . . 0.0 109.21 175.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -69.8 -44.9 69.1 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 120.269 1.395 . . . . 0.0 108.44 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 48.7 mttm -58.87 -47.31 85.37 Favored 'General case' 0 C--N 1.335 -0.025 0 CA-C-O 118.584 -0.722 . . . . 0.0 110.151 177.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 31.8 m -51.45 -59.55 4.12 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 123.684 0.794 . . . . 0.0 110.272 172.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 21.1 mt -53.96 -43.76 59.28 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 C-N-CA 124.278 1.031 . . . . 0.0 111.406 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 51.6 p -57.35 -48.77 78.14 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.207 0.912 . . . . 0.0 109.974 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.5 -33.87 76.66 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.762 1.625 . . . . 0.0 111.304 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.4 m -67.76 -16.58 64.19 Favored 'General case' 0 C--N 1.335 -0.056 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 170.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.86 1.09 61.79 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-N 119.196 0.907 . . . . 0.0 113.664 -172.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -92.65 -175.99 41.46 Favored Glycine 0 N--CA 1.432 -1.608 0 CA-C-N 118.892 1.346 . . . . 0.0 112.193 -175.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -136.09 155.92 49.48 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.537 1.535 . . . . 0.0 109.517 178.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -152.39 147.17 25.97 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 175.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -148.04 161.04 42.18 Favored 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 124.152 0.908 . . . . 0.0 111.638 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.3 mp -106.73 158.17 17.17 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.795 1.638 . . . . 0.0 108.186 -176.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 84.9 t -142.41 135.67 27.55 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -165.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 46.41 57.82 16.62 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 124.904 1.281 . . . . 0.0 109.656 -173.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -72.32 88.75 0.84 Allowed 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.177 2.584 . . . . 0.0 108.604 -178.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -54.46 148.98 11.05 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.657 0.741 . . . . 0.0 110.647 -175.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -54.49 -34.11 61.02 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.671 1.588 . . . . 0.0 111.582 -168.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -49.15 70.23 Favored 'General case' 0 CA--C 1.521 -0.172 0 O-C-N 120.327 -1.483 . . . . 0.0 108.645 177.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.1 t -62.05 -47.9 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 123.774 0.83 . . . . 0.0 110.386 175.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.43 -36.95 64.57 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.827 2.051 . . . . 0.0 109.846 -172.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.84 -59.07 4.18 Favored 'General case' 0 N--CA 1.424 -1.728 0 C-N-CA 126.731 2.012 . . . . 0.0 111.54 177.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.0 t -65.53 -45.58 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 CA-C-N 111.754 -2.476 . . . . 0.0 107.284 -176.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.81 -17.55 16.6 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.965 0.906 . . . . 0.0 110.222 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 65.6 m -117.0 16.7 15.06 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 124.551 1.157 . . . . 0.0 112.314 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 62.2 mt -123.23 -16.25 6.98 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 129.484 3.114 . . . . 0.0 111.435 169.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.7 t -113.61 1.13 14.84 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.837 2.055 . . . . 0.0 110.632 -177.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 44.99 81.59 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.811 1.644 . . . . 0.0 110.201 -165.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.52 -53.26 2.53 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 173.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.89 -12.04 51.57 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.372 1.069 . . . . 0.0 112.867 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.4 mtt85 -98.66 4.05 47.88 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.848 1.659 . . . . 0.0 111.199 -178.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.3 mt -132.84 -37.24 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 126.031 1.732 . . . . 0.0 110.019 -173.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.7 t -111.15 149.78 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 177.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.24 159.01 35.4 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.224 0.61 . . . . 0.0 109.888 174.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -131.99 151.47 35.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 125.041 1.337 . . . . 0.0 108.625 178.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -148.02 173.0 13.35 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 127.055 2.142 . . . . 0.0 110.639 173.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.57 -39.24 14.27 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 123.563 0.745 . . . . 0.0 109.231 177.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 25.2 p -136.86 170.48 16.02 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.043 0.937 . . . . 0.0 110.837 -173.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 19.9 mm -63.94 -45.36 97.1 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 CA-C-O 117.754 -1.117 . . . . 0.0 108.587 172.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.3 t -67.38 -36.72 81.9 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 119.228 0.922 . . . . 0.0 109.134 -169.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -70.87 -15.35 62.62 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 176.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -86.48 -49.34 7.66 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 174.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.95 -52.24 63.61 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.762 1.225 . . . . 0.0 111.316 -160.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.06 -7.98 54.49 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 127.906 2.482 . . . . 0.0 114.446 176.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -104.28 -53.25 2.76 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 118.795 0.725 . . . . 0.0 109.355 -169.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 12.8 t -50.68 -33.63 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 C-N-CA 129.336 3.054 . . . . 0.0 110.39 172.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -43.46 -36.96 2.18 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.006 0.922 . . . . 0.0 113.243 166.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.57 24.08 3.15 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 116.452 2.019 . . . . 0.0 116.452 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 31.5 mmtt . . . . . 0 C--O 1.255 1.383 0 C-N-CA 129.56 3.144 . . . . 0.0 103.174 177.666 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ttp . . . . . 0 N--CA 1.473 0.703 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.91 49.03 0.22 Allowed Glycine 0 CA--C 1.52 0.393 0 CA-C-N 119.086 0.857 . . . . 0.0 111.446 -177.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.7 m 62.3 -22.04 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 128.509 2.723 . . . . 0.0 116.295 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.5 t70 25.01 86.76 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 129.754 3.222 . . . . 0.0 113.806 175.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.2 tttm -151.8 161.8 42.07 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 121.023 -1.048 . . . . 0.0 109.437 176.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.7 tt -83.86 123.27 38.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 166.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -74.57 115.27 13.92 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 169.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -157.88 97.25 1.54 Allowed 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 160.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -151.9 74.88 1.12 Allowed 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.768 -0.583 . . . . 0.0 109.733 174.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -92.83 42.37 1.1 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 122.092 0.949 . . . . 0.0 111.659 178.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -123.07 165.59 16.56 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 154.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 -152.76 56.54 0.8 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 121.287 0.565 . . . . 0.0 110.18 171.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 9.2 ptm -133.96 61.67 1.67 Allowed 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.94 0.896 . . . . 0.0 110.805 -168.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -68.77 154.69 94.46 Favored Pre-proline 0 CA--C 1.544 0.743 0 O-C-N 121.205 -0.935 . . . . 0.0 111.062 170.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -76.29 89.14 1.28 Allowed 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 124.226 3.284 . . . . 0.0 110.993 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -157.14 156.78 33.28 Favored 'General case' 0 C--O 1.239 0.533 0 O-C-N 121.482 -0.761 . . . . 0.0 110.039 175.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.88 170.27 10.28 Favored 'General case' 0 N--CA 1.46 0.069 0 C-N-CA 123.937 0.895 . . . . 0.0 110.286 169.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.1 mt -131.49 150.57 34.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 174.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.4 m -120.27 -133.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 126.408 1.883 . . . . 0.0 107.03 176.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -46.38 -75.41 0.03 OUTLIER 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 127.565 2.346 . . . . 0.0 111.312 -177.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -143.35 27.79 1.54 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.821 1.649 . . . . 0.0 108.434 172.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.418 HG13 ' CE2' ' A' ' 56' ' ' PHE . 11.7 t -121.73 138.94 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 C-N-CA 124.172 0.989 . . . . 0.0 108.451 -175.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 72.5 t -99.21 140.44 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 125.668 1.587 . . . . 0.0 107.546 -178.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mp -119.42 95.98 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 126.402 1.881 . . . . 0.0 105.957 -178.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 31.5 mt -84.8 126.28 33.3 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 177.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 56.1 mtm -125.76 92.02 47.25 Favored Pre-proline 0 N--CA 1.464 0.274 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.76 106.53 1.68 Allowed 'Trans proline' 0 N--CA 1.45 -1.074 0 N-CA-C 108.28 -1.469 . . . . 0.0 108.28 176.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -74.79 55.53 0.68 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.264 1.026 . . . . 0.0 111.549 172.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.99 41.11 3.76 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.447 1.499 . . . . 0.0 112.866 -173.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -105.75 48.85 0.82 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-O 122.222 1.01 . . . . 0.0 110.317 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.61 68.36 8.66 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 123.483 1.611 . . . . 0.0 108.185 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -68.05 3.23 1.67 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 129.577 3.151 . . . . 0.0 114.977 -174.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 mt 65.65 -56.3 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 129.795 3.238 . . . . 0.0 111.378 -167.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -63.81 -31.98 73.34 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 118.258 0.481 . . . . 0.0 109.777 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -59.4 -60.1 4.39 Favored 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 124.147 0.979 . . . . 0.0 109.117 165.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.19 -38.91 54.96 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 120.515 1.507 . . . . 0.0 114.448 -178.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -67.86 -34.04 75.92 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.702 1.137 . . . . 0.0 111.881 178.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.17 -19.0 30.74 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-O 118.154 -0.927 . . . . 0.0 110.883 177.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -46.62 -49.96 18.26 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 127.917 2.487 . . . . 0.0 110.299 -172.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.0 -57.22 11.07 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 124.6 1.16 . . . . 0.0 109.917 175.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -56.55 -48.98 76.13 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 124.561 1.145 . . . . 0.0 112.07 178.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -56.54 -71.77 0.09 Allowed 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 117.574 -1.203 . . . . 0.0 108.055 178.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.6 t -46.39 -42.72 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.089 0.955 . . . . 0.0 109.373 -177.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 -60.22 -59.97 4.57 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 120.606 1.548 . . . . 0.0 111.643 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -68.63 -4.04 14.09 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.619 1.568 . . . . 0.0 111.991 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -107.17 -33.04 7.56 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 116.413 -1.756 . . . . 0.0 108.956 -177.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -134.57 -49.81 0.78 Allowed 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 123.603 2.91 . . . . 0.0 109.335 -174.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -69.49 -57.0 5.79 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 124.039 0.936 . . . . 0.0 110.666 -169.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -62.81 -27.22 69.17 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.571 0.748 . . . . 0.0 109.781 174.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -66.66 -20.14 65.92 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.862 1.665 . . . . 0.0 113.616 171.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.02 6.18 46.02 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.297 1.427 . . . . 0.0 114.787 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -76.57 149.81 36.58 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 119.994 1.897 . . . . 0.0 110.236 172.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -130.02 6.18 5.0 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.216 1.006 . . . . 0.0 112.791 -178.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -133.16 113.09 12.3 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 120.683 1.583 . . . . 0.0 106.856 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.0 mp -118.11 151.2 20.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 104.732 -2.321 . . . . 0.0 104.732 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.418 ' CE2' HG13 ' A' ' 22' ' ' VAL . 20.3 m-85 -132.89 160.28 37.45 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 124.525 1.13 . . . . 0.0 110.318 166.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.4 tp -137.72 86.89 2.21 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.866 1.266 . . . . 0.0 108.71 175.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.4 HG12 ' H ' ' A' ' 60' ' ' SER . 95.0 t -60.74 138.57 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 128.428 2.691 . . . . 0.0 107.2 168.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.9 mp -117.81 37.08 4.06 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.29 1.836 . . . . 0.0 109.445 173.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.4 ' H ' HG12 ' A' ' 58' ' ' VAL . 19.9 t -76.42 -38.85 54.98 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.278 1.431 . . . . 0.0 110.688 178.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.97 2.62 51.77 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.917 0.78 . . . . 0.0 111.604 -173.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.3 p -133.24 174.52 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 127.977 2.511 . . . . 0.0 107.464 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -118.4 -31.38 4.95 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.298 0.639 . . . . 0.0 111.64 177.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.1 t -159.01 158.86 34.0 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.746 0.784 . . . . 0.0 112.478 165.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -76.84 166.29 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-N 113.874 -1.512 . . . . 0.0 108.531 160.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -103.8 159.47 15.61 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.206 1.402 . . . . 0.0 110.608 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.34 6.17 0.84 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.615 1.166 . . . . 0.0 113.491 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -76.87 -78.22 0.13 Allowed 'General case' 0 CA--C 1.535 0.376 0 O-C-N 120.956 -1.09 . . . . 0.0 108.766 155.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.8 t -69.93 -13.74 62.39 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -169.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 33.1 tp -47.06 -31.31 3.26 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.054 1.342 . . . . 0.0 111.674 168.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.06 -28.14 31.97 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 121.458 -0.776 . . . . 0.0 114.466 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 45.7 t -75.27 -35.81 34.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 124.45 1.1 . . . . 0.0 109.59 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.6 mm -55.59 -49.79 71.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 123.75 0.82 . . . . 0.0 110.359 175.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 38.7 t -60.34 -41.34 86.84 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.213 0 CA-C-N 118.123 0.419 . . . . 0.0 110.13 177.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -53.25 -44.67 68.34 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.41 1.005 . . . . 0.0 112.413 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.64 -36.17 73.89 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 123.156 0.582 . . . . 0.0 109.593 177.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -64.7 -42.91 94.95 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.289 0.95 . . . . 0.0 109.479 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 55.1 mttt -60.27 -45.27 93.9 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 118.569 0.622 . . . . 0.0 111.309 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 30.0 m -54.95 -52.13 63.99 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.154 0.182 . . . . 0.0 111.434 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 59.4 mt -65.1 -41.62 92.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 122.585 0.354 . . . . 0.0 110.741 -175.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.2 t -48.38 -59.68 3.27 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.168 1.787 . . . . 0.0 108.127 173.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.7 m -64.8 -33.08 75.13 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.3 m -67.45 -20.41 65.49 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 113.834 1.049 . . . . 0.0 113.834 174.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 94.23 9.99 58.78 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-O 119.067 -0.852 . . . . 0.0 113.5 -171.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -88.03 -173.03 47.54 Favored Glycine 0 N--CA 1.434 -1.441 0 CA-C-N 119.449 1.625 . . . . 0.0 111.456 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -130.54 149.99 51.95 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 126.184 1.793 . . . . 0.0 106.692 171.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -141.06 145.34 35.73 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 174.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -149.61 163.06 38.9 Favored 'General case' 0 N--CA 1.441 -0.888 0 O-C-N 123.79 0.681 . . . . 0.0 111.755 176.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.7 mt -97.68 167.78 10.75 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 123.397 0.679 . . . . 0.0 109.429 176.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -148.59 152.08 12.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 124.702 1.201 . . . . 0.0 111.096 -175.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.6 t 39.92 63.64 4.88 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 127.15 2.18 . . . . 0.0 110.825 178.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.14 175.27 7.81 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.252 1.968 . . . . 0.0 110.341 177.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.47 ' N ' HD21 ' A' ' 93' ' ' ASN . 1.0 OUTLIER -127.34 166.53 17.65 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 173.555 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -58.02 -41.71 83.76 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 124.519 1.127 . . . . 0.0 109.305 174.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -26.08 66.77 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 126.513 1.925 . . . . 0.0 110.65 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.5 t -88.62 -49.38 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 CA-C-O 115.777 -2.059 . . . . 0.0 109.071 177.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.38 -34.85 64.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 122.547 2.431 . . . . 0.0 110.297 177.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -31.01 72.04 Favored 'General case' 0 C--O 1.219 -0.511 0 O-C-N 121.395 -0.815 . . . . 0.0 111.479 -178.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.4 p -100.0 -41.31 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -174.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.9 mp -65.84 -14.58 61.71 Favored 'General case' 0 N--CA 1.434 -1.271 0 C-N-CA 125.972 1.709 . . . . 0.0 112.617 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.74 -41.5 10.1 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 117.328 -1.749 . . . . 0.0 108.197 171.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.48 -34.57 78.6 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.747 1.619 . . . . 0.0 112.486 -172.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 9.0 t -93.25 -2.05 55.48 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 118.094 -0.955 . . . . 0.0 111.701 177.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.401 ' HB3' ' HD3' ' A' ' 107' ' ' ARG . 48.9 m-80 56.86 83.49 0.1 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.633 1.173 . . . . 0.0 109.201 -163.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.55 -58.58 1.68 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 127.876 2.47 . . . . 0.0 109.878 174.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.83 -20.14 65.57 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.698 0.799 . . . . 0.0 111.215 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.401 ' HD3' ' HB3' ' A' ' 104' ' ' ASN . 4.5 ptm85 -84.06 -15.35 47.8 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 177.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 13.9 mm -88.85 -36.79 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 C-N-CA 126.358 1.863 . . . . 0.0 106.06 -172.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.48 149.63 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 124.61 1.194 . . . . 0.0 112.297 -172.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -57.25 156.94 6.79 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.357 0.663 . . . . 0.0 110.807 168.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.12 149.22 16.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 -178.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -140.3 165.04 28.47 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 124.845 1.258 . . . . 0.0 113.389 -170.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.82 -52.35 5.16 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.136 0.974 . . . . 0.0 109.753 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 53.3 p -125.12 175.06 7.63 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.549 1.14 . . . . 0.0 109.359 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 5.6 mm -63.84 -45.08 98.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 118.441 -0.79 . . . . 0.0 109.008 167.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.4 t -71.29 -28.18 63.94 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 119.384 -0.927 . . . . 0.0 110.427 -169.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -69.14 -20.56 64.03 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 119.201 0.91 . . . . 0.0 111.181 173.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -92.51 -49.6 6.04 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 -173.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.99 -60.51 2.71 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.924 2.09 . . . . 0.0 111.539 -166.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -86.61 -16.31 37.13 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.553 0.741 . . . . 0.0 111.012 -175.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -77.54 -59.92 2.58 Favored 'General case' 0 C--O 1.216 -0.695 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -47.85 -28.7 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 126.949 2.1 . . . . 0.0 112.987 -174.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.86 -28.1 65.79 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.484 2.314 . . . . 0.0 113.45 173.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.72 39.51 0.16 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.858 2.063 . . . . 0.0 112.799 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.074 0 C-N-CA 125.776 1.63 . . . . 0.0 110.323 -174.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.7 ttp . . . . . 0 N--CA 1.471 0.616 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.5 -72.44 1.0 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 -170.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.7 t -63.26 165.0 7.96 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 159.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 43.24 68.98 0.44 Allowed 'General case' 0 C--O 1.236 0.351 0 C-N-CA 128.067 2.547 . . . . 0.0 110.632 172.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.85 -36.28 10.24 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.281 -163.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.8 mm 26.93 95.45 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 130.571 3.549 . . . . 0.0 113.037 171.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -60.88 103.93 0.31 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.886 0.875 . . . . 0.0 110.726 175.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -56.48 135.39 54.35 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 172.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 52.7 m170 -138.01 179.94 6.14 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.63 1.172 . . . . 0.0 109.144 176.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 65.31 27.77 11.98 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.896 1.279 . . . . 0.0 114.009 170.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -69.09 89.19 0.43 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.465 1.906 . . . . 0.0 109.903 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -150.82 83.67 1.34 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.077 1.351 . . . . 0.0 109.095 -178.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 13.9 mtm -155.69 130.1 8.95 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.848 1.659 . . . . 0.0 106.993 168.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -110.95 86.39 5.92 Favored Pre-proline 0 N--CA 1.443 -0.796 0 C-N-CA 125.125 1.37 . . . . 0.0 110.864 176.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -76.22 51.09 3.07 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 123.986 3.124 . . . . 0.0 110.685 167.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -159.83 166.96 29.26 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 120.968 -1.082 . . . . 0.0 111.111 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.3 pttt -135.46 170.29 16.17 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 126.073 1.749 . . . . 0.0 109.343 166.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 40.4 mt -120.65 138.28 51.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 C-N-CA 125.296 1.438 . . . . 0.0 107.626 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 76.9 t -131.8 164.67 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 C-N-CA 127.761 2.425 . . . . 0.0 106.769 -177.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -25.07 -63.31 0.06 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 129.553 3.141 . . . . 0.0 113.136 -163.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -145.75 54.01 1.17 Allowed 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 160.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.415 HG12 ' CE2' ' A' ' 56' ' ' PHE . 13.6 t -140.04 152.68 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 124.45 1.1 . . . . 0.0 109.197 170.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.9 t -111.96 138.47 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.8 mp -118.33 106.18 19.2 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.9 mp -82.17 63.13 6.23 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.831 2.052 . . . . 0.0 108.271 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.7 mmm -60.05 98.4 0.14 Allowed Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 126.219 1.808 . . . . 0.0 110.805 -175.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -68.26 -47.42 1.64 Allowed 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 122.918 2.412 . . . . 0.0 109.834 -172.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 31.21 54.67 0.22 Allowed 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 120.88 1.673 . . . . 0.0 113.231 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 78.24 22.77 0.75 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.788 2.035 . . . . 0.0 112.527 173.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -118.31 69.78 0.8 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.617 1.567 . . . . 0.0 108.327 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.4 mt -129.72 20.28 5.56 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.832 1.253 . . . . 0.0 111.581 -177.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -49.51 142.48 7.93 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 131.067 3.747 . . . . 0.0 109.533 -177.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 28.9 mt -55.2 -46.66 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 121.049 1.749 . . . . 0.0 111.551 -176.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -80.6 2.96 23.45 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.207 -0.933 . . . . 0.0 112.772 -176.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -89.42 -57.08 3.01 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 153.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.8 -32.28 19.56 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.112 1.765 . . . . 0.0 114.08 -175.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -66.98 -53.17 34.12 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.53 1.059 . . . . 0.0 110.868 175.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.252 0.0 OUTLIER -81.29 -11.27 59.4 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 120.782 -1.199 . . . . 0.0 112.385 -177.492 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -34.83 -57.4 0.54 Allowed 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 129.275 3.03 . . . . 0.0 112.054 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -60.99 -48.95 79.45 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-O 118.542 -0.742 . . . . 0.0 109.34 -176.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -57.91 -46.35 85.09 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 119.494 1.043 . . . . 0.0 110.656 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.406 ' CE3' HG22 ' A' ' 43' ' ' VAL . 5.5 t90 -56.72 -61.05 2.7 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 108.876 -0.786 . . . . 0.0 108.876 174.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.406 HG22 ' CE3' ' A' ' 42' ' ' TRP . 53.0 t -52.23 -33.01 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 124.37 1.068 . . . . 0.0 113.038 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.405 ' CD1' HD12 ' A' ' 48' ' ' LEU . 3.5 m-85 -64.23 -69.57 0.27 Allowed 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 125.19 1.396 . . . . 0.0 108.815 172.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -80.05 -11.33 59.78 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -166.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -88.51 -27.88 21.17 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.27 1.428 . . . . 0.0 110.74 174.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -135.55 -64.18 0.64 Allowed 'General case' 0 C--N 1.347 0.482 0 CA-C-N 119.513 1.051 . . . . 0.0 111.858 -170.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.405 HD12 ' CD1' ' A' ' 44' ' ' PHE . 41.3 mt -48.6 -55.12 12.08 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 118.518 0.599 . . . . 0.0 111.226 -178.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -86.25 1.71 49.86 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.394 0.678 . . . . 0.0 110.963 -173.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.5 3.63 55.12 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 127.599 2.36 . . . . 0.0 112.038 173.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.04 40.23 25.53 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 119.446 1.021 . . . . 0.0 112.564 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -110.45 165.68 11.6 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 160.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -140.81 3.75 1.86 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.557 2.343 . . . . 0.0 112.141 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.42 133.19 28.99 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 121.135 1.789 . . . . 0.0 109.239 -175.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.9 mp -133.69 149.87 31.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 128.252 2.621 . . . . 0.0 105.206 -172.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.415 ' CE2' HG12 ' A' ' 22' ' ' VAL . 23.5 m-85 -136.23 150.46 48.98 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.087 0.955 . . . . 0.0 112.563 168.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.1 tp -118.35 78.3 1.25 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.475 1.11 . . . . 0.0 110.25 175.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 99.5 t -60.11 102.34 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 C-N-CA 126.586 1.955 . . . . 0.0 109.042 172.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.6 mt -86.61 14.25 7.25 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.809 2.444 . . . . 0.0 112.11 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.8 t -63.5 -50.55 69.19 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.802 0.841 . . . . 0.0 112.052 -168.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -83.48 -10.99 58.0 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.342 1.057 . . . . 0.0 110.65 -166.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.5 p -109.61 168.0 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 128.809 2.844 . . . . 0.0 106.712 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.48 -34.53 8.2 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.527 -0.733 . . . . 0.0 110.079 173.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.8 p -153.15 167.31 29.69 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 -176.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.4 tt -102.16 151.8 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 162.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -94.89 164.96 12.69 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 124.259 1.023 . . . . 0.0 111.109 -178.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.5 m -76.48 52.65 0.8 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.321 1.848 . . . . 0.0 110.654 176.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -133.44 -68.1 0.59 Allowed 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 158.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.5 t -64.31 -24.46 67.66 Favored 'General case' 0 C--N 1.342 0.267 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 60.6 tp -55.81 -16.54 4.6 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 120.819 -1.176 . . . . 0.0 114.103 177.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -91.5 -34.14 7.61 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 119.946 1.248 . . . . 0.0 112.083 168.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.7 t -64.63 -38.31 82.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 126.295 1.838 . . . . 0.0 110.389 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.3 mm -54.96 -48.93 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 125.292 1.437 . . . . 0.0 110.662 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.9 t -63.89 -45.64 96.4 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.471 0 O-C-N 121.144 -0.972 . . . . 0.0 108.648 176.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.17 -39.26 72.06 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.857 0.753 . . . . 0.0 110.977 -177.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.6 mt -59.62 -44.43 93.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 125.642 1.577 . . . . 0.0 110.628 170.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.5 tp -60.46 -50.67 72.66 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 120.325 -1.484 . . . . 0.0 109.214 177.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 48.3 mttt -59.42 -15.17 15.37 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.52 -0.738 . . . . 0.0 111.217 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.5 t -85.91 -48.56 8.61 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.63 0.772 . . . . 0.0 109.674 172.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 30.6 mt -62.44 -41.93 93.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 O-C-N 120.3 -1.5 . . . . 0.0 110.619 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.6 m -76.53 -5.26 46.81 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 173.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 45.6 t -74.84 -48.07 27.03 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 120.949 -1.094 . . . . 0.0 108.443 159.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.8 m -66.49 -56.03 12.82 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.409 1.084 . . . . 0.0 113.495 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.31 13.49 4.8 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.32 0.962 . . . . 0.0 113.81 -167.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -86.46 -163.58 38.56 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-N 119.141 1.471 . . . . 0.0 111.508 174.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -136.31 162.14 33.84 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.459 1.504 . . . . 0.0 110.023 176.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -158.8 139.53 12.7 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 123.959 0.904 . . . . 0.0 109.192 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -145.25 171.7 14.19 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 121.171 0.51 . . . . 0.0 112.239 175.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.08 170.04 8.37 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 176.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -151.17 144.46 16.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 124.73 1.212 . . . . 0.0 110.739 -165.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.9 t 42.79 58.73 11.24 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 125.861 1.664 . . . . 0.0 111.52 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.57 166.34 26.17 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.489 2.126 . . . . 0.0 109.916 176.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -129.68 170.41 13.85 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 174.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -60.55 -42.56 96.81 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.287 1.035 . . . . 0.0 110.212 -176.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.1 -27.22 68.77 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.692 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -86.23 -47.12 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-O 118.635 -0.698 . . . . 0.0 109.607 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -53.63 -44.46 69.56 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 125.581 1.552 . . . . 0.0 108.648 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.19 -23.38 67.29 Favored 'General case' 0 C--O 1.218 -0.592 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.786 -169.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.9 t -95.84 -48.52 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 C-N-CA 126.014 1.726 . . . . 0.0 107.35 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.83 -21.63 57.04 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.108 0.963 . . . . 0.0 109.334 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.7 m -85.05 -11.83 54.45 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.865 0.866 . . . . 0.0 112.874 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 32.6 mt -119.81 -39.7 2.82 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 126.18 1.792 . . . . 0.0 111.033 -166.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.5 t -81.95 1.89 33.29 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.307 1.843 . . . . 0.0 111.095 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 51.18 78.05 0.12 Allowed 'General case' 0 C--N 1.345 0.408 0 C-N-CA 127.386 2.274 . . . . 0.0 111.03 -169.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.78 -57.75 1.61 Allowed 'General case' 0 C--O 1.227 -0.099 0 C-N-CA 123.909 0.883 . . . . 0.0 108.94 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.24 -24.8 66.62 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.548 1.139 . . . . 0.0 111.205 177.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.02 -7.62 59.35 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.6 mt -115.03 -47.63 4.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 125.651 1.58 . . . . 0.0 107.789 -174.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -100.59 143.38 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 123.14 0.576 . . . . 0.0 110.291 178.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.9 161.86 12.15 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 124.141 0.976 . . . . 0.0 112.041 176.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.67 146.14 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -177.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -143.46 172.39 12.84 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 125.722 1.609 . . . . 0.0 110.399 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.64 -40.24 10.86 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.781 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 64.0 p -134.27 167.58 20.43 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.765 1.226 . . . . 0.0 108.792 -171.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 4.7 mm -69.75 -40.55 79.28 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.0 t -78.31 -4.74 49.51 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.194 0.907 . . . . 0.0 111.957 -176.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -90.38 -10.51 43.67 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 118.329 -0.843 . . . . 0.0 110.755 166.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -99.25 -44.5 6.22 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.418 1.087 . . . . 0.0 109.606 177.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -60.26 -40.48 90.48 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 127.801 2.44 . . . . 0.0 115.828 -161.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -112.59 4.31 17.21 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 126.836 2.054 . . . . 0.0 111.31 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -99.64 -63.66 1.11 Allowed 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -46.82 -30.47 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 127.44 2.296 . . . . 0.0 113.04 -176.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 12.1 mtt180 -53.64 -20.51 5.36 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.382 -0.824 . . . . 0.0 112.358 174.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.1 24.34 1.46 Allowed 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 115.151 1.538 . . . . 0.0 115.151 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 116.71 -1.614 . . . . 0.0 110.478 -161.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.475 0.812 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 126.7 136.44 4.38 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 107.909 -2.076 . . . . 0.0 107.909 -168.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.4 m -159.16 161.93 36.3 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 127.48 2.312 . . . . 0.0 106.399 168.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -129.27 -62.85 0.97 Allowed 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -170.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 44.8 mttt 50.2 65.01 1.56 Allowed 'General case' 0 C--O 1.235 0.293 0 C-N-CA 126.324 1.85 . . . . 0.0 110.848 -173.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 89.2 mt -110.61 102.81 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 104.489 -2.411 . . . . 0.0 104.489 173.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -158.47 122.97 4.14 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 167.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -145.79 117.85 8.3 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.458 1.103 . . . . 0.0 108.693 170.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -159.41 164.74 34.35 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.201 1.8 . . . . 0.0 107.455 171.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 60.82 179.36 0.1 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.597 1.159 . . . . 0.0 113.768 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 21.8 t60 58.55 28.68 17.38 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.048 2.139 . . . . 0.0 114.739 175.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -79.54 142.68 35.53 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.572 -0.705 . . . . 0.0 109.395 164.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 13.9 mmm -143.26 104.81 4.31 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 127.069 2.148 . . . . 0.0 108.107 175.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 36.6 62.48 3.04 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 127.32 2.248 . . . . 0.0 112.555 -170.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -74.71 -162.87 0.16 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.961 2.441 . . . . 0.0 110.271 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -57.6 164.11 2.16 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.23 1.012 . . . . 0.0 113.559 -175.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.27 173.51 11.46 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.7 1.2 . . . . 0.0 108.776 174.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 70.7 mt -133.35 104.1 6.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 174.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.7 m -77.74 -171.87 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 166.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -24.59 -68.58 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 128.835 2.854 . . . . 0.0 115.319 -167.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -142.26 19.12 2.08 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 128.279 2.632 . . . . 0.0 109.72 177.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.404 HG12 ' CE2' ' A' ' 56' ' ' PHE . 6.7 t -127.84 133.57 67.13 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 CA-C-O 123.678 1.704 . . . . 0.0 108.783 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -92.66 153.87 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.686 0 CA-C-N 112.151 -2.295 . . . . 0.0 107.044 -175.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.4 mm -138.17 91.36 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.55 118.86 10.74 Favored 'General case' 0 C--O 1.226 -0.174 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 165.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 4.9 mtm -116.65 80.65 10.75 Favored Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 104.829 -2.286 . . . . 0.0 104.829 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -74.47 168.05 25.72 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.256 2.638 . . . . 0.0 112.051 -168.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.86 -106.73 0.1 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.703 1.201 . . . . 0.0 108.853 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -103.67 3.56 34.48 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.036 1.335 . . . . 0.0 111.53 174.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -76.18 -1.77 27.91 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.244 1.017 . . . . 0.0 113.275 -174.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 17.7 mt -77.33 21.67 0.25 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.902 1.681 . . . . 0.0 113.662 -176.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -37.24 133.78 0.65 Allowed 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 127.343 2.257 . . . . 0.0 109.343 166.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.1 tt -52.07 -34.42 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 124.309 1.044 . . . . 0.0 111.987 -176.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -70.2 -37.67 75.13 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.147 -0.97 . . . . 0.0 112.081 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -67.09 -46.5 74.06 Favored 'General case' 0 C--O 1.219 -0.521 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 168.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.91 -44.1 66.71 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.97 0.804 . . . . 0.0 112.187 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 14.3 t-160 -65.34 -43.46 90.82 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 119.93 1.241 . . . . 0.0 111.144 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.26 -14.97 59.66 Favored 'General case' 0 C--O 1.218 -0.554 0 O-C-N 121.574 -0.704 . . . . 0.0 110.379 -178.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -50.25 -44.35 53.51 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 127.167 2.187 . . . . 0.0 111.015 -173.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.438 ' HE3' ' CZ ' ' A' ' 44' ' ' PHE . 0.4 OUTLIER -67.35 -41.6 84.9 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-O 117.823 -1.084 . . . . 0.0 111.266 176.061 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -58.65 -48.58 80.57 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 120.324 1.42 . . . . 0.0 110.346 174.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -58.76 -61.64 2.47 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-O 117.738 -1.125 . . . . 0.0 108.186 177.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.4 t -52.78 -37.34 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 119.943 1.247 . . . . 0.0 111.65 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.438 ' CZ ' ' HE3' ' A' ' 40' ' ' LYS . 3.3 m-85 -59.44 -65.43 0.67 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 118.885 0.766 . . . . 0.0 110.371 174.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -60.74 -50.82 71.92 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 126.504 1.922 . . . . 0.0 111.162 -173.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -67.19 -36.4 81.69 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 127.816 2.446 . . . . 0.0 111.179 -174.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -128.91 -60.34 1.09 Allowed 'General case' 0 C--N 1.347 0.498 0 CA-C-N 119.496 1.044 . . . . 0.0 112.254 -174.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 12.1 mt -64.0 -25.26 68.05 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.564 -0.71 . . . . 0.0 112.843 -165.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -99.83 -15.68 18.33 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 127.283 2.233 . . . . 0.0 111.573 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -69.91 -16.75 63.28 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.435 1.094 . . . . 0.0 110.898 164.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.04 1.64 33.88 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.61 1.576 . . . . 0.0 112.935 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -72.57 145.58 47.3 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 119.066 1.433 . . . . 0.0 110.564 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -126.74 4.5 6.7 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.681 1.192 . . . . 0.0 113.285 -177.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.6 mtmt -145.88 95.32 2.62 Favored 'General case' 0 CA--C 1.514 -0.418 0 O-C-N 119.687 -1.883 . . . . 0.0 107.124 -166.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -101.94 154.11 5.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.404 ' CE2' HG12 ' A' ' 22' ' ' VAL . 16.1 m-30 -124.37 156.15 37.56 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 117.922 0.328 . . . . 0.0 111.332 163.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 29.4 tp -130.1 107.65 9.48 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 124.89 1.276 . . . . 0.0 108.438 175.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -75.81 161.92 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-O 121.37 0.605 . . . . 0.0 110.651 176.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 30.1 mt -139.61 12.51 2.52 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.935 1.294 . . . . 0.0 109.678 -174.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 68.7 m -66.38 -64.35 0.88 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.918 1.287 . . . . 0.0 110.559 -176.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -69.74 -43.6 71.97 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.972 0.415 . . . . 0.0 111.689 -169.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.3 p -67.94 160.98 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 126.47 1.908 . . . . 0.0 110.691 -177.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -95.24 -56.17 2.81 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.795 0.838 . . . . 0.0 109.314 174.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.5 p -156.36 -165.39 1.89 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.372 0.669 . . . . 0.0 110.693 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.0 tt -139.6 145.02 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 C-N-CA 125.858 1.663 . . . . 0.0 106.914 -177.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -82.86 162.13 21.7 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.308 0.643 . . . . 0.0 109.774 175.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.0 m -54.19 -29.38 45.76 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.947 1.299 . . . . 0.0 112.843 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -56.59 -64.41 0.88 Allowed 'General case' 0 C--N 1.344 0.346 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.7 t -77.24 -22.32 52.39 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 118.839 -0.6 . . . . 0.0 111.582 -176.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 22.1 tp -54.98 -27.17 41.88 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.958 1.254 . . . . 0.0 111.887 173.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -83.93 -35.64 15.26 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.16 0.886 . . . . 0.0 112.87 171.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 45.5 t -67.89 -42.01 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 118.524 1.162 . . . . 0.0 109.462 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 12.0 mm -54.73 -49.68 66.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.206 1.002 . . . . 0.0 109.338 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 38.7 t -62.48 -42.34 95.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 O-C-N 121.397 -0.814 . . . . 0.0 110.417 174.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -52.89 -44.08 66.63 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 120.129 1.331 . . . . 0.0 112.239 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 59.8 mt -60.67 -38.44 78.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 124.06 0.944 . . . . 0.0 108.67 176.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.49 -49.23 64.42 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 120.005 1.275 . . . . 0.0 109.466 178.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -52.57 -48.25 66.3 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 118.607 0.64 . . . . 0.0 110.077 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.0 m -60.02 -54.54 44.81 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.248 1.019 . . . . 0.0 110.711 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 48.6 mt -60.17 -43.74 93.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 124.337 1.055 . . . . 0.0 110.647 -177.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.0 t -70.22 -12.52 61.65 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.397 1.079 . . . . 0.0 111.865 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.5 t -83.82 -46.75 11.84 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 119.208 0.913 . . . . 0.0 108.583 167.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 72.1 m -54.12 -53.65 50.37 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.239 0.616 . . . . 0.0 110.41 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 132.88 18.04 1.12 Allowed Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.213 -0.771 . . . . 0.0 112.589 -168.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -109.48 179.35 20.83 Favored Glycine 0 N--CA 1.44 -1.034 0 CA-C-N 119.827 1.813 . . . . 0.0 112.587 -173.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -141.87 108.49 5.35 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.914 2.086 . . . . 0.0 108.815 -172.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -106.57 139.8 40.45 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.76 1.224 . . . . 0.0 107.802 -176.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.92 172.49 12.86 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.155 0.889 . . . . 0.0 111.861 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.11 167.17 13.47 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.58 0.752 . . . . 0.0 109.903 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 92.5 t -142.39 139.13 29.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 C-N-CA 123.36 0.664 . . . . 0.0 110.122 -168.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 t 46.54 54.46 14.82 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 126.304 1.842 . . . . 0.0 111.178 -175.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -69.79 99.89 0.78 Allowed 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 123.149 2.566 . . . . 0.0 108.769 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -62.5 158.3 18.24 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 122.116 0.96 . . . . 0.0 110.954 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 -59.47 -34.77 72.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.216 -171.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.43 -44.93 89.34 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.37 1.468 . . . . 0.0 109.55 175.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.7 t -74.45 -47.22 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-O 117.2 -1.381 . . . . 0.0 109.761 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -54.66 -31.97 58.44 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 121.383 1.901 . . . . 0.0 110.233 -176.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.41 -62.57 1.63 Allowed 'General case' 0 N--CA 1.423 -1.808 0 CA-C-O 123.453 1.597 . . . . 0.0 111.724 175.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.6 p -66.87 -34.58 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 CA-C-N 113.981 -1.463 . . . . 0.0 107.651 -173.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.9 mt -63.26 -23.97 67.66 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.912 0.885 . . . . 0.0 111.36 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.7 m -78.85 -49.59 12.66 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 120.103 1.32 . . . . 0.0 107.829 170.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.71 -15.42 40.37 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.23 2.212 . . . . 0.0 113.582 -174.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.6 t -120.67 -0.18 10.27 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.914 2.086 . . . . 0.0 111.479 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 48.07 69.01 0.58 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 127.266 2.227 . . . . 0.0 112.967 -168.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.38 -49.44 3.57 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.369 1.867 . . . . 0.0 110.096 166.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -65.57 -12.29 51.69 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 119.56 1.073 . . . . 0.0 112.728 -177.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.0 5.04 25.8 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 127.255 2.222 . . . . 0.0 111.049 -174.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.7 mt -125.62 -45.55 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 128.093 2.557 . . . . 0.0 109.579 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.8 t -95.09 166.92 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.678 1.191 . . . . 0.0 107.802 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -95.95 172.64 7.88 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.737 0.815 . . . . 0.0 109.408 168.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -157.98 147.0 9.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 -163.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -148.48 162.95 38.58 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.568 1.147 . . . . 0.0 112.489 -169.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.95 -58.37 2.62 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -178.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 69.2 p -102.87 -162.53 0.92 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 14.6 mm -84.76 -34.17 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-O 118.564 -0.732 . . . . 0.0 111.133 156.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.1 t -70.22 -37.33 75.0 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.373 -156.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -67.14 -39.97 86.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 176.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.63 -41.38 96.21 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -171.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 9.8 ttt -51.39 -43.45 61.93 Favored 'General case' 0 N--CA 1.424 -1.728 0 C-N-CA 127.897 2.479 . . . . 0.0 110.804 -174.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -104.75 -15.48 15.22 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.837 1.255 . . . . 0.0 112.42 -177.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -81.65 -47.21 13.28 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 119.008 0.822 . . . . 0.0 109.096 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -55.24 -19.96 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 124.864 1.265 . . . . 0.0 114.086 176.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 7.7 mtm180 -70.39 -27.94 64.69 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 118.512 -0.756 . . . . 0.0 110.86 173.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.4 47.29 0.11 Allowed 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 120.624 1.556 . . . . 0.0 114.002 -176.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.069 0 C-N-CA 125.134 1.373 . . . . 0.0 111.444 -172.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.8 mtp . . . . . 0 N--CA 1.469 0.509 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -80.44 179.83 53.18 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 163.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.4 m -77.54 -51.27 10.98 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 121.846 -0.796 . . . . 0.0 110.093 173.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -168.61 129.61 1.25 Allowed 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.644 1.178 . . . . 0.0 110.205 -164.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -164.25 158.01 18.44 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 145.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 42.3 mt -119.67 95.54 3.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 170.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 33.2 p80 -76.62 171.75 14.16 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 163.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.14 136.16 57.86 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.241 0.543 . . . . 0.0 111.108 -177.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 29.2 t60 -101.67 128.35 48.01 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 160.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -149.74 100.15 2.93 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 107.194 -1.409 . . . . 0.0 107.194 -173.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -65.05 103.18 0.71 Allowed 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 175.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 58.3 t60 -151.68 104.58 3.05 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 163.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -53.78 164.33 0.58 Allowed 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.939 1.695 . . . . 0.0 114.38 -172.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -126.88 169.05 12.85 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 128.349 2.66 . . . . 0.0 108.062 174.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -85.16 99.5 0.68 Allowed 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.407 2.071 . . . . 0.0 111.084 -174.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -155.29 165.41 36.73 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 120.898 -1.127 . . . . 0.0 110.284 -178.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -125.94 173.45 9.12 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.181 1.392 . . . . 0.0 108.938 164.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 52.1 mt -132.4 119.6 39.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.9 m -114.72 -166.11 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 170.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -45.66 -43.6 12.63 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 128.492 2.717 . . . . 0.0 115.278 -149.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -150.23 19.37 0.86 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.359 0.664 . . . . 0.0 111.163 156.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.3 t -122.15 120.72 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 124.266 1.027 . . . . 0.0 108.532 -173.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.5 t -75.5 143.78 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 176.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.1 mm -119.33 104.03 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 175.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 26.9 mt -85.72 124.64 32.47 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 177.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 65.0 mtm -126.86 76.46 75.36 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -167.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -61.56 148.44 92.99 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.507 2.805 . . . . 0.0 110.934 -170.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.88 -85.27 0.37 Allowed 'General case' 0 C--O 1.225 -0.212 0 CA-C-O 118.931 -0.557 . . . . 0.0 111.123 176.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.5 35.13 4.69 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.194 1.397 . . . . 0.0 109.275 -176.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.94 -19.36 13.43 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 120.791 -1.193 . . . . 0.0 112.385 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.9 mp -72.77 90.21 1.4 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -132.85 26.04 4.31 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.621 1.168 . . . . 0.0 110.801 -164.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.3 mt 65.24 -54.12 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 129.071 2.948 . . . . 0.0 113.558 -172.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -66.31 -32.4 73.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 120.175 1.352 . . . . 0.0 109.509 -174.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.1 -8.12 46.97 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-O 117.265 -1.35 . . . . 0.0 110.364 175.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.06 -65.99 0.77 Allowed 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 120.869 1.668 . . . . 0.0 111.794 -168.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -67.96 -17.39 64.43 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 121.421 1.919 . . . . 0.0 110.97 177.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 69.3 mt -78.04 -9.19 59.02 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.103 1.761 . . . . 0.0 112.087 170.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -69.01 -60.39 2.39 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -169.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.65 -33.43 72.79 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 116.609 -1.662 . . . . 0.0 111.253 174.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -64.63 -50.16 68.21 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 120.801 1.637 . . . . 0.0 107.904 -175.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -48.58 -62.37 1.54 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 118.134 -0.936 . . . . 0.0 108.704 166.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.7 m -57.93 -46.46 87.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 CA-C-O 123.311 1.529 . . . . 0.0 112.671 -166.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 -50.01 -44.95 51.45 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 126.771 2.028 . . . . 0.0 108.98 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.417 ' HA ' HD21 ' A' ' 49' ' ' ASN . 15.2 t0 -78.96 -9.4 59.51 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 128.063 2.545 . . . . 0.0 114.908 -176.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -123.88 -8.69 7.8 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.385 0.993 . . . . 0.0 112.652 177.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -136.16 -61.68 0.69 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.586 0.754 . . . . 0.0 111.069 -174.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.4 mt -67.29 -52.08 44.9 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 118.733 0.697 . . . . 0.0 110.935 -169.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.417 HD21 ' HA ' ' A' ' 45' ' ' ASP . 86.2 m-20 -64.97 -27.16 68.65 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.26 1.024 . . . . 0.0 110.449 173.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.25 -46.81 75.84 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 125.044 1.338 . . . . 0.0 108.74 -178.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 131.0 47.59 0.13 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 125.527 1.537 . . . . 0.0 109.768 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -123.6 133.33 53.96 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 118.32 1.06 . . . . 0.0 110.511 173.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -126.26 22.04 7.23 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 126.097 1.759 . . . . 0.0 111.336 -177.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -143.93 142.25 30.67 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.66 1.184 . . . . 0.0 108.321 162.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.1 mt -141.76 150.62 19.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 129.238 3.015 . . . . 0.0 104.421 -176.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -133.75 153.84 51.41 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 125.219 1.408 . . . . 0.0 109.969 169.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 29.7 tp -118.95 111.57 18.52 Favored 'General case' 0 C--N 1.339 0.143 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 174.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 87.6 t -86.2 103.47 12.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -78.92 -12.71 60.04 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.091 1.356 . . . . 0.0 111.747 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.75 -38.45 47.77 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.919 1.287 . . . . 0.0 111.115 173.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -84.95 -45.66 11.98 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 120.822 0.344 . . . . 0.0 110.792 -165.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.8 p -76.77 -178.75 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 126.619 1.968 . . . . 0.0 109.663 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -122.89 -41.45 2.35 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.41 1.084 . . . . 0.0 108.821 170.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.5 t -154.23 165.36 36.51 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-O 122.623 1.201 . . . . 0.0 113.766 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.7 tt -135.29 152.7 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 129.805 3.242 . . . . 0.0 105.985 176.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.447 ' C ' ' H ' ' A' ' 68' ' ' PHE . 0.5 OUTLIER -111.49 175.13 5.55 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.356 0.662 . . . . 0.0 110.468 -167.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.9 p -62.53 19.0 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 128.244 2.617 . . . . 0.0 114.312 173.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.447 ' H ' ' C ' ' A' ' 66' ' ' ASP . 4.2 t80 -112.38 -73.02 0.68 Allowed 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 166.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 74.7 m -66.05 -29.44 69.78 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 116.878 -1.534 . . . . 0.0 113.778 -172.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.3 mt -48.55 -46.77 39.38 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.606 1.548 . . . . 0.0 110.192 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.17 -33.07 82.85 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-O 119.71 -0.494 . . . . 0.0 112.025 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.2 t -75.5 -29.6 21.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 118.275 1.038 . . . . 0.0 111.087 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 mp -64.58 -40.21 88.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 174.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.1 t -60.64 -43.46 94.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 O-C-N 120.559 -1.338 . . . . 0.0 110.172 169.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -51.24 -43.33 61.45 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.854 1.262 . . . . 0.0 112.204 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.1 mt -58.56 -45.13 90.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 124.406 1.082 . . . . 0.0 109.353 175.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.01 -49.3 70.78 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -51.4 -49.42 61.62 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.018 0.527 . . . . 0.0 109.615 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 13.6 t -64.28 -47.49 79.33 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -176.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 47.7 mt -60.43 -45.17 97.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 C-N-CA 124.979 1.311 . . . . 0.0 111.747 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.5 m -75.29 -23.32 57.35 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.818 0.735 . . . . 0.0 112.143 176.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.78 -45.59 89.05 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.437 1.017 . . . . 0.0 108.543 167.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 74.8 m -63.94 -71.02 0.19 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.889 1.675 . . . . 0.0 112.008 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 141.23 33.74 0.12 Allowed Glycine 0 CA--C 1.527 0.798 0 C-N-CA 124.195 0.902 . . . . 0.0 111.198 -164.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -126.37 -173.78 13.66 Favored Glycine 0 C--N 1.336 0.578 0 O-C-N 120.517 -1.578 . . . . 0.0 109.592 169.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -131.19 164.15 26.17 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.367 1.067 . . . . 0.0 109.902 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -156.03 141.19 17.43 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.973 1.309 . . . . 0.0 109.03 175.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -147.08 178.44 8.37 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 123.727 0.811 . . . . 0.0 112.166 174.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.35 163.56 18.46 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 123.453 0.701 . . . . 0.0 109.911 -178.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 40.2 t -144.08 133.51 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 123.847 0.859 . . . . 0.0 108.837 -163.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.9 t 48.95 58.96 17.72 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 127.029 2.131 . . . . 0.0 111.778 -171.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.05 91.96 0.91 Allowed 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 123.748 2.965 . . . . 0.0 108.711 176.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -51.66 153.5 2.34 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 126.536 1.935 . . . . 0.0 112.092 171.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -54.03 -31.2 50.63 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.989 1.716 . . . . 0.0 111.204 -176.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.84 -44.71 84.72 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 126.798 2.039 . . . . 0.0 109.207 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.1 t -74.1 -44.77 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 125.634 1.574 . . . . 0.0 110.488 172.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -58.49 -23.89 59.06 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 120.496 1.498 . . . . 0.0 110.451 -176.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.91 -62.31 1.79 Allowed 'General case' 0 N--CA 1.427 -1.614 0 CA-C-O 124.804 2.24 . . . . 0.0 111.003 175.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -72.76 -46.16 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.707 0 CA-C-N 111.411 -2.631 . . . . 0.0 104.865 -167.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.5 mp -61.28 -19.83 62.2 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 124.913 1.285 . . . . 0.0 112.568 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.6 m -87.1 -54.89 4.08 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 172.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 68.1 mt -51.37 -51.3 55.82 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.546 1.538 . . . . 0.0 113.08 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.1 t -91.32 3.66 54.32 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.826 1.65 . . . . 0.0 111.987 -167.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 55.38 77.9 0.21 Allowed 'General case' 0 C--N 1.34 0.175 0 C-N-CA 126.387 1.875 . . . . 0.0 109.678 -173.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.22 -55.59 1.76 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.327 1.051 . . . . 0.0 108.636 177.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -60.18 -31.9 70.56 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.235 1.414 . . . . 0.0 110.306 169.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -74.21 1.21 11.83 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 117.556 -1.211 . . . . 0.0 112.965 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.4 mt -133.94 -39.55 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.547 1.139 . . . . 0.0 110.629 -169.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.4 t -106.12 153.92 7.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 119.647 1.112 . . . . 0.0 108.81 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.71 157.27 38.3 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.291 0.567 . . . . 0.0 111.486 174.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.0 145.29 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -172.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -149.19 169.66 20.23 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 127.093 2.157 . . . . 0.0 110.55 -175.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -88.08 -48.24 7.89 Favored 'General case' 0 CA--C 1.521 -0.173 0 O-C-N 121.763 -0.586 . . . . 0.0 109.419 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 67.5 p -121.56 173.52 7.36 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.921 0.888 . . . . 0.0 109.939 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 17.9 mm -70.7 -35.92 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.6 t -74.06 -30.11 62.23 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 119.446 1.021 . . . . 0.0 111.246 -173.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -65.19 -20.41 66.43 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 119.462 -0.304 . . . . 0.0 111.355 169.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -101.91 -39.93 7.13 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -170.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 53.1 ttm -48.72 -50.07 35.23 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 127.781 2.432 . . . . 0.0 111.089 -167.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -101.47 -0.42 35.2 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 117.985 -1.007 . . . . 0.0 112.591 -174.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -119.31 -35.49 3.58 Favored 'General case' 0 C--O 1.216 -0.687 0 C-N-CA 123.79 0.836 . . . . 0.0 111.542 -167.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -54.21 -29.02 18.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 O-C-N 121.14 -0.975 . . . . 0.0 109.559 157.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.11 118.02 17.58 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 102.467 -3.16 . . . . 0.0 102.467 163.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . 0.267 0.0 OUTLIER 85.46 23.42 0.08 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 111.968 -2.378 . . . . 0.0 116.193 165.582 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp . . . . . 0 C--O 1.25 1.111 0 C-N-CA 123.854 0.862 . . . . 0.0 111.187 176.487 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.475 0.823 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 172.3 104.27 0.17 Allowed Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 174.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.9 m -145.01 134.37 23.01 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 169.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 67.11 170.47 0.25 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 128.096 2.558 . . . . 0.0 112.826 -177.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.44 95.59 2.95 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 161.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 82.5 mt -127.17 104.45 12.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 -173.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -142.22 58.03 1.46 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.63 0.729 . . . . 0.0 111.729 -173.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -128.95 -0.48 5.29 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -177.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -70.95 150.73 45.41 Favored 'General case' 0 C--O 1.239 0.522 0 O-C-N 121.179 -0.951 . . . . 0.0 110.103 175.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -147.71 116.6 6.78 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 127.261 2.224 . . . . 0.0 105.138 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -52.89 105.62 0.13 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.731 1.212 . . . . 0.0 112.739 -174.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -157.59 162.18 38.74 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.593 1.557 . . . . 0.0 108.515 170.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 35.1 mmm 63.65 107.03 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 127.509 2.324 . . . . 0.0 111.709 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -108.49 85.56 2.96 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 125.713 1.605 . . . . 0.0 109.446 178.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.67 53.45 4.05 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 123.865 3.043 . . . . 0.0 111.436 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -162.14 163.82 28.27 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 120.788 -1.195 . . . . 0.0 109.804 -175.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.5 pttt -129.6 169.43 15.03 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.651 1.58 . . . . 0.0 108.631 168.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.5 mt -137.95 123.71 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 174.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.8 m -99.26 -154.18 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -24.92 -72.5 0.03 OUTLIER 'General case' 0 C--O 1.237 0.414 0 C-N-CA 130.085 3.354 . . . . 0.0 111.623 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.14 12.14 2.19 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.296 1.439 . . . . 0.0 110.646 172.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.7 t -112.41 137.45 45.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 O-C-N 120.657 -1.277 . . . . 0.0 108.749 -171.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 65.9 t -88.72 143.3 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 175.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mp -126.84 97.56 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -69.03 140.18 54.94 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 162.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 22.8 mtt -131.44 73.25 80.01 Favored Pre-proline 0 C--O 1.236 0.375 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 171.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.53 167.44 24.13 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 121.608 1.539 . . . . 0.0 110.62 174.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -161.16 -107.6 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 126.532 1.933 . . . . 0.0 105.999 -173.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.68 1.87 36.39 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -171.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -90.43 -23.56 20.98 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 120.773 -1.204 . . . . 0.0 113.726 -167.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 16.6 mt -74.9 -76.0 0.15 Allowed 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.155 -153.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . 0.258 0.1 OUTLIER 23.36 60.08 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 129.64 3.176 . . . . 0.0 113.201 153.629 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.8 mt 63.54 -45.29 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 127.908 2.483 . . . . 0.0 114.352 -172.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -63.61 -21.89 66.6 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.226 1.011 . . . . 0.0 112.906 -165.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -127.72 63.22 1.38 Allowed 'General case' 0 C--O 1.232 0.178 0 C-N-CA 125.141 1.376 . . . . 0.0 107.991 170.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.03 -67.94 0.89 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.674 0.79 . . . . 0.0 112.268 -177.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 39.7 t-80 -63.0 -37.1 85.82 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 120.71 1.595 . . . . 0.0 110.188 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.8 -15.3 60.75 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 117.747 -1.12 . . . . 0.0 111.935 173.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -52.59 -48.7 66.09 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 120.581 1.537 . . . . 0.0 110.942 -172.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -67.54 -42.43 82.72 Favored 'General case' 0 C--O 1.211 -0.922 0 CA-C-O 117.428 -1.272 . . . . 0.0 110.381 175.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.5 tttm -55.39 -45.14 76.64 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.937 1.699 . . . . 0.0 111.051 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 8.2 t90 -61.78 -63.04 1.39 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.546 1.138 . . . . 0.0 109.283 176.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.2 t -59.55 -32.39 48.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 119.655 1.116 . . . . 0.0 112.305 -176.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -56.54 -60.37 3.64 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 170.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.24 -44.15 72.57 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 -168.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -76.39 -17.26 59.46 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.228 1.811 . . . . 0.0 111.246 -170.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -141.68 -55.5 0.46 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 66.2 mt -64.9 -50.88 64.8 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.687 1.13 . . . . 0.0 111.451 -170.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -65.0 -29.6 70.53 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 127.867 2.467 . . . . 0.0 109.657 175.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.1 mttm -61.02 -46.87 89.0 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 118.638 -0.696 . . . . 0.0 109.14 169.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.97 4.38 2.66 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.193 1.377 . . . . 0.0 113.06 173.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -64.08 150.83 44.63 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 118.936 1.368 . . . . 0.0 109.593 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -122.29 -1.92 9.12 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.05 1.34 . . . . 0.0 114.409 175.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.0 mtmt -133.75 121.97 22.65 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 120.908 1.686 . . . . 0.0 108.379 -176.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.4 mt -130.39 157.21 42.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 C-N-CA 125.646 1.579 . . . . 0.0 107.366 176.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -131.92 161.4 33.15 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.389 1.476 . . . . 0.0 111.768 165.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.8 tp -128.46 81.23 2.01 Favored 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 125.068 1.347 . . . . 0.0 108.173 173.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 99.1 t -56.25 136.4 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 127.93 2.492 . . . . 0.0 107.563 166.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.59 12.6 12.35 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.182 1.793 . . . . 0.0 110.459 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 68.3 m -43.46 -46.24 6.7 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.68 1.992 . . . . 0.0 112.835 173.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.02 1.42 39.54 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.848 1.259 . . . . 0.0 111.69 -164.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.7 p -132.42 114.46 23.29 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 C-N-CA 126.082 1.753 . . . . 0.0 107.526 -177.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -64.69 -38.55 91.37 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 120.652 -1.28 . . . . 0.0 108.319 176.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 57.2 p -154.52 146.94 23.98 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -174.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 21.3 tt -100.28 151.38 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 113.82 -1.536 . . . . 0.0 107.411 163.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -92.3 168.9 11.0 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 123.083 1.42 . . . . 0.0 110.271 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.0 p -50.75 0.06 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.723 1 C-N-CA 132.565 4.346 . . . . 0.0 115.962 170.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -98.77 -70.52 0.72 Allowed 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.6 t -77.0 -19.88 56.74 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-O 118.552 -0.737 . . . . 0.0 112.082 -172.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 14.3 tp -48.57 -33.94 10.6 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.792 1.178 . . . . 0.0 111.743 170.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -76.4 -37.24 36.67 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 118.114 0.416 . . . . 0.0 113.683 173.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.9 t -65.31 -34.6 71.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 124.176 0.991 . . . . 0.0 109.62 -178.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.58 -48.13 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 123.747 0.819 . . . . 0.0 109.918 175.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.6 t -66.66 -39.85 84.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 O-C-N 121.187 -0.946 . . . . 0.0 109.851 178.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.63 -40.63 72.4 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.643 0.735 . . . . 0.0 110.996 178.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.1 mt -61.88 -39.44 83.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 126.592 1.957 . . . . 0.0 109.641 175.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.22 -41.5 90.03 Favored 'General case' 0 C--N 1.341 0.215 0 O-C-N 119.922 -1.736 . . . . 0.0 109.487 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.8 mttm -54.22 -44.11 71.41 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-O 117.841 -1.076 . . . . 0.0 110.524 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.5 t -53.6 -52.66 59.1 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.822 0.849 . . . . 0.0 110.825 176.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.0 mt -67.66 -39.85 82.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.012 0.525 . . . . 0.0 110.472 -174.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 26.6 t -66.25 -36.22 82.45 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.28 1.432 . . . . 0.0 110.932 176.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 71.8 m -65.39 -40.11 93.07 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 119.386 0.994 . . . . 0.0 109.894 172.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.5 m -73.29 -68.97 0.45 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.733 0.813 . . . . 0.0 111.642 -172.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 146.75 34.43 0.06 OUTLIER Glycine 0 C--N 1.334 0.418 0 CA-C-O 118.798 -1.001 . . . . 0.0 113.354 -166.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -127.6 -163.19 11.33 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 118.948 1.374 . . . . 0.0 111.321 -176.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -137.89 151.85 48.44 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 169.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -147.47 147.53 30.29 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 172.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -153.48 170.73 20.04 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 124.812 1.32 . . . . 0.0 111.211 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.3 mt -108.47 167.4 10.07 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -145.38 152.85 14.21 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.511 0 C-N-CA 124.89 1.276 . . . . 0.0 111.085 -173.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.1 p 41.3 58.88 8.94 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 126.32 1.848 . . . . 0.0 112.812 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -71.35 7.94 1.31 Allowed 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 124.227 3.285 . . . . 0.0 114.498 -170.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 56.26 -160.98 0.2 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.383 1.473 . . . . 0.0 108.993 -176.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -87.9 -15.67 36.01 Favored 'General case' 0 CA--C 1.552 1.044 0 O-C-N 120.706 -1.246 . . . . 0.0 110.892 164.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.62 -33.72 10.85 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 121.062 -1.024 . . . . 0.0 112.606 -160.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.268 0.9 OUTLIER -77.28 -37.67 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 116.254 -1.831 . . . . 0.0 107.615 166.421 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -52.96 -35.17 58.57 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 121.685 2.039 . . . . 0.0 110.235 171.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.06 -40.17 87.01 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.424 -175.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.4 p -92.41 -33.31 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -167.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.4 mp -65.55 -12.07 49.6 Favored 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 124.845 1.258 . . . . 0.0 112.5 178.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.7 t -87.29 -50.68 6.42 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 166.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.21 -38.59 87.16 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.261 1.824 . . . . 0.0 113.14 -168.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 10.9 t -86.47 -18.44 31.66 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 119.01 -0.519 . . . . 0.0 110.786 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 64.45 93.72 0.06 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.563 1.545 . . . . 0.0 107.215 -151.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.64 -50.94 1.73 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.576 1.551 . . . . 0.0 108.706 168.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -29.96 68.18 Favored 'General case' 0 C--N 1.346 0.426 0 N-CA-C 110.002 -0.369 . . . . 0.0 110.002 177.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -77.99 5.65 9.42 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 128.022 2.529 . . . . 0.0 112.353 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.3 mt -124.05 -34.93 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 125.232 1.413 . . . . 0.0 109.006 -177.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.501 HG11 ' H ' ' A' ' 110' ' ' LYS . 1.7 t -123.85 -159.31 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 125.028 1.331 . . . . 0.0 110.546 -177.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.501 ' H ' HG11 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -116.1 158.8 22.63 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 128.837 2.855 . . . . 0.0 108.073 169.932 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.95 154.03 17.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 -178.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -144.87 167.64 22.12 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.934 0.894 . . . . 0.0 112.7 -171.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.75 -50.52 6.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.944 -177.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 70.4 p -130.29 175.46 8.92 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.92 1.288 . . . . 0.0 107.823 -176.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 6.3 mm -68.25 -41.71 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-O 117.687 -1.149 . . . . 0.0 109.218 170.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.2 t -67.35 -35.62 79.76 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 120.102 1.319 . . . . 0.0 109.43 -175.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.69 -6.51 26.61 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-O 117.554 -1.213 . . . . 0.0 112.797 174.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -110.55 -41.06 4.43 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 119.375 0.989 . . . . 0.0 109.772 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 1.9 ttp -59.61 -53.87 53.03 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.754 1.622 . . . . 0.0 111.94 -163.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -84.88 -13.72 50.03 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.187 1.395 . . . . 0.0 111.215 175.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.8 -52.27 5.39 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -168.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -50.31 -25.58 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 128.066 2.547 . . . . 0.0 113.359 177.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.17 -41.71 84.45 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 126.72 2.008 . . . . 0.0 111.423 175.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.54 55.84 0.62 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 127.165 2.186 . . . . 0.0 106.272 -170.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.419 ' HZ3' ' C ' ' A' ' 125' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.027 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 170.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.467 0.386 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -166.11 159.72 33.05 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 170.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.6 m 61.3 132.24 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.571 1.948 . . . . 0.0 112.303 -173.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -57.56 -55.33 36.22 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 121.875 -0.516 . . . . 0.0 109.857 170.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.3 tttm -149.27 155.53 40.7 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 175.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.62 130.22 35.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 176.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -61.14 -31.59 71.31 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.647 0.779 . . . . 0.0 112.745 -172.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.3 t60 39.76 73.01 0.12 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.124 2.57 . . . . 0.0 113.519 177.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.73 172.91 12.9 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.434 1.494 . . . . 0.0 108.964 173.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 69.24 -33.7 0.26 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 128.912 2.885 . . . . 0.0 115.045 162.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -75.5 151.78 37.93 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 121.265 1.848 . . . . 0.0 107.706 156.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -138.3 96.24 3.15 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 -168.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.7 ttm -155.81 122.91 5.39 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.878 0.871 . . . . 0.0 109.597 -161.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -145.73 83.14 9.01 Favored Pre-proline 0 CA--C 1.539 0.552 0 O-C-N 120.75 -1.219 . . . . 0.0 110.913 174.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -80.63 53.91 4.99 Favored 'Trans proline' 0 C--O 1.238 0.525 0 C-N-CA 124.367 3.378 . . . . 0.0 110.913 175.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -163.58 177.71 8.57 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.538 1.135 . . . . 0.0 109.454 -175.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.7 pttt -151.06 178.51 9.12 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 126.86 2.064 . . . . 0.0 108.787 165.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.8 mp -132.07 136.37 56.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 167.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 20.4 m -99.65 -131.63 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 125.214 1.406 . . . . 0.0 107.704 172.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -44.89 -73.64 0.04 OUTLIER 'General case' 0 C--O 1.235 0.306 0 C-N-CA 127.505 2.322 . . . . 0.0 111.359 178.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -143.59 8.63 1.55 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.477 1.911 . . . . 0.0 110.309 171.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.0 t -97.62 132.22 42.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 179.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.7 t -83.44 143.64 11.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 170.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.5 mp -121.93 114.4 42.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 174.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.36 147.05 32.55 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 120.41 1.459 . . . . 0.0 108.719 163.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 8.9 mtt -140.43 77.77 23.26 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 127.834 2.453 . . . . 0.0 107.097 -178.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.99 98.62 0.62 Allowed 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 124.881 3.721 . . . . 0.0 112.858 -172.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -76.53 79.26 3.22 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.419 1.087 . . . . 0.0 113.667 -167.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.266 0.0 OUTLIER 40.7 35.61 0.33 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.607 1.963 . . . . 0.0 114.098 -179.494 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -113.43 -11.51 13.1 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 120.63 -1.294 . . . . 0.0 112.732 -164.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.41 83.11 0.26 Allowed 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 125.596 1.558 . . . . 0.0 108.403 -172.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -123.08 38.29 4.22 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.387 1.875 . . . . 0.0 108.127 -177.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.412 HG12 ' CG ' ' A' ' 68' ' ' PHE 0.304 0.3 OUTLIER 68.96 -26.89 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 130.957 3.703 . . . . 0.0 114.556 -177.833 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -40.51 -32.1 0.18 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 129.659 3.184 . . . . 0.0 115.535 -175.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -117.79 -4.34 11.16 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 127.289 2.236 . . . . 0.0 112.089 -164.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.35 -52.0 18.07 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-N 120.114 1.325 . . . . 0.0 111.755 -166.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -60.48 -41.64 94.64 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.74 -0.6 . . . . 0.0 110.123 -178.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.3 -18.53 58.91 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 118.365 -0.826 . . . . 0.0 111.89 178.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -54.49 -42.87 71.26 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.414 1.461 . . . . 0.0 111.824 -172.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -61.76 -52.67 63.28 Favored 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.7 tmtp? -49.11 -46.32 44.68 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.917 1.687 . . . . 0.0 111.255 175.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -62.71 -65.55 0.67 Allowed 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 116.973 -1.489 . . . . 0.0 110.178 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.6 t -54.94 -35.16 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 120.709 1.595 . . . . 0.0 111.284 -175.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -57.59 -67.9 0.29 Allowed 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 123.913 0.885 . . . . 0.0 109.057 173.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.86 -51.56 69.1 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.807 0.843 . . . . 0.0 112.604 -174.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.32 -30.92 70.01 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.617 1.167 . . . . 0.0 111.379 -168.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -133.7 -65.0 0.69 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 122.884 0.474 . . . . 0.0 109.843 -164.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 52.6 mt -56.71 -54.16 49.36 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.835 0.743 . . . . 0.0 111.382 -174.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -67.19 -23.84 65.79 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 126.086 1.754 . . . . 0.0 111.577 175.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.0 tttm -74.68 -6.29 47.92 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.303 1.041 . . . . 0.0 112.194 169.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.68 7.28 53.77 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 124.791 1.186 . . . . 0.0 114.352 175.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -72.32 162.81 28.95 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 120.033 1.916 . . . . 0.0 110.031 176.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -148.34 4.23 0.69 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.502 1.521 . . . . 0.0 111.652 -176.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -141.54 119.02 11.55 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 -177.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.9 mp -119.89 154.97 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 105.14 -2.171 . . . . 0.0 105.14 174.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -130.91 164.19 25.82 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.48 1.512 . . . . 0.0 110.132 160.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.6 tp -128.16 114.6 17.2 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 170.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.4 t -82.55 110.42 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 125.991 1.716 . . . . 0.0 108.711 175.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -75.38 -10.89 59.86 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.579 0.752 . . . . 0.0 111.588 170.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.9 m -55.93 -23.52 32.3 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.464 1.029 . . . . 0.0 112.347 172.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.57 -14.16 25.28 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.283 0.947 . . . . 0.0 111.824 177.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.5 p -137.39 101.53 2.19 Favored 'Isoleucine or valine' 0 C--N 1.34 0.152 0 C-N-CA 124.798 1.239 . . . . 0.0 109.643 -173.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -55.05 -48.29 73.67 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.8 m -158.97 170.48 21.99 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.8 tt -135.83 155.9 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 C-N-CA 127.059 2.144 . . . . 0.0 107.99 -165.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -91.33 158.47 16.53 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 126.168 1.787 . . . . 0.0 109.774 176.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.7 m -56.07 -24.73 41.83 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 117.594 -1.193 . . . . 0.0 113.337 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.591 ' CE1' ' HB2' ' A' ' 69' ' ' SER 0.278 0.2 OUTLIER -47.59 -64.53 0.76 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 119.686 1.13 . . . . 0.0 111.049 170.766 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.591 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . 30.1 t -92.48 -15.94 26.46 Favored 'General case' 0 CA--C 1.512 -0.486 0 O-C-N 121.52 -0.737 . . . . 0.0 111.642 -168.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 14.2 mt -52.07 -36.22 50.01 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 119.225 -0.99 . . . . 0.0 109.288 170.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -81.27 -25.14 55.64 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-O 118.203 -1.332 . . . . 0.0 114.753 175.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.2 p -72.69 -35.56 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 120.332 2.066 . . . . 0.0 110.048 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 mp -53.34 -49.97 50.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.342 1.457 . . . . 0.0 108.136 173.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 80.7 t -56.61 -52.34 54.84 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 176.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -56.0 -22.46 27.0 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 114.114 1.154 . . . . 0.0 114.114 -174.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 57.8 mt -80.37 -44.34 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.452 1.101 . . . . 0.0 109.481 172.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -54.16 -48.77 70.52 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.452 1.024 . . . . 0.0 109.485 177.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -57.45 -42.75 83.1 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.168 0.587 . . . . 0.0 110.638 -176.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.4 m -60.17 -54.25 48.12 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 118.956 -0.545 . . . . 0.0 110.574 174.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 80.0 mt -57.63 -42.19 80.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.858 0.863 . . . . 0.0 110.803 -176.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -52.07 -40.8 61.72 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.728 1.611 . . . . 0.0 111.242 175.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 t -84.33 0.85 47.64 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.766 2.427 . . . . 0.0 112.799 -174.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.7 m -128.84 -14.26 4.53 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -166.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 130.51 -18.75 5.15 Favored Glycine 0 CA--C 1.521 0.409 0 CA-C-N 117.992 0.36 . . . . 0.0 113.741 177.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -100.3 -173.06 29.86 Favored Glycine 0 N--CA 1.429 -1.781 0 CA-C-O 123.02 1.345 . . . . 0.0 113.283 -156.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -133.46 153.09 51.91 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.461 1.504 . . . . 0.0 108.256 174.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -145.23 146.98 31.93 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 171.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -156.02 173.34 16.95 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.039 1.335 . . . . 0.0 111.153 -175.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.6 mt -121.06 163.78 17.81 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.697 1.199 . . . . 0.0 110.148 -170.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.7 t -141.87 135.0 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 123.963 0.905 . . . . 0.0 111.478 -172.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.6 t 53.0 59.63 13.37 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 128.626 2.77 . . . . 0.0 113.938 175.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -73.11 -51.57 0.16 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.73 1.62 . . . . 0.0 115.808 -169.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 85.01 172.48 0.07 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 128.463 2.705 . . . . 0.0 109.638 -171.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.08 -34.19 42.69 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 125.408 1.483 . . . . 0.0 110.398 169.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.59 -48.12 73.39 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-O 117.883 -1.056 . . . . 0.0 108.619 -173.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 54.8 t -79.82 -52.48 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -176.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -63.92 -9.73 17.06 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.55 1.068 . . . . 0.0 111.23 -176.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.41 -74.53 0.09 Allowed 'General case' 0 CA--C 1.489 -1.4 0 CA-C-O 122.108 0.956 . . . . 0.0 108.547 162.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 17.7 t -70.93 -29.65 38.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 113.585 -1.643 . . . . 0.0 107.114 -156.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.03 -12.44 3.36 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 117.685 -1.15 . . . . 0.0 109.972 173.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.75 -37.03 8.89 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.1 mp -63.79 -18.53 64.18 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.887 2.475 . . . . 0.0 113.257 172.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 12.7 t -128.0 16.48 6.77 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.97 1.308 . . . . 0.0 112.623 -171.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . 0.257 0.1 OUTLIER 40.11 78.95 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.38 1.472 . . . . 0.0 110.661 -173.906 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.79 -49.02 0.82 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.114 1.366 . . . . 0.0 107.93 -178.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.9 p-10 -62.53 -25.32 67.98 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 125.747 1.619 . . . . 0.0 112.072 176.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.5 -11.92 38.78 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.744 1.218 . . . . 0.0 113.895 -178.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.6 mt -105.55 -51.04 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 -173.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.5 t -107.91 142.62 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 121.414 0.626 . . . . 0.0 109.328 -170.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.4 mtmm -69.52 163.36 25.56 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-N 114.673 -1.149 . . . . 0.0 112.261 173.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -148.87 146.0 17.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 113.312 -1.767 . . . . 0.0 108.887 -169.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -148.57 167.55 25.12 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.544 1.138 . . . . 0.0 110.625 -171.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.7 -40.72 13.06 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -177.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.2 p -127.29 172.08 10.92 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.81 0.814 . . . . 0.0 109.501 -179.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 23.8 mm -70.04 -40.71 78.79 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.553 170.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 38.8 t -66.35 -33.12 75.0 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 119.288 0.949 . . . . 0.0 109.846 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -64.66 -11.76 38.98 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.872 0.869 . . . . 0.0 111.952 175.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -113.58 -39.08 4.14 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 124.935 1.294 . . . . 0.0 109.829 -175.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 5.9 ttp -58.17 -46.79 85.12 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.865 1.266 . . . . 0.0 112.348 -164.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -90.09 -19.89 23.81 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.869 1.268 . . . . 0.0 111.623 177.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -83.62 -50.39 8.25 Favored 'General case' 0 C--O 1.219 -0.532 0 C-N-CA 123.685 0.794 . . . . 0.0 109.095 -171.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -53.36 -16.7 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 127.292 2.237 . . . . 0.0 113.173 177.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -47.36 64.07 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.299 2.24 . . . . 0.0 111.746 169.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.22 37.21 1.72 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.559 1.944 . . . . 0.0 113.199 -173.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.107 0 C-N-CA 130.886 3.675 . . . . 0.0 111.666 157.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 ttt . . . . . 0 N--CA 1.47 0.527 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.74 54.29 3.3 Favored Glycine 0 CA--C 1.526 0.746 0 O-C-N 121.155 -0.966 . . . . 0.0 115.131 161.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.0 p -158.12 148.69 20.54 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 150.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -155.99 111.25 2.95 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -175.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.5 tptt 52.85 29.65 7.99 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.522 1.929 . . . . 0.0 113.528 174.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.4 tp -84.83 51.06 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 124.548 1.139 . . . . 0.0 113.061 -164.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 14.4 p-80 -160.53 154.08 22.26 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 120.675 -1.265 . . . . 0.0 110.535 170.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.554 ' CG ' ' H ' ' A' ' 9' ' ' HIS . 81.4 t60 -99.22 -171.56 2.1 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.349 1.86 . . . . 0.0 109.833 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.554 ' H ' ' CG ' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -79.72 101.71 8.58 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 120.063 -1.648 . . . . 0.0 109.949 175.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -132.77 145.41 50.98 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.22 0.608 . . . . 0.0 109.818 177.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -70.02 156.76 38.67 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 123.55 0.74 . . . . 0.0 110.861 173.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -116.18 112.01 21.04 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 126.593 1.957 . . . . 0.0 109.721 -175.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.87 118.27 9.04 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.098 0.959 . . . . 0.0 108.687 173.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -138.98 166.37 25.41 Favored Pre-proline 0 N--CA 1.447 -0.622 0 C-N-CA 126.622 1.969 . . . . 0.0 107.51 172.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -73.55 86.86 1.14 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.836 2.357 . . . . 0.0 109.304 175.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -167.01 172.39 10.21 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.223 1.409 . . . . 0.0 110.839 178.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.535 ' HG2' ' H ' ' A' ' 18' ' ' ILE . 4.9 ttmt -137.65 173.36 11.74 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.563 1.945 . . . . 0.0 109.452 173.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.535 ' H ' ' HG2' ' A' ' 17' ' ' LYS . 67.0 mt -135.53 134.81 51.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 128.866 2.866 . . . . 0.0 105.973 168.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.2 m -108.1 -169.94 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 128.289 2.635 . . . . 0.0 107.038 164.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -23.05 -75.92 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 128.153 2.581 . . . . 0.0 113.311 -171.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -134.15 36.23 3.24 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.256 0.622 . . . . 0.0 110.291 172.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.447 HG12 ' CE2' ' A' ' 56' ' ' PHE . 6.8 t -142.25 153.55 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.049 0 CA-C-O 122.785 1.278 . . . . 0.0 110.572 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -113.41 151.96 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.721 0 CA-C-N 112.67 -2.059 . . . . 0.0 107.487 -168.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.9 mp -132.33 88.54 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -179.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.59 158.26 32.51 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 120.377 1.444 . . . . 0.0 109.811 166.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -168.53 73.18 0.82 Allowed Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 123.905 0.882 . . . . 0.0 110.317 -176.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -68.65 120.86 7.76 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.881 2.387 . . . . 0.0 111.407 -168.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -76.16 66.53 2.32 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.4 -0.812 . . . . 0.0 111.749 175.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? 61.31 8.7 2.21 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.538 1.535 . . . . 0.0 113.155 -175.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.04 26.84 0.14 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.835 1.254 . . . . 0.0 112.789 -178.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.97 80.01 7.87 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 123.353 1.549 . . . . 0.0 106.842 175.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -99.63 148.95 23.79 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 127.191 2.196 . . . . 0.0 107.333 163.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.0 tt -54.37 -30.57 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.465 1.506 . . . . 0.0 112.217 174.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -58.93 -63.62 1.23 Allowed 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 175.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -51.7 -46.06 63.75 Favored 'General case' 0 C--O 1.222 -0.356 0 C-N-CA 125.252 1.421 . . . . 0.0 109.574 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.75 -40.57 63.23 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.838 1.255 . . . . 0.0 113.631 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -64.29 -47.72 78.41 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 119.795 1.18 . . . . 0.0 109.599 177.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.41 -31.77 65.79 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 118.014 -0.993 . . . . 0.0 111.03 -175.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -41.35 -40.3 1.66 Allowed 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 128.075 2.55 . . . . 0.0 110.715 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -55.46 -72.11 0.07 Allowed 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 118.989 0.813 . . . . 0.0 109.41 168.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.53 -35.48 63.24 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.869 0.868 . . . . 0.0 111.132 -172.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 20.7 t90 -59.88 -73.23 0.09 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 117.152 -1.404 . . . . 0.0 111.24 170.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 53.9 t -49.18 -36.33 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-N 120.452 1.478 . . . . 0.0 111.195 -178.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -68.52 -57.48 5.73 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 124.732 1.213 . . . . 0.0 110.538 -178.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -67.72 -31.58 71.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 118.545 0.611 . . . . 0.0 110.636 -177.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -89.24 -20.62 23.92 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 123.334 0.653 . . . . 0.0 111.728 -168.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -133.62 -53.85 0.88 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 118.619 0.645 . . . . 0.0 111.537 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 35.6 mt -64.31 -39.92 94.9 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 119.035 -0.507 . . . . 0.0 110.808 -171.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -72.97 -35.61 66.94 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 126.922 2.089 . . . . 0.0 111.356 173.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.91 -50.62 70.2 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.563 0.745 . . . . 0.0 109.46 175.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 138.21 6.08 1.48 Allowed Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.368 0.985 . . . . 0.0 112.634 -177.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -72.06 155.63 40.09 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 118.464 1.132 . . . . 0.0 109.876 177.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -131.65 15.31 4.89 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.692 1.597 . . . . 0.0 111.187 173.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -153.32 105.11 2.83 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 -163.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -116.09 155.19 17.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 103.801 -2.666 . . . . 0.0 103.801 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.447 ' CE2' HG12 ' A' ' 22' ' ' VAL . 27.4 m-85 -130.29 160.67 33.23 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 159.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 42.0 tp -126.72 103.98 7.83 Favored 'General case' 0 C--N 1.334 -0.083 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 173.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.2 t -78.88 141.27 15.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 171.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.4 mp -122.69 12.24 9.88 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.603 0.638 . . . . 0.0 112.304 -178.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.5 t -50.01 -44.72 51.35 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.655 1.582 . . . . 0.0 111.401 178.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -68.56 -36.22 78.48 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 118.684 -0.674 . . . . 0.0 111.234 -175.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 p -103.44 117.71 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 126.579 1.951 . . . . 0.0 107.753 -160.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -76.13 -39.63 54.65 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.22 -0.925 . . . . 0.0 109.17 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 78.9 p -140.29 163.17 33.47 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -175.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.0 tt -136.7 154.73 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 C-N-CA 126.407 1.883 . . . . 0.0 107.068 175.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.89 160.07 17.37 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.185 1.794 . . . . 0.0 109.847 -175.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.3 t -62.8 -12.89 27.35 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.7 1.2 . . . . 0.0 113.278 174.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -71.37 -68.29 0.46 Allowed 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 168.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.67 -30.3 66.86 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.674 1.189 . . . . 0.0 112.531 -163.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.6 mt -47.42 -42.54 22.44 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.966 0.907 . . . . 0.0 109.759 174.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -71.79 -29.84 66.84 Favored Glycine 0 CA--C 1.528 0.854 0 O-C-N 121.365 -0.834 . . . . 0.0 112.298 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.0 t -67.92 -35.26 71.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 O-C-N 121.583 -0.951 . . . . 0.0 109.314 176.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.8 -47.91 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.6 t -60.88 -39.43 81.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 O-C-N 121.535 -0.728 . . . . 0.0 110.938 174.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.41 -42.76 92.53 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 120.973 -1.08 . . . . 0.0 112.327 -176.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.3 mt -53.64 -43.52 54.83 Favored 'Isoleucine or valine' 0 C--N 1.343 0.308 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 172.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -66.44 -48.35 70.25 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -173.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 24.6 mttm -55.22 -47.59 75.1 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 122.777 0.431 . . . . 0.0 111.099 178.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.1 m -61.87 -46.55 88.95 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.974 0.91 . . . . 0.0 110.391 -177.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 29.4 mt -65.75 -48.06 83.64 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 C-N-CA 124.051 0.94 . . . . 0.0 111.328 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.52 -39.54 80.38 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 177.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 50.6 m -62.57 -41.54 98.99 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.061 176.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.7 m -61.42 -51.22 69.66 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.362 0.983 . . . . 0.0 109.982 174.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 134.75 24.24 0.6 Allowed Glycine 0 CA--C 1.525 0.671 0 C-N-CA 123.711 0.672 . . . . 0.0 112.396 -171.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -119.67 -173.12 15.23 Favored Glycine 0 N--CA 1.439 -1.131 0 CA-C-N 118.599 1.199 . . . . 0.0 111.942 -176.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -131.6 155.3 47.77 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.843 1.657 . . . . 0.0 109.246 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -150.57 135.42 17.5 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.697 0.799 . . . . 0.0 109.595 176.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -139.95 162.24 35.65 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.009 0.433 . . . . 0.0 111.982 -177.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.5 mp -103.03 151.93 21.93 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.025 1.73 . . . . 0.0 107.405 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 70.4 t -145.1 145.43 20.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -168.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 47.1 t 42.37 57.66 10.7 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 124.499 1.119 . . . . 0.0 110.124 -176.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -64.98 -77.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.947 2.431 . . . . 0.0 111.301 -165.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 25.0 p30 142.46 -175.12 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.492 1 C-N-CA 133.337 4.655 . . . . 0.0 106.01 171.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -77.84 -32.91 52.42 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 122.458 1.123 . . . . 0.0 111.849 176.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.74 -51.26 19.9 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 129.921 3.288 . . . . 0.0 110.271 -166.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.2 t -63.94 -48.12 87.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 125.668 1.587 . . . . 0.0 107.75 168.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -61.56 -26.08 67.72 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 122.746 2.521 . . . . 0.0 110.828 -175.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -46.98 85.83 Favored 'General case' 0 C--N 1.344 0.341 0 O-C-N 121.376 -0.827 . . . . 0.0 109.583 175.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.2 p -80.45 -31.31 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -172.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.3 mp -66.06 -17.48 64.72 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 118.037 -0.982 . . . . 0.0 112.462 177.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.6 m -77.86 -58.11 3.44 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 165.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.93 -68.56 0.16 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.019 2.128 . . . . 0.0 111.641 -173.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.7 t -76.92 14.59 0.81 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.671 1.589 . . . . 0.0 112.518 -175.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 42.76 85.05 0.02 OUTLIER 'General case' 0 C--N 1.34 0.194 0 C-N-CA 126.256 1.822 . . . . 0.0 112.014 -169.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . 0.334 0.1 OUTLIER -126.04 -41.47 1.94 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 125.169 1.388 . . . . 0.0 112.362 178.163 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -67.76 -21.18 65.28 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.95 1.25 . . . . 0.0 111.259 171.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.9 mtm180 -79.51 -1.94 39.94 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 118.805 -0.617 . . . . 0.0 111.227 -178.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.7 mm -127.69 -46.17 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 C-N-CA 124.97 1.308 . . . . 0.0 108.384 -164.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.6 t -110.48 149.24 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 -177.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.468 ' HE3' ' H ' ' A' ' 111' ' ' ILE . 0.0 OUTLIER -71.52 160.88 31.93 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.979 173.519 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.468 ' H ' ' HE3' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -145.27 143.29 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -177.249 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -146.55 171.4 15.14 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.349 1.459 . . . . 0.0 110.417 -177.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -87.24 -50.03 6.87 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -177.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 31.8 p -125.55 170.54 11.35 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-O 122.174 0.987 . . . . 0.0 111.141 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 12.4 mm -63.13 -36.76 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 C-N-CA 124.293 1.037 . . . . 0.0 108.379 170.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.79 -43.0 90.04 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 119.869 1.213 . . . . 0.0 110.979 -178.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -71.41 3.87 3.43 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 123.691 0.62 . . . . 0.0 112.169 178.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -114.39 -33.89 5.46 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 174.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.16 -52.31 62.94 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 120.17 -1.582 . . . . 0.0 111.79 -162.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -89.8 -13.81 35.82 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.48 0.712 . . . . 0.0 112.113 172.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.81 -52.36 6.1 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -168.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -53.31 -32.45 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 126.406 1.883 . . . . 0.0 111.322 176.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 43.8 mtm180 -62.18 -25.03 67.55 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 124.221 1.008 . . . . 0.0 111.285 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.22 56.33 1.0 Allowed 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 119.158 0.89 . . . . 0.0 109.862 169.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.199 0 CA-C-O 118.196 -0.907 . . . . 0.0 111.437 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.913 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.96 -170.06 34.26 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -161.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.5 m 62.4 61.76 1.23 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.278 1.431 . . . . 0.0 111.098 -175.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -52.16 -55.25 22.15 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 127.546 2.338 . . . . 0.0 112.128 -174.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? 48.07 37.47 7.95 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.091 1.756 . . . . 0.0 112.907 171.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.5 tp -91.78 5.41 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 124.597 1.159 . . . . 0.0 112.347 -175.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -99.84 73.15 1.76 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.492 1.517 . . . . 0.0 110.289 -174.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.461 ' CG ' ' H ' ' A' ' 9' ' ' HIS . 8.5 p80 -129.56 -71.24 0.62 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 124.718 1.207 . . . . 0.0 108.799 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.461 ' H ' ' CG ' ' A' ' 8' ' ' HIS . 5.7 t60 -61.3 120.07 9.7 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.702 0.801 . . . . 0.0 110.303 -172.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -125.55 159.6 31.66 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.863 0.865 . . . . 0.0 110.42 -165.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -134.92 39.18 2.98 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.135 1.374 . . . . 0.0 110.803 -162.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 55.62 53.3 9.78 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.258 2.223 . . . . 0.0 113.61 176.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 12.5 ttt -74.99 49.16 0.42 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.649 1.179 . . . . 0.0 110.13 162.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -124.55 72.55 59.99 Favored Pre-proline 0 C--O 1.236 0.367 0 C-N-CA 125.043 1.337 . . . . 0.0 109.039 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -81.23 44.64 1.79 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.544 2.829 . . . . 0.0 109.663 172.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -163.21 169.73 18.8 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 121.029 -1.044 . . . . 0.0 112.305 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -141.32 173.14 11.78 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 127.309 2.244 . . . . 0.0 108.365 164.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.6 mt -129.8 120.65 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 167.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.3 m -88.09 -151.96 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 124.938 1.295 . . . . 0.0 108.226 172.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -25.03 -72.39 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 128.6 2.76 . . . . 0.0 113.472 -177.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -145.43 28.03 1.21 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.184 1.394 . . . . 0.0 110.49 165.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.2 t -122.42 137.22 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 O-C-N 120.824 -1.172 . . . . 0.0 110.444 -177.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.4 t -84.8 135.81 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 177.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.1 mp -117.01 103.39 14.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 173.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -76.66 95.52 3.98 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 128.194 2.598 . . . . 0.0 106.765 171.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 14.8 mtm -94.45 95.8 1.58 Allowed Pre-proline 0 CA--C 1.55 0.966 0 CA-C-N 121.539 1.972 . . . . 0.0 106.54 172.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -67.99 172.25 11.13 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 CA-C-N 122.08 1.778 . . . . 0.0 109.488 171.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.471 ' ND2' ' H ' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -152.89 -71.99 0.14 Allowed 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 169.661 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.471 ' H ' ' ND2' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -132.33 17.27 4.47 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.0 1.32 . . . . 0.0 112.488 -176.794 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -89.89 1.13 56.58 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 122.994 0.518 . . . . 0.0 111.13 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 17.9 mt -89.76 89.56 7.83 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -132.68 22.07 4.27 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.499 1.12 . . . . 0.0 113.152 -166.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.255 0.2 OUTLIER 64.12 -43.27 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 129.188 2.995 . . . . 0.0 114.444 -172.795 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -61.39 -19.01 61.42 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 120.765 -1.209 . . . . 0.0 111.061 174.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -115.25 68.77 0.71 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 126.404 1.882 . . . . 0.0 108.288 174.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -132.34 -62.61 0.83 Allowed 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 167.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -59.05 -35.29 73.07 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.238 0.927 . . . . 0.0 110.306 174.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 36.0 mt -67.11 -28.88 68.52 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 124.244 1.017 . . . . 0.0 112.929 173.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -59.13 -57.75 11.69 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 124.62 1.168 . . . . 0.0 108.745 -172.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.496 ' HE2' ' CE2' ' A' ' 44' ' ' PHE . 3.9 ttpm? -54.24 -49.06 70.37 Favored 'General case' 0 C--O 1.216 -0.682 0 CA-C-O 116.684 -1.627 . . . . 0.0 110.216 172.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -43.99 85.67 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 120.667 1.576 . . . . 0.0 111.367 -176.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -67.81 -60.89 2.17 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-O 116.709 -1.615 . . . . 0.0 109.088 177.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.444 HG12 ' CD1' ' A' ' 48' ' ' LEU . 56.7 t -52.1 -38.7 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 121.538 1.972 . . . . 0.0 109.772 -178.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.496 ' CE2' ' HE2' ' A' ' 40' ' ' LYS . 8.0 m-30 -60.26 -69.03 0.24 Allowed 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 124.362 1.065 . . . . 0.0 110.687 176.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.21 -10.13 59.17 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -171.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -90.94 -31.37 16.4 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 116.048 -1.929 . . . . 0.0 110.284 173.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -134.54 -53.42 0.82 Allowed 'General case' 0 C--N 1.357 0.906 0 CA-C-N 122.804 2.547 . . . . 0.0 109.91 -174.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.444 ' CD1' HG12 ' A' ' 43' ' ' VAL . 6.6 mp -55.8 -59.59 4.65 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.818 0.818 . . . . 0.0 110.918 -174.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -75.45 -5.48 45.26 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 124.623 1.169 . . . . 0.0 112.268 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.7 mttm -75.59 -28.8 59.06 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.12 0.873 . . . . 0.0 110.274 163.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 125.0 -6.0 8.29 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 126.143 1.83 . . . . 0.0 112.688 -176.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -71.49 174.79 6.15 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 119.44 1.62 . . . . 0.0 108.928 175.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -172.09 5.72 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.184 1.794 . . . . 0.0 109.598 -169.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.81 112.49 12.54 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 104.889 -2.263 . . . . 0.0 104.889 -176.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mp -122.94 146.38 28.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 178.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.419 ' CZ ' HG21 ' A' ' 122' ' ' VAL . 17.1 m-85 -129.34 128.96 44.17 Favored 'General case' 0 C--O 1.228 -0.051 0 C-N-CA 123.958 0.903 . . . . 0.0 109.735 166.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 47.5 tp -95.16 121.48 36.85 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.296 1.039 . . . . 0.0 109.594 -178.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.4 ' HA ' ' HB ' ' A' ' 90' ' ' VAL . 0.8 OUTLIER -89.09 152.94 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 119.59 1.086 . . . . 0.0 111.402 177.902 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.0 0.8 3.21 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.115 0.966 . . . . 0.0 112.982 175.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.44 -8.19 1.7 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 169.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -116.68 -5.66 11.61 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.563 1.145 . . . . 0.0 111.83 -168.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.4 p -143.8 148.43 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 125.012 1.325 . . . . 0.0 107.47 -170.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -78.0 -46.98 19.53 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 176.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.8 p -155.12 168.2 27.82 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.6 tt -94.13 156.43 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 125.977 1.711 . . . . 0.0 108.178 162.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -111.44 174.57 5.8 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.551 -0.718 . . . . 0.0 110.358 -176.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.5 m -57.87 -39.92 78.98 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 121.412 -0.805 . . . . 0.0 112.241 -172.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -50.36 -53.13 31.36 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.255 1.422 . . . . 0.0 111.232 176.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 p -93.51 -20.75 19.97 Favored 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 121.683 -0.635 . . . . 0.0 112.026 -169.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 31.6 tp -56.97 -17.21 8.87 Favored 'General case' 0 CA--C 1.551 0.988 0 O-C-N 120.844 -1.16 . . . . 0.0 111.468 170.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -101.07 -8.51 47.53 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 125.046 1.308 . . . . 0.0 115.216 169.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -89.16 -38.88 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 119.608 1.704 . . . . 0.0 109.157 175.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.4 mm -58.42 -41.17 80.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 O-C-N 121.127 -0.983 . . . . 0.0 110.706 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 65.8 t -61.36 -42.77 94.94 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 CA-C-N 118.264 0.484 . . . . 0.0 110.212 174.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -63.67 -30.64 71.72 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 120.82 -1.175 . . . . 0.0 111.052 -176.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.9 mt -64.17 -40.06 87.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 171.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -67.84 -49.19 63.51 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 123.931 0.892 . . . . 0.0 109.172 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.3 mttm -48.72 -55.64 10.84 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 124.451 1.1 . . . . 0.0 110.418 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 69.2 m -78.41 -26.75 46.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 118.145 -0.931 . . . . 0.0 112.699 -172.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 25.2 mt -59.04 -44.89 92.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 119.85 1.204 . . . . 0.0 109.306 165.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.2 t -74.59 -18.44 60.57 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.34 1.056 . . . . 0.0 112.135 -176.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.1 m -77.89 -43.78 29.08 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.881 0.872 . . . . 0.0 110.279 166.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.0 m -64.38 -50.9 65.84 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 118.418 -0.801 . . . . 0.0 110.741 -176.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 134.2 23.13 0.69 Allowed Glycine 0 CA--C 1.521 0.426 0 CA-C-O 119.157 -0.801 . . . . 0.0 113.565 -175.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -115.82 -171.98 16.64 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 118.84 1.32 . . . . 0.0 111.81 -170.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.16 158.4 43.75 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.466 1.507 . . . . 0.0 110.201 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -150.5 142.2 23.66 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -144.07 173.22 11.91 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.318 1.447 . . . . 0.0 110.605 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.28 168.14 10.88 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.4 ' HB ' ' HA ' ' A' ' 58' ' ' VAL . 57.7 t -139.48 129.4 30.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 124.425 1.09 . . . . 0.0 108.153 -164.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.9 t 43.84 69.98 2.12 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 127.122 2.169 . . . . 0.0 110.555 -176.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -71.09 118.82 5.89 Favored 'Trans proline' 0 N--CA 1.445 -1.365 0 N-CA-C 107.597 -1.732 . . . . 0.0 107.597 173.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 49.1 p30 -67.33 165.5 16.26 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 122.863 1.316 . . . . 0.0 109.447 163.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -69.19 -24.49 64.05 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.892 -174.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -46.41 78.79 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 126.624 1.97 . . . . 0.0 110.256 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.6 t -77.93 -38.59 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-O 118.263 -0.875 . . . . 0.0 109.982 -178.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -51.25 -39.02 55.78 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 124.744 1.218 . . . . 0.0 110.045 177.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.7 -61.27 1.91 Allowed 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 125.69 1.596 . . . . 0.0 114.222 172.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 77.9 t -71.21 -47.92 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 C-N-CA 125.889 1.676 . . . . 0.0 107.339 -169.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.39 -21.53 60.05 Favored 'General case' 0 N--CA 1.438 -1.028 0 O-C-N 124.495 1.122 . . . . 0.0 108.6 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.4 m -82.47 -52.01 7.27 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 81.1 mt -57.94 -29.0 64.81 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.578 1.951 . . . . 0.0 113.495 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.9 t -111.53 -1.81 15.71 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.917 1.287 . . . . 0.0 111.205 -171.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 53.9 78.9 0.14 Allowed 'General case' 0 C--N 1.343 0.283 0 C-N-CA 127.181 2.192 . . . . 0.0 109.931 -176.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.19 -49.39 1.94 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 126.716 2.006 . . . . 0.0 108.064 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -67.17 -12.19 59.36 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.141 1.376 . . . . 0.0 112.465 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.1 mtp180 -90.22 -0.79 57.79 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.867 1.667 . . . . 0.0 111.433 176.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.6 mm -127.46 -45.21 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 125.623 1.569 . . . . 0.0 107.431 -165.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.2 t -99.21 155.08 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 174.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.45 164.78 25.65 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 121.524 -0.735 . . . . 0.0 109.832 170.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.45 141.83 23.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -145.1 164.91 29.8 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 125.981 1.712 . . . . 0.0 110.095 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -94.94 -54.59 3.4 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 46.7 p -106.96 157.56 17.69 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 118.778 0.717 . . . . 0.0 109.365 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 9.1 mm -58.65 -36.55 60.67 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 175.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 45.0 t -60.79 -41.59 95.9 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 118.933 -0.556 . . . . 0.0 110.654 -175.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -71.92 -21.49 61.61 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 124.163 0.915 . . . . 0.0 110.639 -176.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -79.53 -54.07 6.25 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 104.12 -2.548 . . . . 0.0 104.12 176.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.97 -59.3 3.19 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 125.518 1.527 . . . . 0.0 111.774 -160.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -75.61 -19.21 59.38 Favored 'General case' 0 CA--C 1.521 -0.172 0 O-C-N 123.926 0.766 . . . . 0.0 112.299 -176.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -88.09 -51.49 5.77 Favored 'General case' 0 CA--C 1.495 -1.14 0 CA-C-O 118.568 -0.729 . . . . 0.0 110.134 -172.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.419 HG21 ' CZ ' ' A' ' 56' ' ' PHE . 40.3 t -48.65 -39.44 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 126.439 1.896 . . . . 0.0 110.062 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -47.64 -43.11 25.76 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.545 1.138 . . . . 0.0 112.639 171.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -134.06 33.82 3.37 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.377 2.671 . . . . 0.0 112.752 -172.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.235 0 C-N-CA 126.708 2.003 . . . . 0.0 113.977 -160.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.9 mtt . . . . . 0 N--CA 1.473 0.692 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -85.29 178.58 50.63 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 176.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.4 t -159.38 105.06 1.66 Allowed 'General case' 0 C--O 1.235 0.338 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 160.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.1 t0 53.38 177.34 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 128.451 2.701 . . . . 0.0 113.147 -172.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 47.1 mttt -152.41 98.32 2.37 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 125.965 1.706 . . . . 0.0 107.722 165.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 36.0 mm -126.7 134.73 65.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 11.3 p80 -75.33 -44.74 43.71 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 119.047 -0.502 . . . . 0.0 111.293 175.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 36.76 78.63 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 128.495 2.718 . . . . 0.0 112.123 -173.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -59.15 116.9 4.17 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.0 p-80 -153.47 162.21 41.5 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.121 -1.436 . . . . 0.0 107.121 158.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -127.3 88.36 2.79 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 178.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -87.13 -165.5 1.31 Allowed 'General case' 0 C--O 1.241 0.643 0 C-N-CA 124.296 1.038 . . . . 0.0 109.517 -173.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.25 157.22 29.34 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.346 -0.846 . . . . 0.0 109.42 154.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -120.23 94.22 48.55 Favored Pre-proline 0 N--CA 1.448 -0.564 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 170.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -77.25 52.42 3.85 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.727 2.951 . . . . 0.0 109.817 174.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -168.34 174.18 7.18 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.356 1.063 . . . . 0.0 111.682 -179.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.531 ' HG2' ' H ' ' A' ' 18' ' ' ILE . 3.2 ttmm -136.56 173.17 11.99 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.222 2.209 . . . . 0.0 108.076 161.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.531 ' H ' ' HG2' ' A' ' 17' ' ' LYS . 54.2 mt -135.33 144.96 32.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 129.015 2.926 . . . . 0.0 104.223 163.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.1 m -105.76 -130.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 173.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -50.59 -66.87 0.31 Allowed 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 126.917 2.087 . . . . 0.0 111.263 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -144.48 11.87 1.5 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.825 2.05 . . . . 0.0 111.82 178.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.445 HG11 ' CE2' ' A' ' 56' ' ' PHE . 8.9 t -119.26 135.44 59.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -177.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.452 HG11 ' HA ' ' A' ' 55' ' ' ILE . 0.6 OUTLIER -81.55 150.39 4.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 C-N-CA 128.337 2.655 . . . . 0.0 111.798 174.26 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.1 mp -132.33 88.95 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 175.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.421 ' CD1' ' CH2' ' A' ' 42' ' ' TRP . 4.3 mm? -58.36 140.18 54.03 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 168.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 61.6 mtt -139.2 76.54 32.17 Favored Pre-proline 0 C--N 1.328 -0.339 0 C-N-CA 125.04 1.336 . . . . 0.0 108.483 176.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -75.49 68.02 6.22 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.574 2.183 . . . . 0.0 109.02 176.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.2 93.41 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.461 1.504 . . . . 0.0 107.861 176.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.25 -21.32 0.07 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 127.911 2.484 . . . . 0.0 114.8 -170.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.88 59.0 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 129.535 3.134 . . . . 0.0 113.837 -177.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 65.0 mt -127.98 23.41 6.13 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 119.516 -1.99 . . . . 0.0 112.21 175.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -53.3 150.21 6.51 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 164.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.7 mt -58.31 -37.95 66.21 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 CA-C-O 119.33 -0.367 . . . . 0.0 111.629 -174.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -68.33 -34.56 76.34 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 118.725 0.693 . . . . 0.0 109.343 -171.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -72.66 -43.72 62.78 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 171.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.41 -33.18 65.54 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.883 0.765 . . . . 0.0 111.626 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 25.5 t60 -70.06 -47.96 59.79 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 120.495 -1.378 . . . . 0.0 110.262 174.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.0 -17.34 61.46 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 118.968 -0.539 . . . . 0.0 111.727 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -48.83 -55.78 10.62 Favored 'General case' 0 CA--C 1.513 -0.442 0 C-N-CA 127.999 2.52 . . . . 0.0 110.513 -170.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp -66.48 -28.99 69.01 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 117.86 -1.067 . . . . 0.0 111.047 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.7 ttmt -68.26 -51.99 38.97 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 121.157 1.799 . . . . 0.0 109.211 172.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.421 ' CH2' ' CD1' ' A' ' 25' ' ' LEU . 13.7 t90 -59.91 -59.45 5.4 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.229 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.0 t -50.41 -30.04 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 120.262 1.392 . . . . 0.0 112.199 176.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -72.76 -69.84 0.39 Allowed 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 173.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -61.61 -35.86 79.06 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 124.289 1.036 . . . . 0.0 112.949 -167.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -75.69 -30.94 59.51 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.247 2.219 . . . . 0.0 111.284 175.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -132.02 -67.21 0.68 Allowed 'General case' 0 C--N 1.352 0.694 0 CA-C-N 120.682 1.583 . . . . 0.0 112.286 -174.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.5 mt -59.17 -48.76 80.41 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.372 0.987 . . . . 0.0 112.694 -170.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -65.56 -34.5 78.39 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 125.428 1.491 . . . . 0.0 109.726 177.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.9 mttm -61.38 -21.64 64.25 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.802 1.241 . . . . 0.0 111.811 171.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.6 14.68 36.94 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.329 0.966 . . . . 0.0 112.485 -178.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -70.38 139.14 51.85 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 118.931 1.365 . . . . 0.0 108.085 166.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -119.42 6.02 11.13 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.592 1.157 . . . . 0.0 110.292 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt -146.87 98.05 2.99 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 120.27 1.395 . . . . 0.0 107.254 -167.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.452 ' HA ' HG11 ' A' ' 23' ' ' VAL . 1.2 mp -102.81 151.92 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.445 ' CE2' HG11 ' A' ' 22' ' ' VAL . 22.4 m-85 -123.2 160.42 26.59 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.965 0.79 . . . . 0.0 111.908 157.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.6 tp -125.3 122.48 37.01 Favored 'General case' 0 C--O 1.223 -0.324 0 C-N-CA 124.887 1.275 . . . . 0.0 109.221 171.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.6 t -95.06 141.74 14.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 173.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.3 mp -123.57 6.46 8.9 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.011 1.324 . . . . 0.0 111.133 -174.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.4 t -54.66 -36.8 64.99 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.114 1.765 . . . . 0.0 111.737 174.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -104.76 18.71 21.79 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.113 0.965 . . . . 0.0 111.101 -165.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.4 p -151.18 122.84 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 123.551 0.74 . . . . 0.0 109.386 -175.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -73.24 -43.41 61.22 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 117.995 -1.003 . . . . 0.0 108.979 177.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.4 t -150.35 175.82 11.47 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 119.169 0.895 . . . . 0.0 111.962 -171.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.8 tt -140.91 149.85 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 -175.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -81.45 155.75 25.69 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 123.804 0.842 . . . . 0.0 109.743 -174.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.2 p -54.01 -25.8 22.98 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.068 1.347 . . . . 0.0 112.619 175.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -61.94 -63.24 1.32 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.366 1.466 . . . . 0.0 110.478 169.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 26.4 t -82.46 -22.95 34.99 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.591 1.157 . . . . 0.0 111.974 -163.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 40.8 tp -60.91 -16.66 44.63 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 120.549 -1.344 . . . . 0.0 111.609 170.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -91.85 -29.95 11.08 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-O 118.849 -0.973 . . . . 0.0 112.194 167.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -66.67 -37.23 79.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 119.551 1.676 . . . . 0.0 111.23 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.4 mm -59.68 -46.58 93.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 C-N-CA 124.6 1.16 . . . . 0.0 109.826 175.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 50.8 t -60.98 -41.51 89.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 174.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -55.96 -41.01 74.06 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.408 -0.807 . . . . 0.0 111.344 -176.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 71.1 mt -64.03 -39.75 86.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.719 0.808 . . . . 0.0 110.03 174.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.17 -49.25 76.58 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 119.705 1.139 . . . . 0.0 109.075 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -50.12 -55.53 14.63 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 123.475 0.71 . . . . 0.0 109.88 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.71 -39.9 95.45 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 117.569 -1.205 . . . . 0.0 112.365 -178.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 76.4 mt -64.32 -43.98 97.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 121.023 1.738 . . . . 0.0 109.85 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.3 m -56.8 -48.07 78.79 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.393 0.677 . . . . 0.0 110.899 172.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.4 m -71.77 -10.54 59.92 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.09 1.356 . . . . 0.0 113.935 178.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.2 m -99.7 -25.54 14.36 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.687 1.195 . . . . 0.0 111.94 175.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 120.19 2.61 12.22 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 116.435 1.334 . . . . 0.0 116.435 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -99.2 -158.83 29.17 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 119.682 1.741 . . . . 0.0 112.95 -171.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.496 ' CZ ' ' HE2' ' A' ' 125' ' ' LYS . 0.3 OUTLIER -139.93 160.11 40.67 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 127.0 2.12 . . . . 0.0 109.852 170.387 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -149.31 143.82 26.07 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 176.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.27 165.56 28.89 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.09 0.956 . . . . 0.0 112.157 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.2 mp -113.72 156.39 23.87 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.753 2.021 . . . . 0.0 108.983 -175.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 57.7 t -146.79 149.39 15.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 123.432 0.693 . . . . 0.0 109.934 -159.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.2 t 49.14 54.89 16.83 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 125.029 1.332 . . . . 0.0 111.412 -175.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -82.54 81.7 2.41 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 122.344 2.029 . . . . 0.0 111.69 -164.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.0 156.54 9.13 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 122.044 0.926 . . . . 0.0 110.545 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -62.93 -33.68 75.85 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.803 -1.09 . . . . 0.0 112.241 -163.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.8 -41.59 97.88 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 123.67 0.788 . . . . 0.0 109.264 -174.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.9 t -70.63 -42.37 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-O 117.514 -1.232 . . . . 0.0 110.236 175.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -58.82 -28.65 66.23 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 120.127 1.331 . . . . 0.0 110.804 -172.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -51.08 -60.46 3.07 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-O 125.028 2.347 . . . . 0.0 111.454 173.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.7 t -71.08 -39.01 73.86 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.747 0 CA-C-N 112.508 -2.133 . . . . 0.0 107.454 -172.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.2 mt -61.79 -15.62 42.98 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 118.234 -0.888 . . . . 0.0 110.481 177.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.5 -46.1 10.49 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-O 121.32 0.581 . . . . 0.0 110.164 173.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.73 -62.53 1.8 Allowed 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.703 2.001 . . . . 0.0 108.425 -177.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.0 -5.76 43.33 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 129.129 2.972 . . . . 0.0 111.07 -169.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 49.99 77.73 0.11 Allowed 'General case' 0 C--N 1.344 0.361 0 C-N-CA 127.45 2.3 . . . . 0.0 109.437 -168.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.44 -57.08 2.17 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 173.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -65.52 -12.44 52.82 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 127.427 2.291 . . . . 0.0 112.462 175.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.4 mtt-85 -88.96 2.89 53.19 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.082 0.953 . . . . 0.0 113.08 171.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.8 mt -133.15 -43.08 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 125.098 1.359 . . . . 0.0 109.238 -173.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.1 t -114.16 141.73 29.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 125.501 1.52 . . . . 0.0 106.941 -177.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.46 159.64 23.9 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.618 0.767 . . . . 0.0 112.21 177.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -123.28 154.93 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 125.65 1.58 . . . . 0.0 106.98 169.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -147.44 162.97 37.94 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.98 1.712 . . . . 0.0 109.569 170.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -81.35 -53.24 6.49 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 119.464 -0.895 . . . . 0.0 109.361 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 67.6 p -129.44 161.58 30.06 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 125.327 1.451 . . . . 0.0 108.502 -169.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 26.7 mm -63.79 -38.89 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -173.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.9 t -74.38 -19.97 60.24 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 118.863 -1.135 . . . . 0.0 111.487 -174.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -70.22 -20.46 63.09 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 118.965 0.802 . . . . 0.0 111.173 170.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -105.42 -39.83 6.01 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.997 0.919 . . . . 0.0 109.478 -169.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 5.0 ttm -58.36 -44.12 88.7 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 124.49 1.116 . . . . 0.0 111.972 -162.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -95.16 -10.49 30.39 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.347 1.059 . . . . 0.0 111.726 178.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -93.12 -50.67 5.4 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.041 -172.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -47.98 -37.43 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 125.73 1.612 . . . . 0.0 111.059 173.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -56.49 -32.78 65.35 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-O 118.494 -0.765 . . . . 0.0 111.684 176.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.73 29.42 2.35 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -175.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.496 ' HE2' ' CZ ' ' A' ' 86' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.175 0 C-N-CA 124.317 1.047 . . . . 0.0 110.059 -171.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.6 mtt . . . . . 0 N--CA 1.476 0.828 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 68.48 -166.99 44.88 Favored Glycine 0 CA--C 1.533 1.157 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -170.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.6 m -58.08 95.46 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.255 1.822 . . . . 0.0 113.814 -165.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.44 -43.98 84.37 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.693 1.597 . . . . 0.0 112.139 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.413 ' HA ' ' HE2' ' A' ' 5' ' ' LYS . 8.0 mmpt? 51.56 -170.66 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.426 1.091 . . . . 0.0 111.323 -164.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 37.5 pt -138.87 22.0 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 126.266 1.826 . . . . 0.0 109.88 -175.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -78.99 97.36 6.03 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.453 1.101 . . . . 0.0 108.077 178.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -57.63 111.36 1.1 Allowed 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.47 1.908 . . . . 0.0 109.427 -175.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -146.34 145.47 30.32 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.212 1.805 . . . . 0.0 106.897 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -148.4 171.3 16.25 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.045 0.938 . . . . 0.0 109.531 166.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -99.57 169.13 9.5 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 166.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -146.32 89.67 1.88 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 173.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -120.27 -165.47 1.19 Allowed 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.078 1.351 . . . . 0.0 108.183 169.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -53.3 108.13 1.03 Allowed Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 124.624 1.169 . . . . 0.0 109.934 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -85.68 -167.32 0.39 Allowed 'Trans proline' 0 N--CA 1.445 -1.34 0 C-N-CA 122.369 2.046 . . . . 0.0 110.15 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -48.94 156.48 0.5 Allowed 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 125.498 1.519 . . . . 0.0 114.186 170.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.523 ' HG2' ' H ' ' A' ' 18' ' ' ILE . 3.6 ttmm -122.44 170.85 9.56 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 126.411 1.885 . . . . 0.0 108.667 167.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.523 ' H ' ' HG2' ' A' ' 17' ' ' LYS . 42.7 mt -129.1 130.52 68.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 157.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.7 m -88.87 -141.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 125.311 1.444 . . . . 0.0 108.185 171.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -40.45 -78.38 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 127.585 2.354 . . . . 0.0 111.001 168.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -135.8 9.17 3.32 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 123.308 0.643 . . . . 0.0 111.87 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.7 t -106.25 135.16 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.2 t -84.98 147.52 5.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 171.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.8 mp -130.4 91.85 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 176.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -71.25 111.94 6.99 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 121.072 1.76 . . . . 0.0 108.983 171.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 4.1 mtt -106.11 91.39 5.46 Favored Pre-proline 0 CA--C 1.548 0.869 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.33 122.95 4.78 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.187 2.591 . . . . 0.0 111.499 -171.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.406 ' C ' ' HE2' ' A' ' 29' ' ' LYS . 0.4 OUTLIER -90.63 74.87 6.69 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 122.34 1.067 . . . . 0.0 111.746 175.959 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.406 ' HE2' ' C ' ' A' ' 28' ' ' ASN . 0.0 OUTLIER 55.72 16.9 2.16 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 119.891 -1.756 . . . . 0.0 113.137 -174.036 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -99.09 13.41 32.95 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 121.421 -0.799 . . . . 0.0 112.546 -161.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.95 72.25 6.7 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 171.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -92.35 148.5 22.07 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 169.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -58.65 -34.45 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 120.345 1.43 . . . . 0.0 109.617 -177.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -64.47 -12.14 40.73 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 120.202 -1.561 . . . . 0.0 112.949 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -110.36 -26.71 9.42 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.452 1.501 . . . . 0.0 112.074 168.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.53 -37.57 80.12 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.099 -1.001 . . . . 0.0 111.194 178.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -55.49 -47.65 75.83 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.003 0.921 . . . . 0.0 109.368 168.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 73.0 mt -70.02 -24.01 63.21 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-O 118.081 -0.961 . . . . 0.0 112.496 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -55.43 -38.25 68.74 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.805 1.242 . . . . 0.0 112.151 -162.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -56.87 -65.3 0.64 Allowed 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 118.384 -0.817 . . . . 0.0 109.107 167.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.2 tmtt? -50.74 -47.16 59.43 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 124.199 1.0 . . . . 0.0 111.029 -175.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -61.67 -67.5 0.4 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.809 1.244 . . . . 0.0 109.657 176.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 54.2 t -53.79 -33.22 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 121.411 1.914 . . . . 0.0 111.867 -176.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -60.56 -75.17 0.07 Allowed 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 124.769 1.228 . . . . 0.0 109.581 171.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -70.75 -14.15 62.33 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.886 1.675 . . . . 0.0 113.871 -169.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.88 -33.43 16.46 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 120.739 -1.226 . . . . 0.0 109.865 175.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -136.67 -60.68 0.7 Allowed 'General case' 0 C--N 1.346 0.439 0 CA-C-N 118.86 0.754 . . . . 0.0 111.921 -169.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.1 mt -60.19 -55.93 27.72 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.463 1.029 . . . . 0.0 112.673 -173.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -66.41 -9.62 35.6 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.595 1.158 . . . . 0.0 110.973 174.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.13 -2.77 58.67 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.656 1.982 . . . . 0.0 111.81 171.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.85 5.45 59.82 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.913 1.244 . . . . 0.0 114.204 177.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -77.48 146.72 36.28 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 119.745 1.772 . . . . 0.0 110.017 176.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -138.45 14.48 2.77 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.525 1.93 . . . . 0.0 110.027 -172.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -149.74 116.7 5.95 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 178.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.7 mp -120.8 152.7 23.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 175.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -124.18 158.07 33.26 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.603 1.161 . . . . 0.0 110.082 161.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 54.2 tp -118.09 122.97 44.45 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.963 1.705 . . . . 0.0 107.422 173.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . 0.252 0.7 OUTLIER -95.09 157.48 3.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 119.921 1.237 . . . . 0.0 109.927 174.349 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 24.3 mt -132.24 13.69 4.64 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.226 0.611 . . . . 0.0 111.359 -168.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.1 m -81.53 -46.48 14.43 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -173.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -88.2 -23.12 23.67 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.454 1.025 . . . . 0.0 110.7 -173.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.0 p -78.74 162.66 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 125.538 1.535 . . . . 0.0 109.776 169.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -116.99 -37.51 3.57 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.443 0.697 . . . . 0.0 110.516 170.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.87 176.07 13.04 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 122.438 1.113 . . . . 0.0 110.123 177.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.4 tt -132.6 160.0 42.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 127.361 2.264 . . . . 0.0 108.05 -172.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.454 ' C ' ' H ' ' A' ' 68' ' ' PHE . 35.6 t0 -96.24 168.79 10.37 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 119.625 -1.922 . . . . 0.0 109.79 -168.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.5 m -65.25 31.26 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 128.954 2.902 . . . . 0.0 112.052 165.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.454 ' H ' ' C ' ' A' ' 66' ' ' ASP . 43.5 t80 -132.08 -67.72 0.66 Allowed 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 172.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.28 -25.01 61.43 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.443 -166.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 33.1 tp -55.3 -33.09 62.96 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 120.601 -1.312 . . . . 0.0 110.95 171.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -95.32 1.99 65.0 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 125.111 1.339 . . . . 0.0 114.709 174.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -92.63 -32.79 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 120.181 1.991 . . . . 0.0 109.544 167.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -56.69 -53.02 46.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.339 1.056 . . . . 0.0 109.13 177.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.0 t -59.33 -39.95 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 O-C-N 121.515 -0.741 . . . . 0.0 110.374 176.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -54.94 -38.68 68.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 119.207 0.912 . . . . 0.0 112.231 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 80.5 mt -69.61 -34.21 60.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -63.43 -50.33 70.22 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 119.846 1.203 . . . . 0.0 109.278 175.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -53.31 -48.13 68.67 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.056 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.4 t -58.09 -61.38 2.59 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.395 1.878 . . . . 0.0 111.264 176.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 59.7 mt -54.84 -45.87 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 119.646 1.112 . . . . 0.0 110.798 -177.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.3 t -61.88 -41.04 97.4 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.44 -23.71 65.55 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.133 0.973 . . . . 0.0 113.348 173.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.0 m -79.0 -25.4 43.32 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 118.02 -0.99 . . . . 0.0 112.388 171.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 103.67 15.78 21.69 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.5 -1.167 . . . . 0.0 113.954 -170.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -98.08 -168.28 31.86 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 120.322 2.061 . . . . 0.0 112.586 174.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -133.51 162.65 31.3 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.031 1.333 . . . . 0.0 108.501 168.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -147.88 147.1 29.39 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.298 1.039 . . . . 0.0 108.222 176.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -152.21 172.64 16.08 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.089 1.356 . . . . 0.0 110.72 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.15 171.47 7.79 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 118.588 0.631 . . . . 0.0 109.831 -178.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 86.1 t -146.69 144.06 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.821 1.248 . . . . 0.0 109.83 -168.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 44.09 60.07 12.22 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 127.815 2.446 . . . . 0.0 113.942 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -84.51 92.56 0.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 124.545 3.496 . . . . 0.0 110.141 -170.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.65 160.32 14.31 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 121.848 -0.532 . . . . 0.0 110.269 177.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -63.74 -34.89 78.89 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.779 0.832 . . . . 0.0 111.167 -167.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.446 ' HE2' ' O ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -59.34 -29.99 68.06 Favored 'General case' 0 CA--C 1.517 -0.321 0 O-C-N 121.006 -1.059 . . . . 0.0 109.439 178.903 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.2 t -92.57 -37.48 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-O 117.911 -1.042 . . . . 0.0 110.283 177.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -59.55 -33.31 71.25 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 121.806 2.094 . . . . 0.0 109.723 175.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.64 -27.33 67.6 Favored 'General case' 0 C--O 1.222 -0.349 0 O-C-N 121.234 -0.916 . . . . 0.0 112.463 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.3 p -95.39 -39.65 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -178.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.41 -15.66 18.34 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.075 1.75 . . . . 0.0 111.955 177.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.0 t -93.51 -52.85 4.3 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -53.75 -44.81 70.28 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 128.472 2.709 . . . . 0.0 111.805 -177.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 10.1 t -79.52 -17.42 54.1 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 118.843 -0.598 . . . . 0.0 111.299 -178.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.2 m120 63.67 94.21 0.05 Allowed 'General case' 0 C--N 1.34 0.153 0 C-N-CA 127.098 2.159 . . . . 0.0 108.253 -157.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.98 -57.01 1.26 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.502 1.521 . . . . 0.0 108.575 170.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -57.33 -32.56 66.83 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 122.478 1.132 . . . . 0.0 111.098 171.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 60.6 mtt180 -71.36 -1.68 13.79 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 120.499 -1.376 . . . . 0.0 111.922 178.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.7 mt -122.62 -39.06 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 125.874 1.67 . . . . 0.0 108.714 -175.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.4 t -125.7 144.77 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 124.861 1.264 . . . . 0.0 108.775 -175.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.75 160.32 28.4 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.594 0.757 . . . . 0.0 111.328 176.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.94 142.17 34.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -173.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -146.82 176.18 10.07 Favored 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 125.189 1.396 . . . . 0.0 110.98 -176.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -103.56 -43.14 5.46 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 118.365 0.53 . . . . 0.0 111.797 -175.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 30.6 p -109.22 -162.4 0.81 Allowed 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -176.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 27.1 mm -92.01 -39.89 11.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 117.371 -1.299 . . . . 0.0 111.322 160.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.0 t -68.76 -34.77 76.14 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 120.916 1.689 . . . . 0.0 111.052 -168.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -69.06 -15.73 63.52 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 118.934 0.788 . . . . 0.0 111.696 176.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -91.12 -54.24 4.03 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 176.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 6.6 ttm -54.0 -39.48 66.12 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 124.84 1.256 . . . . 0.0 112.001 -163.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -93.49 -10.61 34.34 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.985 0.914 . . . . 0.0 113.392 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -92.24 -58.24 2.45 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 118.35 -0.833 . . . . 0.0 108.775 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.1 t -41.62 -44.39 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 128.456 2.702 . . . . 0.0 110.824 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . 0.251 1.5 ptp180 -53.12 -26.13 15.59 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.09 41.64 0.44 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 127.852 2.461 . . . . 0.0 111.371 -178.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.929 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 172.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.1 mtt . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 87.11 -98.9 2.42 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 106.211 -2.755 . . . . 0.0 106.211 -151.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.1 m 63.34 166.74 0.13 Allowed 'General case' 0 C--O 1.233 0.201 0 C-N-CA 126.948 2.099 . . . . 0.0 113.575 -173.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.82 162.57 0.41 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.134 1.774 . . . . 0.0 110.575 156.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? 58.34 15.78 3.65 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.38 1.472 . . . . 0.0 114.012 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.1 tt -47.97 -36.5 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -165.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -138.5 -84.75 0.28 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-N 119.878 1.217 . . . . 0.0 109.134 170.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -139.21 -172.96 3.46 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.633 1.973 . . . . 0.0 106.891 -178.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -132.42 154.02 50.24 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.169 0.988 . . . . 0.0 108.556 173.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -141.49 152.63 44.34 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.093 1.757 . . . . 0.0 106.478 175.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 50.53 76.46 0.15 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.842 1.657 . . . . 0.0 111.184 -172.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -135.99 122.75 21.12 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 173.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -117.48 95.28 4.89 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 105.809 -1.922 . . . . 0.0 105.809 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -55.06 168.26 0.55 Allowed Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 128.345 2.658 . . . . 0.0 111.714 -176.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.35 98.06 0.38 Allowed 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.135 1.89 . . . . 0.0 110.502 169.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -145.84 167.08 24.09 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.993 1.317 . . . . 0.0 110.188 176.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt -131.97 171.01 14.11 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.733 0.813 . . . . 0.0 110.942 174.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.3 mt -129.61 110.55 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 104.651 -2.351 . . . . 0.0 104.651 176.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.4 m -93.38 -134.93 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 119.562 1.074 . . . . 0.0 109.172 176.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -45.83 -78.72 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 127.827 2.451 . . . . 0.0 111.785 172.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -137.76 15.3 2.9 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.281 1.832 . . . . 0.0 109.678 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.9 t -121.6 133.55 67.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -168.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 74.6 t -92.22 131.22 39.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.9 mp -112.48 103.63 15.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 176.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.7 137.35 45.92 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 161.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 13.8 mtt -139.96 79.98 21.62 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.57 -98.81 0.01 OUTLIER 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 121.452 1.435 . . . . 0.0 111.508 -170.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.51 ' CG ' ' H ' ' A' ' 29' ' ' LYS . 18.8 p-10 155.82 -106.18 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 O-C-N 119.38 -2.075 . . . . 0.0 107.688 -163.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.51 ' H ' ' CG ' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -126.94 25.68 6.25 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.205 1.802 . . . . 0.0 108.888 167.25 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -63.19 -16.99 61.9 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.869 1.268 . . . . 0.0 111.711 170.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.6 mp -74.09 67.96 1.37 Allowed 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 169.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -124.59 7.44 8.24 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.775 2.03 . . . . 0.0 113.312 -175.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 94.87 -24.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.563 1 C-N-CA 135.457 5.503 . . . . 0.0 110.113 -176.438 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -71.94 -18.69 61.99 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 120.871 -1.143 . . . . 0.0 111.778 -175.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -98.98 -31.21 11.92 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 173.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.15 -41.74 94.46 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 113.647 0.981 . . . . 0.0 113.647 -159.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -64.3 -43.79 93.66 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.981 1.264 . . . . 0.0 110.146 -177.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.01 -22.33 49.46 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.593 -178.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -41.86 -54.27 3.47 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 127.585 2.354 . . . . 0.0 111.972 -171.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.2 pttt -68.99 -41.22 78.14 Favored 'General case' 0 C--O 1.217 -0.609 0 CA-C-O 118.15 -0.929 . . . . 0.0 111.273 -178.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.72 -44.04 90.3 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 120.31 1.414 . . . . 0.0 110.939 178.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 7.1 t90 -58.13 -66.14 0.53 Allowed 'General case' 0 C--O 1.223 -0.341 0 CA-C-O 117.364 -1.303 . . . . 0.0 108.515 171.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 51.3 t -49.44 -38.28 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 120.049 1.295 . . . . 0.0 112.282 -176.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -60.73 -62.68 1.69 Allowed 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 125.106 1.362 . . . . 0.0 109.294 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -70.61 -44.16 67.83 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 118.852 0.751 . . . . 0.0 111.218 -174.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -61.07 -33.95 74.14 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.914 1.285 . . . . 0.0 110.523 -174.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -136.41 -52.56 0.72 Allowed 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -171.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 39.3 mt -63.46 -37.93 89.18 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.207 0.912 . . . . 0.0 111.075 -173.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -84.67 -9.39 58.3 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.158 1.383 . . . . 0.0 110.549 176.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.3 mttt -82.38 3.83 26.41 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.614 1.566 . . . . 0.0 111.148 156.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.95 4.33 88.52 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 125.374 1.464 . . . . 0.0 114.344 176.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -68.89 112.23 5.43 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 119.541 1.671 . . . . 0.0 109.303 176.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 -107.63 16.65 23.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.889 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.48 126.05 32.09 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 121.106 -0.996 . . . . 0.0 108.743 164.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 mt -128.44 160.19 38.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 126.303 1.841 . . . . 0.0 106.64 172.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -132.42 159.22 39.92 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.016 1.326 . . . . 0.0 111.351 161.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 56.2 tp -127.86 87.19 2.57 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.227 0.611 . . . . 0.0 109.418 171.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.43 HG11 ' H ' ' A' ' 60' ' ' SER . 91.2 t -52.1 151.8 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 126.163 1.785 . . . . 0.0 108.326 167.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.6 mt -135.68 18.68 3.3 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.619 1.968 . . . . 0.0 110.292 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.493 ' HG ' ' CB ' ' A' ' 91' ' ' SER . 67.3 m -54.1 -54.11 43.95 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 125.071 1.348 . . . . 0.0 111.281 -169.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -97.41 9.61 41.89 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 123.338 0.655 . . . . 0.0 111.339 175.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 17.6 t -98.62 100.56 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 104.312 -2.477 . . . . 0.0 104.312 -176.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -57.82 -49.87 75.19 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.6 t -152.88 164.42 37.92 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 123.1 1.429 . . . . 0.0 112.861 -175.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.4 tt -95.06 -162.77 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 126.877 2.071 . . . . 0.0 106.838 161.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -143.21 166.67 24.06 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.244 1.417 . . . . 0.0 109.737 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.6 t -53.03 -32.73 48.32 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.14 1.776 . . . . 0.0 112.171 176.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -66.14 -60.12 3.11 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 119.376 0.989 . . . . 0.0 109.697 173.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.05 -19.37 47.75 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -163.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 18.7 mt -55.21 -32.66 62.43 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.405 -0.809 . . . . 0.0 110.766 169.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -69.35 -44.23 66.26 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-O 118.832 -0.982 . . . . 0.0 111.474 170.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.57 -32.88 51.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 119.213 1.506 . . . . 0.0 110.759 -169.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -58.51 -53.18 50.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 125.069 1.348 . . . . 0.0 109.391 175.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 38.2 t -60.98 -38.76 80.16 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.618 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 173.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.1 -38.02 81.72 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 120.278 -1.514 . . . . 0.0 112.073 -176.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 70.6 mt -67.43 -36.19 75.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.288 1.035 . . . . 0.0 110.073 172.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.483 ' C ' ' H ' ' A' ' 79' ' ' SER . 20.0 tp -60.81 -50.5 73.2 Favored 'General case' 0 C--O 1.219 -0.544 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 175.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 44.2 mttt -62.35 4.48 0.14 Allowed 'General case' 0 C--O 1.234 0.257 0 C-N-CA 126.409 1.884 . . . . 0.0 114.316 178.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.483 ' H ' ' C ' ' A' ' 77' ' ' LEU . 3.5 t -103.99 -58.8 1.82 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 167.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 78.3 mt -55.59 -35.82 39.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 125.305 1.442 . . . . 0.0 111.319 -179.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.2 p -53.88 -58.35 7.59 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 126.048 1.739 . . . . 0.0 108.688 -177.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.7 t -61.93 -39.86 93.53 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 127.968 2.507 . . . . 0.0 110.899 -178.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.1 -23.47 67.16 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 175.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.29 17.58 49.63 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-O 118.637 -1.091 . . . . 0.0 112.933 -174.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -89.8 -173.78 45.49 Favored Glycine 0 N--CA 1.438 -1.195 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 172.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -131.75 148.98 52.61 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 125.547 1.539 . . . . 0.0 109.539 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -143.96 149.96 37.58 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.27 1.028 . . . . 0.0 108.425 176.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -154.18 168.4 26.67 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.972 0.909 . . . . 0.0 111.77 177.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.5 mt -113.47 171.74 7.38 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 177.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.401 ' CG2' HG21 ' A' ' 58' ' ' VAL . 0.5 OUTLIER -152.43 146.65 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 C-N-CA 123.898 0.879 . . . . 0.0 110.227 -166.327 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.493 ' CB ' ' HG ' ' A' ' 60' ' ' SER . 4.7 t 43.92 54.11 11.1 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 126.122 1.769 . . . . 0.0 110.264 177.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -61.89 -30.96 84.63 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.976 2.451 . . . . 0.0 112.335 -169.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 63.14 165.58 0.12 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 123.962 1.839 . . . . 0.0 110.755 -161.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -54.36 -33.98 60.2 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 112.343 -2.208 . . . . 0.0 110.666 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.63 -41.58 21.26 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 124.439 1.096 . . . . 0.0 112.067 -158.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.9 m -75.06 -44.33 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.732 0 CA-C-O 118.085 -0.96 . . . . 0.0 110.483 171.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.87 -29.76 63.24 Favored 'General case' 0 N--CA 1.461 0.09 0 C-N-CA 124.334 1.054 . . . . 0.0 108.79 -170.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.34 -62.74 1.14 Allowed 'General case' 0 N--CA 1.428 -1.555 0 C-N-CA 126.153 1.781 . . . . 0.0 112.342 168.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.7 t -72.66 -39.89 61.27 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 CA-C-N 112.365 -2.198 . . . . 0.0 108.295 -173.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.67 -17.51 23.11 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.755 1.222 . . . . 0.0 109.236 177.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.5 -1.89 43.11 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-O 121.607 0.718 . . . . 0.0 112.467 179.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.8 mt -119.45 -42.78 2.63 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 127.187 2.195 . . . . 0.0 109.854 -174.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.1 t -87.23 0.16 55.78 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.978 2.511 . . . . 0.0 111.341 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 42.94 84.35 0.02 OUTLIER 'General case' 0 C--N 1.344 0.351 0 C-N-CA 126.949 2.1 . . . . 0.0 111.808 -168.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.73 -64.41 1.32 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.937 1.295 . . . . 0.0 108.704 170.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -58.9 -29.03 66.75 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.537 0.735 . . . . 0.0 110.483 172.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 26.3 mtp180 -69.12 1.31 3.7 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.903 -1.123 . . . . 0.0 112.147 176.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.8 mt -130.35 -38.77 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 126.696 1.999 . . . . 0.0 109.663 -176.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.2 t -122.09 153.14 26.33 Favored 'Isoleucine or valine' 0 C--N 1.342 0.242 0 C-N-CA 125.299 1.44 . . . . 0.0 110.149 -169.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.43 155.49 35.3 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.236 1.014 . . . . 0.0 112.511 173.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -147.22 147.78 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 126.43 1.892 . . . . 0.0 107.478 -178.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -144.14 169.89 17.0 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.195 1.398 . . . . 0.0 111.571 -175.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -86.65 -37.7 17.77 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 175.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.3 p -137.3 175.91 9.19 Favored 'General case' 0 C--N 1.334 -0.079 0 C-N-CA 124.168 0.987 . . . . 0.0 111.145 -168.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 10.7 mm -72.74 -40.08 60.81 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 CA-C-O 118.479 -0.772 . . . . 0.0 109.918 176.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.3 t -73.2 -32.33 64.73 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 119.294 0.952 . . . . 0.0 109.965 -171.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -66.65 -10.08 42.47 Favored 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 123.436 0.694 . . . . 0.0 112.036 170.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -102.91 -47.62 4.32 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 -178.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -58.08 -54.39 47.47 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 126.565 1.946 . . . . 0.0 113.676 -160.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -87.47 -12.34 46.3 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.01 1.724 . . . . 0.0 111.25 179.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -91.78 -53.3 4.35 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 124.596 1.158 . . . . 0.0 107.941 -166.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -55.06 -23.73 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 128.649 2.78 . . . . 0.0 112.785 176.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 78.8 mtt180 -59.66 -28.48 67.29 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 118.46 -0.781 . . . . 0.0 111.718 169.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.34 26.22 3.81 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 126.5 1.92 . . . . 0.0 115.009 -176.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.6 mmtm . . . . . 0 C--O 1.249 1.069 0 C-N-CA 126.236 1.814 . . . . 0.0 106.724 -176.901 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.2 mtp . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -62.67 171.37 11.38 Favored Glycine 0 CA--C 1.535 1.301 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 145.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.9 p -150.13 121.04 7.63 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.443 1.097 . . . . 0.0 108.574 -171.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -101.13 -61.66 1.34 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.054 1.742 . . . . 0.0 109.566 173.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.3 ptmm? 43.76 166.21 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 129.423 3.089 . . . . 0.0 114.003 -153.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.0 tp -143.71 152.48 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 171.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -136.71 -64.45 0.58 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.161 0.984 . . . . 0.0 108.588 -175.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 61.78 158.73 0.05 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.427 1.891 . . . . 0.0 112.36 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.07 110.95 5.44 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 171.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 26.3 m170 -133.17 172.67 12.35 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 125.802 1.641 . . . . 0.0 108.318 168.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.408 ' HB2' ' CZ ' ' A' ' 14' ' ' PHE . 2.4 p-80 -156.16 -41.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 126.253 1.821 . . . . 0.0 110.973 174.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 44.7 m-70 58.92 -71.15 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 127.513 2.325 . . . . 0.0 113.084 -174.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.8 mtt -155.39 166.64 32.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 120.573 1.533 . . . . 0.0 108.276 173.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.408 ' CZ ' ' HB2' ' A' ' 11' ' ' HIS . 23.2 m-85 -129.95 86.19 55.46 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 123.459 0.703 . . . . 0.0 109.19 -176.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -77.89 51.68 3.71 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 124.461 3.441 . . . . 0.0 110.769 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -163.95 177.31 8.63 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 120.486 -1.384 . . . . 0.0 108.877 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -141.85 175.96 9.31 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.437 1.495 . . . . 0.0 108.503 156.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.2 mt -127.77 138.22 55.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 167.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.0 m -114.08 -156.74 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 C-N-CA 126.356 1.862 . . . . 0.0 107.727 168.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -42.21 -63.02 0.81 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 120.978 1.717 . . . . 0.0 114.641 -162.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -133.82 19.23 3.84 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.689 1.596 . . . . 0.0 110.973 170.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.443 HG13 ' CE2' ' A' ' 56' ' ' PHE . 4.2 t -132.59 119.07 37.14 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 123.137 1.446 . . . . 0.0 109.924 -168.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.44 ' CG1' HD13 ' A' ' 55' ' ' ILE . 0.6 OUTLIER -67.06 150.3 11.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 127.425 2.29 . . . . 0.0 112.383 169.156 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.4 mm -135.68 96.38 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 174.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.452 ' CD1' ' CH2' ' A' ' 42' ' ' TRP . 4.3 mm? -59.99 132.24 53.32 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 164.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 24.8 mmm -127.79 81.32 70.5 Favored Pre-proline 0 C--O 1.234 0.245 0 C-N-CA 126.111 1.764 . . . . 0.0 106.91 178.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -61.69 143.8 96.76 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 122.267 1.978 . . . . 0.0 109.053 170.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.02 -83.11 0.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 179.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.74 1.53 14.18 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.286 1.034 . . . . 0.0 112.035 172.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -67.62 -34.78 77.66 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -171.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.6 tp -73.22 -81.28 0.06 Allowed 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -153.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 34.24 41.38 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 130.062 3.345 . . . . 0.0 114.361 154.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER 61.31 -31.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 130.54 3.536 . . . . 0.0 115.416 -170.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -54.12 -34.65 60.82 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.505 1.122 . . . . 0.0 112.332 -175.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -122.4 60.37 1.0 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -173.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.45 -65.87 1.14 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 118.769 -0.634 . . . . 0.0 111.512 -177.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -60.32 -28.38 68.09 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.073 1.306 . . . . 0.0 111.887 173.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.95 -31.15 44.97 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 117.65 -1.167 . . . . 0.0 110.206 176.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -45.37 -52.66 9.65 Favored 'General case' 0 CA--C 1.508 -0.649 0 O-C-N 124.362 1.039 . . . . 0.0 110.033 178.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.39 -45.98 90.7 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 117.544 -1.217 . . . . 0.0 110.027 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -61.4 -46.95 88.02 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 119.94 1.245 . . . . 0.0 111.38 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.452 ' CH2' ' CD1' ' A' ' 25' ' ' LEU . 15.7 t90 -62.86 -60.79 3.0 Favored 'General case' 0 C--O 1.215 -0.715 0 CA-C-O 117.436 -1.269 . . . . 0.0 108.796 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.7 t -54.16 -30.0 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 CA-C-N 121.468 1.94 . . . . 0.0 111.706 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -66.61 -65.49 0.67 Allowed 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 120.723 -1.236 . . . . 0.0 110.481 170.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -66.63 -37.4 84.77 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.353 1.461 . . . . 0.0 111.781 -171.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -73.14 -31.86 64.54 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 127.941 2.496 . . . . 0.0 111.996 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -129.38 -58.1 1.13 Allowed 'General case' 0 C--N 1.343 0.322 0 CA-C-N 119.596 1.089 . . . . 0.0 111.605 -171.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.0 mt -64.97 -31.54 72.83 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 121.674 -0.641 . . . . 0.0 111.986 -175.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -80.44 -19.44 46.1 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 118.405 -0.807 . . . . 0.0 111.031 176.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.06 -5.22 55.47 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 127.073 2.149 . . . . 0.0 114.128 167.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.03 6.26 79.37 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-O 118.68 -1.067 . . . . 0.0 114.38 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -66.02 143.18 57.52 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 119.29 1.545 . . . . 0.0 109.861 175.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.56 22.99 3.16 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.579 1.551 . . . . 0.0 109.059 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -151.84 98.82 2.51 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 174.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.44 HD13 ' CG1' ' A' ' 23' ' ' VAL . 1.3 mp -96.25 152.64 3.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 172.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.443 ' CE2' HG13 ' A' ' 22' ' ' VAL . 12.0 m-30 -125.68 164.35 20.8 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.704 -0.798 . . . . 0.0 112.524 162.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 21.9 tp -129.11 129.1 44.77 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 124.174 0.989 . . . . 0.0 109.364 167.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.8 t -99.91 139.99 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 167.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.8 mp -120.64 54.04 1.08 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.437 1.017 . . . . 0.0 110.122 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 26.0 t -109.16 -47.32 3.44 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.879 1.272 . . . . 0.0 110.77 -168.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -72.84 -49.93 27.2 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 1.8 p -68.95 141.58 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 124.581 1.153 . . . . 0.0 109.111 171.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -79.0 -36.81 40.62 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 119.153 -0.451 . . . . 0.0 110.009 167.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.498 ' CB ' ' HE2' ' A' ' 95' ' ' LYS . 10.7 t -165.36 159.73 17.43 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 122.706 1.241 . . . . 0.0 113.168 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.0 tt -79.57 169.94 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 C-N-CA 128.257 2.623 . . . . 0.0 109.219 166.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.0 164.14 12.68 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.124 1.37 . . . . 0.0 109.809 177.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 95.2 p -63.24 -24.22 67.78 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -175.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -60.56 -72.01 0.12 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.799 0.84 . . . . 0.0 108.858 171.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.0 t -70.76 -15.18 62.66 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -173.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.7 mt -46.27 -37.49 7.36 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.699 1.136 . . . . 0.0 110.844 169.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.61 -22.18 51.32 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 123.136 0.398 . . . . 0.0 113.971 -178.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 52.9 t -79.12 -35.45 17.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.515 1.126 . . . . 0.0 109.181 177.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 16.7 mm -56.53 -47.45 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 123.499 0.72 . . . . 0.0 110.667 174.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.9 t -62.43 -40.44 88.06 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.266 0 O-C-N 121.558 -0.714 . . . . 0.0 109.739 176.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -52.02 -46.85 65.13 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.466 1.03 . . . . 0.0 112.309 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.3 mt -56.65 -41.32 73.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.374 1.47 . . . . 0.0 110.097 175.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -66.67 -46.87 74.26 Favored 'General case' 0 CA--C 1.52 -0.209 0 O-C-N 121.494 -0.754 . . . . 0.0 109.621 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -55.72 -50.86 69.2 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 118.757 -0.64 . . . . 0.0 110.472 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 33.1 t -53.14 -52.05 59.97 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 124.845 1.34 . . . . 0.0 109.214 178.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 21.6 mt -63.29 -46.9 94.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 C-N-CA 123.467 0.707 . . . . 0.0 110.69 -174.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -51.45 -55.36 19.23 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.798 0.839 . . . . 0.0 110.461 171.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.6 m -65.3 -17.48 64.54 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.227 1.011 . . . . 0.0 113.504 -178.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.5 m -83.84 -47.26 11.28 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.789 0.836 . . . . 0.0 110.915 178.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 133.32 -1.0 4.42 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 118.295 -1.28 . . . . 0.0 113.75 -166.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -101.73 -169.41 27.56 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-N 120.208 2.004 . . . . 0.0 112.509 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.578 ' CZ ' ' HE2' ' A' ' 125' ' ' LYS . 0.1 OUTLIER -135.41 165.71 24.85 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 126.869 2.068 . . . . 0.0 110.8 171.615 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -155.25 141.76 18.75 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 177.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.79 168.6 23.93 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.268 0.627 . . . . 0.0 112.186 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 mt -116.16 164.17 14.88 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.502 1.121 . . . . 0.0 109.438 -171.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 79.6 t -146.13 154.87 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 126.049 1.74 . . . . 0.0 109.998 -169.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 t 46.93 58.4 17.07 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 127.772 2.429 . . . . 0.0 112.15 173.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -76.73 97.31 1.13 Allowed 'Trans proline' 0 N--CA 1.445 -1.363 0 C-N-CA 122.148 1.898 . . . . 0.0 111.23 -177.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.43 158.73 5.4 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 119.251 -0.98 . . . . 0.0 109.723 162.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -69.65 -29.45 66.92 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.339 1.056 . . . . 0.0 111.834 -167.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.498 ' HE2' ' CB ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -56.99 -51.93 67.29 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -173.177 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -78.76 -41.03 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 124.057 0.848 . . . . 0.0 110.286 -173.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.97 -33.65 18.45 Favored 'General case' 0 CA--C 1.503 -0.827 0 C-N-CA 124.456 1.103 . . . . 0.0 110.836 175.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -53.98 47.13 Favored 'General case' 0 N--CA 1.417 -2.121 0 CA-C-O 123.368 1.556 . . . . 0.0 113.107 178.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.0 t -69.69 -43.52 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.832 0 CA-C-N 111.346 -2.661 . . . . 0.0 106.58 -172.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.36 -28.87 56.76 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.933 1.293 . . . . 0.0 108.755 175.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.7 m -92.01 4.09 53.81 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.374 1.47 . . . . 0.0 112.729 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 94.1 mt -125.06 -20.76 4.83 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 127.752 2.421 . . . . 0.0 111.769 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.2 t -111.69 2.24 17.12 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.751 1.62 . . . . 0.0 112.029 -174.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 54.17 87.73 0.04 OUTLIER 'General case' 0 C--N 1.342 0.247 0 C-N-CA 126.541 1.936 . . . . 0.0 109.887 -172.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.73 -57.2 1.45 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 118.544 -0.741 . . . . 0.0 109.702 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.85 -35.29 44.18 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 123.302 1.525 . . . . 0.0 110.585 164.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -72.05 -1.68 15.62 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 120.834 -1.167 . . . . 0.0 111.832 -177.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.7 mt -126.46 -38.63 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 126.34 1.856 . . . . 0.0 109.628 -175.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.2 t -118.21 145.68 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 125.696 1.598 . . . . 0.0 109.332 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -68.14 154.38 41.81 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 123.384 0.673 . . . . 0.0 110.199 174.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -141.98 149.35 19.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -173.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -147.65 165.69 29.67 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.122 1.369 . . . . 0.0 109.434 -172.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -84.66 -46.69 11.24 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 45.3 p -119.35 170.37 9.18 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.232 1.413 . . . . 0.0 108.638 -174.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 8.9 mm -66.95 -42.02 88.24 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.81 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 167.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 48.2 t -67.98 -37.7 81.81 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.787 1.176 . . . . 0.0 110.712 -165.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -63.51 -28.02 69.66 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 118.184 0.447 . . . . 0.0 110.259 176.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -80.69 -54.99 5.14 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -54.89 -29.06 54.88 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 126.213 1.805 . . . . 0.0 112.721 -163.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.63 -23.32 14.28 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 126.5 1.92 . . . . 0.0 111.712 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -81.96 -53.73 5.9 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 120.114 1.325 . . . . 0.0 111.887 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 51.4 t -44.05 -39.91 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 129.293 3.037 . . . . 0.0 110.099 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -49.83 -23.26 1.79 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 127.414 2.286 . . . . 0.0 114.265 174.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.69 37.09 0.19 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.306 2.242 . . . . 0.0 113.274 177.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.578 ' HE2' ' CZ ' ' A' ' 86' ' ' PHE . 0.6 OUTLIER . . . . . 0 C--O 1.248 0.99 0 O-C-N 121.436 -0.79 . . . . 0.0 109.514 -174.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 78.32 84.63 0.54 Allowed Glycine 0 C--N 1.335 0.499 0 CA-C-N 118.66 0.664 . . . . 0.0 111.711 172.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.9 t -150.09 99.53 2.83 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.92 -178.75 3.8 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.27 1.428 . . . . 0.0 111.456 -167.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 155.34 144.03 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 130.843 3.657 . . . . 0.0 109.164 161.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.6 mp 48.26 92.86 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 127.819 2.448 . . . . 0.0 111.37 176.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -153.82 174.78 14.12 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.898 177.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -153.82 177.93 10.46 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.497 1.519 . . . . 0.0 108.855 171.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 70.58 25.16 4.26 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.901 1.28 . . . . 0.0 113.217 167.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -129.77 101.27 5.81 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 159.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -155.62 113.23 3.32 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 106.193 -1.781 . . . . 0.0 106.193 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -160.99 -177.49 6.15 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.934 1.694 . . . . 0.0 109.735 -175.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 5.5 mmt 54.97 76.31 0.26 Allowed 'General case' 0 C--N 1.339 0.122 0 C-N-CA 125.214 1.406 . . . . 0.0 108.563 176.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -110.51 88.06 7.16 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -81.16 98.76 1.05 Allowed 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.979 3.12 . . . . 0.0 110.509 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -151.0 -177.6 6.11 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.015 -1.053 . . . . 0.0 112.661 -177.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.407 ' HE2' ' CG1' ' A' ' 19' ' ' VAL . 0.7 OUTLIER -143.48 164.74 29.49 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.97 2.108 . . . . 0.0 106.823 173.689 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.2 mt -130.36 118.57 43.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 174.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.407 ' CG1' ' HE2' ' A' ' 17' ' ' LYS . 6.4 m -93.34 -162.02 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 125.677 1.591 . . . . 0.0 108.001 168.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -24.6 -70.85 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 129.651 3.181 . . . . 0.0 111.771 171.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -149.96 21.86 0.88 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.734 0.814 . . . . 0.0 110.835 -177.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 20.4 t -127.19 156.62 38.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 95.8 t -116.13 128.52 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mp -101.55 104.95 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 46.8 mt -88.97 128.84 35.71 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 103.551 -2.759 . . . . 0.0 103.551 175.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 30.2 mtm -123.48 95.48 45.1 Favored Pre-proline 0 N--CA 1.465 0.302 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -176.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -69.07 161.44 45.81 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.251 1.967 . . . . 0.0 111.088 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.593 ' ND2' ' H ' ' A' ' 29' ' ' LYS . 0.5 OUTLIER -151.92 -71.48 0.16 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 121.232 0.539 . . . . 0.0 111.964 -173.003 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.593 ' H ' ' ND2' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -147.47 6.06 0.83 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.53 1.932 . . . . 0.0 112.132 -176.238 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -79.58 -2.61 43.21 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 128.333 2.653 . . . . 0.0 112.746 177.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.6 mt -101.56 95.23 6.32 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -166.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -164.72 30.76 0.07 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.886 0.874 . . . . 0.0 112.386 -161.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER 73.7 -46.94 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 127.968 2.507 . . . . 0.0 112.287 175.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -68.85 -5.26 19.94 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 126.353 1.861 . . . . 0.0 113.189 -173.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -127.25 0.98 6.41 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 127.345 2.258 . . . . 0.0 109.127 177.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.14 -57.75 3.62 Favored 'General case' 0 C--O 1.224 -0.241 0 O-C-N 120.229 -1.545 . . . . 0.0 110.868 -173.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -65.05 -24.63 67.52 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 120.831 -1.168 . . . . 0.0 110.98 -178.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -81.54 -33.25 31.85 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 126.219 1.807 . . . . 0.0 110.863 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -42.4 -53.28 4.3 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 126.711 2.004 . . . . 0.0 111.285 176.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.39 -43.26 99.25 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.482 -178.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.13 -49.39 77.14 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.103 0.865 . . . . 0.0 110.639 174.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -58.01 -64.26 0.97 Allowed 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 118.099 -0.953 . . . . 0.0 110.014 177.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 68.8 t -49.56 -37.95 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 120.018 1.281 . . . . 0.0 112.062 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -61.12 -62.21 2.01 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.604 0.762 . . . . 0.0 110.329 175.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.11 -16.66 59.85 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 125.018 1.327 . . . . 0.0 112.867 -170.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -93.62 -31.4 14.51 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.778 1.231 . . . . 0.0 111.732 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -132.01 -54.26 0.98 Allowed 'General case' 0 C--N 1.346 0.42 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -172.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 30.7 mt -60.39 -50.95 71.54 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 118.654 0.661 . . . . 0.0 112.291 -171.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -61.28 -39.43 90.38 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.241 0.616 . . . . 0.0 109.944 177.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -60.09 -1.91 0.37 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 128.318 2.647 . . . . 0.0 114.797 172.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.49 2.75 75.93 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-O 118.304 -1.276 . . . . 0.0 113.02 176.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -72.48 119.09 16.21 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 120.024 1.912 . . . . 0.0 108.791 175.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -114.08 19.2 16.65 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.618 1.167 . . . . 0.0 109.309 -177.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -146.4 130.01 16.96 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.328 1.851 . . . . 0.0 107.353 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.2 mp -138.6 154.26 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 128.062 2.545 . . . . 0.0 105.612 177.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -130.37 156.6 44.44 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 124.633 1.173 . . . . 0.0 113.366 166.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 26.8 tp -121.69 75.83 1.22 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.907 1.283 . . . . 0.0 110.885 177.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.1 t -64.56 118.35 6.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 127.791 2.436 . . . . 0.0 107.023 173.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.7 mt -95.85 5.14 52.02 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.563 0.745 . . . . 0.0 110.643 -176.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.3 m -56.73 -23.61 43.72 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 177.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.46 -7.19 56.98 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.516 1.053 . . . . 0.0 111.272 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 p -134.17 157.23 41.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.902 1.681 . . . . 0.0 110.605 -168.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -85.72 -44.6 12.4 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.236 -0.915 . . . . 0.0 108.682 167.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 m -160.29 161.66 33.4 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 123.345 1.545 . . . . 0.0 113.703 -179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.2 tt -72.47 174.28 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 111.808 -2.451 . . . . 0.0 107.796 163.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -117.88 -144.94 0.38 Allowed 'General case' 0 C--N 1.327 -0.382 0 O-C-N 120.952 -1.093 . . . . 0.0 109.646 -160.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.6 t -50.62 -147.99 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.798 1 C-N-CA 132.111 4.165 . . . . 0.0 112.388 157.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -25.04 -39.91 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.158 1 C-N-CA 132.022 4.129 . . . . 0.0 116.421 177.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.2 t -55.07 -31.55 61.24 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.659 0.784 . . . . 0.0 111.778 -178.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.8 tp -57.49 -18.88 21.06 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.402 1.081 . . . . 0.0 112.73 173.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -98.48 -24.7 10.79 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.559 1.552 . . . . 0.0 113.204 170.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 90.1 t -65.92 -40.86 88.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 119.185 1.493 . . . . 0.0 109.551 173.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.4 mp -51.45 -48.59 34.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.552 1.141 . . . . 0.0 109.628 174.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.8 t -64.92 -46.27 92.26 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.635 0 CA-C-O 117.224 -1.37 . . . . 0.0 109.658 175.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -49.07 -51.29 32.25 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 122.469 2.395 . . . . 0.0 111.814 177.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 77.9 mt -57.85 -37.2 58.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 124.913 1.285 . . . . 0.0 110.143 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 25.7 tp -63.59 -53.6 49.09 Favored 'General case' 0 CA--C 1.52 -0.201 0 O-C-N 121.012 -1.055 . . . . 0.0 109.265 176.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -57.68 -22.82 48.24 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.388 0.675 . . . . 0.0 110.142 -177.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 67.5 m -81.43 -48.24 12.16 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.44 1.096 . . . . 0.0 111.326 177.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 21.8 mt -58.61 -43.97 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 119.983 1.265 . . . . 0.0 109.782 172.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.4 t -65.65 -10.87 39.82 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.637 1.575 . . . . 0.0 112.296 175.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.7 t -96.46 -43.21 7.73 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 120.32 1.418 . . . . 0.0 109.552 171.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.6 m -66.91 -28.01 67.96 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -178.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 110.02 38.85 1.63 Allowed Glycine 0 C--N 1.337 0.613 0 CA-C-O 118.702 -1.054 . . . . 0.0 113.428 -174.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -134.77 -175.64 13.97 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 119.93 1.865 . . . . 0.0 111.644 -177.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -127.31 154.13 45.3 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.874 1.67 . . . . 0.0 109.858 179.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -150.41 139.38 20.98 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -145.99 170.38 16.75 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 120.831 0.348 . . . . 0.0 111.477 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.21 167.34 10.63 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -177.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -148.86 150.06 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 C-N-CA 123.863 0.865 . . . . 0.0 111.541 -170.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 44.2 54.77 12.26 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 126.51 1.924 . . . . 0.0 112.064 171.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.05 167.25 26.62 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.76 2.307 . . . . 0.0 109.714 -178.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -123.06 169.57 11.06 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 173.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -66.69 -34.74 78.52 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 123.686 0.795 . . . . 0.0 110.127 -168.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.99 -35.94 80.0 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.337 1.455 . . . . 0.0 110.953 177.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -81.36 -46.03 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -176.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -57.43 -31.18 65.63 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 125.958 1.703 . . . . 0.0 110.466 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.95 -21.54 66.43 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -175.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.6 t -104.85 -42.55 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.043 0 C-N-CA 125.72 1.608 . . . . 0.0 107.164 -174.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.08 -17.23 24.18 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 116.715 -1.612 . . . . 0.0 108.868 -177.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.8 t -87.18 -50.64 6.48 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 117.62 -1.632 . . . . 0.0 108.569 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.84 -52.78 64.05 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 129.148 2.979 . . . . 0.0 111.047 -172.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -77.07 2.99 13.45 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.157 1.383 . . . . 0.0 110.891 -178.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.6 m120 47.15 75.85 0.12 Allowed 'General case' 0 C--N 1.342 0.249 0 C-N-CA 129.563 3.145 . . . . 0.0 109.816 -171.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.74 -59.86 1.9 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.295 1.438 . . . . 0.0 107.517 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.1 -26.76 67.88 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.776 0.83 . . . . 0.0 111.348 174.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.4 mtp-105 -74.99 -2.2 26.12 Favored 'General case' 0 C--N 1.339 0.112 0 O-C-N 121.751 -0.593 . . . . 0.0 111.75 -178.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.3 mt -128.0 -46.68 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 125.912 1.685 . . . . 0.0 107.272 -171.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.6 t -104.39 148.94 8.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-O 121.898 0.856 . . . . 0.0 109.917 -175.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.07 155.71 39.91 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 123.85 0.86 . . . . 0.0 111.852 173.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -146.42 146.59 18.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -174.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -141.47 163.75 32.1 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.917 0.887 . . . . 0.0 111.178 -171.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.5 -55.01 4.74 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 64.7 p -113.86 175.64 5.38 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.815 0.817 . . . . 0.0 111.048 -177.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 3.4 mm -61.74 -45.87 97.74 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 164.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.2 t -69.34 -33.14 72.66 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 118.774 -0.631 . . . . 0.0 109.855 -164.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -68.85 -24.04 64.3 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.785 0.834 . . . . 0.0 111.155 175.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -82.74 -52.59 6.63 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 6.3 tmm? -55.89 -40.1 72.53 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 125.298 1.439 . . . . 0.0 113.502 -157.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -89.39 -21.38 23.09 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 117.935 -1.031 . . . . 0.0 113.151 175.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.423 ' HG2' ' HE2' ' A' ' 125' ' ' LYS . 1.7 tt0 -84.27 -55.64 4.07 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-N 119.046 0.839 . . . . 0.0 109.76 -172.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.2 t -42.61 -44.19 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 C-N-CA 127.96 2.504 . . . . 0.0 110.586 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 17.9 mtm180 -48.11 -40.93 25.01 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 124.057 0.848 . . . . 0.0 111.083 178.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . 0.321 0.0 OUTLIER -117.83 43.48 2.39 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 125.628 1.571 . . . . 0.0 113.879 176.085 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.423 ' HE2' ' HG2' ' A' ' 121' ' ' GLU . 5.4 mmmt . . . . . 0 C--O 1.251 1.153 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 164.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.684 0 CA-C-O 117.18 -1.391 . . . . 0.0 107.791 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -90.77 -169.77 42.86 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 174.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m -140.39 -34.81 0.52 Allowed 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 125.335 1.454 . . . . 0.0 110.582 174.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.4 t0 42.64 77.47 0.06 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 128.165 2.586 . . . . 0.0 114.173 174.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -139.43 121.45 15.67 Favored 'General case' 0 CA--C 1.523 -0.08 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 172.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.38 139.26 39.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 -179.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -94.61 158.01 15.72 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.001 0.92 . . . . 0.0 108.855 170.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -173.67 -167.09 0.35 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.164 1.786 . . . . 0.0 108.876 163.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 4.4 m80 66.45 -175.47 0.19 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.789 2.436 . . . . 0.0 111.383 178.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 66.16 19.87 11.12 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.639 1.576 . . . . 0.0 113.675 176.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -129.55 101.95 6.16 Favored 'General case' 0 C--O 1.227 -0.095 0 C-N-CA 124.344 1.058 . . . . 0.0 108.251 168.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 74.7 m-70 -144.32 83.07 1.72 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 165.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 34.7 mtm -121.58 -55.68 1.91 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.716 0.806 . . . . 0.0 109.279 174.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 24.79 81.36 0.19 Allowed Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 128.785 2.834 . . . . 0.0 112.522 172.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.56 98.03 1.01 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.949 2.433 . . . . 0.0 110.847 -175.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -157.27 173.26 17.23 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.062 1.345 . . . . 0.0 109.649 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.4 173.1 12.1 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.487 2.315 . . . . 0.0 110.031 176.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.3 mt -137.8 135.31 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 127.93 2.492 . . . . 0.0 107.789 166.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.2 m -101.1 -139.36 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 127.085 2.154 . . . . 0.0 108.638 173.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -41.92 -71.19 0.09 Allowed 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 129.227 3.011 . . . . 0.0 110.524 177.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -147.88 20.94 1.13 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.602 1.961 . . . . 0.0 108.222 -173.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.3 t -131.51 147.65 32.68 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 C-N-CA 124.437 1.095 . . . . 0.0 108.109 -172.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.7 t -103.84 151.13 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.1 mp -129.89 94.71 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 124.871 1.269 . . . . 0.0 108.426 176.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.5 105.51 1.2 Allowed 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 129.677 3.191 . . . . 0.0 109.06 170.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.412 ' HA ' ' CG2' ' A' ' 58' ' ' VAL . 50.8 mtp -113.98 73.68 2.46 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 125.663 1.585 . . . . 0.0 107.943 -172.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -69.75 177.34 5.67 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 123.114 2.542 . . . . 0.0 111.532 -173.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.549 ' ND2' ' H ' ' A' ' 29' ' ' LYS . 2.1 p-10 -156.18 -79.99 0.08 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.982 1.713 . . . . 0.0 109.336 -178.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.549 ' H ' ' ND2' ' A' ' 28' ' ' ASN . 3.9 mppt? -136.58 26.36 3.11 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.972 2.509 . . . . 0.0 109.304 -174.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -91.43 -7.81 49.6 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 125.098 1.359 . . . . 0.0 112.055 177.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.18 75.97 9.9 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 120.977 1.717 . . . . 0.0 108.498 -177.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -105.82 58.51 0.66 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.186 2.195 . . . . 0.0 112.28 -173.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.3 mm 53.85 -75.78 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 127.613 2.365 . . . . 0.0 112.76 -175.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -67.31 -17.99 64.99 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.64 1.176 . . . . 0.0 112.032 -173.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -43.7 -39.43 3.65 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.455 163.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.12 -44.99 96.48 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 175.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 38.5 m170 -67.31 -44.68 78.57 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 118.902 -0.57 . . . . 0.0 109.709 -170.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.78 -19.91 47.49 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-O 116.985 -1.483 . . . . 0.0 111.69 173.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -44.85 -54.02 6.86 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 125.005 1.322 . . . . 0.0 109.785 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt -56.83 -53.8 53.71 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.85 -46.95 81.44 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 117.296 -1.335 . . . . 0.0 111.544 -176.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 6.1 t90 -62.44 -66.16 0.58 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 117.329 -1.32 . . . . 0.0 109.05 177.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 87.7 t -50.46 -37.96 15.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 120.003 1.274 . . . . 0.0 111.117 -176.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -59.51 -74.04 0.08 Allowed 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 171.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -48.92 -43.02 39.04 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.637 1.975 . . . . 0.0 113.267 -171.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.468 ' HG3' ' CE1' ' A' ' 47' ' ' PHE . 3.0 tp10 -84.7 -28.69 26.16 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 126.846 2.058 . . . . 0.0 109.727 -167.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.468 ' CE1' ' HG3' ' A' ' 46' ' ' GLU . 2.8 m-85 -128.77 -66.76 0.82 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 118.925 0.784 . . . . 0.0 110.606 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.6 mt -61.13 -53.41 57.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 118.865 0.757 . . . . 0.0 112.517 -166.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -67.89 -29.06 68.07 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 127.496 2.318 . . . . 0.0 109.572 176.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -63.49 -24.31 67.76 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 118.028 -0.987 . . . . 0.0 111.605 167.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.8 -4.43 19.07 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 126.533 2.016 . . . . 0.0 113.281 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -66.1 156.38 34.07 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 119.429 1.615 . . . . 0.0 111.085 178.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -134.25 1.09 3.17 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.332 -1.303 . . . . 0.0 111.212 -177.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.8 mtmt -138.04 123.18 19.21 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.622 1.101 . . . . 0.0 109.296 -170.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.4 mp -137.45 152.78 27.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 126.701 2.0 . . . . 0.0 106.581 -176.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -141.42 120.12 12.56 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 126.977 2.111 . . . . 0.0 110.216 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 46.2 tp -90.18 119.29 30.38 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 176.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.412 ' CG2' ' HA ' ' A' ' 26' ' ' MET . 0.8 OUTLIER -87.84 154.81 3.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 118.806 0.73 . . . . 0.0 109.963 173.011 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.9 mp -134.38 8.02 3.64 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.871 0.868 . . . . 0.0 111.482 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.03 -36.05 67.56 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.891 -1.131 . . . . 0.0 112.073 -177.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -96.33 -11.38 25.92 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.439 1.096 . . . . 0.0 112.16 178.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.4 t -109.87 113.5 44.38 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -169.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.85 -41.61 43.39 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 -178.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 93.8 p -151.99 168.65 24.53 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -171.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.5 tt -133.64 151.98 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 C-N-CA 124.504 1.122 . . . . 0.0 109.107 176.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.68 162.85 17.69 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.007 0.923 . . . . 0.0 109.006 179.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 85.8 p -66.76 1.9 1.62 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 171.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . 0.25 0.1 OUTLIER -71.03 -78.63 0.07 Allowed 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 123.955 0.902 . . . . 0.0 110.817 156.028 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.31 -24.17 57.4 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 118.901 0.773 . . . . 0.0 111.777 -158.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 35.0 tp -44.72 -38.88 4.72 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.527 1.531 . . . . 0.0 111.889 176.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.41 ' HA2' ' CG1' ' A' ' 74' ' ' VAL . . . -108.94 6.36 32.71 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-O 119.82 -0.433 . . . . 0.0 114.154 -174.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 95.0 t -75.99 -46.18 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 158.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mt -59.57 -54.23 37.29 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 CA-C-O 122.694 1.235 . . . . 0.0 111.61 -173.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.473 HG21 ' HE3' ' A' ' 78' ' ' LYS . 9.0 p -45.69 -56.32 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.835 0 O-C-N 120.404 -1.435 . . . . 0.0 113.841 163.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.409 ' H ' HG12 ' A' ' 74' ' ' VAL . 0.9 OUTLIER -49.43 -43.93 45.06 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 121.369 -0.832 . . . . 0.0 110.97 -174.356 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 56.3 mt -58.11 -41.87 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 O-C-N 124.859 1.349 . . . . 0.0 110.569 173.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.459 ' C ' ' H ' ' A' ' 79' ' ' SER . 21.7 tp -57.99 -54.06 51.26 Favored 'General case' 0 C--O 1.225 -0.196 0 O-C-N 120.278 -1.514 . . . . 0.0 109.695 170.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.473 ' HE3' HG21 ' A' ' 74' ' ' VAL . 72.2 mttt -65.13 3.23 0.63 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.276 1.43 . . . . 0.0 112.419 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.459 ' H ' ' C ' ' A' ' 77' ' ' LEU . 41.4 t -106.2 -51.08 3.03 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 126.631 1.973 . . . . 0.0 107.782 174.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 87.8 mt -59.55 -44.6 93.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.678 0.791 . . . . 0.0 110.367 175.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.58 -19.7 65.29 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.786 0.721 . . . . 0.0 112.638 176.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.9 m -80.64 -33.94 35.31 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.341 0.973 . . . . 0.0 111.405 167.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.4 m -73.12 -62.7 1.37 Allowed 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.339 1.056 . . . . 0.0 110.421 -176.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 148.5 29.03 0.06 OUTLIER Glycine 0 CA--C 1.527 0.819 0 CA-C-O 118.14 -1.367 . . . . 0.0 113.787 -168.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -134.06 -166.4 11.25 Favored Glycine 0 C--N 1.338 0.685 0 CA-C-N 120.245 2.023 . . . . 0.0 113.319 -171.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -135.1 150.18 50.18 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.305 1.442 . . . . 0.0 109.246 178.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -145.9 144.12 30.0 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 170.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -149.99 176.52 10.7 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 126.165 1.786 . . . . 0.0 111.924 -175.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.14 168.32 12.55 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.702 0.801 . . . . 0.0 111.165 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 99.4 t -147.35 141.43 19.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 124.722 1.209 . . . . 0.0 109.787 -160.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.2 t 42.98 58.19 11.6 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 124.527 1.131 . . . . 0.0 109.342 -176.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -71.57 -163.2 0.13 Allowed 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 124.275 3.317 . . . . 0.0 110.114 -177.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -155.9 151.42 27.04 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 124.508 1.123 . . . . 0.0 108.07 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -61.5 -21.53 64.3 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.201 1.0 . . . . 0.0 110.998 -176.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.62 -38.19 48.54 Favored 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 126.422 1.889 . . . . 0.0 111.451 176.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.3 t -62.18 -46.98 95.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-O 117.102 -1.428 . . . . 0.0 108.216 166.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -57.93 -30.45 65.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 119.982 1.265 . . . . 0.0 109.155 176.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.34 -30.46 69.43 Favored 'General case' 0 C--O 1.218 -0.589 0 O-C-N 120.703 -1.248 . . . . 0.0 109.934 -177.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.4 p -101.59 -42.63 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -169.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.7 mp -67.0 -19.67 65.75 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 115.95 -1.976 . . . . 0.0 111.152 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 12.0 t -79.67 -45.44 19.01 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 121.441 1.928 . . . . 0.0 107.31 172.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -67.6 -51.03 55.1 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 126.337 1.855 . . . . 0.0 110.585 -165.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 9.1 t -81.77 6.32 15.84 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.787 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 50.0 88.27 0.02 OUTLIER 'General case' 0 C--O 1.235 0.304 0 C-N-CA 127.162 2.185 . . . . 0.0 110.102 -169.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.87 -55.9 0.88 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 127.563 2.345 . . . . 0.0 110.739 -175.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.77 -27.05 68.93 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.944 1.247 . . . . 0.0 110.681 173.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 -72.44 -18.18 61.72 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.146 0.498 . . . . 0.0 110.109 -177.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.2 mm -97.54 -56.2 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 103.595 -2.742 . . . . 0.0 103.595 -174.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.507 HG12 ' H ' ' A' ' 110' ' ' LYS . 1.4 t -80.41 -165.0 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 125.518 1.527 . . . . 0.0 110.115 -177.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.507 ' H ' HG12 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -125.66 168.82 13.21 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 128.46 2.704 . . . . 0.0 108.813 169.367 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.36 145.73 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -147.02 171.14 15.73 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 126.334 1.854 . . . . 0.0 110.678 -175.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.28 -53.16 4.34 Favored 'General case' 0 CA--C 1.523 -0.067 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -175.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 71.1 p -130.17 162.88 27.89 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.568 0.747 . . . . 0.0 110.895 -175.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 29.1 mm -65.03 -36.48 77.91 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 CA-C-O 118.168 -0.92 . . . . 0.0 108.582 -172.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.9 t -69.04 -31.74 70.75 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.527 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -68.13 -9.15 44.3 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 119.056 0.844 . . . . 0.0 111.672 173.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -110.37 -38.25 5.29 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 119.529 1.059 . . . . 0.0 109.203 -179.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 2.8 ttm -64.1 -46.45 84.14 Favored 'General case' 0 N--CA 1.446 -0.649 0 O-C-N 120.667 -1.271 . . . . 0.0 113.433 -161.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -91.36 -14.68 30.27 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 117.976 -1.012 . . . . 0.0 111.057 175.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -95.22 -46.85 6.59 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 119.327 0.967 . . . . 0.0 110.574 -167.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -49.84 -31.77 7.13 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.18 0 C-N-CA 124.89 1.276 . . . . 0.0 111.002 173.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -52.63 -36.21 56.12 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.518 1.127 . . . . 0.0 111.969 174.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.88 35.34 0.76 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.884 1.274 . . . . 0.0 114.251 -174.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.242 0.679 0 C-N-CA 125.5 1.52 . . . . 0.0 112.957 178.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 37.4 p90 . . . . . 0 C--O 1.237 0.418 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.64 173.26 11.72 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.77 1.228 . . . . 0.0 111.511 165.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.3 mt -119.09 147.4 22.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 174.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 20' ' ' ASP . 46.5 t -125.1 -174.79 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 129.761 3.224 . . . . 0.0 104.849 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.426 ' H ' HG12 ' A' ' 19' ' ' VAL . 2.1 m-20 -51.75 -54.33 29.71 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.869 0.867 . . . . 0.0 113.311 -163.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -127.39 12.37 6.99 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 122.933 0.493 . . . . 0.0 110.367 163.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.828 HG11 ' CE2' ' A' ' 56' ' ' PHE . 22.0 t -119.31 163.77 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 O-C-N 121.114 -0.991 . . . . 0.0 108.585 -166.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.4 t -132.28 125.52 54.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 -170.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.414 HD11 HG21 ' A' ' 19' ' ' VAL . 0.6 OUTLIER -107.69 103.46 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 -176.852 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.7 mt -90.61 104.77 17.31 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 104.886 -2.264 . . . . 0.0 104.886 -178.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 57.7 mtm -112.89 84.98 7.26 Favored Pre-proline 0 C--N 1.332 -0.172 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -171.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -70.49 156.74 60.82 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.853 1.702 . . . . 0.0 109.871 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -122.61 -92.55 0.53 Allowed 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -178.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.63 59.44 1.63 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 121.784 2.084 . . . . 0.0 111.658 -175.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -144.97 9.69 1.3 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -175.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 25.0 mt -79.26 52.93 1.4 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.429 1.013 . . . . 0.0 110.975 -176.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -85.4 169.63 13.49 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 126.598 1.959 . . . . 0.0 109.116 171.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.9 mt -57.53 -35.38 49.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 C-N-CA 124.272 1.029 . . . . 0.0 112.09 -174.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -71.61 -16.18 62.27 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 120.97 -1.081 . . . . 0.0 111.211 -176.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -120.24 56.28 0.98 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.291 1.437 . . . . 0.0 108.804 175.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -140.45 -64.1 0.47 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.405 1.082 . . . . 0.0 110.592 -177.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 28.2 t60 -58.45 -46.19 87.07 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 120.513 -1.367 . . . . 0.0 109.368 169.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.599 HD12 ' C ' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -65.44 -30.05 70.8 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.792 178.604 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -52.93 -54.05 40.54 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.856 1.262 . . . . 0.0 110.017 -174.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.55 ' HE3' ' CE1' ' A' ' 44' ' ' PHE . 0.8 OUTLIER -57.43 -44.74 84.91 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 124.651 1.181 . . . . 0.0 110.866 172.963 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.0 -34.24 77.13 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.569 1.548 . . . . 0.0 112.372 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -69.55 -62.48 1.37 Allowed 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 171.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.7 t -47.64 -41.03 7.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 123.916 0.886 . . . . 0.0 112.763 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.55 ' CE1' ' HE3' ' A' ' 40' ' ' LYS . 1.6 m-85 -61.54 -34.76 76.09 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 123.892 0.877 . . . . 0.0 112.121 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -112.41 -12.23 13.55 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.386 1.074 . . . . 0.0 112.712 -170.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -88.38 -34.67 17.49 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.614 1.566 . . . . 0.0 109.889 171.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -130.35 -62.63 0.92 Allowed 'General case' 0 C--N 1.345 0.373 0 C-N-CA 123.095 0.558 . . . . 0.0 111.807 -169.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.6 mt -62.41 -56.08 21.63 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 119.245 -0.407 . . . . 0.0 111.447 -162.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -60.75 -35.29 76.02 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 118.676 -0.678 . . . . 0.0 110.274 175.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.14 -16.21 12.52 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 127.19 2.196 . . . . 0.0 112.965 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 118.23 -10.15 13.35 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 126.046 1.784 . . . . 0.0 111.988 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -73.62 120.26 18.98 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 118.802 1.301 . . . . 0.0 110.837 -172.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -109.72 13.0 23.91 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.83 2.052 . . . . 0.0 112.074 -176.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.43 ' HB3' HG13 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -150.94 107.31 3.48 Favored 'General case' 0 CA--C 1.518 -0.274 0 O-C-N 120.248 -1.533 . . . . 0.0 107.983 -173.987 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mp -112.02 152.0 13.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 176.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.828 ' CE2' HG11 ' A' ' 22' ' ' VAL . 23.4 m-85 -130.08 150.5 51.32 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.603 1.161 . . . . 0.0 109.492 166.092 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.5 tp -119.91 110.28 16.54 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.204 1.001 . . . . 0.0 108.535 176.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.3 t -84.31 134.47 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 171.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.3 mp -109.82 6.19 23.23 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.62 0.768 . . . . 0.0 111.963 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 33.4 t -51.98 -48.14 64.52 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.158 0.983 . . . . 0.0 111.458 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -87.99 7.05 32.96 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.341 -0.85 . . . . 0.0 112.195 -168.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.6 p -134.45 126.93 49.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 125.579 1.551 . . . . 0.0 108.099 -173.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -75.34 -42.56 54.06 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 120.675 -1.266 . . . . 0.0 108.944 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.567 ' HB3' ' HE2' ' A' ' 95' ' ' LYS . 1.4 p -162.05 -178.15 6.23 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.992 0.901 . . . . 0.0 111.681 -173.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 21.3 tt -139.66 160.03 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 C-N-CA 125.344 1.458 . . . . 0.0 108.586 -175.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.12 156.18 22.26 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.408 1.083 . . . . 0.0 110.421 172.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.4 m -53.51 -28.77 32.93 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.126 1.37 . . . . 0.0 113.434 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -62.01 -66.6 0.51 Allowed 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.73 1.212 . . . . 0.0 109.309 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.0 t -74.27 -24.23 59.24 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.369 -0.824 . . . . 0.0 111.659 -176.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.414 HD11 HG21 ' A' ' 103' ' ' THR . 55.1 tp -49.98 -30.82 11.26 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.944 1.247 . . . . 0.0 112.407 172.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.65 -24.69 29.84 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-N 118.396 0.544 . . . . 0.0 113.448 175.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.8 t -66.16 -39.52 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 118.194 0.997 . . . . 0.0 108.605 173.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 mp -52.55 -53.25 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 123.8 0.84 . . . . 0.0 108.914 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 73.3 t -58.94 -46.29 91.5 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 175.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -55.57 -43.2 75.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 119.46 1.027 . . . . 0.0 112.501 -174.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.2 mt -59.73 -38.89 78.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 124.114 0.966 . . . . 0.0 109.013 176.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.63 -50.94 71.5 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 119.151 0.887 . . . . 0.0 109.478 172.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -53.94 -47.93 70.75 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 118.077 -0.963 . . . . 0.0 110.331 -176.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.7 m -56.33 -57.49 12.04 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 124.092 0.87 . . . . 0.0 110.358 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 50.3 mt -53.28 -46.79 57.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.859 1.264 . . . . 0.0 110.637 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.2 p -61.78 -31.13 71.32 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.972 1.309 . . . . 0.0 111.978 -175.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.31 -31.68 33.45 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.848 1.659 . . . . 0.0 111.696 175.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 39.4 m -78.69 -21.95 47.43 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 117.64 -1.171 . . . . 0.0 113.991 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 121.02 4.92 10.0 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 119.652 1.115 . . . . 0.0 114.546 -174.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -113.32 -176.28 19.38 Favored Glycine 0 N--CA 1.437 -1.261 0 CA-C-N 119.24 1.52 . . . . 0.0 112.196 -173.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -131.47 157.5 43.33 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.825 1.65 . . . . 0.0 108.68 176.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -148.96 135.45 19.47 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 175.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.59 ' C ' HD23 ' A' ' 89' ' ' LEU . . . -140.11 170.84 15.1 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.36 1.464 . . . . 0.0 110.28 -176.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.59 HD23 ' C ' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -119.27 171.58 8.2 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 122.793 0.437 . . . . 0.0 110.467 -176.573 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.557 HG21 HD13 ' A' ' 115' ' ' ILE . 77.9 t -146.77 143.49 20.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 124.939 1.296 . . . . 0.0 109.723 -172.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 29.1 t 43.61 63.81 7.54 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 125.914 1.685 . . . . 0.0 109.119 -176.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -78.32 91.98 1.16 Allowed 'Trans proline' 0 N--CA 1.444 -1.428 0 N-CA-C 106.168 -2.281 . . . . 0.0 106.168 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -55.39 155.19 5.41 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 122.869 1.319 . . . . 0.0 110.125 -177.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -64.69 -25.26 67.87 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 122.318 1.056 . . . . 0.0 110.99 -165.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.567 ' HE2' ' HB3' ' A' ' 64' ' ' SER . 0.0 OUTLIER -68.82 -35.7 77.29 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 126.069 1.748 . . . . 0.0 111.547 177.428 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.0 m -82.44 -38.15 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.745 0 CA-C-N 120.436 1.471 . . . . 0.0 110.429 172.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.2 -33.42 63.01 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 120.193 1.36 . . . . 0.0 109.85 -176.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.45 -31.38 72.53 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 177.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.1 p -96.54 -32.12 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 C-N-CA 124.974 1.31 . . . . 0.0 108.653 -177.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.98 -18.59 65.41 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.408 1.883 . . . . 0.0 111.341 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.1 m -80.16 -57.01 3.82 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 168.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.41 -5.43 5.26 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 130.257 3.423 . . . . 0.0 114.006 -167.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.414 HG21 HD11 ' A' ' 70' ' ' LEU . 0.8 OUTLIER -130.76 6.93 4.74 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 125.381 1.472 . . . . 0.0 110.659 -177.282 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 46.71 73.95 0.17 Allowed 'General case' 0 C--N 1.342 0.262 0 C-N-CA 127.511 2.325 . . . . 0.0 109.706 -170.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.79 -63.13 1.28 Allowed 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 174.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -57.64 -31.95 66.79 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 123.344 1.545 . . . . 0.0 110.284 174.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -76.43 1.91 15.1 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 120.09 -1.631 . . . . 0.0 111.219 -175.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.4 mt -126.54 -53.12 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 126.06 1.744 . . . . 0.0 107.936 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.2 t -103.11 145.8 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 125.878 1.671 . . . . 0.0 108.186 -174.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -71.09 161.28 31.39 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.5 -0.75 . . . . 0.0 111.164 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.19 143.56 27.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.421 1.488 . . . . 0.0 107.113 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -141.23 168.43 19.8 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 128.902 2.881 . . . . 0.0 109.239 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.2 -46.47 13.71 Favored 'General case' 0 CA--C 1.515 -0.372 0 O-C-N 121.53 -0.731 . . . . 0.0 109.697 177.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 60.1 p -119.45 173.79 6.77 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.045 1.338 . . . . 0.0 108.894 -173.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.557 HD13 HG21 ' A' ' 90' ' ' VAL . 8.8 mm -66.88 -41.9 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-O 117.858 -1.068 . . . . 0.0 108.726 168.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 18.6 t -67.9 -37.85 82.24 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 119.982 1.265 . . . . 0.0 110.87 -167.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -60.82 -28.46 68.81 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 118.4 -0.809 . . . . 0.0 109.802 177.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.727 ' O ' HG23 ' A' ' 122' ' ' VAL . . . -81.27 -54.38 5.54 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.15 -28.76 59.27 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 125.917 1.687 . . . . 0.0 114.061 -160.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -104.79 -0.69 27.0 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 125.22 1.408 . . . . 0.0 114.406 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -123.32 -35.03 3.02 Favored 'General case' 0 C--O 1.213 -0.841 0 C-N-CA 125.162 1.385 . . . . 0.0 112.924 -167.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 118' ' ' ALA . 3.4 t -57.02 -27.23 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 126.036 1.734 . . . . 0.0 109.442 161.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 11.8 mtm180 -54.18 -31.65 53.38 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 121.127 -0.983 . . . . 0.0 113.061 162.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.74 23.66 5.02 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 118.326 2.713 . . . . 0.0 118.326 -177.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 21.6 mttp . . . . . 0 N--CA 1.431 -1.383 0 N-CA-C 102.66 -3.089 . . . . 0.0 102.66 -179.933 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.5 p90 . . . . . 0 N--CA 1.447 -0.61 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -126.66 178.78 5.7 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 163.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.6 mt -126.5 152.23 33.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 163.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 23.3 m -111.19 -141.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 125.612 1.565 . . . . 0.0 107.724 174.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -29.94 -79.21 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 129.043 2.937 . . . . 0.0 112.501 166.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -142.82 14.04 1.91 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.952 2.501 . . . . 0.0 109.252 177.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.642 HG11 ' CE2' ' A' ' 56' ' ' PHE . 21.8 t -115.75 140.07 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 O-C-N 121.092 -1.005 . . . . 0.0 108.712 -173.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.4 t -94.14 130.67 42.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.1 mm -106.94 94.32 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 36.1 mt -77.83 133.69 38.13 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 176.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 70.4 mtm -131.24 92.98 31.15 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 124.21 1.004 . . . . 0.0 109.064 -172.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -78.02 44.62 1.62 Allowed 'Trans proline' 0 CA--C 1.542 0.915 1 C-N-CA 125.461 4.107 . . . . 0.0 113.887 -164.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -49.12 88.77 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 128.763 2.825 . . . . 0.0 114.343 -169.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 36.94 35.41 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 128.95 2.9 . . . . 0.0 115.016 -176.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -122.78 7.43 9.38 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -167.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.0 mp -73.84 63.89 0.93 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 126.027 1.731 . . . . 0.0 109.605 -176.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -78.82 26.88 0.23 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 128.938 2.895 . . . . 0.0 113.868 -166.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.6 mm 72.86 -63.09 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 127.068 2.147 . . . . 0.0 110.643 -177.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -70.3 -18.56 63.11 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 120.916 1.689 . . . . 0.0 111.35 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -47.83 -49.58 28.8 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 123.991 0.916 . . . . 0.0 110.516 162.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.73 -37.33 87.23 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.79 0.436 . . . . 0.0 110.446 -177.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -61.89 -51.19 69.17 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.332 0.653 . . . . 0.0 110.017 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.259 0.0 OUTLIER -81.82 -15.76 53.08 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-O 117.599 -1.191 . . . . 0.0 112.608 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -44.48 -50.74 9.28 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.441 1.896 . . . . 0.0 110.661 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.514 ' HE2' ' CZ ' ' A' ' 44' ' ' PHE . 13.6 tmtt? -60.65 -53.16 60.85 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 123.222 0.609 . . . . 0.0 111.19 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.41 -45.91 87.48 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.039 0.836 . . . . 0.0 109.914 -177.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -60.49 -66.98 0.44 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 117.292 -1.337 . . . . 0.0 109.705 176.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 73.5 t -52.13 -32.32 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 120.537 1.517 . . . . 0.0 111.986 -176.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.514 ' CZ ' ' HE2' ' A' ' 40' ' ' LYS . 3.3 m-85 -58.19 -71.78 0.1 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.91 0.777 . . . . 0.0 109.905 172.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -65.89 -30.83 71.49 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 123.887 0.875 . . . . 0.0 112.885 -170.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -77.32 -31.81 54.85 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.011 1.325 . . . . 0.0 110.962 -175.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -138.13 -62.73 0.58 Allowed 'General case' 0 C--N 1.341 0.22 0 CA-C-N 118.522 0.601 . . . . 0.0 110.991 -170.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 46.6 mt -58.81 -59.43 5.44 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.416 0.553 . . . . 0.0 111.176 -171.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -60.68 -35.26 75.83 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.029 1.332 . . . . 0.0 109.647 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 tttm -56.5 -34.7 67.22 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.952 176.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.41 8.82 5.74 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.991 1.281 . . . . 0.0 114.173 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -77.63 159.77 28.98 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 118.941 1.37 . . . . 0.0 110.426 172.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -143.44 11.06 1.68 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.251 1.82 . . . . 0.0 111.795 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.477 ' HB3' HG13 ' A' ' 22' ' ' VAL . 1.7 mtmt -139.34 114.73 9.79 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 119.93 1.241 . . . . 0.0 107.914 -176.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mp -121.91 152.55 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 127.381 2.272 . . . . 0.0 105.118 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.642 ' CE2' HG11 ' A' ' 22' ' ' VAL . 14.2 m-85 -131.4 160.74 34.18 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.985 1.714 . . . . 0.0 109.37 166.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 26.5 tp -127.6 119.44 25.95 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 118.085 -0.96 . . . . 0.0 108.434 169.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.541 HG12 ' H ' ' A' ' 60' ' ' SER . 46.4 t -81.54 139.35 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 120.389 1.449 . . . . 0.0 107.685 170.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.63 ' CD1' HG11 ' A' ' 96' ' ' VAL . 1.3 mt -112.54 8.82 19.39 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.889 0.768 . . . . 0.0 112.22 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.541 ' H ' HG12 ' A' ' 58' ' ' VAL . 71.9 m -74.79 -34.1 62.36 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.297 -0.877 . . . . 0.0 113.233 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -90.76 30.6 1.15 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 122.889 1.328 . . . . 0.0 110.469 -174.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.9 p -160.8 170.7 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 129.344 3.058 . . . . 0.0 104.853 -174.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -129.94 -47.31 1.13 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 172.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.414 ' CB ' ' HE2' ' A' ' 95' ' ' LYS . 41.7 p -143.23 171.76 13.66 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.707 0.803 . . . . 0.0 110.648 -176.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.6 tt -138.32 157.88 31.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 C-N-CA 124.987 1.315 . . . . 0.0 108.393 -174.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -73.53 153.54 40.24 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.74 0.781 . . . . 0.0 109.808 174.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.6 m -76.21 53.23 0.8 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.629 1.172 . . . . 0.0 110.447 164.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -129.29 -69.45 0.69 Allowed 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 160.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.03 -38.84 77.0 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 128.967 2.907 . . . . 0.0 112.031 -173.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 20.9 tp -46.05 -40.39 10.62 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 125.881 1.673 . . . . 0.0 111.966 171.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.82 -31.1 40.98 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-O 119.404 -0.665 . . . . 0.0 111.762 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.2 t -70.62 -33.75 54.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 118.074 0.937 . . . . 0.0 108.659 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 22.7 mm -55.75 -46.98 79.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 O-C-N 121.367 -0.833 . . . . 0.0 109.722 174.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.4 t -60.48 -36.64 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 O-C-N 121.087 -1.008 . . . . 0.0 111.693 172.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -63.73 -28.09 69.65 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 120.873 1.67 . . . . 0.0 112.121 -178.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.4 mt -70.32 -34.95 60.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 O-C-N 121.289 -0.882 . . . . 0.0 109.091 173.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.18 -40.93 82.14 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.1 mttm -54.65 -46.48 73.98 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 117.92 -1.038 . . . . 0.0 111.607 174.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.6 t -58.23 -58.36 8.83 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.1 mt -62.07 -40.28 86.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 123.828 0.851 . . . . 0.0 111.157 -170.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.0 t -60.52 -40.87 93.03 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.68 1.592 . . . . 0.0 110.909 173.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.7 m -69.97 -35.11 74.2 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.985 -0.447 . . . . 0.0 110.613 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.1 m -73.06 -51.08 19.46 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.472 1.109 . . . . 0.0 112.844 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 132.98 18.8 1.05 Allowed Glycine 0 CA--C 1.531 1.04 0 CA-C-O 118.064 -1.409 . . . . 0.0 115.031 -170.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -116.86 -168.06 14.72 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 120.251 2.026 . . . . 0.0 111.72 -172.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.473 ' HB3' HG22 ' A' ' 122' ' ' VAL . 13.1 m-85 -132.4 153.22 51.03 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.639 1.576 . . . . 0.0 109.901 -178.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -153.16 140.69 19.8 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 174.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.529 ' C ' HD23 ' A' ' 89' ' ' LEU . . . -146.6 172.26 13.85 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.61 1.164 . . . . 0.0 111.469 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.529 HD23 ' C ' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -117.02 165.74 13.0 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.576 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.474 HG21 HD13 ' A' ' 115' ' ' ILE . 53.7 t -142.89 134.85 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 C-N-CA 124.723 1.209 . . . . 0.0 108.034 -165.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.6 t 50.74 54.43 15.4 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 126.201 1.801 . . . . 0.0 111.821 -174.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -73.5 107.7 2.45 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 124.175 3.25 . . . . 0.0 109.154 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 32.6 p-10 -66.47 165.52 14.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 122.393 1.092 . . . . 0.0 110.6 174.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -69.09 -26.35 64.88 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.863 -1.148 . . . . 0.0 112.214 -170.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.414 ' HE2' ' CB ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -62.9 -29.18 70.57 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 126.878 2.071 . . . . 0.0 109.66 177.928 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.848 HG13 HD13 ' A' ' 100' ' ' LEU . 13.3 t -84.88 -50.32 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-O 116.105 -1.902 . . . . 0.0 108.875 169.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -54.04 -34.74 60.84 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 122.782 2.537 . . . . 0.0 109.844 -177.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.73 -46.09 89.71 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 121.711 -0.618 . . . . 0.0 111.268 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.685 HG13 HD12 ' A' ' 100' ' ' LEU . 8.8 p -83.95 -38.8 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 -169.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.848 HD13 HG13 ' A' ' 96' ' ' VAL . 10.7 mp -61.28 -24.29 66.3 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.776 1.63 . . . . 0.0 112.644 177.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.81 6.86 34.27 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.376 0.989 . . . . 0.0 111.302 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 41.5 mt -108.67 -39.24 5.43 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 126.773 2.029 . . . . 0.0 110.704 171.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.2 t -94.72 0.42 55.0 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.413 1.885 . . . . 0.0 112.021 -168.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 57.96 79.86 0.19 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.296 1.838 . . . . 0.0 109.432 -168.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.406 ' HB3' ' HG ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -128.28 -55.44 1.26 Allowed 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.97 1.308 . . . . 0.0 108.996 175.224 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -59.54 -18.41 40.34 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.642 1.977 . . . . 0.0 112.183 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.92 -9.09 24.59 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.422 1.889 . . . . 0.0 114.535 -178.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.8 mt -107.62 -38.04 3.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 126.926 2.09 . . . . 0.0 107.914 -176.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.5 t -120.78 145.44 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 123.726 0.81 . . . . 0.0 109.117 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.04 161.01 27.67 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.084 0.554 . . . . 0.0 110.742 175.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.09 144.12 25.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -144.67 167.05 23.49 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 127.363 2.265 . . . . 0.0 110.784 -176.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -84.72 -44.52 13.29 Favored 'General case' 0 C--O 1.233 0.189 0 O-C-N 121.835 -0.54 . . . . 0.0 110.008 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.6 p -128.96 177.22 7.27 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.165 0.986 . . . . 0.0 109.48 -171.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.474 HD13 HG21 ' A' ' 90' ' ' VAL . 13.7 mm -74.95 -42.59 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 174.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 10.0 t -70.82 -25.56 62.9 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 119.573 1.079 . . . . 0.0 110.313 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -65.74 -16.22 63.57 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 119.676 1.126 . . . . 0.0 111.399 170.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -107.98 -38.75 5.72 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 123.762 0.825 . . . . 0.0 109.185 -171.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 8.2 ttp -61.7 -42.75 99.36 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.245 1.018 . . . . 0.0 112.571 -160.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -92.72 -23.53 18.89 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 124.586 1.154 . . . . 0.0 111.861 175.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -81.39 -52.14 7.59 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -169.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.473 HG22 ' HB3' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -46.89 -34.8 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 127.182 2.193 . . . . 0.0 112.637 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 11.7 mtm180 -60.68 -32.6 71.81 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 123.595 0.758 . . . . 0.0 111.834 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.8 60.31 0.93 Allowed 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 127.008 2.123 . . . . 0.0 105.624 -178.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.259 1.59 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -174.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.5 p90 . . . . . 0 C--O 1.237 0.4 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -129.48 175.75 8.52 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 157.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.5 mt -125.41 157.54 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 163.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.1 m -117.34 -143.13 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 168.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -47.33 -66.44 0.41 Allowed 'General case' 0 C--O 1.234 0.268 0 C-N-CA 127.058 2.143 . . . . 0.0 112.134 -175.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -141.93 12.15 2.03 Favored 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 123.711 0.804 . . . . 0.0 112.574 170.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.695 HG11 ' CE2' ' A' ' 56' ' ' PHE . 20.5 t -105.77 139.07 28.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.9 t -90.72 149.87 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.239 1.016 . . . . 0.0 108.307 174.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.7 mp -129.88 107.81 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 176.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.49 158.43 24.51 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 120.57 1.532 . . . . 0.0 108.586 170.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 38.8 mtt -133.49 86.14 41.16 Favored Pre-proline 0 N--CA 1.465 0.296 0 C-N-CA 124.951 1.3 . . . . 0.0 107.941 -175.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -65.12 93.0 0.22 Allowed 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.372 2.714 . . . . 0.0 109.967 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.413 ' C ' ' HE2' ' A' ' 29' ' ' LYS . 15.5 p-10 -74.05 52.79 0.46 Allowed 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 125.639 1.576 . . . . 0.0 109.679 165.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.413 ' HE2' ' C ' ' A' ' 28' ' ' ASN . 0.0 OUTLIER 51.85 -2.01 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 130.048 3.339 . . . . 0.0 117.769 173.618 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -71.84 33.32 0.06 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 128.998 2.919 . . . . 0.0 112.485 176.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.8 mt -84.46 59.7 5.59 Favored 'General case' 0 N--CA 1.457 -0.121 0 O-C-N 120.355 -1.466 . . . . 0.0 108.098 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -73.31 172.35 11.36 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.979 1.712 . . . . 0.0 109.724 169.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.7 mt -71.98 -39.21 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 O-C-N 121.472 -0.767 . . . . 0.0 110.609 -177.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -63.97 -33.81 76.58 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 118.48 0.582 . . . . 0.0 110.117 -170.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -78.47 -21.71 48.64 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 125.267 1.427 . . . . 0.0 111.688 175.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.99 -55.9 6.6 Favored 'General case' 0 CA--C 1.521 -0.17 0 O-C-N 120.639 -1.288 . . . . 0.0 112.294 -171.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -67.11 -30.71 70.8 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 118.717 -1.193 . . . . 0.0 110.191 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.418 ' O ' HD12 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -73.48 -23.36 60.06 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 117.785 -1.102 . . . . 0.0 110.308 176.975 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -49.87 -41.97 46.6 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.296 1.438 . . . . 0.0 111.295 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -58.79 -63.74 1.18 Allowed 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 172.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -44.79 -50.95 9.9 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.865 2.066 . . . . 0.0 111.447 -177.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -61.78 -65.44 0.69 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 117.304 -1.332 . . . . 0.0 109.959 177.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.7 t -53.1 -34.21 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 120.365 1.439 . . . . 0.0 111.416 -176.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.429 ' CD1' HD12 ' A' ' 48' ' ' LEU . 4.9 m-85 -60.75 -69.43 0.23 Allowed 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 124.41 1.084 . . . . 0.0 109.115 174.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -62.81 -39.84 95.53 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.312 0.645 . . . . 0.0 112.538 -173.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -70.55 -31.42 68.46 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.793 1.237 . . . . 0.0 110.858 -175.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -137.71 -58.59 0.67 Allowed 'General case' 0 C--N 1.343 0.298 0 CA-C-N 119.021 0.828 . . . . 0.0 112.238 -171.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.429 HD12 ' CD1' ' A' ' 44' ' ' PHE . 43.7 mt -59.95 -53.04 62.48 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 120.54 -1.35 . . . . 0.0 111.303 -171.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -69.49 -15.65 63.3 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.553 1.941 . . . . 0.0 111.177 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -74.49 -28.89 61.21 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 118.292 -0.861 . . . . 0.0 111.068 168.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.71 1.82 8.17 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.756 1.646 . . . . 0.0 114.235 -177.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -72.83 159.8 33.17 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 120.066 1.933 . . . . 0.0 110.71 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -139.22 -8.29 1.32 Allowed 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 126.349 1.86 . . . . 0.0 111.423 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.544 ' HB3' HG13 ' A' ' 22' ' ' VAL . 4.7 mtmt -129.25 129.25 44.72 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.029 0.931 . . . . 0.0 109.325 -175.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.5 mt -138.39 155.39 28.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 126.706 2.002 . . . . 0.0 106.433 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.695 ' CE2' HG11 ' A' ' 22' ' ' VAL . 23.8 m-85 -134.43 156.96 47.64 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 125.708 1.603 . . . . 0.0 111.459 166.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 46.5 tp -125.97 114.94 19.14 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 117.289 -1.339 . . . . 0.0 108.584 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.7 t -92.85 119.0 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 121.137 1.789 . . . . 0.0 109.206 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.4 mp -90.78 1.38 56.95 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -173.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 73.4 p -51.26 -44.28 61.73 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.636 1.974 . . . . 0.0 114.242 -171.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -68.88 -27.86 66.18 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 120.942 -1.099 . . . . 0.0 111.098 -175.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -95.13 150.86 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 125.344 1.458 . . . . 0.0 109.103 -165.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -70.2 -59.65 2.76 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 158.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.3 t -164.33 176.83 8.75 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 122.699 1.238 . . . . 0.0 110.677 -168.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.0 tt -109.12 177.95 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 128.288 2.635 . . . . 0.0 107.666 172.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -118.88 173.88 6.62 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.247 0.931 . . . . 0.0 110.381 171.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.8 t -50.5 -41.23 53.17 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 126.583 1.953 . . . . 0.0 111.428 -175.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -65.14 -58.7 5.34 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 118.154 -0.927 . . . . 0.0 111.008 -171.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 66.0 m -69.75 -36.72 76.06 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 120.293 1.406 . . . . 0.0 113.012 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.601 HD21 HG21 ' A' ' 103' ' ' THR . 39.8 tp -49.39 -43.48 44.36 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.867 1.667 . . . . 0.0 112.599 -172.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.532 ' HA2' HG12 ' A' ' 74' ' ' VAL . . . -94.98 11.41 69.55 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 120.739 -0.743 . . . . 0.0 113.797 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.6 t -85.03 -39.69 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 118.376 1.088 . . . . 0.0 108.44 153.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.4 mm -56.19 -62.76 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 119.454 1.024 . . . . 0.0 109.68 -177.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.532 HG12 ' HA2' ' A' ' 71' ' ' GLY . 9.8 p -37.13 -49.83 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 124.908 1.283 . . . . 0.0 114.289 165.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.478 ' N ' HG13 ' A' ' 74' ' ' VAL . 3.1 t-20 -60.61 -42.37 96.67 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 123.598 0.759 . . . . 0.0 109.306 -167.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 75.4 mt -55.85 -41.32 66.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.459 1.104 . . . . 0.0 108.221 176.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -58.89 -51.81 68.44 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 124.074 0.95 . . . . 0.0 110.13 177.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -56.57 -45.18 81.44 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 122.882 0.473 . . . . 0.0 110.331 -175.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -46.94 87.67 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 123.013 0.525 . . . . 0.0 110.711 175.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.6 mt -63.77 -41.24 91.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 123.702 0.801 . . . . 0.0 110.652 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.3 m -58.86 -51.11 71.42 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.713 1.205 . . . . 0.0 110.961 173.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.3 m -63.78 -26.53 68.67 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 176.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.9 m -74.24 -51.59 14.9 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.773 0.829 . . . . 0.0 110.967 174.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.74 37.49 0.62 Allowed Glycine 0 CA--C 1.529 0.965 0 CA-C-O 118.699 -1.056 . . . . 0.0 113.662 -165.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -133.76 -168.7 11.9 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 119.755 1.778 . . . . 0.0 111.602 177.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.443 ' HB3' HG22 ' A' ' 122' ' ' VAL . 11.1 m-85 -142.94 119.48 11.03 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.086 1.754 . . . . 0.0 110.111 -171.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -122.77 146.12 47.8 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.173 0.897 . . . . 0.0 109.143 172.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.629 ' C ' HD23 ' A' ' 89' ' ' LEU . . . -152.72 173.35 15.38 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.342 1.057 . . . . 0.0 111.581 -176.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.629 HD23 ' C ' ' A' ' 88' ' ' ALA . 2.5 mt -120.36 164.6 16.1 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.833 0.853 . . . . 0.0 109.527 -176.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.53 HG21 HD13 ' A' ' 115' ' ' ILE . 55.7 t -140.87 147.19 22.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 124.164 0.986 . . . . 0.0 109.468 -175.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 52.98 57.87 14.46 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.991 1.316 . . . . 0.0 111.332 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -77.15 81.69 2.55 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.202 2.601 . . . . 0.0 110.303 177.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.65 143.82 19.32 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.085 0.554 . . . . 0.0 109.668 172.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -54.77 -36.25 64.67 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.983 1.313 . . . . 0.0 113.643 -156.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.3 -41.17 62.69 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.155 0.982 . . . . 0.0 109.204 178.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -81.2 -29.67 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 118.67 0.668 . . . . 0.0 109.676 -173.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -62.81 -26.87 68.95 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.172 0.896 . . . . 0.0 110.801 172.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.75 -44.16 93.94 Favored 'General case' 0 C--N 1.344 0.33 0 O-C-N 121.465 -0.772 . . . . 0.0 109.47 175.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.679 ' O ' HG22 ' A' ' 103' ' ' THR . 9.9 p -86.3 -43.6 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 -168.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.689 HD13 ' HB3' ' A' ' 105' ' ' LEU . 0.2 OUTLIER -58.4 -24.68 60.71 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.674 1.19 . . . . 0.0 111.296 177.753 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 26.3 t -77.42 -52.79 8.54 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 120.271 1.396 . . . . 0.0 108.712 172.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 52.0 mt -58.26 -51.46 69.69 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.942 1.297 . . . . 0.0 111.76 -172.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.679 HG22 ' O ' ' A' ' 99' ' ' VAL . 5.5 t -73.79 -5.29 39.96 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.383 0.538 . . . . 0.0 111.197 -178.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 64.24 76.69 0.34 Allowed 'General case' 0 C--N 1.342 0.263 0 C-N-CA 126.832 2.053 . . . . 0.0 107.583 -174.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.689 ' HB3' HD13 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -126.84 -51.86 1.45 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.751 1.22 . . . . 0.0 109.501 -171.467 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.59 -25.54 66.3 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 122.995 1.378 . . . . 0.0 111.436 172.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 4.7 mtm180 -75.28 -8.34 56.38 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.505 1.122 . . . . 0.0 111.34 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.9 mt -130.47 -34.74 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 125.07 1.348 . . . . 0.0 109.006 -165.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.5 t -112.68 149.14 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 126.339 1.856 . . . . 0.0 108.159 175.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.93 160.97 30.63 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.688 0.795 . . . . 0.0 110.782 172.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -146.67 144.36 20.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -176.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -148.18 174.02 12.39 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.017 1.327 . . . . 0.0 112.437 -172.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.75 -44.48 9.43 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.751 0.821 . . . . 0.0 111.526 -177.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 71.1 p -126.43 168.43 14.22 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.811 1.244 . . . . 0.0 109.063 -176.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.53 HD13 HG21 ' A' ' 90' ' ' VAL . 9.0 mm -62.66 -39.89 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 167.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.3 t -70.66 -36.28 73.28 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 119.502 1.046 . . . . 0.0 110.155 -171.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -69.14 -5.65 23.7 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 118.324 -0.846 . . . . 0.0 112.225 174.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -104.42 -44.55 4.9 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 174.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 10.0 ttm -56.7 -51.83 67.27 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 125.377 1.471 . . . . 0.0 112.593 -163.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -104.8 13.75 30.76 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 126.322 1.849 . . . . 0.0 110.933 -176.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -112.98 -58.13 2.2 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.607 1.563 . . . . 0.0 109.309 -177.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.443 HG22 ' HB3' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -48.75 -39.03 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.071 0 C-N-CA 126.736 2.015 . . . . 0.0 110.501 177.612 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 12.0 mtm180 -56.5 -30.42 62.97 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 122.692 0.397 . . . . 0.0 110.668 -176.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.71 38.69 1.36 Allowed 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.745 1.218 . . . . 0.0 111.366 -174.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.875 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 167.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 11.7 p90 . . . . . 0 CA--C 1.539 0.544 0 CA-C-O 120.386 0.136 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.9 173.7 9.39 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.481 1.112 . . . . 0.0 110.209 164.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.493 ' CD1' HG22 ' A' ' 23' ' ' VAL . 9.5 mm -121.82 135.47 61.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 169.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.5 m -115.88 -169.19 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 C-N-CA 126.185 1.794 . . . . 0.0 108.051 168.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -24.08 -61.14 0.05 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 129.397 3.079 . . . . 0.0 113.823 -170.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -145.62 19.91 1.5 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.874 0.369 . . . . 0.0 111.707 161.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.586 HG11 ' CE2' ' A' ' 56' ' ' PHE . 9.4 t -110.11 136.23 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 O-C-N 120.837 -1.165 . . . . 0.0 109.192 -175.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.493 HG22 ' CD1' ' A' ' 18' ' ' ILE . 66.0 t -85.32 125.31 40.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 106.862 -1.532 . . . . 0.0 106.862 172.021 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.524 HD12 HD12 ' A' ' 115' ' ' ILE . 3.7 mm -103.5 104.2 16.31 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 173.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 25.2 mt -78.24 123.1 26.55 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 172.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 32.9 mtt -125.34 75.94 68.61 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 124.404 1.082 . . . . 0.0 109.295 -168.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -67.0 140.49 54.71 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.298 1.998 . . . . 0.0 110.875 -177.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.9 p30 -130.25 66.43 1.5 Allowed 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 128.731 2.812 . . . . 0.0 109.521 171.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.23 7.33 6.18 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.956 2.102 . . . . 0.0 113.567 167.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -73.19 -3.34 26.06 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.217 1.807 . . . . 0.0 114.435 -177.707 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.6 mt -70.19 31.92 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 128.932 2.893 . . . . 0.0 115.483 -159.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -62.35 151.29 37.2 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 128.641 2.776 . . . . 0.0 112.603 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.7 mt -53.43 -40.31 40.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 124.24 1.016 . . . . 0.0 112.183 -177.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -65.83 -30.47 71.09 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.364 0.666 . . . . 0.0 110.086 -172.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.34 -28.43 14.97 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.27 -34.82 74.28 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 117.924 -1.036 . . . . 0.0 111.831 -176.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -59.71 -64.22 1.02 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 119.569 1.077 . . . . 0.0 109.606 174.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.462 HD22 ' O ' ' A' ' 38' ' ' LEU 0.254 0.0 OUTLIER -74.93 -8.21 55.82 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-O 117.989 -1.005 . . . . 0.0 112.858 -172.922 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -41.65 -42.73 2.59 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.709 2.004 . . . . 0.0 111.993 172.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -53.55 -68.73 0.15 Allowed 'General case' 0 C--N 1.343 0.298 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 170.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -52.62 -42.49 64.64 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 125.54 1.536 . . . . 0.0 111.806 -174.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.411 ' CE3' HG23 ' A' ' 43' ' ' VAL . 15.0 t90 -55.78 -60.63 3.18 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.834 0.854 . . . . 0.0 109.533 172.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.411 HG23 ' CE3' ' A' ' 42' ' ' TRP . 53.9 t -56.37 -35.91 45.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 119.927 1.24 . . . . 0.0 111.716 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -70.06 -37.64 75.57 Favored 'General case' 0 N--CA 1.441 -0.903 0 O-C-N 121.309 -0.87 . . . . 0.0 111.048 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -105.39 -9.2 17.7 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.008 1.323 . . . . 0.0 112.308 -167.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -99.35 -20.24 16.61 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.916 1.234 . . . . 0.0 112.135 165.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -135.67 -49.49 0.71 Allowed 'General case' 0 C--N 1.349 0.577 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -174.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 35.2 mt -67.93 -44.45 76.84 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 120.041 1.291 . . . . 0.0 112.314 -169.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -69.34 -24.56 63.92 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.462 0.705 . . . . 0.0 111.845 173.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.7 mttt -66.26 -6.83 15.16 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.944 1.298 . . . . 0.0 112.676 164.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.3 21.88 72.01 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-O 118.945 -0.92 . . . . 0.0 112.589 178.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -73.08 143.03 47.57 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 119.7 1.75 . . . . 0.0 107.597 163.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -127.82 0.89 6.04 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.601 1.56 . . . . 0.0 112.754 177.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.36 124.59 43.29 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 172.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.482 HD12 HD11 ' A' ' 80' ' ' ILE . 3.3 mt -125.13 147.19 29.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 128.448 2.699 . . . . 0.0 104.362 174.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.586 ' CE2' HG11 ' A' ' 22' ' ' VAL . 18.7 m-30 -126.59 158.29 36.63 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.259 1.423 . . . . 0.0 110.475 166.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 29.5 tp -126.85 111.81 14.61 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 172.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 79.6 t -78.65 135.01 26.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 170.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 mp -117.35 20.02 13.81 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.197 0.999 . . . . 0.0 111.694 176.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.63 -51.5 67.02 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.576 1.151 . . . . 0.0 112.806 172.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -86.83 -9.75 55.08 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.127 -0.983 . . . . 0.0 111.72 -164.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.6 p -108.16 155.01 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 127.212 2.205 . . . . 0.0 108.773 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -101.68 -46.73 4.85 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.792 0.837 . . . . 0.0 109.01 172.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.1 p -155.36 170.58 21.58 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 123.767 1.746 . . . . 0.0 112.643 -166.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.4 tt -137.72 177.52 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 C-N-CA 129.242 3.017 . . . . 0.0 105.592 -176.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -131.28 170.53 14.48 Favored 'General case' 0 C--O 1.238 0.486 0 O-C-N 121.471 -0.768 . . . . 0.0 110.696 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.3 m -67.5 50.63 0.05 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 128.548 2.739 . . . . 0.0 110.994 167.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -133.0 -72.73 0.51 Allowed 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 103.986 -2.598 . . . . 0.0 103.986 155.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 m -65.9 -27.34 68.12 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 124.393 1.077 . . . . 0.0 111.92 -167.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.663 HD22 HG21 ' A' ' 103' ' ' THR . 8.8 mt -51.36 -35.06 36.83 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.218 1.007 . . . . 0.0 112.54 177.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -72.07 -34.17 61.84 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.1 t -75.54 -34.15 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 O-C-N 121.526 -0.985 . . . . 0.0 110.402 -173.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.2 mp -55.89 -45.77 80.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 170.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.7 t -63.78 -45.99 95.69 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 O-C-N 121.048 -1.033 . . . . 0.0 110.04 175.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -50.24 -39.7 45.45 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.883 1.22 . . . . 0.0 113.247 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 65.6 mt -60.88 -47.81 91.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.203 1.001 . . . . 0.0 109.715 174.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.521 ' HG ' HG12 ' A' ' 109' ' ' VAL . 1.1 tm? -59.57 -47.09 86.91 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.7 mttt -56.69 -46.32 81.26 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 119.063 -0.494 . . . . 0.0 110.675 -175.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.8 t -54.39 -58.41 7.55 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 174.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.482 HD11 HD12 ' A' ' 55' ' ' ILE . 81.5 mt -55.58 -48.18 77.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.619 1.167 . . . . 0.0 111.628 -174.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.5 m -69.01 -14.38 63.01 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 117.651 -1.166 . . . . 0.0 112.947 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 51.3 m -87.42 -45.07 10.86 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.474 1.034 . . . . 0.0 110.506 163.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.8 m -66.19 -17.63 64.85 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 126.112 1.765 . . . . 0.0 115.014 -175.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.94 0.2 9.81 Favored Glycine 0 C--N 1.336 0.552 0 CA-C-O 118.116 -1.38 . . . . 0.0 116.307 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -115.85 -165.31 14.36 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-N 119.859 1.829 . . . . 0.0 113.699 -163.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.401 ' HB3' ' CG2' ' A' ' 122' ' ' VAL . 1.0 OUTLIER -131.61 154.41 48.91 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.888 1.675 . . . . 0.0 108.852 173.202 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.494 ' HB3' HD23 ' A' ' 77' ' ' LEU . 13.5 t80 -123.76 141.48 51.99 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 168.063 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.71 ' C ' HD23 ' A' ' 89' ' ' LEU . . . -144.38 167.18 23.09 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 119.468 -0.893 . . . . 0.0 112.163 167.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.71 HD23 ' C ' ' A' ' 88' ' ' ALA . 1.4 mt -120.86 160.05 24.23 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -175.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.489 HG21 HD13 ' A' ' 115' ' ' ILE . 26.4 t -134.28 138.34 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -171.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.7 m 58.45 60.23 5.7 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 125.034 1.334 . . . . 0.0 111.952 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -82.74 101.02 1.01 Allowed 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.171 2.581 . . . . 0.0 110.001 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -65.72 170.54 5.12 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.896 1.278 . . . . 0.0 108.899 175.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -72.2 -30.04 64.55 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.167 -0.958 . . . . 0.0 111.449 -175.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.402 ' HE3' ' O ' ' A' ' 95' ' ' LYS . 0.2 OUTLIER -58.42 -45.95 87.43 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 120.804 -1.185 . . . . 0.0 108.896 176.934 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 31.3 m -79.07 -37.24 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.856 0 CA-C-O 117.355 -1.307 . . . . 0.0 111.261 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -56.36 -30.65 62.93 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 121.292 1.86 . . . . 0.0 109.329 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.62 -38.41 90.12 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.689 177.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.53 ' O ' HG22 ' A' ' 103' ' ' THR . 6.4 p -95.81 -28.41 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -170.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.17 -15.37 63.08 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 124.973 1.309 . . . . 0.0 110.231 177.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.52 -55.28 4.97 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 120.05 1.295 . . . . 0.0 107.881 168.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.28 -43.26 86.9 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.966 2.106 . . . . 0.0 112.191 -163.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.663 HG21 HD22 ' A' ' 70' ' ' LEU . 2.1 t -76.45 -6.34 51.31 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.563 0.745 . . . . 0.0 110.964 177.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.7 m120 52.63 83.56 0.06 Allowed 'General case' 0 C--N 1.346 0.425 0 C-N-CA 129.376 3.071 . . . . 0.0 107.875 -163.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.95 -72.96 0.68 Allowed 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 176.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -61.74 -24.47 66.83 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.77 1.228 . . . . 0.0 110.728 174.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -75.15 5.9 4.89 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 120.777 -1.202 . . . . 0.0 111.313 176.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.9 mt -129.45 -43.39 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 C-N-CA 127.795 2.438 . . . . 0.0 107.829 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.521 HG12 ' HG ' ' A' ' 77' ' ' LEU . 3.3 m -98.25 178.69 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 C-N-CA 127.066 2.146 . . . . 0.0 113.137 -172.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.42 ' HB2' ' HB2' ' A' ' 88' ' ' ALA . 24.7 mmtm -99.58 162.95 12.71 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 124.099 0.96 . . . . 0.0 110.086 170.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -151.18 136.47 10.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -171.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -145.03 167.1 23.47 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.41 1.084 . . . . 0.0 112.668 -169.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.14 -38.64 17.53 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.876 -0.515 . . . . 0.0 111.183 -174.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.1 p -134.64 177.21 7.96 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.524 HD12 HD12 ' A' ' 24' ' ' ILE . 15.1 mm -71.19 -40.56 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.278 174.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.4 t -70.3 -32.63 70.49 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 119.424 1.011 . . . . 0.0 110.143 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -70.7 0.57 6.76 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.617 172.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.39 -37.04 3.83 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 119.259 0.936 . . . . 0.0 109.523 175.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 20.7 ttm -63.67 -55.27 24.77 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.984 1.314 . . . . 0.0 111.788 -160.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -81.61 -18.79 43.52 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.064 0.459 . . . . 0.0 110.265 173.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -80.33 -49.02 12.09 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -162.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.401 ' CG2' ' HB3' ' A' ' 86' ' ' PHE . 4.1 p -42.26 -40.48 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 127.856 2.462 . . . . 0.0 111.461 174.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -58.01 -45.83 86.25 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 125.106 1.362 . . . . 0.0 113.423 177.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.09 34.62 3.08 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.364 1.866 . . . . 0.0 110.778 -166.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.417 ' CG ' ' HE2' ' A' ' 110' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.847 0 C-N-CA 127.076 2.151 . . . . 0.0 111.67 -176.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 20.8 p90 . . . . . 0 N--CA 1.445 -0.723 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -127.62 176.74 7.28 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 120.791 -1.193 . . . . 0.0 108.451 164.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.9 mt -132.32 120.13 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 171.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.6 m -102.33 -175.93 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 166.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -26.74 -55.95 0.08 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 130.199 3.4 . . . . 0.0 113.95 -157.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -143.5 8.97 1.58 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 118.775 -0.631 . . . . 0.0 111.241 164.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.53 HG11 ' CE2' ' A' ' 56' ' ' PHE . 21.3 t -111.32 115.62 50.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 -172.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 38.9 t -68.3 156.4 7.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 173.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.592 HD12 HD12 ' A' ' 115' ' ' ILE . 10.7 mm -130.6 98.4 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 177.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.53 134.49 45.28 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 120.24 1.382 . . . . 0.0 108.25 168.154 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 51.6 mtm -128.83 72.7 81.53 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 123.644 0.778 . . . . 0.0 109.551 -177.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.59 145.3 57.73 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.31 2.674 . . . . 0.0 112.577 -176.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.461 ' HB2' ' HE3' ' A' ' 29' ' ' LYS . 0.5 OUTLIER -118.87 -77.8 0.58 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 126.056 1.742 . . . . 0.0 110.452 174.689 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.461 ' HE3' ' HB2' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -135.56 13.85 3.45 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.001 1.321 . . . . 0.0 111.07 -173.571 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -108.78 18.42 20.8 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 120.967 -1.083 . . . . 0.0 112.103 -162.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 19.8 mt -92.62 68.06 4.68 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 124.146 0.978 . . . . 0.0 109.087 -176.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -81.23 144.24 31.73 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.2 tt -52.83 -37.19 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 CA-C-N 119.006 0.821 . . . . 0.0 111.82 170.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -62.62 -52.73 62.2 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.49 -0.756 . . . . 0.0 109.71 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -76.01 -16.38 59.97 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-O 118.228 -0.892 . . . . 0.0 111.96 177.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.73 -40.8 88.5 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.909 1.231 . . . . 0.0 110.518 171.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -60.6 -39.03 86.63 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 120.433 -1.417 . . . . 0.0 109.575 174.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 90.1 mt -73.04 -23.55 60.6 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.783 1.233 . . . . 0.0 113.05 178.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -53.98 -37.67 64.22 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.175 1.39 . . . . 0.0 110.97 -170.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.412 ' HE2' ' CZ ' ' A' ' 44' ' ' PHE . 0.4 OUTLIER -63.35 -52.49 61.53 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.072 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.89 -47.96 73.64 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 124.815 1.246 . . . . 0.0 109.834 178.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.534 ' CE3' HG23 ' A' ' 43' ' ' VAL . 17.6 t90 -58.57 -69.74 0.17 Allowed 'General case' 0 C--O 1.219 -0.549 0 O-C-N 124.593 1.183 . . . . 0.0 109.79 176.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.534 HG23 ' CE3' ' A' ' 42' ' ' TRP . 71.0 t -52.89 -32.21 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 121.153 1.797 . . . . 0.0 111.549 -175.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.483 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 4.0 m-85 -61.43 -77.15 0.05 OUTLIER 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 123.612 0.765 . . . . 0.0 110.051 172.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.468 ' HA ' ' HB2' ' A' ' 49' ' ' ASN . 0.6 OUTLIER -64.95 -28.47 69.54 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -172.183 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.416 ' HG2' ' CZ ' ' A' ' 47' ' ' PHE . 0.7 OUTLIER -74.9 -30.06 61.17 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.347 1.459 . . . . 0.0 110.445 176.695 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.416 ' CZ ' ' HG2' ' A' ' 46' ' ' GLU . 13.6 m-85 -139.83 -66.71 0.45 Allowed 'General case' 0 C--N 1.348 0.508 0 CA-C-N 119.603 1.092 . . . . 0.0 111.609 -172.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.483 ' HB2' ' HA ' ' A' ' 44' ' ' PHE . 18.5 mt -57.37 -54.35 47.78 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 120.878 -1.139 . . . . 0.0 113.081 -169.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.468 ' HB2' ' HA ' ' A' ' 45' ' ' ASP . 78.4 m-20 -67.48 -34.63 77.56 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 125.864 1.665 . . . . 0.0 109.127 177.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.12 -39.07 71.65 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.106 1.362 . . . . 0.0 111.279 176.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 139.65 8.51 0.94 Allowed Glycine 0 CA--C 1.535 1.334 0 C-N-CA 125.123 1.344 . . . . 0.0 113.93 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -92.34 150.3 20.92 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 119.023 1.412 . . . . 0.0 111.392 -177.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.401 ' O ' ' HA3' ' A' ' 85' ' ' GLY . 0.6 OUTLIER -143.22 44.79 1.55 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.287 1.835 . . . . 0.0 108.247 -172.949 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.462 ' HG3' HG22 ' A' ' 22' ' ' VAL . 0.0 OUTLIER 171.59 149.84 0.05 OUTLIER 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 126.015 1.726 . . . . 0.0 107.829 179.129 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -153.34 163.0 2.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 105.342 -2.095 . . . . 0.0 105.342 -174.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.53 ' CE2' HG11 ' A' ' 22' ' ' VAL . 9.6 m-85 -136.29 148.88 48.18 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.45 1.5 . . . . 0.0 108.615 169.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 50.5 tp -124.27 110.56 14.77 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.251 1.021 . . . . 0.0 109.808 177.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.3 135.57 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 173.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 mp -123.65 43.25 3.02 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.953 0.882 . . . . 0.0 110.288 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.8 t -99.98 -49.58 4.27 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.945 0.898 . . . . 0.0 109.029 -176.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.82 -14.45 58.04 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.126 -0.984 . . . . 0.0 111.159 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.7 p -106.0 118.71 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 125.596 1.559 . . . . 0.0 107.232 174.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -68.83 -51.63 38.6 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 176.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 86.2 p -157.76 166.62 32.27 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.86 -169.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 21.3 tt -135.49 148.99 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 C-N-CA 124.882 1.273 . . . . 0.0 108.333 -168.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -71.49 155.24 40.81 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.2 p -63.97 -14.35 53.24 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 117.902 -1.047 . . . . 0.0 113.77 -174.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -68.53 -71.37 0.22 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.036 1.334 . . . . 0.0 108.934 172.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 41.0 t -63.0 -34.1 76.84 Favored 'General case' 0 C--N 1.339 0.136 0 O-C-N 121.911 -0.493 . . . . 0.0 111.029 -169.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 50.9 tp -40.66 -39.86 1.16 Allowed 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 125.595 1.558 . . . . 0.0 114.041 169.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.401 ' HA2' HG12 ' A' ' 74' ' ' VAL . . . -107.54 0.25 34.63 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 118.44 0.564 . . . . 0.0 113.246 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.0 t -75.28 -30.05 22.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 O-C-N 120.774 -1.427 . . . . 0.0 108.647 161.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.6 mt -66.87 -61.15 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 125.181 1.392 . . . . 0.0 112.542 175.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.401 HG12 ' HA2' ' A' ' 71' ' ' GLY . 7.4 p -41.77 -49.19 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 168.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -45.79 -36.79 5.42 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.567 1.547 . . . . 0.0 112.863 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 90.8 mt -64.52 -46.87 91.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.295 1.038 . . . . 0.0 108.558 175.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -52.9 -48.6 67.08 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.635 0.774 . . . . 0.0 109.728 176.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -56.49 -43.03 79.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 118.955 -0.545 . . . . 0.0 111.067 -174.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.0 m -57.7 -64.79 0.78 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 118.883 -0.58 . . . . 0.0 111.352 166.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 80' ' ' ILE . 51.1 mt -61.52 -42.71 95.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 119.303 0.956 . . . . 0.0 111.502 -166.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.4 m -57.07 -47.55 80.71 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 119.323 0.965 . . . . 0.0 110.179 175.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.5 m -63.54 -34.28 77.44 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.975 0.807 . . . . 0.0 111.689 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 56.6 m -67.57 -38.08 83.56 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 118.604 -0.712 . . . . 0.0 111.941 173.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 105.03 59.37 0.66 Allowed Glycine 0 N--CA 1.448 -0.52 0 CA-C-O 119.162 -0.799 . . . . 0.0 111.136 -166.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 53' ' ' ASN . . . -148.68 -176.45 22.07 Favored Glycine 0 N--CA 1.439 -1.149 0 CA-C-N 118.891 1.345 . . . . 0.0 111.553 177.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.555 ' HB3' HG22 ' A' ' 122' ' ' VAL . 1.8 m-85 -130.9 92.13 3.17 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 122.084 -0.656 . . . . 0.0 112.439 -158.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -104.76 134.75 47.38 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.839 -1.163 . . . . 0.0 110.545 174.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -142.48 167.43 22.11 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.623 1.569 . . . . 0.0 112.472 175.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.438 ' N ' HD12 ' A' ' 89' ' ' LEU . 7.1 mp -113.9 153.13 29.75 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 127.54 2.336 . . . . 0.0 108.299 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 72.8 t -141.09 135.35 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -166.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.7 t 48.46 56.14 17.66 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.691 1.196 . . . . 0.0 110.645 -170.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -72.42 0.09 7.97 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.304 2.669 . . . . 0.0 114.777 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 18.6 p30 47.63 -163.04 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.733 1.613 . . . . 0.0 112.662 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -95.91 -41.54 8.75 Favored 'General case' 0 C--O 1.225 -0.196 0 O-C-N 120.473 -1.392 . . . . 0.0 109.416 174.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.489 ' O ' ' HE3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -53.74 -50.84 65.1 Favored 'General case' 0 C--O 1.227 -0.126 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -175.548 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.3 t -68.84 -47.52 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-O 118.571 -0.728 . . . . 0.0 109.143 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -60.95 -19.74 61.33 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 120.513 1.506 . . . . 0.0 112.273 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.5 -15.52 63.27 Favored 'General case' 0 C--O 1.216 -0.664 0 O-C-N 120.785 -1.197 . . . . 0.0 111.081 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.414 ' O ' HG22 ' A' ' 103' ' ' THR . 2.6 t -118.59 -34.13 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 C-N-CA 125.822 1.649 . . . . 0.0 108.25 -175.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.45 -14.84 31.85 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 117.617 -1.182 . . . . 0.0 109.08 175.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.8 m -79.69 -29.66 40.83 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 117.907 -1.517 . . . . 0.0 109.813 174.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -92.05 -25.33 18.84 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 129.103 2.961 . . . . 0.0 111.421 -159.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.42 HG23 HD23 ' A' ' 105' ' ' LEU . 3.7 t -113.65 35.44 4.05 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.858 1.663 . . . . 0.0 108.296 174.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 35.21 62.38 0.57 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.524 1.93 . . . . 0.0 110.585 176.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.42 HD23 HG23 ' A' ' 103' ' ' THR . 0.0 OUTLIER -114.54 -51.47 2.75 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -166.671 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.5 -24.49 67.84 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 118.616 0.644 . . . . 0.0 111.308 173.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.6 mtt-85 -80.03 -11.25 59.79 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 118.476 -0.773 . . . . 0.0 112.97 -177.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.0 mt -128.1 -37.13 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 C-N-CA 124.49 1.116 . . . . 0.0 109.577 -167.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.6 t -104.26 141.01 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 171.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.52 158.98 34.17 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.882 1.273 . . . . 0.0 111.295 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.1 mp -130.98 146.36 34.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 124.878 1.271 . . . . 0.0 108.077 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -147.02 168.13 22.3 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 127.286 2.234 . . . . 0.0 109.849 175.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.53 -51.77 7.48 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 75.4 p -130.81 171.6 12.95 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 123.165 0.586 . . . . 0.0 109.715 -171.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.592 HD12 HD12 ' A' ' 24' ' ' ILE . 11.8 mm -66.49 -39.3 83.64 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 CA-C-O 118.074 -0.965 . . . . 0.0 108.837 178.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.2 t -67.27 -36.99 82.72 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 118.862 0.756 . . . . 0.0 109.771 -175.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -62.22 -9.31 7.42 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 124.321 1.049 . . . . 0.0 112.256 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.467 ' HB1' ' CZ ' ' A' ' 56' ' ' PHE . . . -116.79 -34.45 4.47 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 124.676 1.19 . . . . 0.0 109.636 -175.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 12.4 ttp -61.8 -46.18 90.67 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 120.593 -1.317 . . . . 0.0 112.549 -161.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.429 ' HA ' ' HG3' ' A' ' 123' ' ' ARG . 14.6 pt-20 -101.52 -2.63 30.18 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.66 1.984 . . . . 0.0 112.112 176.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -91.49 -62.6 1.4 Allowed 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.555 HG22 ' HB3' ' A' ' 86' ' ' PHE . 0.3 OUTLIER -42.43 -37.4 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.307 0 C-N-CA 127.534 2.334 . . . . 0.0 111.553 174.054 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.429 ' HG3' ' HA ' ' A' ' 120' ' ' GLU . 10.1 mmt180 -44.02 -35.45 2.1 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 125.446 1.498 . . . . 0.0 113.32 174.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.09 22.96 2.23 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 172.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.306 0.1 OUTLIER . . . . . 0 C--O 1.249 1.076 0 C-N-CA 129.436 3.094 . . . . 0.0 116.08 -162.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.1 p90 . . . . . 0 N--CA 1.45 -0.444 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.519 ' HE2' HG12 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -135.01 175.31 9.69 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 121.978 -0.451 . . . . 0.0 110.192 168.21 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 67.4 mt -130.45 119.24 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 126.303 1.841 . . . . 0.0 106.944 175.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.519 HG12 ' HE2' ' A' ' 17' ' ' LYS . 33.7 m -100.59 -154.35 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 127.529 2.331 . . . . 0.0 106.792 174.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -25.94 -77.41 0.01 OUTLIER 'General case' 0 C--O 1.241 0.658 0 C-N-CA 129.805 3.242 . . . . 0.0 111.467 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -148.21 28.07 0.92 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 127.961 2.504 . . . . 0.0 109.828 170.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.648 HG11 ' CE2' ' A' ' 56' ' ' PHE . 20.2 t -119.68 148.03 22.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.7 t -103.7 140.29 22.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 177.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.409 HG13 HD12 ' A' ' 115' ' ' ILE . 1.8 mp -118.22 101.54 11.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 177.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.32 146.55 45.18 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 120.416 1.462 . . . . 0.0 108.453 165.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 69.7 mtm -127.98 79.58 73.54 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 124.63 1.172 . . . . 0.0 108.267 178.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -58.05 135.66 70.02 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.813 2.342 . . . . 0.0 110.636 177.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.22 -105.36 0.22 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.339 1.856 . . . . 0.0 106.312 169.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.92 69.4 1.04 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 121.551 1.978 . . . . 0.0 111.247 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -154.9 4.93 0.23 Allowed 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 115.505 1.668 . . . . 0.0 115.505 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.01 37.63 0.55 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 120.576 1.535 . . . . 0.0 109.988 172.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -77.74 157.4 30.06 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.771 1.629 . . . . 0.0 109.599 171.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 61.1 mt -62.15 -35.82 71.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 123.938 0.895 . . . . 0.0 110.704 -174.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -73.33 -8.86 57.67 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.11 -0.994 . . . . 0.0 111.402 -177.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -113.54 28.83 8.47 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.343 1.857 . . . . 0.0 109.754 171.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.68 -54.51 2.6 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 120.733 -1.229 . . . . 0.0 111.7 -175.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 40.7 t60 -62.07 -52.24 64.73 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 120.623 1.556 . . . . 0.0 109.759 175.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.541 HD12 ' C ' ' A' ' 38' ' ' LEU . 0.5 OUTLIER -59.89 -24.73 64.52 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-O 118.748 -0.644 . . . . 0.0 111.167 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -51.86 -44.76 63.81 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 124.88 1.272 . . . . 0.0 110.625 -177.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -64.68 -44.71 89.46 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.82 -41.45 97.87 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 119.038 0.836 . . . . 0.0 112.205 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 15.6 t90 -58.81 -66.28 0.52 Allowed 'General case' 0 C--O 1.221 -0.401 0 CA-C-O 117.23 -1.367 . . . . 0.0 107.479 173.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.5 t -52.93 -36.11 23.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 120.585 1.539 . . . . 0.0 112.193 -177.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -57.76 -67.0 0.38 Allowed 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 124.04 0.936 . . . . 0.0 110.028 173.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.29 -45.43 66.34 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 121.441 -0.787 . . . . 0.0 111.684 -171.118 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -62.42 -28.75 70.01 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.939 1.696 . . . . 0.0 111.006 -175.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -136.69 -65.85 0.55 Allowed 'General case' 0 C--N 1.346 0.432 0 C-N-CA 123.19 0.596 . . . . 0.0 111.53 -172.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 44.3 mt -55.58 -53.68 53.5 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.147 0.885 . . . . 0.0 111.822 -168.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -71.5 -34.26 69.96 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.513 1.925 . . . . 0.0 109.834 176.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.03 -30.16 65.92 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 118.242 -0.885 . . . . 0.0 112.021 177.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 140.26 -0.49 2.03 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 119.25 -0.75 . . . . 0.0 113.805 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -92.51 154.81 18.23 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 119.803 1.801 . . . . 0.0 110.347 -174.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -134.85 6.72 3.44 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.806 1.242 . . . . 0.0 109.816 172.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.407 ' HB3' HG13 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -135.86 132.21 36.29 Favored 'General case' 0 CA--C 1.518 -0.288 0 O-C-N 120.583 -1.323 . . . . 0.0 107.769 -176.846 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.9 mt -135.71 154.02 33.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 126.094 1.758 . . . . 0.0 106.422 175.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.704 ' CE1' HG21 ' A' ' 122' ' ' VAL . 20.1 m-85 -129.54 152.71 48.78 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.725 1.61 . . . . 0.0 109.702 163.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 54.8 tp -118.97 112.35 19.49 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 118.149 -0.929 . . . . 0.0 110.069 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.505 ' CG2' HD11 ' A' ' 115' ' ' ILE . 47.2 t -90.72 111.18 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 119.175 0.898 . . . . 0.0 109.474 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.539 HD22 HG11 ' A' ' 96' ' ' VAL . 1.8 mp -91.64 5.23 50.48 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.425 0.69 . . . . 0.0 112.514 -177.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 24.3 m -51.59 -42.13 61.69 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.094 0.958 . . . . 0.0 113.221 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -85.23 -29.26 24.8 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.766 0.712 . . . . 0.0 111.09 -174.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.8 p -80.82 173.1 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 O-C-N 121.34 -0.85 . . . . 0.0 109.158 -173.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -121.56 -46.14 2.27 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 120.588 -1.32 . . . . 0.0 109.31 172.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.9 p -150.1 172.63 14.97 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.537 0.684 . . . . 0.0 112.402 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.3 tt -133.48 153.18 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 126.072 1.749 . . . . 0.0 107.323 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -85.16 162.5 19.2 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 122.579 0.352 . . . . 0.0 110.206 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.2 -36.79 66.31 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.598 0.759 . . . . 0.0 111.903 179.117 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -55.57 -72.93 0.06 Allowed 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.049 1.74 . . . . 0.0 109.59 -178.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 53.5 m -64.27 -30.86 71.9 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 118.249 -0.881 . . . . 0.0 112.662 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.3 tp -59.39 -16.89 25.89 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 120.521 1.509 . . . . 0.0 112.769 -177.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -90.73 -33.97 8.1 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 118.995 0.816 . . . . 0.0 112.843 167.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.6 t -64.2 -36.84 78.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 O-C-N 121.149 -1.206 . . . . 0.0 110.363 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp -52.72 -51.38 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 175.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.4 t -66.02 -35.74 75.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 O-C-N 120.95 -1.094 . . . . 0.0 110.268 177.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.69 -45.05 82.02 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 119.662 1.119 . . . . 0.0 111.268 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 71.7 mt -59.45 -33.72 52.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 123.438 0.695 . . . . 0.0 109.21 175.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -69.8 -44.9 69.1 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 120.269 1.395 . . . . 0.0 108.44 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 48.7 mttm -58.87 -47.31 85.37 Favored 'General case' 0 C--N 1.335 -0.025 0 CA-C-O 118.584 -0.722 . . . . 0.0 110.151 177.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 31.8 m -51.45 -59.55 4.12 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 123.684 0.794 . . . . 0.0 110.272 172.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 21.1 mt -53.96 -43.76 59.28 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 C-N-CA 124.278 1.031 . . . . 0.0 111.406 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 51.6 p -57.35 -48.77 78.14 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.207 0.912 . . . . 0.0 109.974 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.5 -33.87 76.66 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.762 1.625 . . . . 0.0 111.304 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.4 m -67.76 -16.58 64.19 Favored 'General case' 0 C--N 1.335 -0.056 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 170.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.86 1.09 61.79 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-N 119.196 0.907 . . . . 0.0 113.664 -172.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -92.65 -175.99 41.46 Favored Glycine 0 N--CA 1.432 -1.608 0 CA-C-N 118.892 1.346 . . . . 0.0 112.193 -175.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -136.09 155.92 49.48 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.537 1.535 . . . . 0.0 109.517 178.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -152.39 147.17 25.97 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 175.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -148.04 161.04 42.18 Favored 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 124.152 0.908 . . . . 0.0 111.638 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.449 ' CD1' HG11 ' A' ' 109' ' ' VAL . 7.3 mp -106.73 158.17 17.17 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.795 1.638 . . . . 0.0 108.186 -176.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 84.9 t -142.41 135.67 27.55 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -165.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 46.41 57.82 16.62 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 124.904 1.281 . . . . 0.0 109.656 -173.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -72.32 88.75 0.84 Allowed 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.177 2.584 . . . . 0.0 108.604 -178.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -54.46 148.98 11.05 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.657 0.741 . . . . 0.0 110.647 -175.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -54.49 -34.11 61.02 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.671 1.588 . . . . 0.0 111.582 -168.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -49.15 70.23 Favored 'General case' 0 CA--C 1.521 -0.172 0 O-C-N 120.327 -1.483 . . . . 0.0 108.645 177.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.539 HG11 HD22 ' A' ' 59' ' ' LEU . 1.1 t -62.05 -47.9 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 123.774 0.83 . . . . 0.0 110.386 175.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.43 -36.95 64.57 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.827 2.051 . . . . 0.0 109.846 -172.28 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.84 -59.07 4.18 Favored 'General case' 0 N--CA 1.424 -1.728 0 C-N-CA 126.731 2.012 . . . . 0.0 111.54 177.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.609 ' O ' HG22 ' A' ' 103' ' ' THR . 8.0 t -65.53 -45.58 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 CA-C-N 111.754 -2.476 . . . . 0.0 107.284 -176.117 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.81 -17.55 16.6 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.965 0.906 . . . . 0.0 110.222 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 65.6 m -117.0 16.7 15.06 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 124.551 1.157 . . . . 0.0 112.314 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 62.2 mt -123.23 -16.25 6.98 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 129.484 3.114 . . . . 0.0 111.435 169.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.609 HG22 ' O ' ' A' ' 99' ' ' VAL . 4.7 t -113.61 1.13 14.84 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.837 2.055 . . . . 0.0 110.632 -177.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 44.99 81.59 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.811 1.644 . . . . 0.0 110.201 -165.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.52 -53.26 2.53 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 173.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.89 -12.04 51.57 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.372 1.069 . . . . 0.0 112.867 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.4 mtt85 -98.66 4.05 47.88 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.848 1.659 . . . . 0.0 111.199 -178.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.3 mt -132.84 -37.24 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 126.031 1.732 . . . . 0.0 110.019 -173.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.449 HG11 ' CD1' ' A' ' 89' ' ' LEU . 2.7 t -111.15 149.78 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 177.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.24 159.01 35.4 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.224 0.61 . . . . 0.0 109.888 174.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -131.99 151.47 35.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 125.041 1.337 . . . . 0.0 108.625 178.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -148.02 173.0 13.35 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 127.055 2.142 . . . . 0.0 110.639 173.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.57 -39.24 14.27 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 123.563 0.745 . . . . 0.0 109.231 177.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 25.2 p -136.86 170.48 16.02 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.043 0.937 . . . . 0.0 110.837 -173.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.505 HD11 ' CG2' ' A' ' 58' ' ' VAL . 19.9 mm -63.94 -45.36 97.1 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 CA-C-O 117.754 -1.117 . . . . 0.0 108.587 172.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.3 t -67.38 -36.72 81.9 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 119.228 0.922 . . . . 0.0 109.134 -169.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -70.87 -15.35 62.62 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 176.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.715 ' O ' HG23 ' A' ' 122' ' ' VAL . . . -86.48 -49.34 7.66 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 174.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.95 -52.24 63.61 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.762 1.225 . . . . 0.0 111.316 -160.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.06 -7.98 54.49 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 127.906 2.482 . . . . 0.0 114.446 176.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -104.28 -53.25 2.76 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 118.795 0.725 . . . . 0.0 109.355 -169.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 118' ' ' ALA . 12.8 t -50.68 -33.63 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 C-N-CA 129.336 3.054 . . . . 0.0 110.39 172.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -43.46 -36.96 2.18 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.006 0.922 . . . . 0.0 113.243 166.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.57 24.08 3.15 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 116.452 2.019 . . . . 0.0 116.452 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 31.5 mmtt . . . . . 0 C--O 1.255 1.383 0 C-N-CA 129.56 3.144 . . . . 0.0 103.174 177.666 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 25.9 p90 . . . . . 0 C--O 1.239 0.533 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.88 170.27 10.28 Favored 'General case' 0 N--CA 1.46 0.069 0 C-N-CA 123.937 0.895 . . . . 0.0 110.286 169.118 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.1 mt -131.49 150.57 34.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 174.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.4 m -120.27 -133.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 126.408 1.883 . . . . 0.0 107.03 176.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -46.38 -75.41 0.03 OUTLIER 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 127.565 2.346 . . . . 0.0 111.312 -177.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -143.35 27.79 1.54 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.821 1.649 . . . . 0.0 108.434 172.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.749 HG11 ' CE2' ' A' ' 56' ' ' PHE . 11.7 t -121.73 138.94 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 C-N-CA 124.172 0.989 . . . . 0.0 108.451 -175.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 72.5 t -99.21 140.44 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 125.668 1.587 . . . . 0.0 107.546 -178.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mp -119.42 95.98 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 126.402 1.881 . . . . 0.0 105.957 -178.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 31.5 mt -84.8 126.28 33.3 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 177.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 56.1 mtm -125.76 92.02 47.25 Favored Pre-proline 0 N--CA 1.464 0.274 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.76 106.53 1.68 Allowed 'Trans proline' 0 N--CA 1.45 -1.074 0 N-CA-C 108.28 -1.469 . . . . 0.0 108.28 176.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -74.79 55.53 0.68 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.264 1.026 . . . . 0.0 111.549 172.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.99 41.11 3.76 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.447 1.499 . . . . 0.0 112.866 -173.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -105.75 48.85 0.82 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-O 122.222 1.01 . . . . 0.0 110.317 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.61 68.36 8.66 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 123.483 1.611 . . . . 0.0 108.185 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -68.05 3.23 1.67 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 129.577 3.151 . . . . 0.0 114.977 -174.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 mt 65.65 -56.3 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 129.795 3.238 . . . . 0.0 111.378 -167.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -63.81 -31.98 73.34 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 118.258 0.481 . . . . 0.0 109.777 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -59.4 -60.1 4.39 Favored 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 124.147 0.979 . . . . 0.0 109.117 165.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.454 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . . . -51.19 -38.91 54.96 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 120.515 1.507 . . . . 0.0 114.448 -178.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -67.86 -34.04 75.92 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.702 1.137 . . . . 0.0 111.881 178.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.17 -19.0 30.74 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-O 118.154 -0.927 . . . . 0.0 110.883 177.178 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.454 ' HB2' ' HA ' ' A' ' 36' ' ' ALA . 5.7 t80 -46.62 -49.96 18.26 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 127.917 2.487 . . . . 0.0 110.299 -172.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.0 -57.22 11.07 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 124.6 1.16 . . . . 0.0 109.917 175.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -56.55 -48.98 76.13 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 124.561 1.145 . . . . 0.0 112.07 178.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -56.54 -71.77 0.09 Allowed 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 117.574 -1.203 . . . . 0.0 108.055 178.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.6 t -46.39 -42.72 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.089 0.955 . . . . 0.0 109.373 -177.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 -60.22 -59.97 4.57 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 120.606 1.548 . . . . 0.0 111.643 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -68.63 -4.04 14.09 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.619 1.568 . . . . 0.0 111.991 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -107.17 -33.04 7.56 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 116.413 -1.756 . . . . 0.0 108.956 -177.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.619 ' HB2' HD22 ' A' ' 48' ' ' LEU . 54.4 m-85 -134.57 -49.81 0.78 Allowed 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 123.603 2.91 . . . . 0.0 109.335 -174.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.619 HD22 ' HB2' ' A' ' 47' ' ' PHE . 1.9 mm? -69.49 -57.0 5.79 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 124.039 0.936 . . . . 0.0 110.666 -169.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -62.81 -27.22 69.17 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.571 0.748 . . . . 0.0 109.781 174.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -66.66 -20.14 65.92 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.862 1.665 . . . . 0.0 113.616 171.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.02 6.18 46.02 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.297 1.427 . . . . 0.0 114.787 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -76.57 149.81 36.58 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 119.994 1.897 . . . . 0.0 110.236 172.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -130.02 6.18 5.0 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.216 1.006 . . . . 0.0 112.791 -178.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.512 ' HB3' HG13 ' A' ' 22' ' ' VAL . 1.5 mtmt -133.16 113.09 12.3 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 120.683 1.583 . . . . 0.0 106.856 178.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.0 mp -118.11 151.2 20.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 104.732 -2.321 . . . . 0.0 104.732 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.749 ' CE2' HG11 ' A' ' 22' ' ' VAL . 20.3 m-85 -132.89 160.28 37.45 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 124.525 1.13 . . . . 0.0 110.318 166.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.4 tp -137.72 86.89 2.21 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.866 1.266 . . . . 0.0 108.71 175.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.569 HG12 ' H ' ' A' ' 60' ' ' SER . 95.0 t -60.74 138.57 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 128.428 2.691 . . . . 0.0 107.2 168.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.582 HD22 HG21 ' A' ' 96' ' ' VAL . 2.9 mp -117.81 37.08 4.06 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.29 1.836 . . . . 0.0 109.445 173.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.569 ' H ' HG12 ' A' ' 58' ' ' VAL . 19.9 t -76.42 -38.85 54.98 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.278 1.431 . . . . 0.0 110.688 178.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.97 2.62 51.77 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.917 0.78 . . . . 0.0 111.604 -173.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.3 p -133.24 174.52 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 127.977 2.511 . . . . 0.0 107.464 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -118.4 -31.38 4.95 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.298 0.639 . . . . 0.0 111.64 177.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.1 t -159.01 158.86 34.0 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.746 0.784 . . . . 0.0 112.478 165.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -76.84 166.29 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-N 113.874 -1.512 . . . . 0.0 108.531 160.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -103.8 159.47 15.61 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.206 1.402 . . . . 0.0 110.608 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.34 6.17 0.84 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.615 1.166 . . . . 0.0 113.491 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -76.87 -78.22 0.13 Allowed 'General case' 0 CA--C 1.535 0.376 0 O-C-N 120.956 -1.09 . . . . 0.0 108.766 155.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.8 t -69.93 -13.74 62.39 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -169.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.488 HD21 HG21 ' A' ' 103' ' ' THR . 33.1 tp -47.06 -31.31 3.26 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.054 1.342 . . . . 0.0 111.674 168.021 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.06 -28.14 31.97 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 121.458 -0.776 . . . . 0.0 114.466 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 45.7 t -75.27 -35.81 34.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 124.45 1.1 . . . . 0.0 109.59 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.6 mm -55.59 -49.79 71.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 123.75 0.82 . . . . 0.0 110.359 175.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 38.7 t -60.34 -41.34 86.84 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.213 0 CA-C-N 118.123 0.419 . . . . 0.0 110.13 177.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -53.25 -44.67 68.34 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.41 1.005 . . . . 0.0 112.413 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.64 -36.17 73.89 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 123.156 0.582 . . . . 0.0 109.593 177.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -64.7 -42.91 94.95 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.289 0.95 . . . . 0.0 109.479 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 55.1 mttt -60.27 -45.27 93.9 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 118.569 0.622 . . . . 0.0 111.309 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 30.0 m -54.95 -52.13 63.99 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.154 0.182 . . . . 0.0 111.434 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 59.4 mt -65.1 -41.62 92.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 122.585 0.354 . . . . 0.0 110.741 -175.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.2 t -48.38 -59.68 3.27 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.168 1.787 . . . . 0.0 108.127 173.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.7 m -64.8 -33.08 75.13 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.3 m -67.45 -20.41 65.49 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 113.834 1.049 . . . . 0.0 113.834 174.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 94.23 9.99 58.78 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-O 119.067 -0.852 . . . . 0.0 113.5 -171.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -88.03 -173.03 47.54 Favored Glycine 0 N--CA 1.434 -1.441 0 CA-C-N 119.449 1.625 . . . . 0.0 111.456 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.527 ' HB3' HG22 ' A' ' 122' ' ' VAL . 2.7 m-85 -130.54 149.99 51.95 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 126.184 1.793 . . . . 0.0 106.692 171.013 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -141.06 145.34 35.73 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 174.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -149.61 163.06 38.9 Favored 'General case' 0 N--CA 1.441 -0.888 0 O-C-N 123.79 0.681 . . . . 0.0 111.755 176.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.7 mt -97.68 167.78 10.75 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 123.397 0.679 . . . . 0.0 109.429 176.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.514 HG13 ' N ' ' A' ' 58' ' ' VAL . 0.5 OUTLIER -148.59 152.08 12.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 124.702 1.201 . . . . 0.0 111.096 -175.31 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.6 t 39.92 63.64 4.88 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 127.15 2.18 . . . . 0.0 110.825 178.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.14 175.27 7.81 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.252 1.968 . . . . 0.0 110.341 177.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -127.34 166.53 17.65 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 173.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -58.02 -41.71 83.76 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 124.519 1.127 . . . . 0.0 109.305 174.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -26.08 66.77 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 126.513 1.925 . . . . 0.0 110.65 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.618 HG13 HD13 ' A' ' 100' ' ' LEU . 1.5 t -88.62 -49.38 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 CA-C-O 115.777 -2.059 . . . . 0.0 109.071 177.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.38 -34.85 64.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 122.547 2.431 . . . . 0.0 110.297 177.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -31.01 72.04 Favored 'General case' 0 C--O 1.219 -0.511 0 O-C-N 121.395 -0.815 . . . . 0.0 111.479 -178.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.669 HG13 HD12 ' A' ' 100' ' ' LEU . 7.4 p -100.0 -41.31 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -174.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.669 HD12 HG13 ' A' ' 99' ' ' VAL . 6.9 mp -65.84 -14.58 61.71 Favored 'General case' 0 N--CA 1.434 -1.271 0 C-N-CA 125.972 1.709 . . . . 0.0 112.617 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.74 -41.5 10.1 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 117.328 -1.749 . . . . 0.0 108.197 171.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.48 -34.57 78.6 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.747 1.619 . . . . 0.0 112.486 -172.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.575 HG22 ' O ' ' A' ' 99' ' ' VAL . 9.0 t -93.25 -2.05 55.48 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 118.094 -0.955 . . . . 0.0 111.701 177.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.439 ' HB3' ' HD3' ' A' ' 107' ' ' ARG . 48.9 m-80 56.86 83.49 0.1 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.633 1.173 . . . . 0.0 109.201 -163.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.45 ' HB3' ' HG ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -122.55 -58.58 1.68 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 127.876 2.47 . . . . 0.0 109.878 174.717 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.83 -20.14 65.57 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.698 0.799 . . . . 0.0 111.215 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.439 ' HD3' ' HB3' ' A' ' 104' ' ' ASN . 4.5 ptm85 -84.06 -15.35 47.8 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 177.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 13.9 mm -88.85 -36.79 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 C-N-CA 126.358 1.863 . . . . 0.0 106.06 -172.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.48 149.63 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 124.61 1.194 . . . . 0.0 112.297 -172.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -57.25 156.94 6.79 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.357 0.663 . . . . 0.0 110.807 168.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.12 149.22 16.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 -178.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -140.3 165.04 28.47 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 124.845 1.258 . . . . 0.0 113.389 -170.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.82 -52.35 5.16 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.136 0.974 . . . . 0.0 109.753 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 53.3 p -125.12 175.06 7.63 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.549 1.14 . . . . 0.0 109.359 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.435 HD13 ' HA ' ' A' ' 115' ' ' ILE . 5.6 mm -63.84 -45.08 98.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 118.441 -0.79 . . . . 0.0 109.008 167.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.4 t -71.29 -28.18 63.94 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 119.384 -0.927 . . . . 0.0 110.427 -169.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -69.14 -20.56 64.03 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 119.201 0.91 . . . . 0.0 111.181 173.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -92.51 -49.6 6.04 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 -173.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.99 -60.51 2.71 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.924 2.09 . . . . 0.0 111.539 -166.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -86.61 -16.31 37.13 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.553 0.741 . . . . 0.0 111.012 -175.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -77.54 -59.92 2.58 Favored 'General case' 0 C--O 1.216 -0.695 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.527 HG22 ' HB3' ' A' ' 86' ' ' PHE . 0.3 OUTLIER -47.85 -28.7 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 126.949 2.1 . . . . 0.0 112.987 -174.622 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.86 -28.1 65.79 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.484 2.314 . . . . 0.0 113.45 173.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.72 39.51 0.16 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.858 2.063 . . . . 0.0 112.799 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.074 0 C-N-CA 125.776 1.63 . . . . 0.0 110.323 -174.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.3 p90 . . . . . 0 N--CA 1.448 -0.56 0 CA-C-O 120.489 0.185 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.3 pttt -135.46 170.29 16.17 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 126.073 1.749 . . . . 0.0 109.343 166.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 40.4 mt -120.65 138.28 51.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 C-N-CA 125.296 1.438 . . . . 0.0 107.626 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.492 ' CG2' HD13 ' A' ' 24' ' ' ILE . 76.9 t -131.8 164.67 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 C-N-CA 127.761 2.425 . . . . 0.0 106.769 -177.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -25.07 -63.31 0.06 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 129.553 3.141 . . . . 0.0 113.136 -163.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -145.75 54.01 1.17 Allowed 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 160.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.753 HG11 ' CE2' ' A' ' 56' ' ' PHE . 13.6 t -140.04 152.68 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 124.45 1.1 . . . . 0.0 109.197 170.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.414 ' C ' HD12 ' A' ' 24' ' ' ILE . 13.9 t -111.96 138.47 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.492 HD13 ' CG2' ' A' ' 19' ' ' VAL . 1.8 mp -118.33 106.18 19.2 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.599 HD22 ' CG2' ' A' ' 55' ' ' ILE . 1.9 mp -82.17 63.13 6.23 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.831 2.052 . . . . 0.0 108.271 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.7 mmm -60.05 98.4 0.14 Allowed Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 126.219 1.808 . . . . 0.0 110.805 -175.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -68.26 -47.42 1.64 Allowed 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 122.918 2.412 . . . . 0.0 109.834 -172.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 31.21 54.67 0.22 Allowed 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 120.88 1.673 . . . . 0.0 113.231 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 78.24 22.77 0.75 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.788 2.035 . . . . 0.0 112.527 173.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -118.31 69.78 0.8 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.617 1.567 . . . . 0.0 108.327 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.4 mt -129.72 20.28 5.56 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.832 1.253 . . . . 0.0 111.581 -177.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -49.51 142.48 7.93 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 131.067 3.747 . . . . 0.0 109.533 -177.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 28.9 mt -55.2 -46.66 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 121.049 1.749 . . . . 0.0 111.551 -176.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -80.6 2.96 23.45 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.207 -0.933 . . . . 0.0 112.772 -176.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -89.42 -57.08 3.01 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 153.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.8 -32.28 19.56 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.112 1.765 . . . . 0.0 114.08 -175.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -66.98 -53.17 34.12 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.53 1.059 . . . . 0.0 110.868 175.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.252 0.0 OUTLIER -81.29 -11.27 59.4 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 120.782 -1.199 . . . . 0.0 112.385 -177.492 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -34.83 -57.4 0.54 Allowed 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 129.275 3.03 . . . . 0.0 112.054 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -60.99 -48.95 79.45 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-O 118.542 -0.742 . . . . 0.0 109.34 -176.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -57.91 -46.35 85.09 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 119.494 1.043 . . . . 0.0 110.656 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.464 ' CE3' HG23 ' A' ' 43' ' ' VAL . 5.5 t90 -56.72 -61.05 2.7 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 108.876 -0.786 . . . . 0.0 108.876 174.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.464 HG23 ' CE3' ' A' ' 42' ' ' TRP . 53.0 t -52.23 -33.01 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 124.37 1.068 . . . . 0.0 113.038 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -64.23 -69.57 0.27 Allowed 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 125.19 1.396 . . . . 0.0 108.815 172.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -80.05 -11.33 59.78 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -166.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.427 ' HG2' ' CZ ' ' A' ' 47' ' ' PHE . 1.7 tp10 -88.51 -27.88 21.17 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.27 1.428 . . . . 0.0 110.74 174.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.427 ' CZ ' ' HG2' ' A' ' 46' ' ' GLU . 21.0 m-85 -135.55 -64.18 0.64 Allowed 'General case' 0 C--N 1.347 0.482 0 CA-C-N 119.513 1.051 . . . . 0.0 111.858 -170.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 41.3 mt -48.6 -55.12 12.08 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 118.518 0.599 . . . . 0.0 111.226 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -86.25 1.71 49.86 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.394 0.678 . . . . 0.0 110.963 -173.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.5 3.63 55.12 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 127.599 2.36 . . . . 0.0 112.038 173.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.04 40.23 25.53 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 119.446 1.021 . . . . 0.0 112.564 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -110.45 165.68 11.6 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 160.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -140.81 3.75 1.86 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.557 2.343 . . . . 0.0 112.141 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.581 ' C ' HD12 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -140.42 133.19 28.99 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 121.135 1.789 . . . . 0.0 109.239 -175.806 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.599 ' CG2' HD22 ' A' ' 25' ' ' LEU . 1.9 mp -133.69 149.87 31.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 128.252 2.621 . . . . 0.0 105.206 -172.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.753 ' CE2' HG11 ' A' ' 22' ' ' VAL . 23.5 m-85 -136.23 150.46 48.98 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.087 0.955 . . . . 0.0 112.563 168.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.1 tp -118.35 78.3 1.25 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.475 1.11 . . . . 0.0 110.25 175.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.446 ' N ' HG13 ' A' ' 90' ' ' VAL . 99.5 t -60.11 102.34 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 C-N-CA 126.586 1.955 . . . . 0.0 109.042 172.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.625 HD22 HG21 ' A' ' 96' ' ' VAL . 1.6 mt -86.61 14.25 7.25 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.809 2.444 . . . . 0.0 112.11 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.8 t -63.5 -50.55 69.19 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.802 0.841 . . . . 0.0 112.052 -168.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -83.48 -10.99 58.0 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.342 1.057 . . . . 0.0 110.65 -166.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.5 p -109.61 168.0 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 128.809 2.844 . . . . 0.0 106.712 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.48 -34.53 8.2 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.527 -0.733 . . . . 0.0 110.079 173.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.754 ' HA ' HG23 ' A' ' 96' ' ' VAL . 67.8 p -153.15 167.31 29.69 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 -176.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.4 tt -102.16 151.8 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 162.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -94.89 164.96 12.69 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 124.259 1.023 . . . . 0.0 111.109 -178.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.5 m -76.48 52.65 0.8 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.321 1.848 . . . . 0.0 110.654 176.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -133.44 -68.1 0.59 Allowed 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 158.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.5 t -64.31 -24.46 67.66 Favored 'General case' 0 C--N 1.342 0.267 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 60.6 tp -55.81 -16.54 4.6 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 120.819 -1.176 . . . . 0.0 114.103 177.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -91.5 -34.14 7.61 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 119.946 1.248 . . . . 0.0 112.083 168.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.7 t -64.63 -38.31 82.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 126.295 1.838 . . . . 0.0 110.389 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.3 mm -54.96 -48.93 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 125.292 1.437 . . . . 0.0 110.662 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.9 t -63.89 -45.64 96.4 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.471 0 O-C-N 121.144 -0.972 . . . . 0.0 108.648 176.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.17 -39.26 72.06 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.857 0.753 . . . . 0.0 110.977 -177.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.6 mt -59.62 -44.43 93.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 125.642 1.577 . . . . 0.0 110.628 170.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.419 HD22 HG22 ' A' ' 109' ' ' VAL . 12.5 tp -60.46 -50.67 72.66 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 120.325 -1.484 . . . . 0.0 109.214 177.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 48.3 mttt -59.42 -15.17 15.37 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.52 -0.738 . . . . 0.0 111.217 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.5 t -85.91 -48.56 8.61 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.63 0.772 . . . . 0.0 109.674 172.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 30.6 mt -62.44 -41.93 93.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 O-C-N 120.3 -1.5 . . . . 0.0 110.619 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.6 m -76.53 -5.26 46.81 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 173.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 45.6 t -74.84 -48.07 27.03 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 120.949 -1.094 . . . . 0.0 108.443 159.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.8 m -66.49 -56.03 12.82 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.409 1.084 . . . . 0.0 113.495 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.31 13.49 4.8 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.32 0.962 . . . . 0.0 113.81 -167.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -86.46 -163.58 38.56 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-N 119.141 1.471 . . . . 0.0 111.508 174.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -136.31 162.14 33.84 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.459 1.504 . . . . 0.0 110.023 176.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -158.8 139.53 12.7 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 123.959 0.904 . . . . 0.0 109.192 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.507 ' C ' HD23 ' A' ' 89' ' ' LEU . . . -145.25 171.7 14.19 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 121.171 0.51 . . . . 0.0 112.239 175.177 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.507 HD23 ' C ' ' A' ' 88' ' ' ALA . 0.7 OUTLIER -111.08 170.04 8.37 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 176.174 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.446 HG13 ' N ' ' A' ' 58' ' ' VAL . 0.5 OUTLIER -151.17 144.46 16.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 124.73 1.212 . . . . 0.0 110.739 -165.688 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.9 t 42.79 58.73 11.24 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 125.861 1.664 . . . . 0.0 111.52 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.57 166.34 26.17 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.489 2.126 . . . . 0.0 109.916 176.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -129.68 170.41 13.85 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 174.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -60.55 -42.56 96.81 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.287 1.035 . . . . 0.0 110.212 -176.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.1 -27.22 68.77 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.692 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.754 HG23 ' HA ' ' A' ' 64' ' ' SER . 0.5 OUTLIER -86.23 -47.12 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-O 118.635 -0.698 . . . . 0.0 109.607 179.261 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -53.63 -44.46 69.56 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 125.581 1.552 . . . . 0.0 108.648 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.19 -23.38 67.29 Favored 'General case' 0 C--O 1.218 -0.592 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.786 -169.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.9 t -95.84 -48.52 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 C-N-CA 126.014 1.726 . . . . 0.0 107.35 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.83 -21.63 57.04 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.108 0.963 . . . . 0.0 109.334 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.7 m -85.05 -11.83 54.45 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.865 0.866 . . . . 0.0 112.874 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 32.6 mt -119.81 -39.7 2.82 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 126.18 1.792 . . . . 0.0 111.033 -166.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.5 t -81.95 1.89 33.29 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.307 1.843 . . . . 0.0 111.095 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 51.18 78.05 0.12 Allowed 'General case' 0 C--N 1.345 0.408 0 C-N-CA 127.386 2.274 . . . . 0.0 111.03 -169.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.78 -57.75 1.61 Allowed 'General case' 0 C--O 1.227 -0.099 0 C-N-CA 123.909 0.883 . . . . 0.0 108.94 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.24 -24.8 66.62 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.548 1.139 . . . . 0.0 111.205 177.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.02 -7.62 59.35 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.6 mt -115.03 -47.63 4.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 125.651 1.58 . . . . 0.0 107.789 -174.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.419 HG22 HD22 ' A' ' 77' ' ' LEU . 0.7 OUTLIER -100.59 143.38 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 123.14 0.576 . . . . 0.0 110.291 178.375 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.9 161.86 12.15 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 124.141 0.976 . . . . 0.0 112.041 176.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.67 146.14 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -177.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -143.46 172.39 12.84 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 125.722 1.609 . . . . 0.0 110.399 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.64 -40.24 10.86 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.781 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 64.0 p -134.27 167.58 20.43 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.765 1.226 . . . . 0.0 108.792 -171.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.417 HD13 ' HA ' ' A' ' 115' ' ' ILE . 4.7 mm -69.75 -40.55 79.28 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.0 t -78.31 -4.74 49.51 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.194 0.907 . . . . 0.0 111.957 -176.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -90.38 -10.51 43.67 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 118.329 -0.843 . . . . 0.0 110.755 166.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.476 ' HB1' ' CE1' ' A' ' 56' ' ' PHE . . . -99.25 -44.5 6.22 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.418 1.087 . . . . 0.0 109.606 177.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -60.26 -40.48 90.48 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 127.801 2.44 . . . . 0.0 115.828 -161.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -112.59 4.31 17.21 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 126.836 2.054 . . . . 0.0 111.31 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -99.64 -63.66 1.11 Allowed 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -46.82 -30.47 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 127.44 2.296 . . . . 0.0 113.04 -176.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 12.1 mtt180 -53.64 -20.51 5.36 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.382 -0.824 . . . . 0.0 112.358 174.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.1 24.34 1.46 Allowed 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 115.151 1.538 . . . . 0.0 115.151 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 116.71 -1.614 . . . . 0.0 110.478 -161.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.0 p90 . . . . . 0 N--CA 1.447 -0.614 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.27 173.51 11.46 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.7 1.2 . . . . 0.0 108.776 174.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 70.7 mt -133.35 104.1 6.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 174.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.452 HG22 HD11 ' A' ' 24' ' ' ILE . 21.7 m -77.74 -171.87 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 166.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -24.59 -68.58 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 128.835 2.854 . . . . 0.0 115.319 -167.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -142.26 19.12 2.08 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 128.279 2.632 . . . . 0.0 109.72 177.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.579 HG11 ' CE2' ' A' ' 56' ' ' PHE . 6.7 t -127.84 133.57 67.13 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 CA-C-O 123.678 1.704 . . . . 0.0 108.783 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.586 ' O ' HD13 ' A' ' 24' ' ' ILE . 1.0 OUTLIER -92.66 153.87 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.686 0 CA-C-N 112.151 -2.295 . . . . 0.0 107.044 -175.374 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.586 HD13 ' O ' ' A' ' 23' ' ' VAL . 2.4 mm -138.17 91.36 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.55 118.86 10.74 Favored 'General case' 0 C--O 1.226 -0.174 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 165.049 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.476 ' HA ' HG22 ' A' ' 58' ' ' VAL . 4.9 mtm -116.65 80.65 10.75 Favored Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 104.829 -2.286 . . . . 0.0 104.829 -176.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -74.47 168.05 25.72 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.256 2.638 . . . . 0.0 112.051 -168.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.86 -106.73 0.1 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.703 1.201 . . . . 0.0 108.853 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -103.67 3.56 34.48 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.036 1.335 . . . . 0.0 111.53 174.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -76.18 -1.77 27.91 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.244 1.017 . . . . 0.0 113.275 -174.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 17.7 mt -77.33 21.67 0.25 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.902 1.681 . . . . 0.0 113.662 -176.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -37.24 133.78 0.65 Allowed 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 127.343 2.257 . . . . 0.0 109.343 166.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.1 tt -52.07 -34.42 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 124.309 1.044 . . . . 0.0 111.987 -176.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -70.2 -37.67 75.13 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.147 -0.97 . . . . 0.0 112.081 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -67.09 -46.5 74.06 Favored 'General case' 0 C--O 1.219 -0.521 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 168.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.91 -44.1 66.71 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.97 0.804 . . . . 0.0 112.187 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 14.3 t-160 -65.34 -43.46 90.82 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 119.93 1.241 . . . . 0.0 111.144 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.26 -14.97 59.66 Favored 'General case' 0 C--O 1.218 -0.554 0 O-C-N 121.574 -0.704 . . . . 0.0 110.379 -178.211 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -50.25 -44.35 53.51 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 127.167 2.187 . . . . 0.0 111.015 -173.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.436 ' HE3' ' CZ ' ' A' ' 44' ' ' PHE . 0.4 OUTLIER -67.35 -41.6 84.9 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-O 117.823 -1.084 . . . . 0.0 111.266 176.061 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -58.65 -48.58 80.57 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 120.324 1.42 . . . . 0.0 110.346 174.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -58.76 -61.64 2.47 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-O 117.738 -1.125 . . . . 0.0 108.186 177.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.4 t -52.78 -37.34 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 119.943 1.247 . . . . 0.0 111.65 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.436 ' CZ ' ' HE3' ' A' ' 40' ' ' LYS . 3.3 m-85 -59.44 -65.43 0.67 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 118.885 0.766 . . . . 0.0 110.371 174.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -60.74 -50.82 71.92 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 126.504 1.922 . . . . 0.0 111.162 -173.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -67.19 -36.4 81.69 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 127.816 2.446 . . . . 0.0 111.179 -174.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -128.91 -60.34 1.09 Allowed 'General case' 0 C--N 1.347 0.498 0 CA-C-N 119.496 1.044 . . . . 0.0 112.254 -174.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 12.1 mt -64.0 -25.26 68.05 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.564 -0.71 . . . . 0.0 112.843 -165.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -99.83 -15.68 18.33 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 127.283 2.233 . . . . 0.0 111.573 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -69.91 -16.75 63.28 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.435 1.094 . . . . 0.0 110.898 164.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.04 1.64 33.88 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.61 1.576 . . . . 0.0 112.935 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -72.57 145.58 47.3 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 119.066 1.433 . . . . 0.0 110.564 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -126.74 4.5 6.7 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.681 1.192 . . . . 0.0 113.285 -177.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.6 mtmt -145.88 95.32 2.62 Favored 'General case' 0 CA--C 1.514 -0.418 0 O-C-N 119.687 -1.883 . . . . 0.0 107.124 -166.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -101.94 154.11 5.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.579 ' CE2' HG11 ' A' ' 22' ' ' VAL . 16.1 m-30 -124.37 156.15 37.56 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 117.922 0.328 . . . . 0.0 111.332 163.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 29.4 tp -130.1 107.65 9.48 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 124.89 1.276 . . . . 0.0 108.438 175.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.476 HG22 ' HA ' ' A' ' 26' ' ' MET . 0.8 OUTLIER -75.81 161.92 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-O 121.37 0.605 . . . . 0.0 110.651 176.111 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 30.1 mt -139.61 12.51 2.52 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.935 1.294 . . . . 0.0 109.678 -174.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.4 ' H ' HG23 ' A' ' 58' ' ' VAL . 68.7 m -66.38 -64.35 0.88 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.918 1.287 . . . . 0.0 110.559 -176.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -69.74 -43.6 71.97 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.972 0.415 . . . . 0.0 111.689 -169.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.3 p -67.94 160.98 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 126.47 1.908 . . . . 0.0 110.691 -177.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -95.24 -56.17 2.81 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.795 0.838 . . . . 0.0 109.314 174.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.5 p -156.36 -165.39 1.89 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.372 0.669 . . . . 0.0 110.693 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.0 tt -139.6 145.02 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 C-N-CA 125.858 1.663 . . . . 0.0 106.914 -177.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -82.86 162.13 21.7 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.308 0.643 . . . . 0.0 109.774 175.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.0 m -54.19 -29.38 45.76 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.947 1.299 . . . . 0.0 112.843 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -56.59 -64.41 0.88 Allowed 'General case' 0 C--N 1.344 0.346 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.7 t -77.24 -22.32 52.39 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 118.839 -0.6 . . . . 0.0 111.582 -176.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.579 HD11 HG21 ' A' ' 103' ' ' THR . 22.1 tp -54.98 -27.17 41.88 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.958 1.254 . . . . 0.0 111.887 173.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -83.93 -35.64 15.26 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.16 0.886 . . . . 0.0 112.87 171.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 45.5 t -67.89 -42.01 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 118.524 1.162 . . . . 0.0 109.462 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 12.0 mm -54.73 -49.68 66.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.206 1.002 . . . . 0.0 109.338 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 38.7 t -62.48 -42.34 95.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 O-C-N 121.397 -0.814 . . . . 0.0 110.417 174.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -52.89 -44.08 66.63 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 120.129 1.331 . . . . 0.0 112.239 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 59.8 mt -60.67 -38.44 78.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 124.06 0.944 . . . . 0.0 108.67 176.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.49 -49.23 64.42 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 120.005 1.275 . . . . 0.0 109.466 178.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -52.57 -48.25 66.3 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 118.607 0.64 . . . . 0.0 110.077 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.0 m -60.02 -54.54 44.81 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.248 1.019 . . . . 0.0 110.711 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 48.6 mt -60.17 -43.74 93.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 124.337 1.055 . . . . 0.0 110.647 -177.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.0 t -70.22 -12.52 61.65 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.397 1.079 . . . . 0.0 111.865 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.5 t -83.82 -46.75 11.84 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 119.208 0.913 . . . . 0.0 108.583 167.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 72.1 m -54.12 -53.65 50.37 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.239 0.616 . . . . 0.0 110.41 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 132.88 18.04 1.12 Allowed Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.213 -0.771 . . . . 0.0 112.589 -168.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -109.48 179.35 20.83 Favored Glycine 0 N--CA 1.44 -1.034 0 CA-C-N 119.827 1.813 . . . . 0.0 112.587 -173.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -141.87 108.49 5.35 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.914 2.086 . . . . 0.0 108.815 -172.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -106.57 139.8 40.45 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.76 1.224 . . . . 0.0 107.802 -176.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.461 ' C ' HD23 ' A' ' 89' ' ' LEU . . . -137.92 172.49 12.86 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.155 0.889 . . . . 0.0 111.861 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.461 HD23 ' C ' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -122.11 167.17 13.47 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.58 0.752 . . . . 0.0 109.903 -179.581 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 92.5 t -142.39 139.13 29.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 C-N-CA 123.36 0.664 . . . . 0.0 110.122 -168.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 t 46.54 54.46 14.82 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 126.304 1.842 . . . . 0.0 111.178 -175.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -69.79 99.89 0.78 Allowed 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 123.149 2.566 . . . . 0.0 108.769 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -62.5 158.3 18.24 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 122.116 0.96 . . . . 0.0 110.954 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 -59.47 -34.77 72.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.216 -171.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.43 -44.93 89.34 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.37 1.468 . . . . 0.0 109.55 175.177 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.7 t -74.45 -47.22 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-O 117.2 -1.381 . . . . 0.0 109.761 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -54.66 -31.97 58.44 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 121.383 1.901 . . . . 0.0 110.233 -176.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.41 -62.57 1.63 Allowed 'General case' 0 N--CA 1.423 -1.808 0 CA-C-O 123.453 1.597 . . . . 0.0 111.724 175.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.657 ' O ' HG22 ' A' ' 103' ' ' THR . 4.6 p -66.87 -34.58 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 CA-C-N 113.981 -1.463 . . . . 0.0 107.651 -173.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.9 mt -63.26 -23.97 67.66 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.912 0.885 . . . . 0.0 111.36 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.7 m -78.85 -49.59 12.66 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 120.103 1.32 . . . . 0.0 107.829 170.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.71 -15.42 40.37 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.23 2.212 . . . . 0.0 113.582 -174.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.657 HG22 ' O ' ' A' ' 99' ' ' VAL . 7.6 t -120.67 -0.18 10.27 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.914 2.086 . . . . 0.0 111.479 178.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.42 ' HA ' ' HG3' ' A' ' 107' ' ' ARG . 6.5 m-80 48.07 69.01 0.58 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 127.266 2.227 . . . . 0.0 112.967 -168.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.38 -49.44 3.57 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.369 1.867 . . . . 0.0 110.096 166.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -65.57 -12.29 51.69 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 119.56 1.073 . . . . 0.0 112.728 -177.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.42 ' HG3' ' HA ' ' A' ' 104' ' ' ASN . 0.0 OUTLIER -108.0 5.04 25.8 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 127.255 2.222 . . . . 0.0 111.049 -174.133 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.7 mt -125.62 -45.55 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 128.093 2.557 . . . . 0.0 109.579 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.8 t -95.09 166.92 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.678 1.191 . . . . 0.0 107.802 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.517 ' HE2' ' CB ' ' A' ' 125' ' ' LYS . 3.2 mtmp? -95.95 172.64 7.88 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.737 0.815 . . . . 0.0 109.408 168.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -157.98 147.0 9.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 -163.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.504 ' CG ' ' HB2' ' A' ' 118' ' ' ALA . 82.2 m-85 -148.48 162.95 38.58 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.568 1.147 . . . . 0.0 112.489 -169.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.95 -58.37 2.62 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -178.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 69.2 p -102.87 -162.53 0.92 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.416 HD12 HD12 ' A' ' 24' ' ' ILE . 14.6 mm -84.76 -34.17 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-O 118.564 -0.732 . . . . 0.0 111.133 156.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.1 t -70.22 -37.33 75.0 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.373 -156.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -67.14 -39.97 86.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 176.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.504 ' HB2' ' CG ' ' A' ' 112' ' ' TYR . . . -64.63 -41.38 96.21 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -171.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 9.8 ttt -51.39 -43.45 61.93 Favored 'General case' 0 N--CA 1.424 -1.728 0 C-N-CA 127.897 2.479 . . . . 0.0 110.804 -174.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -104.75 -15.48 15.22 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.837 1.255 . . . . 0.0 112.42 -177.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -81.65 -47.21 13.28 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 119.008 0.822 . . . . 0.0 109.096 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -55.24 -19.96 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 124.864 1.265 . . . . 0.0 114.086 176.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 7.7 mtm180 -70.39 -27.94 64.69 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 118.512 -0.756 . . . . 0.0 110.86 173.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.4 47.29 0.11 Allowed 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 120.624 1.556 . . . . 0.0 114.002 -176.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.517 ' CB ' ' HE2' ' A' ' 110' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.069 0 C-N-CA 125.134 1.373 . . . . 0.0 111.444 -172.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 36.9 p90 . . . . . 0 CA--C 1.533 0.301 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -125.94 173.45 9.12 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.181 1.392 . . . . 0.0 108.938 164.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 52.1 mt -132.4 119.6 39.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.9 m -114.72 -166.11 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 170.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -45.66 -43.6 12.63 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 128.492 2.717 . . . . 0.0 115.278 -149.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -150.23 19.37 0.86 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.359 0.664 . . . . 0.0 111.163 156.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.754 HG11 ' CE2' ' A' ' 56' ' ' PHE . 19.3 t -122.15 120.72 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 124.266 1.027 . . . . 0.0 108.532 -173.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.5 t -75.5 143.78 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 176.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.592 HD12 HD12 ' A' ' 115' ' ' ILE . 5.1 mm -119.33 104.03 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 175.253 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 26.9 mt -85.72 124.64 32.47 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 177.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 65.0 mtm -126.86 76.46 75.36 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -167.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -61.56 148.44 92.99 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.507 2.805 . . . . 0.0 110.934 -170.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.88 -85.27 0.37 Allowed 'General case' 0 C--O 1.225 -0.212 0 CA-C-O 118.931 -0.557 . . . . 0.0 111.123 176.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.5 35.13 4.69 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.194 1.397 . . . . 0.0 109.275 -176.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.94 -19.36 13.43 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 120.791 -1.193 . . . . 0.0 112.385 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.9 mp -72.77 90.21 1.4 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -132.85 26.04 4.31 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.621 1.168 . . . . 0.0 110.801 -164.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.3 mt 65.24 -54.12 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 129.071 2.948 . . . . 0.0 113.558 -172.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -66.31 -32.4 73.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 120.175 1.352 . . . . 0.0 109.509 -174.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.1 -8.12 46.97 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-O 117.265 -1.35 . . . . 0.0 110.364 175.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.06 -65.99 0.77 Allowed 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 120.869 1.668 . . . . 0.0 111.794 -168.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -67.96 -17.39 64.43 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 121.421 1.919 . . . . 0.0 110.97 177.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 69.3 mt -78.04 -9.19 59.02 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.103 1.761 . . . . 0.0 112.087 170.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -69.01 -60.39 2.39 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -169.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.451 ' HA ' HG22 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -60.65 -33.43 72.79 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 116.609 -1.662 . . . . 0.0 111.253 174.475 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -64.63 -50.16 68.21 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 120.801 1.637 . . . . 0.0 107.904 -175.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -48.58 -62.37 1.54 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 118.134 -0.936 . . . . 0.0 108.704 166.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.451 HG22 ' HA ' ' A' ' 40' ' ' LYS . 9.7 m -57.93 -46.46 87.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 CA-C-O 123.311 1.529 . . . . 0.0 112.671 -166.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.511 ' CD1' HD12 ' A' ' 48' ' ' LEU . 4.7 m-30 -50.01 -44.95 51.45 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 126.771 2.028 . . . . 0.0 108.98 177.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -78.96 -9.4 59.51 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 128.063 2.545 . . . . 0.0 114.908 -176.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -123.88 -8.69 7.8 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.385 0.993 . . . . 0.0 112.652 177.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -136.16 -61.68 0.69 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.586 0.754 . . . . 0.0 111.069 -174.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.511 HD12 ' CD1' ' A' ' 44' ' ' PHE . 14.4 mt -67.29 -52.08 44.9 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 118.733 0.697 . . . . 0.0 110.935 -169.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -64.97 -27.16 68.65 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.26 1.024 . . . . 0.0 110.449 173.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.25 -46.81 75.84 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 125.044 1.338 . . . . 0.0 108.74 -178.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 131.0 47.59 0.13 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 125.527 1.537 . . . . 0.0 109.768 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -123.6 133.33 53.96 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 118.32 1.06 . . . . 0.0 110.511 173.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -126.26 22.04 7.23 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 126.097 1.759 . . . . 0.0 111.336 -177.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.688 ' HB3' HG13 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -143.93 142.25 30.67 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.66 1.184 . . . . 0.0 108.321 162.062 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.1 mt -141.76 150.62 19.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 129.238 3.015 . . . . 0.0 104.421 -176.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.754 ' CE2' HG11 ' A' ' 22' ' ' VAL . 11.6 m-85 -133.75 153.84 51.41 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 125.219 1.408 . . . . 0.0 109.969 169.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 29.7 tp -118.95 111.57 18.52 Favored 'General case' 0 C--N 1.339 0.143 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 174.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 87.6 t -86.2 103.47 12.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.462 HD12 HG21 ' A' ' 96' ' ' VAL . 4.2 mm? -78.92 -12.71 60.04 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.091 1.356 . . . . 0.0 111.747 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.75 -38.45 47.77 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.919 1.287 . . . . 0.0 111.115 173.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -84.95 -45.66 11.98 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 120.822 0.344 . . . . 0.0 110.792 -165.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.8 p -76.77 -178.75 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 126.619 1.968 . . . . 0.0 109.663 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -122.89 -41.45 2.35 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.41 1.084 . . . . 0.0 108.821 170.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.5 t -154.23 165.36 36.51 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-O 122.623 1.201 . . . . 0.0 113.766 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.7 tt -135.29 152.7 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 129.805 3.242 . . . . 0.0 105.985 176.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.49 175.13 5.55 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.356 0.662 . . . . 0.0 110.468 -167.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.9 p -62.53 19.0 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 128.244 2.617 . . . . 0.0 114.312 173.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -112.38 -73.02 0.68 Allowed 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 166.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 74.7 m -66.05 -29.44 69.78 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 116.878 -1.534 . . . . 0.0 113.778 -172.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.3 mt -48.55 -46.77 39.38 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.606 1.548 . . . . 0.0 110.192 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.17 -33.07 82.85 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-O 119.71 -0.494 . . . . 0.0 112.025 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.2 t -75.5 -29.6 21.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 118.275 1.038 . . . . 0.0 111.087 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 mp -64.58 -40.21 88.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 174.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.1 t -60.64 -43.46 94.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 O-C-N 120.559 -1.338 . . . . 0.0 110.172 169.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -51.24 -43.33 61.45 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.854 1.262 . . . . 0.0 112.204 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.1 mt -58.56 -45.13 90.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 124.406 1.082 . . . . 0.0 109.353 175.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.01 -49.3 70.78 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -51.4 -49.42 61.62 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.018 0.527 . . . . 0.0 109.615 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 13.6 t -64.28 -47.49 79.33 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -176.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 47.7 mt -60.43 -45.17 97.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 C-N-CA 124.979 1.311 . . . . 0.0 111.747 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.5 m -75.29 -23.32 57.35 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.818 0.735 . . . . 0.0 112.143 176.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.78 -45.59 89.05 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.437 1.017 . . . . 0.0 108.543 167.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 74.8 m -63.94 -71.02 0.19 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.889 1.675 . . . . 0.0 112.008 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 141.23 33.74 0.12 Allowed Glycine 0 CA--C 1.527 0.798 0 C-N-CA 124.195 0.902 . . . . 0.0 111.198 -164.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -126.37 -173.78 13.66 Favored Glycine 0 C--N 1.336 0.578 0 O-C-N 120.517 -1.578 . . . . 0.0 109.592 169.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -131.19 164.15 26.17 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.367 1.067 . . . . 0.0 109.902 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -156.03 141.19 17.43 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.973 1.309 . . . . 0.0 109.03 175.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.565 ' C ' HD23 ' A' ' 89' ' ' LEU . . . -147.08 178.44 8.37 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 123.727 0.811 . . . . 0.0 112.166 174.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.565 HD23 ' C ' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -121.35 163.56 18.46 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 123.453 0.701 . . . . 0.0 109.911 -178.489 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.599 HG21 HD13 ' A' ' 115' ' ' ILE . 40.2 t -144.08 133.51 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 123.847 0.859 . . . . 0.0 108.837 -163.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.9 t 48.95 58.96 17.72 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 127.029 2.131 . . . . 0.0 111.778 -171.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.05 91.96 0.91 Allowed 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 123.748 2.965 . . . . 0.0 108.711 176.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -51.66 153.5 2.34 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 126.536 1.935 . . . . 0.0 112.092 171.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -54.03 -31.2 50.63 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.989 1.716 . . . . 0.0 111.204 -176.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.84 -44.71 84.72 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 126.798 2.039 . . . . 0.0 109.207 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.882 HG13 HD13 ' A' ' 100' ' ' LEU . 1.1 t -74.1 -44.77 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 125.634 1.574 . . . . 0.0 110.488 172.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -58.49 -23.89 59.06 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 120.496 1.498 . . . . 0.0 110.451 -176.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.91 -62.31 1.79 Allowed 'General case' 0 N--CA 1.427 -1.614 0 CA-C-O 124.804 2.24 . . . . 0.0 111.003 175.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.496 ' O ' HG22 ' A' ' 103' ' ' THR . 2.6 t -72.76 -46.16 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.707 0 CA-C-N 111.411 -2.631 . . . . 0.0 104.865 -167.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.882 HD13 HG13 ' A' ' 96' ' ' VAL . 4.5 mp -61.28 -19.83 62.2 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 124.913 1.285 . . . . 0.0 112.568 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.6 m -87.1 -54.89 4.08 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 172.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 68.1 mt -51.37 -51.3 55.82 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.546 1.538 . . . . 0.0 113.08 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 99' ' ' VAL . 1.1 t -91.32 3.66 54.32 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.826 1.65 . . . . 0.0 111.987 -167.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 55.38 77.9 0.21 Allowed 'General case' 0 C--N 1.34 0.175 0 C-N-CA 126.387 1.875 . . . . 0.0 109.678 -173.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.532 ' HB3' HD23 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -123.22 -55.59 1.76 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.327 1.051 . . . . 0.0 108.636 177.541 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -60.18 -31.9 70.56 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.235 1.414 . . . . 0.0 110.306 169.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -74.21 1.21 11.83 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 117.556 -1.211 . . . . 0.0 112.965 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.4 mt -133.94 -39.55 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.547 1.139 . . . . 0.0 110.629 -169.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.4 t -106.12 153.92 7.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 119.647 1.112 . . . . 0.0 108.81 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.71 157.27 38.3 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.291 0.567 . . . . 0.0 111.486 174.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.0 145.29 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -172.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -149.19 169.66 20.23 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 127.093 2.157 . . . . 0.0 110.55 -175.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -88.08 -48.24 7.89 Favored 'General case' 0 CA--C 1.521 -0.173 0 O-C-N 121.763 -0.586 . . . . 0.0 109.419 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 67.5 p -121.56 173.52 7.36 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.921 0.888 . . . . 0.0 109.939 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.599 HD13 HG21 ' A' ' 90' ' ' VAL . 17.9 mm -70.7 -35.92 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.6 t -74.06 -30.11 62.23 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 119.446 1.021 . . . . 0.0 111.246 -173.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -65.19 -20.41 66.43 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 119.462 -0.304 . . . . 0.0 111.355 169.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -101.91 -39.93 7.13 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -170.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 53.1 ttm -48.72 -50.07 35.23 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 127.781 2.432 . . . . 0.0 111.089 -167.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -101.47 -0.42 35.2 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 117.985 -1.007 . . . . 0.0 112.591 -174.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -119.31 -35.49 3.58 Favored 'General case' 0 C--O 1.216 -0.687 0 C-N-CA 123.79 0.836 . . . . 0.0 111.542 -167.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -54.21 -29.02 18.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 O-C-N 121.14 -0.975 . . . . 0.0 109.559 157.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.11 118.02 17.58 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 102.467 -3.16 . . . . 0.0 102.467 163.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . 0.267 0.0 OUTLIER 85.46 23.42 0.08 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 111.968 -2.378 . . . . 0.0 116.193 165.582 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp . . . . . 0 C--O 1.25 1.111 0 C-N-CA 123.854 0.862 . . . . 0.0 111.187 176.487 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.9 p90 . . . . . 0 N--CA 1.452 -0.374 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.5 pttt -129.6 169.43 15.03 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.651 1.58 . . . . 0.0 108.631 168.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.5 mt -137.95 123.71 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 174.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.8 m -99.26 -154.18 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -24.92 -72.5 0.03 OUTLIER 'General case' 0 C--O 1.237 0.414 0 C-N-CA 130.085 3.354 . . . . 0.0 111.623 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.14 12.14 2.19 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.296 1.439 . . . . 0.0 110.646 172.073 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.656 HG11 ' CE2' ' A' ' 56' ' ' PHE . 5.7 t -112.41 137.45 45.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 O-C-N 120.657 -1.277 . . . . 0.0 108.749 -171.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 65.9 t -88.72 143.3 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 175.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mp -126.84 97.56 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.434 HD12 ' CH2' ' A' ' 42' ' ' TRP . 1.2 mm? -69.03 140.18 54.94 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 162.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 22.8 mtt -131.44 73.25 80.01 Favored Pre-proline 0 C--O 1.236 0.375 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 171.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.53 167.44 24.13 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 121.608 1.539 . . . . 0.0 110.62 174.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -161.16 -107.6 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 126.532 1.933 . . . . 0.0 105.999 -173.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.497 ' H ' ' HD2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -82.68 1.87 36.39 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -171.677 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -90.43 -23.56 20.98 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 120.773 -1.204 . . . . 0.0 113.726 -167.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 16.6 mt -74.9 -76.0 0.15 Allowed 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.155 -153.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . 0.258 0.1 OUTLIER 23.36 60.08 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 129.64 3.176 . . . . 0.0 113.201 153.629 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.8 mt 63.54 -45.29 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 127.908 2.483 . . . . 0.0 114.352 -172.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -63.61 -21.89 66.6 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.226 1.011 . . . . 0.0 112.906 -165.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -127.72 63.22 1.38 Allowed 'General case' 0 C--O 1.232 0.178 0 C-N-CA 125.141 1.376 . . . . 0.0 107.991 170.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.03 -67.94 0.89 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.674 0.79 . . . . 0.0 112.268 -177.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 39.7 t-80 -63.0 -37.1 85.82 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 120.71 1.595 . . . . 0.0 110.188 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.8 -15.3 60.75 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 117.747 -1.12 . . . . 0.0 111.935 173.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -52.59 -48.7 66.09 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 120.581 1.537 . . . . 0.0 110.942 -172.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -67.54 -42.43 82.72 Favored 'General case' 0 C--O 1.211 -0.922 0 CA-C-O 117.428 -1.272 . . . . 0.0 110.381 175.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.5 tttm -55.39 -45.14 76.64 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.937 1.699 . . . . 0.0 111.051 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.512 ' CE3' HG23 ' A' ' 43' ' ' VAL . 8.2 t90 -61.78 -63.04 1.39 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.546 1.138 . . . . 0.0 109.283 176.002 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.512 HG23 ' CE3' ' A' ' 42' ' ' TRP . 91.2 t -59.55 -32.39 48.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 119.655 1.116 . . . . 0.0 112.305 -176.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -56.54 -60.37 3.64 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 170.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.24 -44.15 72.57 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 -168.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -76.39 -17.26 59.46 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.228 1.811 . . . . 0.0 111.246 -170.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -141.68 -55.5 0.46 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 66.2 mt -64.9 -50.88 64.8 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.687 1.13 . . . . 0.0 111.451 -170.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -65.0 -29.6 70.53 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 127.867 2.467 . . . . 0.0 109.657 175.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.1 mttm -61.02 -46.87 89.0 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 118.638 -0.696 . . . . 0.0 109.14 169.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.97 4.38 2.66 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.193 1.377 . . . . 0.0 113.06 173.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -64.08 150.83 44.63 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 118.936 1.368 . . . . 0.0 109.593 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -122.29 -1.92 9.12 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.05 1.34 . . . . 0.0 114.409 175.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.425 ' HB3' HG13 ' A' ' 22' ' ' VAL . 2.0 mtmt -133.75 121.97 22.65 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 120.908 1.686 . . . . 0.0 108.379 -176.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.4 mt -130.39 157.21 42.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 C-N-CA 125.646 1.579 . . . . 0.0 107.366 176.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.656 ' CE2' HG11 ' A' ' 22' ' ' VAL . 23.2 m-85 -131.92 161.4 33.15 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.389 1.476 . . . . 0.0 111.768 165.329 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.8 tp -128.46 81.23 2.01 Favored 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 125.068 1.347 . . . . 0.0 108.173 173.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.508 ' N ' HG13 ' A' ' 90' ' ' VAL . 99.1 t -56.25 136.4 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 127.93 2.492 . . . . 0.0 107.563 166.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.59 12.6 12.35 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.182 1.793 . . . . 0.0 110.459 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 68.3 m -43.46 -46.24 6.7 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.68 1.992 . . . . 0.0 112.835 173.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.02 1.42 39.54 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.848 1.259 . . . . 0.0 111.69 -164.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.7 p -132.42 114.46 23.29 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 C-N-CA 126.082 1.753 . . . . 0.0 107.526 -177.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -64.69 -38.55 91.37 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 120.652 -1.28 . . . . 0.0 108.319 176.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 57.2 p -154.52 146.94 23.98 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -174.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 21.3 tt -100.28 151.38 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 113.82 -1.536 . . . . 0.0 107.411 163.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -92.3 168.9 11.0 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 123.083 1.42 . . . . 0.0 110.271 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.0 p -50.75 0.06 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.723 1 C-N-CA 132.565 4.346 . . . . 0.0 115.962 170.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -98.77 -70.52 0.72 Allowed 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.6 t -77.0 -19.88 56.74 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-O 118.552 -0.737 . . . . 0.0 112.082 -172.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 14.3 tp -48.57 -33.94 10.6 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.792 1.178 . . . . 0.0 111.743 170.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -76.4 -37.24 36.67 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 118.114 0.416 . . . . 0.0 113.683 173.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.9 t -65.31 -34.6 71.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 124.176 0.991 . . . . 0.0 109.62 -178.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.58 -48.13 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 123.747 0.819 . . . . 0.0 109.918 175.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.6 t -66.66 -39.85 84.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 O-C-N 121.187 -0.946 . . . . 0.0 109.851 178.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.63 -40.63 72.4 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.643 0.735 . . . . 0.0 110.996 178.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.1 mt -61.88 -39.44 83.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 126.592 1.957 . . . . 0.0 109.641 175.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.423 ' HG ' HG13 ' A' ' 109' ' ' VAL . 3.3 tm? -66.22 -41.5 90.03 Favored 'General case' 0 C--N 1.341 0.215 0 O-C-N 119.922 -1.736 . . . . 0.0 109.487 178.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.8 mttm -54.22 -44.11 71.41 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-O 117.841 -1.076 . . . . 0.0 110.524 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.5 t -53.6 -52.66 59.1 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.822 0.849 . . . . 0.0 110.825 176.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.0 mt -67.66 -39.85 82.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.012 0.525 . . . . 0.0 110.472 -174.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 26.6 t -66.25 -36.22 82.45 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.28 1.432 . . . . 0.0 110.932 176.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 71.8 m -65.39 -40.11 93.07 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 119.386 0.994 . . . . 0.0 109.894 172.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.5 m -73.29 -68.97 0.45 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.733 0.813 . . . . 0.0 111.642 -172.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 146.75 34.43 0.06 OUTLIER Glycine 0 C--N 1.334 0.418 0 CA-C-O 118.798 -1.001 . . . . 0.0 113.354 -166.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -127.6 -163.19 11.33 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 118.948 1.374 . . . . 0.0 111.321 -176.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.546 ' HB3' HG22 ' A' ' 122' ' ' VAL . 1.4 m-85 -137.89 151.85 48.44 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 169.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -147.47 147.53 30.29 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 172.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -153.48 170.73 20.04 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 124.812 1.32 . . . . 0.0 111.211 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.3 mt -108.47 167.4 10.07 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.508 HG13 ' N ' ' A' ' 58' ' ' VAL . 0.5 OUTLIER -145.38 152.85 14.21 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.511 0 C-N-CA 124.89 1.276 . . . . 0.0 111.085 -173.606 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.1 p 41.3 58.88 8.94 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 126.32 1.848 . . . . 0.0 112.812 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -71.35 7.94 1.31 Allowed 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 124.227 3.285 . . . . 0.0 114.498 -170.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 56.26 -160.98 0.2 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.383 1.473 . . . . 0.0 108.993 -176.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -87.9 -15.67 36.01 Favored 'General case' 0 CA--C 1.552 1.044 0 O-C-N 120.706 -1.246 . . . . 0.0 110.892 164.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.62 -33.72 10.85 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 121.062 -1.024 . . . . 0.0 112.606 -160.009 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.818 HG13 HD13 ' A' ' 100' ' ' LEU 0.268 0.9 OUTLIER -77.28 -37.67 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 116.254 -1.831 . . . . 0.0 107.615 166.421 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -52.96 -35.17 58.57 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 121.685 2.039 . . . . 0.0 110.235 171.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.06 -40.17 87.01 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.424 -175.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.536 HG13 HD12 ' A' ' 100' ' ' LEU . 8.4 p -92.41 -33.31 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -167.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.818 HD13 HG13 ' A' ' 96' ' ' VAL . 7.4 mp -65.55 -12.07 49.6 Favored 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 124.845 1.258 . . . . 0.0 112.5 178.14 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.7 t -87.29 -50.68 6.42 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 166.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.21 -38.59 87.16 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.261 1.824 . . . . 0.0 113.14 -168.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 99' ' ' VAL . 10.9 t -86.47 -18.44 31.66 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 119.01 -0.519 . . . . 0.0 110.786 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 64.45 93.72 0.06 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.563 1.545 . . . . 0.0 107.215 -151.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.538 ' HB3' ' HG ' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -124.64 -50.94 1.73 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.576 1.551 . . . . 0.0 108.706 168.494 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -29.96 68.18 Favored 'General case' 0 C--N 1.346 0.426 0 N-CA-C 110.002 -0.369 . . . . 0.0 110.002 177.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -77.99 5.65 9.42 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 128.022 2.529 . . . . 0.0 112.353 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.3 mt -124.05 -34.93 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 125.232 1.413 . . . . 0.0 109.006 -177.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.732 HG12 ' H ' ' A' ' 110' ' ' LYS . 1.7 t -123.85 -159.31 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 125.028 1.331 . . . . 0.0 110.546 -177.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.732 ' H ' HG12 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -116.1 158.8 22.63 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 128.837 2.855 . . . . 0.0 108.073 169.932 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.95 154.03 17.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 -178.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -144.87 167.64 22.12 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.934 0.894 . . . . 0.0 112.7 -171.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.75 -50.52 6.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.944 -177.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 70.4 p -130.29 175.46 8.92 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.92 1.288 . . . . 0.0 107.823 -176.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.439 HD11 ' CG2' ' A' ' 58' ' ' VAL . 6.3 mm -68.25 -41.71 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-O 117.687 -1.149 . . . . 0.0 109.218 170.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.2 t -67.35 -35.62 79.76 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 120.102 1.319 . . . . 0.0 109.43 -175.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.69 -6.51 26.61 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-O 117.554 -1.213 . . . . 0.0 112.797 174.217 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -110.55 -41.06 4.43 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 119.375 0.989 . . . . 0.0 109.772 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 1.9 ttp -59.61 -53.87 53.03 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.754 1.622 . . . . 0.0 111.94 -163.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -84.88 -13.72 50.03 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.187 1.395 . . . . 0.0 111.215 175.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.8 -52.27 5.39 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -168.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.546 HG22 ' HB3' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -50.31 -25.58 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 128.066 2.547 . . . . 0.0 113.359 177.23 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.17 -41.71 84.45 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 126.72 2.008 . . . . 0.0 111.423 175.022 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.54 55.84 0.62 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 127.165 2.186 . . . . 0.0 106.272 -170.035 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.027 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 170.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 43.9 p90 . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.7 pttt -151.06 178.51 9.12 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 126.86 2.064 . . . . 0.0 108.787 165.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.8 mp -132.07 136.37 56.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 167.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 20.4 m -99.65 -131.63 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 125.214 1.406 . . . . 0.0 107.704 172.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -44.89 -73.64 0.04 OUTLIER 'General case' 0 C--O 1.235 0.306 0 C-N-CA 127.505 2.322 . . . . 0.0 111.359 178.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -143.59 8.63 1.55 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.477 1.911 . . . . 0.0 110.309 171.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.695 HG11 ' CE2' ' A' ' 56' ' ' PHE . 22.0 t -97.62 132.22 42.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.7 t -83.44 143.64 11.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 170.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.5 mp -121.93 114.4 42.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 174.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.36 147.05 32.55 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 120.41 1.459 . . . . 0.0 108.719 163.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 8.9 mtt -140.43 77.77 23.26 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 127.834 2.453 . . . . 0.0 107.097 -178.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.99 98.62 0.62 Allowed 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 124.881 3.721 . . . . 0.0 112.858 -172.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -76.53 79.26 3.22 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.419 1.087 . . . . 0.0 113.667 -167.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.266 0.0 OUTLIER 40.7 35.61 0.33 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.607 1.963 . . . . 0.0 114.098 -179.494 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -113.43 -11.51 13.1 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 120.63 -1.294 . . . . 0.0 112.732 -164.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.41 83.11 0.26 Allowed 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 125.596 1.558 . . . . 0.0 108.403 -172.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -123.08 38.29 4.22 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.387 1.875 . . . . 0.0 108.127 -177.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.414 HG12 ' CG ' ' A' ' 68' ' ' PHE 0.304 0.3 OUTLIER 68.96 -26.89 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 130.957 3.703 . . . . 0.0 114.556 -177.833 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -40.51 -32.1 0.18 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 129.659 3.184 . . . . 0.0 115.535 -175.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -117.79 -4.34 11.16 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 127.289 2.236 . . . . 0.0 112.089 -164.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.603 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . . . -72.35 -52.0 18.07 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-N 120.114 1.325 . . . . 0.0 111.755 -166.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -60.48 -41.64 94.64 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.74 -0.6 . . . . 0.0 110.123 -178.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.3 -18.53 58.91 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 118.365 -0.826 . . . . 0.0 111.89 178.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -54.49 -42.87 71.26 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.414 1.461 . . . . 0.0 111.824 -172.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -61.76 -52.67 63.28 Favored 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.7 tmtp? -49.11 -46.32 44.68 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.917 1.687 . . . . 0.0 111.255 175.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.554 ' CE3' HG23 ' A' ' 43' ' ' VAL . 10.7 t90 -62.71 -65.55 0.67 Allowed 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 116.973 -1.489 . . . . 0.0 110.178 177.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.554 HG23 ' CE3' ' A' ' 42' ' ' TRP . 58.6 t -54.94 -35.16 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 120.709 1.595 . . . . 0.0 111.284 -175.429 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -57.59 -67.9 0.29 Allowed 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 123.913 0.885 . . . . 0.0 109.057 173.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.86 -51.56 69.1 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.807 0.843 . . . . 0.0 112.604 -174.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.32 -30.92 70.01 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.617 1.167 . . . . 0.0 111.379 -168.092 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -133.7 -65.0 0.69 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 122.884 0.474 . . . . 0.0 109.843 -164.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 52.6 mt -56.71 -54.16 49.36 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.835 0.743 . . . . 0.0 111.382 -174.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -67.19 -23.84 65.79 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 126.086 1.754 . . . . 0.0 111.577 175.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.0 tttm -74.68 -6.29 47.92 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.303 1.041 . . . . 0.0 112.194 169.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.68 7.28 53.77 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 124.791 1.186 . . . . 0.0 114.352 175.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -72.32 162.81 28.95 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 120.033 1.916 . . . . 0.0 110.031 176.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -148.34 4.23 0.69 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.502 1.521 . . . . 0.0 111.652 -176.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.488 ' HB3' HG13 ' A' ' 22' ' ' VAL . 1.5 mtmt -141.54 119.02 11.55 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 -177.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.9 mp -119.89 154.97 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 105.14 -2.171 . . . . 0.0 105.14 174.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.695 ' CE2' HG11 ' A' ' 22' ' ' VAL . 24.3 m-85 -130.91 164.19 25.82 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.48 1.512 . . . . 0.0 110.132 160.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.6 tp -128.16 114.6 17.2 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 170.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.573 ' CG2' HD11 ' A' ' 115' ' ' ILE . 53.4 t -82.55 110.42 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 125.991 1.716 . . . . 0.0 108.711 175.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -75.38 -10.89 59.86 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.579 0.752 . . . . 0.0 111.588 170.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.9 m -55.93 -23.52 32.3 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.464 1.029 . . . . 0.0 112.347 172.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.57 -14.16 25.28 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.283 0.947 . . . . 0.0 111.824 177.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.5 p -137.39 101.53 2.19 Favored 'Isoleucine or valine' 0 C--N 1.34 0.152 0 C-N-CA 124.798 1.239 . . . . 0.0 109.643 -173.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -55.05 -48.29 73.67 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.8 m -158.97 170.48 21.99 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.465 HD11 ' CB ' ' A' ' 69' ' ' SER . 8.8 tt -135.83 155.9 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 C-N-CA 127.059 2.144 . . . . 0.0 107.99 -165.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.407 ' HB3' ' CD2' ' A' ' 68' ' ' PHE . 15.8 t70 -91.33 158.47 16.53 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 126.168 1.787 . . . . 0.0 109.774 176.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.7 m -56.07 -24.73 41.83 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 117.594 -1.193 . . . . 0.0 113.337 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.709 ' CE1' ' HB2' ' A' ' 69' ' ' SER 0.278 0.2 OUTLIER -47.59 -64.53 0.76 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 119.686 1.13 . . . . 0.0 111.049 170.766 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.709 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . 30.1 t -92.48 -15.94 26.46 Favored 'General case' 0 CA--C 1.512 -0.486 0 O-C-N 121.52 -0.737 . . . . 0.0 111.642 -168.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.503 HD22 HG21 ' A' ' 103' ' ' THR . 14.2 mt -52.07 -36.22 50.01 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 119.225 -0.99 . . . . 0.0 109.288 170.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -81.27 -25.14 55.64 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-O 118.203 -1.332 . . . . 0.0 114.753 175.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.2 p -72.69 -35.56 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 120.332 2.066 . . . . 0.0 110.048 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 mp -53.34 -49.97 50.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.342 1.457 . . . . 0.0 108.136 173.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 80.7 t -56.61 -52.34 54.84 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 176.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -56.0 -22.46 27.0 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 114.114 1.154 . . . . 0.0 114.114 -174.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 57.8 mt -80.37 -44.34 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.452 1.101 . . . . 0.0 109.481 172.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -54.16 -48.77 70.52 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.452 1.024 . . . . 0.0 109.485 177.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -57.45 -42.75 83.1 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.168 0.587 . . . . 0.0 110.638 -176.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.4 m -60.17 -54.25 48.12 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 118.956 -0.545 . . . . 0.0 110.574 174.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 80.0 mt -57.63 -42.19 80.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.858 0.863 . . . . 0.0 110.803 -176.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -52.07 -40.8 61.72 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.728 1.611 . . . . 0.0 111.242 175.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 t -84.33 0.85 47.64 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.766 2.427 . . . . 0.0 112.799 -174.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.7 m -128.84 -14.26 4.53 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -166.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 130.51 -18.75 5.15 Favored Glycine 0 CA--C 1.521 0.409 0 CA-C-N 117.992 0.36 . . . . 0.0 113.741 177.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -100.3 -173.06 29.86 Favored Glycine 0 N--CA 1.429 -1.781 0 CA-C-O 123.02 1.345 . . . . 0.0 113.283 -156.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.524 ' HB3' HG22 ' A' ' 122' ' ' VAL . 2.1 m-85 -133.46 153.09 51.91 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.461 1.504 . . . . 0.0 108.256 174.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -145.23 146.98 31.93 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 171.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.58 ' C ' HD23 ' A' ' 89' ' ' LEU . . . -156.02 173.34 16.95 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.039 1.335 . . . . 0.0 111.153 -175.267 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.58 HD23 ' C ' ' A' ' 88' ' ' ALA . 5.6 mt -121.06 163.78 17.81 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.697 1.199 . . . . 0.0 110.148 -170.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.855 HG21 HD13 ' A' ' 115' ' ' ILE . 42.7 t -141.87 135.0 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 123.963 0.905 . . . . 0.0 111.478 -172.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.6 t 53.0 59.63 13.37 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 128.626 2.77 . . . . 0.0 113.938 175.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -73.11 -51.57 0.16 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.73 1.62 . . . . 0.0 115.808 -169.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 85.01 172.48 0.07 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 128.463 2.705 . . . . 0.0 109.638 -171.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.08 -34.19 42.69 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 125.408 1.483 . . . . 0.0 110.398 169.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.59 -48.12 73.39 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-O 117.883 -1.056 . . . . 0.0 108.619 -173.132 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 54.8 t -79.82 -52.48 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -176.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -63.92 -9.73 17.06 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.55 1.068 . . . . 0.0 111.23 -176.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.41 -74.53 0.09 Allowed 'General case' 0 CA--C 1.489 -1.4 0 CA-C-O 122.108 0.956 . . . . 0.0 108.547 162.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.661 ' O ' HG22 ' A' ' 103' ' ' THR . 17.7 t -70.93 -29.65 38.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 113.585 -1.643 . . . . 0.0 107.114 -156.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.03 -12.44 3.36 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 117.685 -1.15 . . . . 0.0 109.972 173.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.75 -37.03 8.89 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.1 mp -63.79 -18.53 64.18 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.887 2.475 . . . . 0.0 113.257 172.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.661 HG22 ' O ' ' A' ' 99' ' ' VAL . 12.7 t -128.0 16.48 6.77 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.97 1.308 . . . . 0.0 112.623 -171.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . 0.257 0.1 OUTLIER 40.11 78.95 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.38 1.472 . . . . 0.0 110.661 -173.906 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.402 ' HB2' HG23 ' A' ' 103' ' ' THR . 0.1 OUTLIER -133.79 -49.02 0.82 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.114 1.366 . . . . 0.0 107.93 -178.291 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.9 p-10 -62.53 -25.32 67.98 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 125.747 1.619 . . . . 0.0 112.072 176.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.5 -11.92 38.78 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.744 1.218 . . . . 0.0 113.895 -178.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.6 mt -105.55 -51.04 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 -173.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.5 t -107.91 142.62 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 121.414 0.626 . . . . 0.0 109.328 -170.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.416 ' HE3' ' HG3' ' A' ' 125' ' ' LYS . 14.4 mtmm -69.52 163.36 25.56 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-N 114.673 -1.149 . . . . 0.0 112.261 173.497 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -148.87 146.0 17.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 113.312 -1.767 . . . . 0.0 108.887 -169.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -148.57 167.55 25.12 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.544 1.138 . . . . 0.0 110.625 -171.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.7 -40.72 13.06 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -177.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.2 p -127.29 172.08 10.92 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.81 0.814 . . . . 0.0 109.501 -179.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.855 HD13 HG21 ' A' ' 90' ' ' VAL . 23.8 mm -70.04 -40.71 78.79 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.553 170.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 38.8 t -66.35 -33.12 75.0 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 119.288 0.949 . . . . 0.0 109.846 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -64.66 -11.76 38.98 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.872 0.869 . . . . 0.0 111.952 175.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -113.58 -39.08 4.14 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 124.935 1.294 . . . . 0.0 109.829 -175.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 5.9 ttp -58.17 -46.79 85.12 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.865 1.266 . . . . 0.0 112.348 -164.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -90.09 -19.89 23.81 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.869 1.268 . . . . 0.0 111.623 177.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -83.62 -50.39 8.25 Favored 'General case' 0 C--O 1.219 -0.532 0 C-N-CA 123.685 0.794 . . . . 0.0 109.095 -171.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.524 HG22 ' HB3' ' A' ' 86' ' ' PHE . 0.3 OUTLIER -53.36 -16.7 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 127.292 2.237 . . . . 0.0 113.173 177.72 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -47.36 64.07 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.299 2.24 . . . . 0.0 111.746 169.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.22 37.21 1.72 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.559 1.944 . . . . 0.0 113.199 -173.413 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.416 ' HG3' ' HE3' ' A' ' 110' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.107 0 C-N-CA 130.886 3.675 . . . . 0.0 111.666 157.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 9.2 p90 . . . . . 0 CA--C 1.535 0.383 0 CA-C-O 119.495 -0.288 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.427 ' HG2' ' H ' ' A' ' 18' ' ' ILE . 4.9 ttmt -137.65 173.36 11.74 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.563 1.945 . . . . 0.0 109.452 173.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.427 ' H ' ' HG2' ' A' ' 17' ' ' LYS . 67.0 mt -135.53 134.81 51.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 128.866 2.866 . . . . 0.0 105.973 168.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.2 m -108.1 -169.94 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 128.289 2.635 . . . . 0.0 107.038 164.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -23.05 -75.92 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 128.153 2.581 . . . . 0.0 113.311 -171.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -134.15 36.23 3.24 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.256 0.622 . . . . 0.0 110.291 172.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.758 HG11 ' CE2' ' A' ' 56' ' ' PHE . 6.8 t -142.25 153.55 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.049 0 CA-C-O 122.785 1.278 . . . . 0.0 110.572 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.448 ' C ' HD12 ' A' ' 24' ' ' ILE . 0.9 OUTLIER -113.41 151.96 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.721 0 CA-C-N 112.67 -2.059 . . . . 0.0 107.487 -168.552 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.448 HD12 ' C ' ' A' ' 23' ' ' VAL . 3.9 mp -132.33 88.54 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -179.067 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.428 ' CD2' HG23 ' A' ' 55' ' ' ILE . 0.5 OUTLIER -67.59 158.26 32.51 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 120.377 1.444 . . . . 0.0 109.811 166.619 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -168.53 73.18 0.82 Allowed Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 123.905 0.882 . . . . 0.0 110.317 -176.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -68.65 120.86 7.76 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.881 2.387 . . . . 0.0 111.407 -168.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -76.16 66.53 2.32 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.4 -0.812 . . . . 0.0 111.749 175.09 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? 61.31 8.7 2.21 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.538 1.535 . . . . 0.0 113.155 -175.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.04 26.84 0.14 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.835 1.254 . . . . 0.0 112.789 -178.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.97 80.01 7.87 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 123.353 1.549 . . . . 0.0 106.842 175.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -99.63 148.95 23.79 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 127.191 2.196 . . . . 0.0 107.333 163.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.0 tt -54.37 -30.57 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.465 1.506 . . . . 0.0 112.217 174.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.407 ' O ' HD22 ' A' ' 38' ' ' LEU . 46.9 mt-10 -58.93 -63.62 1.23 Allowed 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 175.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -51.7 -46.06 63.75 Favored 'General case' 0 C--O 1.222 -0.356 0 C-N-CA 125.252 1.421 . . . . 0.0 109.574 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.75 -40.57 63.23 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.838 1.255 . . . . 0.0 113.631 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -64.29 -47.72 78.41 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 119.795 1.18 . . . . 0.0 109.599 177.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.407 HD22 ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -72.41 -31.77 65.79 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 118.014 -0.993 . . . . 0.0 111.03 -175.157 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -41.35 -40.3 1.66 Allowed 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 128.075 2.55 . . . . 0.0 110.715 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -55.46 -72.11 0.07 Allowed 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 118.989 0.813 . . . . 0.0 109.41 168.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.53 -35.48 63.24 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.869 0.868 . . . . 0.0 111.132 -172.028 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 20.7 t90 -59.88 -73.23 0.09 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 117.152 -1.404 . . . . 0.0 111.24 170.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 53.9 t -49.18 -36.33 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-N 120.452 1.478 . . . . 0.0 111.195 -178.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -68.52 -57.48 5.73 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 124.732 1.213 . . . . 0.0 110.538 -178.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -67.72 -31.58 71.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 118.545 0.611 . . . . 0.0 110.636 -177.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -89.24 -20.62 23.92 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 123.334 0.653 . . . . 0.0 111.728 -168.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -133.62 -53.85 0.88 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 118.619 0.645 . . . . 0.0 111.537 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 35.6 mt -64.31 -39.92 94.9 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 119.035 -0.507 . . . . 0.0 110.808 -171.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -72.97 -35.61 66.94 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 126.922 2.089 . . . . 0.0 111.356 173.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.91 -50.62 70.2 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.563 0.745 . . . . 0.0 109.46 175.022 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 138.21 6.08 1.48 Allowed Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.368 0.985 . . . . 0.0 112.634 -177.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -72.06 155.63 40.09 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 118.464 1.132 . . . . 0.0 109.876 177.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -131.65 15.31 4.89 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.692 1.597 . . . . 0.0 111.187 173.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.469 ' HB3' HG13 ' A' ' 22' ' ' VAL . 0.3 OUTLIER -153.32 105.11 2.83 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 -163.13 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.428 HG23 ' CD2' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -116.09 155.19 17.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 103.801 -2.666 . . . . 0.0 103.801 179.505 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.758 ' CE2' HG11 ' A' ' 22' ' ' VAL . 27.4 m-85 -130.29 160.67 33.23 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 159.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 42.0 tp -126.72 103.98 7.83 Favored 'General case' 0 C--N 1.334 -0.083 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 173.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.2 t -78.88 141.27 15.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 171.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 92' ' ' PRO . 3.4 mp -122.69 12.24 9.88 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.603 0.638 . . . . 0.0 112.304 -178.021 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.5 t -50.01 -44.72 51.35 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.655 1.582 . . . . 0.0 111.401 178.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -68.56 -36.22 78.48 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 118.684 -0.674 . . . . 0.0 111.234 -175.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 p -103.44 117.71 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 126.579 1.951 . . . . 0.0 107.753 -160.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -76.13 -39.63 54.65 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.22 -0.925 . . . . 0.0 109.17 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 78.9 p -140.29 163.17 33.47 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -175.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.404 HD11 ' HB2' ' A' ' 69' ' ' SER . 20.0 tt -136.7 154.73 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 C-N-CA 126.407 1.883 . . . . 0.0 107.068 175.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.89 160.07 17.37 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.185 1.794 . . . . 0.0 109.847 -175.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.3 t -62.8 -12.89 27.35 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.7 1.2 . . . . 0.0 113.278 174.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -71.37 -68.29 0.46 Allowed 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 168.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.404 ' HB2' HD11 ' A' ' 65' ' ' ILE . 0.6 OUTLIER -70.67 -30.3 66.86 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.674 1.189 . . . . 0.0 112.531 -163.236 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.539 HD22 HD13 ' A' ' 105' ' ' LEU . 11.6 mt -47.42 -42.54 22.44 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.966 0.907 . . . . 0.0 109.759 174.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -71.79 -29.84 66.84 Favored Glycine 0 CA--C 1.528 0.854 0 O-C-N 121.365 -0.834 . . . . 0.0 112.298 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.0 t -67.92 -35.26 71.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 O-C-N 121.583 -0.951 . . . . 0.0 109.314 176.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.8 -47.91 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.6 t -60.88 -39.43 81.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 O-C-N 121.535 -0.728 . . . . 0.0 110.938 174.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.41 -42.76 92.53 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 120.973 -1.08 . . . . 0.0 112.327 -176.115 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.3 mt -53.64 -43.52 54.83 Favored 'Isoleucine or valine' 0 C--N 1.343 0.308 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 172.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.434 ' C ' HD13 ' A' ' 77' ' ' LEU . 3.1 tm? -66.44 -48.35 70.25 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -173.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 24.6 mttm -55.22 -47.59 75.1 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 122.777 0.431 . . . . 0.0 111.099 178.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.1 m -61.87 -46.55 88.95 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.974 0.91 . . . . 0.0 110.391 -177.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 29.4 mt -65.75 -48.06 83.64 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 C-N-CA 124.051 0.94 . . . . 0.0 111.328 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.52 -39.54 80.38 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 177.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 50.6 m -62.57 -41.54 98.99 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.061 176.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.7 m -61.42 -51.22 69.66 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.362 0.983 . . . . 0.0 109.982 174.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 134.75 24.24 0.6 Allowed Glycine 0 CA--C 1.525 0.671 0 C-N-CA 123.711 0.672 . . . . 0.0 112.396 -171.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -119.67 -173.12 15.23 Favored Glycine 0 N--CA 1.439 -1.131 0 CA-C-N 118.599 1.199 . . . . 0.0 111.942 -176.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.586 ' HB3' HG22 ' A' ' 122' ' ' VAL . 3.4 m-85 -131.6 155.3 47.77 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.843 1.657 . . . . 0.0 109.246 177.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -150.57 135.42 17.5 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.697 0.799 . . . . 0.0 109.595 176.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -139.95 162.24 35.65 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.009 0.433 . . . . 0.0 111.982 -177.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.466 ' N ' HD12 ' A' ' 89' ' ' LEU . 7.5 mp -103.03 151.93 21.93 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.025 1.73 . . . . 0.0 107.405 178.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 70.4 t -145.1 145.43 20.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -168.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 47.1 t 42.37 57.66 10.7 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 124.499 1.119 . . . . 0.0 110.124 -176.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.4 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 30.5 Cg_endo -64.98 -77.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.947 2.431 . . . . 0.0 111.301 -165.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 25.0 p30 142.46 -175.12 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.492 1 C-N-CA 133.337 4.655 . . . . 0.0 106.01 171.207 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -77.84 -32.91 52.42 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 122.458 1.123 . . . . 0.0 111.849 176.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.74 -51.26 19.9 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 129.921 3.288 . . . . 0.0 110.271 -166.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.824 HG13 HD13 ' A' ' 100' ' ' LEU . 1.2 t -63.94 -48.12 87.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 125.668 1.587 . . . . 0.0 107.75 168.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -61.56 -26.08 67.72 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 122.746 2.521 . . . . 0.0 110.828 -175.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -46.98 85.83 Favored 'General case' 0 C--N 1.344 0.341 0 O-C-N 121.376 -0.827 . . . . 0.0 109.583 175.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.2 p -80.45 -31.31 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -172.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.824 HD13 HG13 ' A' ' 96' ' ' VAL . 3.3 mp -66.06 -17.48 64.72 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 118.037 -0.982 . . . . 0.0 112.462 177.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.6 m -77.86 -58.11 3.44 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 165.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.93 -68.56 0.16 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.019 2.128 . . . . 0.0 111.641 -173.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.628 HG23 HD12 ' A' ' 105' ' ' LEU . 5.7 t -76.92 14.59 0.81 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.671 1.589 . . . . 0.0 112.518 -175.495 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 42.76 85.05 0.02 OUTLIER 'General case' 0 C--N 1.34 0.194 0 C-N-CA 126.256 1.822 . . . . 0.0 112.014 -169.18 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.628 HD12 HG23 ' A' ' 103' ' ' THR 0.334 0.1 OUTLIER -126.04 -41.47 1.94 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 125.169 1.388 . . . . 0.0 112.362 178.163 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -67.76 -21.18 65.28 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.95 1.25 . . . . 0.0 111.259 171.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.9 mtm180 -79.51 -1.94 39.94 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 118.805 -0.617 . . . . 0.0 111.227 -178.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.7 mm -127.69 -46.17 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 C-N-CA 124.97 1.308 . . . . 0.0 108.384 -164.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.446 HG11 ' CD1' ' A' ' 89' ' ' LEU . 2.6 t -110.48 149.24 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 -177.373 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.471 ' HE3' ' H ' ' A' ' 111' ' ' ILE . 0.0 OUTLIER -71.52 160.88 31.93 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.979 173.519 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.471 ' H ' ' HE3' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -145.27 143.29 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -177.249 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -146.55 171.4 15.14 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.349 1.459 . . . . 0.0 110.417 -177.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -87.24 -50.03 6.87 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -177.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 31.8 p -125.55 170.54 11.35 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-O 122.174 0.987 . . . . 0.0 111.141 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 12.4 mm -63.13 -36.76 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 C-N-CA 124.293 1.037 . . . . 0.0 108.379 170.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.79 -43.0 90.04 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 119.869 1.213 . . . . 0.0 110.979 -178.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -71.41 3.87 3.43 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 123.691 0.62 . . . . 0.0 112.169 178.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.466 ' HB1' ' CE1' ' A' ' 56' ' ' PHE . . . -114.39 -33.89 5.46 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 174.12 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.16 -52.31 62.94 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 120.17 -1.582 . . . . 0.0 111.79 -162.15 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -89.8 -13.81 35.82 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.48 0.712 . . . . 0.0 112.113 172.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.81 -52.36 6.1 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -168.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.586 HG22 ' HB3' ' A' ' 86' ' ' PHE . 0.3 OUTLIER -53.31 -32.45 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 126.406 1.883 . . . . 0.0 111.322 176.194 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 43.8 mtm180 -62.18 -25.03 67.55 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 124.221 1.008 . . . . 0.0 111.285 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.22 56.33 1.0 Allowed 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 119.158 0.89 . . . . 0.0 109.862 169.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.199 0 CA-C-O 118.196 -0.907 . . . . 0.0 111.437 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 15.2 p90 . . . . . 0 N--CA 1.451 -0.418 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -141.32 173.14 11.78 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 127.309 2.244 . . . . 0.0 108.365 164.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.6 mt -129.8 120.65 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 167.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.3 m -88.09 -151.96 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 124.938 1.295 . . . . 0.0 108.226 172.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -25.03 -72.39 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 128.6 2.76 . . . . 0.0 113.472 -177.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -145.43 28.03 1.21 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.184 1.394 . . . . 0.0 110.49 165.09 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.735 HG11 ' CE2' ' A' ' 56' ' ' PHE . 24.2 t -122.42 137.22 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 O-C-N 120.824 -1.172 . . . . 0.0 110.444 -177.086 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.4 t -84.8 135.81 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 177.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.1 mp -117.01 103.39 14.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 173.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.454 HD23 HG23 ' A' ' 55' ' ' ILE . 3.8 mm? -76.66 95.52 3.98 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 128.194 2.598 . . . . 0.0 106.765 171.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 14.8 mtm -94.45 95.8 1.58 Allowed Pre-proline 0 CA--C 1.55 0.966 0 CA-C-N 121.539 1.972 . . . . 0.0 106.54 172.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -67.99 172.25 11.13 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 CA-C-N 122.08 1.778 . . . . 0.0 109.488 171.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -152.89 -71.99 0.14 Allowed 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 169.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.33 17.27 4.47 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.0 1.32 . . . . 0.0 112.488 -176.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -89.89 1.13 56.58 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 122.994 0.518 . . . . 0.0 111.13 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 17.9 mt -89.76 89.56 7.83 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -132.68 22.07 4.27 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.499 1.12 . . . . 0.0 113.152 -166.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.255 0.2 OUTLIER 64.12 -43.27 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 129.188 2.995 . . . . 0.0 114.444 -172.795 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -61.39 -19.01 61.42 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 120.765 -1.209 . . . . 0.0 111.061 174.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -115.25 68.77 0.71 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 126.404 1.882 . . . . 0.0 108.288 174.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.582 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . . . -132.34 -62.61 0.83 Allowed 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 167.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -59.05 -35.29 73.07 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.238 0.927 . . . . 0.0 110.306 174.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 36.0 mt -67.11 -28.88 68.52 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 124.244 1.017 . . . . 0.0 112.929 173.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -59.13 -57.75 11.69 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 124.62 1.168 . . . . 0.0 108.745 -172.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.489 ' HE2' ' CE2' ' A' ' 44' ' ' PHE . 3.9 ttpm? -54.24 -49.06 70.37 Favored 'General case' 0 C--O 1.216 -0.682 0 CA-C-O 116.684 -1.627 . . . . 0.0 110.216 172.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -43.99 85.67 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 120.667 1.576 . . . . 0.0 111.367 -176.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -67.81 -60.89 2.17 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-O 116.709 -1.615 . . . . 0.0 109.088 177.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.551 HG12 ' CD1' ' A' ' 48' ' ' LEU . 56.7 t -52.1 -38.7 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 121.538 1.972 . . . . 0.0 109.772 -178.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.517 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 8.0 m-30 -60.26 -69.03 0.24 Allowed 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 124.362 1.065 . . . . 0.0 110.687 176.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.21 -10.13 59.17 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -171.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -90.94 -31.37 16.4 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 116.048 -1.929 . . . . 0.0 110.284 173.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -134.54 -53.42 0.82 Allowed 'General case' 0 C--N 1.357 0.906 0 CA-C-N 122.804 2.547 . . . . 0.0 109.91 -174.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.551 ' CD1' HG12 ' A' ' 43' ' ' VAL . 6.6 mp -55.8 -59.59 4.65 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.818 0.818 . . . . 0.0 110.918 -174.347 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -75.45 -5.48 45.26 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 124.623 1.169 . . . . 0.0 112.268 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.7 mttm -75.59 -28.8 59.06 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.12 0.873 . . . . 0.0 110.274 163.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 125.0 -6.0 8.29 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 126.143 1.83 . . . . 0.0 112.688 -176.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -71.49 174.79 6.15 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 119.44 1.62 . . . . 0.0 108.928 175.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -172.09 5.72 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.184 1.794 . . . . 0.0 109.598 -169.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.477 ' HB3' HG13 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -131.81 112.49 12.54 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 104.889 -2.263 . . . . 0.0 104.889 -176.513 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.454 HG23 HD23 ' A' ' 25' ' ' LEU . 1.8 mp -122.94 146.38 28.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 178.353 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.785 ' CE1' HG21 ' A' ' 122' ' ' VAL . 17.1 m-85 -129.34 128.96 44.17 Favored 'General case' 0 C--O 1.228 -0.051 0 C-N-CA 123.958 0.903 . . . . 0.0 109.735 166.042 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 47.5 tp -95.16 121.48 36.85 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.296 1.039 . . . . 0.0 109.594 -178.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.438 ' HA ' ' HB ' ' A' ' 90' ' ' VAL . 0.8 OUTLIER -89.09 152.94 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 119.59 1.086 . . . . 0.0 111.402 177.902 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.517 ' CD2' HG21 ' A' ' 96' ' ' VAL . 0.9 OUTLIER -134.0 0.8 3.21 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.115 0.966 . . . . 0.0 112.982 175.083 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.44 -8.19 1.7 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 169.102 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -116.68 -5.66 11.61 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.563 1.145 . . . . 0.0 111.83 -168.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.4 p -143.8 148.43 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 125.012 1.325 . . . . 0.0 107.47 -170.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -78.0 -46.98 19.53 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 176.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.8 p -155.12 168.2 27.82 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.6 tt -94.13 156.43 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 125.977 1.711 . . . . 0.0 108.178 162.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -111.44 174.57 5.8 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.551 -0.718 . . . . 0.0 110.358 -176.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.5 m -57.87 -39.92 78.98 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 121.412 -0.805 . . . . 0.0 112.241 -172.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.582 ' CE1' ' HB2' ' A' ' 36' ' ' ALA . 0.9 OUTLIER -50.36 -53.13 31.36 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.255 1.422 . . . . 0.0 111.232 176.646 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 p -93.51 -20.75 19.97 Favored 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 121.683 -0.635 . . . . 0.0 112.026 -169.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 31.6 tp -56.97 -17.21 8.87 Favored 'General case' 0 CA--C 1.551 0.988 0 O-C-N 120.844 -1.16 . . . . 0.0 111.468 170.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -101.07 -8.51 47.53 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 125.046 1.308 . . . . 0.0 115.216 169.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -89.16 -38.88 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 119.608 1.704 . . . . 0.0 109.157 175.183 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.4 mm -58.42 -41.17 80.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 O-C-N 121.127 -0.983 . . . . 0.0 110.706 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 65.8 t -61.36 -42.77 94.94 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 CA-C-N 118.264 0.484 . . . . 0.0 110.212 174.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -63.67 -30.64 71.72 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 120.82 -1.175 . . . . 0.0 111.052 -176.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.9 mt -64.17 -40.06 87.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 171.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -67.84 -49.19 63.51 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 123.931 0.892 . . . . 0.0 109.172 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.3 mttm -48.72 -55.64 10.84 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 124.451 1.1 . . . . 0.0 110.418 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 69.2 m -78.41 -26.75 46.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 118.145 -0.931 . . . . 0.0 112.699 -172.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 25.2 mt -59.04 -44.89 92.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 119.85 1.204 . . . . 0.0 109.306 165.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.2 t -74.59 -18.44 60.57 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.34 1.056 . . . . 0.0 112.135 -176.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.1 m -77.89 -43.78 29.08 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.881 0.872 . . . . 0.0 110.279 166.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.0 m -64.38 -50.9 65.84 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 118.418 -0.801 . . . . 0.0 110.741 -176.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 134.2 23.13 0.69 Allowed Glycine 0 CA--C 1.521 0.426 0 CA-C-O 119.157 -0.801 . . . . 0.0 113.565 -175.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -115.82 -171.98 16.64 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 118.84 1.32 . . . . 0.0 111.81 -170.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.16 158.4 43.75 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.466 1.507 . . . . 0.0 110.201 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -150.5 142.2 23.66 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.491 ' C ' HD23 ' A' ' 89' ' ' LEU . . . -144.07 173.22 11.91 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.318 1.447 . . . . 0.0 110.605 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.491 HD23 ' C ' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -118.28 168.14 10.88 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.926 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.438 ' HB ' ' HA ' ' A' ' 58' ' ' VAL . 57.7 t -139.48 129.4 30.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 124.425 1.09 . . . . 0.0 108.153 -164.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.9 t 43.84 69.98 2.12 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 127.122 2.169 . . . . 0.0 110.555 -176.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -71.09 118.82 5.89 Favored 'Trans proline' 0 N--CA 1.445 -1.365 0 N-CA-C 107.597 -1.732 . . . . 0.0 107.597 173.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 49.1 p30 -67.33 165.5 16.26 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 122.863 1.316 . . . . 0.0 109.447 163.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -69.19 -24.49 64.05 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.892 -174.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -46.41 78.79 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 126.624 1.97 . . . . 0.0 110.256 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.517 HG21 ' CD2' ' A' ' 59' ' ' LEU . 6.6 t -77.93 -38.59 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-O 118.263 -0.875 . . . . 0.0 109.982 -178.067 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -51.25 -39.02 55.78 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 124.744 1.218 . . . . 0.0 110.045 177.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.7 -61.27 1.91 Allowed 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 125.69 1.596 . . . . 0.0 114.222 172.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.569 ' O ' HG22 ' A' ' 103' ' ' THR . 77.9 t -71.21 -47.92 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 C-N-CA 125.889 1.676 . . . . 0.0 107.339 -169.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.39 -21.53 60.05 Favored 'General case' 0 N--CA 1.438 -1.028 0 O-C-N 124.495 1.122 . . . . 0.0 108.6 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.4 m -82.47 -52.01 7.27 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 81.1 mt -57.94 -29.0 64.81 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.578 1.951 . . . . 0.0 113.495 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.569 HG22 ' O ' ' A' ' 99' ' ' VAL . 1.9 t -111.53 -1.81 15.71 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.917 1.287 . . . . 0.0 111.205 -171.299 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 53.9 78.9 0.14 Allowed 'General case' 0 C--N 1.343 0.283 0 C-N-CA 127.181 2.192 . . . . 0.0 109.931 -176.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.19 -49.39 1.94 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 126.716 2.006 . . . . 0.0 108.064 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -67.17 -12.19 59.36 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.141 1.376 . . . . 0.0 112.465 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.1 mtp180 -90.22 -0.79 57.79 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.867 1.667 . . . . 0.0 111.433 176.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.6 mm -127.46 -45.21 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 125.623 1.569 . . . . 0.0 107.431 -165.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.2 t -99.21 155.08 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 174.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.4 ' HD2' ' HE2' ' A' ' 125' ' ' LYS . 0.1 OUTLIER -76.45 164.78 25.65 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 121.524 -0.735 . . . . 0.0 109.832 170.978 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.45 141.83 23.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -145.1 164.91 29.8 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 125.981 1.712 . . . . 0.0 110.095 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -94.94 -54.59 3.4 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 46.7 p -106.96 157.56 17.69 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 118.778 0.717 . . . . 0.0 109.365 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 9.1 mm -58.65 -36.55 60.67 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 175.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 45.0 t -60.79 -41.59 95.9 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 118.933 -0.556 . . . . 0.0 110.654 -175.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -71.92 -21.49 61.61 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 124.163 0.915 . . . . 0.0 110.639 -176.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.733 ' O ' HG23 ' A' ' 122' ' ' VAL . . . -79.53 -54.07 6.25 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 104.12 -2.548 . . . . 0.0 104.12 176.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.97 -59.3 3.19 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 125.518 1.527 . . . . 0.0 111.774 -160.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -75.61 -19.21 59.38 Favored 'General case' 0 CA--C 1.521 -0.172 0 O-C-N 123.926 0.766 . . . . 0.0 112.299 -176.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -88.09 -51.49 5.77 Favored 'General case' 0 CA--C 1.495 -1.14 0 CA-C-O 118.568 -0.729 . . . . 0.0 110.134 -172.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.785 HG21 ' CE1' ' A' ' 56' ' ' PHE . 40.3 t -48.65 -39.44 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 126.439 1.896 . . . . 0.0 110.062 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -47.64 -43.11 25.76 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.545 1.138 . . . . 0.0 112.639 171.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -134.06 33.82 3.37 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.377 2.671 . . . . 0.0 112.752 -172.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.4 ' HE2' ' HD2' ' A' ' 110' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.235 0 C-N-CA 126.708 2.003 . . . . 0.0 113.977 -160.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 14.4 p90 . . . . . 0 CA--C 1.541 0.604 0 CA-C-O 121.468 0.651 . . . . 0.0 111.682 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.2 ttmm -136.56 173.17 11.99 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.222 2.209 . . . . 0.0 108.076 161.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 54.2 mt -135.33 144.96 32.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 129.015 2.926 . . . . 0.0 104.223 163.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.1 m -105.76 -130.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 173.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -50.59 -66.87 0.31 Allowed 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 126.917 2.087 . . . . 0.0 111.263 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -144.48 11.87 1.5 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.825 2.05 . . . . 0.0 111.82 178.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.627 HG11 ' CE2' ' A' ' 56' ' ' PHE . 8.9 t -119.26 135.44 59.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -177.408 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.51 HG13 ' HA ' ' A' ' 55' ' ' ILE . 0.6 OUTLIER -81.55 150.39 4.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 C-N-CA 128.337 2.655 . . . . 0.0 111.798 174.26 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.446 HD12 ' C ' ' A' ' 23' ' ' VAL . 4.1 mp -132.33 88.95 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 175.061 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.48 HD23 HG23 ' A' ' 55' ' ' ILE . 4.3 mm? -58.36 140.18 54.03 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 168.118 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 61.6 mtt -139.2 76.54 32.17 Favored Pre-proline 0 C--N 1.328 -0.339 0 C-N-CA 125.04 1.336 . . . . 0.0 108.483 176.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -75.49 68.02 6.22 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.574 2.183 . . . . 0.0 109.02 176.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.2 93.41 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.461 1.504 . . . . 0.0 107.861 176.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.25 -21.32 0.07 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 127.911 2.484 . . . . 0.0 114.8 -170.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.88 59.0 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 129.535 3.134 . . . . 0.0 113.837 -177.218 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 65.0 mt -127.98 23.41 6.13 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 119.516 -1.99 . . . . 0.0 112.21 175.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -53.3 150.21 6.51 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 164.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.7 mt -58.31 -37.95 66.21 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 CA-C-O 119.33 -0.367 . . . . 0.0 111.629 -174.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -68.33 -34.56 76.34 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 118.725 0.693 . . . . 0.0 109.343 -171.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -72.66 -43.72 62.78 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 171.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.41 -33.18 65.54 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.883 0.765 . . . . 0.0 111.626 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 25.5 t60 -70.06 -47.96 59.79 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 120.495 -1.378 . . . . 0.0 110.262 174.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.468 HD12 ' C ' ' A' ' 38' ' ' LEU . 0.5 OUTLIER -73.0 -17.34 61.46 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 118.968 -0.539 . . . . 0.0 111.727 -178.961 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -48.83 -55.78 10.62 Favored 'General case' 0 CA--C 1.513 -0.442 0 C-N-CA 127.999 2.52 . . . . 0.0 110.513 -170.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp -66.48 -28.99 69.01 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 117.86 -1.067 . . . . 0.0 111.047 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.7 ttmt -68.26 -51.99 38.97 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 121.157 1.799 . . . . 0.0 109.211 172.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.421 ' CH2' ' CD1' ' A' ' 25' ' ' LEU . 13.7 t90 -59.91 -59.45 5.4 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.229 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.0 t -50.41 -30.04 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 120.262 1.392 . . . . 0.0 112.199 176.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.442 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 3.6 m-85 -72.76 -69.84 0.39 Allowed 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 173.131 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.41 ' HA ' ' HB2' ' A' ' 49' ' ' ASN . 3.3 t0 -61.61 -35.86 79.06 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 124.289 1.036 . . . . 0.0 112.949 -167.086 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -75.69 -30.94 59.51 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.247 2.219 . . . . 0.0 111.284 175.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -132.02 -67.21 0.68 Allowed 'General case' 0 C--N 1.352 0.694 0 CA-C-N 120.682 1.583 . . . . 0.0 112.286 -174.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.442 ' HB2' ' HA ' ' A' ' 44' ' ' PHE . 6.5 mt -59.17 -48.76 80.41 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.372 0.987 . . . . 0.0 112.694 -170.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.41 ' HB2' ' HA ' ' A' ' 45' ' ' ASP . 76.4 m-20 -65.56 -34.5 78.39 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 125.428 1.491 . . . . 0.0 109.726 177.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.9 mttm -61.38 -21.64 64.25 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.802 1.241 . . . . 0.0 111.811 171.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.6 14.68 36.94 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.329 0.966 . . . . 0.0 112.485 -178.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -70.38 139.14 51.85 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 118.931 1.365 . . . . 0.0 108.085 166.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -119.42 6.02 11.13 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.592 1.157 . . . . 0.0 110.292 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt -146.87 98.05 2.99 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 120.27 1.395 . . . . 0.0 107.254 -167.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.51 ' HA ' HG13 ' A' ' 23' ' ' VAL . 1.2 mp -102.81 151.92 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.627 ' CE2' HG11 ' A' ' 22' ' ' VAL . 22.4 m-85 -123.2 160.42 26.59 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.965 0.79 . . . . 0.0 111.908 157.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.6 tp -125.3 122.48 37.01 Favored 'General case' 0 C--O 1.223 -0.324 0 C-N-CA 124.887 1.275 . . . . 0.0 109.221 171.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.423 HG12 ' H ' ' A' ' 60' ' ' SER . 15.6 t -95.06 141.74 14.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 173.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.486 HD22 HG11 ' A' ' 96' ' ' VAL . 4.3 mp -123.57 6.46 8.9 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.011 1.324 . . . . 0.0 111.133 -174.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.423 ' H ' HG12 ' A' ' 58' ' ' VAL . 2.4 t -54.66 -36.8 64.99 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.114 1.765 . . . . 0.0 111.737 174.228 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -104.76 18.71 21.79 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.113 0.965 . . . . 0.0 111.101 -165.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.4 p -151.18 122.84 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 123.551 0.74 . . . . 0.0 109.386 -175.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -73.24 -43.41 61.22 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 117.995 -1.003 . . . . 0.0 108.979 177.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.4 t -150.35 175.82 11.47 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 119.169 0.895 . . . . 0.0 111.962 -171.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.8 tt -140.91 149.85 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 -175.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -81.45 155.75 25.69 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 123.804 0.842 . . . . 0.0 109.743 -174.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.2 p -54.01 -25.8 22.98 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.068 1.347 . . . . 0.0 112.619 175.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -61.94 -63.24 1.32 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.366 1.466 . . . . 0.0 110.478 169.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 26.4 t -82.46 -22.95 34.99 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.591 1.157 . . . . 0.0 111.974 -163.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 40.8 tp -60.91 -16.66 44.63 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 120.549 -1.344 . . . . 0.0 111.609 170.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -91.85 -29.95 11.08 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-O 118.849 -0.973 . . . . 0.0 112.194 167.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -66.67 -37.23 79.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 119.551 1.676 . . . . 0.0 111.23 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.4 mm -59.68 -46.58 93.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 C-N-CA 124.6 1.16 . . . . 0.0 109.826 175.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 50.8 t -60.98 -41.51 89.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 174.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -55.96 -41.01 74.06 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.408 -0.807 . . . . 0.0 111.344 -176.103 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 71.1 mt -64.03 -39.75 86.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.719 0.808 . . . . 0.0 110.03 174.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.422 ' HG ' HG22 ' A' ' 109' ' ' VAL . 3.0 tm? -62.17 -49.25 76.58 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 119.705 1.139 . . . . 0.0 109.075 178.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -50.12 -55.53 14.63 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 123.475 0.71 . . . . 0.0 109.88 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.71 -39.9 95.45 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 117.569 -1.205 . . . . 0.0 112.365 -178.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 76.4 mt -64.32 -43.98 97.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 121.023 1.738 . . . . 0.0 109.85 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.3 m -56.8 -48.07 78.79 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.393 0.677 . . . . 0.0 110.899 172.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.4 m -71.77 -10.54 59.92 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.09 1.356 . . . . 0.0 113.935 178.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.2 m -99.7 -25.54 14.36 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.687 1.195 . . . . 0.0 111.94 175.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 120.19 2.61 12.22 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 116.435 1.334 . . . . 0.0 116.435 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -99.2 -158.83 29.17 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 119.682 1.741 . . . . 0.0 112.95 -171.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.503 ' CZ ' ' HE2' ' A' ' 125' ' ' LYS . 0.3 OUTLIER -139.93 160.11 40.67 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 127.0 2.12 . . . . 0.0 109.852 170.387 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -149.31 143.82 26.07 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 176.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.27 165.56 28.89 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.09 0.956 . . . . 0.0 112.157 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.405 ' N ' HD12 ' A' ' 89' ' ' LEU . 7.2 mp -113.72 156.39 23.87 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.753 2.021 . . . . 0.0 108.983 -175.08 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 57.7 t -146.79 149.39 15.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 123.432 0.693 . . . . 0.0 109.934 -159.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.2 t 49.14 54.89 16.83 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 125.029 1.332 . . . . 0.0 111.412 -175.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -82.54 81.7 2.41 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 122.344 2.029 . . . . 0.0 111.69 -164.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.0 156.54 9.13 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 122.044 0.926 . . . . 0.0 110.545 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -62.93 -33.68 75.85 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.803 -1.09 . . . . 0.0 112.241 -163.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.8 -41.59 97.88 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 123.67 0.788 . . . . 0.0 109.264 -174.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.486 HG11 HD22 ' A' ' 59' ' ' LEU . 17.9 t -70.63 -42.37 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-O 117.514 -1.232 . . . . 0.0 110.236 175.215 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -58.82 -28.65 66.23 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 120.127 1.331 . . . . 0.0 110.804 -172.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -51.08 -60.46 3.07 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-O 125.028 2.347 . . . . 0.0 111.454 173.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.446 ' O ' HG22 ' A' ' 103' ' ' THR . 4.7 t -71.08 -39.01 73.86 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.747 0 CA-C-N 112.508 -2.133 . . . . 0.0 107.454 -172.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.2 mt -61.79 -15.62 42.98 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 118.234 -0.888 . . . . 0.0 110.481 177.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.5 -46.1 10.49 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-O 121.32 0.581 . . . . 0.0 110.164 173.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.73 -62.53 1.8 Allowed 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.703 2.001 . . . . 0.0 108.425 -177.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.446 HG22 ' O ' ' A' ' 99' ' ' VAL . 0.6 OUTLIER -74.0 -5.76 43.33 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 129.129 2.972 . . . . 0.0 111.07 -169.28 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 49.99 77.73 0.11 Allowed 'General case' 0 C--N 1.344 0.361 0 C-N-CA 127.45 2.3 . . . . 0.0 109.437 -168.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.44 -57.08 2.17 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 173.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -65.52 -12.44 52.82 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 127.427 2.291 . . . . 0.0 112.462 175.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.4 mtt-85 -88.96 2.89 53.19 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.082 0.953 . . . . 0.0 113.08 171.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.8 mt -133.15 -43.08 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 125.098 1.359 . . . . 0.0 109.238 -173.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.422 HG22 ' HG ' ' A' ' 77' ' ' LEU . 2.1 t -114.16 141.73 29.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 125.501 1.52 . . . . 0.0 106.941 -177.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.46 159.64 23.9 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.618 0.767 . . . . 0.0 112.21 177.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -123.28 154.93 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 125.65 1.58 . . . . 0.0 106.98 169.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -147.44 162.97 37.94 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.98 1.712 . . . . 0.0 109.569 170.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -81.35 -53.24 6.49 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 119.464 -0.895 . . . . 0.0 109.361 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 67.6 p -129.44 161.58 30.06 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 125.327 1.451 . . . . 0.0 108.502 -169.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 26.7 mm -63.79 -38.89 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -173.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.9 t -74.38 -19.97 60.24 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 118.863 -1.135 . . . . 0.0 111.487 -174.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -70.22 -20.46 63.09 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 118.965 0.802 . . . . 0.0 111.173 170.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.457 ' HB1' ' CZ ' ' A' ' 56' ' ' PHE . . . -105.42 -39.83 6.01 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.997 0.919 . . . . 0.0 109.478 -169.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 5.0 ttm -58.36 -44.12 88.7 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 124.49 1.116 . . . . 0.0 111.972 -162.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -95.16 -10.49 30.39 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.347 1.059 . . . . 0.0 111.726 178.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -93.12 -50.67 5.4 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.041 -172.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.487 HG22 ' HB3' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -47.98 -37.43 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 125.73 1.612 . . . . 0.0 111.059 173.597 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -56.49 -32.78 65.35 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-O 118.494 -0.765 . . . . 0.0 111.684 176.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.73 29.42 2.35 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -175.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.503 ' HE2' ' CZ ' ' A' ' 86' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.175 0 C-N-CA 124.317 1.047 . . . . 0.0 110.059 -171.557 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.6 p90 . . . . . 0 N--CA 1.442 -0.844 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.6 ttmm -122.44 170.85 9.56 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 126.411 1.885 . . . . 0.0 108.667 167.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.7 mt -129.1 130.52 68.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 157.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.7 m -88.87 -141.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 125.311 1.444 . . . . 0.0 108.185 171.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -40.45 -78.38 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 127.585 2.354 . . . . 0.0 111.001 168.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -135.8 9.17 3.32 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 123.308 0.643 . . . . 0.0 111.87 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.765 HG11 ' CE2' ' A' ' 56' ' ' PHE . 21.7 t -106.25 135.16 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.2 t -84.98 147.52 5.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 171.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.8 mp -130.4 91.85 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 176.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.406 HD12 ' CH2' ' A' ' 42' ' ' TRP . 1.3 mm? -71.25 111.94 6.99 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 121.072 1.76 . . . . 0.0 108.983 171.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 4.1 mtt -106.11 91.39 5.46 Favored Pre-proline 0 CA--C 1.548 0.869 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.33 122.95 4.78 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.187 2.591 . . . . 0.0 111.499 -171.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.417 ' C ' ' HE2' ' A' ' 29' ' ' LYS . 0.4 OUTLIER -90.63 74.87 6.69 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 122.34 1.067 . . . . 0.0 111.746 175.959 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.417 ' HE2' ' C ' ' A' ' 28' ' ' ASN . 0.0 OUTLIER 55.72 16.9 2.16 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 119.891 -1.756 . . . . 0.0 113.137 -174.036 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -99.09 13.41 32.95 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 121.421 -0.799 . . . . 0.0 112.546 -161.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.95 72.25 6.7 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 171.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -92.35 148.5 22.07 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 169.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.571 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 0.5 OUTLIER -58.65 -34.45 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 120.345 1.43 . . . . 0.0 109.617 -177.31 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -64.47 -12.14 40.73 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 120.202 -1.561 . . . . 0.0 112.949 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -110.36 -26.71 9.42 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.452 1.501 . . . . 0.0 112.074 168.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.571 ' HB3' ' HA ' ' A' ' 33' ' ' ILE . . . -68.53 -37.57 80.12 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.099 -1.001 . . . . 0.0 111.194 178.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -55.49 -47.65 75.83 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.003 0.921 . . . . 0.0 109.368 168.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 73.0 mt -70.02 -24.01 63.21 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-O 118.081 -0.961 . . . . 0.0 112.496 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.43 ' HB2' ' HA ' ' A' ' 36' ' ' ALA . 1.0 OUTLIER -55.43 -38.25 68.74 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.805 1.242 . . . . 0.0 112.151 -162.363 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -56.87 -65.3 0.64 Allowed 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 118.384 -0.817 . . . . 0.0 109.107 167.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.2 tmtt? -50.74 -47.16 59.43 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 124.199 1.0 . . . . 0.0 111.029 -175.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.406 ' CH2' HD12 ' A' ' 25' ' ' LEU . 27.1 t90 -61.67 -67.5 0.4 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.809 1.244 . . . . 0.0 109.657 176.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 54.2 t -53.79 -33.22 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 121.411 1.914 . . . . 0.0 111.867 -176.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.442 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 3.8 m-85 -60.56 -75.17 0.07 Allowed 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 124.769 1.228 . . . . 0.0 109.581 171.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -70.75 -14.15 62.33 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.886 1.675 . . . . 0.0 113.871 -169.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.88 -33.43 16.46 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 120.739 -1.226 . . . . 0.0 109.865 175.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -136.67 -60.68 0.7 Allowed 'General case' 0 C--N 1.346 0.439 0 CA-C-N 118.86 0.754 . . . . 0.0 111.921 -169.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.442 ' HB2' ' HA ' ' A' ' 44' ' ' PHE . 10.1 mt -60.19 -55.93 27.72 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.463 1.029 . . . . 0.0 112.673 -173.176 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -66.41 -9.62 35.6 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.595 1.158 . . . . 0.0 110.973 174.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.13 -2.77 58.67 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.656 1.982 . . . . 0.0 111.81 171.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.85 5.45 59.82 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.913 1.244 . . . . 0.0 114.204 177.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -77.48 146.72 36.28 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 119.745 1.772 . . . . 0.0 110.017 176.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -138.45 14.48 2.77 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.525 1.93 . . . . 0.0 110.027 -172.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.595 ' HB3' HG13 ' A' ' 22' ' ' VAL . 0.9 OUTLIER -149.74 116.7 5.95 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 178.116 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.7 mp -120.8 152.7 23.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 175.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.765 ' CE2' HG11 ' A' ' 22' ' ' VAL . 21.9 m-85 -124.18 158.07 33.26 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.603 1.161 . . . . 0.0 110.082 161.052 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 54.2 tp -118.09 122.97 44.45 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.963 1.705 . . . . 0.0 107.422 173.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . 0.252 0.7 OUTLIER -95.09 157.48 3.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 119.921 1.237 . . . . 0.0 109.927 174.349 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 24.3 mt -132.24 13.69 4.64 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.226 0.611 . . . . 0.0 111.359 -168.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.1 m -81.53 -46.48 14.43 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -173.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -88.2 -23.12 23.67 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.454 1.025 . . . . 0.0 110.7 -173.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.0 p -78.74 162.66 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 125.538 1.535 . . . . 0.0 109.776 169.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -116.99 -37.51 3.57 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.443 0.697 . . . . 0.0 110.516 170.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.87 176.07 13.04 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 122.438 1.113 . . . . 0.0 110.123 177.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.4 tt -132.6 160.0 42.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 127.361 2.264 . . . . 0.0 108.05 -172.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.453 ' C ' ' H ' ' A' ' 68' ' ' PHE . 35.6 t0 -96.24 168.79 10.37 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 119.625 -1.922 . . . . 0.0 109.79 -168.025 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.5 m -65.25 31.26 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 128.954 2.902 . . . . 0.0 112.052 165.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.453 ' H ' ' C ' ' A' ' 66' ' ' ASP . 43.5 t80 -132.08 -67.72 0.66 Allowed 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 172.196 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.28 -25.01 61.43 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.443 -166.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.48 HD11 HG21 ' A' ' 103' ' ' THR . 33.1 tp -55.3 -33.09 62.96 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 120.601 -1.312 . . . . 0.0 110.95 171.434 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -95.32 1.99 65.0 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 125.111 1.339 . . . . 0.0 114.709 174.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -92.63 -32.79 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 120.181 1.991 . . . . 0.0 109.544 167.274 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -56.69 -53.02 46.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.339 1.056 . . . . 0.0 109.13 177.233 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.0 t -59.33 -39.95 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 O-C-N 121.515 -0.741 . . . . 0.0 110.374 176.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -54.94 -38.68 68.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 119.207 0.912 . . . . 0.0 112.231 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 80.5 mt -69.61 -34.21 60.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -63.43 -50.33 70.22 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 119.846 1.203 . . . . 0.0 109.278 175.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -53.31 -48.13 68.67 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.056 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.4 t -58.09 -61.38 2.59 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.395 1.878 . . . . 0.0 111.264 176.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 59.7 mt -54.84 -45.87 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 119.646 1.112 . . . . 0.0 110.798 -177.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.3 t -61.88 -41.04 97.4 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.44 -23.71 65.55 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.133 0.973 . . . . 0.0 113.348 173.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.0 m -79.0 -25.4 43.32 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 118.02 -0.99 . . . . 0.0 112.388 171.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 103.67 15.78 21.69 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.5 -1.167 . . . . 0.0 113.954 -170.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -98.08 -168.28 31.86 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 120.322 2.061 . . . . 0.0 112.586 174.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -133.51 162.65 31.3 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.031 1.333 . . . . 0.0 108.501 168.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -147.88 147.1 29.39 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.298 1.039 . . . . 0.0 108.222 176.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.414 ' C ' HD23 ' A' ' 89' ' ' LEU . . . -152.21 172.64 16.08 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.089 1.356 . . . . 0.0 110.72 178.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.414 HD23 ' C ' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -116.15 171.47 7.79 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 118.588 0.631 . . . . 0.0 109.831 -178.146 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 86.1 t -146.69 144.06 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.821 1.248 . . . . 0.0 109.83 -168.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 44.09 60.07 12.22 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 127.815 2.446 . . . . 0.0 113.942 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -84.51 92.56 0.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 124.545 3.496 . . . . 0.0 110.141 -170.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.65 160.32 14.31 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 121.848 -0.532 . . . . 0.0 110.269 177.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -63.74 -34.89 78.89 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.779 0.832 . . . . 0.0 111.167 -167.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.47 ' HE2' ' O ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -59.34 -29.99 68.06 Favored 'General case' 0 CA--C 1.517 -0.321 0 O-C-N 121.006 -1.059 . . . . 0.0 109.439 178.903 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.2 t -92.57 -37.48 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-O 117.911 -1.042 . . . . 0.0 110.283 177.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -59.55 -33.31 71.25 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 121.806 2.094 . . . . 0.0 109.723 175.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.64 -27.33 67.6 Favored 'General case' 0 C--O 1.222 -0.349 0 O-C-N 121.234 -0.916 . . . . 0.0 112.463 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.621 ' O ' HG22 ' A' ' 103' ' ' THR . 7.3 p -95.39 -39.65 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -178.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.418 HD23 HG13 ' A' ' 99' ' ' VAL . 0.2 OUTLIER -59.41 -15.66 18.34 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.075 1.75 . . . . 0.0 111.955 177.649 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.0 t -93.51 -52.85 4.3 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -53.75 -44.81 70.28 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 128.472 2.709 . . . . 0.0 111.805 -177.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.621 HG22 ' O ' ' A' ' 99' ' ' VAL . 10.1 t -79.52 -17.42 54.1 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 118.843 -0.598 . . . . 0.0 111.299 -178.386 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 63.67 94.21 0.05 Allowed 'General case' 0 C--N 1.34 0.153 0 C-N-CA 127.098 2.159 . . . . 0.0 108.253 -157.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.98 -57.01 1.26 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.502 1.521 . . . . 0.0 108.575 170.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -57.33 -32.56 66.83 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 122.478 1.132 . . . . 0.0 111.098 171.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 60.6 mtt180 -71.36 -1.68 13.79 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 120.499 -1.376 . . . . 0.0 111.922 178.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.7 mt -122.62 -39.06 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 125.874 1.67 . . . . 0.0 108.714 -175.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.4 t -125.7 144.77 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 124.861 1.264 . . . . 0.0 108.775 -175.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.75 160.32 28.4 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.594 0.757 . . . . 0.0 111.328 176.001 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.94 142.17 34.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -173.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -146.82 176.18 10.07 Favored 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 125.189 1.396 . . . . 0.0 110.98 -176.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -103.56 -43.14 5.46 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 118.365 0.53 . . . . 0.0 111.797 -175.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 30.6 p -109.22 -162.4 0.81 Allowed 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -176.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 27.1 mm -92.01 -39.89 11.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 117.371 -1.299 . . . . 0.0 111.322 160.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.0 t -68.76 -34.77 76.14 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 120.916 1.689 . . . . 0.0 111.052 -168.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -69.06 -15.73 63.52 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 118.934 0.788 . . . . 0.0 111.696 176.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.663 ' O ' HG23 ' A' ' 122' ' ' VAL . . . -91.12 -54.24 4.03 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 176.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 6.6 ttm -54.0 -39.48 66.12 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 124.84 1.256 . . . . 0.0 112.001 -163.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -93.49 -10.61 34.34 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.985 0.914 . . . . 0.0 113.392 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -92.24 -58.24 2.45 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 118.35 -0.833 . . . . 0.0 108.775 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.747 HG21 ' CE1' ' A' ' 56' ' ' PHE . 48.1 t -41.62 -44.39 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 128.456 2.702 . . . . 0.0 110.824 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . 0.251 1.5 ptp180 -53.12 -26.13 15.59 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.09 41.64 0.44 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 127.852 2.461 . . . . 0.0 111.371 -178.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.929 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 172.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 28.2 p90 . . . . . 0 C--O 1.234 0.279 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt -131.97 171.01 14.11 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.733 0.813 . . . . 0.0 110.942 174.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.3 mt -129.61 110.55 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 104.651 -2.351 . . . . 0.0 104.651 176.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.4 m -93.38 -134.93 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 119.562 1.074 . . . . 0.0 109.172 176.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -45.83 -78.72 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 127.827 2.451 . . . . 0.0 111.785 172.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -137.76 15.3 2.9 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.281 1.832 . . . . 0.0 109.678 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.681 HG11 ' CE2' ' A' ' 56' ' ' PHE . 11.9 t -121.6 133.55 67.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -168.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 74.6 t -92.22 131.22 39.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.416 HG13 HD12 ' A' ' 115' ' ' ILE . 1.9 mp -112.48 103.63 15.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 176.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.7 137.35 45.92 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 161.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 13.8 mtt -139.96 79.98 21.62 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.57 -98.81 0.01 OUTLIER 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 121.452 1.435 . . . . 0.0 111.508 -170.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.474 ' ND2' ' H ' ' A' ' 29' ' ' LYS . 18.8 p-10 155.82 -106.18 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 O-C-N 119.38 -2.075 . . . . 0.0 107.688 -163.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.474 ' H ' ' ND2' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -126.94 25.68 6.25 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.205 1.802 . . . . 0.0 108.888 167.25 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -63.19 -16.99 61.9 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.869 1.268 . . . . 0.0 111.711 170.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.6 mp -74.09 67.96 1.37 Allowed 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 169.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -124.59 7.44 8.24 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.775 2.03 . . . . 0.0 113.312 -175.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 94.87 -24.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.563 1 C-N-CA 135.457 5.503 . . . . 0.0 110.113 -176.438 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -71.94 -18.69 61.99 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 120.871 -1.143 . . . . 0.0 111.778 -175.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -98.98 -31.21 11.92 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 173.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.15 -41.74 94.46 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 113.647 0.981 . . . . 0.0 113.647 -159.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -64.3 -43.79 93.66 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.981 1.264 . . . . 0.0 110.146 -177.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.01 -22.33 49.46 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.593 -178.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -41.86 -54.27 3.47 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 127.585 2.354 . . . . 0.0 111.972 -171.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.2 pttt -68.99 -41.22 78.14 Favored 'General case' 0 C--O 1.217 -0.609 0 CA-C-O 118.15 -0.929 . . . . 0.0 111.273 -178.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.72 -44.04 90.3 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 120.31 1.414 . . . . 0.0 110.939 178.601 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 7.1 t90 -58.13 -66.14 0.53 Allowed 'General case' 0 C--O 1.223 -0.341 0 CA-C-O 117.364 -1.303 . . . . 0.0 108.515 171.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 51.3 t -49.44 -38.28 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 120.049 1.295 . . . . 0.0 112.282 -176.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -60.73 -62.68 1.69 Allowed 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 125.106 1.362 . . . . 0.0 109.294 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -70.61 -44.16 67.83 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 118.852 0.751 . . . . 0.0 111.218 -174.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -61.07 -33.95 74.14 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.914 1.285 . . . . 0.0 110.523 -174.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -136.41 -52.56 0.72 Allowed 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -171.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 39.3 mt -63.46 -37.93 89.18 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.207 0.912 . . . . 0.0 111.075 -173.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -84.67 -9.39 58.3 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.158 1.383 . . . . 0.0 110.549 176.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.3 mttt -82.38 3.83 26.41 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.614 1.566 . . . . 0.0 111.148 156.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.95 4.33 88.52 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 125.374 1.464 . . . . 0.0 114.344 176.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -68.89 112.23 5.43 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 119.541 1.671 . . . . 0.0 109.303 176.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 -107.63 16.65 23.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.889 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.494 ' HB3' HG13 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -132.48 126.05 32.09 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 121.106 -0.996 . . . . 0.0 108.743 164.993 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.434 HD12 HD11 ' A' ' 80' ' ' ILE . 5.8 mt -128.44 160.19 38.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 126.303 1.841 . . . . 0.0 106.64 172.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.681 ' CE2' HG11 ' A' ' 22' ' ' VAL . 24.3 m-85 -132.42 159.22 39.92 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.016 1.326 . . . . 0.0 111.351 161.043 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 56.2 tp -127.86 87.19 2.57 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.227 0.611 . . . . 0.0 109.418 171.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.576 HG12 ' H ' ' A' ' 60' ' ' SER . 91.2 t -52.1 151.8 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 126.163 1.785 . . . . 0.0 108.326 167.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.6 mt -135.68 18.68 3.3 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.619 1.968 . . . . 0.0 110.292 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.576 ' H ' HG12 ' A' ' 58' ' ' VAL . 67.3 m -54.1 -54.11 43.95 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 125.071 1.348 . . . . 0.0 111.281 -169.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.41 ' O ' ' HE2' ' A' ' 29' ' ' LYS . 7.0 t0 -97.41 9.61 41.89 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 123.338 0.655 . . . . 0.0 111.339 175.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 17.6 t -98.62 100.56 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 104.312 -2.477 . . . . 0.0 104.312 -176.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -57.82 -49.87 75.19 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.6 t -152.88 164.42 37.92 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 123.1 1.429 . . . . 0.0 112.861 -175.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.4 tt -95.06 -162.77 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 126.877 2.071 . . . . 0.0 106.838 161.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -143.21 166.67 24.06 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.244 1.417 . . . . 0.0 109.737 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.6 t -53.03 -32.73 48.32 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.14 1.776 . . . . 0.0 112.171 176.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -66.14 -60.12 3.11 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 119.376 0.989 . . . . 0.0 109.697 173.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.05 -19.37 47.75 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -163.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 18.7 mt -55.21 -32.66 62.43 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.405 -0.809 . . . . 0.0 110.766 169.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -69.35 -44.23 66.26 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-O 118.832 -0.982 . . . . 0.0 111.474 170.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.57 -32.88 51.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 119.213 1.506 . . . . 0.0 110.759 -169.234 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -58.51 -53.18 50.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 125.069 1.348 . . . . 0.0 109.391 175.179 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 38.2 t -60.98 -38.76 80.16 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.618 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 173.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.1 -38.02 81.72 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 120.278 -1.514 . . . . 0.0 112.073 -176.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 70.6 mt -67.43 -36.19 75.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.288 1.035 . . . . 0.0 110.073 172.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.478 HD22 HG22 ' A' ' 109' ' ' VAL . 20.0 tp -60.81 -50.5 73.2 Favored 'General case' 0 C--O 1.219 -0.544 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 175.026 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 44.2 mttt -62.35 4.48 0.14 Allowed 'General case' 0 C--O 1.234 0.257 0 C-N-CA 126.409 1.884 . . . . 0.0 114.316 178.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.5 t -103.99 -58.8 1.82 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 167.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.434 HD11 HD12 ' A' ' 55' ' ' ILE . 78.3 mt -55.59 -35.82 39.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 125.305 1.442 . . . . 0.0 111.319 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.2 p -53.88 -58.35 7.59 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 126.048 1.739 . . . . 0.0 108.688 -177.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.7 t -61.93 -39.86 93.53 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 127.968 2.507 . . . . 0.0 110.899 -178.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.1 -23.47 67.16 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 175.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.29 17.58 49.63 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-O 118.637 -1.091 . . . . 0.0 112.933 -174.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -89.8 -173.78 45.49 Favored Glycine 0 N--CA 1.438 -1.195 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 172.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.432 ' HB3' HG22 ' A' ' 122' ' ' VAL . 2.5 m-85 -131.75 148.98 52.61 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 125.547 1.539 . . . . 0.0 109.539 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -143.96 149.96 37.58 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.27 1.028 . . . . 0.0 108.425 176.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.555 ' C ' HD23 ' A' ' 89' ' ' LEU . . . -154.18 168.4 26.67 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.972 0.909 . . . . 0.0 111.77 177.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.555 HD23 ' C ' ' A' ' 88' ' ' ALA . 1.5 mt -113.47 171.74 7.38 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 177.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.508 HG13 ' N ' ' A' ' 58' ' ' VAL . 0.5 OUTLIER -152.43 146.65 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 C-N-CA 123.898 0.879 . . . . 0.0 110.227 -166.327 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.7 t 43.92 54.11 11.1 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 126.122 1.769 . . . . 0.0 110.264 177.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.439 ' O ' HG22 ' A' ' 96' ' ' VAL . 25.3 Cg_endo -61.89 -30.96 84.63 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.976 2.451 . . . . 0.0 112.335 -169.03 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 63.14 165.58 0.12 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 123.962 1.839 . . . . 0.0 110.755 -161.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -54.36 -33.98 60.2 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 112.343 -2.208 . . . . 0.0 110.666 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.63 -41.58 21.26 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 124.439 1.096 . . . . 0.0 112.067 -158.329 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 92' ' ' PRO . 18.9 m -75.06 -44.33 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.732 0 CA-C-O 118.085 -0.96 . . . . 0.0 110.483 171.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.87 -29.76 63.24 Favored 'General case' 0 N--CA 1.461 0.09 0 C-N-CA 124.334 1.054 . . . . 0.0 108.79 -170.009 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.34 -62.74 1.14 Allowed 'General case' 0 N--CA 1.428 -1.555 0 C-N-CA 126.153 1.781 . . . . 0.0 112.342 168.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.7 t -72.66 -39.89 61.27 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 CA-C-N 112.365 -2.198 . . . . 0.0 108.295 -173.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.413 ' HB3' ' H ' ' A' ' 106' ' ' ASP . 0.7 OUTLIER -58.67 -17.51 23.11 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.755 1.222 . . . . 0.0 109.236 177.391 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.5 -1.89 43.11 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-O 121.607 0.718 . . . . 0.0 112.467 179.347 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.8 mt -119.45 -42.78 2.63 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 127.187 2.195 . . . . 0.0 109.854 -174.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.1 t -87.23 0.16 55.78 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.978 2.511 . . . . 0.0 111.341 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 42.94 84.35 0.02 OUTLIER 'General case' 0 C--N 1.344 0.351 0 C-N-CA 126.949 2.1 . . . . 0.0 111.808 -168.02 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.73 -64.41 1.32 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.937 1.295 . . . . 0.0 108.704 170.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.413 ' H ' ' HB3' ' A' ' 100' ' ' LEU . 3.3 t70 -58.9 -29.03 66.75 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.537 0.735 . . . . 0.0 110.483 172.51 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 26.3 mtp180 -69.12 1.31 3.7 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.903 -1.123 . . . . 0.0 112.147 176.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.8 mt -130.35 -38.77 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 126.696 1.999 . . . . 0.0 109.663 -176.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.478 HG22 HD22 ' A' ' 77' ' ' LEU . 2.2 t -122.09 153.14 26.33 Favored 'Isoleucine or valine' 0 C--N 1.342 0.242 0 C-N-CA 125.299 1.44 . . . . 0.0 110.149 -169.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.43 155.49 35.3 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.236 1.014 . . . . 0.0 112.511 173.121 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -147.22 147.78 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 126.43 1.892 . . . . 0.0 107.478 -178.245 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -144.14 169.89 17.0 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.195 1.398 . . . . 0.0 111.571 -175.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -86.65 -37.7 17.77 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 175.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.3 p -137.3 175.91 9.19 Favored 'General case' 0 C--N 1.334 -0.079 0 C-N-CA 124.168 0.987 . . . . 0.0 111.145 -168.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.472 HD11 ' CG2' ' A' ' 58' ' ' VAL . 10.7 mm -72.74 -40.08 60.81 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 CA-C-O 118.479 -0.772 . . . . 0.0 109.918 176.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.3 t -73.2 -32.33 64.73 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 119.294 0.952 . . . . 0.0 109.965 -171.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -66.65 -10.08 42.47 Favored 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 123.436 0.694 . . . . 0.0 112.036 170.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -102.91 -47.62 4.32 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 -178.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -58.08 -54.39 47.47 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 126.565 1.946 . . . . 0.0 113.676 -160.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -87.47 -12.34 46.3 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.01 1.724 . . . . 0.0 111.25 179.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -91.78 -53.3 4.35 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 124.596 1.158 . . . . 0.0 107.941 -166.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.432 HG22 ' HB3' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -55.06 -23.73 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 128.649 2.78 . . . . 0.0 112.785 176.126 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 78.8 mtt180 -59.66 -28.48 67.29 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 118.46 -0.781 . . . . 0.0 111.718 169.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.34 26.22 3.81 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 126.5 1.92 . . . . 0.0 115.009 -176.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.6 mmtm . . . . . 0 C--O 1.249 1.069 0 C-N-CA 126.236 1.814 . . . . 0.0 106.724 -176.901 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 7.6 p90 . . . . . 0 C--O 1.234 0.288 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -141.85 175.96 9.31 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.437 1.495 . . . . 0.0 108.503 156.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.2 mt -127.77 138.22 55.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 167.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.0 m -114.08 -156.74 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 C-N-CA 126.356 1.862 . . . . 0.0 107.727 168.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -42.21 -63.02 0.81 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 120.978 1.717 . . . . 0.0 114.641 -162.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -133.82 19.23 3.84 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.689 1.596 . . . . 0.0 110.973 170.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.694 HG11 ' CE2' ' A' ' 56' ' ' PHE . 4.2 t -132.59 119.07 37.14 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 123.137 1.446 . . . . 0.0 109.924 -168.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.526 ' O ' HD13 ' A' ' 24' ' ' ILE . 0.6 OUTLIER -67.06 150.3 11.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 127.425 2.29 . . . . 0.0 112.383 169.156 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.673 HD12 HD12 ' A' ' 115' ' ' ILE . 4.4 mm -135.68 96.38 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 174.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.495 HD23 HG23 ' A' ' 55' ' ' ILE . 4.3 mm? -59.99 132.24 53.32 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 164.248 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 24.8 mmm -127.79 81.32 70.5 Favored Pre-proline 0 C--O 1.234 0.245 0 C-N-CA 126.111 1.764 . . . . 0.0 106.91 178.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -61.69 143.8 96.76 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 122.267 1.978 . . . . 0.0 109.053 170.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.02 -83.11 0.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 179.122 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.74 1.53 14.18 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.286 1.034 . . . . 0.0 112.035 172.128 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -67.62 -34.78 77.66 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -171.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 31' ' ' LEU . 1.6 tp -73.22 -81.28 0.06 Allowed 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -153.52 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 34.24 41.38 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 130.062 3.345 . . . . 0.0 114.361 154.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER 61.31 -31.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 130.54 3.536 . . . . 0.0 115.416 -170.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -54.12 -34.65 60.82 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.505 1.122 . . . . 0.0 112.332 -175.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -122.4 60.37 1.0 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -173.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.45 -65.87 1.14 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 118.769 -0.634 . . . . 0.0 111.512 -177.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -60.32 -28.38 68.09 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.073 1.306 . . . . 0.0 111.887 173.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.71 ' H ' HD22 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -78.95 -31.15 44.97 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 117.65 -1.167 . . . . 0.0 110.206 176.969 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -45.37 -52.66 9.65 Favored 'General case' 0 CA--C 1.508 -0.649 0 O-C-N 124.362 1.039 . . . . 0.0 110.033 178.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.39 -45.98 90.7 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 117.544 -1.217 . . . . 0.0 110.027 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -61.4 -46.95 88.02 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 119.94 1.245 . . . . 0.0 111.38 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.452 ' CH2' ' CD1' ' A' ' 25' ' ' LEU . 15.7 t90 -62.86 -60.79 3.0 Favored 'General case' 0 C--O 1.215 -0.715 0 CA-C-O 117.436 -1.269 . . . . 0.0 108.796 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.7 t -54.16 -30.0 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 CA-C-N 121.468 1.94 . . . . 0.0 111.706 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -66.61 -65.49 0.67 Allowed 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 120.723 -1.236 . . . . 0.0 110.481 170.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -66.63 -37.4 84.77 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.353 1.461 . . . . 0.0 111.781 -171.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -73.14 -31.86 64.54 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 127.941 2.496 . . . . 0.0 111.996 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -129.38 -58.1 1.13 Allowed 'General case' 0 C--N 1.343 0.322 0 CA-C-N 119.596 1.089 . . . . 0.0 111.605 -171.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.0 mt -64.97 -31.54 72.83 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 121.674 -0.641 . . . . 0.0 111.986 -175.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -80.44 -19.44 46.1 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 118.405 -0.807 . . . . 0.0 111.031 176.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.06 -5.22 55.47 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 127.073 2.149 . . . . 0.0 114.128 167.26 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.03 6.26 79.37 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-O 118.68 -1.067 . . . . 0.0 114.38 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -66.02 143.18 57.52 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 119.29 1.545 . . . . 0.0 109.861 175.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.56 22.99 3.16 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.579 1.551 . . . . 0.0 109.059 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.448 ' HB3' HG13 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -151.84 98.82 2.51 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 174.121 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.495 HG23 HD23 ' A' ' 25' ' ' LEU . 1.3 mp -96.25 152.64 3.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 172.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.695 ' CE1' HG21 ' A' ' 122' ' ' VAL . 12.0 m-30 -125.68 164.35 20.8 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.704 -0.798 . . . . 0.0 112.524 162.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 21.9 tp -129.11 129.1 44.77 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 124.174 0.989 . . . . 0.0 109.364 167.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.8 t -99.91 139.99 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 167.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.49 HD22 HG11 ' A' ' 96' ' ' VAL . 3.8 mp -120.64 54.04 1.08 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.437 1.017 . . . . 0.0 110.122 178.452 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 26.0 t -109.16 -47.32 3.44 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.879 1.272 . . . . 0.0 110.77 -168.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -72.84 -49.93 27.2 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 1.8 p -68.95 141.58 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 124.581 1.153 . . . . 0.0 109.111 171.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -79.0 -36.81 40.62 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 119.153 -0.451 . . . . 0.0 110.009 167.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.579 ' CB ' ' HE2' ' A' ' 95' ' ' LYS . 10.7 t -165.36 159.73 17.43 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 122.706 1.241 . . . . 0.0 113.168 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.543 HG22 HG21 ' A' ' 96' ' ' VAL . 14.0 tt -79.57 169.94 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 C-N-CA 128.257 2.623 . . . . 0.0 109.219 166.49 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.0 164.14 12.68 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.124 1.37 . . . . 0.0 109.809 177.258 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.45 ' HA ' HD12 ' A' ' 70' ' ' LEU . 95.2 p -63.24 -24.22 67.78 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -175.252 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -60.56 -72.01 0.12 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.799 0.84 . . . . 0.0 108.858 171.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.0 t -70.76 -15.18 62.66 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -173.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 67' ' ' SER . 2.7 mt -46.27 -37.49 7.36 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.699 1.136 . . . . 0.0 110.844 169.042 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.61 -22.18 51.32 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 123.136 0.398 . . . . 0.0 113.971 -178.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 52.9 t -79.12 -35.45 17.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.515 1.126 . . . . 0.0 109.181 177.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 16.7 mm -56.53 -47.45 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 123.499 0.72 . . . . 0.0 110.667 174.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.9 t -62.43 -40.44 88.06 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.266 0 O-C-N 121.558 -0.714 . . . . 0.0 109.739 176.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -52.02 -46.85 65.13 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.466 1.03 . . . . 0.0 112.309 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.3 mt -56.65 -41.32 73.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.374 1.47 . . . . 0.0 110.097 175.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -66.67 -46.87 74.26 Favored 'General case' 0 CA--C 1.52 -0.209 0 O-C-N 121.494 -0.754 . . . . 0.0 109.621 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -55.72 -50.86 69.2 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 118.757 -0.64 . . . . 0.0 110.472 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 33.1 t -53.14 -52.05 59.97 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 124.845 1.34 . . . . 0.0 109.214 178.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 21.6 mt -63.29 -46.9 94.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 C-N-CA 123.467 0.707 . . . . 0.0 110.69 -174.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -51.45 -55.36 19.23 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.798 0.839 . . . . 0.0 110.461 171.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.6 m -65.3 -17.48 64.54 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.227 1.011 . . . . 0.0 113.504 -178.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.5 m -83.84 -47.26 11.28 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.789 0.836 . . . . 0.0 110.915 178.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 133.32 -1.0 4.42 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 118.295 -1.28 . . . . 0.0 113.75 -166.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -101.73 -169.41 27.56 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-N 120.208 2.004 . . . . 0.0 112.509 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.593 ' CZ ' ' HE2' ' A' ' 125' ' ' LYS . 0.1 OUTLIER -135.41 165.71 24.85 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 126.869 2.068 . . . . 0.0 110.8 171.615 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -155.25 141.76 18.75 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 177.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.79 168.6 23.93 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.268 0.627 . . . . 0.0 112.186 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 mt -116.16 164.17 14.88 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.502 1.121 . . . . 0.0 109.438 -171.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.703 HG21 HD13 ' A' ' 115' ' ' ILE . 79.6 t -146.13 154.87 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 126.049 1.74 . . . . 0.0 109.998 -169.24 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 t 46.93 58.4 17.07 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 127.772 2.429 . . . . 0.0 112.15 173.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -76.73 97.31 1.13 Allowed 'Trans proline' 0 N--CA 1.445 -1.363 0 C-N-CA 122.148 1.898 . . . . 0.0 111.23 -177.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.43 158.73 5.4 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 119.251 -0.98 . . . . 0.0 109.723 162.235 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -69.65 -29.45 66.92 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.339 1.056 . . . . 0.0 111.834 -167.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.579 ' HE2' ' CB ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -56.99 -51.93 67.29 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -173.177 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.543 HG21 HG22 ' A' ' 65' ' ' ILE . 0.5 OUTLIER -78.76 -41.03 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 124.057 0.848 . . . . 0.0 110.286 -173.515 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.97 -33.65 18.45 Favored 'General case' 0 CA--C 1.503 -0.827 0 C-N-CA 124.456 1.103 . . . . 0.0 110.836 175.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -53.98 47.13 Favored 'General case' 0 N--CA 1.417 -2.121 0 CA-C-O 123.368 1.556 . . . . 0.0 113.107 178.04 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.53 ' O ' HG22 ' A' ' 103' ' ' THR . 15.0 t -69.69 -43.52 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.832 0 CA-C-N 111.346 -2.661 . . . . 0.0 106.58 -172.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.412 HD21 HG22 ' A' ' 96' ' ' VAL . 0.4 OUTLIER -55.36 -28.87 56.76 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.933 1.293 . . . . 0.0 108.755 175.264 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.7 m -92.01 4.09 53.81 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.374 1.47 . . . . 0.0 112.729 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 94.1 mt -125.06 -20.76 4.83 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 127.752 2.421 . . . . 0.0 111.769 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.53 HG22 ' O ' ' A' ' 99' ' ' VAL . 7.2 t -111.69 2.24 17.12 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.751 1.62 . . . . 0.0 112.029 -174.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 54.17 87.73 0.04 OUTLIER 'General case' 0 C--N 1.342 0.247 0 C-N-CA 126.541 1.936 . . . . 0.0 109.887 -172.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.73 -57.2 1.45 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 118.544 -0.741 . . . . 0.0 109.702 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.85 -35.29 44.18 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 123.302 1.525 . . . . 0.0 110.585 164.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -72.05 -1.68 15.62 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 120.834 -1.167 . . . . 0.0 111.832 -177.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.7 mt -126.46 -38.63 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 126.34 1.856 . . . . 0.0 109.628 -175.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.2 t -118.21 145.68 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 125.696 1.598 . . . . 0.0 109.332 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -68.14 154.38 41.81 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 123.384 0.673 . . . . 0.0 110.199 174.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -141.98 149.35 19.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -173.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -147.65 165.69 29.67 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.122 1.369 . . . . 0.0 109.434 -172.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -84.66 -46.69 11.24 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 45.3 p -119.35 170.37 9.18 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.232 1.413 . . . . 0.0 108.638 -174.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.703 HD13 HG21 ' A' ' 90' ' ' VAL . 8.9 mm -66.95 -42.02 88.24 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.81 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 167.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 48.2 t -67.98 -37.7 81.81 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.787 1.176 . . . . 0.0 110.712 -165.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -63.51 -28.02 69.66 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 118.184 0.447 . . . . 0.0 110.259 176.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.646 ' O ' HG23 ' A' ' 122' ' ' VAL . . . -80.69 -54.99 5.14 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -54.89 -29.06 54.88 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 126.213 1.805 . . . . 0.0 112.721 -163.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.63 -23.32 14.28 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 126.5 1.92 . . . . 0.0 111.712 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -81.96 -53.73 5.9 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 120.114 1.325 . . . . 0.0 111.887 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.695 HG21 ' CE1' ' A' ' 56' ' ' PHE . 51.4 t -44.05 -39.91 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 129.293 3.037 . . . . 0.0 110.099 -178.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -49.83 -23.26 1.79 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 127.414 2.286 . . . . 0.0 114.265 174.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.69 37.09 0.19 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.306 2.242 . . . . 0.0 113.274 177.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.593 ' HE2' ' CZ ' ' A' ' 86' ' ' PHE . 0.6 OUTLIER . . . . . 0 C--O 1.248 0.99 0 O-C-N 121.436 -0.79 . . . . 0.0 109.514 -174.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 37.4 p90 . . . . . 0 CA--C 1.538 0.508 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.437 ' HE2' ' CG1' ' A' ' 19' ' ' VAL . 0.7 OUTLIER -143.48 164.74 29.49 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.97 2.108 . . . . 0.0 106.823 173.689 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.2 mt -130.36 118.57 43.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 174.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.437 ' CG1' ' HE2' ' A' ' 17' ' ' LYS . 6.4 m -93.34 -162.02 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 125.677 1.591 . . . . 0.0 108.001 168.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -24.6 -70.85 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 129.651 3.181 . . . . 0.0 111.771 171.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -149.96 21.86 0.88 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.734 0.814 . . . . 0.0 110.835 -177.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.616 HG11 ' CE2' ' A' ' 56' ' ' PHE . 20.4 t -127.19 156.62 38.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 95.8 t -116.13 128.52 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mp -101.55 104.95 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 46.8 mt -88.97 128.84 35.71 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 103.551 -2.759 . . . . 0.0 103.551 175.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 30.2 mtm -123.48 95.48 45.1 Favored Pre-proline 0 N--CA 1.465 0.302 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -176.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -69.07 161.44 45.81 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.251 1.967 . . . . 0.0 111.088 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -151.92 -71.48 0.16 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 121.232 0.539 . . . . 0.0 111.964 -173.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.47 6.06 0.83 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.53 1.932 . . . . 0.0 112.132 -176.238 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -79.58 -2.61 43.21 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 128.333 2.653 . . . . 0.0 112.746 177.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.6 mt -101.56 95.23 6.32 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -166.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -164.72 30.76 0.07 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.886 0.874 . . . . 0.0 112.386 -161.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER 73.7 -46.94 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 127.968 2.507 . . . . 0.0 112.287 175.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -68.85 -5.26 19.94 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 126.353 1.861 . . . . 0.0 113.189 -173.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -127.25 0.98 6.41 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 127.345 2.258 . . . . 0.0 109.127 177.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.14 -57.75 3.62 Favored 'General case' 0 C--O 1.224 -0.241 0 O-C-N 120.229 -1.545 . . . . 0.0 110.868 -173.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -65.05 -24.63 67.52 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 120.831 -1.168 . . . . 0.0 110.98 -178.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.447 HD22 ' H ' ' A' ' 38' ' ' LEU . 1.7 mm? -81.54 -33.25 31.85 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 126.219 1.807 . . . . 0.0 110.863 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -42.4 -53.28 4.3 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 126.711 2.004 . . . . 0.0 111.285 176.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.39 -43.26 99.25 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.482 -178.424 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.13 -49.39 77.14 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.103 0.865 . . . . 0.0 110.639 174.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -58.01 -64.26 0.97 Allowed 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 118.099 -0.953 . . . . 0.0 110.014 177.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 68.8 t -49.56 -37.95 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 120.018 1.281 . . . . 0.0 112.062 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.591 ' CD1' HD12 ' A' ' 48' ' ' LEU . 3.2 m-85 -61.12 -62.21 2.01 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.604 0.762 . . . . 0.0 110.329 175.278 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.11 -16.66 59.85 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 125.018 1.327 . . . . 0.0 112.867 -170.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -93.62 -31.4 14.51 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.778 1.231 . . . . 0.0 111.732 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -132.01 -54.26 0.98 Allowed 'General case' 0 C--N 1.346 0.42 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -172.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.591 HD12 ' CD1' ' A' ' 44' ' ' PHE . 30.7 mt -60.39 -50.95 71.54 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 118.654 0.661 . . . . 0.0 112.291 -171.308 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -61.28 -39.43 90.38 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.241 0.616 . . . . 0.0 109.944 177.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -60.09 -1.91 0.37 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 128.318 2.647 . . . . 0.0 114.797 172.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.49 2.75 75.93 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-O 118.304 -1.276 . . . . 0.0 113.02 176.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -72.48 119.09 16.21 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 120.024 1.912 . . . . 0.0 108.791 175.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -114.08 19.2 16.65 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.618 1.167 . . . . 0.0 109.309 -177.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.412 ' HB3' HG13 ' A' ' 22' ' ' VAL . 2.5 mtmt -146.4 130.01 16.96 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.328 1.851 . . . . 0.0 107.353 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.694 HD13 HD11 ' A' ' 80' ' ' ILE . 1.2 mp -138.6 154.26 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 128.062 2.545 . . . . 0.0 105.612 177.373 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.787 ' CE1' HG21 ' A' ' 122' ' ' VAL . 21.2 m-85 -130.37 156.6 44.44 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 124.633 1.173 . . . . 0.0 113.366 166.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 26.8 tp -121.69 75.83 1.22 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.907 1.283 . . . . 0.0 110.885 177.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.443 ' CG2' HD11 ' A' ' 115' ' ' ILE . 96.1 t -64.56 118.35 6.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 127.791 2.436 . . . . 0.0 107.023 173.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.7 mt -95.85 5.14 52.02 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.563 0.745 . . . . 0.0 110.643 -176.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.3 m -56.73 -23.61 43.72 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 177.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.46 -7.19 56.98 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.516 1.053 . . . . 0.0 111.272 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 p -134.17 157.23 41.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.902 1.681 . . . . 0.0 110.605 -168.039 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -85.72 -44.6 12.4 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.236 -0.915 . . . . 0.0 108.682 167.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 m -160.29 161.66 33.4 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 123.345 1.545 . . . . 0.0 113.703 -179.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.2 tt -72.47 174.28 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 111.808 -2.451 . . . . 0.0 107.796 163.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -117.88 -144.94 0.38 Allowed 'General case' 0 C--N 1.327 -0.382 0 O-C-N 120.952 -1.093 . . . . 0.0 109.646 -160.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.6 t -50.62 -147.99 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.798 1 C-N-CA 132.111 4.165 . . . . 0.0 112.388 157.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -25.04 -39.91 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.158 1 C-N-CA 132.022 4.129 . . . . 0.0 116.421 177.119 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.2 t -55.07 -31.55 61.24 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.659 0.784 . . . . 0.0 111.778 -178.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.8 tp -57.49 -18.88 21.06 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.402 1.081 . . . . 0.0 112.73 173.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -98.48 -24.7 10.79 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.559 1.552 . . . . 0.0 113.204 170.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 90.1 t -65.92 -40.86 88.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 119.185 1.493 . . . . 0.0 109.551 173.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.4 mp -51.45 -48.59 34.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.552 1.141 . . . . 0.0 109.628 174.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.8 t -64.92 -46.27 92.26 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.635 0 CA-C-O 117.224 -1.37 . . . . 0.0 109.658 175.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -49.07 -51.29 32.25 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 122.469 2.395 . . . . 0.0 111.814 177.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 77.9 mt -57.85 -37.2 58.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 124.913 1.285 . . . . 0.0 110.143 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.545 HD22 HG22 ' A' ' 109' ' ' VAL . 25.7 tp -63.59 -53.6 49.09 Favored 'General case' 0 CA--C 1.52 -0.201 0 O-C-N 121.012 -1.055 . . . . 0.0 109.265 176.203 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -57.68 -22.82 48.24 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.388 0.675 . . . . 0.0 110.142 -177.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 67.5 m -81.43 -48.24 12.16 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.44 1.096 . . . . 0.0 111.326 177.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.694 HD11 HD13 ' A' ' 55' ' ' ILE . 21.8 mt -58.61 -43.97 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 119.983 1.265 . . . . 0.0 109.782 172.276 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.4 t -65.65 -10.87 39.82 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.637 1.575 . . . . 0.0 112.296 175.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.7 t -96.46 -43.21 7.73 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 120.32 1.418 . . . . 0.0 109.552 171.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.6 m -66.91 -28.01 67.96 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -178.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 110.02 38.85 1.63 Allowed Glycine 0 C--N 1.337 0.613 0 CA-C-O 118.702 -1.054 . . . . 0.0 113.428 -174.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -134.77 -175.64 13.97 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 119.93 1.865 . . . . 0.0 111.644 -177.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -127.31 154.13 45.3 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.874 1.67 . . . . 0.0 109.858 179.266 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -150.41 139.38 20.98 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -145.99 170.38 16.75 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 120.831 0.348 . . . . 0.0 111.477 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.21 167.34 10.63 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -177.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.431 HG13 ' N ' ' A' ' 58' ' ' VAL . 0.5 OUTLIER -148.86 150.06 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 C-N-CA 123.863 0.865 . . . . 0.0 111.541 -170.93 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 44.2 54.77 12.26 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 126.51 1.924 . . . . 0.0 112.064 171.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.05 167.25 26.62 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.76 2.307 . . . . 0.0 109.714 -178.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -123.06 169.57 11.06 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 173.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -66.69 -34.74 78.52 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 123.686 0.795 . . . . 0.0 110.127 -168.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.433 ' O ' ' HE3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -61.99 -35.94 80.0 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.337 1.455 . . . . 0.0 110.953 177.14 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -81.36 -46.03 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -176.509 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -57.43 -31.18 65.63 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 125.958 1.703 . . . . 0.0 110.466 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.95 -21.54 66.43 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -175.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.6 t -104.85 -42.55 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.043 0 C-N-CA 125.72 1.608 . . . . 0.0 107.164 -174.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.08 -17.23 24.18 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 116.715 -1.612 . . . . 0.0 108.868 -177.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.8 t -87.18 -50.64 6.48 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 117.62 -1.632 . . . . 0.0 108.569 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.84 -52.78 64.05 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 129.148 2.979 . . . . 0.0 111.047 -172.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -77.07 2.99 13.45 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.157 1.383 . . . . 0.0 110.891 -178.46 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.6 m120 47.15 75.85 0.12 Allowed 'General case' 0 C--N 1.342 0.249 0 C-N-CA 129.563 3.145 . . . . 0.0 109.816 -171.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.74 -59.86 1.9 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.295 1.438 . . . . 0.0 107.517 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.1 -26.76 67.88 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.776 0.83 . . . . 0.0 111.348 174.28 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.4 mtp-105 -74.99 -2.2 26.12 Favored 'General case' 0 C--N 1.339 0.112 0 O-C-N 121.751 -0.593 . . . . 0.0 111.75 -178.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.3 mt -128.0 -46.68 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 125.912 1.685 . . . . 0.0 107.272 -171.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.545 HG22 HD22 ' A' ' 77' ' ' LEU . 1.6 t -104.39 148.94 8.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-O 121.898 0.856 . . . . 0.0 109.917 -175.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.07 155.71 39.91 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 123.85 0.86 . . . . 0.0 111.852 173.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -146.42 146.59 18.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -174.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -141.47 163.75 32.1 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.917 0.887 . . . . 0.0 111.178 -171.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.5 -55.01 4.74 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.09 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 64.7 p -113.86 175.64 5.38 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.815 0.817 . . . . 0.0 111.048 -177.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.501 ' HA ' HD13 ' A' ' 115' ' ' ILE . 3.4 mm -61.74 -45.87 97.74 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 164.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.2 t -69.34 -33.14 72.66 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 118.774 -0.631 . . . . 0.0 109.855 -164.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -68.85 -24.04 64.3 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.785 0.834 . . . . 0.0 111.155 175.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.678 ' O ' HG23 ' A' ' 122' ' ' VAL . . . -82.74 -52.59 6.63 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 178.166 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 6.3 tmm? -55.89 -40.1 72.53 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 125.298 1.439 . . . . 0.0 113.502 -157.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -89.39 -21.38 23.09 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 117.935 -1.031 . . . . 0.0 113.151 175.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.431 ' HG2' ' HE2' ' A' ' 125' ' ' LYS . 1.7 tt0 -84.27 -55.64 4.07 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-N 119.046 0.839 . . . . 0.0 109.76 -172.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.787 HG21 ' CE1' ' A' ' 56' ' ' PHE . 41.2 t -42.61 -44.19 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 C-N-CA 127.96 2.504 . . . . 0.0 110.586 178.33 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 17.9 mtm180 -48.11 -40.93 25.01 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 124.057 0.848 . . . . 0.0 111.083 178.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . 0.321 0.0 OUTLIER -117.83 43.48 2.39 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 125.628 1.571 . . . . 0.0 113.879 176.085 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.431 ' HE2' ' HG2' ' A' ' 121' ' ' GLU . 5.4 mmmt . . . . . 0 C--O 1.251 1.153 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 164.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 11.4 p90 . . . . . 0 N--CA 1.45 -0.474 0 CA-C-O 121.368 0.604 . . . . 0.0 109.649 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.4 173.1 12.1 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.487 2.315 . . . . 0.0 110.031 176.472 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.3 mt -137.8 135.31 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 127.93 2.492 . . . . 0.0 107.789 166.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.413 HG13 HD13 ' A' ' 24' ' ' ILE . 27.2 m -101.1 -139.36 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 127.085 2.154 . . . . 0.0 108.638 173.114 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -41.92 -71.19 0.09 Allowed 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 129.227 3.011 . . . . 0.0 110.524 177.135 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -147.88 20.94 1.13 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.602 1.961 . . . . 0.0 108.222 -173.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.703 HG11 ' CE2' ' A' ' 56' ' ' PHE . 15.3 t -131.51 147.65 32.68 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 C-N-CA 124.437 1.095 . . . . 0.0 108.109 -172.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.473 HG11 ' CZ ' ' A' ' 47' ' ' PHE . 33.7 t -103.84 151.13 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.413 HD13 HG13 ' A' ' 19' ' ' VAL . 5.1 mp -129.89 94.71 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 124.871 1.269 . . . . 0.0 108.426 176.013 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.675 HD22 HG23 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -65.5 105.51 1.2 Allowed 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 129.677 3.191 . . . . 0.0 109.06 170.036 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.548 ' HA ' HG22 ' A' ' 58' ' ' VAL . 50.8 mtp -113.98 73.68 2.46 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 125.663 1.585 . . . . 0.0 107.943 -172.281 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -69.75 177.34 5.67 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 123.114 2.542 . . . . 0.0 111.532 -173.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -156.18 -79.99 0.08 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.982 1.713 . . . . 0.0 109.336 -178.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -136.58 26.36 3.11 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.972 2.509 . . . . 0.0 109.304 -174.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -91.43 -7.81 49.6 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 125.098 1.359 . . . . 0.0 112.055 177.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.18 75.97 9.9 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 120.977 1.717 . . . . 0.0 108.498 -177.514 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -105.82 58.51 0.66 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.186 2.195 . . . . 0.0 112.28 -173.37 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.3 mm 53.85 -75.78 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 127.613 2.365 . . . . 0.0 112.76 -175.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -67.31 -17.99 64.99 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.64 1.176 . . . . 0.0 112.032 -173.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.423 ' O ' HD13 ' A' ' 38' ' ' LEU . 11.6 t-20 -43.7 -39.43 3.65 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.455 163.382 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.689 ' HB1' HG21 ' A' ' 72' ' ' VAL . . . -61.12 -44.99 96.48 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 175.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 38.5 m170 -67.31 -44.68 78.57 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 118.902 -0.57 . . . . 0.0 109.709 -170.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.483 HD22 ' C ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -79.78 -19.91 47.49 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-O 116.985 -1.483 . . . . 0.0 111.69 173.755 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -44.85 -54.02 6.86 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 125.005 1.322 . . . . 0.0 109.785 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.409 ' HG2' ' CE1' ' A' ' 44' ' ' PHE . 13.2 ttpt -56.83 -53.8 53.71 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.85 -46.95 81.44 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 117.296 -1.335 . . . . 0.0 111.544 -176.69 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 6.1 t90 -62.44 -66.16 0.58 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 117.329 -1.32 . . . . 0.0 109.05 177.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 87.7 t -50.46 -37.96 15.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 120.003 1.274 . . . . 0.0 111.117 -176.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.409 ' CE1' ' HG2' ' A' ' 40' ' ' LYS . 4.3 m-85 -59.51 -74.04 0.08 Allowed 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 171.103 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -48.92 -43.02 39.04 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.637 1.975 . . . . 0.0 113.267 -171.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.497 ' HG3' ' CE1' ' A' ' 47' ' ' PHE . 3.0 tp10 -84.7 -28.69 26.16 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 126.846 2.058 . . . . 0.0 109.727 -167.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.497 ' CE1' ' HG3' ' A' ' 46' ' ' GLU . 2.8 m-85 -128.77 -66.76 0.82 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 118.925 0.784 . . . . 0.0 110.606 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.6 mt -61.13 -53.41 57.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 118.865 0.757 . . . . 0.0 112.517 -166.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -67.89 -29.06 68.07 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 127.496 2.318 . . . . 0.0 109.572 176.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -63.49 -24.31 67.76 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 118.028 -0.987 . . . . 0.0 111.605 167.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.8 -4.43 19.07 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 126.533 2.016 . . . . 0.0 113.281 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -66.1 156.38 34.07 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 119.429 1.615 . . . . 0.0 111.085 178.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -134.25 1.09 3.17 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.332 -1.303 . . . . 0.0 111.212 -177.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.567 ' HB3' HG13 ' A' ' 22' ' ' VAL . 8.8 mtmt -138.04 123.18 19.21 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.622 1.101 . . . . 0.0 109.296 -170.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.675 HG23 HD22 ' A' ' 25' ' ' LEU . 1.4 mp -137.45 152.78 27.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 126.701 2.0 . . . . 0.0 106.581 -176.187 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.703 ' CE2' HG11 ' A' ' 22' ' ' VAL . 21.9 m-85 -141.42 120.12 12.56 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 126.977 2.111 . . . . 0.0 110.216 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 46.2 tp -90.18 119.29 30.38 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 176.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.548 HG22 ' HA ' ' A' ' 26' ' ' MET . 0.8 OUTLIER -87.84 154.81 3.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 118.806 0.73 . . . . 0.0 109.963 173.011 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.565 HD22 HG21 ' A' ' 96' ' ' VAL . 3.9 mp -134.38 8.02 3.64 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.871 0.868 . . . . 0.0 111.482 178.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.03 -36.05 67.56 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.891 -1.131 . . . . 0.0 112.073 -177.47 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -96.33 -11.38 25.92 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.439 1.096 . . . . 0.0 112.16 178.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.4 t -109.87 113.5 44.38 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -169.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.85 -41.61 43.39 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 -178.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 93.8 p -151.99 168.65 24.53 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -171.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.702 HD11 ' HB2' ' A' ' 69' ' ' SER . 4.5 tt -133.64 151.98 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 C-N-CA 124.504 1.122 . . . . 0.0 109.107 176.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.68 162.85 17.69 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.007 0.923 . . . . 0.0 109.006 179.078 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 85.8 p -66.76 1.9 1.62 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 171.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.52 ' CE1' ' HB2' ' A' ' 36' ' ' ALA 0.25 0.1 OUTLIER -71.03 -78.63 0.07 Allowed 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 123.955 0.902 . . . . 0.0 110.817 156.028 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.702 ' HB2' HD11 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -75.31 -24.17 57.4 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 118.901 0.773 . . . . 0.0 111.777 -158.981 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 1.011 HD21 HG21 ' A' ' 103' ' ' THR . 35.0 tp -44.72 -38.88 4.72 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.527 1.531 . . . . 0.0 111.889 176.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.681 ' HA2' HG12 ' A' ' 74' ' ' VAL . . . -108.94 6.36 32.71 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-O 119.82 -0.433 . . . . 0.0 114.154 -174.526 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.689 HG21 ' HB1' ' A' ' 36' ' ' ALA . 95.0 t -75.99 -46.18 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 158.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.588 HD12 ' O ' ' A' ' 69' ' ' SER . 1.7 mt -59.57 -54.23 37.29 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 CA-C-O 122.694 1.235 . . . . 0.0 111.61 -173.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.681 HG12 ' HA2' ' A' ' 71' ' ' GLY . 9.0 p -45.69 -56.32 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.835 0 O-C-N 120.404 -1.435 . . . . 0.0 113.841 163.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.466 ' N ' HG13 ' A' ' 74' ' ' VAL . 0.9 OUTLIER -49.43 -43.93 45.06 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 121.369 -0.832 . . . . 0.0 110.97 -174.356 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 56.3 mt -58.11 -41.87 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 O-C-N 124.859 1.349 . . . . 0.0 110.569 173.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 21.7 tp -57.99 -54.06 51.26 Favored 'General case' 0 C--O 1.225 -0.196 0 O-C-N 120.278 -1.514 . . . . 0.0 109.695 170.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.497 ' HE3' HG22 ' A' ' 74' ' ' VAL . 72.2 mttt -65.13 3.23 0.63 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.276 1.43 . . . . 0.0 112.419 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 41.4 t -106.2 -51.08 3.03 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 126.631 1.973 . . . . 0.0 107.782 174.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 87.8 mt -59.55 -44.6 93.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.678 0.791 . . . . 0.0 110.367 175.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.58 -19.7 65.29 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.786 0.721 . . . . 0.0 112.638 176.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.9 m -80.64 -33.94 35.31 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.341 0.973 . . . . 0.0 111.405 167.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.4 m -73.12 -62.7 1.37 Allowed 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.339 1.056 . . . . 0.0 110.421 -176.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 148.5 29.03 0.06 OUTLIER Glycine 0 CA--C 1.527 0.819 0 CA-C-O 118.14 -1.367 . . . . 0.0 113.787 -168.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -134.06 -166.4 11.25 Favored Glycine 0 C--N 1.338 0.685 0 CA-C-N 120.245 2.023 . . . . 0.0 113.319 -171.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.513 ' HB3' HG22 ' A' ' 122' ' ' VAL . 5.8 m-85 -135.1 150.18 50.18 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.305 1.442 . . . . 0.0 109.246 178.337 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -145.9 144.12 30.0 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 170.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.469 ' C ' HD23 ' A' ' 89' ' ' LEU . . . -149.99 176.52 10.7 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 126.165 1.786 . . . . 0.0 111.924 -175.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.469 HD23 ' C ' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -123.14 168.32 12.55 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.702 0.801 . . . . 0.0 111.165 -179.566 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.405 ' HB ' ' HA ' ' A' ' 58' ' ' VAL . 99.4 t -147.35 141.43 19.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 124.722 1.209 . . . . 0.0 109.787 -160.049 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.2 t 42.98 58.19 11.6 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 124.527 1.131 . . . . 0.0 109.342 -176.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -71.57 -163.2 0.13 Allowed 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 124.275 3.317 . . . . 0.0 110.114 -177.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -155.9 151.42 27.04 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 124.508 1.123 . . . . 0.0 108.07 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -61.5 -21.53 64.3 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.201 1.0 . . . . 0.0 110.998 -176.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.402 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -77.62 -38.19 48.54 Favored 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 126.422 1.889 . . . . 0.0 111.451 176.212 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.872 HG13 HD13 ' A' ' 100' ' ' LEU . 2.3 t -62.18 -46.98 95.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-O 117.102 -1.428 . . . . 0.0 108.216 166.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -57.93 -30.45 65.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 119.982 1.265 . . . . 0.0 109.155 176.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -68.34 -30.46 69.43 Favored 'General case' 0 C--O 1.218 -0.589 0 O-C-N 120.703 -1.248 . . . . 0.0 109.934 -177.574 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.677 ' O ' HG22 ' A' ' 103' ' ' THR . 5.4 p -101.59 -42.63 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -169.342 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.872 HD13 HG13 ' A' ' 96' ' ' VAL . 5.7 mp -67.0 -19.67 65.75 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 115.95 -1.976 . . . . 0.0 111.152 177.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 12.0 t -79.67 -45.44 19.01 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 121.441 1.928 . . . . 0.0 107.31 172.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -67.6 -51.03 55.1 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 126.337 1.855 . . . . 0.0 110.585 -165.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' THR . . . . . 1.011 HG21 HD21 ' A' ' 70' ' ' LEU . 9.1 t -81.77 6.32 15.84 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.787 179.347 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 50.0 88.27 0.02 OUTLIER 'General case' 0 C--O 1.235 0.304 0 C-N-CA 127.162 2.185 . . . . 0.0 110.102 -169.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.476 ' HB3' ' HG ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -133.87 -55.9 0.88 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 127.563 2.345 . . . . 0.0 110.739 -175.992 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.77 -27.05 68.93 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.944 1.247 . . . . 0.0 110.681 173.278 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 -72.44 -18.18 61.72 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.146 0.498 . . . . 0.0 110.109 -177.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.2 mm -97.54 -56.2 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 103.595 -2.742 . . . . 0.0 103.595 -174.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.561 HG12 ' H ' ' A' ' 110' ' ' LYS . 1.4 t -80.41 -165.0 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 125.518 1.527 . . . . 0.0 110.115 -177.208 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.561 ' H ' HG12 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -125.66 168.82 13.21 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 128.46 2.704 . . . . 0.0 108.813 169.367 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.36 145.73 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -147.02 171.14 15.73 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 126.334 1.854 . . . . 0.0 110.678 -175.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.28 -53.16 4.34 Favored 'General case' 0 CA--C 1.523 -0.067 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -175.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 71.1 p -130.17 162.88 27.89 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.568 0.747 . . . . 0.0 110.895 -175.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 29.1 mm -65.03 -36.48 77.91 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 CA-C-O 118.168 -0.92 . . . . 0.0 108.582 -172.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.9 t -69.04 -31.74 70.75 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.527 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -68.13 -9.15 44.3 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 119.056 0.844 . . . . 0.0 111.672 173.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -110.37 -38.25 5.29 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 119.529 1.059 . . . . 0.0 109.203 -179.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 2.8 ttm -64.1 -46.45 84.14 Favored 'General case' 0 N--CA 1.446 -0.649 0 O-C-N 120.667 -1.271 . . . . 0.0 113.433 -161.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -91.36 -14.68 30.27 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 117.976 -1.012 . . . . 0.0 111.057 175.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -95.22 -46.85 6.59 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 119.327 0.967 . . . . 0.0 110.574 -167.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.513 HG22 ' HB3' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -49.84 -31.77 7.13 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.18 0 C-N-CA 124.89 1.276 . . . . 0.0 111.002 173.779 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -52.63 -36.21 56.12 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.518 1.127 . . . . 0.0 111.969 174.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.88 35.34 0.76 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.884 1.274 . . . . 0.0 114.251 -174.481 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.242 0.679 0 C-N-CA 125.5 1.52 . . . . 0.0 112.957 178.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 tpt . . . . . 0 N--CA 1.47 0.561 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 144.82 158.19 7.53 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 124.103 0.859 . . . . 0.0 111.344 171.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.3 m 60.52 148.5 0.02 OUTLIER 'General case' 0 C--O 1.237 0.441 0 C-N-CA 127.082 2.153 . . . . 0.0 112.051 -164.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -80.72 135.11 35.94 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.432 -174.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.76 100.98 5.64 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.7 tp -137.69 98.82 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 37.6 t-80 -153.38 96.01 1.99 Allowed 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -61.38 169.84 2.05 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.774 0.829 . . . . 0.0 111.613 173.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -93.22 92.84 7.92 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -167.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 40.3 t60 -148.32 43.62 1.03 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.732 0.813 . . . . 0.0 109.89 -178.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -63.28 147.67 50.4 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 172.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -88.77 -95.65 0.1 Allowed 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 169.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 13.2 ttt -156.96 96.16 1.58 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 105.318 -2.105 . . . . 0.0 105.318 -167.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -69.51 122.0 84.19 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-O 118.269 -0.872 . . . . 0.0 109.905 -171.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -78.46 101.24 1.44 Allowed 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.494 2.129 . . . . 0.0 110.038 172.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -162.69 175.36 11.42 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 126.474 1.91 . . . . 0.0 109.74 170.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.64 173.26 11.72 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.77 1.228 . . . . 0.0 111.511 165.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.3 mt -119.09 147.4 22.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 174.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 20' ' ' ASP . 46.5 t -125.1 -174.79 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 129.761 3.224 . . . . 0.0 104.849 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.426 ' H ' HG12 ' A' ' 19' ' ' VAL . 2.1 m-20 -51.75 -54.33 29.71 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.869 0.867 . . . . 0.0 113.311 -163.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -127.39 12.37 6.99 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 122.933 0.493 . . . . 0.0 110.367 163.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.828 HG11 ' CE2' ' A' ' 56' ' ' PHE . 22.0 t -119.31 163.77 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 O-C-N 121.114 -0.991 . . . . 0.0 108.585 -166.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.4 t -132.28 125.52 54.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 -170.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.414 HD11 HG21 ' A' ' 19' ' ' VAL . 0.6 OUTLIER -107.69 103.46 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 -176.852 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.7 mt -90.61 104.77 17.31 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 104.886 -2.264 . . . . 0.0 104.886 -178.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 57.7 mtm -112.89 84.98 7.26 Favored Pre-proline 0 C--N 1.332 -0.172 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -171.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -70.49 156.74 60.82 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.853 1.702 . . . . 0.0 109.871 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -122.61 -92.55 0.53 Allowed 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -178.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.63 59.44 1.63 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 121.784 2.084 . . . . 0.0 111.658 -175.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -144.97 9.69 1.3 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -175.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 25.0 mt -79.26 52.93 1.4 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.429 1.013 . . . . 0.0 110.975 -176.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -85.4 169.63 13.49 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 126.598 1.959 . . . . 0.0 109.116 171.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.9 mt -57.53 -35.38 49.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 C-N-CA 124.272 1.029 . . . . 0.0 112.09 -174.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -71.61 -16.18 62.27 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 120.97 -1.081 . . . . 0.0 111.211 -176.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -120.24 56.28 0.98 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.291 1.437 . . . . 0.0 108.804 175.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -140.45 -64.1 0.47 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.405 1.082 . . . . 0.0 110.592 -177.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 28.2 t60 -58.45 -46.19 87.07 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 120.513 -1.367 . . . . 0.0 109.368 169.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.599 HD12 ' C ' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -65.44 -30.05 70.8 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.792 178.604 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -52.93 -54.05 40.54 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.856 1.262 . . . . 0.0 110.017 -174.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.55 ' HE3' ' CE1' ' A' ' 44' ' ' PHE . 0.8 OUTLIER -57.43 -44.74 84.91 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 124.651 1.181 . . . . 0.0 110.866 172.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.0 -34.24 77.13 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.569 1.548 . . . . 0.0 112.372 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -69.55 -62.48 1.37 Allowed 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 171.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.7 t -47.64 -41.03 7.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 123.916 0.886 . . . . 0.0 112.763 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.55 ' CE1' ' HE3' ' A' ' 40' ' ' LYS . 1.6 m-85 -61.54 -34.76 76.09 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 123.892 0.877 . . . . 0.0 112.121 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -112.41 -12.23 13.55 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.386 1.074 . . . . 0.0 112.712 -170.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -88.38 -34.67 17.49 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.614 1.566 . . . . 0.0 109.889 171.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -130.35 -62.63 0.92 Allowed 'General case' 0 C--N 1.345 0.373 0 C-N-CA 123.095 0.558 . . . . 0.0 111.807 -169.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.6 mt -62.41 -56.08 21.63 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 119.245 -0.407 . . . . 0.0 111.447 -162.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -60.75 -35.29 76.02 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 118.676 -0.678 . . . . 0.0 110.274 175.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.14 -16.21 12.52 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 127.19 2.196 . . . . 0.0 112.965 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 118.23 -10.15 13.35 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 126.046 1.784 . . . . 0.0 111.988 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -73.62 120.26 18.98 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 118.802 1.301 . . . . 0.0 110.837 -172.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -109.72 13.0 23.91 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.83 2.052 . . . . 0.0 112.074 -176.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.43 ' HB3' HG13 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -150.94 107.31 3.48 Favored 'General case' 0 CA--C 1.518 -0.274 0 O-C-N 120.248 -1.533 . . . . 0.0 107.983 -173.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mp -112.02 152.0 13.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 176.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.828 ' CE2' HG11 ' A' ' 22' ' ' VAL . 23.4 m-85 -130.08 150.5 51.32 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.603 1.161 . . . . 0.0 109.492 166.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.5 tp -119.91 110.28 16.54 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.204 1.001 . . . . 0.0 108.535 176.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.3 t -84.31 134.47 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 171.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.3 mp -109.82 6.19 23.23 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.62 0.768 . . . . 0.0 111.963 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 33.4 t -51.98 -48.14 64.52 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.158 0.983 . . . . 0.0 111.458 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -87.99 7.05 32.96 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.341 -0.85 . . . . 0.0 112.195 -168.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.6 p -134.45 126.93 49.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 125.579 1.551 . . . . 0.0 108.099 -173.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -75.34 -42.56 54.06 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 120.675 -1.266 . . . . 0.0 108.944 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.567 ' HB3' ' HE2' ' A' ' 95' ' ' LYS . 1.4 p -162.05 -178.15 6.23 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.992 0.901 . . . . 0.0 111.681 -173.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 21.3 tt -139.66 160.03 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 C-N-CA 125.344 1.458 . . . . 0.0 108.586 -175.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.12 156.18 22.26 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.408 1.083 . . . . 0.0 110.421 172.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.4 m -53.51 -28.77 32.93 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.126 1.37 . . . . 0.0 113.434 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -62.01 -66.6 0.51 Allowed 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.73 1.212 . . . . 0.0 109.309 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.0 t -74.27 -24.23 59.24 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.369 -0.824 . . . . 0.0 111.659 -176.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.414 HD11 HG21 ' A' ' 103' ' ' THR . 55.1 tp -49.98 -30.82 11.26 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.944 1.247 . . . . 0.0 112.407 172.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.65 -24.69 29.84 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-N 118.396 0.544 . . . . 0.0 113.448 175.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.8 t -66.16 -39.52 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 118.194 0.997 . . . . 0.0 108.605 173.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 mp -52.55 -53.25 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 123.8 0.84 . . . . 0.0 108.914 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 73.3 t -58.94 -46.29 91.5 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 175.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -55.57 -43.2 75.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 119.46 1.027 . . . . 0.0 112.501 -174.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.2 mt -59.73 -38.89 78.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 124.114 0.966 . . . . 0.0 109.013 176.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.63 -50.94 71.5 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 119.151 0.887 . . . . 0.0 109.478 172.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -53.94 -47.93 70.75 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 118.077 -0.963 . . . . 0.0 110.331 -176.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.7 m -56.33 -57.49 12.04 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 124.092 0.87 . . . . 0.0 110.358 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 50.3 mt -53.28 -46.79 57.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.859 1.264 . . . . 0.0 110.637 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.2 p -61.78 -31.13 71.32 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.972 1.309 . . . . 0.0 111.978 -175.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.31 -31.68 33.45 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.848 1.659 . . . . 0.0 111.696 175.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 39.4 m -78.69 -21.95 47.43 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 117.64 -1.171 . . . . 0.0 113.991 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 121.02 4.92 10.0 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 119.652 1.115 . . . . 0.0 114.546 -174.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -113.32 -176.28 19.38 Favored Glycine 0 N--CA 1.437 -1.261 0 CA-C-N 119.24 1.52 . . . . 0.0 112.196 -173.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -131.47 157.5 43.33 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.825 1.65 . . . . 0.0 108.68 176.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -148.96 135.45 19.47 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 175.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.59 ' C ' HD23 ' A' ' 89' ' ' LEU . . . -140.11 170.84 15.1 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.36 1.464 . . . . 0.0 110.28 -176.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.59 HD23 ' C ' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -119.27 171.58 8.2 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 122.793 0.437 . . . . 0.0 110.467 -176.573 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.557 HG21 HD13 ' A' ' 115' ' ' ILE . 77.9 t -146.77 143.49 20.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 124.939 1.296 . . . . 0.0 109.723 -172.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 29.1 t 43.61 63.81 7.54 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 125.914 1.685 . . . . 0.0 109.119 -176.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -78.32 91.98 1.16 Allowed 'Trans proline' 0 N--CA 1.444 -1.428 0 N-CA-C 106.168 -2.281 . . . . 0.0 106.168 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -55.39 155.19 5.41 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 122.869 1.319 . . . . 0.0 110.125 -177.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -64.69 -25.26 67.87 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 122.318 1.056 . . . . 0.0 110.99 -165.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.567 ' HE2' ' HB3' ' A' ' 64' ' ' SER . 0.0 OUTLIER -68.82 -35.7 77.29 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 126.069 1.748 . . . . 0.0 111.547 177.428 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.0 m -82.44 -38.15 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.745 0 CA-C-N 120.436 1.471 . . . . 0.0 110.429 172.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.2 -33.42 63.01 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 120.193 1.36 . . . . 0.0 109.85 -176.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.45 -31.38 72.53 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 177.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.1 p -96.54 -32.12 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 C-N-CA 124.974 1.31 . . . . 0.0 108.653 -177.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.98 -18.59 65.41 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.408 1.883 . . . . 0.0 111.341 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.1 m -80.16 -57.01 3.82 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 168.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.41 -5.43 5.26 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 130.257 3.423 . . . . 0.0 114.006 -167.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.414 HG21 HD11 ' A' ' 70' ' ' LEU . 0.8 OUTLIER -130.76 6.93 4.74 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 125.381 1.472 . . . . 0.0 110.659 -177.282 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 46.71 73.95 0.17 Allowed 'General case' 0 C--N 1.342 0.262 0 C-N-CA 127.511 2.325 . . . . 0.0 109.706 -170.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.79 -63.13 1.28 Allowed 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 174.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -57.64 -31.95 66.79 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 123.344 1.545 . . . . 0.0 110.284 174.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -76.43 1.91 15.1 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 120.09 -1.631 . . . . 0.0 111.219 -175.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.4 mt -126.54 -53.12 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 126.06 1.744 . . . . 0.0 107.936 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.2 t -103.11 145.8 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 125.878 1.671 . . . . 0.0 108.186 -174.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -71.09 161.28 31.39 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.5 -0.75 . . . . 0.0 111.164 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.19 143.56 27.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.421 1.488 . . . . 0.0 107.113 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -141.23 168.43 19.8 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 128.902 2.881 . . . . 0.0 109.239 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.2 -46.47 13.71 Favored 'General case' 0 CA--C 1.515 -0.372 0 O-C-N 121.53 -0.731 . . . . 0.0 109.697 177.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 60.1 p -119.45 173.79 6.77 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.045 1.338 . . . . 0.0 108.894 -173.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.557 HD13 HG21 ' A' ' 90' ' ' VAL . 8.8 mm -66.88 -41.9 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-O 117.858 -1.068 . . . . 0.0 108.726 168.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 18.6 t -67.9 -37.85 82.24 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 119.982 1.265 . . . . 0.0 110.87 -167.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -60.82 -28.46 68.81 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 118.4 -0.809 . . . . 0.0 109.802 177.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.727 ' O ' HG23 ' A' ' 122' ' ' VAL . . . -81.27 -54.38 5.54 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.15 -28.76 59.27 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 125.917 1.687 . . . . 0.0 114.061 -160.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -104.79 -0.69 27.0 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 125.22 1.408 . . . . 0.0 114.406 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -123.32 -35.03 3.02 Favored 'General case' 0 C--O 1.213 -0.841 0 C-N-CA 125.162 1.385 . . . . 0.0 112.924 -167.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 118' ' ' ALA . 3.4 t -57.02 -27.23 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 126.036 1.734 . . . . 0.0 109.442 161.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 11.8 mtm180 -54.18 -31.65 53.38 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 121.127 -0.983 . . . . 0.0 113.061 162.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.74 23.66 5.02 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 118.326 2.713 . . . . 0.0 118.326 -177.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 21.6 mttp . . . . . 0 N--CA 1.431 -1.383 0 N-CA-C 102.66 -3.089 . . . . 0.0 102.66 -179.933 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mpt? . . . . . 0 N--CA 1.468 0.458 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 48.6 36.68 18.73 Favored Glycine 0 C--N 1.339 0.726 0 C-N-CA 125.446 1.498 . . . . 0.0 115.087 165.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.2 p -61.44 179.51 0.22 Allowed 'General case' 0 C--O 1.239 0.522 0 CA-C-N 118.003 0.902 . . . . 0.0 109.638 167.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -64.88 171.77 3.27 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 122.995 1.378 . . . . 0.0 111.098 163.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -67.66 129.36 39.67 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 172.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 36.3 mm -90.11 -60.8 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -177.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.2 t60 50.69 102.22 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.007 2.123 . . . . 0.0 111.958 -166.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -59.36 162.16 4.99 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 122.216 1.008 . . . . 0.0 111.809 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -75.22 166.75 23.14 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.805 0.842 . . . . 0.0 111.972 -172.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.73 175.32 5.8 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.695 0.798 . . . . 0.0 111.173 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 3.8 m80 55.31 104.35 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.098 0 C-N-CA 128.201 2.6 . . . . 0.0 112.649 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -142.98 166.26 25.12 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.009 1.324 . . . . 0.0 107.539 174.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.8 mpt? -120.15 175.95 5.69 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 126.71 2.004 . . . . 0.0 107.598 175.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -104.71 96.86 11.24 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 124.088 0.955 . . . . 0.0 109.696 -175.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -77.65 49.22 2.84 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 124.928 3.752 . . . . 0.0 111.198 176.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -160.41 165.11 31.7 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 125.689 1.596 . . . . 0.0 107.909 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -126.66 178.78 5.7 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 163.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.6 mt -126.5 152.23 33.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 163.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 23.3 m -111.19 -141.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 125.612 1.565 . . . . 0.0 107.724 174.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -29.94 -79.21 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 129.043 2.937 . . . . 0.0 112.501 166.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -142.82 14.04 1.91 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.952 2.501 . . . . 0.0 109.252 177.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.642 HG11 ' CE2' ' A' ' 56' ' ' PHE . 21.8 t -115.75 140.07 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 O-C-N 121.092 -1.005 . . . . 0.0 108.712 -173.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.4 t -94.14 130.67 42.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.1 mm -106.94 94.32 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 36.1 mt -77.83 133.69 38.13 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 176.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 70.4 mtm -131.24 92.98 31.15 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 124.21 1.004 . . . . 0.0 109.064 -172.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -78.02 44.62 1.62 Allowed 'Trans proline' 0 CA--C 1.542 0.915 1 C-N-CA 125.461 4.107 . . . . 0.0 113.887 -164.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -49.12 88.77 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 128.763 2.825 . . . . 0.0 114.343 -169.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 36.94 35.41 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 128.95 2.9 . . . . 0.0 115.016 -176.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -122.78 7.43 9.38 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -167.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.0 mp -73.84 63.89 0.93 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 126.027 1.731 . . . . 0.0 109.605 -176.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -78.82 26.88 0.23 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 128.938 2.895 . . . . 0.0 113.868 -166.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.6 mm 72.86 -63.09 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 127.068 2.147 . . . . 0.0 110.643 -177.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -70.3 -18.56 63.11 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 120.916 1.689 . . . . 0.0 111.35 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -47.83 -49.58 28.8 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 123.991 0.916 . . . . 0.0 110.516 162.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.73 -37.33 87.23 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.79 0.436 . . . . 0.0 110.446 -177.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -61.89 -51.19 69.17 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.332 0.653 . . . . 0.0 110.017 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.259 0.0 OUTLIER -81.82 -15.76 53.08 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-O 117.599 -1.191 . . . . 0.0 112.608 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -44.48 -50.74 9.28 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.441 1.896 . . . . 0.0 110.661 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.514 ' HE2' ' CZ ' ' A' ' 44' ' ' PHE . 13.6 tmtt? -60.65 -53.16 60.85 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 123.222 0.609 . . . . 0.0 111.19 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.41 -45.91 87.48 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.039 0.836 . . . . 0.0 109.914 -177.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -60.49 -66.98 0.44 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 117.292 -1.337 . . . . 0.0 109.705 176.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 73.5 t -52.13 -32.32 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 120.537 1.517 . . . . 0.0 111.986 -176.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.514 ' CZ ' ' HE2' ' A' ' 40' ' ' LYS . 3.3 m-85 -58.19 -71.78 0.1 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.91 0.777 . . . . 0.0 109.905 172.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -65.89 -30.83 71.49 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 123.887 0.875 . . . . 0.0 112.885 -170.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -77.32 -31.81 54.85 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.011 1.325 . . . . 0.0 110.962 -175.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -138.13 -62.73 0.58 Allowed 'General case' 0 C--N 1.341 0.22 0 CA-C-N 118.522 0.601 . . . . 0.0 110.991 -170.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 46.6 mt -58.81 -59.43 5.44 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.416 0.553 . . . . 0.0 111.176 -171.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -60.68 -35.26 75.83 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.029 1.332 . . . . 0.0 109.647 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 tttm -56.5 -34.7 67.22 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.952 176.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.41 8.82 5.74 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.991 1.281 . . . . 0.0 114.173 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -77.63 159.77 28.98 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 118.941 1.37 . . . . 0.0 110.426 172.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -143.44 11.06 1.68 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.251 1.82 . . . . 0.0 111.795 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.477 ' HB3' HG13 ' A' ' 22' ' ' VAL . 1.7 mtmt -139.34 114.73 9.79 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 119.93 1.241 . . . . 0.0 107.914 -176.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mp -121.91 152.55 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 127.381 2.272 . . . . 0.0 105.118 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.642 ' CE2' HG11 ' A' ' 22' ' ' VAL . 14.2 m-85 -131.4 160.74 34.18 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.985 1.714 . . . . 0.0 109.37 166.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 26.5 tp -127.6 119.44 25.95 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 118.085 -0.96 . . . . 0.0 108.434 169.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.541 HG12 ' H ' ' A' ' 60' ' ' SER . 46.4 t -81.54 139.35 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 120.389 1.449 . . . . 0.0 107.685 170.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.63 ' CD1' HG11 ' A' ' 96' ' ' VAL . 1.3 mt -112.54 8.82 19.39 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.889 0.768 . . . . 0.0 112.22 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.541 ' H ' HG12 ' A' ' 58' ' ' VAL . 71.9 m -74.79 -34.1 62.36 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.297 -0.877 . . . . 0.0 113.233 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -90.76 30.6 1.15 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 122.889 1.328 . . . . 0.0 110.469 -174.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.9 p -160.8 170.7 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 129.344 3.058 . . . . 0.0 104.853 -174.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -129.94 -47.31 1.13 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 172.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.414 ' CB ' ' HE2' ' A' ' 95' ' ' LYS . 41.7 p -143.23 171.76 13.66 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.707 0.803 . . . . 0.0 110.648 -176.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.6 tt -138.32 157.88 31.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 C-N-CA 124.987 1.315 . . . . 0.0 108.393 -174.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -73.53 153.54 40.24 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.74 0.781 . . . . 0.0 109.808 174.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.6 m -76.21 53.23 0.8 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.629 1.172 . . . . 0.0 110.447 164.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -129.29 -69.45 0.69 Allowed 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 160.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.03 -38.84 77.0 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 128.967 2.907 . . . . 0.0 112.031 -173.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 20.9 tp -46.05 -40.39 10.62 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 125.881 1.673 . . . . 0.0 111.966 171.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.82 -31.1 40.98 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-O 119.404 -0.665 . . . . 0.0 111.762 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.2 t -70.62 -33.75 54.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 118.074 0.937 . . . . 0.0 108.659 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 22.7 mm -55.75 -46.98 79.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 O-C-N 121.367 -0.833 . . . . 0.0 109.722 174.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.4 t -60.48 -36.64 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 O-C-N 121.087 -1.008 . . . . 0.0 111.693 172.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -63.73 -28.09 69.65 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 120.873 1.67 . . . . 0.0 112.121 -178.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.4 mt -70.32 -34.95 60.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 O-C-N 121.289 -0.882 . . . . 0.0 109.091 173.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.18 -40.93 82.14 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.1 mttm -54.65 -46.48 73.98 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 117.92 -1.038 . . . . 0.0 111.607 174.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.6 t -58.23 -58.36 8.83 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.1 mt -62.07 -40.28 86.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 123.828 0.851 . . . . 0.0 111.157 -170.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.0 t -60.52 -40.87 93.03 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.68 1.592 . . . . 0.0 110.909 173.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.7 m -69.97 -35.11 74.2 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.985 -0.447 . . . . 0.0 110.613 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.1 m -73.06 -51.08 19.46 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.472 1.109 . . . . 0.0 112.844 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 132.98 18.8 1.05 Allowed Glycine 0 CA--C 1.531 1.04 0 CA-C-O 118.064 -1.409 . . . . 0.0 115.031 -170.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -116.86 -168.06 14.72 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 120.251 2.026 . . . . 0.0 111.72 -172.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.473 ' HB3' HG22 ' A' ' 122' ' ' VAL . 13.1 m-85 -132.4 153.22 51.03 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.639 1.576 . . . . 0.0 109.901 -178.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -153.16 140.69 19.8 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 174.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.529 ' C ' HD23 ' A' ' 89' ' ' LEU . . . -146.6 172.26 13.85 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.61 1.164 . . . . 0.0 111.469 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.529 HD23 ' C ' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -117.02 165.74 13.0 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.576 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.474 HG21 HD13 ' A' ' 115' ' ' ILE . 53.7 t -142.89 134.85 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 C-N-CA 124.723 1.209 . . . . 0.0 108.034 -165.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.6 t 50.74 54.43 15.4 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 126.201 1.801 . . . . 0.0 111.821 -174.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -73.5 107.7 2.45 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 124.175 3.25 . . . . 0.0 109.154 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 32.6 p-10 -66.47 165.52 14.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 122.393 1.092 . . . . 0.0 110.6 174.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -69.09 -26.35 64.88 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.863 -1.148 . . . . 0.0 112.214 -170.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.414 ' HE2' ' CB ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -62.9 -29.18 70.57 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 126.878 2.071 . . . . 0.0 109.66 177.928 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.848 HG13 HD13 ' A' ' 100' ' ' LEU . 13.3 t -84.88 -50.32 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-O 116.105 -1.902 . . . . 0.0 108.875 169.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -54.04 -34.74 60.84 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 122.782 2.537 . . . . 0.0 109.844 -177.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.73 -46.09 89.71 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 121.711 -0.618 . . . . 0.0 111.268 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.685 HG13 HD12 ' A' ' 100' ' ' LEU . 8.8 p -83.95 -38.8 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 -169.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.848 HD13 HG13 ' A' ' 96' ' ' VAL . 10.7 mp -61.28 -24.29 66.3 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.776 1.63 . . . . 0.0 112.644 177.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.81 6.86 34.27 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.376 0.989 . . . . 0.0 111.302 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 41.5 mt -108.67 -39.24 5.43 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 126.773 2.029 . . . . 0.0 110.704 171.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.2 t -94.72 0.42 55.0 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.413 1.885 . . . . 0.0 112.021 -168.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 57.96 79.86 0.19 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.296 1.838 . . . . 0.0 109.432 -168.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.406 ' HB3' ' HG ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -128.28 -55.44 1.26 Allowed 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.97 1.308 . . . . 0.0 108.996 175.224 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -59.54 -18.41 40.34 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.642 1.977 . . . . 0.0 112.183 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.92 -9.09 24.59 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.422 1.889 . . . . 0.0 114.535 -178.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.8 mt -107.62 -38.04 3.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 126.926 2.09 . . . . 0.0 107.914 -176.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.5 t -120.78 145.44 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 123.726 0.81 . . . . 0.0 109.117 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.04 161.01 27.67 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.084 0.554 . . . . 0.0 110.742 175.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.09 144.12 25.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -144.67 167.05 23.49 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 127.363 2.265 . . . . 0.0 110.784 -176.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -84.72 -44.52 13.29 Favored 'General case' 0 C--O 1.233 0.189 0 O-C-N 121.835 -0.54 . . . . 0.0 110.008 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.6 p -128.96 177.22 7.27 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.165 0.986 . . . . 0.0 109.48 -171.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.474 HD13 HG21 ' A' ' 90' ' ' VAL . 13.7 mm -74.95 -42.59 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 174.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 10.0 t -70.82 -25.56 62.9 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 119.573 1.079 . . . . 0.0 110.313 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -65.74 -16.22 63.57 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 119.676 1.126 . . . . 0.0 111.399 170.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -107.98 -38.75 5.72 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 123.762 0.825 . . . . 0.0 109.185 -171.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 8.2 ttp -61.7 -42.75 99.36 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.245 1.018 . . . . 0.0 112.571 -160.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -92.72 -23.53 18.89 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 124.586 1.154 . . . . 0.0 111.861 175.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -81.39 -52.14 7.59 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -169.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.473 HG22 ' HB3' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -46.89 -34.8 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 127.182 2.193 . . . . 0.0 112.637 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 11.7 mtm180 -60.68 -32.6 71.81 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 123.595 0.758 . . . . 0.0 111.834 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.8 60.31 0.93 Allowed 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 127.008 2.123 . . . . 0.0 105.624 -178.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.259 1.59 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -174.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.646 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -142.65 174.33 23.54 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 177.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.3 m -161.88 -6.75 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.311 1.844 . . . . 0.0 112.253 168.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 47.99 55.82 8.12 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.886 1.274 . . . . 0.0 113.555 128.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -61.79 -68.8 0.29 Allowed 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.334 -0.853 . . . . 0.0 110.513 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.7 mp 53.31 -96.26 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 125.289 1.435 . . . . 0.0 107.862 -163.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.63 140.36 58.5 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 120.253 1.388 . . . . 0.0 109.749 172.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -123.82 166.47 15.56 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.029 0.932 . . . . 0.0 108.804 170.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 54.73 -178.81 0.03 OUTLIER 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.406 1.098 . . . . 0.0 112.436 -166.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -129.94 139.61 51.07 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 175.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -136.15 73.73 1.47 Allowed 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 -176.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -121.37 -58.46 1.78 Allowed 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 171.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.0 ptt? 53.41 -179.09 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 127.71 2.404 . . . . 0.0 113.205 -172.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -153.5 147.83 19.11 Favored Pre-proline 0 CA--C 1.539 0.525 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 168.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -74.64 132.88 16.46 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.635 2.224 . . . . 0.0 113.014 172.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -153.63 173.62 15.54 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.16 1.384 . . . . 0.0 108.951 177.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -129.48 175.75 8.52 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 157.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.5 mt -125.41 157.54 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 163.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.1 m -117.34 -143.13 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 168.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -47.33 -66.44 0.41 Allowed 'General case' 0 C--O 1.234 0.268 0 C-N-CA 127.058 2.143 . . . . 0.0 112.134 -175.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -141.93 12.15 2.03 Favored 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 123.711 0.804 . . . . 0.0 112.574 170.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.695 HG11 ' CE2' ' A' ' 56' ' ' PHE . 20.5 t -105.77 139.07 28.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.9 t -90.72 149.87 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.239 1.016 . . . . 0.0 108.307 174.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.7 mp -129.88 107.81 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 176.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.49 158.43 24.51 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 120.57 1.532 . . . . 0.0 108.586 170.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 38.8 mtt -133.49 86.14 41.16 Favored Pre-proline 0 N--CA 1.465 0.296 0 C-N-CA 124.951 1.3 . . . . 0.0 107.941 -175.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -65.12 93.0 0.22 Allowed 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.372 2.714 . . . . 0.0 109.967 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.413 ' C ' ' HE2' ' A' ' 29' ' ' LYS . 15.5 p-10 -74.05 52.79 0.46 Allowed 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 125.639 1.576 . . . . 0.0 109.679 165.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.413 ' HE2' ' C ' ' A' ' 28' ' ' ASN . 0.0 OUTLIER 51.85 -2.01 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 130.048 3.339 . . . . 0.0 117.769 173.618 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -71.84 33.32 0.06 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 128.998 2.919 . . . . 0.0 112.485 176.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.8 mt -84.46 59.7 5.59 Favored 'General case' 0 N--CA 1.457 -0.121 0 O-C-N 120.355 -1.466 . . . . 0.0 108.098 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -73.31 172.35 11.36 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.979 1.712 . . . . 0.0 109.724 169.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.7 mt -71.98 -39.21 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 O-C-N 121.472 -0.767 . . . . 0.0 110.609 -177.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -63.97 -33.81 76.58 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 118.48 0.582 . . . . 0.0 110.117 -170.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -78.47 -21.71 48.64 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 125.267 1.427 . . . . 0.0 111.688 175.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.99 -55.9 6.6 Favored 'General case' 0 CA--C 1.521 -0.17 0 O-C-N 120.639 -1.288 . . . . 0.0 112.294 -171.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -67.11 -30.71 70.8 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 118.717 -1.193 . . . . 0.0 110.191 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.418 ' O ' HD12 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -73.48 -23.36 60.06 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 117.785 -1.102 . . . . 0.0 110.308 176.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -49.87 -41.97 46.6 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.296 1.438 . . . . 0.0 111.295 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -58.79 -63.74 1.18 Allowed 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 172.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -44.79 -50.95 9.9 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.865 2.066 . . . . 0.0 111.447 -177.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -61.78 -65.44 0.69 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 117.304 -1.332 . . . . 0.0 109.959 177.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.7 t -53.1 -34.21 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 120.365 1.439 . . . . 0.0 111.416 -176.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.429 ' CD1' HD12 ' A' ' 48' ' ' LEU . 4.9 m-85 -60.75 -69.43 0.23 Allowed 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 124.41 1.084 . . . . 0.0 109.115 174.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -62.81 -39.84 95.53 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.312 0.645 . . . . 0.0 112.538 -173.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -70.55 -31.42 68.46 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.793 1.237 . . . . 0.0 110.858 -175.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -137.71 -58.59 0.67 Allowed 'General case' 0 C--N 1.343 0.298 0 CA-C-N 119.021 0.828 . . . . 0.0 112.238 -171.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.429 HD12 ' CD1' ' A' ' 44' ' ' PHE . 43.7 mt -59.95 -53.04 62.48 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 120.54 -1.35 . . . . 0.0 111.303 -171.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -69.49 -15.65 63.3 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.553 1.941 . . . . 0.0 111.177 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -74.49 -28.89 61.21 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 118.292 -0.861 . . . . 0.0 111.068 168.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.71 1.82 8.17 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.756 1.646 . . . . 0.0 114.235 -177.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -72.83 159.8 33.17 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 120.066 1.933 . . . . 0.0 110.71 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -139.22 -8.29 1.32 Allowed 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 126.349 1.86 . . . . 0.0 111.423 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.544 ' HB3' HG13 ' A' ' 22' ' ' VAL . 4.7 mtmt -129.25 129.25 44.72 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.029 0.931 . . . . 0.0 109.325 -175.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.5 mt -138.39 155.39 28.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 126.706 2.002 . . . . 0.0 106.433 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.695 ' CE2' HG11 ' A' ' 22' ' ' VAL . 23.8 m-85 -134.43 156.96 47.64 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 125.708 1.603 . . . . 0.0 111.459 166.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 46.5 tp -125.97 114.94 19.14 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 117.289 -1.339 . . . . 0.0 108.584 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.7 t -92.85 119.0 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 121.137 1.789 . . . . 0.0 109.206 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.4 mp -90.78 1.38 56.95 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -173.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 73.4 p -51.26 -44.28 61.73 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.636 1.974 . . . . 0.0 114.242 -171.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -68.88 -27.86 66.18 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 120.942 -1.099 . . . . 0.0 111.098 -175.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -95.13 150.86 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 125.344 1.458 . . . . 0.0 109.103 -165.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -70.2 -59.65 2.76 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 158.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.3 t -164.33 176.83 8.75 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 122.699 1.238 . . . . 0.0 110.677 -168.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.0 tt -109.12 177.95 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 128.288 2.635 . . . . 0.0 107.666 172.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -118.88 173.88 6.62 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.247 0.931 . . . . 0.0 110.381 171.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.8 t -50.5 -41.23 53.17 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 126.583 1.953 . . . . 0.0 111.428 -175.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -65.14 -58.7 5.34 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 118.154 -0.927 . . . . 0.0 111.008 -171.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 66.0 m -69.75 -36.72 76.06 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 120.293 1.406 . . . . 0.0 113.012 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.601 HD21 HG21 ' A' ' 103' ' ' THR . 39.8 tp -49.39 -43.48 44.36 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.867 1.667 . . . . 0.0 112.599 -172.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.532 ' HA2' HG12 ' A' ' 74' ' ' VAL . . . -94.98 11.41 69.55 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 120.739 -0.743 . . . . 0.0 113.797 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.6 t -85.03 -39.69 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 118.376 1.088 . . . . 0.0 108.44 153.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.4 mm -56.19 -62.76 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 119.454 1.024 . . . . 0.0 109.68 -177.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.532 HG12 ' HA2' ' A' ' 71' ' ' GLY . 9.8 p -37.13 -49.83 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 124.908 1.283 . . . . 0.0 114.289 165.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.478 ' N ' HG13 ' A' ' 74' ' ' VAL . 3.1 t-20 -60.61 -42.37 96.67 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 123.598 0.759 . . . . 0.0 109.306 -167.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 75.4 mt -55.85 -41.32 66.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.459 1.104 . . . . 0.0 108.221 176.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -58.89 -51.81 68.44 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 124.074 0.95 . . . . 0.0 110.13 177.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -56.57 -45.18 81.44 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 122.882 0.473 . . . . 0.0 110.331 -175.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -46.94 87.67 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 123.013 0.525 . . . . 0.0 110.711 175.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.6 mt -63.77 -41.24 91.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 123.702 0.801 . . . . 0.0 110.652 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.3 m -58.86 -51.11 71.42 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.713 1.205 . . . . 0.0 110.961 173.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.3 m -63.78 -26.53 68.67 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 176.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.9 m -74.24 -51.59 14.9 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.773 0.829 . . . . 0.0 110.967 174.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.74 37.49 0.62 Allowed Glycine 0 CA--C 1.529 0.965 0 CA-C-O 118.699 -1.056 . . . . 0.0 113.662 -165.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -133.76 -168.7 11.9 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 119.755 1.778 . . . . 0.0 111.602 177.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.443 ' HB3' HG22 ' A' ' 122' ' ' VAL . 11.1 m-85 -142.94 119.48 11.03 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.086 1.754 . . . . 0.0 110.111 -171.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -122.77 146.12 47.8 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.173 0.897 . . . . 0.0 109.143 172.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.629 ' C ' HD23 ' A' ' 89' ' ' LEU . . . -152.72 173.35 15.38 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.342 1.057 . . . . 0.0 111.581 -176.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.629 HD23 ' C ' ' A' ' 88' ' ' ALA . 2.5 mt -120.36 164.6 16.1 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.833 0.853 . . . . 0.0 109.527 -176.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.53 HG21 HD13 ' A' ' 115' ' ' ILE . 55.7 t -140.87 147.19 22.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 124.164 0.986 . . . . 0.0 109.468 -175.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 52.98 57.87 14.46 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.991 1.316 . . . . 0.0 111.332 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -77.15 81.69 2.55 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.202 2.601 . . . . 0.0 110.303 177.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.65 143.82 19.32 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.085 0.554 . . . . 0.0 109.668 172.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -54.77 -36.25 64.67 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.983 1.313 . . . . 0.0 113.643 -156.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.3 -41.17 62.69 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.155 0.982 . . . . 0.0 109.204 178.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -81.2 -29.67 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 118.67 0.668 . . . . 0.0 109.676 -173.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -62.81 -26.87 68.95 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.172 0.896 . . . . 0.0 110.801 172.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.75 -44.16 93.94 Favored 'General case' 0 C--N 1.344 0.33 0 O-C-N 121.465 -0.772 . . . . 0.0 109.47 175.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.679 ' O ' HG22 ' A' ' 103' ' ' THR . 9.9 p -86.3 -43.6 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 -168.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.689 HD13 ' HB3' ' A' ' 105' ' ' LEU . 0.2 OUTLIER -58.4 -24.68 60.71 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.674 1.19 . . . . 0.0 111.296 177.753 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 26.3 t -77.42 -52.79 8.54 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 120.271 1.396 . . . . 0.0 108.712 172.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 52.0 mt -58.26 -51.46 69.69 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.942 1.297 . . . . 0.0 111.76 -172.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.679 HG22 ' O ' ' A' ' 99' ' ' VAL . 5.5 t -73.79 -5.29 39.96 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.383 0.538 . . . . 0.0 111.197 -178.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 64.24 76.69 0.34 Allowed 'General case' 0 C--N 1.342 0.263 0 C-N-CA 126.832 2.053 . . . . 0.0 107.583 -174.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.689 ' HB3' HD13 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -126.84 -51.86 1.45 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.751 1.22 . . . . 0.0 109.501 -171.467 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.59 -25.54 66.3 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 122.995 1.378 . . . . 0.0 111.436 172.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 4.7 mtm180 -75.28 -8.34 56.38 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.505 1.122 . . . . 0.0 111.34 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.9 mt -130.47 -34.74 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 125.07 1.348 . . . . 0.0 109.006 -165.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.5 t -112.68 149.14 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 126.339 1.856 . . . . 0.0 108.159 175.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.93 160.97 30.63 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.688 0.795 . . . . 0.0 110.782 172.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -146.67 144.36 20.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -176.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -148.18 174.02 12.39 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.017 1.327 . . . . 0.0 112.437 -172.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.75 -44.48 9.43 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.751 0.821 . . . . 0.0 111.526 -177.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 71.1 p -126.43 168.43 14.22 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.811 1.244 . . . . 0.0 109.063 -176.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.53 HD13 HG21 ' A' ' 90' ' ' VAL . 9.0 mm -62.66 -39.89 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 167.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.3 t -70.66 -36.28 73.28 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 119.502 1.046 . . . . 0.0 110.155 -171.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -69.14 -5.65 23.7 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 118.324 -0.846 . . . . 0.0 112.225 174.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -104.42 -44.55 4.9 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 174.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 10.0 ttm -56.7 -51.83 67.27 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 125.377 1.471 . . . . 0.0 112.593 -163.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -104.8 13.75 30.76 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 126.322 1.849 . . . . 0.0 110.933 -176.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -112.98 -58.13 2.2 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.607 1.563 . . . . 0.0 109.309 -177.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.443 HG22 ' HB3' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -48.75 -39.03 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.071 0 C-N-CA 126.736 2.015 . . . . 0.0 110.501 177.612 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 12.0 mtm180 -56.5 -30.42 62.97 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 122.692 0.397 . . . . 0.0 110.668 -176.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.71 38.69 1.36 Allowed 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.745 1.218 . . . . 0.0 111.366 -174.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.875 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 167.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.419 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.28 162.42 35.78 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.684 -0.566 . . . . 0.0 111.684 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.1 p -74.2 100.59 3.73 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.699 1.2 . . . . 0.0 109.225 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 53.9 t0 59.98 -85.58 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.231 1.812 . . . . 0.0 112.707 -175.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 29.1 pttt -139.46 25.45 2.42 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.961 1.704 . . . . 0.0 113.415 -154.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 29.7 mm -57.88 136.99 20.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 123.674 0.79 . . . . 0.0 110.576 -174.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.457 ' CG ' ' H ' ' A' ' 8' ' ' HIS . 13.0 p-80 -164.94 -77.98 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.275 1.83 . . . . 0.0 108.302 161.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.457 ' H ' ' CG ' ' A' ' 7' ' ' HIS . 14.3 m80 -60.21 116.18 4.04 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 124.572 1.149 . . . . 0.0 110.393 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -144.11 17.06 1.74 Allowed 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -177.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -80.23 141.57 35.47 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.585 0.63 . . . . 0.0 110.484 169.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 18.3 m80 31.03 84.09 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 129.511 3.124 . . . . 0.0 113.587 170.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -126.13 21.3 7.43 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.825 1.25 . . . . 0.0 112.296 -176.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.3 tmm? 91.57 144.25 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 130.589 3.555 . . . . 0.0 110.242 -176.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -142.0 86.24 10.53 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 125.493 1.517 . . . . 0.0 108.622 -167.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -80.98 68.32 8.37 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.469 2.78 . . . . 0.0 110.188 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -159.26 164.64 34.77 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 120.773 -1.204 . . . . 0.0 111.088 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.9 173.7 9.39 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.481 1.112 . . . . 0.0 110.209 164.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.493 ' CD1' HG22 ' A' ' 23' ' ' VAL . 9.5 mm -121.82 135.47 61.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 169.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.5 m -115.88 -169.19 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 C-N-CA 126.185 1.794 . . . . 0.0 108.051 168.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -24.08 -61.14 0.05 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 129.397 3.079 . . . . 0.0 113.823 -170.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -145.62 19.91 1.5 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.874 0.369 . . . . 0.0 111.707 161.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.586 HG11 ' CE2' ' A' ' 56' ' ' PHE . 9.4 t -110.11 136.23 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 O-C-N 120.837 -1.165 . . . . 0.0 109.192 -175.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.493 HG22 ' CD1' ' A' ' 18' ' ' ILE . 66.0 t -85.32 125.31 40.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 106.862 -1.532 . . . . 0.0 106.862 172.021 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.524 HD12 HD12 ' A' ' 115' ' ' ILE . 3.7 mm -103.5 104.2 16.31 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 173.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 25.2 mt -78.24 123.1 26.55 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 172.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 32.9 mtt -125.34 75.94 68.61 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 124.404 1.082 . . . . 0.0 109.295 -168.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -67.0 140.49 54.71 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.298 1.998 . . . . 0.0 110.875 -177.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.9 p30 -130.25 66.43 1.5 Allowed 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 128.731 2.812 . . . . 0.0 109.521 171.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.23 7.33 6.18 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.956 2.102 . . . . 0.0 113.567 167.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -73.19 -3.34 26.06 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.217 1.807 . . . . 0.0 114.435 -177.707 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.6 mt -70.19 31.92 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 128.932 2.893 . . . . 0.0 115.483 -159.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -62.35 151.29 37.2 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 128.641 2.776 . . . . 0.0 112.603 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.7 mt -53.43 -40.31 40.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 124.24 1.016 . . . . 0.0 112.183 -177.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -65.83 -30.47 71.09 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.364 0.666 . . . . 0.0 110.086 -172.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.34 -28.43 14.97 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.27 -34.82 74.28 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 117.924 -1.036 . . . . 0.0 111.831 -176.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -59.71 -64.22 1.02 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 119.569 1.077 . . . . 0.0 109.606 174.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.462 HD22 ' O ' ' A' ' 38' ' ' LEU 0.254 0.0 OUTLIER -74.93 -8.21 55.82 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-O 117.989 -1.005 . . . . 0.0 112.858 -172.922 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -41.65 -42.73 2.59 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.709 2.004 . . . . 0.0 111.993 172.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -53.55 -68.73 0.15 Allowed 'General case' 0 C--N 1.343 0.298 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 170.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -52.62 -42.49 64.64 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 125.54 1.536 . . . . 0.0 111.806 -174.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.411 ' CE3' HG23 ' A' ' 43' ' ' VAL . 15.0 t90 -55.78 -60.63 3.18 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.834 0.854 . . . . 0.0 109.533 172.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.411 HG23 ' CE3' ' A' ' 42' ' ' TRP . 53.9 t -56.37 -35.91 45.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 119.927 1.24 . . . . 0.0 111.716 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -70.06 -37.64 75.57 Favored 'General case' 0 N--CA 1.441 -0.903 0 O-C-N 121.309 -0.87 . . . . 0.0 111.048 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -105.39 -9.2 17.7 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.008 1.323 . . . . 0.0 112.308 -167.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -99.35 -20.24 16.61 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.916 1.234 . . . . 0.0 112.135 165.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -135.67 -49.49 0.71 Allowed 'General case' 0 C--N 1.349 0.577 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -174.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 35.2 mt -67.93 -44.45 76.84 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 120.041 1.291 . . . . 0.0 112.314 -169.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -69.34 -24.56 63.92 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.462 0.705 . . . . 0.0 111.845 173.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.7 mttt -66.26 -6.83 15.16 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.944 1.298 . . . . 0.0 112.676 164.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.3 21.88 72.01 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-O 118.945 -0.92 . . . . 0.0 112.589 178.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -73.08 143.03 47.57 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 119.7 1.75 . . . . 0.0 107.597 163.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -127.82 0.89 6.04 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.601 1.56 . . . . 0.0 112.754 177.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.36 124.59 43.29 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 172.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.482 HD12 HD11 ' A' ' 80' ' ' ILE . 3.3 mt -125.13 147.19 29.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 128.448 2.699 . . . . 0.0 104.362 174.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.586 ' CE2' HG11 ' A' ' 22' ' ' VAL . 18.7 m-30 -126.59 158.29 36.63 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.259 1.423 . . . . 0.0 110.475 166.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 29.5 tp -126.85 111.81 14.61 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 172.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 79.6 t -78.65 135.01 26.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 170.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 mp -117.35 20.02 13.81 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.197 0.999 . . . . 0.0 111.694 176.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.63 -51.5 67.02 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.576 1.151 . . . . 0.0 112.806 172.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -86.83 -9.75 55.08 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.127 -0.983 . . . . 0.0 111.72 -164.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.6 p -108.16 155.01 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 127.212 2.205 . . . . 0.0 108.773 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -101.68 -46.73 4.85 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.792 0.837 . . . . 0.0 109.01 172.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.1 p -155.36 170.58 21.58 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 123.767 1.746 . . . . 0.0 112.643 -166.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.4 tt -137.72 177.52 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 C-N-CA 129.242 3.017 . . . . 0.0 105.592 -176.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -131.28 170.53 14.48 Favored 'General case' 0 C--O 1.238 0.486 0 O-C-N 121.471 -0.768 . . . . 0.0 110.696 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.3 m -67.5 50.63 0.05 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 128.548 2.739 . . . . 0.0 110.994 167.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -133.0 -72.73 0.51 Allowed 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 103.986 -2.598 . . . . 0.0 103.986 155.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 m -65.9 -27.34 68.12 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 124.393 1.077 . . . . 0.0 111.92 -167.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.663 HD22 HG21 ' A' ' 103' ' ' THR . 8.8 mt -51.36 -35.06 36.83 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.218 1.007 . . . . 0.0 112.54 177.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -72.07 -34.17 61.84 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.1 t -75.54 -34.15 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 O-C-N 121.526 -0.985 . . . . 0.0 110.402 -173.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.2 mp -55.89 -45.77 80.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 170.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.7 t -63.78 -45.99 95.69 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 O-C-N 121.048 -1.033 . . . . 0.0 110.04 175.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -50.24 -39.7 45.45 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.883 1.22 . . . . 0.0 113.247 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 65.6 mt -60.88 -47.81 91.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.203 1.001 . . . . 0.0 109.715 174.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.521 ' HG ' HG12 ' A' ' 109' ' ' VAL . 1.1 tm? -59.57 -47.09 86.91 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.7 mttt -56.69 -46.32 81.26 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 119.063 -0.494 . . . . 0.0 110.675 -175.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.8 t -54.39 -58.41 7.55 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 174.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.482 HD11 HD12 ' A' ' 55' ' ' ILE . 81.5 mt -55.58 -48.18 77.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.619 1.167 . . . . 0.0 111.628 -174.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.5 m -69.01 -14.38 63.01 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 117.651 -1.166 . . . . 0.0 112.947 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 51.3 m -87.42 -45.07 10.86 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.474 1.034 . . . . 0.0 110.506 163.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.8 m -66.19 -17.63 64.85 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 126.112 1.765 . . . . 0.0 115.014 -175.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.94 0.2 9.81 Favored Glycine 0 C--N 1.336 0.552 0 CA-C-O 118.116 -1.38 . . . . 0.0 116.307 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -115.85 -165.31 14.36 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-N 119.859 1.829 . . . . 0.0 113.699 -163.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.401 ' HB3' ' CG2' ' A' ' 122' ' ' VAL . 1.0 OUTLIER -131.61 154.41 48.91 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.888 1.675 . . . . 0.0 108.852 173.202 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.494 ' HB3' HD23 ' A' ' 77' ' ' LEU . 13.5 t80 -123.76 141.48 51.99 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 168.063 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.71 ' C ' HD23 ' A' ' 89' ' ' LEU . . . -144.38 167.18 23.09 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 119.468 -0.893 . . . . 0.0 112.163 167.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.71 HD23 ' C ' ' A' ' 88' ' ' ALA . 1.4 mt -120.86 160.05 24.23 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -175.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.489 HG21 HD13 ' A' ' 115' ' ' ILE . 26.4 t -134.28 138.34 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -171.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.7 m 58.45 60.23 5.7 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 125.034 1.334 . . . . 0.0 111.952 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -82.74 101.02 1.01 Allowed 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.171 2.581 . . . . 0.0 110.001 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -65.72 170.54 5.12 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.896 1.278 . . . . 0.0 108.899 175.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -72.2 -30.04 64.55 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.167 -0.958 . . . . 0.0 111.449 -175.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.402 ' HE3' ' O ' ' A' ' 95' ' ' LYS . 0.2 OUTLIER -58.42 -45.95 87.43 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 120.804 -1.185 . . . . 0.0 108.896 176.934 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 31.3 m -79.07 -37.24 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.856 0 CA-C-O 117.355 -1.307 . . . . 0.0 111.261 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -56.36 -30.65 62.93 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 121.292 1.86 . . . . 0.0 109.329 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.62 -38.41 90.12 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.689 177.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.53 ' O ' HG22 ' A' ' 103' ' ' THR . 6.4 p -95.81 -28.41 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -170.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.17 -15.37 63.08 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 124.973 1.309 . . . . 0.0 110.231 177.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.52 -55.28 4.97 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 120.05 1.295 . . . . 0.0 107.881 168.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.28 -43.26 86.9 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.966 2.106 . . . . 0.0 112.191 -163.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.663 HG21 HD22 ' A' ' 70' ' ' LEU . 2.1 t -76.45 -6.34 51.31 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.563 0.745 . . . . 0.0 110.964 177.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.7 m120 52.63 83.56 0.06 Allowed 'General case' 0 C--N 1.346 0.425 0 C-N-CA 129.376 3.071 . . . . 0.0 107.875 -163.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.95 -72.96 0.68 Allowed 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 176.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -61.74 -24.47 66.83 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.77 1.228 . . . . 0.0 110.728 174.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -75.15 5.9 4.89 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 120.777 -1.202 . . . . 0.0 111.313 176.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.9 mt -129.45 -43.39 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 C-N-CA 127.795 2.438 . . . . 0.0 107.829 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.521 HG12 ' HG ' ' A' ' 77' ' ' LEU . 3.3 m -98.25 178.69 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 C-N-CA 127.066 2.146 . . . . 0.0 113.137 -172.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.42 ' HB2' ' HB2' ' A' ' 88' ' ' ALA . 24.7 mmtm -99.58 162.95 12.71 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 124.099 0.96 . . . . 0.0 110.086 170.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -151.18 136.47 10.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -171.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -145.03 167.1 23.47 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.41 1.084 . . . . 0.0 112.668 -169.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.14 -38.64 17.53 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.876 -0.515 . . . . 0.0 111.183 -174.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.1 p -134.64 177.21 7.96 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.524 HD12 HD12 ' A' ' 24' ' ' ILE . 15.1 mm -71.19 -40.56 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.278 174.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.4 t -70.3 -32.63 70.49 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 119.424 1.011 . . . . 0.0 110.143 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -70.7 0.57 6.76 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.617 172.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.39 -37.04 3.83 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 119.259 0.936 . . . . 0.0 109.523 175.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 20.7 ttm -63.67 -55.27 24.77 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.984 1.314 . . . . 0.0 111.788 -160.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -81.61 -18.79 43.52 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.064 0.459 . . . . 0.0 110.265 173.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -80.33 -49.02 12.09 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -162.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.401 ' CG2' ' HB3' ' A' ' 86' ' ' PHE . 4.1 p -42.26 -40.48 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 127.856 2.462 . . . . 0.0 111.461 174.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -58.01 -45.83 86.25 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 125.106 1.362 . . . . 0.0 113.423 177.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.09 34.62 3.08 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.364 1.866 . . . . 0.0 110.778 -166.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.417 ' CG ' ' HE2' ' A' ' 110' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.847 0 C-N-CA 127.076 2.151 . . . . 0.0 111.67 -176.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.9 mtm . . . . . 0 N--CA 1.472 0.637 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 141.61 -79.85 0.26 Allowed Glycine 0 C--N 1.337 0.599 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 80.8 p 53.95 -167.11 0.07 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.282 1.833 . . . . 0.0 112.172 -171.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -99.25 150.04 22.5 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 165.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.5 pttt -149.73 174.82 12.18 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.032 0.933 . . . . 0.0 109.631 178.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.5 mt 70.98 -48.41 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 128.078 2.551 . . . . 0.0 111.579 177.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.5 t60 62.89 -77.72 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.625 2.37 . . . . 0.0 111.031 -178.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 28.3 m170 -61.38 140.14 58.07 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.694 1.598 . . . . 0.0 111.235 -176.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -155.87 126.07 6.63 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 172.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -140.47 145.1 36.49 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 126.335 1.854 . . . . 0.0 106.752 154.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 24.7 p-80 176.34 -50.51 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.3 2.24 . . . . 0.0 109.736 167.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -73.21 167.44 21.17 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 169.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 18.0 ttt -125.4 70.27 1.17 Allowed 'General case' 0 C--O 1.231 0.084 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 174.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 34.08 80.03 0.27 Allowed Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 127.691 2.397 . . . . 0.0 112.345 176.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -78.3 48.06 2.59 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 124.913 3.742 . . . . 0.0 112.105 -169.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -155.57 168.38 27.31 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 127.635 2.374 . . . . 0.0 106.02 -171.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -127.62 176.74 7.28 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 120.791 -1.193 . . . . 0.0 108.451 164.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.9 mt -132.32 120.13 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 171.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.6 m -102.33 -175.93 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 166.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -26.74 -55.95 0.08 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 130.199 3.4 . . . . 0.0 113.95 -157.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -143.5 8.97 1.58 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 118.775 -0.631 . . . . 0.0 111.241 164.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.53 HG11 ' CE2' ' A' ' 56' ' ' PHE . 21.3 t -111.32 115.62 50.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 -172.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 38.9 t -68.3 156.4 7.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 173.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.592 HD12 HD12 ' A' ' 115' ' ' ILE . 10.7 mm -130.6 98.4 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 177.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.53 134.49 45.28 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 120.24 1.382 . . . . 0.0 108.25 168.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 51.6 mtm -128.83 72.7 81.53 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 123.644 0.778 . . . . 0.0 109.551 -177.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.59 145.3 57.73 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.31 2.674 . . . . 0.0 112.577 -176.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.461 ' HB2' ' HE3' ' A' ' 29' ' ' LYS . 0.5 OUTLIER -118.87 -77.8 0.58 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 126.056 1.742 . . . . 0.0 110.452 174.689 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.461 ' HE3' ' HB2' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -135.56 13.85 3.45 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.001 1.321 . . . . 0.0 111.07 -173.571 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -108.78 18.42 20.8 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 120.967 -1.083 . . . . 0.0 112.103 -162.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 19.8 mt -92.62 68.06 4.68 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 124.146 0.978 . . . . 0.0 109.087 -176.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -81.23 144.24 31.73 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.2 tt -52.83 -37.19 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 CA-C-N 119.006 0.821 . . . . 0.0 111.82 170.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -62.62 -52.73 62.2 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.49 -0.756 . . . . 0.0 109.71 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -76.01 -16.38 59.97 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-O 118.228 -0.892 . . . . 0.0 111.96 177.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.73 -40.8 88.5 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.909 1.231 . . . . 0.0 110.518 171.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -60.6 -39.03 86.63 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 120.433 -1.417 . . . . 0.0 109.575 174.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 90.1 mt -73.04 -23.55 60.6 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.783 1.233 . . . . 0.0 113.05 178.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -53.98 -37.67 64.22 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.175 1.39 . . . . 0.0 110.97 -170.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.412 ' HE2' ' CZ ' ' A' ' 44' ' ' PHE . 0.4 OUTLIER -63.35 -52.49 61.53 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.072 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.89 -47.96 73.64 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 124.815 1.246 . . . . 0.0 109.834 178.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.534 ' CE3' HG23 ' A' ' 43' ' ' VAL . 17.6 t90 -58.57 -69.74 0.17 Allowed 'General case' 0 C--O 1.219 -0.549 0 O-C-N 124.593 1.183 . . . . 0.0 109.79 176.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.534 HG23 ' CE3' ' A' ' 42' ' ' TRP . 71.0 t -52.89 -32.21 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 121.153 1.797 . . . . 0.0 111.549 -175.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.483 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 4.0 m-85 -61.43 -77.15 0.05 OUTLIER 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 123.612 0.765 . . . . 0.0 110.051 172.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.468 ' HA ' ' HB2' ' A' ' 49' ' ' ASN . 0.6 OUTLIER -64.95 -28.47 69.54 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -172.183 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.416 ' HG2' ' CZ ' ' A' ' 47' ' ' PHE . 0.7 OUTLIER -74.9 -30.06 61.17 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.347 1.459 . . . . 0.0 110.445 176.695 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.416 ' CZ ' ' HG2' ' A' ' 46' ' ' GLU . 13.6 m-85 -139.83 -66.71 0.45 Allowed 'General case' 0 C--N 1.348 0.508 0 CA-C-N 119.603 1.092 . . . . 0.0 111.609 -172.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.483 ' HB2' ' HA ' ' A' ' 44' ' ' PHE . 18.5 mt -57.37 -54.35 47.78 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 120.878 -1.139 . . . . 0.0 113.081 -169.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.468 ' HB2' ' HA ' ' A' ' 45' ' ' ASP . 78.4 m-20 -67.48 -34.63 77.56 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 125.864 1.665 . . . . 0.0 109.127 177.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.12 -39.07 71.65 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.106 1.362 . . . . 0.0 111.279 176.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 139.65 8.51 0.94 Allowed Glycine 0 CA--C 1.535 1.334 0 C-N-CA 125.123 1.344 . . . . 0.0 113.93 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -92.34 150.3 20.92 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 119.023 1.412 . . . . 0.0 111.392 -177.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.401 ' O ' ' HA3' ' A' ' 85' ' ' GLY . 0.6 OUTLIER -143.22 44.79 1.55 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.287 1.835 . . . . 0.0 108.247 -172.949 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.462 ' HG3' HG22 ' A' ' 22' ' ' VAL . 0.0 OUTLIER 171.59 149.84 0.05 OUTLIER 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 126.015 1.726 . . . . 0.0 107.829 179.129 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -153.34 163.0 2.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 105.342 -2.095 . . . . 0.0 105.342 -174.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.53 ' CE2' HG11 ' A' ' 22' ' ' VAL . 9.6 m-85 -136.29 148.88 48.18 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.45 1.5 . . . . 0.0 108.615 169.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 50.5 tp -124.27 110.56 14.77 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.251 1.021 . . . . 0.0 109.808 177.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.3 135.57 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 173.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 mp -123.65 43.25 3.02 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.953 0.882 . . . . 0.0 110.288 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.8 t -99.98 -49.58 4.27 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.945 0.898 . . . . 0.0 109.029 -176.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.82 -14.45 58.04 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.126 -0.984 . . . . 0.0 111.159 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.7 p -106.0 118.71 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 125.596 1.559 . . . . 0.0 107.232 174.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -68.83 -51.63 38.6 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 176.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 86.2 p -157.76 166.62 32.27 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.86 -169.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 21.3 tt -135.49 148.99 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 C-N-CA 124.882 1.273 . . . . 0.0 108.333 -168.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -71.49 155.24 40.81 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.2 p -63.97 -14.35 53.24 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 117.902 -1.047 . . . . 0.0 113.77 -174.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -68.53 -71.37 0.22 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.036 1.334 . . . . 0.0 108.934 172.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 41.0 t -63.0 -34.1 76.84 Favored 'General case' 0 C--N 1.339 0.136 0 O-C-N 121.911 -0.493 . . . . 0.0 111.029 -169.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 50.9 tp -40.66 -39.86 1.16 Allowed 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 125.595 1.558 . . . . 0.0 114.041 169.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.401 ' HA2' HG12 ' A' ' 74' ' ' VAL . . . -107.54 0.25 34.63 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 118.44 0.564 . . . . 0.0 113.246 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.0 t -75.28 -30.05 22.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 O-C-N 120.774 -1.427 . . . . 0.0 108.647 161.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.6 mt -66.87 -61.15 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 125.181 1.392 . . . . 0.0 112.542 175.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.401 HG12 ' HA2' ' A' ' 71' ' ' GLY . 7.4 p -41.77 -49.19 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 168.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -45.79 -36.79 5.42 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.567 1.547 . . . . 0.0 112.863 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 90.8 mt -64.52 -46.87 91.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.295 1.038 . . . . 0.0 108.558 175.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -52.9 -48.6 67.08 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.635 0.774 . . . . 0.0 109.728 176.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -56.49 -43.03 79.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 118.955 -0.545 . . . . 0.0 111.067 -174.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.0 m -57.7 -64.79 0.78 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 118.883 -0.58 . . . . 0.0 111.352 166.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 80' ' ' ILE . 51.1 mt -61.52 -42.71 95.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 119.303 0.956 . . . . 0.0 111.502 -166.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.4 m -57.07 -47.55 80.71 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 119.323 0.965 . . . . 0.0 110.179 175.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.5 m -63.54 -34.28 77.44 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.975 0.807 . . . . 0.0 111.689 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 56.6 m -67.57 -38.08 83.56 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 118.604 -0.712 . . . . 0.0 111.941 173.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 105.03 59.37 0.66 Allowed Glycine 0 N--CA 1.448 -0.52 0 CA-C-O 119.162 -0.799 . . . . 0.0 111.136 -166.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 53' ' ' ASN . . . -148.68 -176.45 22.07 Favored Glycine 0 N--CA 1.439 -1.149 0 CA-C-N 118.891 1.345 . . . . 0.0 111.553 177.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.555 ' HB3' HG22 ' A' ' 122' ' ' VAL . 1.8 m-85 -130.9 92.13 3.17 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 122.084 -0.656 . . . . 0.0 112.439 -158.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -104.76 134.75 47.38 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.839 -1.163 . . . . 0.0 110.545 174.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -142.48 167.43 22.11 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.623 1.569 . . . . 0.0 112.472 175.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.438 ' N ' HD12 ' A' ' 89' ' ' LEU . 7.1 mp -113.9 153.13 29.75 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 127.54 2.336 . . . . 0.0 108.299 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 72.8 t -141.09 135.35 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -166.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.7 t 48.46 56.14 17.66 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.691 1.196 . . . . 0.0 110.645 -170.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -72.42 0.09 7.97 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.304 2.669 . . . . 0.0 114.777 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 18.6 p30 47.63 -163.04 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.733 1.613 . . . . 0.0 112.662 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -95.91 -41.54 8.75 Favored 'General case' 0 C--O 1.225 -0.196 0 O-C-N 120.473 -1.392 . . . . 0.0 109.416 174.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.489 ' O ' ' HE3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -53.74 -50.84 65.1 Favored 'General case' 0 C--O 1.227 -0.126 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -175.548 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.3 t -68.84 -47.52 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-O 118.571 -0.728 . . . . 0.0 109.143 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -60.95 -19.74 61.33 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 120.513 1.506 . . . . 0.0 112.273 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.5 -15.52 63.27 Favored 'General case' 0 C--O 1.216 -0.664 0 O-C-N 120.785 -1.197 . . . . 0.0 111.081 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.414 ' O ' HG22 ' A' ' 103' ' ' THR . 2.6 t -118.59 -34.13 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 C-N-CA 125.822 1.649 . . . . 0.0 108.25 -175.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.45 -14.84 31.85 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 117.617 -1.182 . . . . 0.0 109.08 175.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.8 m -79.69 -29.66 40.83 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 117.907 -1.517 . . . . 0.0 109.813 174.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -92.05 -25.33 18.84 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 129.103 2.961 . . . . 0.0 111.421 -159.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.42 HG23 HD23 ' A' ' 105' ' ' LEU . 3.7 t -113.65 35.44 4.05 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.858 1.663 . . . . 0.0 108.296 174.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 35.21 62.38 0.57 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.524 1.93 . . . . 0.0 110.585 176.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.42 HD23 HG23 ' A' ' 103' ' ' THR . 0.0 OUTLIER -114.54 -51.47 2.75 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -166.671 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.5 -24.49 67.84 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 118.616 0.644 . . . . 0.0 111.308 173.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.6 mtt-85 -80.03 -11.25 59.79 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 118.476 -0.773 . . . . 0.0 112.97 -177.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.0 mt -128.1 -37.13 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 C-N-CA 124.49 1.116 . . . . 0.0 109.577 -167.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.6 t -104.26 141.01 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 171.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.52 158.98 34.17 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.882 1.273 . . . . 0.0 111.295 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.1 mp -130.98 146.36 34.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 124.878 1.271 . . . . 0.0 108.077 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -147.02 168.13 22.3 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 127.286 2.234 . . . . 0.0 109.849 175.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.53 -51.77 7.48 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 75.4 p -130.81 171.6 12.95 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 123.165 0.586 . . . . 0.0 109.715 -171.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.592 HD12 HD12 ' A' ' 24' ' ' ILE . 11.8 mm -66.49 -39.3 83.64 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 CA-C-O 118.074 -0.965 . . . . 0.0 108.837 178.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.2 t -67.27 -36.99 82.72 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 118.862 0.756 . . . . 0.0 109.771 -175.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -62.22 -9.31 7.42 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 124.321 1.049 . . . . 0.0 112.256 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.467 ' HB1' ' CZ ' ' A' ' 56' ' ' PHE . . . -116.79 -34.45 4.47 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 124.676 1.19 . . . . 0.0 109.636 -175.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 12.4 ttp -61.8 -46.18 90.67 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 120.593 -1.317 . . . . 0.0 112.549 -161.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.429 ' HA ' ' HG3' ' A' ' 123' ' ' ARG . 14.6 pt-20 -101.52 -2.63 30.18 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.66 1.984 . . . . 0.0 112.112 176.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -91.49 -62.6 1.4 Allowed 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.555 HG22 ' HB3' ' A' ' 86' ' ' PHE . 0.3 OUTLIER -42.43 -37.4 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.307 0 C-N-CA 127.534 2.334 . . . . 0.0 111.553 174.054 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.429 ' HG3' ' HA ' ' A' ' 120' ' ' GLU . 10.1 mmt180 -44.02 -35.45 2.1 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 125.446 1.498 . . . . 0.0 113.32 174.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.09 22.96 2.23 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 172.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.306 0.1 OUTLIER . . . . . 0 C--O 1.249 1.076 0 C-N-CA 129.436 3.094 . . . . 0.0 116.08 -162.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.5 ptt? . . . . . 0 N--CA 1.472 0.65 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 178.47 -169.46 41.1 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.9 t -82.72 -82.88 0.14 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 175.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -147.9 148.98 31.41 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 119.694 1.134 . . . . 0.0 110.499 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -141.73 161.0 39.03 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.917 1.687 . . . . 0.0 108.671 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.46 124.86 55.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -177.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -72.67 96.55 2.02 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.85 1.26 . . . . 0.0 110.456 -175.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -78.77 170.06 17.26 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.341 -0.849 . . . . 0.0 110.454 168.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 8.1 m80 58.0 -176.21 0.07 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.695 1.598 . . . . 0.0 112.076 -175.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 71.3 m80 52.02 88.68 0.03 OUTLIER 'General case' 0 C--O 1.234 0.241 0 C-N-CA 128.539 2.735 . . . . 0.0 113.435 -177.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -40.02 102.83 0.03 OUTLIER 'General case' 0 C--O 1.24 0.598 0 C-N-CA 128.422 2.689 . . . . 0.0 110.811 -175.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 62.3 t60 -71.5 131.49 43.36 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.23 1.412 . . . . 0.0 109.094 -173.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.4 ttt -168.89 97.46 0.37 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.438 1.895 . . . . 0.0 107.285 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -62.6 165.26 9.75 Favored Pre-proline 0 CA--C 1.551 1.012 0 O-C-N 121.54 -0.725 . . . . 0.0 111.134 172.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.19 89.23 1.06 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 124.807 3.672 . . . . 0.0 109.977 174.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -153.0 169.37 23.05 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.519 ' HE2' HG12 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -135.01 175.31 9.69 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 121.978 -0.451 . . . . 0.0 110.192 168.21 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 67.4 mt -130.45 119.24 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 126.303 1.841 . . . . 0.0 106.944 175.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.519 HG12 ' HE2' ' A' ' 17' ' ' LYS . 33.7 m -100.59 -154.35 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 127.529 2.331 . . . . 0.0 106.792 174.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -25.94 -77.41 0.01 OUTLIER 'General case' 0 C--O 1.241 0.658 0 C-N-CA 129.805 3.242 . . . . 0.0 111.467 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -148.21 28.07 0.92 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 127.961 2.504 . . . . 0.0 109.828 170.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.648 HG11 ' CE2' ' A' ' 56' ' ' PHE . 20.2 t -119.68 148.03 22.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.7 t -103.7 140.29 22.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 177.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.409 HG13 HD12 ' A' ' 115' ' ' ILE . 1.8 mp -118.22 101.54 11.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 177.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.32 146.55 45.18 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 120.416 1.462 . . . . 0.0 108.453 165.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 69.7 mtm -127.98 79.58 73.54 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 124.63 1.172 . . . . 0.0 108.267 178.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -58.05 135.66 70.02 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.813 2.342 . . . . 0.0 110.636 177.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -135.22 -105.36 0.22 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.339 1.856 . . . . 0.0 106.312 169.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.92 69.4 1.04 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 121.551 1.978 . . . . 0.0 111.247 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -154.9 4.93 0.23 Allowed 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 115.505 1.668 . . . . 0.0 115.505 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.01 37.63 0.55 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 120.576 1.535 . . . . 0.0 109.988 172.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -77.74 157.4 30.06 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.771 1.629 . . . . 0.0 109.599 171.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 61.1 mt -62.15 -35.82 71.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 123.938 0.895 . . . . 0.0 110.704 -174.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -73.33 -8.86 57.67 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.11 -0.994 . . . . 0.0 111.402 -177.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -113.54 28.83 8.47 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.343 1.857 . . . . 0.0 109.754 171.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.68 -54.51 2.6 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 120.733 -1.229 . . . . 0.0 111.7 -175.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 40.7 t60 -62.07 -52.24 64.73 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 120.623 1.556 . . . . 0.0 109.759 175.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.541 HD12 ' C ' ' A' ' 38' ' ' LEU . 0.5 OUTLIER -59.89 -24.73 64.52 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-O 118.748 -0.644 . . . . 0.0 111.167 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -51.86 -44.76 63.81 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 124.88 1.272 . . . . 0.0 110.625 -177.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -64.68 -44.71 89.46 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.82 -41.45 97.87 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 119.038 0.836 . . . . 0.0 112.205 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 15.6 t90 -58.81 -66.28 0.52 Allowed 'General case' 0 C--O 1.221 -0.401 0 CA-C-O 117.23 -1.367 . . . . 0.0 107.479 173.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.5 t -52.93 -36.11 23.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 120.585 1.539 . . . . 0.0 112.193 -177.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -57.76 -67.0 0.38 Allowed 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 124.04 0.936 . . . . 0.0 110.028 173.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.29 -45.43 66.34 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 121.441 -0.787 . . . . 0.0 111.684 -171.118 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -62.42 -28.75 70.01 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.939 1.696 . . . . 0.0 111.006 -175.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -136.69 -65.85 0.55 Allowed 'General case' 0 C--N 1.346 0.432 0 C-N-CA 123.19 0.596 . . . . 0.0 111.53 -172.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 44.3 mt -55.58 -53.68 53.5 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.147 0.885 . . . . 0.0 111.822 -168.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -71.5 -34.26 69.96 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.513 1.925 . . . . 0.0 109.834 176.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.03 -30.16 65.92 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 118.242 -0.885 . . . . 0.0 112.021 177.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 140.26 -0.49 2.03 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 119.25 -0.75 . . . . 0.0 113.805 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -92.51 154.81 18.23 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 119.803 1.801 . . . . 0.0 110.347 -174.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -134.85 6.72 3.44 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.806 1.242 . . . . 0.0 109.816 172.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.407 ' HB3' HG13 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -135.86 132.21 36.29 Favored 'General case' 0 CA--C 1.518 -0.288 0 O-C-N 120.583 -1.323 . . . . 0.0 107.769 -176.846 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.9 mt -135.71 154.02 33.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 126.094 1.758 . . . . 0.0 106.422 175.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.704 ' CE1' HG21 ' A' ' 122' ' ' VAL . 20.1 m-85 -129.54 152.71 48.78 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.725 1.61 . . . . 0.0 109.702 163.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 54.8 tp -118.97 112.35 19.49 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 118.149 -0.929 . . . . 0.0 110.069 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.505 ' CG2' HD11 ' A' ' 115' ' ' ILE . 47.2 t -90.72 111.18 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 119.175 0.898 . . . . 0.0 109.474 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.539 HD22 HG11 ' A' ' 96' ' ' VAL . 1.8 mp -91.64 5.23 50.48 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.425 0.69 . . . . 0.0 112.514 -177.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 24.3 m -51.59 -42.13 61.69 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.094 0.958 . . . . 0.0 113.221 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -85.23 -29.26 24.8 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.766 0.712 . . . . 0.0 111.09 -174.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.8 p -80.82 173.1 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 O-C-N 121.34 -0.85 . . . . 0.0 109.158 -173.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -121.56 -46.14 2.27 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 120.588 -1.32 . . . . 0.0 109.31 172.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.9 p -150.1 172.63 14.97 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.537 0.684 . . . . 0.0 112.402 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.3 tt -133.48 153.18 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 126.072 1.749 . . . . 0.0 107.323 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -85.16 162.5 19.2 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 122.579 0.352 . . . . 0.0 110.206 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.2 -36.79 66.31 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.598 0.759 . . . . 0.0 111.903 179.117 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -55.57 -72.93 0.06 Allowed 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.049 1.74 . . . . 0.0 109.59 -178.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 53.5 m -64.27 -30.86 71.9 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 118.249 -0.881 . . . . 0.0 112.662 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.3 tp -59.39 -16.89 25.89 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 120.521 1.509 . . . . 0.0 112.769 -177.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -90.73 -33.97 8.1 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 118.995 0.816 . . . . 0.0 112.843 167.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.6 t -64.2 -36.84 78.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 O-C-N 121.149 -1.206 . . . . 0.0 110.363 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp -52.72 -51.38 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 175.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.4 t -66.02 -35.74 75.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 O-C-N 120.95 -1.094 . . . . 0.0 110.268 177.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.69 -45.05 82.02 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 119.662 1.119 . . . . 0.0 111.268 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 71.7 mt -59.45 -33.72 52.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 123.438 0.695 . . . . 0.0 109.21 175.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -69.8 -44.9 69.1 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 120.269 1.395 . . . . 0.0 108.44 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 48.7 mttm -58.87 -47.31 85.37 Favored 'General case' 0 C--N 1.335 -0.025 0 CA-C-O 118.584 -0.722 . . . . 0.0 110.151 177.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 31.8 m -51.45 -59.55 4.12 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 123.684 0.794 . . . . 0.0 110.272 172.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 21.1 mt -53.96 -43.76 59.28 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 C-N-CA 124.278 1.031 . . . . 0.0 111.406 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 51.6 p -57.35 -48.77 78.14 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.207 0.912 . . . . 0.0 109.974 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.5 -33.87 76.66 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.762 1.625 . . . . 0.0 111.304 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.4 m -67.76 -16.58 64.19 Favored 'General case' 0 C--N 1.335 -0.056 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 170.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.86 1.09 61.79 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-N 119.196 0.907 . . . . 0.0 113.664 -172.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -92.65 -175.99 41.46 Favored Glycine 0 N--CA 1.432 -1.608 0 CA-C-N 118.892 1.346 . . . . 0.0 112.193 -175.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -136.09 155.92 49.48 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.537 1.535 . . . . 0.0 109.517 178.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -152.39 147.17 25.97 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 175.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -148.04 161.04 42.18 Favored 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 124.152 0.908 . . . . 0.0 111.638 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.449 ' CD1' HG11 ' A' ' 109' ' ' VAL . 7.3 mp -106.73 158.17 17.17 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.795 1.638 . . . . 0.0 108.186 -176.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 84.9 t -142.41 135.67 27.55 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -165.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 46.41 57.82 16.62 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 124.904 1.281 . . . . 0.0 109.656 -173.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -72.32 88.75 0.84 Allowed 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.177 2.584 . . . . 0.0 108.604 -178.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -54.46 148.98 11.05 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.657 0.741 . . . . 0.0 110.647 -175.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -54.49 -34.11 61.02 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.671 1.588 . . . . 0.0 111.582 -168.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -49.15 70.23 Favored 'General case' 0 CA--C 1.521 -0.172 0 O-C-N 120.327 -1.483 . . . . 0.0 108.645 177.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.539 HG11 HD22 ' A' ' 59' ' ' LEU . 1.1 t -62.05 -47.9 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 123.774 0.83 . . . . 0.0 110.386 175.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.43 -36.95 64.57 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.827 2.051 . . . . 0.0 109.846 -172.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.84 -59.07 4.18 Favored 'General case' 0 N--CA 1.424 -1.728 0 C-N-CA 126.731 2.012 . . . . 0.0 111.54 177.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.609 ' O ' HG22 ' A' ' 103' ' ' THR . 8.0 t -65.53 -45.58 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 CA-C-N 111.754 -2.476 . . . . 0.0 107.284 -176.117 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.81 -17.55 16.6 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.965 0.906 . . . . 0.0 110.222 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 65.6 m -117.0 16.7 15.06 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 124.551 1.157 . . . . 0.0 112.314 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 62.2 mt -123.23 -16.25 6.98 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 129.484 3.114 . . . . 0.0 111.435 169.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.609 HG22 ' O ' ' A' ' 99' ' ' VAL . 4.7 t -113.61 1.13 14.84 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.837 2.055 . . . . 0.0 110.632 -177.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 44.99 81.59 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.811 1.644 . . . . 0.0 110.201 -165.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.52 -53.26 2.53 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 173.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.89 -12.04 51.57 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.372 1.069 . . . . 0.0 112.867 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.4 mtt85 -98.66 4.05 47.88 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.848 1.659 . . . . 0.0 111.199 -178.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.3 mt -132.84 -37.24 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 126.031 1.732 . . . . 0.0 110.019 -173.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.449 HG11 ' CD1' ' A' ' 89' ' ' LEU . 2.7 t -111.15 149.78 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 177.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.24 159.01 35.4 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.224 0.61 . . . . 0.0 109.888 174.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -131.99 151.47 35.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 125.041 1.337 . . . . 0.0 108.625 178.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -148.02 173.0 13.35 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 127.055 2.142 . . . . 0.0 110.639 173.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.57 -39.24 14.27 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 123.563 0.745 . . . . 0.0 109.231 177.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 25.2 p -136.86 170.48 16.02 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.043 0.937 . . . . 0.0 110.837 -173.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.505 HD11 ' CG2' ' A' ' 58' ' ' VAL . 19.9 mm -63.94 -45.36 97.1 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 CA-C-O 117.754 -1.117 . . . . 0.0 108.587 172.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.3 t -67.38 -36.72 81.9 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 119.228 0.922 . . . . 0.0 109.134 -169.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -70.87 -15.35 62.62 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 176.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.715 ' O ' HG23 ' A' ' 122' ' ' VAL . . . -86.48 -49.34 7.66 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 174.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.95 -52.24 63.61 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.762 1.225 . . . . 0.0 111.316 -160.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.06 -7.98 54.49 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 127.906 2.482 . . . . 0.0 114.446 176.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -104.28 -53.25 2.76 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 118.795 0.725 . . . . 0.0 109.355 -169.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 118' ' ' ALA . 12.8 t -50.68 -33.63 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 C-N-CA 129.336 3.054 . . . . 0.0 110.39 172.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -43.46 -36.96 2.18 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.006 0.922 . . . . 0.0 113.243 166.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.57 24.08 3.15 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 116.452 2.019 . . . . 0.0 116.452 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 31.5 mmtt . . . . . 0 C--O 1.255 1.383 0 C-N-CA 129.56 3.144 . . . . 0.0 103.174 177.666 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ttp . . . . . 0 N--CA 1.473 0.703 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.91 49.03 0.22 Allowed Glycine 0 CA--C 1.52 0.393 0 CA-C-N 119.086 0.857 . . . . 0.0 111.446 -177.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.7 m 62.3 -22.04 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 128.509 2.723 . . . . 0.0 116.295 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.5 t70 25.01 86.76 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 129.754 3.222 . . . . 0.0 113.806 175.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.2 tttm -151.8 161.8 42.07 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 121.023 -1.048 . . . . 0.0 109.437 176.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.7 tt -83.86 123.27 38.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 166.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -74.57 115.27 13.92 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 169.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -157.88 97.25 1.54 Allowed 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 160.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -151.9 74.88 1.12 Allowed 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.768 -0.583 . . . . 0.0 109.733 174.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -92.83 42.37 1.1 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 122.092 0.949 . . . . 0.0 111.659 178.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -123.07 165.59 16.56 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 154.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 -152.76 56.54 0.8 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 121.287 0.565 . . . . 0.0 110.18 171.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 9.2 ptm -133.96 61.67 1.67 Allowed 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.94 0.896 . . . . 0.0 110.805 -168.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -68.77 154.69 94.46 Favored Pre-proline 0 CA--C 1.544 0.743 0 O-C-N 121.205 -0.935 . . . . 0.0 111.062 170.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -76.29 89.14 1.28 Allowed 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 124.226 3.284 . . . . 0.0 110.993 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -157.14 156.78 33.28 Favored 'General case' 0 C--O 1.239 0.533 0 O-C-N 121.482 -0.761 . . . . 0.0 110.039 175.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.88 170.27 10.28 Favored 'General case' 0 N--CA 1.46 0.069 0 C-N-CA 123.937 0.895 . . . . 0.0 110.286 169.118 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.1 mt -131.49 150.57 34.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 174.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.4 m -120.27 -133.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 126.408 1.883 . . . . 0.0 107.03 176.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -46.38 -75.41 0.03 OUTLIER 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 127.565 2.346 . . . . 0.0 111.312 -177.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -143.35 27.79 1.54 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.821 1.649 . . . . 0.0 108.434 172.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.749 HG11 ' CE2' ' A' ' 56' ' ' PHE . 11.7 t -121.73 138.94 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 C-N-CA 124.172 0.989 . . . . 0.0 108.451 -175.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 72.5 t -99.21 140.44 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 125.668 1.587 . . . . 0.0 107.546 -178.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mp -119.42 95.98 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 126.402 1.881 . . . . 0.0 105.957 -178.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 31.5 mt -84.8 126.28 33.3 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 177.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 56.1 mtm -125.76 92.02 47.25 Favored Pre-proline 0 N--CA 1.464 0.274 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.76 106.53 1.68 Allowed 'Trans proline' 0 N--CA 1.45 -1.074 0 N-CA-C 108.28 -1.469 . . . . 0.0 108.28 176.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -74.79 55.53 0.68 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.264 1.026 . . . . 0.0 111.549 172.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.99 41.11 3.76 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.447 1.499 . . . . 0.0 112.866 -173.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -105.75 48.85 0.82 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-O 122.222 1.01 . . . . 0.0 110.317 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.61 68.36 8.66 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 123.483 1.611 . . . . 0.0 108.185 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -68.05 3.23 1.67 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 129.577 3.151 . . . . 0.0 114.977 -174.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 mt 65.65 -56.3 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 129.795 3.238 . . . . 0.0 111.378 -167.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -63.81 -31.98 73.34 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 118.258 0.481 . . . . 0.0 109.777 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -59.4 -60.1 4.39 Favored 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 124.147 0.979 . . . . 0.0 109.117 165.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.454 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . . . -51.19 -38.91 54.96 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 120.515 1.507 . . . . 0.0 114.448 -178.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -67.86 -34.04 75.92 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.702 1.137 . . . . 0.0 111.881 178.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.17 -19.0 30.74 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-O 118.154 -0.927 . . . . 0.0 110.883 177.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.454 ' HB2' ' HA ' ' A' ' 36' ' ' ALA . 5.7 t80 -46.62 -49.96 18.26 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 127.917 2.487 . . . . 0.0 110.299 -172.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.0 -57.22 11.07 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 124.6 1.16 . . . . 0.0 109.917 175.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -56.55 -48.98 76.13 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 124.561 1.145 . . . . 0.0 112.07 178.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -56.54 -71.77 0.09 Allowed 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 117.574 -1.203 . . . . 0.0 108.055 178.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.6 t -46.39 -42.72 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.089 0.955 . . . . 0.0 109.373 -177.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 -60.22 -59.97 4.57 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 120.606 1.548 . . . . 0.0 111.643 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -68.63 -4.04 14.09 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.619 1.568 . . . . 0.0 111.991 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -107.17 -33.04 7.56 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 116.413 -1.756 . . . . 0.0 108.956 -177.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.619 ' HB2' HD22 ' A' ' 48' ' ' LEU . 54.4 m-85 -134.57 -49.81 0.78 Allowed 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 123.603 2.91 . . . . 0.0 109.335 -174.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.619 HD22 ' HB2' ' A' ' 47' ' ' PHE . 1.9 mm? -69.49 -57.0 5.79 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 124.039 0.936 . . . . 0.0 110.666 -169.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -62.81 -27.22 69.17 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.571 0.748 . . . . 0.0 109.781 174.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -66.66 -20.14 65.92 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.862 1.665 . . . . 0.0 113.616 171.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.02 6.18 46.02 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.297 1.427 . . . . 0.0 114.787 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -76.57 149.81 36.58 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 119.994 1.897 . . . . 0.0 110.236 172.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -130.02 6.18 5.0 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.216 1.006 . . . . 0.0 112.791 -178.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.512 ' HB3' HG13 ' A' ' 22' ' ' VAL . 1.5 mtmt -133.16 113.09 12.3 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 120.683 1.583 . . . . 0.0 106.856 178.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.0 mp -118.11 151.2 20.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 104.732 -2.321 . . . . 0.0 104.732 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.749 ' CE2' HG11 ' A' ' 22' ' ' VAL . 20.3 m-85 -132.89 160.28 37.45 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 124.525 1.13 . . . . 0.0 110.318 166.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.4 tp -137.72 86.89 2.21 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.866 1.266 . . . . 0.0 108.71 175.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.569 HG12 ' H ' ' A' ' 60' ' ' SER . 95.0 t -60.74 138.57 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 128.428 2.691 . . . . 0.0 107.2 168.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.582 HD22 HG21 ' A' ' 96' ' ' VAL . 2.9 mp -117.81 37.08 4.06 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.29 1.836 . . . . 0.0 109.445 173.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.569 ' H ' HG12 ' A' ' 58' ' ' VAL . 19.9 t -76.42 -38.85 54.98 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.278 1.431 . . . . 0.0 110.688 178.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.97 2.62 51.77 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.917 0.78 . . . . 0.0 111.604 -173.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.3 p -133.24 174.52 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 127.977 2.511 . . . . 0.0 107.464 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -118.4 -31.38 4.95 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.298 0.639 . . . . 0.0 111.64 177.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.1 t -159.01 158.86 34.0 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.746 0.784 . . . . 0.0 112.478 165.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -76.84 166.29 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-N 113.874 -1.512 . . . . 0.0 108.531 160.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -103.8 159.47 15.61 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.206 1.402 . . . . 0.0 110.608 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.34 6.17 0.84 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.615 1.166 . . . . 0.0 113.491 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -76.87 -78.22 0.13 Allowed 'General case' 0 CA--C 1.535 0.376 0 O-C-N 120.956 -1.09 . . . . 0.0 108.766 155.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.8 t -69.93 -13.74 62.39 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -169.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.488 HD21 HG21 ' A' ' 103' ' ' THR . 33.1 tp -47.06 -31.31 3.26 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.054 1.342 . . . . 0.0 111.674 168.021 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.06 -28.14 31.97 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 121.458 -0.776 . . . . 0.0 114.466 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 45.7 t -75.27 -35.81 34.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 124.45 1.1 . . . . 0.0 109.59 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.6 mm -55.59 -49.79 71.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 123.75 0.82 . . . . 0.0 110.359 175.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 38.7 t -60.34 -41.34 86.84 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.213 0 CA-C-N 118.123 0.419 . . . . 0.0 110.13 177.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -53.25 -44.67 68.34 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.41 1.005 . . . . 0.0 112.413 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.64 -36.17 73.89 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 123.156 0.582 . . . . 0.0 109.593 177.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -64.7 -42.91 94.95 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.289 0.95 . . . . 0.0 109.479 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 55.1 mttt -60.27 -45.27 93.9 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 118.569 0.622 . . . . 0.0 111.309 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 30.0 m -54.95 -52.13 63.99 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.154 0.182 . . . . 0.0 111.434 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 59.4 mt -65.1 -41.62 92.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 122.585 0.354 . . . . 0.0 110.741 -175.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.2 t -48.38 -59.68 3.27 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.168 1.787 . . . . 0.0 108.127 173.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.7 m -64.8 -33.08 75.13 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.3 m -67.45 -20.41 65.49 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 113.834 1.049 . . . . 0.0 113.834 174.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 94.23 9.99 58.78 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-O 119.067 -0.852 . . . . 0.0 113.5 -171.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -88.03 -173.03 47.54 Favored Glycine 0 N--CA 1.434 -1.441 0 CA-C-N 119.449 1.625 . . . . 0.0 111.456 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.527 ' HB3' HG22 ' A' ' 122' ' ' VAL . 2.7 m-85 -130.54 149.99 51.95 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 126.184 1.793 . . . . 0.0 106.692 171.013 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -141.06 145.34 35.73 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 174.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -149.61 163.06 38.9 Favored 'General case' 0 N--CA 1.441 -0.888 0 O-C-N 123.79 0.681 . . . . 0.0 111.755 176.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.7 mt -97.68 167.78 10.75 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 123.397 0.679 . . . . 0.0 109.429 176.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.514 HG13 ' N ' ' A' ' 58' ' ' VAL . 0.5 OUTLIER -148.59 152.08 12.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 124.702 1.201 . . . . 0.0 111.096 -175.31 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.6 t 39.92 63.64 4.88 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 127.15 2.18 . . . . 0.0 110.825 178.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.14 175.27 7.81 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.252 1.968 . . . . 0.0 110.341 177.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -127.34 166.53 17.65 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 173.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -58.02 -41.71 83.76 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 124.519 1.127 . . . . 0.0 109.305 174.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -26.08 66.77 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 126.513 1.925 . . . . 0.0 110.65 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.618 HG13 HD13 ' A' ' 100' ' ' LEU . 1.5 t -88.62 -49.38 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 CA-C-O 115.777 -2.059 . . . . 0.0 109.071 177.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.38 -34.85 64.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 122.547 2.431 . . . . 0.0 110.297 177.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -31.01 72.04 Favored 'General case' 0 C--O 1.219 -0.511 0 O-C-N 121.395 -0.815 . . . . 0.0 111.479 -178.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.669 HG13 HD12 ' A' ' 100' ' ' LEU . 7.4 p -100.0 -41.31 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -174.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.669 HD12 HG13 ' A' ' 99' ' ' VAL . 6.9 mp -65.84 -14.58 61.71 Favored 'General case' 0 N--CA 1.434 -1.271 0 C-N-CA 125.972 1.709 . . . . 0.0 112.617 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.74 -41.5 10.1 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 117.328 -1.749 . . . . 0.0 108.197 171.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.48 -34.57 78.6 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.747 1.619 . . . . 0.0 112.486 -172.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.575 HG22 ' O ' ' A' ' 99' ' ' VAL . 9.0 t -93.25 -2.05 55.48 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 118.094 -0.955 . . . . 0.0 111.701 177.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.439 ' HB3' ' HD3' ' A' ' 107' ' ' ARG . 48.9 m-80 56.86 83.49 0.1 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.633 1.173 . . . . 0.0 109.201 -163.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.45 ' HB3' ' HG ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -122.55 -58.58 1.68 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 127.876 2.47 . . . . 0.0 109.878 174.717 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.83 -20.14 65.57 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.698 0.799 . . . . 0.0 111.215 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.439 ' HD3' ' HB3' ' A' ' 104' ' ' ASN . 4.5 ptm85 -84.06 -15.35 47.8 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 177.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 13.9 mm -88.85 -36.79 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 C-N-CA 126.358 1.863 . . . . 0.0 106.06 -172.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.48 149.63 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 124.61 1.194 . . . . 0.0 112.297 -172.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -57.25 156.94 6.79 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.357 0.663 . . . . 0.0 110.807 168.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.12 149.22 16.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 -178.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -140.3 165.04 28.47 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 124.845 1.258 . . . . 0.0 113.389 -170.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.82 -52.35 5.16 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.136 0.974 . . . . 0.0 109.753 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 53.3 p -125.12 175.06 7.63 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.549 1.14 . . . . 0.0 109.359 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.435 HD13 ' HA ' ' A' ' 115' ' ' ILE . 5.6 mm -63.84 -45.08 98.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 118.441 -0.79 . . . . 0.0 109.008 167.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.4 t -71.29 -28.18 63.94 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 119.384 -0.927 . . . . 0.0 110.427 -169.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -69.14 -20.56 64.03 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 119.201 0.91 . . . . 0.0 111.181 173.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -92.51 -49.6 6.04 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 -173.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.99 -60.51 2.71 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.924 2.09 . . . . 0.0 111.539 -166.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -86.61 -16.31 37.13 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.553 0.741 . . . . 0.0 111.012 -175.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -77.54 -59.92 2.58 Favored 'General case' 0 C--O 1.216 -0.695 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.527 HG22 ' HB3' ' A' ' 86' ' ' PHE . 0.3 OUTLIER -47.85 -28.7 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 126.949 2.1 . . . . 0.0 112.987 -174.622 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.86 -28.1 65.79 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.484 2.314 . . . . 0.0 113.45 173.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.72 39.51 0.16 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.858 2.063 . . . . 0.0 112.799 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.074 0 C-N-CA 125.776 1.63 . . . . 0.0 110.323 -174.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.7 ttp . . . . . 0 N--CA 1.471 0.616 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.5 -72.44 1.0 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 -170.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.7 t -63.26 165.0 7.96 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 159.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 43.24 68.98 0.44 Allowed 'General case' 0 C--O 1.236 0.351 0 C-N-CA 128.067 2.547 . . . . 0.0 110.632 172.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.85 -36.28 10.24 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.281 -163.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.8 mm 26.93 95.45 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 130.571 3.549 . . . . 0.0 113.037 171.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -60.88 103.93 0.31 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.886 0.875 . . . . 0.0 110.726 175.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -56.48 135.39 54.35 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 172.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -138.01 179.94 6.14 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.63 1.172 . . . . 0.0 109.144 176.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 65.31 27.77 11.98 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.896 1.279 . . . . 0.0 114.009 170.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -69.09 89.19 0.43 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.465 1.906 . . . . 0.0 109.903 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -150.82 83.67 1.34 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.077 1.351 . . . . 0.0 109.095 -178.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 13.9 mtm -155.69 130.1 8.95 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.848 1.659 . . . . 0.0 106.993 168.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -110.95 86.39 5.92 Favored Pre-proline 0 N--CA 1.443 -0.796 0 C-N-CA 125.125 1.37 . . . . 0.0 110.864 176.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -76.22 51.09 3.07 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 123.986 3.124 . . . . 0.0 110.685 167.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -159.83 166.96 29.26 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 120.968 -1.082 . . . . 0.0 111.111 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.3 pttt -135.46 170.29 16.17 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 126.073 1.749 . . . . 0.0 109.343 166.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 40.4 mt -120.65 138.28 51.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 C-N-CA 125.296 1.438 . . . . 0.0 107.626 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.492 ' CG2' HD13 ' A' ' 24' ' ' ILE . 76.9 t -131.8 164.67 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 C-N-CA 127.761 2.425 . . . . 0.0 106.769 -177.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -25.07 -63.31 0.06 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 129.553 3.141 . . . . 0.0 113.136 -163.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -145.75 54.01 1.17 Allowed 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 160.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.753 HG11 ' CE2' ' A' ' 56' ' ' PHE . 13.6 t -140.04 152.68 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 124.45 1.1 . . . . 0.0 109.197 170.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.414 ' C ' HD12 ' A' ' 24' ' ' ILE . 13.9 t -111.96 138.47 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.492 HD13 ' CG2' ' A' ' 19' ' ' VAL . 1.8 mp -118.33 106.18 19.2 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.599 HD22 ' CG2' ' A' ' 55' ' ' ILE . 1.9 mp -82.17 63.13 6.23 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.831 2.052 . . . . 0.0 108.271 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.7 mmm -60.05 98.4 0.14 Allowed Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 126.219 1.808 . . . . 0.0 110.805 -175.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -68.26 -47.42 1.64 Allowed 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 122.918 2.412 . . . . 0.0 109.834 -172.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 31.21 54.67 0.22 Allowed 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 120.88 1.673 . . . . 0.0 113.231 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 78.24 22.77 0.75 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.788 2.035 . . . . 0.0 112.527 173.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -118.31 69.78 0.8 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.617 1.567 . . . . 0.0 108.327 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.4 mt -129.72 20.28 5.56 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.832 1.253 . . . . 0.0 111.581 -177.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -49.51 142.48 7.93 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 131.067 3.747 . . . . 0.0 109.533 -177.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 28.9 mt -55.2 -46.66 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 121.049 1.749 . . . . 0.0 111.551 -176.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -80.6 2.96 23.45 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.207 -0.933 . . . . 0.0 112.772 -176.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -89.42 -57.08 3.01 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 153.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.8 -32.28 19.56 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.112 1.765 . . . . 0.0 114.08 -175.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -66.98 -53.17 34.12 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.53 1.059 . . . . 0.0 110.868 175.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.252 0.0 OUTLIER -81.29 -11.27 59.4 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 120.782 -1.199 . . . . 0.0 112.385 -177.492 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -34.83 -57.4 0.54 Allowed 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 129.275 3.03 . . . . 0.0 112.054 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -60.99 -48.95 79.45 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-O 118.542 -0.742 . . . . 0.0 109.34 -176.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -57.91 -46.35 85.09 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 119.494 1.043 . . . . 0.0 110.656 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.464 ' CE3' HG23 ' A' ' 43' ' ' VAL . 5.5 t90 -56.72 -61.05 2.7 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 108.876 -0.786 . . . . 0.0 108.876 174.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.464 HG23 ' CE3' ' A' ' 42' ' ' TRP . 53.0 t -52.23 -33.01 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 124.37 1.068 . . . . 0.0 113.038 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -64.23 -69.57 0.27 Allowed 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 125.19 1.396 . . . . 0.0 108.815 172.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -80.05 -11.33 59.78 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -166.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.427 ' HG2' ' CZ ' ' A' ' 47' ' ' PHE . 1.7 tp10 -88.51 -27.88 21.17 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.27 1.428 . . . . 0.0 110.74 174.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.427 ' CZ ' ' HG2' ' A' ' 46' ' ' GLU . 21.0 m-85 -135.55 -64.18 0.64 Allowed 'General case' 0 C--N 1.347 0.482 0 CA-C-N 119.513 1.051 . . . . 0.0 111.858 -170.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 41.3 mt -48.6 -55.12 12.08 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 118.518 0.599 . . . . 0.0 111.226 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -86.25 1.71 49.86 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.394 0.678 . . . . 0.0 110.963 -173.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.5 3.63 55.12 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 127.599 2.36 . . . . 0.0 112.038 173.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.04 40.23 25.53 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 119.446 1.021 . . . . 0.0 112.564 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -110.45 165.68 11.6 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 160.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -140.81 3.75 1.86 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.557 2.343 . . . . 0.0 112.141 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.581 ' C ' HD12 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -140.42 133.19 28.99 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 121.135 1.789 . . . . 0.0 109.239 -175.806 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.599 ' CG2' HD22 ' A' ' 25' ' ' LEU . 1.9 mp -133.69 149.87 31.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 128.252 2.621 . . . . 0.0 105.206 -172.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.753 ' CE2' HG11 ' A' ' 22' ' ' VAL . 23.5 m-85 -136.23 150.46 48.98 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.087 0.955 . . . . 0.0 112.563 168.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.1 tp -118.35 78.3 1.25 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.475 1.11 . . . . 0.0 110.25 175.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.446 ' N ' HG13 ' A' ' 90' ' ' VAL . 99.5 t -60.11 102.34 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 C-N-CA 126.586 1.955 . . . . 0.0 109.042 172.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.625 HD22 HG21 ' A' ' 96' ' ' VAL . 1.6 mt -86.61 14.25 7.25 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.809 2.444 . . . . 0.0 112.11 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.8 t -63.5 -50.55 69.19 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.802 0.841 . . . . 0.0 112.052 -168.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -83.48 -10.99 58.0 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.342 1.057 . . . . 0.0 110.65 -166.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.5 p -109.61 168.0 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 128.809 2.844 . . . . 0.0 106.712 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.48 -34.53 8.2 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.527 -0.733 . . . . 0.0 110.079 173.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.754 ' HA ' HG23 ' A' ' 96' ' ' VAL . 67.8 p -153.15 167.31 29.69 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 -176.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.4 tt -102.16 151.8 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 162.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -94.89 164.96 12.69 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 124.259 1.023 . . . . 0.0 111.109 -178.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.5 m -76.48 52.65 0.8 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.321 1.848 . . . . 0.0 110.654 176.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -133.44 -68.1 0.59 Allowed 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 158.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.5 t -64.31 -24.46 67.66 Favored 'General case' 0 C--N 1.342 0.267 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 60.6 tp -55.81 -16.54 4.6 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 120.819 -1.176 . . . . 0.0 114.103 177.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -91.5 -34.14 7.61 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 119.946 1.248 . . . . 0.0 112.083 168.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.7 t -64.63 -38.31 82.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 126.295 1.838 . . . . 0.0 110.389 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.3 mm -54.96 -48.93 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 125.292 1.437 . . . . 0.0 110.662 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.9 t -63.89 -45.64 96.4 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.471 0 O-C-N 121.144 -0.972 . . . . 0.0 108.648 176.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.17 -39.26 72.06 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.857 0.753 . . . . 0.0 110.977 -177.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.6 mt -59.62 -44.43 93.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 125.642 1.577 . . . . 0.0 110.628 170.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.419 HD22 HG22 ' A' ' 109' ' ' VAL . 12.5 tp -60.46 -50.67 72.66 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 120.325 -1.484 . . . . 0.0 109.214 177.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 48.3 mttt -59.42 -15.17 15.37 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.52 -0.738 . . . . 0.0 111.217 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.5 t -85.91 -48.56 8.61 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.63 0.772 . . . . 0.0 109.674 172.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 30.6 mt -62.44 -41.93 93.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 O-C-N 120.3 -1.5 . . . . 0.0 110.619 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.6 m -76.53 -5.26 46.81 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 173.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 45.6 t -74.84 -48.07 27.03 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 120.949 -1.094 . . . . 0.0 108.443 159.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.8 m -66.49 -56.03 12.82 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.409 1.084 . . . . 0.0 113.495 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.31 13.49 4.8 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.32 0.962 . . . . 0.0 113.81 -167.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -86.46 -163.58 38.56 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-N 119.141 1.471 . . . . 0.0 111.508 174.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -136.31 162.14 33.84 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.459 1.504 . . . . 0.0 110.023 176.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -158.8 139.53 12.7 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 123.959 0.904 . . . . 0.0 109.192 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.507 ' C ' HD23 ' A' ' 89' ' ' LEU . . . -145.25 171.7 14.19 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 121.171 0.51 . . . . 0.0 112.239 175.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.507 HD23 ' C ' ' A' ' 88' ' ' ALA . 0.7 OUTLIER -111.08 170.04 8.37 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 176.174 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.446 HG13 ' N ' ' A' ' 58' ' ' VAL . 0.5 OUTLIER -151.17 144.46 16.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 124.73 1.212 . . . . 0.0 110.739 -165.688 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.9 t 42.79 58.73 11.24 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 125.861 1.664 . . . . 0.0 111.52 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.57 166.34 26.17 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.489 2.126 . . . . 0.0 109.916 176.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -129.68 170.41 13.85 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 174.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -60.55 -42.56 96.81 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.287 1.035 . . . . 0.0 110.212 -176.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.1 -27.22 68.77 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.692 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.754 HG23 ' HA ' ' A' ' 64' ' ' SER . 0.5 OUTLIER -86.23 -47.12 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-O 118.635 -0.698 . . . . 0.0 109.607 179.261 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -53.63 -44.46 69.56 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 125.581 1.552 . . . . 0.0 108.648 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.19 -23.38 67.29 Favored 'General case' 0 C--O 1.218 -0.592 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.786 -169.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.9 t -95.84 -48.52 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 C-N-CA 126.014 1.726 . . . . 0.0 107.35 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.83 -21.63 57.04 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.108 0.963 . . . . 0.0 109.334 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.7 m -85.05 -11.83 54.45 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.865 0.866 . . . . 0.0 112.874 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 32.6 mt -119.81 -39.7 2.82 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 126.18 1.792 . . . . 0.0 111.033 -166.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.5 t -81.95 1.89 33.29 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.307 1.843 . . . . 0.0 111.095 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 51.18 78.05 0.12 Allowed 'General case' 0 C--N 1.345 0.408 0 C-N-CA 127.386 2.274 . . . . 0.0 111.03 -169.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.78 -57.75 1.61 Allowed 'General case' 0 C--O 1.227 -0.099 0 C-N-CA 123.909 0.883 . . . . 0.0 108.94 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.24 -24.8 66.62 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.548 1.139 . . . . 0.0 111.205 177.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.02 -7.62 59.35 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.6 mt -115.03 -47.63 4.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 125.651 1.58 . . . . 0.0 107.789 -174.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.419 HG22 HD22 ' A' ' 77' ' ' LEU . 0.7 OUTLIER -100.59 143.38 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 123.14 0.576 . . . . 0.0 110.291 178.375 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.9 161.86 12.15 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 124.141 0.976 . . . . 0.0 112.041 176.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.67 146.14 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -177.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -143.46 172.39 12.84 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 125.722 1.609 . . . . 0.0 110.399 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.64 -40.24 10.86 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.781 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 64.0 p -134.27 167.58 20.43 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.765 1.226 . . . . 0.0 108.792 -171.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.417 HD13 ' HA ' ' A' ' 115' ' ' ILE . 4.7 mm -69.75 -40.55 79.28 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.0 t -78.31 -4.74 49.51 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.194 0.907 . . . . 0.0 111.957 -176.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -90.38 -10.51 43.67 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 118.329 -0.843 . . . . 0.0 110.755 166.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.476 ' HB1' ' CE1' ' A' ' 56' ' ' PHE . . . -99.25 -44.5 6.22 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.418 1.087 . . . . 0.0 109.606 177.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -60.26 -40.48 90.48 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 127.801 2.44 . . . . 0.0 115.828 -161.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -112.59 4.31 17.21 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 126.836 2.054 . . . . 0.0 111.31 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -99.64 -63.66 1.11 Allowed 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -46.82 -30.47 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 127.44 2.296 . . . . 0.0 113.04 -176.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 12.1 mtt180 -53.64 -20.51 5.36 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.382 -0.824 . . . . 0.0 112.358 174.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.1 24.34 1.46 Allowed 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 115.151 1.538 . . . . 0.0 115.151 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 116.71 -1.614 . . . . 0.0 110.478 -161.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.475 0.812 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 126.7 136.44 4.38 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 107.909 -2.076 . . . . 0.0 107.909 -168.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.4 m -159.16 161.93 36.3 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 127.48 2.312 . . . . 0.0 106.399 168.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -129.27 -62.85 0.97 Allowed 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -170.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 44.8 mttt 50.2 65.01 1.56 Allowed 'General case' 0 C--O 1.235 0.293 0 C-N-CA 126.324 1.85 . . . . 0.0 110.848 -173.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 89.2 mt -110.61 102.81 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 104.489 -2.411 . . . . 0.0 104.489 173.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -158.47 122.97 4.14 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 167.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -145.79 117.85 8.3 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.458 1.103 . . . . 0.0 108.693 170.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -159.41 164.74 34.35 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.201 1.8 . . . . 0.0 107.455 171.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 60.82 179.36 0.1 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.597 1.159 . . . . 0.0 113.768 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 21.8 t60 58.55 28.68 17.38 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.048 2.139 . . . . 0.0 114.739 175.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -79.54 142.68 35.53 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.572 -0.705 . . . . 0.0 109.395 164.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 13.9 mmm -143.26 104.81 4.31 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 127.069 2.148 . . . . 0.0 108.107 175.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 36.6 62.48 3.04 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 127.32 2.248 . . . . 0.0 112.555 -170.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -74.71 -162.87 0.16 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.961 2.441 . . . . 0.0 110.271 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -57.6 164.11 2.16 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.23 1.012 . . . . 0.0 113.559 -175.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.27 173.51 11.46 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.7 1.2 . . . . 0.0 108.776 174.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 70.7 mt -133.35 104.1 6.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 174.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.452 HG22 HD11 ' A' ' 24' ' ' ILE . 21.7 m -77.74 -171.87 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 166.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -24.59 -68.58 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 128.835 2.854 . . . . 0.0 115.319 -167.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -142.26 19.12 2.08 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 128.279 2.632 . . . . 0.0 109.72 177.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.579 HG11 ' CE2' ' A' ' 56' ' ' PHE . 6.7 t -127.84 133.57 67.13 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 CA-C-O 123.678 1.704 . . . . 0.0 108.783 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.586 ' O ' HD13 ' A' ' 24' ' ' ILE . 1.0 OUTLIER -92.66 153.87 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.686 0 CA-C-N 112.151 -2.295 . . . . 0.0 107.044 -175.374 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.586 HD13 ' O ' ' A' ' 23' ' ' VAL . 2.4 mm -138.17 91.36 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.55 118.86 10.74 Favored 'General case' 0 C--O 1.226 -0.174 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 165.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.476 ' HA ' HG22 ' A' ' 58' ' ' VAL . 4.9 mtm -116.65 80.65 10.75 Favored Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 104.829 -2.286 . . . . 0.0 104.829 -176.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -74.47 168.05 25.72 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.256 2.638 . . . . 0.0 112.051 -168.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.86 -106.73 0.1 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.703 1.201 . . . . 0.0 108.853 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -103.67 3.56 34.48 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.036 1.335 . . . . 0.0 111.53 174.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -76.18 -1.77 27.91 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.244 1.017 . . . . 0.0 113.275 -174.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 17.7 mt -77.33 21.67 0.25 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.902 1.681 . . . . 0.0 113.662 -176.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -37.24 133.78 0.65 Allowed 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 127.343 2.257 . . . . 0.0 109.343 166.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.1 tt -52.07 -34.42 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 124.309 1.044 . . . . 0.0 111.987 -176.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -70.2 -37.67 75.13 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.147 -0.97 . . . . 0.0 112.081 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -67.09 -46.5 74.06 Favored 'General case' 0 C--O 1.219 -0.521 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 168.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.91 -44.1 66.71 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.97 0.804 . . . . 0.0 112.187 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 14.3 t-160 -65.34 -43.46 90.82 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 119.93 1.241 . . . . 0.0 111.144 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.26 -14.97 59.66 Favored 'General case' 0 C--O 1.218 -0.554 0 O-C-N 121.574 -0.704 . . . . 0.0 110.379 -178.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -50.25 -44.35 53.51 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 127.167 2.187 . . . . 0.0 111.015 -173.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.436 ' HE3' ' CZ ' ' A' ' 44' ' ' PHE . 0.4 OUTLIER -67.35 -41.6 84.9 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-O 117.823 -1.084 . . . . 0.0 111.266 176.061 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -58.65 -48.58 80.57 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 120.324 1.42 . . . . 0.0 110.346 174.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -58.76 -61.64 2.47 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-O 117.738 -1.125 . . . . 0.0 108.186 177.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.4 t -52.78 -37.34 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 119.943 1.247 . . . . 0.0 111.65 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.436 ' CZ ' ' HE3' ' A' ' 40' ' ' LYS . 3.3 m-85 -59.44 -65.43 0.67 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 118.885 0.766 . . . . 0.0 110.371 174.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -60.74 -50.82 71.92 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 126.504 1.922 . . . . 0.0 111.162 -173.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -67.19 -36.4 81.69 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 127.816 2.446 . . . . 0.0 111.179 -174.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -128.91 -60.34 1.09 Allowed 'General case' 0 C--N 1.347 0.498 0 CA-C-N 119.496 1.044 . . . . 0.0 112.254 -174.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 12.1 mt -64.0 -25.26 68.05 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.564 -0.71 . . . . 0.0 112.843 -165.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -99.83 -15.68 18.33 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 127.283 2.233 . . . . 0.0 111.573 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -69.91 -16.75 63.28 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.435 1.094 . . . . 0.0 110.898 164.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.04 1.64 33.88 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.61 1.576 . . . . 0.0 112.935 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -72.57 145.58 47.3 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 119.066 1.433 . . . . 0.0 110.564 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -126.74 4.5 6.7 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.681 1.192 . . . . 0.0 113.285 -177.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.6 mtmt -145.88 95.32 2.62 Favored 'General case' 0 CA--C 1.514 -0.418 0 O-C-N 119.687 -1.883 . . . . 0.0 107.124 -166.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -101.94 154.11 5.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.579 ' CE2' HG11 ' A' ' 22' ' ' VAL . 16.1 m-30 -124.37 156.15 37.56 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 117.922 0.328 . . . . 0.0 111.332 163.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 29.4 tp -130.1 107.65 9.48 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 124.89 1.276 . . . . 0.0 108.438 175.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.476 HG22 ' HA ' ' A' ' 26' ' ' MET . 0.8 OUTLIER -75.81 161.92 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-O 121.37 0.605 . . . . 0.0 110.651 176.111 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 30.1 mt -139.61 12.51 2.52 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.935 1.294 . . . . 0.0 109.678 -174.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.4 ' H ' HG23 ' A' ' 58' ' ' VAL . 68.7 m -66.38 -64.35 0.88 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.918 1.287 . . . . 0.0 110.559 -176.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -69.74 -43.6 71.97 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.972 0.415 . . . . 0.0 111.689 -169.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.3 p -67.94 160.98 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 126.47 1.908 . . . . 0.0 110.691 -177.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -95.24 -56.17 2.81 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.795 0.838 . . . . 0.0 109.314 174.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.5 p -156.36 -165.39 1.89 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.372 0.669 . . . . 0.0 110.693 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.0 tt -139.6 145.02 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 C-N-CA 125.858 1.663 . . . . 0.0 106.914 -177.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -82.86 162.13 21.7 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.308 0.643 . . . . 0.0 109.774 175.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.0 m -54.19 -29.38 45.76 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.947 1.299 . . . . 0.0 112.843 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -56.59 -64.41 0.88 Allowed 'General case' 0 C--N 1.344 0.346 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.7 t -77.24 -22.32 52.39 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 118.839 -0.6 . . . . 0.0 111.582 -176.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.579 HD11 HG21 ' A' ' 103' ' ' THR . 22.1 tp -54.98 -27.17 41.88 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.958 1.254 . . . . 0.0 111.887 173.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -83.93 -35.64 15.26 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.16 0.886 . . . . 0.0 112.87 171.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 45.5 t -67.89 -42.01 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 118.524 1.162 . . . . 0.0 109.462 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 12.0 mm -54.73 -49.68 66.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.206 1.002 . . . . 0.0 109.338 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 38.7 t -62.48 -42.34 95.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 O-C-N 121.397 -0.814 . . . . 0.0 110.417 174.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -52.89 -44.08 66.63 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 120.129 1.331 . . . . 0.0 112.239 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 59.8 mt -60.67 -38.44 78.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 124.06 0.944 . . . . 0.0 108.67 176.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.49 -49.23 64.42 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 120.005 1.275 . . . . 0.0 109.466 178.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -52.57 -48.25 66.3 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 118.607 0.64 . . . . 0.0 110.077 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.0 m -60.02 -54.54 44.81 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.248 1.019 . . . . 0.0 110.711 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 48.6 mt -60.17 -43.74 93.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 124.337 1.055 . . . . 0.0 110.647 -177.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.0 t -70.22 -12.52 61.65 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.397 1.079 . . . . 0.0 111.865 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.5 t -83.82 -46.75 11.84 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 119.208 0.913 . . . . 0.0 108.583 167.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 72.1 m -54.12 -53.65 50.37 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.239 0.616 . . . . 0.0 110.41 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 132.88 18.04 1.12 Allowed Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.213 -0.771 . . . . 0.0 112.589 -168.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -109.48 179.35 20.83 Favored Glycine 0 N--CA 1.44 -1.034 0 CA-C-N 119.827 1.813 . . . . 0.0 112.587 -173.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -141.87 108.49 5.35 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.914 2.086 . . . . 0.0 108.815 -172.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -106.57 139.8 40.45 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.76 1.224 . . . . 0.0 107.802 -176.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.461 ' C ' HD23 ' A' ' 89' ' ' LEU . . . -137.92 172.49 12.86 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.155 0.889 . . . . 0.0 111.861 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.461 HD23 ' C ' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -122.11 167.17 13.47 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.58 0.752 . . . . 0.0 109.903 -179.581 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 92.5 t -142.39 139.13 29.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 C-N-CA 123.36 0.664 . . . . 0.0 110.122 -168.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 t 46.54 54.46 14.82 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 126.304 1.842 . . . . 0.0 111.178 -175.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -69.79 99.89 0.78 Allowed 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 123.149 2.566 . . . . 0.0 108.769 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -62.5 158.3 18.24 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 122.116 0.96 . . . . 0.0 110.954 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 -59.47 -34.77 72.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.216 -171.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.43 -44.93 89.34 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.37 1.468 . . . . 0.0 109.55 175.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.7 t -74.45 -47.22 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-O 117.2 -1.381 . . . . 0.0 109.761 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -54.66 -31.97 58.44 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 121.383 1.901 . . . . 0.0 110.233 -176.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.41 -62.57 1.63 Allowed 'General case' 0 N--CA 1.423 -1.808 0 CA-C-O 123.453 1.597 . . . . 0.0 111.724 175.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.657 ' O ' HG22 ' A' ' 103' ' ' THR . 4.6 p -66.87 -34.58 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 CA-C-N 113.981 -1.463 . . . . 0.0 107.651 -173.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.9 mt -63.26 -23.97 67.66 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.912 0.885 . . . . 0.0 111.36 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.7 m -78.85 -49.59 12.66 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 120.103 1.32 . . . . 0.0 107.829 170.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.71 -15.42 40.37 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.23 2.212 . . . . 0.0 113.582 -174.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.657 HG22 ' O ' ' A' ' 99' ' ' VAL . 7.6 t -120.67 -0.18 10.27 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.914 2.086 . . . . 0.0 111.479 178.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.42 ' HA ' ' HG3' ' A' ' 107' ' ' ARG . 6.5 m-80 48.07 69.01 0.58 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 127.266 2.227 . . . . 0.0 112.967 -168.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.38 -49.44 3.57 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.369 1.867 . . . . 0.0 110.096 166.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -65.57 -12.29 51.69 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 119.56 1.073 . . . . 0.0 112.728 -177.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.42 ' HG3' ' HA ' ' A' ' 104' ' ' ASN . 0.0 OUTLIER -108.0 5.04 25.8 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 127.255 2.222 . . . . 0.0 111.049 -174.133 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.7 mt -125.62 -45.55 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 128.093 2.557 . . . . 0.0 109.579 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.8 t -95.09 166.92 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.678 1.191 . . . . 0.0 107.802 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.517 ' HE2' ' CB ' ' A' ' 125' ' ' LYS . 3.2 mtmp? -95.95 172.64 7.88 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.737 0.815 . . . . 0.0 109.408 168.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -157.98 147.0 9.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 -163.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.504 ' CG ' ' HB2' ' A' ' 118' ' ' ALA . 82.2 m-85 -148.48 162.95 38.58 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.568 1.147 . . . . 0.0 112.489 -169.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.95 -58.37 2.62 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -178.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 69.2 p -102.87 -162.53 0.92 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.416 HD12 HD12 ' A' ' 24' ' ' ILE . 14.6 mm -84.76 -34.17 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-O 118.564 -0.732 . . . . 0.0 111.133 156.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.1 t -70.22 -37.33 75.0 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.373 -156.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -67.14 -39.97 86.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 176.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.504 ' HB2' ' CG ' ' A' ' 112' ' ' TYR . . . -64.63 -41.38 96.21 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -171.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 9.8 ttt -51.39 -43.45 61.93 Favored 'General case' 0 N--CA 1.424 -1.728 0 C-N-CA 127.897 2.479 . . . . 0.0 110.804 -174.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -104.75 -15.48 15.22 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.837 1.255 . . . . 0.0 112.42 -177.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -81.65 -47.21 13.28 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 119.008 0.822 . . . . 0.0 109.096 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -55.24 -19.96 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 124.864 1.265 . . . . 0.0 114.086 176.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 7.7 mtm180 -70.39 -27.94 64.69 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 118.512 -0.756 . . . . 0.0 110.86 173.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.4 47.29 0.11 Allowed 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 120.624 1.556 . . . . 0.0 114.002 -176.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.517 ' CB ' ' HE2' ' A' ' 110' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.069 0 C-N-CA 125.134 1.373 . . . . 0.0 111.444 -172.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.8 mtp . . . . . 0 N--CA 1.469 0.509 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -80.44 179.83 53.18 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 163.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.4 m -77.54 -51.27 10.98 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 121.846 -0.796 . . . . 0.0 110.093 173.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -168.61 129.61 1.25 Allowed 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.644 1.178 . . . . 0.0 110.205 -164.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -164.25 158.01 18.44 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 145.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 42.3 mt -119.67 95.54 3.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 170.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 33.2 p80 -76.62 171.75 14.16 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 163.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.14 136.16 57.86 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.241 0.543 . . . . 0.0 111.108 -177.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 29.2 t60 -101.67 128.35 48.01 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 160.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -149.74 100.15 2.93 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 107.194 -1.409 . . . . 0.0 107.194 -173.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -65.05 103.18 0.71 Allowed 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 175.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 58.3 t60 -151.68 104.58 3.05 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 163.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -53.78 164.33 0.58 Allowed 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.939 1.695 . . . . 0.0 114.38 -172.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -126.88 169.05 12.85 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 128.349 2.66 . . . . 0.0 108.062 174.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -85.16 99.5 0.68 Allowed 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.407 2.071 . . . . 0.0 111.084 -174.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -155.29 165.41 36.73 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 120.898 -1.127 . . . . 0.0 110.284 -178.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -125.94 173.45 9.12 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.181 1.392 . . . . 0.0 108.938 164.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 52.1 mt -132.4 119.6 39.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.9 m -114.72 -166.11 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 170.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -45.66 -43.6 12.63 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 128.492 2.717 . . . . 0.0 115.278 -149.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -150.23 19.37 0.86 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.359 0.664 . . . . 0.0 111.163 156.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.754 HG11 ' CE2' ' A' ' 56' ' ' PHE . 19.3 t -122.15 120.72 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 124.266 1.027 . . . . 0.0 108.532 -173.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.5 t -75.5 143.78 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 176.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.592 HD12 HD12 ' A' ' 115' ' ' ILE . 5.1 mm -119.33 104.03 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 175.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 26.9 mt -85.72 124.64 32.47 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 177.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 65.0 mtm -126.86 76.46 75.36 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -167.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -61.56 148.44 92.99 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.507 2.805 . . . . 0.0 110.934 -170.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.526 HD22 ' H ' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -135.88 -85.27 0.37 Allowed 'General case' 0 C--O 1.225 -0.212 0 CA-C-O 118.931 -0.557 . . . . 0.0 111.123 176.002 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.526 ' H ' HD22 ' A' ' 28' ' ' ASN . 0.0 OUTLIER -126.5 35.13 4.69 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.194 1.397 . . . . 0.0 109.275 -176.72 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.94 -19.36 13.43 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 120.791 -1.193 . . . . 0.0 112.385 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.9 mp -72.77 90.21 1.4 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -132.85 26.04 4.31 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.621 1.168 . . . . 0.0 110.801 -164.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.3 mt 65.24 -54.12 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 129.071 2.948 . . . . 0.0 113.558 -172.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -66.31 -32.4 73.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 120.175 1.352 . . . . 0.0 109.509 -174.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.1 -8.12 46.97 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-O 117.265 -1.35 . . . . 0.0 110.364 175.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.06 -65.99 0.77 Allowed 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 120.869 1.668 . . . . 0.0 111.794 -168.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -67.96 -17.39 64.43 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 121.421 1.919 . . . . 0.0 110.97 177.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 69.3 mt -78.04 -9.19 59.02 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.103 1.761 . . . . 0.0 112.087 170.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -69.01 -60.39 2.39 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -169.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.451 ' HA ' HG22 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -60.65 -33.43 72.79 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 116.609 -1.662 . . . . 0.0 111.253 174.475 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -64.63 -50.16 68.21 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 120.801 1.637 . . . . 0.0 107.904 -175.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -48.58 -62.37 1.54 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 118.134 -0.936 . . . . 0.0 108.704 166.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.451 HG22 ' HA ' ' A' ' 40' ' ' LYS . 9.7 m -57.93 -46.46 87.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 CA-C-O 123.311 1.529 . . . . 0.0 112.671 -166.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.511 ' CD1' HD12 ' A' ' 48' ' ' LEU . 4.7 m-30 -50.01 -44.95 51.45 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 126.771 2.028 . . . . 0.0 108.98 177.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -78.96 -9.4 59.51 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 128.063 2.545 . . . . 0.0 114.908 -176.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -123.88 -8.69 7.8 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.385 0.993 . . . . 0.0 112.652 177.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -136.16 -61.68 0.69 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.586 0.754 . . . . 0.0 111.069 -174.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.511 HD12 ' CD1' ' A' ' 44' ' ' PHE . 14.4 mt -67.29 -52.08 44.9 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 118.733 0.697 . . . . 0.0 110.935 -169.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -64.97 -27.16 68.65 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.26 1.024 . . . . 0.0 110.449 173.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.25 -46.81 75.84 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 125.044 1.338 . . . . 0.0 108.74 -178.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 131.0 47.59 0.13 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 125.527 1.537 . . . . 0.0 109.768 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -123.6 133.33 53.96 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 118.32 1.06 . . . . 0.0 110.511 173.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -126.26 22.04 7.23 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 126.097 1.759 . . . . 0.0 111.336 -177.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.688 ' HB3' HG13 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -143.93 142.25 30.67 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.66 1.184 . . . . 0.0 108.321 162.062 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.1 mt -141.76 150.62 19.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 129.238 3.015 . . . . 0.0 104.421 -176.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.754 ' CE2' HG11 ' A' ' 22' ' ' VAL . 11.6 m-85 -133.75 153.84 51.41 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 125.219 1.408 . . . . 0.0 109.969 169.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 29.7 tp -118.95 111.57 18.52 Favored 'General case' 0 C--N 1.339 0.143 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 174.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 87.6 t -86.2 103.47 12.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.462 HD12 HG21 ' A' ' 96' ' ' VAL . 4.2 mm? -78.92 -12.71 60.04 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.091 1.356 . . . . 0.0 111.747 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.75 -38.45 47.77 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.919 1.287 . . . . 0.0 111.115 173.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -84.95 -45.66 11.98 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 120.822 0.344 . . . . 0.0 110.792 -165.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.8 p -76.77 -178.75 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 126.619 1.968 . . . . 0.0 109.663 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -122.89 -41.45 2.35 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.41 1.084 . . . . 0.0 108.821 170.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.5 t -154.23 165.36 36.51 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-O 122.623 1.201 . . . . 0.0 113.766 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.7 tt -135.29 152.7 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 129.805 3.242 . . . . 0.0 105.985 176.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.49 175.13 5.55 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.356 0.662 . . . . 0.0 110.468 -167.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.9 p -62.53 19.0 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 128.244 2.617 . . . . 0.0 114.312 173.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -112.38 -73.02 0.68 Allowed 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 166.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 74.7 m -66.05 -29.44 69.78 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 116.878 -1.534 . . . . 0.0 113.778 -172.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.3 mt -48.55 -46.77 39.38 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.606 1.548 . . . . 0.0 110.192 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.17 -33.07 82.85 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-O 119.71 -0.494 . . . . 0.0 112.025 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.2 t -75.5 -29.6 21.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 118.275 1.038 . . . . 0.0 111.087 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 mp -64.58 -40.21 88.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 174.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.1 t -60.64 -43.46 94.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 O-C-N 120.559 -1.338 . . . . 0.0 110.172 169.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -51.24 -43.33 61.45 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.854 1.262 . . . . 0.0 112.204 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.1 mt -58.56 -45.13 90.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 124.406 1.082 . . . . 0.0 109.353 175.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.01 -49.3 70.78 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -51.4 -49.42 61.62 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.018 0.527 . . . . 0.0 109.615 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 13.6 t -64.28 -47.49 79.33 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -176.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 47.7 mt -60.43 -45.17 97.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 C-N-CA 124.979 1.311 . . . . 0.0 111.747 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.5 m -75.29 -23.32 57.35 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.818 0.735 . . . . 0.0 112.143 176.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.78 -45.59 89.05 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.437 1.017 . . . . 0.0 108.543 167.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 74.8 m -63.94 -71.02 0.19 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.889 1.675 . . . . 0.0 112.008 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 141.23 33.74 0.12 Allowed Glycine 0 CA--C 1.527 0.798 0 C-N-CA 124.195 0.902 . . . . 0.0 111.198 -164.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -126.37 -173.78 13.66 Favored Glycine 0 C--N 1.336 0.578 0 O-C-N 120.517 -1.578 . . . . 0.0 109.592 169.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -131.19 164.15 26.17 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.367 1.067 . . . . 0.0 109.902 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -156.03 141.19 17.43 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.973 1.309 . . . . 0.0 109.03 175.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.565 ' C ' HD23 ' A' ' 89' ' ' LEU . . . -147.08 178.44 8.37 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 123.727 0.811 . . . . 0.0 112.166 174.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.565 HD23 ' C ' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -121.35 163.56 18.46 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 123.453 0.701 . . . . 0.0 109.911 -178.489 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.599 HG21 HD13 ' A' ' 115' ' ' ILE . 40.2 t -144.08 133.51 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 123.847 0.859 . . . . 0.0 108.837 -163.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.9 t 48.95 58.96 17.72 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 127.029 2.131 . . . . 0.0 111.778 -171.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.05 91.96 0.91 Allowed 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 123.748 2.965 . . . . 0.0 108.711 176.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -51.66 153.5 2.34 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 126.536 1.935 . . . . 0.0 112.092 171.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -54.03 -31.2 50.63 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.989 1.716 . . . . 0.0 111.204 -176.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.84 -44.71 84.72 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 126.798 2.039 . . . . 0.0 109.207 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.882 HG13 HD13 ' A' ' 100' ' ' LEU . 1.1 t -74.1 -44.77 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 125.634 1.574 . . . . 0.0 110.488 172.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -58.49 -23.89 59.06 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 120.496 1.498 . . . . 0.0 110.451 -176.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.91 -62.31 1.79 Allowed 'General case' 0 N--CA 1.427 -1.614 0 CA-C-O 124.804 2.24 . . . . 0.0 111.003 175.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.496 ' O ' HG22 ' A' ' 103' ' ' THR . 2.6 t -72.76 -46.16 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.707 0 CA-C-N 111.411 -2.631 . . . . 0.0 104.865 -167.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.882 HD13 HG13 ' A' ' 96' ' ' VAL . 4.5 mp -61.28 -19.83 62.2 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 124.913 1.285 . . . . 0.0 112.568 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.6 m -87.1 -54.89 4.08 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 172.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 68.1 mt -51.37 -51.3 55.82 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.546 1.538 . . . . 0.0 113.08 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 99' ' ' VAL . 1.1 t -91.32 3.66 54.32 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.826 1.65 . . . . 0.0 111.987 -167.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 55.38 77.9 0.21 Allowed 'General case' 0 C--N 1.34 0.175 0 C-N-CA 126.387 1.875 . . . . 0.0 109.678 -173.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.532 ' HB3' HD23 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -123.22 -55.59 1.76 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.327 1.051 . . . . 0.0 108.636 177.541 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -60.18 -31.9 70.56 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.235 1.414 . . . . 0.0 110.306 169.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -74.21 1.21 11.83 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 117.556 -1.211 . . . . 0.0 112.965 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.4 mt -133.94 -39.55 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.547 1.139 . . . . 0.0 110.629 -169.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.4 t -106.12 153.92 7.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 119.647 1.112 . . . . 0.0 108.81 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.71 157.27 38.3 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.291 0.567 . . . . 0.0 111.486 174.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.0 145.29 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -172.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -149.19 169.66 20.23 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 127.093 2.157 . . . . 0.0 110.55 -175.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -88.08 -48.24 7.89 Favored 'General case' 0 CA--C 1.521 -0.173 0 O-C-N 121.763 -0.586 . . . . 0.0 109.419 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 67.5 p -121.56 173.52 7.36 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.921 0.888 . . . . 0.0 109.939 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.599 HD13 HG21 ' A' ' 90' ' ' VAL . 17.9 mm -70.7 -35.92 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.6 t -74.06 -30.11 62.23 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 119.446 1.021 . . . . 0.0 111.246 -173.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -65.19 -20.41 66.43 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 119.462 -0.304 . . . . 0.0 111.355 169.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -101.91 -39.93 7.13 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -170.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 53.1 ttm -48.72 -50.07 35.23 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 127.781 2.432 . . . . 0.0 111.089 -167.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -101.47 -0.42 35.2 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 117.985 -1.007 . . . . 0.0 112.591 -174.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -119.31 -35.49 3.58 Favored 'General case' 0 C--O 1.216 -0.687 0 C-N-CA 123.79 0.836 . . . . 0.0 111.542 -167.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -54.21 -29.02 18.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 O-C-N 121.14 -0.975 . . . . 0.0 109.559 157.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.11 118.02 17.58 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 102.467 -3.16 . . . . 0.0 102.467 163.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . 0.267 0.0 OUTLIER 85.46 23.42 0.08 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 111.968 -2.378 . . . . 0.0 116.193 165.582 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp . . . . . 0 C--O 1.25 1.111 0 C-N-CA 123.854 0.862 . . . . 0.0 111.187 176.487 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.475 0.823 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 172.3 104.27 0.17 Allowed Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 174.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.9 m -145.01 134.37 23.01 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 169.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 67.11 170.47 0.25 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 128.096 2.558 . . . . 0.0 112.826 -177.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.44 95.59 2.95 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 161.049 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 82.5 mt -127.17 104.45 12.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 -173.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -142.22 58.03 1.46 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.63 0.729 . . . . 0.0 111.729 -173.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -128.95 -0.48 5.29 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -177.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -70.95 150.73 45.41 Favored 'General case' 0 C--O 1.239 0.522 0 O-C-N 121.179 -0.951 . . . . 0.0 110.103 175.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -147.71 116.6 6.78 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 127.261 2.224 . . . . 0.0 105.138 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -52.89 105.62 0.13 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.731 1.212 . . . . 0.0 112.739 -174.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -157.59 162.18 38.74 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.593 1.557 . . . . 0.0 108.515 170.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 35.1 mmm 63.65 107.03 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 127.509 2.324 . . . . 0.0 111.709 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -108.49 85.56 2.96 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 125.713 1.605 . . . . 0.0 109.446 178.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.67 53.45 4.05 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 123.865 3.043 . . . . 0.0 111.436 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -162.14 163.82 28.27 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 120.788 -1.195 . . . . 0.0 109.804 -175.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.5 pttt -129.6 169.43 15.03 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.651 1.58 . . . . 0.0 108.631 168.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.5 mt -137.95 123.71 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 174.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.8 m -99.26 -154.18 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -24.92 -72.5 0.03 OUTLIER 'General case' 0 C--O 1.237 0.414 0 C-N-CA 130.085 3.354 . . . . 0.0 111.623 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.14 12.14 2.19 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.296 1.439 . . . . 0.0 110.646 172.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.656 HG11 ' CE2' ' A' ' 56' ' ' PHE . 5.7 t -112.41 137.45 45.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 O-C-N 120.657 -1.277 . . . . 0.0 108.749 -171.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 65.9 t -88.72 143.3 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 175.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mp -126.84 97.56 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.434 HD12 ' CH2' ' A' ' 42' ' ' TRP . 1.2 mm? -69.03 140.18 54.94 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 162.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 22.8 mtt -131.44 73.25 80.01 Favored Pre-proline 0 C--O 1.236 0.375 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 171.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.53 167.44 24.13 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 121.608 1.539 . . . . 0.0 110.62 174.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -161.16 -107.6 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 126.532 1.933 . . . . 0.0 105.999 -173.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.497 ' H ' ' HD2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -82.68 1.87 36.39 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -171.677 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -90.43 -23.56 20.98 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 120.773 -1.204 . . . . 0.0 113.726 -167.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 16.6 mt -74.9 -76.0 0.15 Allowed 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.155 -153.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . 0.258 0.1 OUTLIER 23.36 60.08 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 129.64 3.176 . . . . 0.0 113.201 153.629 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.8 mt 63.54 -45.29 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 127.908 2.483 . . . . 0.0 114.352 -172.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -63.61 -21.89 66.6 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.226 1.011 . . . . 0.0 112.906 -165.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -127.72 63.22 1.38 Allowed 'General case' 0 C--O 1.232 0.178 0 C-N-CA 125.141 1.376 . . . . 0.0 107.991 170.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.03 -67.94 0.89 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.674 0.79 . . . . 0.0 112.268 -177.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 39.7 t-80 -63.0 -37.1 85.82 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 120.71 1.595 . . . . 0.0 110.188 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.8 -15.3 60.75 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 117.747 -1.12 . . . . 0.0 111.935 173.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -52.59 -48.7 66.09 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 120.581 1.537 . . . . 0.0 110.942 -172.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -67.54 -42.43 82.72 Favored 'General case' 0 C--O 1.211 -0.922 0 CA-C-O 117.428 -1.272 . . . . 0.0 110.381 175.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.5 tttm -55.39 -45.14 76.64 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.937 1.699 . . . . 0.0 111.051 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.512 ' CE3' HG23 ' A' ' 43' ' ' VAL . 8.2 t90 -61.78 -63.04 1.39 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.546 1.138 . . . . 0.0 109.283 176.002 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.512 HG23 ' CE3' ' A' ' 42' ' ' TRP . 91.2 t -59.55 -32.39 48.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 119.655 1.116 . . . . 0.0 112.305 -176.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -56.54 -60.37 3.64 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 170.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.24 -44.15 72.57 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 -168.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -76.39 -17.26 59.46 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.228 1.811 . . . . 0.0 111.246 -170.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -141.68 -55.5 0.46 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 66.2 mt -64.9 -50.88 64.8 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.687 1.13 . . . . 0.0 111.451 -170.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -65.0 -29.6 70.53 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 127.867 2.467 . . . . 0.0 109.657 175.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.1 mttm -61.02 -46.87 89.0 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 118.638 -0.696 . . . . 0.0 109.14 169.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.97 4.38 2.66 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.193 1.377 . . . . 0.0 113.06 173.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -64.08 150.83 44.63 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 118.936 1.368 . . . . 0.0 109.593 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -122.29 -1.92 9.12 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.05 1.34 . . . . 0.0 114.409 175.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.425 ' HB3' HG13 ' A' ' 22' ' ' VAL . 2.0 mtmt -133.75 121.97 22.65 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 120.908 1.686 . . . . 0.0 108.379 -176.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.4 mt -130.39 157.21 42.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 C-N-CA 125.646 1.579 . . . . 0.0 107.366 176.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.656 ' CE2' HG11 ' A' ' 22' ' ' VAL . 23.2 m-85 -131.92 161.4 33.15 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.389 1.476 . . . . 0.0 111.768 165.329 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.8 tp -128.46 81.23 2.01 Favored 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 125.068 1.347 . . . . 0.0 108.173 173.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.508 ' N ' HG13 ' A' ' 90' ' ' VAL . 99.1 t -56.25 136.4 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 127.93 2.492 . . . . 0.0 107.563 166.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.59 12.6 12.35 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.182 1.793 . . . . 0.0 110.459 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 68.3 m -43.46 -46.24 6.7 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.68 1.992 . . . . 0.0 112.835 173.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.02 1.42 39.54 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.848 1.259 . . . . 0.0 111.69 -164.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.7 p -132.42 114.46 23.29 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 C-N-CA 126.082 1.753 . . . . 0.0 107.526 -177.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -64.69 -38.55 91.37 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 120.652 -1.28 . . . . 0.0 108.319 176.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 57.2 p -154.52 146.94 23.98 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -174.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 21.3 tt -100.28 151.38 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 113.82 -1.536 . . . . 0.0 107.411 163.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -92.3 168.9 11.0 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 123.083 1.42 . . . . 0.0 110.271 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.0 p -50.75 0.06 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.723 1 C-N-CA 132.565 4.346 . . . . 0.0 115.962 170.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -98.77 -70.52 0.72 Allowed 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.6 t -77.0 -19.88 56.74 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-O 118.552 -0.737 . . . . 0.0 112.082 -172.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 14.3 tp -48.57 -33.94 10.6 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.792 1.178 . . . . 0.0 111.743 170.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -76.4 -37.24 36.67 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 118.114 0.416 . . . . 0.0 113.683 173.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.9 t -65.31 -34.6 71.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 124.176 0.991 . . . . 0.0 109.62 -178.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.58 -48.13 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 123.747 0.819 . . . . 0.0 109.918 175.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.6 t -66.66 -39.85 84.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 O-C-N 121.187 -0.946 . . . . 0.0 109.851 178.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.63 -40.63 72.4 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.643 0.735 . . . . 0.0 110.996 178.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.1 mt -61.88 -39.44 83.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 126.592 1.957 . . . . 0.0 109.641 175.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.423 ' HG ' HG13 ' A' ' 109' ' ' VAL . 3.3 tm? -66.22 -41.5 90.03 Favored 'General case' 0 C--N 1.341 0.215 0 O-C-N 119.922 -1.736 . . . . 0.0 109.487 178.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.8 mttm -54.22 -44.11 71.41 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-O 117.841 -1.076 . . . . 0.0 110.524 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.5 t -53.6 -52.66 59.1 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.822 0.849 . . . . 0.0 110.825 176.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.0 mt -67.66 -39.85 82.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.012 0.525 . . . . 0.0 110.472 -174.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 26.6 t -66.25 -36.22 82.45 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.28 1.432 . . . . 0.0 110.932 176.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 71.8 m -65.39 -40.11 93.07 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 119.386 0.994 . . . . 0.0 109.894 172.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.5 m -73.29 -68.97 0.45 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.733 0.813 . . . . 0.0 111.642 -172.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 146.75 34.43 0.06 OUTLIER Glycine 0 C--N 1.334 0.418 0 CA-C-O 118.798 -1.001 . . . . 0.0 113.354 -166.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -127.6 -163.19 11.33 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 118.948 1.374 . . . . 0.0 111.321 -176.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.546 ' HB3' HG22 ' A' ' 122' ' ' VAL . 1.4 m-85 -137.89 151.85 48.44 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 169.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -147.47 147.53 30.29 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 172.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -153.48 170.73 20.04 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 124.812 1.32 . . . . 0.0 111.211 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.3 mt -108.47 167.4 10.07 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.508 HG13 ' N ' ' A' ' 58' ' ' VAL . 0.5 OUTLIER -145.38 152.85 14.21 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.511 0 C-N-CA 124.89 1.276 . . . . 0.0 111.085 -173.606 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.1 p 41.3 58.88 8.94 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 126.32 1.848 . . . . 0.0 112.812 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -71.35 7.94 1.31 Allowed 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 124.227 3.285 . . . . 0.0 114.498 -170.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 56.26 -160.98 0.2 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.383 1.473 . . . . 0.0 108.993 -176.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -87.9 -15.67 36.01 Favored 'General case' 0 CA--C 1.552 1.044 0 O-C-N 120.706 -1.246 . . . . 0.0 110.892 164.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.62 -33.72 10.85 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 121.062 -1.024 . . . . 0.0 112.606 -160.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.818 HG13 HD13 ' A' ' 100' ' ' LEU 0.268 0.9 OUTLIER -77.28 -37.67 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 116.254 -1.831 . . . . 0.0 107.615 166.421 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -52.96 -35.17 58.57 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 121.685 2.039 . . . . 0.0 110.235 171.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.06 -40.17 87.01 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.424 -175.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.536 HG13 HD12 ' A' ' 100' ' ' LEU . 8.4 p -92.41 -33.31 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -167.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.818 HD13 HG13 ' A' ' 96' ' ' VAL . 7.4 mp -65.55 -12.07 49.6 Favored 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 124.845 1.258 . . . . 0.0 112.5 178.14 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.7 t -87.29 -50.68 6.42 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 166.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.21 -38.59 87.16 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.261 1.824 . . . . 0.0 113.14 -168.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 99' ' ' VAL . 10.9 t -86.47 -18.44 31.66 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 119.01 -0.519 . . . . 0.0 110.786 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 64.45 93.72 0.06 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.563 1.545 . . . . 0.0 107.215 -151.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.538 ' HB3' ' HG ' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -124.64 -50.94 1.73 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.576 1.551 . . . . 0.0 108.706 168.494 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -29.96 68.18 Favored 'General case' 0 C--N 1.346 0.426 0 N-CA-C 110.002 -0.369 . . . . 0.0 110.002 177.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -77.99 5.65 9.42 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 128.022 2.529 . . . . 0.0 112.353 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.3 mt -124.05 -34.93 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 125.232 1.413 . . . . 0.0 109.006 -177.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.732 HG12 ' H ' ' A' ' 110' ' ' LYS . 1.7 t -123.85 -159.31 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 125.028 1.331 . . . . 0.0 110.546 -177.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.732 ' H ' HG12 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -116.1 158.8 22.63 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 128.837 2.855 . . . . 0.0 108.073 169.932 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.95 154.03 17.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 -178.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -144.87 167.64 22.12 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.934 0.894 . . . . 0.0 112.7 -171.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.75 -50.52 6.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.944 -177.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 70.4 p -130.29 175.46 8.92 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.92 1.288 . . . . 0.0 107.823 -176.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.439 HD11 ' CG2' ' A' ' 58' ' ' VAL . 6.3 mm -68.25 -41.71 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-O 117.687 -1.149 . . . . 0.0 109.218 170.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.2 t -67.35 -35.62 79.76 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 120.102 1.319 . . . . 0.0 109.43 -175.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.69 -6.51 26.61 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-O 117.554 -1.213 . . . . 0.0 112.797 174.217 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -110.55 -41.06 4.43 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 119.375 0.989 . . . . 0.0 109.772 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 1.9 ttp -59.61 -53.87 53.03 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.754 1.622 . . . . 0.0 111.94 -163.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -84.88 -13.72 50.03 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.187 1.395 . . . . 0.0 111.215 175.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.8 -52.27 5.39 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -168.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.546 HG22 ' HB3' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -50.31 -25.58 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 128.066 2.547 . . . . 0.0 113.359 177.23 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.17 -41.71 84.45 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 126.72 2.008 . . . . 0.0 111.423 175.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.54 55.84 0.62 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 127.165 2.186 . . . . 0.0 106.272 -170.035 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.027 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 170.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.467 0.386 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -166.11 159.72 33.05 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 170.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.6 m 61.3 132.24 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.571 1.948 . . . . 0.0 112.303 -173.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -57.56 -55.33 36.22 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 121.875 -0.516 . . . . 0.0 109.857 170.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.3 tttm -149.27 155.53 40.7 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 175.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.62 130.22 35.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 176.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -61.14 -31.59 71.31 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.647 0.779 . . . . 0.0 112.745 -172.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.3 t60 39.76 73.01 0.12 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.124 2.57 . . . . 0.0 113.519 177.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.73 172.91 12.9 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.434 1.494 . . . . 0.0 108.964 173.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 69.24 -33.7 0.26 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 128.912 2.885 . . . . 0.0 115.045 162.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -75.5 151.78 37.93 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 121.265 1.848 . . . . 0.0 107.706 156.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -138.3 96.24 3.15 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 -168.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.7 ttm -155.81 122.91 5.39 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.878 0.871 . . . . 0.0 109.597 -161.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -145.73 83.14 9.01 Favored Pre-proline 0 CA--C 1.539 0.552 0 O-C-N 120.75 -1.219 . . . . 0.0 110.913 174.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -80.63 53.91 4.99 Favored 'Trans proline' 0 C--O 1.238 0.525 0 C-N-CA 124.367 3.378 . . . . 0.0 110.913 175.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -163.58 177.71 8.57 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.538 1.135 . . . . 0.0 109.454 -175.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.7 pttt -151.06 178.51 9.12 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 126.86 2.064 . . . . 0.0 108.787 165.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.8 mp -132.07 136.37 56.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 167.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 20.4 m -99.65 -131.63 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 125.214 1.406 . . . . 0.0 107.704 172.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -44.89 -73.64 0.04 OUTLIER 'General case' 0 C--O 1.235 0.306 0 C-N-CA 127.505 2.322 . . . . 0.0 111.359 178.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -143.59 8.63 1.55 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.477 1.911 . . . . 0.0 110.309 171.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.695 HG11 ' CE2' ' A' ' 56' ' ' PHE . 22.0 t -97.62 132.22 42.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.7 t -83.44 143.64 11.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 170.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.5 mp -121.93 114.4 42.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 174.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.36 147.05 32.55 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 120.41 1.459 . . . . 0.0 108.719 163.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 8.9 mtt -140.43 77.77 23.26 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 127.834 2.453 . . . . 0.0 107.097 -178.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.99 98.62 0.62 Allowed 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 124.881 3.721 . . . . 0.0 112.858 -172.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -76.53 79.26 3.22 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.419 1.087 . . . . 0.0 113.667 -167.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.266 0.0 OUTLIER 40.7 35.61 0.33 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.607 1.963 . . . . 0.0 114.098 -179.494 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -113.43 -11.51 13.1 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 120.63 -1.294 . . . . 0.0 112.732 -164.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.41 83.11 0.26 Allowed 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 125.596 1.558 . . . . 0.0 108.403 -172.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -123.08 38.29 4.22 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.387 1.875 . . . . 0.0 108.127 -177.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.414 HG12 ' CG ' ' A' ' 68' ' ' PHE 0.304 0.3 OUTLIER 68.96 -26.89 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 130.957 3.703 . . . . 0.0 114.556 -177.833 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -40.51 -32.1 0.18 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 129.659 3.184 . . . . 0.0 115.535 -175.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -117.79 -4.34 11.16 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 127.289 2.236 . . . . 0.0 112.089 -164.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.603 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . . . -72.35 -52.0 18.07 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-N 120.114 1.325 . . . . 0.0 111.755 -166.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -60.48 -41.64 94.64 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.74 -0.6 . . . . 0.0 110.123 -178.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.3 -18.53 58.91 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 118.365 -0.826 . . . . 0.0 111.89 178.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -54.49 -42.87 71.26 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.414 1.461 . . . . 0.0 111.824 -172.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -61.76 -52.67 63.28 Favored 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.7 tmtp? -49.11 -46.32 44.68 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.917 1.687 . . . . 0.0 111.255 175.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.554 ' CE3' HG23 ' A' ' 43' ' ' VAL . 10.7 t90 -62.71 -65.55 0.67 Allowed 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 116.973 -1.489 . . . . 0.0 110.178 177.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.554 HG23 ' CE3' ' A' ' 42' ' ' TRP . 58.6 t -54.94 -35.16 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 120.709 1.595 . . . . 0.0 111.284 -175.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -57.59 -67.9 0.29 Allowed 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 123.913 0.885 . . . . 0.0 109.057 173.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.86 -51.56 69.1 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.807 0.843 . . . . 0.0 112.604 -174.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.32 -30.92 70.01 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.617 1.167 . . . . 0.0 111.379 -168.092 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -133.7 -65.0 0.69 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 122.884 0.474 . . . . 0.0 109.843 -164.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 52.6 mt -56.71 -54.16 49.36 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.835 0.743 . . . . 0.0 111.382 -174.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -67.19 -23.84 65.79 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 126.086 1.754 . . . . 0.0 111.577 175.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.0 tttm -74.68 -6.29 47.92 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.303 1.041 . . . . 0.0 112.194 169.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.68 7.28 53.77 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 124.791 1.186 . . . . 0.0 114.352 175.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -72.32 162.81 28.95 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 120.033 1.916 . . . . 0.0 110.031 176.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -148.34 4.23 0.69 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.502 1.521 . . . . 0.0 111.652 -176.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.488 ' HB3' HG13 ' A' ' 22' ' ' VAL . 1.5 mtmt -141.54 119.02 11.55 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 -177.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.9 mp -119.89 154.97 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 105.14 -2.171 . . . . 0.0 105.14 174.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.695 ' CE2' HG11 ' A' ' 22' ' ' VAL . 24.3 m-85 -130.91 164.19 25.82 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.48 1.512 . . . . 0.0 110.132 160.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.6 tp -128.16 114.6 17.2 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 170.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.573 ' CG2' HD11 ' A' ' 115' ' ' ILE . 53.4 t -82.55 110.42 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 125.991 1.716 . . . . 0.0 108.711 175.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -75.38 -10.89 59.86 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.579 0.752 . . . . 0.0 111.588 170.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.9 m -55.93 -23.52 32.3 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.464 1.029 . . . . 0.0 112.347 172.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.57 -14.16 25.28 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.283 0.947 . . . . 0.0 111.824 177.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.5 p -137.39 101.53 2.19 Favored 'Isoleucine or valine' 0 C--N 1.34 0.152 0 C-N-CA 124.798 1.239 . . . . 0.0 109.643 -173.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -55.05 -48.29 73.67 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.8 m -158.97 170.48 21.99 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.465 HD11 ' CB ' ' A' ' 69' ' ' SER . 8.8 tt -135.83 155.9 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 C-N-CA 127.059 2.144 . . . . 0.0 107.99 -165.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.407 ' HB3' ' CD2' ' A' ' 68' ' ' PHE . 15.8 t70 -91.33 158.47 16.53 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 126.168 1.787 . . . . 0.0 109.774 176.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.7 m -56.07 -24.73 41.83 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 117.594 -1.193 . . . . 0.0 113.337 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.709 ' CE1' ' HB2' ' A' ' 69' ' ' SER 0.278 0.2 OUTLIER -47.59 -64.53 0.76 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 119.686 1.13 . . . . 0.0 111.049 170.766 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.709 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . 30.1 t -92.48 -15.94 26.46 Favored 'General case' 0 CA--C 1.512 -0.486 0 O-C-N 121.52 -0.737 . . . . 0.0 111.642 -168.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.503 HD22 HG21 ' A' ' 103' ' ' THR . 14.2 mt -52.07 -36.22 50.01 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 119.225 -0.99 . . . . 0.0 109.288 170.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -81.27 -25.14 55.64 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-O 118.203 -1.332 . . . . 0.0 114.753 175.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.2 p -72.69 -35.56 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 120.332 2.066 . . . . 0.0 110.048 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 mp -53.34 -49.97 50.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.342 1.457 . . . . 0.0 108.136 173.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 80.7 t -56.61 -52.34 54.84 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 176.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -56.0 -22.46 27.0 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 114.114 1.154 . . . . 0.0 114.114 -174.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 57.8 mt -80.37 -44.34 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.452 1.101 . . . . 0.0 109.481 172.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -54.16 -48.77 70.52 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.452 1.024 . . . . 0.0 109.485 177.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -57.45 -42.75 83.1 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.168 0.587 . . . . 0.0 110.638 -176.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.4 m -60.17 -54.25 48.12 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 118.956 -0.545 . . . . 0.0 110.574 174.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 80.0 mt -57.63 -42.19 80.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.858 0.863 . . . . 0.0 110.803 -176.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -52.07 -40.8 61.72 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.728 1.611 . . . . 0.0 111.242 175.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 t -84.33 0.85 47.64 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.766 2.427 . . . . 0.0 112.799 -174.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.7 m -128.84 -14.26 4.53 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -166.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 130.51 -18.75 5.15 Favored Glycine 0 CA--C 1.521 0.409 0 CA-C-N 117.992 0.36 . . . . 0.0 113.741 177.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -100.3 -173.06 29.86 Favored Glycine 0 N--CA 1.429 -1.781 0 CA-C-O 123.02 1.345 . . . . 0.0 113.283 -156.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.524 ' HB3' HG22 ' A' ' 122' ' ' VAL . 2.1 m-85 -133.46 153.09 51.91 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.461 1.504 . . . . 0.0 108.256 174.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -145.23 146.98 31.93 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 171.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.58 ' C ' HD23 ' A' ' 89' ' ' LEU . . . -156.02 173.34 16.95 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.039 1.335 . . . . 0.0 111.153 -175.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.58 HD23 ' C ' ' A' ' 88' ' ' ALA . 5.6 mt -121.06 163.78 17.81 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.697 1.199 . . . . 0.0 110.148 -170.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.855 HG21 HD13 ' A' ' 115' ' ' ILE . 42.7 t -141.87 135.0 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 123.963 0.905 . . . . 0.0 111.478 -172.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.6 t 53.0 59.63 13.37 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 128.626 2.77 . . . . 0.0 113.938 175.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -73.11 -51.57 0.16 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.73 1.62 . . . . 0.0 115.808 -169.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 85.01 172.48 0.07 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 128.463 2.705 . . . . 0.0 109.638 -171.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.08 -34.19 42.69 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 125.408 1.483 . . . . 0.0 110.398 169.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.59 -48.12 73.39 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-O 117.883 -1.056 . . . . 0.0 108.619 -173.132 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 54.8 t -79.82 -52.48 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -176.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -63.92 -9.73 17.06 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.55 1.068 . . . . 0.0 111.23 -176.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.41 -74.53 0.09 Allowed 'General case' 0 CA--C 1.489 -1.4 0 CA-C-O 122.108 0.956 . . . . 0.0 108.547 162.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.661 ' O ' HG22 ' A' ' 103' ' ' THR . 17.7 t -70.93 -29.65 38.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 113.585 -1.643 . . . . 0.0 107.114 -156.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.03 -12.44 3.36 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 117.685 -1.15 . . . . 0.0 109.972 173.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.75 -37.03 8.89 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.1 mp -63.79 -18.53 64.18 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.887 2.475 . . . . 0.0 113.257 172.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.661 HG22 ' O ' ' A' ' 99' ' ' VAL . 12.7 t -128.0 16.48 6.77 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.97 1.308 . . . . 0.0 112.623 -171.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . 0.257 0.1 OUTLIER 40.11 78.95 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.38 1.472 . . . . 0.0 110.661 -173.906 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.402 ' HB2' HG23 ' A' ' 103' ' ' THR . 0.1 OUTLIER -133.79 -49.02 0.82 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.114 1.366 . . . . 0.0 107.93 -178.291 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.9 p-10 -62.53 -25.32 67.98 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 125.747 1.619 . . . . 0.0 112.072 176.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.5 -11.92 38.78 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.744 1.218 . . . . 0.0 113.895 -178.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.6 mt -105.55 -51.04 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 -173.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.5 t -107.91 142.62 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 121.414 0.626 . . . . 0.0 109.328 -170.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.416 ' HE3' ' HG3' ' A' ' 125' ' ' LYS . 14.4 mtmm -69.52 163.36 25.56 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-N 114.673 -1.149 . . . . 0.0 112.261 173.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -148.87 146.0 17.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 113.312 -1.767 . . . . 0.0 108.887 -169.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -148.57 167.55 25.12 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.544 1.138 . . . . 0.0 110.625 -171.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.7 -40.72 13.06 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -177.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.2 p -127.29 172.08 10.92 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.81 0.814 . . . . 0.0 109.501 -179.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.855 HD13 HG21 ' A' ' 90' ' ' VAL . 23.8 mm -70.04 -40.71 78.79 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.553 170.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 38.8 t -66.35 -33.12 75.0 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 119.288 0.949 . . . . 0.0 109.846 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -64.66 -11.76 38.98 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.872 0.869 . . . . 0.0 111.952 175.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -113.58 -39.08 4.14 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 124.935 1.294 . . . . 0.0 109.829 -175.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 5.9 ttp -58.17 -46.79 85.12 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.865 1.266 . . . . 0.0 112.348 -164.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -90.09 -19.89 23.81 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.869 1.268 . . . . 0.0 111.623 177.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -83.62 -50.39 8.25 Favored 'General case' 0 C--O 1.219 -0.532 0 C-N-CA 123.685 0.794 . . . . 0.0 109.095 -171.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.524 HG22 ' HB3' ' A' ' 86' ' ' PHE . 0.3 OUTLIER -53.36 -16.7 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 127.292 2.237 . . . . 0.0 113.173 177.72 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -47.36 64.07 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.299 2.24 . . . . 0.0 111.746 169.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.22 37.21 1.72 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.559 1.944 . . . . 0.0 113.199 -173.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.416 ' HG3' ' HE3' ' A' ' 110' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.107 0 C-N-CA 130.886 3.675 . . . . 0.0 111.666 157.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 ttt . . . . . 0 N--CA 1.47 0.527 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.74 54.29 3.3 Favored Glycine 0 CA--C 1.526 0.746 0 O-C-N 121.155 -0.966 . . . . 0.0 115.131 161.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.0 p -158.12 148.69 20.54 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 150.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -155.99 111.25 2.95 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -175.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.5 tptt 52.85 29.65 7.99 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.522 1.929 . . . . 0.0 113.528 174.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.4 tp -84.83 51.06 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 124.548 1.139 . . . . 0.0 113.061 -164.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 14.4 p-80 -160.53 154.08 22.26 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 120.675 -1.265 . . . . 0.0 110.535 170.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.469 ' CG ' ' H ' ' A' ' 9' ' ' HIS . 81.4 t60 -99.22 -171.56 2.1 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.349 1.86 . . . . 0.0 109.833 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.469 ' H ' ' CG ' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -79.72 101.71 8.58 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 120.063 -1.648 . . . . 0.0 109.949 175.973 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -132.77 145.41 50.98 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.22 0.608 . . . . 0.0 109.818 177.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -70.02 156.76 38.67 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 123.55 0.74 . . . . 0.0 110.861 173.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -116.18 112.01 21.04 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 126.593 1.957 . . . . 0.0 109.721 -175.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.87 118.27 9.04 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.098 0.959 . . . . 0.0 108.687 173.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -138.98 166.37 25.41 Favored Pre-proline 0 N--CA 1.447 -0.622 0 C-N-CA 126.622 1.969 . . . . 0.0 107.51 172.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -73.55 86.86 1.14 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.836 2.357 . . . . 0.0 109.304 175.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -167.01 172.39 10.21 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.223 1.409 . . . . 0.0 110.839 178.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.427 ' HG2' ' H ' ' A' ' 18' ' ' ILE . 4.9 ttmt -137.65 173.36 11.74 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.563 1.945 . . . . 0.0 109.452 173.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.427 ' H ' ' HG2' ' A' ' 17' ' ' LYS . 67.0 mt -135.53 134.81 51.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 128.866 2.866 . . . . 0.0 105.973 168.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.2 m -108.1 -169.94 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 128.289 2.635 . . . . 0.0 107.038 164.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -23.05 -75.92 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 128.153 2.581 . . . . 0.0 113.311 -171.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -134.15 36.23 3.24 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.256 0.622 . . . . 0.0 110.291 172.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.758 HG11 ' CE2' ' A' ' 56' ' ' PHE . 6.8 t -142.25 153.55 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.049 0 CA-C-O 122.785 1.278 . . . . 0.0 110.572 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.448 ' C ' HD12 ' A' ' 24' ' ' ILE . 0.9 OUTLIER -113.41 151.96 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.721 0 CA-C-N 112.67 -2.059 . . . . 0.0 107.487 -168.552 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.448 HD12 ' C ' ' A' ' 23' ' ' VAL . 3.9 mp -132.33 88.54 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -179.067 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.428 ' CD2' HG23 ' A' ' 55' ' ' ILE . 0.5 OUTLIER -67.59 158.26 32.51 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 120.377 1.444 . . . . 0.0 109.811 166.619 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -168.53 73.18 0.82 Allowed Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 123.905 0.882 . . . . 0.0 110.317 -176.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -68.65 120.86 7.76 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.881 2.387 . . . . 0.0 111.407 -168.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -76.16 66.53 2.32 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.4 -0.812 . . . . 0.0 111.749 175.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? 61.31 8.7 2.21 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.538 1.535 . . . . 0.0 113.155 -175.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.04 26.84 0.14 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.835 1.254 . . . . 0.0 112.789 -178.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.97 80.01 7.87 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 123.353 1.549 . . . . 0.0 106.842 175.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -99.63 148.95 23.79 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 127.191 2.196 . . . . 0.0 107.333 163.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.0 tt -54.37 -30.57 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.465 1.506 . . . . 0.0 112.217 174.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.407 ' O ' HD22 ' A' ' 38' ' ' LEU . 46.9 mt-10 -58.93 -63.62 1.23 Allowed 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 175.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -51.7 -46.06 63.75 Favored 'General case' 0 C--O 1.222 -0.356 0 C-N-CA 125.252 1.421 . . . . 0.0 109.574 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.75 -40.57 63.23 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.838 1.255 . . . . 0.0 113.631 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -64.29 -47.72 78.41 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 119.795 1.18 . . . . 0.0 109.599 177.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.407 HD22 ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -72.41 -31.77 65.79 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 118.014 -0.993 . . . . 0.0 111.03 -175.157 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -41.35 -40.3 1.66 Allowed 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 128.075 2.55 . . . . 0.0 110.715 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -55.46 -72.11 0.07 Allowed 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 118.989 0.813 . . . . 0.0 109.41 168.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.53 -35.48 63.24 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.869 0.868 . . . . 0.0 111.132 -172.028 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 20.7 t90 -59.88 -73.23 0.09 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 117.152 -1.404 . . . . 0.0 111.24 170.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 53.9 t -49.18 -36.33 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-N 120.452 1.478 . . . . 0.0 111.195 -178.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -68.52 -57.48 5.73 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 124.732 1.213 . . . . 0.0 110.538 -178.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -67.72 -31.58 71.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 118.545 0.611 . . . . 0.0 110.636 -177.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -89.24 -20.62 23.92 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 123.334 0.653 . . . . 0.0 111.728 -168.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -133.62 -53.85 0.88 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 118.619 0.645 . . . . 0.0 111.537 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 35.6 mt -64.31 -39.92 94.9 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 119.035 -0.507 . . . . 0.0 110.808 -171.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -72.97 -35.61 66.94 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 126.922 2.089 . . . . 0.0 111.356 173.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.91 -50.62 70.2 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.563 0.745 . . . . 0.0 109.46 175.022 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 138.21 6.08 1.48 Allowed Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.368 0.985 . . . . 0.0 112.634 -177.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -72.06 155.63 40.09 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 118.464 1.132 . . . . 0.0 109.876 177.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -131.65 15.31 4.89 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.692 1.597 . . . . 0.0 111.187 173.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.469 ' HB3' HG13 ' A' ' 22' ' ' VAL . 0.3 OUTLIER -153.32 105.11 2.83 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 -163.13 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.428 HG23 ' CD2' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -116.09 155.19 17.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 103.801 -2.666 . . . . 0.0 103.801 179.505 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.758 ' CE2' HG11 ' A' ' 22' ' ' VAL . 27.4 m-85 -130.29 160.67 33.23 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 159.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 42.0 tp -126.72 103.98 7.83 Favored 'General case' 0 C--N 1.334 -0.083 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 173.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.2 t -78.88 141.27 15.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 171.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 92' ' ' PRO . 3.4 mp -122.69 12.24 9.88 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.603 0.638 . . . . 0.0 112.304 -178.021 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.5 t -50.01 -44.72 51.35 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.655 1.582 . . . . 0.0 111.401 178.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -68.56 -36.22 78.48 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 118.684 -0.674 . . . . 0.0 111.234 -175.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 p -103.44 117.71 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 126.579 1.951 . . . . 0.0 107.753 -160.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -76.13 -39.63 54.65 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.22 -0.925 . . . . 0.0 109.17 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 78.9 p -140.29 163.17 33.47 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -175.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.404 HD11 ' HB2' ' A' ' 69' ' ' SER . 20.0 tt -136.7 154.73 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 C-N-CA 126.407 1.883 . . . . 0.0 107.068 175.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.89 160.07 17.37 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.185 1.794 . . . . 0.0 109.847 -175.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.3 t -62.8 -12.89 27.35 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.7 1.2 . . . . 0.0 113.278 174.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -71.37 -68.29 0.46 Allowed 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 168.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.404 ' HB2' HD11 ' A' ' 65' ' ' ILE . 0.6 OUTLIER -70.67 -30.3 66.86 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.674 1.189 . . . . 0.0 112.531 -163.236 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.539 HD22 HD13 ' A' ' 105' ' ' LEU . 11.6 mt -47.42 -42.54 22.44 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.966 0.907 . . . . 0.0 109.759 174.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -71.79 -29.84 66.84 Favored Glycine 0 CA--C 1.528 0.854 0 O-C-N 121.365 -0.834 . . . . 0.0 112.298 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.0 t -67.92 -35.26 71.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 O-C-N 121.583 -0.951 . . . . 0.0 109.314 176.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.8 -47.91 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.6 t -60.88 -39.43 81.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 O-C-N 121.535 -0.728 . . . . 0.0 110.938 174.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.41 -42.76 92.53 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 120.973 -1.08 . . . . 0.0 112.327 -176.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.3 mt -53.64 -43.52 54.83 Favored 'Isoleucine or valine' 0 C--N 1.343 0.308 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 172.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.434 HD13 ' C ' ' A' ' 77' ' ' LEU . 3.1 tm? -66.44 -48.35 70.25 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -173.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 24.6 mttm -55.22 -47.59 75.1 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 122.777 0.431 . . . . 0.0 111.099 178.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.1 m -61.87 -46.55 88.95 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.974 0.91 . . . . 0.0 110.391 -177.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 29.4 mt -65.75 -48.06 83.64 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 C-N-CA 124.051 0.94 . . . . 0.0 111.328 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.52 -39.54 80.38 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 177.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 50.6 m -62.57 -41.54 98.99 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.061 176.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.7 m -61.42 -51.22 69.66 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.362 0.983 . . . . 0.0 109.982 174.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 134.75 24.24 0.6 Allowed Glycine 0 CA--C 1.525 0.671 0 C-N-CA 123.711 0.672 . . . . 0.0 112.396 -171.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -119.67 -173.12 15.23 Favored Glycine 0 N--CA 1.439 -1.131 0 CA-C-N 118.599 1.199 . . . . 0.0 111.942 -176.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.586 ' HB3' HG22 ' A' ' 122' ' ' VAL . 3.4 m-85 -131.6 155.3 47.77 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.843 1.657 . . . . 0.0 109.246 177.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -150.57 135.42 17.5 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.697 0.799 . . . . 0.0 109.595 176.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -139.95 162.24 35.65 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.009 0.433 . . . . 0.0 111.982 -177.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.466 HD12 ' N ' ' A' ' 89' ' ' LEU . 7.5 mp -103.03 151.93 21.93 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.025 1.73 . . . . 0.0 107.405 178.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 70.4 t -145.1 145.43 20.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -168.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 47.1 t 42.37 57.66 10.7 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 124.499 1.119 . . . . 0.0 110.124 -176.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.4 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 30.5 Cg_endo -64.98 -77.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.947 2.431 . . . . 0.0 111.301 -165.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 25.0 p30 142.46 -175.12 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.492 1 C-N-CA 133.337 4.655 . . . . 0.0 106.01 171.207 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -77.84 -32.91 52.42 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 122.458 1.123 . . . . 0.0 111.849 176.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.74 -51.26 19.9 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 129.921 3.288 . . . . 0.0 110.271 -166.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.824 HG13 HD13 ' A' ' 100' ' ' LEU . 1.2 t -63.94 -48.12 87.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 125.668 1.587 . . . . 0.0 107.75 168.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -61.56 -26.08 67.72 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 122.746 2.521 . . . . 0.0 110.828 -175.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -46.98 85.83 Favored 'General case' 0 C--N 1.344 0.341 0 O-C-N 121.376 -0.827 . . . . 0.0 109.583 175.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.2 p -80.45 -31.31 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -172.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.824 HD13 HG13 ' A' ' 96' ' ' VAL . 3.3 mp -66.06 -17.48 64.72 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 118.037 -0.982 . . . . 0.0 112.462 177.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.6 m -77.86 -58.11 3.44 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 165.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.93 -68.56 0.16 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.019 2.128 . . . . 0.0 111.641 -173.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.628 HG23 HD12 ' A' ' 105' ' ' LEU . 5.7 t -76.92 14.59 0.81 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.671 1.589 . . . . 0.0 112.518 -175.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 42.76 85.05 0.02 OUTLIER 'General case' 0 C--N 1.34 0.194 0 C-N-CA 126.256 1.822 . . . . 0.0 112.014 -169.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.628 HD12 HG23 ' A' ' 103' ' ' THR 0.334 0.1 OUTLIER -126.04 -41.47 1.94 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 125.169 1.388 . . . . 0.0 112.362 178.163 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -67.76 -21.18 65.28 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.95 1.25 . . . . 0.0 111.259 171.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.9 mtm180 -79.51 -1.94 39.94 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 118.805 -0.617 . . . . 0.0 111.227 -178.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.7 mm -127.69 -46.17 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 C-N-CA 124.97 1.308 . . . . 0.0 108.384 -164.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.446 HG11 ' CD1' ' A' ' 89' ' ' LEU . 2.6 t -110.48 149.24 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 -177.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.471 ' HE3' ' H ' ' A' ' 111' ' ' ILE . 0.0 OUTLIER -71.52 160.88 31.93 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.979 173.519 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.471 ' H ' ' HE3' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -145.27 143.29 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -177.249 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -146.55 171.4 15.14 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.349 1.459 . . . . 0.0 110.417 -177.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -87.24 -50.03 6.87 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -177.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 31.8 p -125.55 170.54 11.35 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-O 122.174 0.987 . . . . 0.0 111.141 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 12.4 mm -63.13 -36.76 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 C-N-CA 124.293 1.037 . . . . 0.0 108.379 170.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.79 -43.0 90.04 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 119.869 1.213 . . . . 0.0 110.979 -178.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -71.41 3.87 3.43 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 123.691 0.62 . . . . 0.0 112.169 178.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.466 ' HB1' ' CE1' ' A' ' 56' ' ' PHE . . . -114.39 -33.89 5.46 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 174.12 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.16 -52.31 62.94 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 120.17 -1.582 . . . . 0.0 111.79 -162.15 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -89.8 -13.81 35.82 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.48 0.712 . . . . 0.0 112.113 172.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.81 -52.36 6.1 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -168.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.586 HG22 ' HB3' ' A' ' 86' ' ' PHE . 0.3 OUTLIER -53.31 -32.45 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 126.406 1.883 . . . . 0.0 111.322 176.194 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 43.8 mtm180 -62.18 -25.03 67.55 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 124.221 1.008 . . . . 0.0 111.285 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.22 56.33 1.0 Allowed 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 119.158 0.89 . . . . 0.0 109.862 169.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.199 0 CA-C-O 118.196 -0.907 . . . . 0.0 111.437 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.913 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.96 -170.06 34.26 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -161.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.5 m 62.4 61.76 1.23 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.278 1.431 . . . . 0.0 111.098 -175.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -52.16 -55.25 22.15 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 127.546 2.338 . . . . 0.0 112.128 -174.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? 48.07 37.47 7.95 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.091 1.756 . . . . 0.0 112.907 171.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.5 tp -91.78 5.41 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 124.597 1.159 . . . . 0.0 112.347 -175.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -99.84 73.15 1.76 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.492 1.517 . . . . 0.0 110.289 -174.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -129.56 -71.24 0.62 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 124.718 1.207 . . . . 0.0 108.799 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -61.3 120.07 9.7 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.702 0.801 . . . . 0.0 110.303 -172.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -125.55 159.6 31.66 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.863 0.865 . . . . 0.0 110.42 -165.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -134.92 39.18 2.98 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.135 1.374 . . . . 0.0 110.803 -162.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 55.62 53.3 9.78 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.258 2.223 . . . . 0.0 113.61 176.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 12.5 ttt -74.99 49.16 0.42 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.649 1.179 . . . . 0.0 110.13 162.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -124.55 72.55 59.99 Favored Pre-proline 0 C--O 1.236 0.367 0 C-N-CA 125.043 1.337 . . . . 0.0 109.039 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -81.23 44.64 1.79 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.544 2.829 . . . . 0.0 109.663 172.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -163.21 169.73 18.8 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 121.029 -1.044 . . . . 0.0 112.305 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -141.32 173.14 11.78 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 127.309 2.244 . . . . 0.0 108.365 164.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.6 mt -129.8 120.65 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 167.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.3 m -88.09 -151.96 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 124.938 1.295 . . . . 0.0 108.226 172.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -25.03 -72.39 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 128.6 2.76 . . . . 0.0 113.472 -177.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -145.43 28.03 1.21 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.184 1.394 . . . . 0.0 110.49 165.09 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.735 HG11 ' CE2' ' A' ' 56' ' ' PHE . 24.2 t -122.42 137.22 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 O-C-N 120.824 -1.172 . . . . 0.0 110.444 -177.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.4 t -84.8 135.81 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 177.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.1 mp -117.01 103.39 14.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 173.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.454 HD23 HG23 ' A' ' 55' ' ' ILE . 3.8 mm? -76.66 95.52 3.98 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 128.194 2.598 . . . . 0.0 106.765 171.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 14.8 mtm -94.45 95.8 1.58 Allowed Pre-proline 0 CA--C 1.55 0.966 0 CA-C-N 121.539 1.972 . . . . 0.0 106.54 172.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -67.99 172.25 11.13 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 CA-C-N 122.08 1.778 . . . . 0.0 109.488 171.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -152.89 -71.99 0.14 Allowed 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 169.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.33 17.27 4.47 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.0 1.32 . . . . 0.0 112.488 -176.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -89.89 1.13 56.58 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 122.994 0.518 . . . . 0.0 111.13 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 17.9 mt -89.76 89.56 7.83 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -132.68 22.07 4.27 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.499 1.12 . . . . 0.0 113.152 -166.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.255 0.2 OUTLIER 64.12 -43.27 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 129.188 2.995 . . . . 0.0 114.444 -172.795 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -61.39 -19.01 61.42 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 120.765 -1.209 . . . . 0.0 111.061 174.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -115.25 68.77 0.71 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 126.404 1.882 . . . . 0.0 108.288 174.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.582 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . . . -132.34 -62.61 0.83 Allowed 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 167.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -59.05 -35.29 73.07 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.238 0.927 . . . . 0.0 110.306 174.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 36.0 mt -67.11 -28.88 68.52 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 124.244 1.017 . . . . 0.0 112.929 173.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -59.13 -57.75 11.69 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 124.62 1.168 . . . . 0.0 108.745 -172.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.489 ' HE2' ' CE2' ' A' ' 44' ' ' PHE . 3.9 ttpm? -54.24 -49.06 70.37 Favored 'General case' 0 C--O 1.216 -0.682 0 CA-C-O 116.684 -1.627 . . . . 0.0 110.216 172.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -43.99 85.67 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 120.667 1.576 . . . . 0.0 111.367 -176.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -67.81 -60.89 2.17 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-O 116.709 -1.615 . . . . 0.0 109.088 177.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.551 HG12 ' CD1' ' A' ' 48' ' ' LEU . 56.7 t -52.1 -38.7 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 121.538 1.972 . . . . 0.0 109.772 -178.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.517 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 8.0 m-30 -60.26 -69.03 0.24 Allowed 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 124.362 1.065 . . . . 0.0 110.687 176.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.21 -10.13 59.17 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -171.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -90.94 -31.37 16.4 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 116.048 -1.929 . . . . 0.0 110.284 173.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -134.54 -53.42 0.82 Allowed 'General case' 0 C--N 1.357 0.906 0 CA-C-N 122.804 2.547 . . . . 0.0 109.91 -174.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.551 ' CD1' HG12 ' A' ' 43' ' ' VAL . 6.6 mp -55.8 -59.59 4.65 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.818 0.818 . . . . 0.0 110.918 -174.347 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -75.45 -5.48 45.26 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 124.623 1.169 . . . . 0.0 112.268 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.7 mttm -75.59 -28.8 59.06 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.12 0.873 . . . . 0.0 110.274 163.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 125.0 -6.0 8.29 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 126.143 1.83 . . . . 0.0 112.688 -176.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -71.49 174.79 6.15 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 119.44 1.62 . . . . 0.0 108.928 175.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -172.09 5.72 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.184 1.794 . . . . 0.0 109.598 -169.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.477 ' HB3' HG13 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -131.81 112.49 12.54 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 104.889 -2.263 . . . . 0.0 104.889 -176.513 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.454 HG23 HD23 ' A' ' 25' ' ' LEU . 1.8 mp -122.94 146.38 28.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 178.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.785 ' CE1' HG21 ' A' ' 122' ' ' VAL . 17.1 m-85 -129.34 128.96 44.17 Favored 'General case' 0 C--O 1.228 -0.051 0 C-N-CA 123.958 0.903 . . . . 0.0 109.735 166.042 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 47.5 tp -95.16 121.48 36.85 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.296 1.039 . . . . 0.0 109.594 -178.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.438 ' HA ' ' HB ' ' A' ' 90' ' ' VAL . 0.8 OUTLIER -89.09 152.94 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 119.59 1.086 . . . . 0.0 111.402 177.902 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.517 ' CD2' HG21 ' A' ' 96' ' ' VAL . 0.9 OUTLIER -134.0 0.8 3.21 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.115 0.966 . . . . 0.0 112.982 175.083 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.44 -8.19 1.7 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 169.102 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -116.68 -5.66 11.61 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.563 1.145 . . . . 0.0 111.83 -168.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.4 p -143.8 148.43 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 125.012 1.325 . . . . 0.0 107.47 -170.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -78.0 -46.98 19.53 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 176.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.8 p -155.12 168.2 27.82 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.6 tt -94.13 156.43 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 125.977 1.711 . . . . 0.0 108.178 162.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -111.44 174.57 5.8 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.551 -0.718 . . . . 0.0 110.358 -176.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.5 m -57.87 -39.92 78.98 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 121.412 -0.805 . . . . 0.0 112.241 -172.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.582 ' CE1' ' HB2' ' A' ' 36' ' ' ALA . 0.9 OUTLIER -50.36 -53.13 31.36 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.255 1.422 . . . . 0.0 111.232 176.646 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 p -93.51 -20.75 19.97 Favored 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 121.683 -0.635 . . . . 0.0 112.026 -169.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 31.6 tp -56.97 -17.21 8.87 Favored 'General case' 0 CA--C 1.551 0.988 0 O-C-N 120.844 -1.16 . . . . 0.0 111.468 170.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -101.07 -8.51 47.53 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 125.046 1.308 . . . . 0.0 115.216 169.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -89.16 -38.88 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 119.608 1.704 . . . . 0.0 109.157 175.183 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.4 mm -58.42 -41.17 80.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 O-C-N 121.127 -0.983 . . . . 0.0 110.706 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 65.8 t -61.36 -42.77 94.94 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 CA-C-N 118.264 0.484 . . . . 0.0 110.212 174.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -63.67 -30.64 71.72 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 120.82 -1.175 . . . . 0.0 111.052 -176.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.9 mt -64.17 -40.06 87.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 171.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -67.84 -49.19 63.51 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 123.931 0.892 . . . . 0.0 109.172 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.3 mttm -48.72 -55.64 10.84 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 124.451 1.1 . . . . 0.0 110.418 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 69.2 m -78.41 -26.75 46.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 118.145 -0.931 . . . . 0.0 112.699 -172.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 25.2 mt -59.04 -44.89 92.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 119.85 1.204 . . . . 0.0 109.306 165.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.2 t -74.59 -18.44 60.57 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.34 1.056 . . . . 0.0 112.135 -176.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.1 m -77.89 -43.78 29.08 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.881 0.872 . . . . 0.0 110.279 166.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.0 m -64.38 -50.9 65.84 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 118.418 -0.801 . . . . 0.0 110.741 -176.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 134.2 23.13 0.69 Allowed Glycine 0 CA--C 1.521 0.426 0 CA-C-O 119.157 -0.801 . . . . 0.0 113.565 -175.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -115.82 -171.98 16.64 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 118.84 1.32 . . . . 0.0 111.81 -170.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.16 158.4 43.75 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.466 1.507 . . . . 0.0 110.201 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -150.5 142.2 23.66 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.491 ' C ' HD23 ' A' ' 89' ' ' LEU . . . -144.07 173.22 11.91 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.318 1.447 . . . . 0.0 110.605 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.491 HD23 ' C ' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -118.28 168.14 10.88 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.926 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.438 ' HB ' ' HA ' ' A' ' 58' ' ' VAL . 57.7 t -139.48 129.4 30.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 124.425 1.09 . . . . 0.0 108.153 -164.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.9 t 43.84 69.98 2.12 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 127.122 2.169 . . . . 0.0 110.555 -176.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -71.09 118.82 5.89 Favored 'Trans proline' 0 N--CA 1.445 -1.365 0 N-CA-C 107.597 -1.732 . . . . 0.0 107.597 173.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 49.1 p30 -67.33 165.5 16.26 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 122.863 1.316 . . . . 0.0 109.447 163.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -69.19 -24.49 64.05 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.892 -174.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -46.41 78.79 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 126.624 1.97 . . . . 0.0 110.256 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.517 HG21 ' CD2' ' A' ' 59' ' ' LEU . 6.6 t -77.93 -38.59 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-O 118.263 -0.875 . . . . 0.0 109.982 -178.067 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -51.25 -39.02 55.78 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 124.744 1.218 . . . . 0.0 110.045 177.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.7 -61.27 1.91 Allowed 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 125.69 1.596 . . . . 0.0 114.222 172.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.569 ' O ' HG22 ' A' ' 103' ' ' THR . 77.9 t -71.21 -47.92 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 C-N-CA 125.889 1.676 . . . . 0.0 107.339 -169.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.39 -21.53 60.05 Favored 'General case' 0 N--CA 1.438 -1.028 0 O-C-N 124.495 1.122 . . . . 0.0 108.6 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.4 m -82.47 -52.01 7.27 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 81.1 mt -57.94 -29.0 64.81 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.578 1.951 . . . . 0.0 113.495 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.569 HG22 ' O ' ' A' ' 99' ' ' VAL . 1.9 t -111.53 -1.81 15.71 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.917 1.287 . . . . 0.0 111.205 -171.299 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 53.9 78.9 0.14 Allowed 'General case' 0 C--N 1.343 0.283 0 C-N-CA 127.181 2.192 . . . . 0.0 109.931 -176.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.19 -49.39 1.94 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 126.716 2.006 . . . . 0.0 108.064 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -67.17 -12.19 59.36 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.141 1.376 . . . . 0.0 112.465 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.1 mtp180 -90.22 -0.79 57.79 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.867 1.667 . . . . 0.0 111.433 176.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.6 mm -127.46 -45.21 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 125.623 1.569 . . . . 0.0 107.431 -165.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.2 t -99.21 155.08 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 174.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.4 ' HD2' ' HE2' ' A' ' 125' ' ' LYS . 0.1 OUTLIER -76.45 164.78 25.65 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 121.524 -0.735 . . . . 0.0 109.832 170.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.45 141.83 23.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -145.1 164.91 29.8 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 125.981 1.712 . . . . 0.0 110.095 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -94.94 -54.59 3.4 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 46.7 p -106.96 157.56 17.69 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 118.778 0.717 . . . . 0.0 109.365 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 9.1 mm -58.65 -36.55 60.67 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 175.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 45.0 t -60.79 -41.59 95.9 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 118.933 -0.556 . . . . 0.0 110.654 -175.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -71.92 -21.49 61.61 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 124.163 0.915 . . . . 0.0 110.639 -176.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.733 ' O ' HG23 ' A' ' 122' ' ' VAL . . . -79.53 -54.07 6.25 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 104.12 -2.548 . . . . 0.0 104.12 176.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.97 -59.3 3.19 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 125.518 1.527 . . . . 0.0 111.774 -160.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -75.61 -19.21 59.38 Favored 'General case' 0 CA--C 1.521 -0.172 0 O-C-N 123.926 0.766 . . . . 0.0 112.299 -176.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -88.09 -51.49 5.77 Favored 'General case' 0 CA--C 1.495 -1.14 0 CA-C-O 118.568 -0.729 . . . . 0.0 110.134 -172.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.785 HG21 ' CE1' ' A' ' 56' ' ' PHE . 40.3 t -48.65 -39.44 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 126.439 1.896 . . . . 0.0 110.062 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -47.64 -43.11 25.76 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.545 1.138 . . . . 0.0 112.639 171.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -134.06 33.82 3.37 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.377 2.671 . . . . 0.0 112.752 -172.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.4 ' HE2' ' HD2' ' A' ' 110' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.235 0 C-N-CA 126.708 2.003 . . . . 0.0 113.977 -160.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.9 mtt . . . . . 0 N--CA 1.473 0.692 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -85.29 178.58 50.63 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 176.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.4 t -159.38 105.06 1.66 Allowed 'General case' 0 C--O 1.235 0.338 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 160.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.1 t0 53.38 177.34 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 128.451 2.701 . . . . 0.0 113.147 -172.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 47.1 mttt -152.41 98.32 2.37 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 125.965 1.706 . . . . 0.0 107.722 165.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 36.0 mm -126.7 134.73 65.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 11.3 p80 -75.33 -44.74 43.71 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 119.047 -0.502 . . . . 0.0 111.293 175.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 36.76 78.63 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 128.495 2.718 . . . . 0.0 112.123 -173.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -59.15 116.9 4.17 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.0 p-80 -153.47 162.21 41.5 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.121 -1.436 . . . . 0.0 107.121 158.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -127.3 88.36 2.79 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 178.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -87.13 -165.5 1.31 Allowed 'General case' 0 C--O 1.241 0.643 0 C-N-CA 124.296 1.038 . . . . 0.0 109.517 -173.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.25 157.22 29.34 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.346 -0.846 . . . . 0.0 109.42 154.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -120.23 94.22 48.55 Favored Pre-proline 0 N--CA 1.448 -0.564 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 170.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -77.25 52.42 3.85 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.727 2.951 . . . . 0.0 109.817 174.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -168.34 174.18 7.18 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.356 1.063 . . . . 0.0 111.682 -179.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.2 ttmm -136.56 173.17 11.99 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.222 2.209 . . . . 0.0 108.076 161.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 54.2 mt -135.33 144.96 32.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 129.015 2.926 . . . . 0.0 104.223 163.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.1 m -105.76 -130.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 173.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -50.59 -66.87 0.31 Allowed 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 126.917 2.087 . . . . 0.0 111.263 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -144.48 11.87 1.5 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.825 2.05 . . . . 0.0 111.82 178.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.627 HG11 ' CE2' ' A' ' 56' ' ' PHE . 8.9 t -119.26 135.44 59.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -177.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.51 HG13 ' HA ' ' A' ' 55' ' ' ILE . 0.6 OUTLIER -81.55 150.39 4.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 C-N-CA 128.337 2.655 . . . . 0.0 111.798 174.26 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.446 HD12 ' C ' ' A' ' 23' ' ' VAL . 4.1 mp -132.33 88.95 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 175.061 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.48 HD23 HG23 ' A' ' 55' ' ' ILE . 4.3 mm? -58.36 140.18 54.03 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 168.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 61.6 mtt -139.2 76.54 32.17 Favored Pre-proline 0 C--N 1.328 -0.339 0 C-N-CA 125.04 1.336 . . . . 0.0 108.483 176.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -75.49 68.02 6.22 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.574 2.183 . . . . 0.0 109.02 176.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.2 93.41 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.461 1.504 . . . . 0.0 107.861 176.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.25 -21.32 0.07 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 127.911 2.484 . . . . 0.0 114.8 -170.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.88 59.0 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 129.535 3.134 . . . . 0.0 113.837 -177.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 65.0 mt -127.98 23.41 6.13 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 119.516 -1.99 . . . . 0.0 112.21 175.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -53.3 150.21 6.51 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 164.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.7 mt -58.31 -37.95 66.21 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 CA-C-O 119.33 -0.367 . . . . 0.0 111.629 -174.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -68.33 -34.56 76.34 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 118.725 0.693 . . . . 0.0 109.343 -171.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -72.66 -43.72 62.78 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 171.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.41 -33.18 65.54 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.883 0.765 . . . . 0.0 111.626 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 25.5 t60 -70.06 -47.96 59.79 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 120.495 -1.378 . . . . 0.0 110.262 174.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.468 HD12 ' C ' ' A' ' 38' ' ' LEU . 0.5 OUTLIER -73.0 -17.34 61.46 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 118.968 -0.539 . . . . 0.0 111.727 -178.961 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -48.83 -55.78 10.62 Favored 'General case' 0 CA--C 1.513 -0.442 0 C-N-CA 127.999 2.52 . . . . 0.0 110.513 -170.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp -66.48 -28.99 69.01 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 117.86 -1.067 . . . . 0.0 111.047 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.7 ttmt -68.26 -51.99 38.97 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 121.157 1.799 . . . . 0.0 109.211 172.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.421 ' CH2' ' CD1' ' A' ' 25' ' ' LEU . 13.7 t90 -59.91 -59.45 5.4 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.229 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.0 t -50.41 -30.04 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 120.262 1.392 . . . . 0.0 112.199 176.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.442 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 3.6 m-85 -72.76 -69.84 0.39 Allowed 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 173.131 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.41 ' HA ' ' HB2' ' A' ' 49' ' ' ASN . 3.3 t0 -61.61 -35.86 79.06 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 124.289 1.036 . . . . 0.0 112.949 -167.086 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -75.69 -30.94 59.51 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.247 2.219 . . . . 0.0 111.284 175.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -132.02 -67.21 0.68 Allowed 'General case' 0 C--N 1.352 0.694 0 CA-C-N 120.682 1.583 . . . . 0.0 112.286 -174.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.442 ' HB2' ' HA ' ' A' ' 44' ' ' PHE . 6.5 mt -59.17 -48.76 80.41 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.372 0.987 . . . . 0.0 112.694 -170.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.41 ' HB2' ' HA ' ' A' ' 45' ' ' ASP . 76.4 m-20 -65.56 -34.5 78.39 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 125.428 1.491 . . . . 0.0 109.726 177.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.9 mttm -61.38 -21.64 64.25 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.802 1.241 . . . . 0.0 111.811 171.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.6 14.68 36.94 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.329 0.966 . . . . 0.0 112.485 -178.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -70.38 139.14 51.85 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 118.931 1.365 . . . . 0.0 108.085 166.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -119.42 6.02 11.13 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.592 1.157 . . . . 0.0 110.292 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt -146.87 98.05 2.99 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 120.27 1.395 . . . . 0.0 107.254 -167.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.51 ' HA ' HG13 ' A' ' 23' ' ' VAL . 1.2 mp -102.81 151.92 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.627 ' CE2' HG11 ' A' ' 22' ' ' VAL . 22.4 m-85 -123.2 160.42 26.59 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.965 0.79 . . . . 0.0 111.908 157.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.6 tp -125.3 122.48 37.01 Favored 'General case' 0 C--O 1.223 -0.324 0 C-N-CA 124.887 1.275 . . . . 0.0 109.221 171.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.423 HG12 ' H ' ' A' ' 60' ' ' SER . 15.6 t -95.06 141.74 14.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 173.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.486 HD22 HG11 ' A' ' 96' ' ' VAL . 4.3 mp -123.57 6.46 8.9 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.011 1.324 . . . . 0.0 111.133 -174.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.423 ' H ' HG12 ' A' ' 58' ' ' VAL . 2.4 t -54.66 -36.8 64.99 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.114 1.765 . . . . 0.0 111.737 174.228 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -104.76 18.71 21.79 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.113 0.965 . . . . 0.0 111.101 -165.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.4 p -151.18 122.84 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 123.551 0.74 . . . . 0.0 109.386 -175.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -73.24 -43.41 61.22 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 117.995 -1.003 . . . . 0.0 108.979 177.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.4 t -150.35 175.82 11.47 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 119.169 0.895 . . . . 0.0 111.962 -171.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.8 tt -140.91 149.85 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 -175.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -81.45 155.75 25.69 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 123.804 0.842 . . . . 0.0 109.743 -174.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.2 p -54.01 -25.8 22.98 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.068 1.347 . . . . 0.0 112.619 175.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -61.94 -63.24 1.32 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.366 1.466 . . . . 0.0 110.478 169.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 26.4 t -82.46 -22.95 34.99 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.591 1.157 . . . . 0.0 111.974 -163.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 40.8 tp -60.91 -16.66 44.63 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 120.549 -1.344 . . . . 0.0 111.609 170.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -91.85 -29.95 11.08 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-O 118.849 -0.973 . . . . 0.0 112.194 167.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -66.67 -37.23 79.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 119.551 1.676 . . . . 0.0 111.23 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.4 mm -59.68 -46.58 93.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 C-N-CA 124.6 1.16 . . . . 0.0 109.826 175.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 50.8 t -60.98 -41.51 89.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 174.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -55.96 -41.01 74.06 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.408 -0.807 . . . . 0.0 111.344 -176.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 71.1 mt -64.03 -39.75 86.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.719 0.808 . . . . 0.0 110.03 174.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.422 ' HG ' HG22 ' A' ' 109' ' ' VAL . 3.0 tm? -62.17 -49.25 76.58 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 119.705 1.139 . . . . 0.0 109.075 178.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -50.12 -55.53 14.63 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 123.475 0.71 . . . . 0.0 109.88 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.71 -39.9 95.45 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 117.569 -1.205 . . . . 0.0 112.365 -178.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 76.4 mt -64.32 -43.98 97.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 121.023 1.738 . . . . 0.0 109.85 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.3 m -56.8 -48.07 78.79 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.393 0.677 . . . . 0.0 110.899 172.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.4 m -71.77 -10.54 59.92 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.09 1.356 . . . . 0.0 113.935 178.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.2 m -99.7 -25.54 14.36 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.687 1.195 . . . . 0.0 111.94 175.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 120.19 2.61 12.22 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 116.435 1.334 . . . . 0.0 116.435 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -99.2 -158.83 29.17 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 119.682 1.741 . . . . 0.0 112.95 -171.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.503 ' CZ ' ' HE2' ' A' ' 125' ' ' LYS . 0.3 OUTLIER -139.93 160.11 40.67 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 127.0 2.12 . . . . 0.0 109.852 170.387 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -149.31 143.82 26.07 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 176.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.27 165.56 28.89 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.09 0.956 . . . . 0.0 112.157 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.405 ' N ' HD12 ' A' ' 89' ' ' LEU . 7.2 mp -113.72 156.39 23.87 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.753 2.021 . . . . 0.0 108.983 -175.08 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 57.7 t -146.79 149.39 15.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 123.432 0.693 . . . . 0.0 109.934 -159.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.2 t 49.14 54.89 16.83 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 125.029 1.332 . . . . 0.0 111.412 -175.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -82.54 81.7 2.41 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 122.344 2.029 . . . . 0.0 111.69 -164.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.0 156.54 9.13 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 122.044 0.926 . . . . 0.0 110.545 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -62.93 -33.68 75.85 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.803 -1.09 . . . . 0.0 112.241 -163.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.8 -41.59 97.88 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 123.67 0.788 . . . . 0.0 109.264 -174.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.486 HG11 HD22 ' A' ' 59' ' ' LEU . 17.9 t -70.63 -42.37 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-O 117.514 -1.232 . . . . 0.0 110.236 175.215 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -58.82 -28.65 66.23 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 120.127 1.331 . . . . 0.0 110.804 -172.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -51.08 -60.46 3.07 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-O 125.028 2.347 . . . . 0.0 111.454 173.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.446 ' O ' HG22 ' A' ' 103' ' ' THR . 4.7 t -71.08 -39.01 73.86 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.747 0 CA-C-N 112.508 -2.133 . . . . 0.0 107.454 -172.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.2 mt -61.79 -15.62 42.98 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 118.234 -0.888 . . . . 0.0 110.481 177.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.5 -46.1 10.49 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-O 121.32 0.581 . . . . 0.0 110.164 173.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.73 -62.53 1.8 Allowed 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.703 2.001 . . . . 0.0 108.425 -177.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.446 HG22 ' O ' ' A' ' 99' ' ' VAL . 0.6 OUTLIER -74.0 -5.76 43.33 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 129.129 2.972 . . . . 0.0 111.07 -169.28 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 49.99 77.73 0.11 Allowed 'General case' 0 C--N 1.344 0.361 0 C-N-CA 127.45 2.3 . . . . 0.0 109.437 -168.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.44 -57.08 2.17 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 173.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -65.52 -12.44 52.82 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 127.427 2.291 . . . . 0.0 112.462 175.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.4 mtt-85 -88.96 2.89 53.19 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.082 0.953 . . . . 0.0 113.08 171.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.8 mt -133.15 -43.08 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 125.098 1.359 . . . . 0.0 109.238 -173.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.422 HG22 ' HG ' ' A' ' 77' ' ' LEU . 2.1 t -114.16 141.73 29.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 125.501 1.52 . . . . 0.0 106.941 -177.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.46 159.64 23.9 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.618 0.767 . . . . 0.0 112.21 177.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -123.28 154.93 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 125.65 1.58 . . . . 0.0 106.98 169.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -147.44 162.97 37.94 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.98 1.712 . . . . 0.0 109.569 170.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -81.35 -53.24 6.49 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 119.464 -0.895 . . . . 0.0 109.361 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 67.6 p -129.44 161.58 30.06 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 125.327 1.451 . . . . 0.0 108.502 -169.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 26.7 mm -63.79 -38.89 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -173.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.9 t -74.38 -19.97 60.24 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 118.863 -1.135 . . . . 0.0 111.487 -174.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -70.22 -20.46 63.09 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 118.965 0.802 . . . . 0.0 111.173 170.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.457 ' HB1' ' CZ ' ' A' ' 56' ' ' PHE . . . -105.42 -39.83 6.01 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.997 0.919 . . . . 0.0 109.478 -169.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 5.0 ttm -58.36 -44.12 88.7 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 124.49 1.116 . . . . 0.0 111.972 -162.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -95.16 -10.49 30.39 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.347 1.059 . . . . 0.0 111.726 178.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -93.12 -50.67 5.4 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.041 -172.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.487 HG22 ' HB3' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -47.98 -37.43 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 125.73 1.612 . . . . 0.0 111.059 173.597 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -56.49 -32.78 65.35 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-O 118.494 -0.765 . . . . 0.0 111.684 176.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.73 29.42 2.35 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -175.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.503 ' HE2' ' CZ ' ' A' ' 86' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.175 0 C-N-CA 124.317 1.047 . . . . 0.0 110.059 -171.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.6 mtt . . . . . 0 N--CA 1.476 0.828 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 68.48 -166.99 44.88 Favored Glycine 0 CA--C 1.533 1.157 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -170.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.6 m -58.08 95.46 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.255 1.822 . . . . 0.0 113.814 -165.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.44 -43.98 84.37 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.693 1.597 . . . . 0.0 112.139 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.44 ' HE2' ' HA ' ' A' ' 5' ' ' LYS . 8.0 mmpt? 51.56 -170.66 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.426 1.091 . . . . 0.0 111.323 -164.179 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 37.5 pt -138.87 22.0 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 126.266 1.826 . . . . 0.0 109.88 -175.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -78.99 97.36 6.03 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.453 1.101 . . . . 0.0 108.077 178.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -57.63 111.36 1.1 Allowed 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.47 1.908 . . . . 0.0 109.427 -175.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -146.34 145.47 30.32 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.212 1.805 . . . . 0.0 106.897 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -148.4 171.3 16.25 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.045 0.938 . . . . 0.0 109.531 166.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -99.57 169.13 9.5 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 166.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -146.32 89.67 1.88 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 173.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -120.27 -165.47 1.19 Allowed 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.078 1.351 . . . . 0.0 108.183 169.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -53.3 108.13 1.03 Allowed Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 124.624 1.169 . . . . 0.0 109.934 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -85.68 -167.32 0.39 Allowed 'Trans proline' 0 N--CA 1.445 -1.34 0 C-N-CA 122.369 2.046 . . . . 0.0 110.15 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -48.94 156.48 0.5 Allowed 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 125.498 1.519 . . . . 0.0 114.186 170.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.6 ttmm -122.44 170.85 9.56 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 126.411 1.885 . . . . 0.0 108.667 167.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.7 mt -129.1 130.52 68.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 157.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.7 m -88.87 -141.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 125.311 1.444 . . . . 0.0 108.185 171.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -40.45 -78.38 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 127.585 2.354 . . . . 0.0 111.001 168.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -135.8 9.17 3.32 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 123.308 0.643 . . . . 0.0 111.87 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.765 HG11 ' CE2' ' A' ' 56' ' ' PHE . 21.7 t -106.25 135.16 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.2 t -84.98 147.52 5.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 171.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.8 mp -130.4 91.85 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 176.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.406 HD12 ' CH2' ' A' ' 42' ' ' TRP . 1.3 mm? -71.25 111.94 6.99 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 121.072 1.76 . . . . 0.0 108.983 171.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 4.1 mtt -106.11 91.39 5.46 Favored Pre-proline 0 CA--C 1.548 0.869 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.33 122.95 4.78 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.187 2.591 . . . . 0.0 111.499 -171.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.417 ' C ' ' HE2' ' A' ' 29' ' ' LYS . 0.4 OUTLIER -90.63 74.87 6.69 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 122.34 1.067 . . . . 0.0 111.746 175.959 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.417 ' HE2' ' C ' ' A' ' 28' ' ' ASN . 0.0 OUTLIER 55.72 16.9 2.16 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 119.891 -1.756 . . . . 0.0 113.137 -174.036 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -99.09 13.41 32.95 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 121.421 -0.799 . . . . 0.0 112.546 -161.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.95 72.25 6.7 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 171.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -92.35 148.5 22.07 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 169.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.571 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 0.5 OUTLIER -58.65 -34.45 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 120.345 1.43 . . . . 0.0 109.617 -177.31 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -64.47 -12.14 40.73 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 120.202 -1.561 . . . . 0.0 112.949 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -110.36 -26.71 9.42 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.452 1.501 . . . . 0.0 112.074 168.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.571 ' HB3' ' HA ' ' A' ' 33' ' ' ILE . . . -68.53 -37.57 80.12 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.099 -1.001 . . . . 0.0 111.194 178.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -55.49 -47.65 75.83 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.003 0.921 . . . . 0.0 109.368 168.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 73.0 mt -70.02 -24.01 63.21 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-O 118.081 -0.961 . . . . 0.0 112.496 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.43 ' HB2' ' HA ' ' A' ' 36' ' ' ALA . 1.0 OUTLIER -55.43 -38.25 68.74 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.805 1.242 . . . . 0.0 112.151 -162.363 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -56.87 -65.3 0.64 Allowed 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 118.384 -0.817 . . . . 0.0 109.107 167.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.2 tmtt? -50.74 -47.16 59.43 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 124.199 1.0 . . . . 0.0 111.029 -175.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.406 ' CH2' HD12 ' A' ' 25' ' ' LEU . 27.1 t90 -61.67 -67.5 0.4 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.809 1.244 . . . . 0.0 109.657 176.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 54.2 t -53.79 -33.22 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 121.411 1.914 . . . . 0.0 111.867 -176.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.442 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 3.8 m-85 -60.56 -75.17 0.07 Allowed 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 124.769 1.228 . . . . 0.0 109.581 171.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -70.75 -14.15 62.33 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.886 1.675 . . . . 0.0 113.871 -169.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.88 -33.43 16.46 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 120.739 -1.226 . . . . 0.0 109.865 175.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -136.67 -60.68 0.7 Allowed 'General case' 0 C--N 1.346 0.439 0 CA-C-N 118.86 0.754 . . . . 0.0 111.921 -169.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.442 ' HB2' ' HA ' ' A' ' 44' ' ' PHE . 10.1 mt -60.19 -55.93 27.72 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.463 1.029 . . . . 0.0 112.673 -173.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -66.41 -9.62 35.6 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.595 1.158 . . . . 0.0 110.973 174.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.13 -2.77 58.67 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.656 1.982 . . . . 0.0 111.81 171.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.85 5.45 59.82 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.913 1.244 . . . . 0.0 114.204 177.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -77.48 146.72 36.28 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 119.745 1.772 . . . . 0.0 110.017 176.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -138.45 14.48 2.77 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.525 1.93 . . . . 0.0 110.027 -172.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.595 ' HB3' HG13 ' A' ' 22' ' ' VAL . 0.9 OUTLIER -149.74 116.7 5.95 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 178.116 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.7 mp -120.8 152.7 23.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 175.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.765 ' CE2' HG11 ' A' ' 22' ' ' VAL . 21.9 m-85 -124.18 158.07 33.26 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.603 1.161 . . . . 0.0 110.082 161.052 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 54.2 tp -118.09 122.97 44.45 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.963 1.705 . . . . 0.0 107.422 173.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . 0.252 0.7 OUTLIER -95.09 157.48 3.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 119.921 1.237 . . . . 0.0 109.927 174.349 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 24.3 mt -132.24 13.69 4.64 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.226 0.611 . . . . 0.0 111.359 -168.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.1 m -81.53 -46.48 14.43 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -173.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -88.2 -23.12 23.67 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.454 1.025 . . . . 0.0 110.7 -173.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.0 p -78.74 162.66 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 125.538 1.535 . . . . 0.0 109.776 169.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -116.99 -37.51 3.57 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.443 0.697 . . . . 0.0 110.516 170.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.87 176.07 13.04 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 122.438 1.113 . . . . 0.0 110.123 177.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.4 tt -132.6 160.0 42.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 127.361 2.264 . . . . 0.0 108.05 -172.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.453 ' C ' ' H ' ' A' ' 68' ' ' PHE . 35.6 t0 -96.24 168.79 10.37 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 119.625 -1.922 . . . . 0.0 109.79 -168.025 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.5 m -65.25 31.26 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 128.954 2.902 . . . . 0.0 112.052 165.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.453 ' H ' ' C ' ' A' ' 66' ' ' ASP . 43.5 t80 -132.08 -67.72 0.66 Allowed 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 172.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.28 -25.01 61.43 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.443 -166.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.48 HD11 HG21 ' A' ' 103' ' ' THR . 33.1 tp -55.3 -33.09 62.96 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 120.601 -1.312 . . . . 0.0 110.95 171.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -95.32 1.99 65.0 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 125.111 1.339 . . . . 0.0 114.709 174.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -92.63 -32.79 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 120.181 1.991 . . . . 0.0 109.544 167.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -56.69 -53.02 46.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.339 1.056 . . . . 0.0 109.13 177.233 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.0 t -59.33 -39.95 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 O-C-N 121.515 -0.741 . . . . 0.0 110.374 176.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -54.94 -38.68 68.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 119.207 0.912 . . . . 0.0 112.231 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 80.5 mt -69.61 -34.21 60.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -63.43 -50.33 70.22 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 119.846 1.203 . . . . 0.0 109.278 175.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -53.31 -48.13 68.67 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.056 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.4 t -58.09 -61.38 2.59 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.395 1.878 . . . . 0.0 111.264 176.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 59.7 mt -54.84 -45.87 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 119.646 1.112 . . . . 0.0 110.798 -177.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.3 t -61.88 -41.04 97.4 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.44 -23.71 65.55 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.133 0.973 . . . . 0.0 113.348 173.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.0 m -79.0 -25.4 43.32 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 118.02 -0.99 . . . . 0.0 112.388 171.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 103.67 15.78 21.69 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.5 -1.167 . . . . 0.0 113.954 -170.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -98.08 -168.28 31.86 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 120.322 2.061 . . . . 0.0 112.586 174.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -133.51 162.65 31.3 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.031 1.333 . . . . 0.0 108.501 168.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -147.88 147.1 29.39 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.298 1.039 . . . . 0.0 108.222 176.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.414 ' C ' HD23 ' A' ' 89' ' ' LEU . . . -152.21 172.64 16.08 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.089 1.356 . . . . 0.0 110.72 178.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.414 HD23 ' C ' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -116.15 171.47 7.79 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 118.588 0.631 . . . . 0.0 109.831 -178.146 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 86.1 t -146.69 144.06 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.821 1.248 . . . . 0.0 109.83 -168.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 44.09 60.07 12.22 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 127.815 2.446 . . . . 0.0 113.942 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -84.51 92.56 0.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 124.545 3.496 . . . . 0.0 110.141 -170.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.65 160.32 14.31 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 121.848 -0.532 . . . . 0.0 110.269 177.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -63.74 -34.89 78.89 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.779 0.832 . . . . 0.0 111.167 -167.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.47 ' HE2' ' O ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -59.34 -29.99 68.06 Favored 'General case' 0 CA--C 1.517 -0.321 0 O-C-N 121.006 -1.059 . . . . 0.0 109.439 178.903 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.2 t -92.57 -37.48 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-O 117.911 -1.042 . . . . 0.0 110.283 177.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -59.55 -33.31 71.25 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 121.806 2.094 . . . . 0.0 109.723 175.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.64 -27.33 67.6 Favored 'General case' 0 C--O 1.222 -0.349 0 O-C-N 121.234 -0.916 . . . . 0.0 112.463 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.621 ' O ' HG22 ' A' ' 103' ' ' THR . 7.3 p -95.39 -39.65 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -178.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.418 HD23 HG13 ' A' ' 99' ' ' VAL . 0.2 OUTLIER -59.41 -15.66 18.34 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.075 1.75 . . . . 0.0 111.955 177.649 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.0 t -93.51 -52.85 4.3 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -53.75 -44.81 70.28 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 128.472 2.709 . . . . 0.0 111.805 -177.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.621 HG22 ' O ' ' A' ' 99' ' ' VAL . 10.1 t -79.52 -17.42 54.1 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 118.843 -0.598 . . . . 0.0 111.299 -178.386 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 63.67 94.21 0.05 Allowed 'General case' 0 C--N 1.34 0.153 0 C-N-CA 127.098 2.159 . . . . 0.0 108.253 -157.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.98 -57.01 1.26 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.502 1.521 . . . . 0.0 108.575 170.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -57.33 -32.56 66.83 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 122.478 1.132 . . . . 0.0 111.098 171.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 60.6 mtt180 -71.36 -1.68 13.79 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 120.499 -1.376 . . . . 0.0 111.922 178.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.7 mt -122.62 -39.06 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 125.874 1.67 . . . . 0.0 108.714 -175.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.4 t -125.7 144.77 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 124.861 1.264 . . . . 0.0 108.775 -175.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.75 160.32 28.4 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.594 0.757 . . . . 0.0 111.328 176.001 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.94 142.17 34.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -173.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -146.82 176.18 10.07 Favored 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 125.189 1.396 . . . . 0.0 110.98 -176.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -103.56 -43.14 5.46 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 118.365 0.53 . . . . 0.0 111.797 -175.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 30.6 p -109.22 -162.4 0.81 Allowed 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -176.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 27.1 mm -92.01 -39.89 11.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 117.371 -1.299 . . . . 0.0 111.322 160.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.0 t -68.76 -34.77 76.14 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 120.916 1.689 . . . . 0.0 111.052 -168.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -69.06 -15.73 63.52 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 118.934 0.788 . . . . 0.0 111.696 176.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.663 ' O ' HG23 ' A' ' 122' ' ' VAL . . . -91.12 -54.24 4.03 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 176.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 6.6 ttm -54.0 -39.48 66.12 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 124.84 1.256 . . . . 0.0 112.001 -163.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -93.49 -10.61 34.34 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.985 0.914 . . . . 0.0 113.392 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -92.24 -58.24 2.45 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 118.35 -0.833 . . . . 0.0 108.775 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.747 HG21 ' CE1' ' A' ' 56' ' ' PHE . 48.1 t -41.62 -44.39 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 128.456 2.702 . . . . 0.0 110.824 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . 0.251 1.5 ptp180 -53.12 -26.13 15.59 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.09 41.64 0.44 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 127.852 2.461 . . . . 0.0 111.371 -178.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.929 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 172.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.1 mtt . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 87.11 -98.9 2.42 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 106.211 -2.755 . . . . 0.0 106.211 -151.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.1 m 63.34 166.74 0.13 Allowed 'General case' 0 C--O 1.233 0.201 0 C-N-CA 126.948 2.099 . . . . 0.0 113.575 -173.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.82 162.57 0.41 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.134 1.774 . . . . 0.0 110.575 156.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? 58.34 15.78 3.65 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.38 1.472 . . . . 0.0 114.012 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.1 tt -47.97 -36.5 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -165.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -138.5 -84.75 0.28 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-N 119.878 1.217 . . . . 0.0 109.134 170.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -139.21 -172.96 3.46 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.633 1.973 . . . . 0.0 106.891 -178.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -132.42 154.02 50.24 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.169 0.988 . . . . 0.0 108.556 173.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -141.49 152.63 44.34 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.093 1.757 . . . . 0.0 106.478 175.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 50.53 76.46 0.15 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.842 1.657 . . . . 0.0 111.184 -172.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -135.99 122.75 21.12 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 173.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -117.48 95.28 4.89 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 105.809 -1.922 . . . . 0.0 105.809 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -55.06 168.26 0.55 Allowed Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 128.345 2.658 . . . . 0.0 111.714 -176.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.35 98.06 0.38 Allowed 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.135 1.89 . . . . 0.0 110.502 169.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -145.84 167.08 24.09 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.993 1.317 . . . . 0.0 110.188 176.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt -131.97 171.01 14.11 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.733 0.813 . . . . 0.0 110.942 174.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.3 mt -129.61 110.55 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 104.651 -2.351 . . . . 0.0 104.651 176.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.4 m -93.38 -134.93 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 119.562 1.074 . . . . 0.0 109.172 176.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -45.83 -78.72 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 127.827 2.451 . . . . 0.0 111.785 172.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -137.76 15.3 2.9 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.281 1.832 . . . . 0.0 109.678 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.681 HG11 ' CE2' ' A' ' 56' ' ' PHE . 11.9 t -121.6 133.55 67.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -168.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 74.6 t -92.22 131.22 39.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.416 HG13 HD12 ' A' ' 115' ' ' ILE . 1.9 mp -112.48 103.63 15.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 176.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.7 137.35 45.92 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 161.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 13.8 mtt -139.96 79.98 21.62 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.57 -98.81 0.01 OUTLIER 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 121.452 1.435 . . . . 0.0 111.508 -170.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.474 ' ND2' ' H ' ' A' ' 29' ' ' LYS . 18.8 p-10 155.82 -106.18 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 O-C-N 119.38 -2.075 . . . . 0.0 107.688 -163.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.474 ' H ' ' ND2' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -126.94 25.68 6.25 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.205 1.802 . . . . 0.0 108.888 167.25 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -63.19 -16.99 61.9 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.869 1.268 . . . . 0.0 111.711 170.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.6 mp -74.09 67.96 1.37 Allowed 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 169.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -124.59 7.44 8.24 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.775 2.03 . . . . 0.0 113.312 -175.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 94.87 -24.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.563 1 C-N-CA 135.457 5.503 . . . . 0.0 110.113 -176.438 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -71.94 -18.69 61.99 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 120.871 -1.143 . . . . 0.0 111.778 -175.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -98.98 -31.21 11.92 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 173.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.15 -41.74 94.46 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 113.647 0.981 . . . . 0.0 113.647 -159.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -64.3 -43.79 93.66 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.981 1.264 . . . . 0.0 110.146 -177.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.01 -22.33 49.46 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.593 -178.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -41.86 -54.27 3.47 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 127.585 2.354 . . . . 0.0 111.972 -171.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.2 pttt -68.99 -41.22 78.14 Favored 'General case' 0 C--O 1.217 -0.609 0 CA-C-O 118.15 -0.929 . . . . 0.0 111.273 -178.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.72 -44.04 90.3 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 120.31 1.414 . . . . 0.0 110.939 178.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 7.1 t90 -58.13 -66.14 0.53 Allowed 'General case' 0 C--O 1.223 -0.341 0 CA-C-O 117.364 -1.303 . . . . 0.0 108.515 171.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 51.3 t -49.44 -38.28 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 120.049 1.295 . . . . 0.0 112.282 -176.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -60.73 -62.68 1.69 Allowed 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 125.106 1.362 . . . . 0.0 109.294 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -70.61 -44.16 67.83 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 118.852 0.751 . . . . 0.0 111.218 -174.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -61.07 -33.95 74.14 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.914 1.285 . . . . 0.0 110.523 -174.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -136.41 -52.56 0.72 Allowed 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -171.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 39.3 mt -63.46 -37.93 89.18 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.207 0.912 . . . . 0.0 111.075 -173.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -84.67 -9.39 58.3 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.158 1.383 . . . . 0.0 110.549 176.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.3 mttt -82.38 3.83 26.41 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.614 1.566 . . . . 0.0 111.148 156.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.95 4.33 88.52 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 125.374 1.464 . . . . 0.0 114.344 176.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -68.89 112.23 5.43 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 119.541 1.671 . . . . 0.0 109.303 176.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 -107.63 16.65 23.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.889 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.494 ' HB3' HG13 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -132.48 126.05 32.09 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 121.106 -0.996 . . . . 0.0 108.743 164.993 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.434 HD12 HD11 ' A' ' 80' ' ' ILE . 5.8 mt -128.44 160.19 38.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 126.303 1.841 . . . . 0.0 106.64 172.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.681 ' CE2' HG11 ' A' ' 22' ' ' VAL . 24.3 m-85 -132.42 159.22 39.92 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.016 1.326 . . . . 0.0 111.351 161.043 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 56.2 tp -127.86 87.19 2.57 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.227 0.611 . . . . 0.0 109.418 171.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.576 HG12 ' H ' ' A' ' 60' ' ' SER . 91.2 t -52.1 151.8 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 126.163 1.785 . . . . 0.0 108.326 167.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.6 mt -135.68 18.68 3.3 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.619 1.968 . . . . 0.0 110.292 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.576 ' H ' HG12 ' A' ' 58' ' ' VAL . 67.3 m -54.1 -54.11 43.95 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 125.071 1.348 . . . . 0.0 111.281 -169.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.41 ' O ' ' HE2' ' A' ' 29' ' ' LYS . 7.0 t0 -97.41 9.61 41.89 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 123.338 0.655 . . . . 0.0 111.339 175.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 17.6 t -98.62 100.56 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 104.312 -2.477 . . . . 0.0 104.312 -176.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -57.82 -49.87 75.19 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.6 t -152.88 164.42 37.92 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 123.1 1.429 . . . . 0.0 112.861 -175.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.4 tt -95.06 -162.77 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 126.877 2.071 . . . . 0.0 106.838 161.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -143.21 166.67 24.06 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.244 1.417 . . . . 0.0 109.737 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.6 t -53.03 -32.73 48.32 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.14 1.776 . . . . 0.0 112.171 176.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -66.14 -60.12 3.11 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 119.376 0.989 . . . . 0.0 109.697 173.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.05 -19.37 47.75 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -163.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 18.7 mt -55.21 -32.66 62.43 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.405 -0.809 . . . . 0.0 110.766 169.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -69.35 -44.23 66.26 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-O 118.832 -0.982 . . . . 0.0 111.474 170.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.57 -32.88 51.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 119.213 1.506 . . . . 0.0 110.759 -169.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -58.51 -53.18 50.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 125.069 1.348 . . . . 0.0 109.391 175.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 38.2 t -60.98 -38.76 80.16 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.618 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 173.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.1 -38.02 81.72 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 120.278 -1.514 . . . . 0.0 112.073 -176.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 70.6 mt -67.43 -36.19 75.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.288 1.035 . . . . 0.0 110.073 172.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.478 HD22 HG22 ' A' ' 109' ' ' VAL . 20.0 tp -60.81 -50.5 73.2 Favored 'General case' 0 C--O 1.219 -0.544 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 175.026 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 44.2 mttt -62.35 4.48 0.14 Allowed 'General case' 0 C--O 1.234 0.257 0 C-N-CA 126.409 1.884 . . . . 0.0 114.316 178.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.5 t -103.99 -58.8 1.82 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 167.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.434 HD11 HD12 ' A' ' 55' ' ' ILE . 78.3 mt -55.59 -35.82 39.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 125.305 1.442 . . . . 0.0 111.319 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.2 p -53.88 -58.35 7.59 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 126.048 1.739 . . . . 0.0 108.688 -177.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.7 t -61.93 -39.86 93.53 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 127.968 2.507 . . . . 0.0 110.899 -178.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.1 -23.47 67.16 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 175.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.29 17.58 49.63 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-O 118.637 -1.091 . . . . 0.0 112.933 -174.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -89.8 -173.78 45.49 Favored Glycine 0 N--CA 1.438 -1.195 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 172.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.432 ' HB3' HG22 ' A' ' 122' ' ' VAL . 2.5 m-85 -131.75 148.98 52.61 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 125.547 1.539 . . . . 0.0 109.539 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -143.96 149.96 37.58 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.27 1.028 . . . . 0.0 108.425 176.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.555 ' C ' HD23 ' A' ' 89' ' ' LEU . . . -154.18 168.4 26.67 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.972 0.909 . . . . 0.0 111.77 177.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.555 HD23 ' C ' ' A' ' 88' ' ' ALA . 1.5 mt -113.47 171.74 7.38 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 177.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.508 HG13 ' N ' ' A' ' 58' ' ' VAL . 0.5 OUTLIER -152.43 146.65 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 C-N-CA 123.898 0.879 . . . . 0.0 110.227 -166.327 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.7 t 43.92 54.11 11.1 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 126.122 1.769 . . . . 0.0 110.264 177.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.439 ' O ' HG22 ' A' ' 96' ' ' VAL . 25.3 Cg_endo -61.89 -30.96 84.63 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.976 2.451 . . . . 0.0 112.335 -169.03 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 63.14 165.58 0.12 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 123.962 1.839 . . . . 0.0 110.755 -161.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -54.36 -33.98 60.2 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 112.343 -2.208 . . . . 0.0 110.666 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.63 -41.58 21.26 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 124.439 1.096 . . . . 0.0 112.067 -158.329 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 92' ' ' PRO . 18.9 m -75.06 -44.33 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.732 0 CA-C-O 118.085 -0.96 . . . . 0.0 110.483 171.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.87 -29.76 63.24 Favored 'General case' 0 N--CA 1.461 0.09 0 C-N-CA 124.334 1.054 . . . . 0.0 108.79 -170.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.34 -62.74 1.14 Allowed 'General case' 0 N--CA 1.428 -1.555 0 C-N-CA 126.153 1.781 . . . . 0.0 112.342 168.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.7 t -72.66 -39.89 61.27 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 CA-C-N 112.365 -2.198 . . . . 0.0 108.295 -173.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.413 ' HB3' ' H ' ' A' ' 106' ' ' ASP . 0.7 OUTLIER -58.67 -17.51 23.11 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.755 1.222 . . . . 0.0 109.236 177.391 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.5 -1.89 43.11 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-O 121.607 0.718 . . . . 0.0 112.467 179.347 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.8 mt -119.45 -42.78 2.63 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 127.187 2.195 . . . . 0.0 109.854 -174.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.1 t -87.23 0.16 55.78 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.978 2.511 . . . . 0.0 111.341 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 42.94 84.35 0.02 OUTLIER 'General case' 0 C--N 1.344 0.351 0 C-N-CA 126.949 2.1 . . . . 0.0 111.808 -168.02 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.73 -64.41 1.32 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.937 1.295 . . . . 0.0 108.704 170.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.413 ' H ' ' HB3' ' A' ' 100' ' ' LEU . 3.3 t70 -58.9 -29.03 66.75 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.537 0.735 . . . . 0.0 110.483 172.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 26.3 mtp180 -69.12 1.31 3.7 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.903 -1.123 . . . . 0.0 112.147 176.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.8 mt -130.35 -38.77 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 126.696 1.999 . . . . 0.0 109.663 -176.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.478 HG22 HD22 ' A' ' 77' ' ' LEU . 2.2 t -122.09 153.14 26.33 Favored 'Isoleucine or valine' 0 C--N 1.342 0.242 0 C-N-CA 125.299 1.44 . . . . 0.0 110.149 -169.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.43 155.49 35.3 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.236 1.014 . . . . 0.0 112.511 173.121 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -147.22 147.78 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 126.43 1.892 . . . . 0.0 107.478 -178.245 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -144.14 169.89 17.0 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.195 1.398 . . . . 0.0 111.571 -175.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -86.65 -37.7 17.77 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 175.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.3 p -137.3 175.91 9.19 Favored 'General case' 0 C--N 1.334 -0.079 0 C-N-CA 124.168 0.987 . . . . 0.0 111.145 -168.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.472 HD11 ' CG2' ' A' ' 58' ' ' VAL . 10.7 mm -72.74 -40.08 60.81 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 CA-C-O 118.479 -0.772 . . . . 0.0 109.918 176.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.3 t -73.2 -32.33 64.73 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 119.294 0.952 . . . . 0.0 109.965 -171.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -66.65 -10.08 42.47 Favored 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 123.436 0.694 . . . . 0.0 112.036 170.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -102.91 -47.62 4.32 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 -178.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -58.08 -54.39 47.47 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 126.565 1.946 . . . . 0.0 113.676 -160.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -87.47 -12.34 46.3 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.01 1.724 . . . . 0.0 111.25 179.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -91.78 -53.3 4.35 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 124.596 1.158 . . . . 0.0 107.941 -166.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.432 HG22 ' HB3' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -55.06 -23.73 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 128.649 2.78 . . . . 0.0 112.785 176.126 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 78.8 mtt180 -59.66 -28.48 67.29 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 118.46 -0.781 . . . . 0.0 111.718 169.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.34 26.22 3.81 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 126.5 1.92 . . . . 0.0 115.009 -176.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.6 mmtm . . . . . 0 C--O 1.249 1.069 0 C-N-CA 126.236 1.814 . . . . 0.0 106.724 -176.901 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.2 mtp . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -62.67 171.37 11.38 Favored Glycine 0 CA--C 1.535 1.301 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 145.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.9 p -150.13 121.04 7.63 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.443 1.097 . . . . 0.0 108.574 -171.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -101.13 -61.66 1.34 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.054 1.742 . . . . 0.0 109.566 173.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.3 ptmm? 43.76 166.21 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 129.423 3.089 . . . . 0.0 114.003 -153.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.0 tp -143.71 152.48 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 171.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -136.71 -64.45 0.58 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.161 0.984 . . . . 0.0 108.588 -175.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 61.78 158.73 0.05 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.427 1.891 . . . . 0.0 112.36 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.07 110.95 5.44 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 171.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 26.3 m170 -133.17 172.67 12.35 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 125.802 1.641 . . . . 0.0 108.318 168.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.467 ' HB2' ' CZ ' ' A' ' 14' ' ' PHE . 2.4 p-80 -156.16 -41.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 126.253 1.821 . . . . 0.0 110.973 174.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 44.7 m-70 58.92 -71.15 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 127.513 2.325 . . . . 0.0 113.084 -174.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.8 mtt -155.39 166.64 32.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 120.573 1.533 . . . . 0.0 108.276 173.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.467 ' CZ ' ' HB2' ' A' ' 11' ' ' HIS . 23.2 m-85 -129.95 86.19 55.46 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 123.459 0.703 . . . . 0.0 109.19 -176.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -77.89 51.68 3.71 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 124.461 3.441 . . . . 0.0 110.769 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -163.95 177.31 8.63 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 120.486 -1.384 . . . . 0.0 108.877 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -141.85 175.96 9.31 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.437 1.495 . . . . 0.0 108.503 156.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.2 mt -127.77 138.22 55.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 167.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.0 m -114.08 -156.74 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 C-N-CA 126.356 1.862 . . . . 0.0 107.727 168.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -42.21 -63.02 0.81 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 120.978 1.717 . . . . 0.0 114.641 -162.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -133.82 19.23 3.84 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.689 1.596 . . . . 0.0 110.973 170.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.694 HG11 ' CE2' ' A' ' 56' ' ' PHE . 4.2 t -132.59 119.07 37.14 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 123.137 1.446 . . . . 0.0 109.924 -168.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.526 ' O ' HD13 ' A' ' 24' ' ' ILE . 0.6 OUTLIER -67.06 150.3 11.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 127.425 2.29 . . . . 0.0 112.383 169.156 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.673 HD12 HD12 ' A' ' 115' ' ' ILE . 4.4 mm -135.68 96.38 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 174.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.495 HD23 HG23 ' A' ' 55' ' ' ILE . 4.3 mm? -59.99 132.24 53.32 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 164.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 24.8 mmm -127.79 81.32 70.5 Favored Pre-proline 0 C--O 1.234 0.245 0 C-N-CA 126.111 1.764 . . . . 0.0 106.91 178.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -61.69 143.8 96.76 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 122.267 1.978 . . . . 0.0 109.053 170.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.02 -83.11 0.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 179.122 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.74 1.53 14.18 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.286 1.034 . . . . 0.0 112.035 172.128 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -67.62 -34.78 77.66 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -171.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 31' ' ' LEU . 1.6 tp -73.22 -81.28 0.06 Allowed 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -153.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 34.24 41.38 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 130.062 3.345 . . . . 0.0 114.361 154.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER 61.31 -31.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 130.54 3.536 . . . . 0.0 115.416 -170.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -54.12 -34.65 60.82 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.505 1.122 . . . . 0.0 112.332 -175.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -122.4 60.37 1.0 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -173.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.45 -65.87 1.14 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 118.769 -0.634 . . . . 0.0 111.512 -177.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -60.32 -28.38 68.09 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.073 1.306 . . . . 0.0 111.887 173.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.71 ' H ' HD22 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -78.95 -31.15 44.97 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 117.65 -1.167 . . . . 0.0 110.206 176.969 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -45.37 -52.66 9.65 Favored 'General case' 0 CA--C 1.508 -0.649 0 O-C-N 124.362 1.039 . . . . 0.0 110.033 178.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.39 -45.98 90.7 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 117.544 -1.217 . . . . 0.0 110.027 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -61.4 -46.95 88.02 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 119.94 1.245 . . . . 0.0 111.38 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.452 ' CH2' ' CD1' ' A' ' 25' ' ' LEU . 15.7 t90 -62.86 -60.79 3.0 Favored 'General case' 0 C--O 1.215 -0.715 0 CA-C-O 117.436 -1.269 . . . . 0.0 108.796 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.7 t -54.16 -30.0 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 CA-C-N 121.468 1.94 . . . . 0.0 111.706 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -66.61 -65.49 0.67 Allowed 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 120.723 -1.236 . . . . 0.0 110.481 170.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -66.63 -37.4 84.77 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.353 1.461 . . . . 0.0 111.781 -171.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -73.14 -31.86 64.54 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 127.941 2.496 . . . . 0.0 111.996 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -129.38 -58.1 1.13 Allowed 'General case' 0 C--N 1.343 0.322 0 CA-C-N 119.596 1.089 . . . . 0.0 111.605 -171.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.0 mt -64.97 -31.54 72.83 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 121.674 -0.641 . . . . 0.0 111.986 -175.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -80.44 -19.44 46.1 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 118.405 -0.807 . . . . 0.0 111.031 176.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.06 -5.22 55.47 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 127.073 2.149 . . . . 0.0 114.128 167.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.03 6.26 79.37 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-O 118.68 -1.067 . . . . 0.0 114.38 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -66.02 143.18 57.52 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 119.29 1.545 . . . . 0.0 109.861 175.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.56 22.99 3.16 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.579 1.551 . . . . 0.0 109.059 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.448 ' HB3' HG13 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -151.84 98.82 2.51 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 174.121 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.495 HG23 HD23 ' A' ' 25' ' ' LEU . 1.3 mp -96.25 152.64 3.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 172.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.695 ' CE1' HG21 ' A' ' 122' ' ' VAL . 12.0 m-30 -125.68 164.35 20.8 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.704 -0.798 . . . . 0.0 112.524 162.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 21.9 tp -129.11 129.1 44.77 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 124.174 0.989 . . . . 0.0 109.364 167.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.8 t -99.91 139.99 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 167.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.49 HD22 HG11 ' A' ' 96' ' ' VAL . 3.8 mp -120.64 54.04 1.08 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.437 1.017 . . . . 0.0 110.122 178.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 26.0 t -109.16 -47.32 3.44 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.879 1.272 . . . . 0.0 110.77 -168.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -72.84 -49.93 27.2 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 1.8 p -68.95 141.58 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 124.581 1.153 . . . . 0.0 109.111 171.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -79.0 -36.81 40.62 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 119.153 -0.451 . . . . 0.0 110.009 167.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.579 ' CB ' ' HE2' ' A' ' 95' ' ' LYS . 10.7 t -165.36 159.73 17.43 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 122.706 1.241 . . . . 0.0 113.168 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.543 HG22 HG21 ' A' ' 96' ' ' VAL . 14.0 tt -79.57 169.94 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 C-N-CA 128.257 2.623 . . . . 0.0 109.219 166.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.0 164.14 12.68 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.124 1.37 . . . . 0.0 109.809 177.258 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.45 ' HA ' HD12 ' A' ' 70' ' ' LEU . 95.2 p -63.24 -24.22 67.78 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -175.252 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -60.56 -72.01 0.12 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.799 0.84 . . . . 0.0 108.858 171.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.0 t -70.76 -15.18 62.66 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -173.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 67' ' ' SER . 2.7 mt -46.27 -37.49 7.36 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.699 1.136 . . . . 0.0 110.844 169.042 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.61 -22.18 51.32 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 123.136 0.398 . . . . 0.0 113.971 -178.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 52.9 t -79.12 -35.45 17.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.515 1.126 . . . . 0.0 109.181 177.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 16.7 mm -56.53 -47.45 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 123.499 0.72 . . . . 0.0 110.667 174.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.9 t -62.43 -40.44 88.06 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.266 0 O-C-N 121.558 -0.714 . . . . 0.0 109.739 176.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -52.02 -46.85 65.13 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.466 1.03 . . . . 0.0 112.309 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.3 mt -56.65 -41.32 73.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.374 1.47 . . . . 0.0 110.097 175.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -66.67 -46.87 74.26 Favored 'General case' 0 CA--C 1.52 -0.209 0 O-C-N 121.494 -0.754 . . . . 0.0 109.621 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -55.72 -50.86 69.2 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 118.757 -0.64 . . . . 0.0 110.472 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 33.1 t -53.14 -52.05 59.97 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 124.845 1.34 . . . . 0.0 109.214 178.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 21.6 mt -63.29 -46.9 94.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 C-N-CA 123.467 0.707 . . . . 0.0 110.69 -174.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -51.45 -55.36 19.23 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.798 0.839 . . . . 0.0 110.461 171.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.6 m -65.3 -17.48 64.54 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.227 1.011 . . . . 0.0 113.504 -178.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.5 m -83.84 -47.26 11.28 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.789 0.836 . . . . 0.0 110.915 178.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 133.32 -1.0 4.42 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 118.295 -1.28 . . . . 0.0 113.75 -166.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -101.73 -169.41 27.56 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-N 120.208 2.004 . . . . 0.0 112.509 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.593 ' CZ ' ' HE2' ' A' ' 125' ' ' LYS . 0.1 OUTLIER -135.41 165.71 24.85 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 126.869 2.068 . . . . 0.0 110.8 171.615 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -155.25 141.76 18.75 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 177.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.79 168.6 23.93 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.268 0.627 . . . . 0.0 112.186 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 mt -116.16 164.17 14.88 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.502 1.121 . . . . 0.0 109.438 -171.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.703 HG21 HD13 ' A' ' 115' ' ' ILE . 79.6 t -146.13 154.87 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 126.049 1.74 . . . . 0.0 109.998 -169.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 t 46.93 58.4 17.07 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 127.772 2.429 . . . . 0.0 112.15 173.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -76.73 97.31 1.13 Allowed 'Trans proline' 0 N--CA 1.445 -1.363 0 C-N-CA 122.148 1.898 . . . . 0.0 111.23 -177.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.43 158.73 5.4 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 119.251 -0.98 . . . . 0.0 109.723 162.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -69.65 -29.45 66.92 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.339 1.056 . . . . 0.0 111.834 -167.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.579 ' HE2' ' CB ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -56.99 -51.93 67.29 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -173.177 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.543 HG21 HG22 ' A' ' 65' ' ' ILE . 0.5 OUTLIER -78.76 -41.03 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 124.057 0.848 . . . . 0.0 110.286 -173.515 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.97 -33.65 18.45 Favored 'General case' 0 CA--C 1.503 -0.827 0 C-N-CA 124.456 1.103 . . . . 0.0 110.836 175.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -53.98 47.13 Favored 'General case' 0 N--CA 1.417 -2.121 0 CA-C-O 123.368 1.556 . . . . 0.0 113.107 178.04 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.53 ' O ' HG22 ' A' ' 103' ' ' THR . 15.0 t -69.69 -43.52 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.832 0 CA-C-N 111.346 -2.661 . . . . 0.0 106.58 -172.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.412 HD21 HG22 ' A' ' 96' ' ' VAL . 0.4 OUTLIER -55.36 -28.87 56.76 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.933 1.293 . . . . 0.0 108.755 175.264 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.7 m -92.01 4.09 53.81 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.374 1.47 . . . . 0.0 112.729 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 94.1 mt -125.06 -20.76 4.83 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 127.752 2.421 . . . . 0.0 111.769 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.53 HG22 ' O ' ' A' ' 99' ' ' VAL . 7.2 t -111.69 2.24 17.12 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.751 1.62 . . . . 0.0 112.029 -174.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 54.17 87.73 0.04 OUTLIER 'General case' 0 C--N 1.342 0.247 0 C-N-CA 126.541 1.936 . . . . 0.0 109.887 -172.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.73 -57.2 1.45 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 118.544 -0.741 . . . . 0.0 109.702 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.85 -35.29 44.18 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 123.302 1.525 . . . . 0.0 110.585 164.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -72.05 -1.68 15.62 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 120.834 -1.167 . . . . 0.0 111.832 -177.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.7 mt -126.46 -38.63 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 126.34 1.856 . . . . 0.0 109.628 -175.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.2 t -118.21 145.68 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 125.696 1.598 . . . . 0.0 109.332 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -68.14 154.38 41.81 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 123.384 0.673 . . . . 0.0 110.199 174.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -141.98 149.35 19.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -173.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -147.65 165.69 29.67 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.122 1.369 . . . . 0.0 109.434 -172.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -84.66 -46.69 11.24 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 45.3 p -119.35 170.37 9.18 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.232 1.413 . . . . 0.0 108.638 -174.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.703 HD13 HG21 ' A' ' 90' ' ' VAL . 8.9 mm -66.95 -42.02 88.24 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.81 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 167.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 48.2 t -67.98 -37.7 81.81 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.787 1.176 . . . . 0.0 110.712 -165.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -63.51 -28.02 69.66 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 118.184 0.447 . . . . 0.0 110.259 176.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.646 ' O ' HG23 ' A' ' 122' ' ' VAL . . . -80.69 -54.99 5.14 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -54.89 -29.06 54.88 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 126.213 1.805 . . . . 0.0 112.721 -163.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.63 -23.32 14.28 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 126.5 1.92 . . . . 0.0 111.712 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -81.96 -53.73 5.9 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 120.114 1.325 . . . . 0.0 111.887 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.695 HG21 ' CE1' ' A' ' 56' ' ' PHE . 51.4 t -44.05 -39.91 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 129.293 3.037 . . . . 0.0 110.099 -178.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -49.83 -23.26 1.79 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 127.414 2.286 . . . . 0.0 114.265 174.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.69 37.09 0.19 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.306 2.242 . . . . 0.0 113.274 177.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.593 ' HE2' ' CZ ' ' A' ' 86' ' ' PHE . 0.6 OUTLIER . . . . . 0 C--O 1.248 0.99 0 O-C-N 121.436 -0.79 . . . . 0.0 109.514 -174.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 78.32 84.63 0.54 Allowed Glycine 0 C--N 1.335 0.499 0 CA-C-N 118.66 0.664 . . . . 0.0 111.711 172.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.9 t -150.09 99.53 2.83 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.92 -178.75 3.8 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.27 1.428 . . . . 0.0 111.456 -167.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 155.34 144.03 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 130.843 3.657 . . . . 0.0 109.164 161.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.6 mp 48.26 92.86 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 127.819 2.448 . . . . 0.0 111.37 176.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -153.82 174.78 14.12 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.898 177.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -153.82 177.93 10.46 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.497 1.519 . . . . 0.0 108.855 171.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 70.58 25.16 4.26 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.901 1.28 . . . . 0.0 113.217 167.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -129.77 101.27 5.81 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 159.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -155.62 113.23 3.32 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 106.193 -1.781 . . . . 0.0 106.193 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -160.99 -177.49 6.15 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.934 1.694 . . . . 0.0 109.735 -175.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 5.5 mmt 54.97 76.31 0.26 Allowed 'General case' 0 C--N 1.339 0.122 0 C-N-CA 125.214 1.406 . . . . 0.0 108.563 176.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -110.51 88.06 7.16 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -81.16 98.76 1.05 Allowed 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.979 3.12 . . . . 0.0 110.509 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -151.0 -177.6 6.11 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.015 -1.053 . . . . 0.0 112.661 -177.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.437 ' HE2' ' CG1' ' A' ' 19' ' ' VAL . 0.7 OUTLIER -143.48 164.74 29.49 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.97 2.108 . . . . 0.0 106.823 173.689 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.2 mt -130.36 118.57 43.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 174.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.437 ' CG1' ' HE2' ' A' ' 17' ' ' LYS . 6.4 m -93.34 -162.02 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 125.677 1.591 . . . . 0.0 108.001 168.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -24.6 -70.85 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 129.651 3.181 . . . . 0.0 111.771 171.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -149.96 21.86 0.88 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.734 0.814 . . . . 0.0 110.835 -177.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.616 HG11 ' CE2' ' A' ' 56' ' ' PHE . 20.4 t -127.19 156.62 38.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 95.8 t -116.13 128.52 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mp -101.55 104.95 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 46.8 mt -88.97 128.84 35.71 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 103.551 -2.759 . . . . 0.0 103.551 175.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 30.2 mtm -123.48 95.48 45.1 Favored Pre-proline 0 N--CA 1.465 0.302 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -176.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -69.07 161.44 45.81 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.251 1.967 . . . . 0.0 111.088 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -151.92 -71.48 0.16 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 121.232 0.539 . . . . 0.0 111.964 -173.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.47 6.06 0.83 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.53 1.932 . . . . 0.0 112.132 -176.238 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -79.58 -2.61 43.21 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 128.333 2.653 . . . . 0.0 112.746 177.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.6 mt -101.56 95.23 6.32 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -166.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -164.72 30.76 0.07 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.886 0.874 . . . . 0.0 112.386 -161.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER 73.7 -46.94 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 127.968 2.507 . . . . 0.0 112.287 175.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -68.85 -5.26 19.94 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 126.353 1.861 . . . . 0.0 113.189 -173.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -127.25 0.98 6.41 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 127.345 2.258 . . . . 0.0 109.127 177.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.14 -57.75 3.62 Favored 'General case' 0 C--O 1.224 -0.241 0 O-C-N 120.229 -1.545 . . . . 0.0 110.868 -173.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -65.05 -24.63 67.52 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 120.831 -1.168 . . . . 0.0 110.98 -178.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.447 HD22 ' H ' ' A' ' 38' ' ' LEU . 1.7 mm? -81.54 -33.25 31.85 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 126.219 1.807 . . . . 0.0 110.863 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -42.4 -53.28 4.3 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 126.711 2.004 . . . . 0.0 111.285 176.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.39 -43.26 99.25 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.482 -178.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.13 -49.39 77.14 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.103 0.865 . . . . 0.0 110.639 174.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -58.01 -64.26 0.97 Allowed 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 118.099 -0.953 . . . . 0.0 110.014 177.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 68.8 t -49.56 -37.95 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 120.018 1.281 . . . . 0.0 112.062 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.591 ' CD1' HD12 ' A' ' 48' ' ' LEU . 3.2 m-85 -61.12 -62.21 2.01 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.604 0.762 . . . . 0.0 110.329 175.278 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.11 -16.66 59.85 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 125.018 1.327 . . . . 0.0 112.867 -170.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -93.62 -31.4 14.51 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.778 1.231 . . . . 0.0 111.732 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -132.01 -54.26 0.98 Allowed 'General case' 0 C--N 1.346 0.42 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -172.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.591 HD12 ' CD1' ' A' ' 44' ' ' PHE . 30.7 mt -60.39 -50.95 71.54 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 118.654 0.661 . . . . 0.0 112.291 -171.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -61.28 -39.43 90.38 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.241 0.616 . . . . 0.0 109.944 177.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -60.09 -1.91 0.37 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 128.318 2.647 . . . . 0.0 114.797 172.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.49 2.75 75.93 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-O 118.304 -1.276 . . . . 0.0 113.02 176.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -72.48 119.09 16.21 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 120.024 1.912 . . . . 0.0 108.791 175.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -114.08 19.2 16.65 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.618 1.167 . . . . 0.0 109.309 -177.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.412 ' HB3' HG13 ' A' ' 22' ' ' VAL . 2.5 mtmt -146.4 130.01 16.96 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.328 1.851 . . . . 0.0 107.353 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.694 HD13 HD11 ' A' ' 80' ' ' ILE . 1.2 mp -138.6 154.26 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 128.062 2.545 . . . . 0.0 105.612 177.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.787 ' CE1' HG21 ' A' ' 122' ' ' VAL . 21.2 m-85 -130.37 156.6 44.44 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 124.633 1.173 . . . . 0.0 113.366 166.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 26.8 tp -121.69 75.83 1.22 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.907 1.283 . . . . 0.0 110.885 177.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.443 ' CG2' HD11 ' A' ' 115' ' ' ILE . 96.1 t -64.56 118.35 6.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 127.791 2.436 . . . . 0.0 107.023 173.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.7 mt -95.85 5.14 52.02 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.563 0.745 . . . . 0.0 110.643 -176.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.3 m -56.73 -23.61 43.72 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 177.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.46 -7.19 56.98 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.516 1.053 . . . . 0.0 111.272 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 p -134.17 157.23 41.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.902 1.681 . . . . 0.0 110.605 -168.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -85.72 -44.6 12.4 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.236 -0.915 . . . . 0.0 108.682 167.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 m -160.29 161.66 33.4 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 123.345 1.545 . . . . 0.0 113.703 -179.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.2 tt -72.47 174.28 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 111.808 -2.451 . . . . 0.0 107.796 163.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -117.88 -144.94 0.38 Allowed 'General case' 0 C--N 1.327 -0.382 0 O-C-N 120.952 -1.093 . . . . 0.0 109.646 -160.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.6 t -50.62 -147.99 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.798 1 C-N-CA 132.111 4.165 . . . . 0.0 112.388 157.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -25.04 -39.91 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.158 1 C-N-CA 132.022 4.129 . . . . 0.0 116.421 177.119 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.2 t -55.07 -31.55 61.24 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.659 0.784 . . . . 0.0 111.778 -178.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.8 tp -57.49 -18.88 21.06 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.402 1.081 . . . . 0.0 112.73 173.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -98.48 -24.7 10.79 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.559 1.552 . . . . 0.0 113.204 170.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 90.1 t -65.92 -40.86 88.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 119.185 1.493 . . . . 0.0 109.551 173.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.4 mp -51.45 -48.59 34.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.552 1.141 . . . . 0.0 109.628 174.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.8 t -64.92 -46.27 92.26 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.635 0 CA-C-O 117.224 -1.37 . . . . 0.0 109.658 175.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -49.07 -51.29 32.25 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 122.469 2.395 . . . . 0.0 111.814 177.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 77.9 mt -57.85 -37.2 58.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 124.913 1.285 . . . . 0.0 110.143 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.545 HD22 HG22 ' A' ' 109' ' ' VAL . 25.7 tp -63.59 -53.6 49.09 Favored 'General case' 0 CA--C 1.52 -0.201 0 O-C-N 121.012 -1.055 . . . . 0.0 109.265 176.203 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -57.68 -22.82 48.24 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.388 0.675 . . . . 0.0 110.142 -177.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 67.5 m -81.43 -48.24 12.16 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.44 1.096 . . . . 0.0 111.326 177.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.694 HD11 HD13 ' A' ' 55' ' ' ILE . 21.8 mt -58.61 -43.97 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 119.983 1.265 . . . . 0.0 109.782 172.276 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.4 t -65.65 -10.87 39.82 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.637 1.575 . . . . 0.0 112.296 175.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.7 t -96.46 -43.21 7.73 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 120.32 1.418 . . . . 0.0 109.552 171.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.6 m -66.91 -28.01 67.96 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -178.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 110.02 38.85 1.63 Allowed Glycine 0 C--N 1.337 0.613 0 CA-C-O 118.702 -1.054 . . . . 0.0 113.428 -174.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -134.77 -175.64 13.97 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 119.93 1.865 . . . . 0.0 111.644 -177.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -127.31 154.13 45.3 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.874 1.67 . . . . 0.0 109.858 179.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -150.41 139.38 20.98 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -145.99 170.38 16.75 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 120.831 0.348 . . . . 0.0 111.477 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.21 167.34 10.63 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -177.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.431 HG13 ' N ' ' A' ' 58' ' ' VAL . 0.5 OUTLIER -148.86 150.06 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 C-N-CA 123.863 0.865 . . . . 0.0 111.541 -170.93 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 44.2 54.77 12.26 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 126.51 1.924 . . . . 0.0 112.064 171.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.05 167.25 26.62 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.76 2.307 . . . . 0.0 109.714 -178.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -123.06 169.57 11.06 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 173.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -66.69 -34.74 78.52 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 123.686 0.795 . . . . 0.0 110.127 -168.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.433 ' O ' ' HE3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -61.99 -35.94 80.0 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.337 1.455 . . . . 0.0 110.953 177.14 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -81.36 -46.03 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -176.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -57.43 -31.18 65.63 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 125.958 1.703 . . . . 0.0 110.466 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.95 -21.54 66.43 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -175.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.6 t -104.85 -42.55 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.043 0 C-N-CA 125.72 1.608 . . . . 0.0 107.164 -174.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.08 -17.23 24.18 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 116.715 -1.612 . . . . 0.0 108.868 -177.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.8 t -87.18 -50.64 6.48 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 117.62 -1.632 . . . . 0.0 108.569 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.84 -52.78 64.05 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 129.148 2.979 . . . . 0.0 111.047 -172.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -77.07 2.99 13.45 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.157 1.383 . . . . 0.0 110.891 -178.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.6 m120 47.15 75.85 0.12 Allowed 'General case' 0 C--N 1.342 0.249 0 C-N-CA 129.563 3.145 . . . . 0.0 109.816 -171.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.74 -59.86 1.9 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.295 1.438 . . . . 0.0 107.517 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.1 -26.76 67.88 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.776 0.83 . . . . 0.0 111.348 174.28 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.4 mtp-105 -74.99 -2.2 26.12 Favored 'General case' 0 C--N 1.339 0.112 0 O-C-N 121.751 -0.593 . . . . 0.0 111.75 -178.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.3 mt -128.0 -46.68 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 125.912 1.685 . . . . 0.0 107.272 -171.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.545 HG22 HD22 ' A' ' 77' ' ' LEU . 1.6 t -104.39 148.94 8.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-O 121.898 0.856 . . . . 0.0 109.917 -175.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.07 155.71 39.91 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 123.85 0.86 . . . . 0.0 111.852 173.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -146.42 146.59 18.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -174.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -141.47 163.75 32.1 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.917 0.887 . . . . 0.0 111.178 -171.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.5 -55.01 4.74 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.09 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 64.7 p -113.86 175.64 5.38 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.815 0.817 . . . . 0.0 111.048 -177.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.501 ' HA ' HD13 ' A' ' 115' ' ' ILE . 3.4 mm -61.74 -45.87 97.74 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 164.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.2 t -69.34 -33.14 72.66 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 118.774 -0.631 . . . . 0.0 109.855 -164.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -68.85 -24.04 64.3 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.785 0.834 . . . . 0.0 111.155 175.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.678 ' O ' HG23 ' A' ' 122' ' ' VAL . . . -82.74 -52.59 6.63 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 178.166 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 6.3 tmm? -55.89 -40.1 72.53 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 125.298 1.439 . . . . 0.0 113.502 -157.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -89.39 -21.38 23.09 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 117.935 -1.031 . . . . 0.0 113.151 175.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.431 ' HG2' ' HE2' ' A' ' 125' ' ' LYS . 1.7 tt0 -84.27 -55.64 4.07 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-N 119.046 0.839 . . . . 0.0 109.76 -172.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.787 HG21 ' CE1' ' A' ' 56' ' ' PHE . 41.2 t -42.61 -44.19 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 C-N-CA 127.96 2.504 . . . . 0.0 110.586 178.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 17.9 mtm180 -48.11 -40.93 25.01 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 124.057 0.848 . . . . 0.0 111.083 178.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . 0.321 0.0 OUTLIER -117.83 43.48 2.39 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 125.628 1.571 . . . . 0.0 113.879 176.085 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.431 ' HE2' ' HG2' ' A' ' 121' ' ' GLU . 5.4 mmmt . . . . . 0 C--O 1.251 1.153 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 164.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.684 0 CA-C-O 117.18 -1.391 . . . . 0.0 107.791 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -90.77 -169.77 42.86 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 174.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m -140.39 -34.81 0.52 Allowed 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 125.335 1.454 . . . . 0.0 110.582 174.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.4 t0 42.64 77.47 0.06 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 128.165 2.586 . . . . 0.0 114.173 174.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -139.43 121.45 15.67 Favored 'General case' 0 CA--C 1.523 -0.08 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 172.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.38 139.26 39.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 -179.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -94.61 158.01 15.72 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.001 0.92 . . . . 0.0 108.855 170.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -173.67 -167.09 0.35 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.164 1.786 . . . . 0.0 108.876 163.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 4.4 m80 66.45 -175.47 0.19 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.789 2.436 . . . . 0.0 111.383 178.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 66.16 19.87 11.12 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.639 1.576 . . . . 0.0 113.675 176.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -129.55 101.95 6.16 Favored 'General case' 0 C--O 1.227 -0.095 0 C-N-CA 124.344 1.058 . . . . 0.0 108.251 168.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 74.7 m-70 -144.32 83.07 1.72 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 165.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 34.7 mtm -121.58 -55.68 1.91 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.716 0.806 . . . . 0.0 109.279 174.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 24.79 81.36 0.19 Allowed Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 128.785 2.834 . . . . 0.0 112.522 172.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.56 98.03 1.01 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.949 2.433 . . . . 0.0 110.847 -175.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -157.27 173.26 17.23 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.062 1.345 . . . . 0.0 109.649 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.4 173.1 12.1 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.487 2.315 . . . . 0.0 110.031 176.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.3 mt -137.8 135.31 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 127.93 2.492 . . . . 0.0 107.789 166.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.413 HG13 HD13 ' A' ' 24' ' ' ILE . 27.2 m -101.1 -139.36 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 127.085 2.154 . . . . 0.0 108.638 173.114 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -41.92 -71.19 0.09 Allowed 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 129.227 3.011 . . . . 0.0 110.524 177.135 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -147.88 20.94 1.13 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.602 1.961 . . . . 0.0 108.222 -173.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.703 HG11 ' CE2' ' A' ' 56' ' ' PHE . 15.3 t -131.51 147.65 32.68 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 C-N-CA 124.437 1.095 . . . . 0.0 108.109 -172.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.473 HG11 ' CZ ' ' A' ' 47' ' ' PHE . 33.7 t -103.84 151.13 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.413 HD13 HG13 ' A' ' 19' ' ' VAL . 5.1 mp -129.89 94.71 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 124.871 1.269 . . . . 0.0 108.426 176.013 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.675 HD22 HG23 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -65.5 105.51 1.2 Allowed 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 129.677 3.191 . . . . 0.0 109.06 170.036 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.548 ' HA ' HG22 ' A' ' 58' ' ' VAL . 50.8 mtp -113.98 73.68 2.46 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 125.663 1.585 . . . . 0.0 107.943 -172.281 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -69.75 177.34 5.67 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 123.114 2.542 . . . . 0.0 111.532 -173.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -156.18 -79.99 0.08 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.982 1.713 . . . . 0.0 109.336 -178.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -136.58 26.36 3.11 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.972 2.509 . . . . 0.0 109.304 -174.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -91.43 -7.81 49.6 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 125.098 1.359 . . . . 0.0 112.055 177.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.18 75.97 9.9 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 120.977 1.717 . . . . 0.0 108.498 -177.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -105.82 58.51 0.66 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.186 2.195 . . . . 0.0 112.28 -173.37 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.3 mm 53.85 -75.78 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 127.613 2.365 . . . . 0.0 112.76 -175.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -67.31 -17.99 64.99 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.64 1.176 . . . . 0.0 112.032 -173.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.423 ' O ' HD13 ' A' ' 38' ' ' LEU . 11.6 t-20 -43.7 -39.43 3.65 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.455 163.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.689 ' HB1' HG21 ' A' ' 72' ' ' VAL . . . -61.12 -44.99 96.48 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 175.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 38.5 m170 -67.31 -44.68 78.57 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 118.902 -0.57 . . . . 0.0 109.709 -170.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.483 HD22 ' C ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -79.78 -19.91 47.49 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-O 116.985 -1.483 . . . . 0.0 111.69 173.755 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -44.85 -54.02 6.86 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 125.005 1.322 . . . . 0.0 109.785 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.409 ' HG2' ' CE1' ' A' ' 44' ' ' PHE . 13.2 ttpt -56.83 -53.8 53.71 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.85 -46.95 81.44 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 117.296 -1.335 . . . . 0.0 111.544 -176.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 6.1 t90 -62.44 -66.16 0.58 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 117.329 -1.32 . . . . 0.0 109.05 177.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 87.7 t -50.46 -37.96 15.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 120.003 1.274 . . . . 0.0 111.117 -176.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.409 ' CE1' ' HG2' ' A' ' 40' ' ' LYS . 4.3 m-85 -59.51 -74.04 0.08 Allowed 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 171.103 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -48.92 -43.02 39.04 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.637 1.975 . . . . 0.0 113.267 -171.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.497 ' HG3' ' CE1' ' A' ' 47' ' ' PHE . 3.0 tp10 -84.7 -28.69 26.16 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 126.846 2.058 . . . . 0.0 109.727 -167.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.497 ' CE1' ' HG3' ' A' ' 46' ' ' GLU . 2.8 m-85 -128.77 -66.76 0.82 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 118.925 0.784 . . . . 0.0 110.606 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.6 mt -61.13 -53.41 57.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 118.865 0.757 . . . . 0.0 112.517 -166.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -67.89 -29.06 68.07 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 127.496 2.318 . . . . 0.0 109.572 176.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -63.49 -24.31 67.76 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 118.028 -0.987 . . . . 0.0 111.605 167.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.8 -4.43 19.07 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 126.533 2.016 . . . . 0.0 113.281 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -66.1 156.38 34.07 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 119.429 1.615 . . . . 0.0 111.085 178.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -134.25 1.09 3.17 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.332 -1.303 . . . . 0.0 111.212 -177.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.567 ' HB3' HG13 ' A' ' 22' ' ' VAL . 8.8 mtmt -138.04 123.18 19.21 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.622 1.101 . . . . 0.0 109.296 -170.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.675 HG23 HD22 ' A' ' 25' ' ' LEU . 1.4 mp -137.45 152.78 27.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 126.701 2.0 . . . . 0.0 106.581 -176.187 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.703 ' CE2' HG11 ' A' ' 22' ' ' VAL . 21.9 m-85 -141.42 120.12 12.56 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 126.977 2.111 . . . . 0.0 110.216 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 46.2 tp -90.18 119.29 30.38 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 176.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.548 HG22 ' HA ' ' A' ' 26' ' ' MET . 0.8 OUTLIER -87.84 154.81 3.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 118.806 0.73 . . . . 0.0 109.963 173.011 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.565 HD22 HG21 ' A' ' 96' ' ' VAL . 3.9 mp -134.38 8.02 3.64 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.871 0.868 . . . . 0.0 111.482 178.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.03 -36.05 67.56 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.891 -1.131 . . . . 0.0 112.073 -177.47 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -96.33 -11.38 25.92 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.439 1.096 . . . . 0.0 112.16 178.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.4 t -109.87 113.5 44.38 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -169.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.85 -41.61 43.39 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 -178.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 93.8 p -151.99 168.65 24.53 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -171.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.702 HD11 ' HB2' ' A' ' 69' ' ' SER . 4.5 tt -133.64 151.98 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 C-N-CA 124.504 1.122 . . . . 0.0 109.107 176.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.68 162.85 17.69 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.007 0.923 . . . . 0.0 109.006 179.078 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 85.8 p -66.76 1.9 1.62 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 171.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.52 ' CE1' ' HB2' ' A' ' 36' ' ' ALA 0.25 0.1 OUTLIER -71.03 -78.63 0.07 Allowed 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 123.955 0.902 . . . . 0.0 110.817 156.028 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.702 ' HB2' HD11 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -75.31 -24.17 57.4 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 118.901 0.773 . . . . 0.0 111.777 -158.981 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 1.011 HD21 HG21 ' A' ' 103' ' ' THR . 35.0 tp -44.72 -38.88 4.72 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.527 1.531 . . . . 0.0 111.889 176.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.681 ' HA2' HG12 ' A' ' 74' ' ' VAL . . . -108.94 6.36 32.71 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-O 119.82 -0.433 . . . . 0.0 114.154 -174.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.689 HG21 ' HB1' ' A' ' 36' ' ' ALA . 95.0 t -75.99 -46.18 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 158.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.588 HD12 ' O ' ' A' ' 69' ' ' SER . 1.7 mt -59.57 -54.23 37.29 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 CA-C-O 122.694 1.235 . . . . 0.0 111.61 -173.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.681 HG12 ' HA2' ' A' ' 71' ' ' GLY . 9.0 p -45.69 -56.32 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.835 0 O-C-N 120.404 -1.435 . . . . 0.0 113.841 163.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.466 ' N ' HG13 ' A' ' 74' ' ' VAL . 0.9 OUTLIER -49.43 -43.93 45.06 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 121.369 -0.832 . . . . 0.0 110.97 -174.356 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 56.3 mt -58.11 -41.87 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 O-C-N 124.859 1.349 . . . . 0.0 110.569 173.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 21.7 tp -57.99 -54.06 51.26 Favored 'General case' 0 C--O 1.225 -0.196 0 O-C-N 120.278 -1.514 . . . . 0.0 109.695 170.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.497 ' HE3' HG22 ' A' ' 74' ' ' VAL . 72.2 mttt -65.13 3.23 0.63 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.276 1.43 . . . . 0.0 112.419 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 41.4 t -106.2 -51.08 3.03 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 126.631 1.973 . . . . 0.0 107.782 174.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 87.8 mt -59.55 -44.6 93.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.678 0.791 . . . . 0.0 110.367 175.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.58 -19.7 65.29 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.786 0.721 . . . . 0.0 112.638 176.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.9 m -80.64 -33.94 35.31 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.341 0.973 . . . . 0.0 111.405 167.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.4 m -73.12 -62.7 1.37 Allowed 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.339 1.056 . . . . 0.0 110.421 -176.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 148.5 29.03 0.06 OUTLIER Glycine 0 CA--C 1.527 0.819 0 CA-C-O 118.14 -1.367 . . . . 0.0 113.787 -168.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -134.06 -166.4 11.25 Favored Glycine 0 C--N 1.338 0.685 0 CA-C-N 120.245 2.023 . . . . 0.0 113.319 -171.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.513 ' HB3' HG22 ' A' ' 122' ' ' VAL . 5.8 m-85 -135.1 150.18 50.18 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.305 1.442 . . . . 0.0 109.246 178.337 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -145.9 144.12 30.0 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 170.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.469 ' C ' HD23 ' A' ' 89' ' ' LEU . . . -149.99 176.52 10.7 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 126.165 1.786 . . . . 0.0 111.924 -175.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.469 HD23 ' C ' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -123.14 168.32 12.55 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.702 0.801 . . . . 0.0 111.165 -179.566 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.405 ' HB ' ' HA ' ' A' ' 58' ' ' VAL . 99.4 t -147.35 141.43 19.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 124.722 1.209 . . . . 0.0 109.787 -160.049 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.2 t 42.98 58.19 11.6 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 124.527 1.131 . . . . 0.0 109.342 -176.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -71.57 -163.2 0.13 Allowed 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 124.275 3.317 . . . . 0.0 110.114 -177.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -155.9 151.42 27.04 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 124.508 1.123 . . . . 0.0 108.07 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -61.5 -21.53 64.3 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.201 1.0 . . . . 0.0 110.998 -176.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.402 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -77.62 -38.19 48.54 Favored 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 126.422 1.889 . . . . 0.0 111.451 176.212 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.872 HG13 HD13 ' A' ' 100' ' ' LEU . 2.3 t -62.18 -46.98 95.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-O 117.102 -1.428 . . . . 0.0 108.216 166.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -57.93 -30.45 65.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 119.982 1.265 . . . . 0.0 109.155 176.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -68.34 -30.46 69.43 Favored 'General case' 0 C--O 1.218 -0.589 0 O-C-N 120.703 -1.248 . . . . 0.0 109.934 -177.574 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.677 ' O ' HG22 ' A' ' 103' ' ' THR . 5.4 p -101.59 -42.63 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -169.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.872 HD13 HG13 ' A' ' 96' ' ' VAL . 5.7 mp -67.0 -19.67 65.75 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 115.95 -1.976 . . . . 0.0 111.152 177.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 12.0 t -79.67 -45.44 19.01 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 121.441 1.928 . . . . 0.0 107.31 172.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -67.6 -51.03 55.1 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 126.337 1.855 . . . . 0.0 110.585 -165.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' THR . . . . . 1.011 HG21 HD21 ' A' ' 70' ' ' LEU . 9.1 t -81.77 6.32 15.84 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.787 179.347 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 50.0 88.27 0.02 OUTLIER 'General case' 0 C--O 1.235 0.304 0 C-N-CA 127.162 2.185 . . . . 0.0 110.102 -169.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.476 ' HB3' ' HG ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -133.87 -55.9 0.88 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 127.563 2.345 . . . . 0.0 110.739 -175.992 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.77 -27.05 68.93 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.944 1.247 . . . . 0.0 110.681 173.278 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 -72.44 -18.18 61.72 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.146 0.498 . . . . 0.0 110.109 -177.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.2 mm -97.54 -56.2 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 103.595 -2.742 . . . . 0.0 103.595 -174.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.561 HG12 ' H ' ' A' ' 110' ' ' LYS . 1.4 t -80.41 -165.0 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 125.518 1.527 . . . . 0.0 110.115 -177.208 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.561 ' H ' HG12 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -125.66 168.82 13.21 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 128.46 2.704 . . . . 0.0 108.813 169.367 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.36 145.73 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -147.02 171.14 15.73 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 126.334 1.854 . . . . 0.0 110.678 -175.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.28 -53.16 4.34 Favored 'General case' 0 CA--C 1.523 -0.067 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -175.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 71.1 p -130.17 162.88 27.89 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.568 0.747 . . . . 0.0 110.895 -175.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 29.1 mm -65.03 -36.48 77.91 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 CA-C-O 118.168 -0.92 . . . . 0.0 108.582 -172.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.9 t -69.04 -31.74 70.75 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.527 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -68.13 -9.15 44.3 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 119.056 0.844 . . . . 0.0 111.672 173.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -110.37 -38.25 5.29 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 119.529 1.059 . . . . 0.0 109.203 -179.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 2.8 ttm -64.1 -46.45 84.14 Favored 'General case' 0 N--CA 1.446 -0.649 0 O-C-N 120.667 -1.271 . . . . 0.0 113.433 -161.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -91.36 -14.68 30.27 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 117.976 -1.012 . . . . 0.0 111.057 175.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -95.22 -46.85 6.59 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 119.327 0.967 . . . . 0.0 110.574 -167.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.513 HG22 ' HB3' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -49.84 -31.77 7.13 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.18 0 C-N-CA 124.89 1.276 . . . . 0.0 111.002 173.779 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -52.63 -36.21 56.12 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.518 1.127 . . . . 0.0 111.969 174.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.88 35.34 0.76 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.884 1.274 . . . . 0.0 114.251 -174.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.242 0.679 0 C-N-CA 125.5 1.52 . . . . 0.0 112.957 178.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 37.4 p90 . . . . . 0 C--O 1.237 0.418 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.64 173.26 11.72 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.77 1.228 . . . . 0.0 111.511 165.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.3 mt -119.09 147.4 22.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 174.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 20' ' ' ASP . 46.5 t -125.1 -174.79 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 129.761 3.224 . . . . 0.0 104.849 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.426 ' H ' HG12 ' A' ' 19' ' ' VAL . 2.1 m-20 -51.75 -54.33 29.71 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.869 0.867 . . . . 0.0 113.311 -163.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -127.39 12.37 6.99 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 122.933 0.493 . . . . 0.0 110.367 163.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.828 HG11 ' CE2' ' A' ' 56' ' ' PHE . 22.0 t -119.31 163.77 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 O-C-N 121.114 -0.991 . . . . 0.0 108.585 -166.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.4 t -132.28 125.52 54.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 -170.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.414 HD11 HG21 ' A' ' 19' ' ' VAL . 0.6 OUTLIER -107.69 103.46 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 -176.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.7 mt -90.61 104.77 17.31 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 104.886 -2.264 . . . . 0.0 104.886 -178.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 57.7 mtm -112.89 84.98 7.26 Favored Pre-proline 0 C--N 1.332 -0.172 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -171.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -70.49 156.74 60.82 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.853 1.702 . . . . 0.0 109.871 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -122.61 -92.55 0.53 Allowed 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -178.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.63 59.44 1.63 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 121.784 2.084 . . . . 0.0 111.658 -175.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -144.97 9.69 1.3 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -175.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 25.0 mt -79.26 52.93 1.4 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.429 1.013 . . . . 0.0 110.975 -176.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -85.4 169.63 13.49 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 126.598 1.959 . . . . 0.0 109.116 171.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.9 mt -57.53 -35.38 49.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 C-N-CA 124.272 1.029 . . . . 0.0 112.09 -174.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -71.61 -16.18 62.27 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 120.97 -1.081 . . . . 0.0 111.211 -176.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -120.24 56.28 0.98 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.291 1.437 . . . . 0.0 108.804 175.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -140.45 -64.1 0.47 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.405 1.082 . . . . 0.0 110.592 -177.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 28.2 t60 -58.45 -46.19 87.07 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 120.513 -1.367 . . . . 0.0 109.368 169.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.599 HD12 ' C ' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -65.44 -30.05 70.8 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.792 178.604 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -52.93 -54.05 40.54 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.856 1.262 . . . . 0.0 110.017 -174.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.55 ' HE3' ' CE1' ' A' ' 44' ' ' PHE . 0.8 OUTLIER -57.43 -44.74 84.91 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 124.651 1.181 . . . . 0.0 110.866 172.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.0 -34.24 77.13 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.569 1.548 . . . . 0.0 112.372 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -69.55 -62.48 1.37 Allowed 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 171.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.7 t -47.64 -41.03 7.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 123.916 0.886 . . . . 0.0 112.763 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.55 ' CE1' ' HE3' ' A' ' 40' ' ' LYS . 1.6 m-85 -61.54 -34.76 76.09 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 123.892 0.877 . . . . 0.0 112.121 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -112.41 -12.23 13.55 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.386 1.074 . . . . 0.0 112.712 -170.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -88.38 -34.67 17.49 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.614 1.566 . . . . 0.0 109.889 171.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -130.35 -62.63 0.92 Allowed 'General case' 0 C--N 1.345 0.373 0 C-N-CA 123.095 0.558 . . . . 0.0 111.807 -169.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.6 mt -62.41 -56.08 21.63 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 119.245 -0.407 . . . . 0.0 111.447 -162.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -60.75 -35.29 76.02 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 118.676 -0.678 . . . . 0.0 110.274 175.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.14 -16.21 12.52 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 127.19 2.196 . . . . 0.0 112.965 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 118.23 -10.15 13.35 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 126.046 1.784 . . . . 0.0 111.988 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -73.62 120.26 18.98 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 118.802 1.301 . . . . 0.0 110.837 -172.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -109.72 13.0 23.91 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.83 2.052 . . . . 0.0 112.074 -176.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.43 ' HB3' HG13 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -150.94 107.31 3.48 Favored 'General case' 0 CA--C 1.518 -0.274 0 O-C-N 120.248 -1.533 . . . . 0.0 107.983 -173.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mp -112.02 152.0 13.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 176.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.828 ' CE2' HG11 ' A' ' 22' ' ' VAL . 23.4 m-85 -130.08 150.5 51.32 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.603 1.161 . . . . 0.0 109.492 166.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.5 tp -119.91 110.28 16.54 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.204 1.001 . . . . 0.0 108.535 176.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.3 t -84.31 134.47 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 171.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.3 mp -109.82 6.19 23.23 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.62 0.768 . . . . 0.0 111.963 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 33.4 t -51.98 -48.14 64.52 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.158 0.983 . . . . 0.0 111.458 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -87.99 7.05 32.96 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.341 -0.85 . . . . 0.0 112.195 -168.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.6 p -134.45 126.93 49.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 125.579 1.551 . . . . 0.0 108.099 -173.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -75.34 -42.56 54.06 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 120.675 -1.266 . . . . 0.0 108.944 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.567 ' HB3' ' HE2' ' A' ' 95' ' ' LYS . 1.4 p -162.05 -178.15 6.23 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.992 0.901 . . . . 0.0 111.681 -173.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 21.3 tt -139.66 160.03 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 C-N-CA 125.344 1.458 . . . . 0.0 108.586 -175.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.12 156.18 22.26 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.408 1.083 . . . . 0.0 110.421 172.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.4 m -53.51 -28.77 32.93 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.126 1.37 . . . . 0.0 113.434 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -62.01 -66.6 0.51 Allowed 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.73 1.212 . . . . 0.0 109.309 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.0 t -74.27 -24.23 59.24 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.369 -0.824 . . . . 0.0 111.659 -176.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.414 HD11 HG21 ' A' ' 103' ' ' THR . 55.1 tp -49.98 -30.82 11.26 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.944 1.247 . . . . 0.0 112.407 172.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.65 -24.69 29.84 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-N 118.396 0.544 . . . . 0.0 113.448 175.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.8 t -66.16 -39.52 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 118.194 0.997 . . . . 0.0 108.605 173.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 mp -52.55 -53.25 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 123.8 0.84 . . . . 0.0 108.914 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 73.3 t -58.94 -46.29 91.5 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 175.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -55.57 -43.2 75.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 119.46 1.027 . . . . 0.0 112.501 -174.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.2 mt -59.73 -38.89 78.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 124.114 0.966 . . . . 0.0 109.013 176.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.63 -50.94 71.5 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 119.151 0.887 . . . . 0.0 109.478 172.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -53.94 -47.93 70.75 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 118.077 -0.963 . . . . 0.0 110.331 -176.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.7 m -56.33 -57.49 12.04 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 124.092 0.87 . . . . 0.0 110.358 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 50.3 mt -53.28 -46.79 57.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.859 1.264 . . . . 0.0 110.637 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.2 p -61.78 -31.13 71.32 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.972 1.309 . . . . 0.0 111.978 -175.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.31 -31.68 33.45 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.848 1.659 . . . . 0.0 111.696 175.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 39.4 m -78.69 -21.95 47.43 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 117.64 -1.171 . . . . 0.0 113.991 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 121.02 4.92 10.0 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 119.652 1.115 . . . . 0.0 114.546 -174.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -113.32 -176.28 19.38 Favored Glycine 0 N--CA 1.437 -1.261 0 CA-C-N 119.24 1.52 . . . . 0.0 112.196 -173.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -131.47 157.5 43.33 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.825 1.65 . . . . 0.0 108.68 176.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -148.96 135.45 19.47 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 175.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.59 ' C ' HD23 ' A' ' 89' ' ' LEU . . . -140.11 170.84 15.1 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.36 1.464 . . . . 0.0 110.28 -176.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.59 HD23 ' C ' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -119.27 171.58 8.2 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 122.793 0.437 . . . . 0.0 110.467 -176.573 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.557 HG21 HD13 ' A' ' 115' ' ' ILE . 77.9 t -146.77 143.49 20.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 124.939 1.296 . . . . 0.0 109.723 -172.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 29.1 t 43.61 63.81 7.54 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 125.914 1.685 . . . . 0.0 109.119 -176.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -78.32 91.98 1.16 Allowed 'Trans proline' 0 N--CA 1.444 -1.428 0 N-CA-C 106.168 -2.281 . . . . 0.0 106.168 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -55.39 155.19 5.41 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 122.869 1.319 . . . . 0.0 110.125 -177.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -64.69 -25.26 67.87 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 122.318 1.056 . . . . 0.0 110.99 -165.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.567 ' HE2' ' HB3' ' A' ' 64' ' ' SER . 0.0 OUTLIER -68.82 -35.7 77.29 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 126.069 1.748 . . . . 0.0 111.547 177.428 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.0 m -82.44 -38.15 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.745 0 CA-C-N 120.436 1.471 . . . . 0.0 110.429 172.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.2 -33.42 63.01 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 120.193 1.36 . . . . 0.0 109.85 -176.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.45 -31.38 72.53 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 177.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.1 p -96.54 -32.12 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 C-N-CA 124.974 1.31 . . . . 0.0 108.653 -177.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.98 -18.59 65.41 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.408 1.883 . . . . 0.0 111.341 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.1 m -80.16 -57.01 3.82 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 168.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.41 -5.43 5.26 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 130.257 3.423 . . . . 0.0 114.006 -167.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.414 HG21 HD11 ' A' ' 70' ' ' LEU . 0.8 OUTLIER -130.76 6.93 4.74 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 125.381 1.472 . . . . 0.0 110.659 -177.282 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 46.71 73.95 0.17 Allowed 'General case' 0 C--N 1.342 0.262 0 C-N-CA 127.511 2.325 . . . . 0.0 109.706 -170.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.79 -63.13 1.28 Allowed 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 174.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -57.64 -31.95 66.79 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 123.344 1.545 . . . . 0.0 110.284 174.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -76.43 1.91 15.1 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 120.09 -1.631 . . . . 0.0 111.219 -175.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.4 mt -126.54 -53.12 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 126.06 1.744 . . . . 0.0 107.936 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.2 t -103.11 145.8 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 125.878 1.671 . . . . 0.0 108.186 -174.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -71.09 161.28 31.39 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.5 -0.75 . . . . 0.0 111.164 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.19 143.56 27.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.421 1.488 . . . . 0.0 107.113 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -141.23 168.43 19.8 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 128.902 2.881 . . . . 0.0 109.239 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.2 -46.47 13.71 Favored 'General case' 0 CA--C 1.515 -0.372 0 O-C-N 121.53 -0.731 . . . . 0.0 109.697 177.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 60.1 p -119.45 173.79 6.77 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.045 1.338 . . . . 0.0 108.894 -173.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.557 HD13 HG21 ' A' ' 90' ' ' VAL . 8.8 mm -66.88 -41.9 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-O 117.858 -1.068 . . . . 0.0 108.726 168.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 18.6 t -67.9 -37.85 82.24 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 119.982 1.265 . . . . 0.0 110.87 -167.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -60.82 -28.46 68.81 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 118.4 -0.809 . . . . 0.0 109.802 177.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.727 ' O ' HG23 ' A' ' 122' ' ' VAL . . . -81.27 -54.38 5.54 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.15 -28.76 59.27 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 125.917 1.687 . . . . 0.0 114.061 -160.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -104.79 -0.69 27.0 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 125.22 1.408 . . . . 0.0 114.406 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -123.32 -35.03 3.02 Favored 'General case' 0 C--O 1.213 -0.841 0 C-N-CA 125.162 1.385 . . . . 0.0 112.924 -167.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 118' ' ' ALA . 3.4 t -57.02 -27.23 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 126.036 1.734 . . . . 0.0 109.442 161.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 11.8 mtm180 -54.18 -31.65 53.38 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 121.127 -0.983 . . . . 0.0 113.061 162.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.74 23.66 5.02 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 118.326 2.713 . . . . 0.0 118.326 -177.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 21.6 mttp . . . . . 0 N--CA 1.431 -1.383 0 N-CA-C 102.66 -3.089 . . . . 0.0 102.66 -179.933 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.5 p90 . . . . . 0 N--CA 1.447 -0.61 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -126.66 178.78 5.7 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 163.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.6 mt -126.5 152.23 33.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 163.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 23.3 m -111.19 -141.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 125.612 1.565 . . . . 0.0 107.724 174.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -29.94 -79.21 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 129.043 2.937 . . . . 0.0 112.501 166.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -142.82 14.04 1.91 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.952 2.501 . . . . 0.0 109.252 177.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.642 HG11 ' CE2' ' A' ' 56' ' ' PHE . 21.8 t -115.75 140.07 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 O-C-N 121.092 -1.005 . . . . 0.0 108.712 -173.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.4 t -94.14 130.67 42.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.1 mm -106.94 94.32 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 36.1 mt -77.83 133.69 38.13 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 176.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 70.4 mtm -131.24 92.98 31.15 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 124.21 1.004 . . . . 0.0 109.064 -172.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -78.02 44.62 1.62 Allowed 'Trans proline' 0 CA--C 1.542 0.915 1 C-N-CA 125.461 4.107 . . . . 0.0 113.887 -164.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -49.12 88.77 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 128.763 2.825 . . . . 0.0 114.343 -169.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 36.94 35.41 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 128.95 2.9 . . . . 0.0 115.016 -176.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -122.78 7.43 9.38 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -167.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.0 mp -73.84 63.89 0.93 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 126.027 1.731 . . . . 0.0 109.605 -176.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -78.82 26.88 0.23 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 128.938 2.895 . . . . 0.0 113.868 -166.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.6 mm 72.86 -63.09 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 127.068 2.147 . . . . 0.0 110.643 -177.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -70.3 -18.56 63.11 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 120.916 1.689 . . . . 0.0 111.35 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -47.83 -49.58 28.8 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 123.991 0.916 . . . . 0.0 110.516 162.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.73 -37.33 87.23 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.79 0.436 . . . . 0.0 110.446 -177.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -61.89 -51.19 69.17 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.332 0.653 . . . . 0.0 110.017 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.259 0.0 OUTLIER -81.82 -15.76 53.08 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-O 117.599 -1.191 . . . . 0.0 112.608 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -44.48 -50.74 9.28 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.441 1.896 . . . . 0.0 110.661 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.514 ' HE2' ' CZ ' ' A' ' 44' ' ' PHE . 13.6 tmtt? -60.65 -53.16 60.85 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 123.222 0.609 . . . . 0.0 111.19 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.41 -45.91 87.48 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.039 0.836 . . . . 0.0 109.914 -177.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -60.49 -66.98 0.44 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 117.292 -1.337 . . . . 0.0 109.705 176.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 73.5 t -52.13 -32.32 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 120.537 1.517 . . . . 0.0 111.986 -176.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.514 ' CZ ' ' HE2' ' A' ' 40' ' ' LYS . 3.3 m-85 -58.19 -71.78 0.1 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.91 0.777 . . . . 0.0 109.905 172.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -65.89 -30.83 71.49 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 123.887 0.875 . . . . 0.0 112.885 -170.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -77.32 -31.81 54.85 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.011 1.325 . . . . 0.0 110.962 -175.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -138.13 -62.73 0.58 Allowed 'General case' 0 C--N 1.341 0.22 0 CA-C-N 118.522 0.601 . . . . 0.0 110.991 -170.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 46.6 mt -58.81 -59.43 5.44 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.416 0.553 . . . . 0.0 111.176 -171.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -60.68 -35.26 75.83 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.029 1.332 . . . . 0.0 109.647 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 tttm -56.5 -34.7 67.22 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.952 176.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.41 8.82 5.74 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.991 1.281 . . . . 0.0 114.173 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -77.63 159.77 28.98 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 118.941 1.37 . . . . 0.0 110.426 172.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -143.44 11.06 1.68 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.251 1.82 . . . . 0.0 111.795 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.477 ' HB3' HG13 ' A' ' 22' ' ' VAL . 1.7 mtmt -139.34 114.73 9.79 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 119.93 1.241 . . . . 0.0 107.914 -176.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mp -121.91 152.55 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 127.381 2.272 . . . . 0.0 105.118 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.642 ' CE2' HG11 ' A' ' 22' ' ' VAL . 14.2 m-85 -131.4 160.74 34.18 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.985 1.714 . . . . 0.0 109.37 166.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 26.5 tp -127.6 119.44 25.95 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 118.085 -0.96 . . . . 0.0 108.434 169.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.541 HG12 ' H ' ' A' ' 60' ' ' SER . 46.4 t -81.54 139.35 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 120.389 1.449 . . . . 0.0 107.685 170.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.63 ' CD1' HG11 ' A' ' 96' ' ' VAL . 1.3 mt -112.54 8.82 19.39 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.889 0.768 . . . . 0.0 112.22 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.541 ' H ' HG12 ' A' ' 58' ' ' VAL . 71.9 m -74.79 -34.1 62.36 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.297 -0.877 . . . . 0.0 113.233 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -90.76 30.6 1.15 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 122.889 1.328 . . . . 0.0 110.469 -174.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.9 p -160.8 170.7 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 129.344 3.058 . . . . 0.0 104.853 -174.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -129.94 -47.31 1.13 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 172.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.414 ' CB ' ' HE2' ' A' ' 95' ' ' LYS . 41.7 p -143.23 171.76 13.66 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.707 0.803 . . . . 0.0 110.648 -176.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.6 tt -138.32 157.88 31.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 C-N-CA 124.987 1.315 . . . . 0.0 108.393 -174.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -73.53 153.54 40.24 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.74 0.781 . . . . 0.0 109.808 174.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.6 m -76.21 53.23 0.8 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.629 1.172 . . . . 0.0 110.447 164.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -129.29 -69.45 0.69 Allowed 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 160.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.03 -38.84 77.0 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 128.967 2.907 . . . . 0.0 112.031 -173.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 20.9 tp -46.05 -40.39 10.62 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 125.881 1.673 . . . . 0.0 111.966 171.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.82 -31.1 40.98 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-O 119.404 -0.665 . . . . 0.0 111.762 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.2 t -70.62 -33.75 54.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 118.074 0.937 . . . . 0.0 108.659 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 22.7 mm -55.75 -46.98 79.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 O-C-N 121.367 -0.833 . . . . 0.0 109.722 174.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.4 t -60.48 -36.64 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 O-C-N 121.087 -1.008 . . . . 0.0 111.693 172.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -63.73 -28.09 69.65 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 120.873 1.67 . . . . 0.0 112.121 -178.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.4 mt -70.32 -34.95 60.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 O-C-N 121.289 -0.882 . . . . 0.0 109.091 173.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.18 -40.93 82.14 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.1 mttm -54.65 -46.48 73.98 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 117.92 -1.038 . . . . 0.0 111.607 174.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.6 t -58.23 -58.36 8.83 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.1 mt -62.07 -40.28 86.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 123.828 0.851 . . . . 0.0 111.157 -170.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.0 t -60.52 -40.87 93.03 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.68 1.592 . . . . 0.0 110.909 173.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.7 m -69.97 -35.11 74.2 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.985 -0.447 . . . . 0.0 110.613 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.1 m -73.06 -51.08 19.46 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.472 1.109 . . . . 0.0 112.844 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 132.98 18.8 1.05 Allowed Glycine 0 CA--C 1.531 1.04 0 CA-C-O 118.064 -1.409 . . . . 0.0 115.031 -170.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -116.86 -168.06 14.72 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 120.251 2.026 . . . . 0.0 111.72 -172.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.473 ' HB3' HG22 ' A' ' 122' ' ' VAL . 13.1 m-85 -132.4 153.22 51.03 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.639 1.576 . . . . 0.0 109.901 -178.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -153.16 140.69 19.8 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 174.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.529 ' C ' HD23 ' A' ' 89' ' ' LEU . . . -146.6 172.26 13.85 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.61 1.164 . . . . 0.0 111.469 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.529 HD23 ' C ' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -117.02 165.74 13.0 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.576 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.474 HG21 HD13 ' A' ' 115' ' ' ILE . 53.7 t -142.89 134.85 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 C-N-CA 124.723 1.209 . . . . 0.0 108.034 -165.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.6 t 50.74 54.43 15.4 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 126.201 1.801 . . . . 0.0 111.821 -174.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -73.5 107.7 2.45 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 124.175 3.25 . . . . 0.0 109.154 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 32.6 p-10 -66.47 165.52 14.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 122.393 1.092 . . . . 0.0 110.6 174.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -69.09 -26.35 64.88 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.863 -1.148 . . . . 0.0 112.214 -170.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.414 ' HE2' ' CB ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -62.9 -29.18 70.57 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 126.878 2.071 . . . . 0.0 109.66 177.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.848 HG13 HD13 ' A' ' 100' ' ' LEU . 13.3 t -84.88 -50.32 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-O 116.105 -1.902 . . . . 0.0 108.875 169.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -54.04 -34.74 60.84 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 122.782 2.537 . . . . 0.0 109.844 -177.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.73 -46.09 89.71 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 121.711 -0.618 . . . . 0.0 111.268 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.685 HG13 HD12 ' A' ' 100' ' ' LEU . 8.8 p -83.95 -38.8 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 -169.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.848 HD13 HG13 ' A' ' 96' ' ' VAL . 10.7 mp -61.28 -24.29 66.3 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.776 1.63 . . . . 0.0 112.644 177.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.81 6.86 34.27 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.376 0.989 . . . . 0.0 111.302 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 41.5 mt -108.67 -39.24 5.43 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 126.773 2.029 . . . . 0.0 110.704 171.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.2 t -94.72 0.42 55.0 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.413 1.885 . . . . 0.0 112.021 -168.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 57.96 79.86 0.19 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.296 1.838 . . . . 0.0 109.432 -168.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.406 ' HB3' ' HG ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -128.28 -55.44 1.26 Allowed 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.97 1.308 . . . . 0.0 108.996 175.224 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -59.54 -18.41 40.34 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.642 1.977 . . . . 0.0 112.183 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.92 -9.09 24.59 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.422 1.889 . . . . 0.0 114.535 -178.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.8 mt -107.62 -38.04 3.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 126.926 2.09 . . . . 0.0 107.914 -176.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.5 t -120.78 145.44 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 123.726 0.81 . . . . 0.0 109.117 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.04 161.01 27.67 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.084 0.554 . . . . 0.0 110.742 175.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.09 144.12 25.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -144.67 167.05 23.49 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 127.363 2.265 . . . . 0.0 110.784 -176.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -84.72 -44.52 13.29 Favored 'General case' 0 C--O 1.233 0.189 0 O-C-N 121.835 -0.54 . . . . 0.0 110.008 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.6 p -128.96 177.22 7.27 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.165 0.986 . . . . 0.0 109.48 -171.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.474 HD13 HG21 ' A' ' 90' ' ' VAL . 13.7 mm -74.95 -42.59 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 174.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 10.0 t -70.82 -25.56 62.9 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 119.573 1.079 . . . . 0.0 110.313 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -65.74 -16.22 63.57 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 119.676 1.126 . . . . 0.0 111.399 170.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -107.98 -38.75 5.72 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 123.762 0.825 . . . . 0.0 109.185 -171.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 8.2 ttp -61.7 -42.75 99.36 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.245 1.018 . . . . 0.0 112.571 -160.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -92.72 -23.53 18.89 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 124.586 1.154 . . . . 0.0 111.861 175.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -81.39 -52.14 7.59 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -169.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.473 HG22 ' HB3' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -46.89 -34.8 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 127.182 2.193 . . . . 0.0 112.637 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 11.7 mtm180 -60.68 -32.6 71.81 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 123.595 0.758 . . . . 0.0 111.834 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.8 60.31 0.93 Allowed 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 127.008 2.123 . . . . 0.0 105.624 -178.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.259 1.59 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -174.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.5 p90 . . . . . 0 C--O 1.237 0.4 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -129.48 175.75 8.52 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 157.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.5 mt -125.41 157.54 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 163.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.1 m -117.34 -143.13 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 168.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -47.33 -66.44 0.41 Allowed 'General case' 0 C--O 1.234 0.268 0 C-N-CA 127.058 2.143 . . . . 0.0 112.134 -175.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -141.93 12.15 2.03 Favored 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 123.711 0.804 . . . . 0.0 112.574 170.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.695 HG11 ' CE2' ' A' ' 56' ' ' PHE . 20.5 t -105.77 139.07 28.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.9 t -90.72 149.87 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.239 1.016 . . . . 0.0 108.307 174.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.7 mp -129.88 107.81 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 176.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.49 158.43 24.51 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 120.57 1.532 . . . . 0.0 108.586 170.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 38.8 mtt -133.49 86.14 41.16 Favored Pre-proline 0 N--CA 1.465 0.296 0 C-N-CA 124.951 1.3 . . . . 0.0 107.941 -175.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -65.12 93.0 0.22 Allowed 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.372 2.714 . . . . 0.0 109.967 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.413 ' C ' ' HE2' ' A' ' 29' ' ' LYS . 15.5 p-10 -74.05 52.79 0.46 Allowed 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 125.639 1.576 . . . . 0.0 109.679 165.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.413 ' HE2' ' C ' ' A' ' 28' ' ' ASN . 0.0 OUTLIER 51.85 -2.01 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 130.048 3.339 . . . . 0.0 117.769 173.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -71.84 33.32 0.06 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 128.998 2.919 . . . . 0.0 112.485 176.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.8 mt -84.46 59.7 5.59 Favored 'General case' 0 N--CA 1.457 -0.121 0 O-C-N 120.355 -1.466 . . . . 0.0 108.098 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -73.31 172.35 11.36 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.979 1.712 . . . . 0.0 109.724 169.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.7 mt -71.98 -39.21 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 O-C-N 121.472 -0.767 . . . . 0.0 110.609 -177.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -63.97 -33.81 76.58 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 118.48 0.582 . . . . 0.0 110.117 -170.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -78.47 -21.71 48.64 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 125.267 1.427 . . . . 0.0 111.688 175.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.99 -55.9 6.6 Favored 'General case' 0 CA--C 1.521 -0.17 0 O-C-N 120.639 -1.288 . . . . 0.0 112.294 -171.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -67.11 -30.71 70.8 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 118.717 -1.193 . . . . 0.0 110.191 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.418 ' O ' HD12 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -73.48 -23.36 60.06 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 117.785 -1.102 . . . . 0.0 110.308 176.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -49.87 -41.97 46.6 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.296 1.438 . . . . 0.0 111.295 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -58.79 -63.74 1.18 Allowed 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 172.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -44.79 -50.95 9.9 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.865 2.066 . . . . 0.0 111.447 -177.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -61.78 -65.44 0.69 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 117.304 -1.332 . . . . 0.0 109.959 177.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.7 t -53.1 -34.21 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 120.365 1.439 . . . . 0.0 111.416 -176.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.429 ' CD1' HD12 ' A' ' 48' ' ' LEU . 4.9 m-85 -60.75 -69.43 0.23 Allowed 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 124.41 1.084 . . . . 0.0 109.115 174.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -62.81 -39.84 95.53 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.312 0.645 . . . . 0.0 112.538 -173.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -70.55 -31.42 68.46 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.793 1.237 . . . . 0.0 110.858 -175.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -137.71 -58.59 0.67 Allowed 'General case' 0 C--N 1.343 0.298 0 CA-C-N 119.021 0.828 . . . . 0.0 112.238 -171.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.429 HD12 ' CD1' ' A' ' 44' ' ' PHE . 43.7 mt -59.95 -53.04 62.48 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 120.54 -1.35 . . . . 0.0 111.303 -171.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -69.49 -15.65 63.3 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.553 1.941 . . . . 0.0 111.177 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -74.49 -28.89 61.21 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 118.292 -0.861 . . . . 0.0 111.068 168.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.71 1.82 8.17 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.756 1.646 . . . . 0.0 114.235 -177.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -72.83 159.8 33.17 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 120.066 1.933 . . . . 0.0 110.71 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -139.22 -8.29 1.32 Allowed 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 126.349 1.86 . . . . 0.0 111.423 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.544 ' HB3' HG13 ' A' ' 22' ' ' VAL . 4.7 mtmt -129.25 129.25 44.72 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.029 0.931 . . . . 0.0 109.325 -175.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.5 mt -138.39 155.39 28.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 126.706 2.002 . . . . 0.0 106.433 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.695 ' CE2' HG11 ' A' ' 22' ' ' VAL . 23.8 m-85 -134.43 156.96 47.64 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 125.708 1.603 . . . . 0.0 111.459 166.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 46.5 tp -125.97 114.94 19.14 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 117.289 -1.339 . . . . 0.0 108.584 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.7 t -92.85 119.0 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 121.137 1.789 . . . . 0.0 109.206 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.4 mp -90.78 1.38 56.95 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -173.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 73.4 p -51.26 -44.28 61.73 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.636 1.974 . . . . 0.0 114.242 -171.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -68.88 -27.86 66.18 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 120.942 -1.099 . . . . 0.0 111.098 -175.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -95.13 150.86 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 125.344 1.458 . . . . 0.0 109.103 -165.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -70.2 -59.65 2.76 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 158.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.3 t -164.33 176.83 8.75 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 122.699 1.238 . . . . 0.0 110.677 -168.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.0 tt -109.12 177.95 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 128.288 2.635 . . . . 0.0 107.666 172.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -118.88 173.88 6.62 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.247 0.931 . . . . 0.0 110.381 171.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.8 t -50.5 -41.23 53.17 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 126.583 1.953 . . . . 0.0 111.428 -175.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -65.14 -58.7 5.34 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 118.154 -0.927 . . . . 0.0 111.008 -171.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 66.0 m -69.75 -36.72 76.06 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 120.293 1.406 . . . . 0.0 113.012 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.601 HD21 HG21 ' A' ' 103' ' ' THR . 39.8 tp -49.39 -43.48 44.36 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.867 1.667 . . . . 0.0 112.599 -172.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.532 ' HA2' HG12 ' A' ' 74' ' ' VAL . . . -94.98 11.41 69.55 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 120.739 -0.743 . . . . 0.0 113.797 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.6 t -85.03 -39.69 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 118.376 1.088 . . . . 0.0 108.44 153.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.4 mm -56.19 -62.76 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 119.454 1.024 . . . . 0.0 109.68 -177.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.532 HG12 ' HA2' ' A' ' 71' ' ' GLY . 9.8 p -37.13 -49.83 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 124.908 1.283 . . . . 0.0 114.289 165.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.478 ' N ' HG13 ' A' ' 74' ' ' VAL . 3.1 t-20 -60.61 -42.37 96.67 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 123.598 0.759 . . . . 0.0 109.306 -167.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 75.4 mt -55.85 -41.32 66.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.459 1.104 . . . . 0.0 108.221 176.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -58.89 -51.81 68.44 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 124.074 0.95 . . . . 0.0 110.13 177.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -56.57 -45.18 81.44 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 122.882 0.473 . . . . 0.0 110.331 -175.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -46.94 87.67 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 123.013 0.525 . . . . 0.0 110.711 175.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.6 mt -63.77 -41.24 91.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 123.702 0.801 . . . . 0.0 110.652 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.3 m -58.86 -51.11 71.42 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.713 1.205 . . . . 0.0 110.961 173.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.3 m -63.78 -26.53 68.67 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 176.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.9 m -74.24 -51.59 14.9 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.773 0.829 . . . . 0.0 110.967 174.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.74 37.49 0.62 Allowed Glycine 0 CA--C 1.529 0.965 0 CA-C-O 118.699 -1.056 . . . . 0.0 113.662 -165.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -133.76 -168.7 11.9 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 119.755 1.778 . . . . 0.0 111.602 177.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.443 ' HB3' HG22 ' A' ' 122' ' ' VAL . 11.1 m-85 -142.94 119.48 11.03 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.086 1.754 . . . . 0.0 110.111 -171.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -122.77 146.12 47.8 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.173 0.897 . . . . 0.0 109.143 172.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.629 ' C ' HD23 ' A' ' 89' ' ' LEU . . . -152.72 173.35 15.38 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.342 1.057 . . . . 0.0 111.581 -176.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.629 HD23 ' C ' ' A' ' 88' ' ' ALA . 2.5 mt -120.36 164.6 16.1 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.833 0.853 . . . . 0.0 109.527 -176.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.53 HG21 HD13 ' A' ' 115' ' ' ILE . 55.7 t -140.87 147.19 22.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 124.164 0.986 . . . . 0.0 109.468 -175.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 52.98 57.87 14.46 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.991 1.316 . . . . 0.0 111.332 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -77.15 81.69 2.55 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.202 2.601 . . . . 0.0 110.303 177.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.65 143.82 19.32 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.085 0.554 . . . . 0.0 109.668 172.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -54.77 -36.25 64.67 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.983 1.313 . . . . 0.0 113.643 -156.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.3 -41.17 62.69 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.155 0.982 . . . . 0.0 109.204 178.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -81.2 -29.67 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 118.67 0.668 . . . . 0.0 109.676 -173.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -62.81 -26.87 68.95 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.172 0.896 . . . . 0.0 110.801 172.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.75 -44.16 93.94 Favored 'General case' 0 C--N 1.344 0.33 0 O-C-N 121.465 -0.772 . . . . 0.0 109.47 175.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.679 ' O ' HG22 ' A' ' 103' ' ' THR . 9.9 p -86.3 -43.6 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 -168.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.689 HD13 ' HB3' ' A' ' 105' ' ' LEU . 0.2 OUTLIER -58.4 -24.68 60.71 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.674 1.19 . . . . 0.0 111.296 177.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 26.3 t -77.42 -52.79 8.54 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 120.271 1.396 . . . . 0.0 108.712 172.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 52.0 mt -58.26 -51.46 69.69 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.942 1.297 . . . . 0.0 111.76 -172.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.679 HG22 ' O ' ' A' ' 99' ' ' VAL . 5.5 t -73.79 -5.29 39.96 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.383 0.538 . . . . 0.0 111.197 -178.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 64.24 76.69 0.34 Allowed 'General case' 0 C--N 1.342 0.263 0 C-N-CA 126.832 2.053 . . . . 0.0 107.583 -174.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.689 ' HB3' HD13 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -126.84 -51.86 1.45 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.751 1.22 . . . . 0.0 109.501 -171.467 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.59 -25.54 66.3 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 122.995 1.378 . . . . 0.0 111.436 172.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 4.7 mtm180 -75.28 -8.34 56.38 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.505 1.122 . . . . 0.0 111.34 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.9 mt -130.47 -34.74 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 125.07 1.348 . . . . 0.0 109.006 -165.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.5 t -112.68 149.14 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 126.339 1.856 . . . . 0.0 108.159 175.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.93 160.97 30.63 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.688 0.795 . . . . 0.0 110.782 172.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -146.67 144.36 20.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -176.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -148.18 174.02 12.39 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.017 1.327 . . . . 0.0 112.437 -172.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.75 -44.48 9.43 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.751 0.821 . . . . 0.0 111.526 -177.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 71.1 p -126.43 168.43 14.22 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.811 1.244 . . . . 0.0 109.063 -176.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.53 HD13 HG21 ' A' ' 90' ' ' VAL . 9.0 mm -62.66 -39.89 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 167.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.3 t -70.66 -36.28 73.28 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 119.502 1.046 . . . . 0.0 110.155 -171.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -69.14 -5.65 23.7 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 118.324 -0.846 . . . . 0.0 112.225 174.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -104.42 -44.55 4.9 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 174.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 10.0 ttm -56.7 -51.83 67.27 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 125.377 1.471 . . . . 0.0 112.593 -163.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -104.8 13.75 30.76 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 126.322 1.849 . . . . 0.0 110.933 -176.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -112.98 -58.13 2.2 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.607 1.563 . . . . 0.0 109.309 -177.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.443 HG22 ' HB3' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -48.75 -39.03 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.071 0 C-N-CA 126.736 2.015 . . . . 0.0 110.501 177.612 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 12.0 mtm180 -56.5 -30.42 62.97 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 122.692 0.397 . . . . 0.0 110.668 -176.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.71 38.69 1.36 Allowed 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.745 1.218 . . . . 0.0 111.366 -174.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.875 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 167.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 11.7 p90 . . . . . 0 CA--C 1.539 0.544 0 CA-C-O 120.386 0.136 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.9 173.7 9.39 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.481 1.112 . . . . 0.0 110.209 164.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.493 ' CD1' HG22 ' A' ' 23' ' ' VAL . 9.5 mm -121.82 135.47 61.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 169.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.5 m -115.88 -169.19 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 C-N-CA 126.185 1.794 . . . . 0.0 108.051 168.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -24.08 -61.14 0.05 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 129.397 3.079 . . . . 0.0 113.823 -170.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -145.62 19.91 1.5 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.874 0.369 . . . . 0.0 111.707 161.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.586 HG11 ' CE2' ' A' ' 56' ' ' PHE . 9.4 t -110.11 136.23 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 O-C-N 120.837 -1.165 . . . . 0.0 109.192 -175.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.493 HG22 ' CD1' ' A' ' 18' ' ' ILE . 66.0 t -85.32 125.31 40.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 106.862 -1.532 . . . . 0.0 106.862 172.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.524 HD12 HD12 ' A' ' 115' ' ' ILE . 3.7 mm -103.5 104.2 16.31 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 173.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 25.2 mt -78.24 123.1 26.55 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 172.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 32.9 mtt -125.34 75.94 68.61 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 124.404 1.082 . . . . 0.0 109.295 -168.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -67.0 140.49 54.71 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.298 1.998 . . . . 0.0 110.875 -177.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -130.25 66.43 1.5 Allowed 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 128.731 2.812 . . . . 0.0 109.521 171.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.23 7.33 6.18 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.956 2.102 . . . . 0.0 113.567 167.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -73.19 -3.34 26.06 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.217 1.807 . . . . 0.0 114.435 -177.707 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.6 mt -70.19 31.92 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 128.932 2.893 . . . . 0.0 115.483 -159.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -62.35 151.29 37.2 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 128.641 2.776 . . . . 0.0 112.603 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.7 mt -53.43 -40.31 40.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 124.24 1.016 . . . . 0.0 112.183 -177.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -65.83 -30.47 71.09 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.364 0.666 . . . . 0.0 110.086 -172.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.34 -28.43 14.97 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.27 -34.82 74.28 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 117.924 -1.036 . . . . 0.0 111.831 -176.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -59.71 -64.22 1.02 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 119.569 1.077 . . . . 0.0 109.606 174.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.462 HD22 ' O ' ' A' ' 38' ' ' LEU 0.254 0.0 OUTLIER -74.93 -8.21 55.82 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-O 117.989 -1.005 . . . . 0.0 112.858 -172.922 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -41.65 -42.73 2.59 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.709 2.004 . . . . 0.0 111.993 172.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -53.55 -68.73 0.15 Allowed 'General case' 0 C--N 1.343 0.298 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 170.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -52.62 -42.49 64.64 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 125.54 1.536 . . . . 0.0 111.806 -174.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.411 ' CE3' HG23 ' A' ' 43' ' ' VAL . 15.0 t90 -55.78 -60.63 3.18 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.834 0.854 . . . . 0.0 109.533 172.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.411 HG23 ' CE3' ' A' ' 42' ' ' TRP . 53.9 t -56.37 -35.91 45.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 119.927 1.24 . . . . 0.0 111.716 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -70.06 -37.64 75.57 Favored 'General case' 0 N--CA 1.441 -0.903 0 O-C-N 121.309 -0.87 . . . . 0.0 111.048 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -105.39 -9.2 17.7 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.008 1.323 . . . . 0.0 112.308 -167.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -99.35 -20.24 16.61 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.916 1.234 . . . . 0.0 112.135 165.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -135.67 -49.49 0.71 Allowed 'General case' 0 C--N 1.349 0.577 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -174.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 35.2 mt -67.93 -44.45 76.84 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 120.041 1.291 . . . . 0.0 112.314 -169.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -69.34 -24.56 63.92 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.462 0.705 . . . . 0.0 111.845 173.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.7 mttt -66.26 -6.83 15.16 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.944 1.298 . . . . 0.0 112.676 164.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.3 21.88 72.01 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-O 118.945 -0.92 . . . . 0.0 112.589 178.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -73.08 143.03 47.57 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 119.7 1.75 . . . . 0.0 107.597 163.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -127.82 0.89 6.04 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.601 1.56 . . . . 0.0 112.754 177.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.36 124.59 43.29 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 172.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.482 HD12 HD11 ' A' ' 80' ' ' ILE . 3.3 mt -125.13 147.19 29.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 128.448 2.699 . . . . 0.0 104.362 174.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.586 ' CE2' HG11 ' A' ' 22' ' ' VAL . 18.7 m-30 -126.59 158.29 36.63 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.259 1.423 . . . . 0.0 110.475 166.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 29.5 tp -126.85 111.81 14.61 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 172.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 79.6 t -78.65 135.01 26.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 170.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 mp -117.35 20.02 13.81 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.197 0.999 . . . . 0.0 111.694 176.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.63 -51.5 67.02 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.576 1.151 . . . . 0.0 112.806 172.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -86.83 -9.75 55.08 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.127 -0.983 . . . . 0.0 111.72 -164.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.6 p -108.16 155.01 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 127.212 2.205 . . . . 0.0 108.773 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -101.68 -46.73 4.85 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.792 0.837 . . . . 0.0 109.01 172.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.1 p -155.36 170.58 21.58 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 123.767 1.746 . . . . 0.0 112.643 -166.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.4 tt -137.72 177.52 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 C-N-CA 129.242 3.017 . . . . 0.0 105.592 -176.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -131.28 170.53 14.48 Favored 'General case' 0 C--O 1.238 0.486 0 O-C-N 121.471 -0.768 . . . . 0.0 110.696 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.3 m -67.5 50.63 0.05 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 128.548 2.739 . . . . 0.0 110.994 167.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -133.0 -72.73 0.51 Allowed 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 103.986 -2.598 . . . . 0.0 103.986 155.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 m -65.9 -27.34 68.12 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 124.393 1.077 . . . . 0.0 111.92 -167.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.663 HD22 HG21 ' A' ' 103' ' ' THR . 8.8 mt -51.36 -35.06 36.83 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.218 1.007 . . . . 0.0 112.54 177.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -72.07 -34.17 61.84 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.1 t -75.54 -34.15 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 O-C-N 121.526 -0.985 . . . . 0.0 110.402 -173.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.2 mp -55.89 -45.77 80.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 170.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.7 t -63.78 -45.99 95.69 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 O-C-N 121.048 -1.033 . . . . 0.0 110.04 175.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -50.24 -39.7 45.45 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.883 1.22 . . . . 0.0 113.247 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 65.6 mt -60.88 -47.81 91.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.203 1.001 . . . . 0.0 109.715 174.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.521 ' HG ' HG12 ' A' ' 109' ' ' VAL . 1.1 tm? -59.57 -47.09 86.91 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.7 mttt -56.69 -46.32 81.26 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 119.063 -0.494 . . . . 0.0 110.675 -175.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.8 t -54.39 -58.41 7.55 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 174.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.482 HD11 HD12 ' A' ' 55' ' ' ILE . 81.5 mt -55.58 -48.18 77.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.619 1.167 . . . . 0.0 111.628 -174.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.5 m -69.01 -14.38 63.01 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 117.651 -1.166 . . . . 0.0 112.947 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 51.3 m -87.42 -45.07 10.86 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.474 1.034 . . . . 0.0 110.506 163.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.8 m -66.19 -17.63 64.85 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 126.112 1.765 . . . . 0.0 115.014 -175.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.94 0.2 9.81 Favored Glycine 0 C--N 1.336 0.552 0 CA-C-O 118.116 -1.38 . . . . 0.0 116.307 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -115.85 -165.31 14.36 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-N 119.859 1.829 . . . . 0.0 113.699 -163.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.401 ' HB3' ' CG2' ' A' ' 122' ' ' VAL . 1.0 OUTLIER -131.61 154.41 48.91 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.888 1.675 . . . . 0.0 108.852 173.202 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.494 ' HB3' HD23 ' A' ' 77' ' ' LEU . 13.5 t80 -123.76 141.48 51.99 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 168.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.71 ' C ' HD23 ' A' ' 89' ' ' LEU . . . -144.38 167.18 23.09 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 119.468 -0.893 . . . . 0.0 112.163 167.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.71 HD23 ' C ' ' A' ' 88' ' ' ALA . 1.4 mt -120.86 160.05 24.23 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -175.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.489 HG21 HD13 ' A' ' 115' ' ' ILE . 26.4 t -134.28 138.34 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -171.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.7 m 58.45 60.23 5.7 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 125.034 1.334 . . . . 0.0 111.952 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -82.74 101.02 1.01 Allowed 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.171 2.581 . . . . 0.0 110.001 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -65.72 170.54 5.12 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.896 1.278 . . . . 0.0 108.899 175.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -72.2 -30.04 64.55 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.167 -0.958 . . . . 0.0 111.449 -175.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.402 ' HE3' ' O ' ' A' ' 95' ' ' LYS . 0.2 OUTLIER -58.42 -45.95 87.43 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 120.804 -1.185 . . . . 0.0 108.896 176.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 31.3 m -79.07 -37.24 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.856 0 CA-C-O 117.355 -1.307 . . . . 0.0 111.261 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -56.36 -30.65 62.93 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 121.292 1.86 . . . . 0.0 109.329 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.62 -38.41 90.12 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.689 177.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.53 ' O ' HG22 ' A' ' 103' ' ' THR . 6.4 p -95.81 -28.41 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -170.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.17 -15.37 63.08 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 124.973 1.309 . . . . 0.0 110.231 177.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.52 -55.28 4.97 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 120.05 1.295 . . . . 0.0 107.881 168.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.28 -43.26 86.9 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.966 2.106 . . . . 0.0 112.191 -163.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.663 HG21 HD22 ' A' ' 70' ' ' LEU . 2.1 t -76.45 -6.34 51.31 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.563 0.745 . . . . 0.0 110.964 177.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.7 m120 52.63 83.56 0.06 Allowed 'General case' 0 C--N 1.346 0.425 0 C-N-CA 129.376 3.071 . . . . 0.0 107.875 -163.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.95 -72.96 0.68 Allowed 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 176.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -61.74 -24.47 66.83 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.77 1.228 . . . . 0.0 110.728 174.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -75.15 5.9 4.89 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 120.777 -1.202 . . . . 0.0 111.313 176.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.9 mt -129.45 -43.39 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 C-N-CA 127.795 2.438 . . . . 0.0 107.829 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.521 HG12 ' HG ' ' A' ' 77' ' ' LEU . 3.3 m -98.25 178.69 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 C-N-CA 127.066 2.146 . . . . 0.0 113.137 -172.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.42 ' HB2' ' HB2' ' A' ' 88' ' ' ALA . 24.7 mmtm -99.58 162.95 12.71 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 124.099 0.96 . . . . 0.0 110.086 170.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -151.18 136.47 10.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -171.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -145.03 167.1 23.47 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.41 1.084 . . . . 0.0 112.668 -169.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.14 -38.64 17.53 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.876 -0.515 . . . . 0.0 111.183 -174.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.1 p -134.64 177.21 7.96 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.524 HD12 HD12 ' A' ' 24' ' ' ILE . 15.1 mm -71.19 -40.56 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.278 174.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.4 t -70.3 -32.63 70.49 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 119.424 1.011 . . . . 0.0 110.143 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -70.7 0.57 6.76 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.617 172.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.39 -37.04 3.83 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 119.259 0.936 . . . . 0.0 109.523 175.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 20.7 ttm -63.67 -55.27 24.77 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.984 1.314 . . . . 0.0 111.788 -160.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -81.61 -18.79 43.52 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.064 0.459 . . . . 0.0 110.265 173.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -80.33 -49.02 12.09 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -162.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.401 ' CG2' ' HB3' ' A' ' 86' ' ' PHE . 4.1 p -42.26 -40.48 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 127.856 2.462 . . . . 0.0 111.461 174.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -58.01 -45.83 86.25 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 125.106 1.362 . . . . 0.0 113.423 177.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.09 34.62 3.08 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.364 1.866 . . . . 0.0 110.778 -166.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.417 ' CG ' ' HE2' ' A' ' 110' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.847 0 C-N-CA 127.076 2.151 . . . . 0.0 111.67 -176.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 20.8 p90 . . . . . 0 N--CA 1.445 -0.723 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -127.62 176.74 7.28 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 120.791 -1.193 . . . . 0.0 108.451 164.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.9 mt -132.32 120.13 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 171.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.6 m -102.33 -175.93 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 166.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -26.74 -55.95 0.08 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 130.199 3.4 . . . . 0.0 113.95 -157.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -143.5 8.97 1.58 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 118.775 -0.631 . . . . 0.0 111.241 164.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.53 HG11 ' CE2' ' A' ' 56' ' ' PHE . 21.3 t -111.32 115.62 50.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 -172.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 38.9 t -68.3 156.4 7.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 173.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.592 HD12 HD12 ' A' ' 115' ' ' ILE . 10.7 mm -130.6 98.4 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 177.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.53 134.49 45.28 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 120.24 1.382 . . . . 0.0 108.25 168.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 51.6 mtm -128.83 72.7 81.53 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 123.644 0.778 . . . . 0.0 109.551 -177.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.59 145.3 57.73 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.31 2.674 . . . . 0.0 112.577 -176.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.602 HD22 ' H ' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -118.87 -77.8 0.58 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 126.056 1.742 . . . . 0.0 110.452 174.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.602 ' H ' HD22 ' A' ' 28' ' ' ASN . 0.0 OUTLIER -135.56 13.85 3.45 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.001 1.321 . . . . 0.0 111.07 -173.571 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -108.78 18.42 20.8 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 120.967 -1.083 . . . . 0.0 112.103 -162.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 19.8 mt -92.62 68.06 4.68 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 124.146 0.978 . . . . 0.0 109.087 -176.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -81.23 144.24 31.73 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.2 tt -52.83 -37.19 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 CA-C-N 119.006 0.821 . . . . 0.0 111.82 170.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -62.62 -52.73 62.2 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.49 -0.756 . . . . 0.0 109.71 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -76.01 -16.38 59.97 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-O 118.228 -0.892 . . . . 0.0 111.96 177.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.73 -40.8 88.5 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.909 1.231 . . . . 0.0 110.518 171.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -60.6 -39.03 86.63 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 120.433 -1.417 . . . . 0.0 109.575 174.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 90.1 mt -73.04 -23.55 60.6 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.783 1.233 . . . . 0.0 113.05 178.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -53.98 -37.67 64.22 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.175 1.39 . . . . 0.0 110.97 -170.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.412 ' HE2' ' CZ ' ' A' ' 44' ' ' PHE . 0.4 OUTLIER -63.35 -52.49 61.53 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.072 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.89 -47.96 73.64 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 124.815 1.246 . . . . 0.0 109.834 178.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.534 ' CE3' HG23 ' A' ' 43' ' ' VAL . 17.6 t90 -58.57 -69.74 0.17 Allowed 'General case' 0 C--O 1.219 -0.549 0 O-C-N 124.593 1.183 . . . . 0.0 109.79 176.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.534 HG23 ' CE3' ' A' ' 42' ' ' TRP . 71.0 t -52.89 -32.21 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 121.153 1.797 . . . . 0.0 111.549 -175.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.483 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 4.0 m-85 -61.43 -77.15 0.05 OUTLIER 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 123.612 0.765 . . . . 0.0 110.051 172.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.468 ' HA ' ' HB2' ' A' ' 49' ' ' ASN . 0.6 OUTLIER -64.95 -28.47 69.54 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -172.183 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.416 ' HG2' ' CZ ' ' A' ' 47' ' ' PHE . 0.7 OUTLIER -74.9 -30.06 61.17 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.347 1.459 . . . . 0.0 110.445 176.695 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.416 ' CZ ' ' HG2' ' A' ' 46' ' ' GLU . 13.6 m-85 -139.83 -66.71 0.45 Allowed 'General case' 0 C--N 1.348 0.508 0 CA-C-N 119.603 1.092 . . . . 0.0 111.609 -172.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.483 ' HB2' ' HA ' ' A' ' 44' ' ' PHE . 18.5 mt -57.37 -54.35 47.78 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 120.878 -1.139 . . . . 0.0 113.081 -169.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.468 ' HB2' ' HA ' ' A' ' 45' ' ' ASP . 78.4 m-20 -67.48 -34.63 77.56 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 125.864 1.665 . . . . 0.0 109.127 177.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.12 -39.07 71.65 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.106 1.362 . . . . 0.0 111.279 176.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 139.65 8.51 0.94 Allowed Glycine 0 CA--C 1.535 1.334 0 C-N-CA 125.123 1.344 . . . . 0.0 113.93 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -92.34 150.3 20.92 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 119.023 1.412 . . . . 0.0 111.392 -177.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.401 ' O ' ' HA3' ' A' ' 85' ' ' GLY . 1.1 m120 -143.22 44.79 1.55 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.287 1.835 . . . . 0.0 108.247 -172.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.462 ' HG3' HG22 ' A' ' 22' ' ' VAL . 0.0 OUTLIER 171.59 149.84 0.05 OUTLIER 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 126.015 1.726 . . . . 0.0 107.829 179.129 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -153.34 163.0 2.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 105.342 -2.095 . . . . 0.0 105.342 -174.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.53 ' CE2' HG11 ' A' ' 22' ' ' VAL . 9.6 m-85 -136.29 148.88 48.18 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.45 1.5 . . . . 0.0 108.615 169.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 50.5 tp -124.27 110.56 14.77 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.251 1.021 . . . . 0.0 109.808 177.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.3 135.57 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 173.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 mp -123.65 43.25 3.02 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.953 0.882 . . . . 0.0 110.288 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.8 t -99.98 -49.58 4.27 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.945 0.898 . . . . 0.0 109.029 -176.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.82 -14.45 58.04 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.126 -0.984 . . . . 0.0 111.159 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.7 p -106.0 118.71 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 125.596 1.559 . . . . 0.0 107.232 174.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -68.83 -51.63 38.6 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 176.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 86.2 p -157.76 166.62 32.27 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.86 -169.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 21.3 tt -135.49 148.99 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 C-N-CA 124.882 1.273 . . . . 0.0 108.333 -168.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -71.49 155.24 40.81 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.2 p -63.97 -14.35 53.24 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 117.902 -1.047 . . . . 0.0 113.77 -174.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -68.53 -71.37 0.22 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.036 1.334 . . . . 0.0 108.934 172.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 41.0 t -63.0 -34.1 76.84 Favored 'General case' 0 C--N 1.339 0.136 0 O-C-N 121.911 -0.493 . . . . 0.0 111.029 -169.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 50.9 tp -40.66 -39.86 1.16 Allowed 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 125.595 1.558 . . . . 0.0 114.041 169.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.401 ' HA2' HG12 ' A' ' 74' ' ' VAL . . . -107.54 0.25 34.63 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 118.44 0.564 . . . . 0.0 113.246 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.0 t -75.28 -30.05 22.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 O-C-N 120.774 -1.427 . . . . 0.0 108.647 161.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.6 mt -66.87 -61.15 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 125.181 1.392 . . . . 0.0 112.542 175.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.401 HG12 ' HA2' ' A' ' 71' ' ' GLY . 7.4 p -41.77 -49.19 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 168.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -45.79 -36.79 5.42 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.567 1.547 . . . . 0.0 112.863 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 90.8 mt -64.52 -46.87 91.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.295 1.038 . . . . 0.0 108.558 175.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -52.9 -48.6 67.08 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.635 0.774 . . . . 0.0 109.728 176.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -56.49 -43.03 79.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 118.955 -0.545 . . . . 0.0 111.067 -174.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.0 m -57.7 -64.79 0.78 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 118.883 -0.58 . . . . 0.0 111.352 166.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 80' ' ' ILE . 51.1 mt -61.52 -42.71 95.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 119.303 0.956 . . . . 0.0 111.502 -166.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.4 m -57.07 -47.55 80.71 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 119.323 0.965 . . . . 0.0 110.179 175.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.5 m -63.54 -34.28 77.44 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.975 0.807 . . . . 0.0 111.689 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 56.6 m -67.57 -38.08 83.56 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 118.604 -0.712 . . . . 0.0 111.941 173.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 105.03 59.37 0.66 Allowed Glycine 0 N--CA 1.448 -0.52 0 CA-C-O 119.162 -0.799 . . . . 0.0 111.136 -166.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 53' ' ' ASN . . . -148.68 -176.45 22.07 Favored Glycine 0 N--CA 1.439 -1.149 0 CA-C-N 118.891 1.345 . . . . 0.0 111.553 177.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.555 ' HB3' HG22 ' A' ' 122' ' ' VAL . 1.8 m-85 -130.9 92.13 3.17 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 122.084 -0.656 . . . . 0.0 112.439 -158.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -104.76 134.75 47.38 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.839 -1.163 . . . . 0.0 110.545 174.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -142.48 167.43 22.11 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.623 1.569 . . . . 0.0 112.472 175.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.438 ' N ' HD12 ' A' ' 89' ' ' LEU . 7.1 mp -113.9 153.13 29.75 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 127.54 2.336 . . . . 0.0 108.299 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 72.8 t -141.09 135.35 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -166.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.7 t 48.46 56.14 17.66 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.691 1.196 . . . . 0.0 110.645 -170.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -72.42 0.09 7.97 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.304 2.669 . . . . 0.0 114.777 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 18.6 p30 47.63 -163.04 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.733 1.613 . . . . 0.0 112.662 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -95.91 -41.54 8.75 Favored 'General case' 0 C--O 1.225 -0.196 0 O-C-N 120.473 -1.392 . . . . 0.0 109.416 174.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.489 ' O ' ' HE3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -53.74 -50.84 65.1 Favored 'General case' 0 C--O 1.227 -0.126 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -175.548 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.3 t -68.84 -47.52 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-O 118.571 -0.728 . . . . 0.0 109.143 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -60.95 -19.74 61.33 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 120.513 1.506 . . . . 0.0 112.273 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.5 -15.52 63.27 Favored 'General case' 0 C--O 1.216 -0.664 0 O-C-N 120.785 -1.197 . . . . 0.0 111.081 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.414 ' O ' HG22 ' A' ' 103' ' ' THR . 2.6 t -118.59 -34.13 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 C-N-CA 125.822 1.649 . . . . 0.0 108.25 -175.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.45 -14.84 31.85 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 117.617 -1.182 . . . . 0.0 109.08 175.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.8 m -79.69 -29.66 40.83 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 117.907 -1.517 . . . . 0.0 109.813 174.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -92.05 -25.33 18.84 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 129.103 2.961 . . . . 0.0 111.421 -159.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.42 HG23 HD23 ' A' ' 105' ' ' LEU . 3.7 t -113.65 35.44 4.05 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.858 1.663 . . . . 0.0 108.296 174.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 35.21 62.38 0.57 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.524 1.93 . . . . 0.0 110.585 176.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.42 HD23 HG23 ' A' ' 103' ' ' THR . 0.0 OUTLIER -114.54 -51.47 2.75 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -166.671 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.5 -24.49 67.84 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 118.616 0.644 . . . . 0.0 111.308 173.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.6 mtt-85 -80.03 -11.25 59.79 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 118.476 -0.773 . . . . 0.0 112.97 -177.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.0 mt -128.1 -37.13 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 C-N-CA 124.49 1.116 . . . . 0.0 109.577 -167.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.6 t -104.26 141.01 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 171.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.52 158.98 34.17 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.882 1.273 . . . . 0.0 111.295 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.1 mp -130.98 146.36 34.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 124.878 1.271 . . . . 0.0 108.077 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -147.02 168.13 22.3 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 127.286 2.234 . . . . 0.0 109.849 175.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.53 -51.77 7.48 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 75.4 p -130.81 171.6 12.95 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 123.165 0.586 . . . . 0.0 109.715 -171.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.592 HD12 HD12 ' A' ' 24' ' ' ILE . 11.8 mm -66.49 -39.3 83.64 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 CA-C-O 118.074 -0.965 . . . . 0.0 108.837 178.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.2 t -67.27 -36.99 82.72 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 118.862 0.756 . . . . 0.0 109.771 -175.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -62.22 -9.31 7.42 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 124.321 1.049 . . . . 0.0 112.256 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.467 ' HB1' ' CZ ' ' A' ' 56' ' ' PHE . . . -116.79 -34.45 4.47 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 124.676 1.19 . . . . 0.0 109.636 -175.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 12.4 ttp -61.8 -46.18 90.67 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 120.593 -1.317 . . . . 0.0 112.549 -161.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.429 ' HA ' ' HG3' ' A' ' 123' ' ' ARG . 14.6 pt-20 -101.52 -2.63 30.18 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.66 1.984 . . . . 0.0 112.112 176.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -91.49 -62.6 1.4 Allowed 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.555 HG22 ' HB3' ' A' ' 86' ' ' PHE . 0.3 OUTLIER -42.43 -37.4 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.307 0 C-N-CA 127.534 2.334 . . . . 0.0 111.553 174.054 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.429 ' HG3' ' HA ' ' A' ' 120' ' ' GLU . 10.1 mmt180 -44.02 -35.45 2.1 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 125.446 1.498 . . . . 0.0 113.32 174.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.09 22.96 2.23 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 172.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.306 0.1 OUTLIER . . . . . 0 C--O 1.249 1.076 0 C-N-CA 129.436 3.094 . . . . 0.0 116.08 -162.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.1 p90 . . . . . 0 N--CA 1.45 -0.444 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.519 ' HE2' HG12 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -135.01 175.31 9.69 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 121.978 -0.451 . . . . 0.0 110.192 168.21 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 67.4 mt -130.45 119.24 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 126.303 1.841 . . . . 0.0 106.944 175.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.519 HG12 ' HE2' ' A' ' 17' ' ' LYS . 33.7 m -100.59 -154.35 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 127.529 2.331 . . . . 0.0 106.792 174.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -25.94 -77.41 0.01 OUTLIER 'General case' 0 C--O 1.241 0.658 0 C-N-CA 129.805 3.242 . . . . 0.0 111.467 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -148.21 28.07 0.92 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 127.961 2.504 . . . . 0.0 109.828 170.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.648 HG11 ' CE2' ' A' ' 56' ' ' PHE . 20.2 t -119.68 148.03 22.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.7 t -103.7 140.29 22.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 177.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.409 HG13 HD12 ' A' ' 115' ' ' ILE . 1.8 mp -118.22 101.54 11.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 177.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.32 146.55 45.18 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 120.416 1.462 . . . . 0.0 108.453 165.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 69.7 mtm -127.98 79.58 73.54 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 124.63 1.172 . . . . 0.0 108.267 178.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -58.05 135.66 70.02 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.813 2.342 . . . . 0.0 110.636 177.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.22 -105.36 0.22 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.339 1.856 . . . . 0.0 106.312 169.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.92 69.4 1.04 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 121.551 1.978 . . . . 0.0 111.247 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -154.9 4.93 0.23 Allowed 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 115.505 1.668 . . . . 0.0 115.505 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.01 37.63 0.55 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 120.576 1.535 . . . . 0.0 109.988 172.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -77.74 157.4 30.06 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.771 1.629 . . . . 0.0 109.599 171.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 61.1 mt -62.15 -35.82 71.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 123.938 0.895 . . . . 0.0 110.704 -174.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -73.33 -8.86 57.67 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.11 -0.994 . . . . 0.0 111.402 -177.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -113.54 28.83 8.47 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.343 1.857 . . . . 0.0 109.754 171.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.68 -54.51 2.6 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 120.733 -1.229 . . . . 0.0 111.7 -175.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 40.7 t60 -62.07 -52.24 64.73 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 120.623 1.556 . . . . 0.0 109.759 175.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.541 HD12 ' C ' ' A' ' 38' ' ' LEU . 0.5 OUTLIER -59.89 -24.73 64.52 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-O 118.748 -0.644 . . . . 0.0 111.167 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -51.86 -44.76 63.81 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 124.88 1.272 . . . . 0.0 110.625 -177.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -64.68 -44.71 89.46 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.82 -41.45 97.87 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 119.038 0.836 . . . . 0.0 112.205 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 15.6 t90 -58.81 -66.28 0.52 Allowed 'General case' 0 C--O 1.221 -0.401 0 CA-C-O 117.23 -1.367 . . . . 0.0 107.479 173.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.5 t -52.93 -36.11 23.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 120.585 1.539 . . . . 0.0 112.193 -177.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -57.76 -67.0 0.38 Allowed 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 124.04 0.936 . . . . 0.0 110.028 173.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.29 -45.43 66.34 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 121.441 -0.787 . . . . 0.0 111.684 -171.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -62.42 -28.75 70.01 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.939 1.696 . . . . 0.0 111.006 -175.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -136.69 -65.85 0.55 Allowed 'General case' 0 C--N 1.346 0.432 0 C-N-CA 123.19 0.596 . . . . 0.0 111.53 -172.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 44.3 mt -55.58 -53.68 53.5 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.147 0.885 . . . . 0.0 111.822 -168.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -71.5 -34.26 69.96 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.513 1.925 . . . . 0.0 109.834 176.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.03 -30.16 65.92 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 118.242 -0.885 . . . . 0.0 112.021 177.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 140.26 -0.49 2.03 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 119.25 -0.75 . . . . 0.0 113.805 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -92.51 154.81 18.23 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 119.803 1.801 . . . . 0.0 110.347 -174.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -134.85 6.72 3.44 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.806 1.242 . . . . 0.0 109.816 172.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.407 ' HB3' HG13 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -135.86 132.21 36.29 Favored 'General case' 0 CA--C 1.518 -0.288 0 O-C-N 120.583 -1.323 . . . . 0.0 107.769 -176.846 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.9 mt -135.71 154.02 33.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 126.094 1.758 . . . . 0.0 106.422 175.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.704 ' CE1' HG21 ' A' ' 122' ' ' VAL . 20.1 m-85 -129.54 152.71 48.78 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.725 1.61 . . . . 0.0 109.702 163.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 54.8 tp -118.97 112.35 19.49 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 118.149 -0.929 . . . . 0.0 110.069 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.505 ' CG2' HD11 ' A' ' 115' ' ' ILE . 47.2 t -90.72 111.18 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 119.175 0.898 . . . . 0.0 109.474 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.539 HD22 HG11 ' A' ' 96' ' ' VAL . 1.8 mp -91.64 5.23 50.48 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.425 0.69 . . . . 0.0 112.514 -177.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 24.3 m -51.59 -42.13 61.69 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.094 0.958 . . . . 0.0 113.221 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -85.23 -29.26 24.8 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.766 0.712 . . . . 0.0 111.09 -174.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.8 p -80.82 173.1 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 O-C-N 121.34 -0.85 . . . . 0.0 109.158 -173.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -121.56 -46.14 2.27 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 120.588 -1.32 . . . . 0.0 109.31 172.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.9 p -150.1 172.63 14.97 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.537 0.684 . . . . 0.0 112.402 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.3 tt -133.48 153.18 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 126.072 1.749 . . . . 0.0 107.323 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -85.16 162.5 19.2 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 122.579 0.352 . . . . 0.0 110.206 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.2 -36.79 66.31 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.598 0.759 . . . . 0.0 111.903 179.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -55.57 -72.93 0.06 Allowed 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.049 1.74 . . . . 0.0 109.59 -178.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 53.5 m -64.27 -30.86 71.9 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 118.249 -0.881 . . . . 0.0 112.662 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.3 tp -59.39 -16.89 25.89 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 120.521 1.509 . . . . 0.0 112.769 -177.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -90.73 -33.97 8.1 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 118.995 0.816 . . . . 0.0 112.843 167.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.6 t -64.2 -36.84 78.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 O-C-N 121.149 -1.206 . . . . 0.0 110.363 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp -52.72 -51.38 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 175.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.4 t -66.02 -35.74 75.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 O-C-N 120.95 -1.094 . . . . 0.0 110.268 177.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.69 -45.05 82.02 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 119.662 1.119 . . . . 0.0 111.268 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 71.7 mt -59.45 -33.72 52.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 123.438 0.695 . . . . 0.0 109.21 175.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -69.8 -44.9 69.1 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 120.269 1.395 . . . . 0.0 108.44 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 48.7 mttm -58.87 -47.31 85.37 Favored 'General case' 0 C--N 1.335 -0.025 0 CA-C-O 118.584 -0.722 . . . . 0.0 110.151 177.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 31.8 m -51.45 -59.55 4.12 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 123.684 0.794 . . . . 0.0 110.272 172.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 21.1 mt -53.96 -43.76 59.28 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 C-N-CA 124.278 1.031 . . . . 0.0 111.406 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 51.6 p -57.35 -48.77 78.14 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.207 0.912 . . . . 0.0 109.974 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.5 -33.87 76.66 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.762 1.625 . . . . 0.0 111.304 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.4 m -67.76 -16.58 64.19 Favored 'General case' 0 C--N 1.335 -0.056 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 170.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.86 1.09 61.79 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-N 119.196 0.907 . . . . 0.0 113.664 -172.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -92.65 -175.99 41.46 Favored Glycine 0 N--CA 1.432 -1.608 0 CA-C-N 118.892 1.346 . . . . 0.0 112.193 -175.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -136.09 155.92 49.48 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.537 1.535 . . . . 0.0 109.517 178.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -152.39 147.17 25.97 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 175.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -148.04 161.04 42.18 Favored 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 124.152 0.908 . . . . 0.0 111.638 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.449 ' CD1' HG11 ' A' ' 109' ' ' VAL . 7.3 mp -106.73 158.17 17.17 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.795 1.638 . . . . 0.0 108.186 -176.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 84.9 t -142.41 135.67 27.55 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -165.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 46.41 57.82 16.62 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 124.904 1.281 . . . . 0.0 109.656 -173.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -72.32 88.75 0.84 Allowed 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.177 2.584 . . . . 0.0 108.604 -178.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -54.46 148.98 11.05 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.657 0.741 . . . . 0.0 110.647 -175.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -54.49 -34.11 61.02 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.671 1.588 . . . . 0.0 111.582 -168.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -49.15 70.23 Favored 'General case' 0 CA--C 1.521 -0.172 0 O-C-N 120.327 -1.483 . . . . 0.0 108.645 177.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.539 HG11 HD22 ' A' ' 59' ' ' LEU . 1.1 t -62.05 -47.9 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 123.774 0.83 . . . . 0.0 110.386 175.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.43 -36.95 64.57 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.827 2.051 . . . . 0.0 109.846 -172.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.84 -59.07 4.18 Favored 'General case' 0 N--CA 1.424 -1.728 0 C-N-CA 126.731 2.012 . . . . 0.0 111.54 177.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.609 ' O ' HG22 ' A' ' 103' ' ' THR . 8.0 t -65.53 -45.58 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 CA-C-N 111.754 -2.476 . . . . 0.0 107.284 -176.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.81 -17.55 16.6 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.965 0.906 . . . . 0.0 110.222 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 65.6 m -117.0 16.7 15.06 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 124.551 1.157 . . . . 0.0 112.314 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 62.2 mt -123.23 -16.25 6.98 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 129.484 3.114 . . . . 0.0 111.435 169.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.609 HG22 ' O ' ' A' ' 99' ' ' VAL . 4.7 t -113.61 1.13 14.84 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.837 2.055 . . . . 0.0 110.632 -177.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 44.99 81.59 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.811 1.644 . . . . 0.0 110.201 -165.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.52 -53.26 2.53 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 173.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.89 -12.04 51.57 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.372 1.069 . . . . 0.0 112.867 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.4 mtt85 -98.66 4.05 47.88 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.848 1.659 . . . . 0.0 111.199 -178.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.3 mt -132.84 -37.24 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 126.031 1.732 . . . . 0.0 110.019 -173.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.449 HG11 ' CD1' ' A' ' 89' ' ' LEU . 2.7 t -111.15 149.78 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 177.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.24 159.01 35.4 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.224 0.61 . . . . 0.0 109.888 174.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -131.99 151.47 35.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 125.041 1.337 . . . . 0.0 108.625 178.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -148.02 173.0 13.35 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 127.055 2.142 . . . . 0.0 110.639 173.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.57 -39.24 14.27 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 123.563 0.745 . . . . 0.0 109.231 177.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 25.2 p -136.86 170.48 16.02 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.043 0.937 . . . . 0.0 110.837 -173.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.505 HD11 ' CG2' ' A' ' 58' ' ' VAL . 19.9 mm -63.94 -45.36 97.1 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 CA-C-O 117.754 -1.117 . . . . 0.0 108.587 172.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.3 t -67.38 -36.72 81.9 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 119.228 0.922 . . . . 0.0 109.134 -169.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -70.87 -15.35 62.62 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 176.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.715 ' O ' HG23 ' A' ' 122' ' ' VAL . . . -86.48 -49.34 7.66 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 174.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.95 -52.24 63.61 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.762 1.225 . . . . 0.0 111.316 -160.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.06 -7.98 54.49 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 127.906 2.482 . . . . 0.0 114.446 176.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -104.28 -53.25 2.76 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 118.795 0.725 . . . . 0.0 109.355 -169.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 118' ' ' ALA . 12.8 t -50.68 -33.63 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 C-N-CA 129.336 3.054 . . . . 0.0 110.39 172.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -43.46 -36.96 2.18 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.006 0.922 . . . . 0.0 113.243 166.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.57 24.08 3.15 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 116.452 2.019 . . . . 0.0 116.452 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 31.5 mmtt . . . . . 0 C--O 1.255 1.383 0 C-N-CA 129.56 3.144 . . . . 0.0 103.174 177.666 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 25.9 p90 . . . . . 0 C--O 1.239 0.533 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.88 170.27 10.28 Favored 'General case' 0 N--CA 1.46 0.069 0 C-N-CA 123.937 0.895 . . . . 0.0 110.286 169.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.1 mt -131.49 150.57 34.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 174.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.4 m -120.27 -133.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 126.408 1.883 . . . . 0.0 107.03 176.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -46.38 -75.41 0.03 OUTLIER 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 127.565 2.346 . . . . 0.0 111.312 -177.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -143.35 27.79 1.54 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.821 1.649 . . . . 0.0 108.434 172.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.749 HG11 ' CE2' ' A' ' 56' ' ' PHE . 11.7 t -121.73 138.94 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 C-N-CA 124.172 0.989 . . . . 0.0 108.451 -175.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 72.5 t -99.21 140.44 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 125.668 1.587 . . . . 0.0 107.546 -178.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mp -119.42 95.98 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 126.402 1.881 . . . . 0.0 105.957 -178.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 31.5 mt -84.8 126.28 33.3 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 177.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 56.1 mtm -125.76 92.02 47.25 Favored Pre-proline 0 N--CA 1.464 0.274 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.76 106.53 1.68 Allowed 'Trans proline' 0 N--CA 1.45 -1.074 0 N-CA-C 108.28 -1.469 . . . . 0.0 108.28 176.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -74.79 55.53 0.68 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.264 1.026 . . . . 0.0 111.549 172.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.99 41.11 3.76 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.447 1.499 . . . . 0.0 112.866 -173.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -105.75 48.85 0.82 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-O 122.222 1.01 . . . . 0.0 110.317 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.61 68.36 8.66 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 123.483 1.611 . . . . 0.0 108.185 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -68.05 3.23 1.67 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 129.577 3.151 . . . . 0.0 114.977 -174.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 mt 65.65 -56.3 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 129.795 3.238 . . . . 0.0 111.378 -167.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -63.81 -31.98 73.34 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 118.258 0.481 . . . . 0.0 109.777 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -59.4 -60.1 4.39 Favored 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 124.147 0.979 . . . . 0.0 109.117 165.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.454 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . . . -51.19 -38.91 54.96 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 120.515 1.507 . . . . 0.0 114.448 -178.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -67.86 -34.04 75.92 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.702 1.137 . . . . 0.0 111.881 178.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.17 -19.0 30.74 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-O 118.154 -0.927 . . . . 0.0 110.883 177.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.454 ' HB2' ' HA ' ' A' ' 36' ' ' ALA . 5.7 t80 -46.62 -49.96 18.26 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 127.917 2.487 . . . . 0.0 110.299 -172.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.0 -57.22 11.07 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 124.6 1.16 . . . . 0.0 109.917 175.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -56.55 -48.98 76.13 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 124.561 1.145 . . . . 0.0 112.07 178.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -56.54 -71.77 0.09 Allowed 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 117.574 -1.203 . . . . 0.0 108.055 178.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.6 t -46.39 -42.72 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.089 0.955 . . . . 0.0 109.373 -177.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 -60.22 -59.97 4.57 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 120.606 1.548 . . . . 0.0 111.643 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -68.63 -4.04 14.09 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.619 1.568 . . . . 0.0 111.991 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -107.17 -33.04 7.56 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 116.413 -1.756 . . . . 0.0 108.956 -177.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.619 ' HB2' HD22 ' A' ' 48' ' ' LEU . 54.4 m-85 -134.57 -49.81 0.78 Allowed 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 123.603 2.91 . . . . 0.0 109.335 -174.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.619 HD22 ' HB2' ' A' ' 47' ' ' PHE . 1.9 mm? -69.49 -57.0 5.79 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 124.039 0.936 . . . . 0.0 110.666 -169.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -62.81 -27.22 69.17 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.571 0.748 . . . . 0.0 109.781 174.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -66.66 -20.14 65.92 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.862 1.665 . . . . 0.0 113.616 171.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.02 6.18 46.02 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.297 1.427 . . . . 0.0 114.787 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -76.57 149.81 36.58 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 119.994 1.897 . . . . 0.0 110.236 172.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -130.02 6.18 5.0 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.216 1.006 . . . . 0.0 112.791 -178.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.512 ' HB3' HG13 ' A' ' 22' ' ' VAL . 1.5 mtmt -133.16 113.09 12.3 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 120.683 1.583 . . . . 0.0 106.856 178.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.0 mp -118.11 151.2 20.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 104.732 -2.321 . . . . 0.0 104.732 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.749 ' CE2' HG11 ' A' ' 22' ' ' VAL . 20.3 m-85 -132.89 160.28 37.45 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 124.525 1.13 . . . . 0.0 110.318 166.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.4 tp -137.72 86.89 2.21 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.866 1.266 . . . . 0.0 108.71 175.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.569 HG12 ' H ' ' A' ' 60' ' ' SER . 95.0 t -60.74 138.57 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 128.428 2.691 . . . . 0.0 107.2 168.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.582 HD22 HG21 ' A' ' 96' ' ' VAL . 2.9 mp -117.81 37.08 4.06 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.29 1.836 . . . . 0.0 109.445 173.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.569 ' H ' HG12 ' A' ' 58' ' ' VAL . 19.9 t -76.42 -38.85 54.98 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.278 1.431 . . . . 0.0 110.688 178.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.97 2.62 51.77 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.917 0.78 . . . . 0.0 111.604 -173.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.3 p -133.24 174.52 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 127.977 2.511 . . . . 0.0 107.464 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -118.4 -31.38 4.95 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.298 0.639 . . . . 0.0 111.64 177.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.1 t -159.01 158.86 34.0 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.746 0.784 . . . . 0.0 112.478 165.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -76.84 166.29 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-N 113.874 -1.512 . . . . 0.0 108.531 160.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -103.8 159.47 15.61 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.206 1.402 . . . . 0.0 110.608 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.34 6.17 0.84 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.615 1.166 . . . . 0.0 113.491 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -76.87 -78.22 0.13 Allowed 'General case' 0 CA--C 1.535 0.376 0 O-C-N 120.956 -1.09 . . . . 0.0 108.766 155.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.8 t -69.93 -13.74 62.39 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -169.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.488 HD21 HG21 ' A' ' 103' ' ' THR . 33.1 tp -47.06 -31.31 3.26 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.054 1.342 . . . . 0.0 111.674 168.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.06 -28.14 31.97 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 121.458 -0.776 . . . . 0.0 114.466 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 45.7 t -75.27 -35.81 34.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 124.45 1.1 . . . . 0.0 109.59 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.6 mm -55.59 -49.79 71.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 123.75 0.82 . . . . 0.0 110.359 175.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 38.7 t -60.34 -41.34 86.84 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.213 0 CA-C-N 118.123 0.419 . . . . 0.0 110.13 177.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -53.25 -44.67 68.34 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.41 1.005 . . . . 0.0 112.413 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.64 -36.17 73.89 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 123.156 0.582 . . . . 0.0 109.593 177.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -64.7 -42.91 94.95 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.289 0.95 . . . . 0.0 109.479 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 55.1 mttt -60.27 -45.27 93.9 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 118.569 0.622 . . . . 0.0 111.309 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 30.0 m -54.95 -52.13 63.99 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.154 0.182 . . . . 0.0 111.434 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 59.4 mt -65.1 -41.62 92.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 122.585 0.354 . . . . 0.0 110.741 -175.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.2 t -48.38 -59.68 3.27 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.168 1.787 . . . . 0.0 108.127 173.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.7 m -64.8 -33.08 75.13 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.3 m -67.45 -20.41 65.49 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 113.834 1.049 . . . . 0.0 113.834 174.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 94.23 9.99 58.78 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-O 119.067 -0.852 . . . . 0.0 113.5 -171.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -88.03 -173.03 47.54 Favored Glycine 0 N--CA 1.434 -1.441 0 CA-C-N 119.449 1.625 . . . . 0.0 111.456 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.527 ' HB3' HG22 ' A' ' 122' ' ' VAL . 2.7 m-85 -130.54 149.99 51.95 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 126.184 1.793 . . . . 0.0 106.692 171.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -141.06 145.34 35.73 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 174.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -149.61 163.06 38.9 Favored 'General case' 0 N--CA 1.441 -0.888 0 O-C-N 123.79 0.681 . . . . 0.0 111.755 176.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.7 mt -97.68 167.78 10.75 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 123.397 0.679 . . . . 0.0 109.429 176.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.514 HG13 ' N ' ' A' ' 58' ' ' VAL . 0.5 OUTLIER -148.59 152.08 12.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 124.702 1.201 . . . . 0.0 111.096 -175.31 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.6 t 39.92 63.64 4.88 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 127.15 2.18 . . . . 0.0 110.825 178.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.14 175.27 7.81 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.252 1.968 . . . . 0.0 110.341 177.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -127.34 166.53 17.65 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 173.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -58.02 -41.71 83.76 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 124.519 1.127 . . . . 0.0 109.305 174.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -26.08 66.77 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 126.513 1.925 . . . . 0.0 110.65 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.618 HG13 HD13 ' A' ' 100' ' ' LEU . 1.5 t -88.62 -49.38 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 CA-C-O 115.777 -2.059 . . . . 0.0 109.071 177.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.38 -34.85 64.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 122.547 2.431 . . . . 0.0 110.297 177.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -31.01 72.04 Favored 'General case' 0 C--O 1.219 -0.511 0 O-C-N 121.395 -0.815 . . . . 0.0 111.479 -178.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.669 HG13 HD12 ' A' ' 100' ' ' LEU . 7.4 p -100.0 -41.31 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -174.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.669 HD12 HG13 ' A' ' 99' ' ' VAL . 6.9 mp -65.84 -14.58 61.71 Favored 'General case' 0 N--CA 1.434 -1.271 0 C-N-CA 125.972 1.709 . . . . 0.0 112.617 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.74 -41.5 10.1 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 117.328 -1.749 . . . . 0.0 108.197 171.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.48 -34.57 78.6 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.747 1.619 . . . . 0.0 112.486 -172.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.575 HG22 ' O ' ' A' ' 99' ' ' VAL . 9.0 t -93.25 -2.05 55.48 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 118.094 -0.955 . . . . 0.0 111.701 177.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.439 ' HB3' ' HD3' ' A' ' 107' ' ' ARG . 48.9 m-80 56.86 83.49 0.1 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.633 1.173 . . . . 0.0 109.201 -163.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.45 ' HB3' ' HG ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -122.55 -58.58 1.68 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 127.876 2.47 . . . . 0.0 109.878 174.717 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.83 -20.14 65.57 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.698 0.799 . . . . 0.0 111.215 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.439 ' HD3' ' HB3' ' A' ' 104' ' ' ASN . 4.5 ptm85 -84.06 -15.35 47.8 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 177.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 13.9 mm -88.85 -36.79 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 C-N-CA 126.358 1.863 . . . . 0.0 106.06 -172.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.48 149.63 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 124.61 1.194 . . . . 0.0 112.297 -172.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -57.25 156.94 6.79 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.357 0.663 . . . . 0.0 110.807 168.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.12 149.22 16.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 -178.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -140.3 165.04 28.47 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 124.845 1.258 . . . . 0.0 113.389 -170.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.82 -52.35 5.16 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.136 0.974 . . . . 0.0 109.753 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 53.3 p -125.12 175.06 7.63 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.549 1.14 . . . . 0.0 109.359 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.435 HD13 ' HA ' ' A' ' 115' ' ' ILE . 5.6 mm -63.84 -45.08 98.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 118.441 -0.79 . . . . 0.0 109.008 167.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.4 t -71.29 -28.18 63.94 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 119.384 -0.927 . . . . 0.0 110.427 -169.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -69.14 -20.56 64.03 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 119.201 0.91 . . . . 0.0 111.181 173.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -92.51 -49.6 6.04 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 -173.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.99 -60.51 2.71 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.924 2.09 . . . . 0.0 111.539 -166.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -86.61 -16.31 37.13 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.553 0.741 . . . . 0.0 111.012 -175.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -77.54 -59.92 2.58 Favored 'General case' 0 C--O 1.216 -0.695 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.527 HG22 ' HB3' ' A' ' 86' ' ' PHE . 0.3 OUTLIER -47.85 -28.7 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 126.949 2.1 . . . . 0.0 112.987 -174.622 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.86 -28.1 65.79 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.484 2.314 . . . . 0.0 113.45 173.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.72 39.51 0.16 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.858 2.063 . . . . 0.0 112.799 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.074 0 C-N-CA 125.776 1.63 . . . . 0.0 110.323 -174.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.3 p90 . . . . . 0 N--CA 1.448 -0.56 0 CA-C-O 120.489 0.185 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.3 pttt -135.46 170.29 16.17 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 126.073 1.749 . . . . 0.0 109.343 166.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 40.4 mt -120.65 138.28 51.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 C-N-CA 125.296 1.438 . . . . 0.0 107.626 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.492 ' CG2' HD13 ' A' ' 24' ' ' ILE . 76.9 t -131.8 164.67 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 C-N-CA 127.761 2.425 . . . . 0.0 106.769 -177.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -25.07 -63.31 0.06 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 129.553 3.141 . . . . 0.0 113.136 -163.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -145.75 54.01 1.17 Allowed 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 160.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.753 HG11 ' CE2' ' A' ' 56' ' ' PHE . 13.6 t -140.04 152.68 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 124.45 1.1 . . . . 0.0 109.197 170.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.414 ' C ' HD12 ' A' ' 24' ' ' ILE . 13.9 t -111.96 138.47 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.492 HD13 ' CG2' ' A' ' 19' ' ' VAL . 1.8 mp -118.33 106.18 19.2 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.599 HD22 ' CG2' ' A' ' 55' ' ' ILE . 1.9 mp -82.17 63.13 6.23 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.831 2.052 . . . . 0.0 108.271 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.7 mmm -60.05 98.4 0.14 Allowed Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 126.219 1.808 . . . . 0.0 110.805 -175.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -68.26 -47.42 1.64 Allowed 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 122.918 2.412 . . . . 0.0 109.834 -172.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 31.21 54.67 0.22 Allowed 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 120.88 1.673 . . . . 0.0 113.231 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 78.24 22.77 0.75 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.788 2.035 . . . . 0.0 112.527 173.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -118.31 69.78 0.8 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.617 1.567 . . . . 0.0 108.327 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.4 mt -129.72 20.28 5.56 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.832 1.253 . . . . 0.0 111.581 -177.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -49.51 142.48 7.93 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 131.067 3.747 . . . . 0.0 109.533 -177.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 28.9 mt -55.2 -46.66 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 121.049 1.749 . . . . 0.0 111.551 -176.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -80.6 2.96 23.45 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.207 -0.933 . . . . 0.0 112.772 -176.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -89.42 -57.08 3.01 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 153.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.8 -32.28 19.56 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.112 1.765 . . . . 0.0 114.08 -175.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -66.98 -53.17 34.12 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.53 1.059 . . . . 0.0 110.868 175.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.252 0.0 OUTLIER -81.29 -11.27 59.4 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 120.782 -1.199 . . . . 0.0 112.385 -177.492 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -34.83 -57.4 0.54 Allowed 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 129.275 3.03 . . . . 0.0 112.054 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -60.99 -48.95 79.45 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-O 118.542 -0.742 . . . . 0.0 109.34 -176.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -57.91 -46.35 85.09 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 119.494 1.043 . . . . 0.0 110.656 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.464 ' CE3' HG23 ' A' ' 43' ' ' VAL . 5.5 t90 -56.72 -61.05 2.7 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 108.876 -0.786 . . . . 0.0 108.876 174.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.464 HG23 ' CE3' ' A' ' 42' ' ' TRP . 53.0 t -52.23 -33.01 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 124.37 1.068 . . . . 0.0 113.038 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -64.23 -69.57 0.27 Allowed 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 125.19 1.396 . . . . 0.0 108.815 172.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -80.05 -11.33 59.78 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -166.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.427 ' HG2' ' CZ ' ' A' ' 47' ' ' PHE . 1.7 tp10 -88.51 -27.88 21.17 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.27 1.428 . . . . 0.0 110.74 174.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.427 ' CZ ' ' HG2' ' A' ' 46' ' ' GLU . 21.0 m-85 -135.55 -64.18 0.64 Allowed 'General case' 0 C--N 1.347 0.482 0 CA-C-N 119.513 1.051 . . . . 0.0 111.858 -170.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 41.3 mt -48.6 -55.12 12.08 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 118.518 0.599 . . . . 0.0 111.226 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -86.25 1.71 49.86 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.394 0.678 . . . . 0.0 110.963 -173.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.5 3.63 55.12 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 127.599 2.36 . . . . 0.0 112.038 173.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.04 40.23 25.53 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 119.446 1.021 . . . . 0.0 112.564 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -110.45 165.68 11.6 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 160.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -140.81 3.75 1.86 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.557 2.343 . . . . 0.0 112.141 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.581 ' C ' HD12 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -140.42 133.19 28.99 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 121.135 1.789 . . . . 0.0 109.239 -175.806 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.599 ' CG2' HD22 ' A' ' 25' ' ' LEU . 1.9 mp -133.69 149.87 31.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 128.252 2.621 . . . . 0.0 105.206 -172.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.753 ' CE2' HG11 ' A' ' 22' ' ' VAL . 23.5 m-85 -136.23 150.46 48.98 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.087 0.955 . . . . 0.0 112.563 168.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.1 tp -118.35 78.3 1.25 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.475 1.11 . . . . 0.0 110.25 175.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.446 ' N ' HG13 ' A' ' 90' ' ' VAL . 99.5 t -60.11 102.34 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 C-N-CA 126.586 1.955 . . . . 0.0 109.042 172.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.625 HD22 HG21 ' A' ' 96' ' ' VAL . 1.6 mt -86.61 14.25 7.25 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.809 2.444 . . . . 0.0 112.11 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.8 t -63.5 -50.55 69.19 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.802 0.841 . . . . 0.0 112.052 -168.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -83.48 -10.99 58.0 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.342 1.057 . . . . 0.0 110.65 -166.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.5 p -109.61 168.0 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 128.809 2.844 . . . . 0.0 106.712 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.48 -34.53 8.2 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.527 -0.733 . . . . 0.0 110.079 173.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.754 ' HA ' HG23 ' A' ' 96' ' ' VAL . 67.8 p -153.15 167.31 29.69 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 -176.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.4 tt -102.16 151.8 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 162.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -94.89 164.96 12.69 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 124.259 1.023 . . . . 0.0 111.109 -178.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.5 m -76.48 52.65 0.8 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.321 1.848 . . . . 0.0 110.654 176.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -133.44 -68.1 0.59 Allowed 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 158.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.5 t -64.31 -24.46 67.66 Favored 'General case' 0 C--N 1.342 0.267 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 60.6 tp -55.81 -16.54 4.6 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 120.819 -1.176 . . . . 0.0 114.103 177.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -91.5 -34.14 7.61 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 119.946 1.248 . . . . 0.0 112.083 168.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.7 t -64.63 -38.31 82.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 126.295 1.838 . . . . 0.0 110.389 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.3 mm -54.96 -48.93 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 125.292 1.437 . . . . 0.0 110.662 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.9 t -63.89 -45.64 96.4 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.471 0 O-C-N 121.144 -0.972 . . . . 0.0 108.648 176.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.17 -39.26 72.06 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.857 0.753 . . . . 0.0 110.977 -177.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.6 mt -59.62 -44.43 93.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 125.642 1.577 . . . . 0.0 110.628 170.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.419 HD22 HG22 ' A' ' 109' ' ' VAL . 12.5 tp -60.46 -50.67 72.66 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 120.325 -1.484 . . . . 0.0 109.214 177.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 48.3 mttt -59.42 -15.17 15.37 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.52 -0.738 . . . . 0.0 111.217 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.5 t -85.91 -48.56 8.61 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.63 0.772 . . . . 0.0 109.674 172.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 30.6 mt -62.44 -41.93 93.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 O-C-N 120.3 -1.5 . . . . 0.0 110.619 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.6 m -76.53 -5.26 46.81 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 173.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 45.6 t -74.84 -48.07 27.03 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 120.949 -1.094 . . . . 0.0 108.443 159.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.8 m -66.49 -56.03 12.82 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.409 1.084 . . . . 0.0 113.495 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.31 13.49 4.8 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.32 0.962 . . . . 0.0 113.81 -167.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -86.46 -163.58 38.56 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-N 119.141 1.471 . . . . 0.0 111.508 174.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -136.31 162.14 33.84 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.459 1.504 . . . . 0.0 110.023 176.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -158.8 139.53 12.7 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 123.959 0.904 . . . . 0.0 109.192 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.507 ' C ' HD23 ' A' ' 89' ' ' LEU . . . -145.25 171.7 14.19 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 121.171 0.51 . . . . 0.0 112.239 175.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.507 HD23 ' C ' ' A' ' 88' ' ' ALA . 0.7 OUTLIER -111.08 170.04 8.37 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 176.174 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.446 HG13 ' N ' ' A' ' 58' ' ' VAL . 0.5 OUTLIER -151.17 144.46 16.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 124.73 1.212 . . . . 0.0 110.739 -165.688 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.9 t 42.79 58.73 11.24 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 125.861 1.664 . . . . 0.0 111.52 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.57 166.34 26.17 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.489 2.126 . . . . 0.0 109.916 176.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -129.68 170.41 13.85 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 174.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -60.55 -42.56 96.81 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.287 1.035 . . . . 0.0 110.212 -176.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.1 -27.22 68.77 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.692 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.754 HG23 ' HA ' ' A' ' 64' ' ' SER . 0.5 OUTLIER -86.23 -47.12 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-O 118.635 -0.698 . . . . 0.0 109.607 179.261 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -53.63 -44.46 69.56 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 125.581 1.552 . . . . 0.0 108.648 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.19 -23.38 67.29 Favored 'General case' 0 C--O 1.218 -0.592 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.786 -169.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.9 t -95.84 -48.52 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 C-N-CA 126.014 1.726 . . . . 0.0 107.35 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.83 -21.63 57.04 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.108 0.963 . . . . 0.0 109.334 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.7 m -85.05 -11.83 54.45 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.865 0.866 . . . . 0.0 112.874 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 32.6 mt -119.81 -39.7 2.82 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 126.18 1.792 . . . . 0.0 111.033 -166.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.5 t -81.95 1.89 33.29 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.307 1.843 . . . . 0.0 111.095 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 51.18 78.05 0.12 Allowed 'General case' 0 C--N 1.345 0.408 0 C-N-CA 127.386 2.274 . . . . 0.0 111.03 -169.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.78 -57.75 1.61 Allowed 'General case' 0 C--O 1.227 -0.099 0 C-N-CA 123.909 0.883 . . . . 0.0 108.94 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.24 -24.8 66.62 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.548 1.139 . . . . 0.0 111.205 177.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.02 -7.62 59.35 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.6 mt -115.03 -47.63 4.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 125.651 1.58 . . . . 0.0 107.789 -174.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.419 HG22 HD22 ' A' ' 77' ' ' LEU . 0.7 OUTLIER -100.59 143.38 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 123.14 0.576 . . . . 0.0 110.291 178.375 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.9 161.86 12.15 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 124.141 0.976 . . . . 0.0 112.041 176.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.67 146.14 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -177.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -143.46 172.39 12.84 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 125.722 1.609 . . . . 0.0 110.399 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.64 -40.24 10.86 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.781 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 64.0 p -134.27 167.58 20.43 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.765 1.226 . . . . 0.0 108.792 -171.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.417 HD13 ' HA ' ' A' ' 115' ' ' ILE . 4.7 mm -69.75 -40.55 79.28 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.0 t -78.31 -4.74 49.51 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.194 0.907 . . . . 0.0 111.957 -176.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -90.38 -10.51 43.67 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 118.329 -0.843 . . . . 0.0 110.755 166.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.476 ' HB1' ' CE1' ' A' ' 56' ' ' PHE . . . -99.25 -44.5 6.22 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.418 1.087 . . . . 0.0 109.606 177.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -60.26 -40.48 90.48 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 127.801 2.44 . . . . 0.0 115.828 -161.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -112.59 4.31 17.21 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 126.836 2.054 . . . . 0.0 111.31 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -99.64 -63.66 1.11 Allowed 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -46.82 -30.47 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 127.44 2.296 . . . . 0.0 113.04 -176.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 12.1 mtt180 -53.64 -20.51 5.36 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.382 -0.824 . . . . 0.0 112.358 174.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.1 24.34 1.46 Allowed 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 115.151 1.538 . . . . 0.0 115.151 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 116.71 -1.614 . . . . 0.0 110.478 -161.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.0 p90 . . . . . 0 N--CA 1.447 -0.614 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.27 173.51 11.46 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.7 1.2 . . . . 0.0 108.776 174.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 70.7 mt -133.35 104.1 6.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 174.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.452 HG22 HD11 ' A' ' 24' ' ' ILE . 21.7 m -77.74 -171.87 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 166.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -24.59 -68.58 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 128.835 2.854 . . . . 0.0 115.319 -167.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -142.26 19.12 2.08 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 128.279 2.632 . . . . 0.0 109.72 177.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.579 HG11 ' CE2' ' A' ' 56' ' ' PHE . 6.7 t -127.84 133.57 67.13 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 CA-C-O 123.678 1.704 . . . . 0.0 108.783 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.586 ' O ' HD13 ' A' ' 24' ' ' ILE . 1.0 OUTLIER -92.66 153.87 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.686 0 CA-C-N 112.151 -2.295 . . . . 0.0 107.044 -175.374 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.586 HD13 ' O ' ' A' ' 23' ' ' VAL . 2.4 mm -138.17 91.36 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.55 118.86 10.74 Favored 'General case' 0 C--O 1.226 -0.174 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 165.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.476 ' HA ' HG22 ' A' ' 58' ' ' VAL . 4.9 mtm -116.65 80.65 10.75 Favored Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 104.829 -2.286 . . . . 0.0 104.829 -176.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -74.47 168.05 25.72 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.256 2.638 . . . . 0.0 112.051 -168.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.442 HD22 ' H ' ' A' ' 29' ' ' LYS . 0.6 OUTLIER -145.86 -106.73 0.1 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.703 1.201 . . . . 0.0 108.853 -178.883 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.442 ' H ' HD22 ' A' ' 28' ' ' ASN . 1.7 mppt? -103.67 3.56 34.48 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.036 1.335 . . . . 0.0 111.53 174.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -76.18 -1.77 27.91 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.244 1.017 . . . . 0.0 113.275 -174.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 17.7 mt -77.33 21.67 0.25 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.902 1.681 . . . . 0.0 113.662 -176.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -37.24 133.78 0.65 Allowed 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 127.343 2.257 . . . . 0.0 109.343 166.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.1 tt -52.07 -34.42 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 124.309 1.044 . . . . 0.0 111.987 -176.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -70.2 -37.67 75.13 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.147 -0.97 . . . . 0.0 112.081 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -67.09 -46.5 74.06 Favored 'General case' 0 C--O 1.219 -0.521 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 168.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.91 -44.1 66.71 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.97 0.804 . . . . 0.0 112.187 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 14.3 t-160 -65.34 -43.46 90.82 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 119.93 1.241 . . . . 0.0 111.144 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.26 -14.97 59.66 Favored 'General case' 0 C--O 1.218 -0.554 0 O-C-N 121.574 -0.704 . . . . 0.0 110.379 -178.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -50.25 -44.35 53.51 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 127.167 2.187 . . . . 0.0 111.015 -173.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.436 ' HE3' ' CZ ' ' A' ' 44' ' ' PHE . 0.4 OUTLIER -67.35 -41.6 84.9 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-O 117.823 -1.084 . . . . 0.0 111.266 176.061 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -58.65 -48.58 80.57 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 120.324 1.42 . . . . 0.0 110.346 174.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -58.76 -61.64 2.47 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-O 117.738 -1.125 . . . . 0.0 108.186 177.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.4 t -52.78 -37.34 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 119.943 1.247 . . . . 0.0 111.65 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.436 ' CZ ' ' HE3' ' A' ' 40' ' ' LYS . 3.3 m-85 -59.44 -65.43 0.67 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 118.885 0.766 . . . . 0.0 110.371 174.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -60.74 -50.82 71.92 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 126.504 1.922 . . . . 0.0 111.162 -173.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -67.19 -36.4 81.69 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 127.816 2.446 . . . . 0.0 111.179 -174.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -128.91 -60.34 1.09 Allowed 'General case' 0 C--N 1.347 0.498 0 CA-C-N 119.496 1.044 . . . . 0.0 112.254 -174.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 12.1 mt -64.0 -25.26 68.05 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.564 -0.71 . . . . 0.0 112.843 -165.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -99.83 -15.68 18.33 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 127.283 2.233 . . . . 0.0 111.573 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -69.91 -16.75 63.28 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.435 1.094 . . . . 0.0 110.898 164.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.04 1.64 33.88 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.61 1.576 . . . . 0.0 112.935 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -72.57 145.58 47.3 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 119.066 1.433 . . . . 0.0 110.564 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -126.74 4.5 6.7 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.681 1.192 . . . . 0.0 113.285 -177.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.6 mtmt -145.88 95.32 2.62 Favored 'General case' 0 CA--C 1.514 -0.418 0 O-C-N 119.687 -1.883 . . . . 0.0 107.124 -166.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -101.94 154.11 5.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.579 ' CE2' HG11 ' A' ' 22' ' ' VAL . 16.1 m-30 -124.37 156.15 37.56 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 117.922 0.328 . . . . 0.0 111.332 163.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 29.4 tp -130.1 107.65 9.48 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 124.89 1.276 . . . . 0.0 108.438 175.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.476 HG22 ' HA ' ' A' ' 26' ' ' MET . 0.8 OUTLIER -75.81 161.92 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-O 121.37 0.605 . . . . 0.0 110.651 176.111 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 30.1 mt -139.61 12.51 2.52 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.935 1.294 . . . . 0.0 109.678 -174.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.4 ' H ' HG23 ' A' ' 58' ' ' VAL . 68.7 m -66.38 -64.35 0.88 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.918 1.287 . . . . 0.0 110.559 -176.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -69.74 -43.6 71.97 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.972 0.415 . . . . 0.0 111.689 -169.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.3 p -67.94 160.98 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 126.47 1.908 . . . . 0.0 110.691 -177.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -95.24 -56.17 2.81 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.795 0.838 . . . . 0.0 109.314 174.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.5 p -156.36 -165.39 1.89 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.372 0.669 . . . . 0.0 110.693 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.0 tt -139.6 145.02 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 C-N-CA 125.858 1.663 . . . . 0.0 106.914 -177.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -82.86 162.13 21.7 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.308 0.643 . . . . 0.0 109.774 175.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.0 m -54.19 -29.38 45.76 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.947 1.299 . . . . 0.0 112.843 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -56.59 -64.41 0.88 Allowed 'General case' 0 C--N 1.344 0.346 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.7 t -77.24 -22.32 52.39 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 118.839 -0.6 . . . . 0.0 111.582 -176.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.579 HD11 HG21 ' A' ' 103' ' ' THR . 22.1 tp -54.98 -27.17 41.88 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.958 1.254 . . . . 0.0 111.887 173.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -83.93 -35.64 15.26 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.16 0.886 . . . . 0.0 112.87 171.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 45.5 t -67.89 -42.01 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 118.524 1.162 . . . . 0.0 109.462 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 12.0 mm -54.73 -49.68 66.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.206 1.002 . . . . 0.0 109.338 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 38.7 t -62.48 -42.34 95.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 O-C-N 121.397 -0.814 . . . . 0.0 110.417 174.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -52.89 -44.08 66.63 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 120.129 1.331 . . . . 0.0 112.239 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 59.8 mt -60.67 -38.44 78.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 124.06 0.944 . . . . 0.0 108.67 176.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.49 -49.23 64.42 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 120.005 1.275 . . . . 0.0 109.466 178.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -52.57 -48.25 66.3 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 118.607 0.64 . . . . 0.0 110.077 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.0 m -60.02 -54.54 44.81 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.248 1.019 . . . . 0.0 110.711 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 48.6 mt -60.17 -43.74 93.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 124.337 1.055 . . . . 0.0 110.647 -177.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.0 t -70.22 -12.52 61.65 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.397 1.079 . . . . 0.0 111.865 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.5 t -83.82 -46.75 11.84 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 119.208 0.913 . . . . 0.0 108.583 167.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 72.1 m -54.12 -53.65 50.37 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.239 0.616 . . . . 0.0 110.41 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 132.88 18.04 1.12 Allowed Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.213 -0.771 . . . . 0.0 112.589 -168.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -109.48 179.35 20.83 Favored Glycine 0 N--CA 1.44 -1.034 0 CA-C-N 119.827 1.813 . . . . 0.0 112.587 -173.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -141.87 108.49 5.35 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.914 2.086 . . . . 0.0 108.815 -172.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -106.57 139.8 40.45 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.76 1.224 . . . . 0.0 107.802 -176.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.461 ' C ' HD23 ' A' ' 89' ' ' LEU . . . -137.92 172.49 12.86 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.155 0.889 . . . . 0.0 111.861 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.461 HD23 ' C ' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -122.11 167.17 13.47 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.58 0.752 . . . . 0.0 109.903 -179.581 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 92.5 t -142.39 139.13 29.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 C-N-CA 123.36 0.664 . . . . 0.0 110.122 -168.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 t 46.54 54.46 14.82 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 126.304 1.842 . . . . 0.0 111.178 -175.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -69.79 99.89 0.78 Allowed 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 123.149 2.566 . . . . 0.0 108.769 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -62.5 158.3 18.24 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 122.116 0.96 . . . . 0.0 110.954 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 -59.47 -34.77 72.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.216 -171.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.43 -44.93 89.34 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.37 1.468 . . . . 0.0 109.55 175.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.7 t -74.45 -47.22 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-O 117.2 -1.381 . . . . 0.0 109.761 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -54.66 -31.97 58.44 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 121.383 1.901 . . . . 0.0 110.233 -176.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.41 -62.57 1.63 Allowed 'General case' 0 N--CA 1.423 -1.808 0 CA-C-O 123.453 1.597 . . . . 0.0 111.724 175.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.657 ' O ' HG22 ' A' ' 103' ' ' THR . 4.6 p -66.87 -34.58 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 CA-C-N 113.981 -1.463 . . . . 0.0 107.651 -173.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.9 mt -63.26 -23.97 67.66 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.912 0.885 . . . . 0.0 111.36 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.7 m -78.85 -49.59 12.66 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 120.103 1.32 . . . . 0.0 107.829 170.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.71 -15.42 40.37 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.23 2.212 . . . . 0.0 113.582 -174.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.657 HG22 ' O ' ' A' ' 99' ' ' VAL . 7.6 t -120.67 -0.18 10.27 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.914 2.086 . . . . 0.0 111.479 178.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.42 ' HA ' ' HG3' ' A' ' 107' ' ' ARG . 6.5 m-80 48.07 69.01 0.58 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 127.266 2.227 . . . . 0.0 112.967 -168.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.38 -49.44 3.57 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.369 1.867 . . . . 0.0 110.096 166.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -65.57 -12.29 51.69 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 119.56 1.073 . . . . 0.0 112.728 -177.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.42 ' HG3' ' HA ' ' A' ' 104' ' ' ASN . 0.0 OUTLIER -108.0 5.04 25.8 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 127.255 2.222 . . . . 0.0 111.049 -174.133 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.7 mt -125.62 -45.55 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 128.093 2.557 . . . . 0.0 109.579 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.8 t -95.09 166.92 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.678 1.191 . . . . 0.0 107.802 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.517 ' HE2' ' CB ' ' A' ' 125' ' ' LYS . 3.2 mtmp? -95.95 172.64 7.88 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.737 0.815 . . . . 0.0 109.408 168.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -157.98 147.0 9.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 -163.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.504 ' CG ' ' HB2' ' A' ' 118' ' ' ALA . 82.2 m-85 -148.48 162.95 38.58 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.568 1.147 . . . . 0.0 112.489 -169.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.95 -58.37 2.62 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -178.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 69.2 p -102.87 -162.53 0.92 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.416 HD12 HD12 ' A' ' 24' ' ' ILE . 14.6 mm -84.76 -34.17 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-O 118.564 -0.732 . . . . 0.0 111.133 156.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.1 t -70.22 -37.33 75.0 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.373 -156.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -67.14 -39.97 86.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 176.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.504 ' HB2' ' CG ' ' A' ' 112' ' ' TYR . . . -64.63 -41.38 96.21 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -171.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 9.8 ttt -51.39 -43.45 61.93 Favored 'General case' 0 N--CA 1.424 -1.728 0 C-N-CA 127.897 2.479 . . . . 0.0 110.804 -174.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -104.75 -15.48 15.22 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.837 1.255 . . . . 0.0 112.42 -177.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -81.65 -47.21 13.28 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 119.008 0.822 . . . . 0.0 109.096 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -55.24 -19.96 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 124.864 1.265 . . . . 0.0 114.086 176.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 7.7 mtm180 -70.39 -27.94 64.69 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 118.512 -0.756 . . . . 0.0 110.86 173.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.4 47.29 0.11 Allowed 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 120.624 1.556 . . . . 0.0 114.002 -176.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.517 ' CB ' ' HE2' ' A' ' 110' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.069 0 C-N-CA 125.134 1.373 . . . . 0.0 111.444 -172.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 36.9 p90 . . . . . 0 CA--C 1.533 0.301 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -125.94 173.45 9.12 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.181 1.392 . . . . 0.0 108.938 164.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 52.1 mt -132.4 119.6 39.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.9 m -114.72 -166.11 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 170.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -45.66 -43.6 12.63 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 128.492 2.717 . . . . 0.0 115.278 -149.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -150.23 19.37 0.86 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.359 0.664 . . . . 0.0 111.163 156.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.754 HG11 ' CE2' ' A' ' 56' ' ' PHE . 19.3 t -122.15 120.72 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 124.266 1.027 . . . . 0.0 108.532 -173.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.5 t -75.5 143.78 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 176.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.592 HD12 HD12 ' A' ' 115' ' ' ILE . 5.1 mm -119.33 104.03 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 175.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 26.9 mt -85.72 124.64 32.47 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 177.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 65.0 mtm -126.86 76.46 75.36 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -167.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -61.56 148.44 92.99 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.507 2.805 . . . . 0.0 110.934 -170.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.526 HD22 ' H ' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -135.88 -85.27 0.37 Allowed 'General case' 0 C--O 1.225 -0.212 0 CA-C-O 118.931 -0.557 . . . . 0.0 111.123 176.002 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.526 ' H ' HD22 ' A' ' 28' ' ' ASN . 0.0 OUTLIER -126.5 35.13 4.69 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.194 1.397 . . . . 0.0 109.275 -176.72 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.94 -19.36 13.43 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 120.791 -1.193 . . . . 0.0 112.385 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.9 mp -72.77 90.21 1.4 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -132.85 26.04 4.31 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.621 1.168 . . . . 0.0 110.801 -164.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.3 mt 65.24 -54.12 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 129.071 2.948 . . . . 0.0 113.558 -172.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -66.31 -32.4 73.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 120.175 1.352 . . . . 0.0 109.509 -174.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.1 -8.12 46.97 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-O 117.265 -1.35 . . . . 0.0 110.364 175.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.06 -65.99 0.77 Allowed 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 120.869 1.668 . . . . 0.0 111.794 -168.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -67.96 -17.39 64.43 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 121.421 1.919 . . . . 0.0 110.97 177.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 69.3 mt -78.04 -9.19 59.02 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.103 1.761 . . . . 0.0 112.087 170.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -69.01 -60.39 2.39 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -169.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.451 ' HA ' HG22 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -60.65 -33.43 72.79 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 116.609 -1.662 . . . . 0.0 111.253 174.475 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -64.63 -50.16 68.21 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 120.801 1.637 . . . . 0.0 107.904 -175.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -48.58 -62.37 1.54 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 118.134 -0.936 . . . . 0.0 108.704 166.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.451 HG22 ' HA ' ' A' ' 40' ' ' LYS . 9.7 m -57.93 -46.46 87.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 CA-C-O 123.311 1.529 . . . . 0.0 112.671 -166.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.511 ' CD1' HD12 ' A' ' 48' ' ' LEU . 4.7 m-30 -50.01 -44.95 51.45 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 126.771 2.028 . . . . 0.0 108.98 177.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.4 ' HA ' HD22 ' A' ' 49' ' ' ASN . 15.2 t0 -78.96 -9.4 59.51 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 128.063 2.545 . . . . 0.0 114.908 -176.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -123.88 -8.69 7.8 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.385 0.993 . . . . 0.0 112.652 177.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -136.16 -61.68 0.69 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.586 0.754 . . . . 0.0 111.069 -174.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.511 HD12 ' CD1' ' A' ' 44' ' ' PHE . 14.4 mt -67.29 -52.08 44.9 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 118.733 0.697 . . . . 0.0 110.935 -169.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.4 HD22 ' HA ' ' A' ' 45' ' ' ASP . 86.2 m-20 -64.97 -27.16 68.65 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.26 1.024 . . . . 0.0 110.449 173.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.25 -46.81 75.84 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 125.044 1.338 . . . . 0.0 108.74 -178.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 131.0 47.59 0.13 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 125.527 1.537 . . . . 0.0 109.768 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -123.6 133.33 53.96 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 118.32 1.06 . . . . 0.0 110.511 173.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -126.26 22.04 7.23 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 126.097 1.759 . . . . 0.0 111.336 -177.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.688 ' HB3' HG13 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -143.93 142.25 30.67 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.66 1.184 . . . . 0.0 108.321 162.062 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.1 mt -141.76 150.62 19.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 129.238 3.015 . . . . 0.0 104.421 -176.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.754 ' CE2' HG11 ' A' ' 22' ' ' VAL . 11.6 m-85 -133.75 153.84 51.41 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 125.219 1.408 . . . . 0.0 109.969 169.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 29.7 tp -118.95 111.57 18.52 Favored 'General case' 0 C--N 1.339 0.143 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 174.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 87.6 t -86.2 103.47 12.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.462 HD12 HG21 ' A' ' 96' ' ' VAL . 4.2 mm? -78.92 -12.71 60.04 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.091 1.356 . . . . 0.0 111.747 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.75 -38.45 47.77 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.919 1.287 . . . . 0.0 111.115 173.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -84.95 -45.66 11.98 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 120.822 0.344 . . . . 0.0 110.792 -165.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.8 p -76.77 -178.75 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 126.619 1.968 . . . . 0.0 109.663 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -122.89 -41.45 2.35 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.41 1.084 . . . . 0.0 108.821 170.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.5 t -154.23 165.36 36.51 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-O 122.623 1.201 . . . . 0.0 113.766 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.7 tt -135.29 152.7 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 129.805 3.242 . . . . 0.0 105.985 176.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.49 175.13 5.55 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.356 0.662 . . . . 0.0 110.468 -167.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.9 p -62.53 19.0 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 128.244 2.617 . . . . 0.0 114.312 173.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -112.38 -73.02 0.68 Allowed 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 166.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 74.7 m -66.05 -29.44 69.78 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 116.878 -1.534 . . . . 0.0 113.778 -172.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.3 mt -48.55 -46.77 39.38 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.606 1.548 . . . . 0.0 110.192 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.17 -33.07 82.85 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-O 119.71 -0.494 . . . . 0.0 112.025 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.2 t -75.5 -29.6 21.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 118.275 1.038 . . . . 0.0 111.087 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 mp -64.58 -40.21 88.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 174.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.1 t -60.64 -43.46 94.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 O-C-N 120.559 -1.338 . . . . 0.0 110.172 169.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -51.24 -43.33 61.45 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.854 1.262 . . . . 0.0 112.204 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.1 mt -58.56 -45.13 90.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 124.406 1.082 . . . . 0.0 109.353 175.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.01 -49.3 70.78 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -51.4 -49.42 61.62 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.018 0.527 . . . . 0.0 109.615 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 13.6 t -64.28 -47.49 79.33 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -176.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 47.7 mt -60.43 -45.17 97.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 C-N-CA 124.979 1.311 . . . . 0.0 111.747 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.5 m -75.29 -23.32 57.35 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.818 0.735 . . . . 0.0 112.143 176.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.78 -45.59 89.05 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.437 1.017 . . . . 0.0 108.543 167.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 74.8 m -63.94 -71.02 0.19 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.889 1.675 . . . . 0.0 112.008 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 141.23 33.74 0.12 Allowed Glycine 0 CA--C 1.527 0.798 0 C-N-CA 124.195 0.902 . . . . 0.0 111.198 -164.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -126.37 -173.78 13.66 Favored Glycine 0 C--N 1.336 0.578 0 O-C-N 120.517 -1.578 . . . . 0.0 109.592 169.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -131.19 164.15 26.17 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.367 1.067 . . . . 0.0 109.902 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -156.03 141.19 17.43 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.973 1.309 . . . . 0.0 109.03 175.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.565 ' C ' HD23 ' A' ' 89' ' ' LEU . . . -147.08 178.44 8.37 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 123.727 0.811 . . . . 0.0 112.166 174.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.565 HD23 ' C ' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -121.35 163.56 18.46 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 123.453 0.701 . . . . 0.0 109.911 -178.489 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.599 HG21 HD13 ' A' ' 115' ' ' ILE . 40.2 t -144.08 133.51 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 123.847 0.859 . . . . 0.0 108.837 -163.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.9 t 48.95 58.96 17.72 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 127.029 2.131 . . . . 0.0 111.778 -171.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.05 91.96 0.91 Allowed 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 123.748 2.965 . . . . 0.0 108.711 176.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -51.66 153.5 2.34 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 126.536 1.935 . . . . 0.0 112.092 171.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -54.03 -31.2 50.63 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.989 1.716 . . . . 0.0 111.204 -176.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.84 -44.71 84.72 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 126.798 2.039 . . . . 0.0 109.207 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.882 HG13 HD13 ' A' ' 100' ' ' LEU . 1.1 t -74.1 -44.77 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 125.634 1.574 . . . . 0.0 110.488 172.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -58.49 -23.89 59.06 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 120.496 1.498 . . . . 0.0 110.451 -176.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.91 -62.31 1.79 Allowed 'General case' 0 N--CA 1.427 -1.614 0 CA-C-O 124.804 2.24 . . . . 0.0 111.003 175.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.496 ' O ' HG22 ' A' ' 103' ' ' THR . 2.6 t -72.76 -46.16 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.707 0 CA-C-N 111.411 -2.631 . . . . 0.0 104.865 -167.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.882 HD13 HG13 ' A' ' 96' ' ' VAL . 4.5 mp -61.28 -19.83 62.2 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 124.913 1.285 . . . . 0.0 112.568 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.6 m -87.1 -54.89 4.08 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 172.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 68.1 mt -51.37 -51.3 55.82 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.546 1.538 . . . . 0.0 113.08 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 99' ' ' VAL . 1.1 t -91.32 3.66 54.32 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.826 1.65 . . . . 0.0 111.987 -167.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 55.38 77.9 0.21 Allowed 'General case' 0 C--N 1.34 0.175 0 C-N-CA 126.387 1.875 . . . . 0.0 109.678 -173.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.532 ' HB3' HD23 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -123.22 -55.59 1.76 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.327 1.051 . . . . 0.0 108.636 177.541 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -60.18 -31.9 70.56 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.235 1.414 . . . . 0.0 110.306 169.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -74.21 1.21 11.83 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 117.556 -1.211 . . . . 0.0 112.965 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.4 mt -133.94 -39.55 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.547 1.139 . . . . 0.0 110.629 -169.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.4 t -106.12 153.92 7.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 119.647 1.112 . . . . 0.0 108.81 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.71 157.27 38.3 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.291 0.567 . . . . 0.0 111.486 174.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.0 145.29 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -172.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -149.19 169.66 20.23 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 127.093 2.157 . . . . 0.0 110.55 -175.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -88.08 -48.24 7.89 Favored 'General case' 0 CA--C 1.521 -0.173 0 O-C-N 121.763 -0.586 . . . . 0.0 109.419 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 67.5 p -121.56 173.52 7.36 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.921 0.888 . . . . 0.0 109.939 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.599 HD13 HG21 ' A' ' 90' ' ' VAL . 17.9 mm -70.7 -35.92 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.6 t -74.06 -30.11 62.23 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 119.446 1.021 . . . . 0.0 111.246 -173.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -65.19 -20.41 66.43 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 119.462 -0.304 . . . . 0.0 111.355 169.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -101.91 -39.93 7.13 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -170.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 53.1 ttm -48.72 -50.07 35.23 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 127.781 2.432 . . . . 0.0 111.089 -167.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -101.47 -0.42 35.2 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 117.985 -1.007 . . . . 0.0 112.591 -174.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -119.31 -35.49 3.58 Favored 'General case' 0 C--O 1.216 -0.687 0 C-N-CA 123.79 0.836 . . . . 0.0 111.542 -167.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -54.21 -29.02 18.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 O-C-N 121.14 -0.975 . . . . 0.0 109.559 157.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.11 118.02 17.58 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 102.467 -3.16 . . . . 0.0 102.467 163.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . 0.267 0.0 OUTLIER 85.46 23.42 0.08 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 111.968 -2.378 . . . . 0.0 116.193 165.582 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp . . . . . 0 C--O 1.25 1.111 0 C-N-CA 123.854 0.862 . . . . 0.0 111.187 176.487 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.9 p90 . . . . . 0 N--CA 1.452 -0.374 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.5 pttt -129.6 169.43 15.03 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.651 1.58 . . . . 0.0 108.631 168.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.5 mt -137.95 123.71 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 174.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.8 m -99.26 -154.18 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -24.92 -72.5 0.03 OUTLIER 'General case' 0 C--O 1.237 0.414 0 C-N-CA 130.085 3.354 . . . . 0.0 111.623 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.14 12.14 2.19 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.296 1.439 . . . . 0.0 110.646 172.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.656 HG11 ' CE2' ' A' ' 56' ' ' PHE . 5.7 t -112.41 137.45 45.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 O-C-N 120.657 -1.277 . . . . 0.0 108.749 -171.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 65.9 t -88.72 143.3 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 175.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mp -126.84 97.56 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.434 HD12 ' CH2' ' A' ' 42' ' ' TRP . 1.2 mm? -69.03 140.18 54.94 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 162.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 22.8 mtt -131.44 73.25 80.01 Favored Pre-proline 0 C--O 1.236 0.375 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 171.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.53 167.44 24.13 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 121.608 1.539 . . . . 0.0 110.62 174.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -161.16 -107.6 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 126.532 1.933 . . . . 0.0 105.999 -173.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.497 ' H ' ' HD2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -82.68 1.87 36.39 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -171.677 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -90.43 -23.56 20.98 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 120.773 -1.204 . . . . 0.0 113.726 -167.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 16.6 mt -74.9 -76.0 0.15 Allowed 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.155 -153.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . 0.258 0.1 OUTLIER 23.36 60.08 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 129.64 3.176 . . . . 0.0 113.201 153.629 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.8 mt 63.54 -45.29 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 127.908 2.483 . . . . 0.0 114.352 -172.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -63.61 -21.89 66.6 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.226 1.011 . . . . 0.0 112.906 -165.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -127.72 63.22 1.38 Allowed 'General case' 0 C--O 1.232 0.178 0 C-N-CA 125.141 1.376 . . . . 0.0 107.991 170.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.03 -67.94 0.89 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.674 0.79 . . . . 0.0 112.268 -177.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 39.7 t-80 -63.0 -37.1 85.82 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 120.71 1.595 . . . . 0.0 110.188 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.8 -15.3 60.75 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 117.747 -1.12 . . . . 0.0 111.935 173.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -52.59 -48.7 66.09 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 120.581 1.537 . . . . 0.0 110.942 -172.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -67.54 -42.43 82.72 Favored 'General case' 0 C--O 1.211 -0.922 0 CA-C-O 117.428 -1.272 . . . . 0.0 110.381 175.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.5 tttm -55.39 -45.14 76.64 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.937 1.699 . . . . 0.0 111.051 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.512 ' CE3' HG23 ' A' ' 43' ' ' VAL . 8.2 t90 -61.78 -63.04 1.39 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.546 1.138 . . . . 0.0 109.283 176.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.512 HG23 ' CE3' ' A' ' 42' ' ' TRP . 91.2 t -59.55 -32.39 48.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 119.655 1.116 . . . . 0.0 112.305 -176.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -56.54 -60.37 3.64 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 170.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.24 -44.15 72.57 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 -168.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -76.39 -17.26 59.46 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.228 1.811 . . . . 0.0 111.246 -170.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -141.68 -55.5 0.46 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 66.2 mt -64.9 -50.88 64.8 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.687 1.13 . . . . 0.0 111.451 -170.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -65.0 -29.6 70.53 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 127.867 2.467 . . . . 0.0 109.657 175.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.1 mttm -61.02 -46.87 89.0 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 118.638 -0.696 . . . . 0.0 109.14 169.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.97 4.38 2.66 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.193 1.377 . . . . 0.0 113.06 173.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -64.08 150.83 44.63 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 118.936 1.368 . . . . 0.0 109.593 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -122.29 -1.92 9.12 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.05 1.34 . . . . 0.0 114.409 175.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.425 ' HB3' HG13 ' A' ' 22' ' ' VAL . 2.0 mtmt -133.75 121.97 22.65 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 120.908 1.686 . . . . 0.0 108.379 -176.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.4 mt -130.39 157.21 42.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 C-N-CA 125.646 1.579 . . . . 0.0 107.366 176.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.656 ' CE2' HG11 ' A' ' 22' ' ' VAL . 23.2 m-85 -131.92 161.4 33.15 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.389 1.476 . . . . 0.0 111.768 165.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.8 tp -128.46 81.23 2.01 Favored 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 125.068 1.347 . . . . 0.0 108.173 173.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.508 ' N ' HG13 ' A' ' 90' ' ' VAL . 99.1 t -56.25 136.4 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 127.93 2.492 . . . . 0.0 107.563 166.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.59 12.6 12.35 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.182 1.793 . . . . 0.0 110.459 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 68.3 m -43.46 -46.24 6.7 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.68 1.992 . . . . 0.0 112.835 173.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.02 1.42 39.54 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.848 1.259 . . . . 0.0 111.69 -164.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.7 p -132.42 114.46 23.29 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 C-N-CA 126.082 1.753 . . . . 0.0 107.526 -177.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -64.69 -38.55 91.37 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 120.652 -1.28 . . . . 0.0 108.319 176.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 57.2 p -154.52 146.94 23.98 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -174.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 21.3 tt -100.28 151.38 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 113.82 -1.536 . . . . 0.0 107.411 163.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -92.3 168.9 11.0 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 123.083 1.42 . . . . 0.0 110.271 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.0 p -50.75 0.06 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.723 1 C-N-CA 132.565 4.346 . . . . 0.0 115.962 170.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -98.77 -70.52 0.72 Allowed 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.6 t -77.0 -19.88 56.74 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-O 118.552 -0.737 . . . . 0.0 112.082 -172.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 14.3 tp -48.57 -33.94 10.6 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.792 1.178 . . . . 0.0 111.743 170.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -76.4 -37.24 36.67 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 118.114 0.416 . . . . 0.0 113.683 173.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.9 t -65.31 -34.6 71.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 124.176 0.991 . . . . 0.0 109.62 -178.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.58 -48.13 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 123.747 0.819 . . . . 0.0 109.918 175.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.6 t -66.66 -39.85 84.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 O-C-N 121.187 -0.946 . . . . 0.0 109.851 178.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.63 -40.63 72.4 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.643 0.735 . . . . 0.0 110.996 178.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.1 mt -61.88 -39.44 83.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 126.592 1.957 . . . . 0.0 109.641 175.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.423 ' HG ' HG13 ' A' ' 109' ' ' VAL . 3.3 tm? -66.22 -41.5 90.03 Favored 'General case' 0 C--N 1.341 0.215 0 O-C-N 119.922 -1.736 . . . . 0.0 109.487 178.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.8 mttm -54.22 -44.11 71.41 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-O 117.841 -1.076 . . . . 0.0 110.524 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.5 t -53.6 -52.66 59.1 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.822 0.849 . . . . 0.0 110.825 176.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.0 mt -67.66 -39.85 82.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.012 0.525 . . . . 0.0 110.472 -174.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 26.6 t -66.25 -36.22 82.45 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.28 1.432 . . . . 0.0 110.932 176.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 71.8 m -65.39 -40.11 93.07 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 119.386 0.994 . . . . 0.0 109.894 172.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.5 m -73.29 -68.97 0.45 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.733 0.813 . . . . 0.0 111.642 -172.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 146.75 34.43 0.06 OUTLIER Glycine 0 C--N 1.334 0.418 0 CA-C-O 118.798 -1.001 . . . . 0.0 113.354 -166.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -127.6 -163.19 11.33 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 118.948 1.374 . . . . 0.0 111.321 -176.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.546 ' HB3' HG22 ' A' ' 122' ' ' VAL . 1.4 m-85 -137.89 151.85 48.44 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 169.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -147.47 147.53 30.29 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 172.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -153.48 170.73 20.04 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 124.812 1.32 . . . . 0.0 111.211 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.3 mt -108.47 167.4 10.07 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.508 HG13 ' N ' ' A' ' 58' ' ' VAL . 0.5 OUTLIER -145.38 152.85 14.21 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.511 0 C-N-CA 124.89 1.276 . . . . 0.0 111.085 -173.606 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.1 p 41.3 58.88 8.94 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 126.32 1.848 . . . . 0.0 112.812 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -71.35 7.94 1.31 Allowed 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 124.227 3.285 . . . . 0.0 114.498 -170.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 56.26 -160.98 0.2 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.383 1.473 . . . . 0.0 108.993 -176.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -87.9 -15.67 36.01 Favored 'General case' 0 CA--C 1.552 1.044 0 O-C-N 120.706 -1.246 . . . . 0.0 110.892 164.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.62 -33.72 10.85 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 121.062 -1.024 . . . . 0.0 112.606 -160.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.818 HG13 HD13 ' A' ' 100' ' ' LEU 0.268 0.9 OUTLIER -77.28 -37.67 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 116.254 -1.831 . . . . 0.0 107.615 166.421 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -52.96 -35.17 58.57 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 121.685 2.039 . . . . 0.0 110.235 171.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.06 -40.17 87.01 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.424 -175.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.536 HG13 HD12 ' A' ' 100' ' ' LEU . 8.4 p -92.41 -33.31 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -167.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.818 HD13 HG13 ' A' ' 96' ' ' VAL . 7.4 mp -65.55 -12.07 49.6 Favored 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 124.845 1.258 . . . . 0.0 112.5 178.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.7 t -87.29 -50.68 6.42 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 166.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.21 -38.59 87.16 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.261 1.824 . . . . 0.0 113.14 -168.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 99' ' ' VAL . 10.9 t -86.47 -18.44 31.66 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 119.01 -0.519 . . . . 0.0 110.786 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 64.45 93.72 0.06 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.563 1.545 . . . . 0.0 107.215 -151.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.538 ' HB3' ' HG ' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -124.64 -50.94 1.73 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.576 1.551 . . . . 0.0 108.706 168.494 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -29.96 68.18 Favored 'General case' 0 C--N 1.346 0.426 0 N-CA-C 110.002 -0.369 . . . . 0.0 110.002 177.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -77.99 5.65 9.42 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 128.022 2.529 . . . . 0.0 112.353 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.3 mt -124.05 -34.93 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 125.232 1.413 . . . . 0.0 109.006 -177.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.732 HG12 ' H ' ' A' ' 110' ' ' LYS . 1.7 t -123.85 -159.31 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 125.028 1.331 . . . . 0.0 110.546 -177.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.732 ' H ' HG12 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -116.1 158.8 22.63 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 128.837 2.855 . . . . 0.0 108.073 169.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.95 154.03 17.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 -178.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -144.87 167.64 22.12 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.934 0.894 . . . . 0.0 112.7 -171.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.75 -50.52 6.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.944 -177.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 70.4 p -130.29 175.46 8.92 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.92 1.288 . . . . 0.0 107.823 -176.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.439 HD11 ' CG2' ' A' ' 58' ' ' VAL . 6.3 mm -68.25 -41.71 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-O 117.687 -1.149 . . . . 0.0 109.218 170.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.2 t -67.35 -35.62 79.76 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 120.102 1.319 . . . . 0.0 109.43 -175.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.69 -6.51 26.61 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-O 117.554 -1.213 . . . . 0.0 112.797 174.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -110.55 -41.06 4.43 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 119.375 0.989 . . . . 0.0 109.772 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 1.9 ttp -59.61 -53.87 53.03 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.754 1.622 . . . . 0.0 111.94 -163.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -84.88 -13.72 50.03 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.187 1.395 . . . . 0.0 111.215 175.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.8 -52.27 5.39 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -168.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.546 HG22 ' HB3' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -50.31 -25.58 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 128.066 2.547 . . . . 0.0 113.359 177.23 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.17 -41.71 84.45 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 126.72 2.008 . . . . 0.0 111.423 175.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.54 55.84 0.62 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 127.165 2.186 . . . . 0.0 106.272 -170.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.027 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 170.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 43.9 p90 . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.7 pttt -151.06 178.51 9.12 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 126.86 2.064 . . . . 0.0 108.787 165.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.8 mp -132.07 136.37 56.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 167.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 20.4 m -99.65 -131.63 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 125.214 1.406 . . . . 0.0 107.704 172.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -44.89 -73.64 0.04 OUTLIER 'General case' 0 C--O 1.235 0.306 0 C-N-CA 127.505 2.322 . . . . 0.0 111.359 178.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -143.59 8.63 1.55 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.477 1.911 . . . . 0.0 110.309 171.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.695 HG11 ' CE2' ' A' ' 56' ' ' PHE . 22.0 t -97.62 132.22 42.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.7 t -83.44 143.64 11.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 170.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.5 mp -121.93 114.4 42.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 174.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.36 147.05 32.55 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 120.41 1.459 . . . . 0.0 108.719 163.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 8.9 mtt -140.43 77.77 23.26 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 127.834 2.453 . . . . 0.0 107.097 -178.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.99 98.62 0.62 Allowed 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 124.881 3.721 . . . . 0.0 112.858 -172.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -76.53 79.26 3.22 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.419 1.087 . . . . 0.0 113.667 -167.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.266 0.0 OUTLIER 40.7 35.61 0.33 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.607 1.963 . . . . 0.0 114.098 -179.494 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -113.43 -11.51 13.1 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 120.63 -1.294 . . . . 0.0 112.732 -164.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.41 83.11 0.26 Allowed 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 125.596 1.558 . . . . 0.0 108.403 -172.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -123.08 38.29 4.22 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.387 1.875 . . . . 0.0 108.127 -177.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.414 HG12 ' CG ' ' A' ' 68' ' ' PHE 0.304 0.3 OUTLIER 68.96 -26.89 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 130.957 3.703 . . . . 0.0 114.556 -177.833 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -40.51 -32.1 0.18 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 129.659 3.184 . . . . 0.0 115.535 -175.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -117.79 -4.34 11.16 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 127.289 2.236 . . . . 0.0 112.089 -164.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.603 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . . . -72.35 -52.0 18.07 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-N 120.114 1.325 . . . . 0.0 111.755 -166.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -60.48 -41.64 94.64 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.74 -0.6 . . . . 0.0 110.123 -178.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.3 -18.53 58.91 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 118.365 -0.826 . . . . 0.0 111.89 178.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -54.49 -42.87 71.26 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.414 1.461 . . . . 0.0 111.824 -172.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -61.76 -52.67 63.28 Favored 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.7 tmtp? -49.11 -46.32 44.68 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.917 1.687 . . . . 0.0 111.255 175.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.554 ' CE3' HG23 ' A' ' 43' ' ' VAL . 10.7 t90 -62.71 -65.55 0.67 Allowed 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 116.973 -1.489 . . . . 0.0 110.178 177.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.554 HG23 ' CE3' ' A' ' 42' ' ' TRP . 58.6 t -54.94 -35.16 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 120.709 1.595 . . . . 0.0 111.284 -175.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -57.59 -67.9 0.29 Allowed 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 123.913 0.885 . . . . 0.0 109.057 173.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.86 -51.56 69.1 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.807 0.843 . . . . 0.0 112.604 -174.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.32 -30.92 70.01 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.617 1.167 . . . . 0.0 111.379 -168.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -133.7 -65.0 0.69 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 122.884 0.474 . . . . 0.0 109.843 -164.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 52.6 mt -56.71 -54.16 49.36 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.835 0.743 . . . . 0.0 111.382 -174.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -67.19 -23.84 65.79 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 126.086 1.754 . . . . 0.0 111.577 175.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.0 tttm -74.68 -6.29 47.92 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.303 1.041 . . . . 0.0 112.194 169.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.68 7.28 53.77 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 124.791 1.186 . . . . 0.0 114.352 175.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -72.32 162.81 28.95 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 120.033 1.916 . . . . 0.0 110.031 176.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -148.34 4.23 0.69 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.502 1.521 . . . . 0.0 111.652 -176.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.488 ' HB3' HG13 ' A' ' 22' ' ' VAL . 1.5 mtmt -141.54 119.02 11.55 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 -177.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.9 mp -119.89 154.97 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 105.14 -2.171 . . . . 0.0 105.14 174.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.695 ' CE2' HG11 ' A' ' 22' ' ' VAL . 24.3 m-85 -130.91 164.19 25.82 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.48 1.512 . . . . 0.0 110.132 160.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.6 tp -128.16 114.6 17.2 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 170.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.573 ' CG2' HD11 ' A' ' 115' ' ' ILE . 53.4 t -82.55 110.42 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 125.991 1.716 . . . . 0.0 108.711 175.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -75.38 -10.89 59.86 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.579 0.752 . . . . 0.0 111.588 170.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.9 m -55.93 -23.52 32.3 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.464 1.029 . . . . 0.0 112.347 172.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.57 -14.16 25.28 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.283 0.947 . . . . 0.0 111.824 177.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.5 p -137.39 101.53 2.19 Favored 'Isoleucine or valine' 0 C--N 1.34 0.152 0 C-N-CA 124.798 1.239 . . . . 0.0 109.643 -173.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -55.05 -48.29 73.67 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.8 m -158.97 170.48 21.99 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.465 HD11 ' CB ' ' A' ' 69' ' ' SER . 8.8 tt -135.83 155.9 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 C-N-CA 127.059 2.144 . . . . 0.0 107.99 -165.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.407 ' HB3' ' CD2' ' A' ' 68' ' ' PHE . 15.8 t70 -91.33 158.47 16.53 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 126.168 1.787 . . . . 0.0 109.774 176.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.7 m -56.07 -24.73 41.83 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 117.594 -1.193 . . . . 0.0 113.337 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.709 ' CE1' ' HB2' ' A' ' 69' ' ' SER 0.278 0.2 OUTLIER -47.59 -64.53 0.76 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 119.686 1.13 . . . . 0.0 111.049 170.766 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.709 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . 30.1 t -92.48 -15.94 26.46 Favored 'General case' 0 CA--C 1.512 -0.486 0 O-C-N 121.52 -0.737 . . . . 0.0 111.642 -168.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.503 HD22 HG21 ' A' ' 103' ' ' THR . 14.2 mt -52.07 -36.22 50.01 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 119.225 -0.99 . . . . 0.0 109.288 170.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -81.27 -25.14 55.64 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-O 118.203 -1.332 . . . . 0.0 114.753 175.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.2 p -72.69 -35.56 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 120.332 2.066 . . . . 0.0 110.048 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 mp -53.34 -49.97 50.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.342 1.457 . . . . 0.0 108.136 173.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 80.7 t -56.61 -52.34 54.84 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 176.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -56.0 -22.46 27.0 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 114.114 1.154 . . . . 0.0 114.114 -174.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 57.8 mt -80.37 -44.34 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.452 1.101 . . . . 0.0 109.481 172.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -54.16 -48.77 70.52 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.452 1.024 . . . . 0.0 109.485 177.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -57.45 -42.75 83.1 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.168 0.587 . . . . 0.0 110.638 -176.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.4 m -60.17 -54.25 48.12 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 118.956 -0.545 . . . . 0.0 110.574 174.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 80.0 mt -57.63 -42.19 80.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.858 0.863 . . . . 0.0 110.803 -176.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -52.07 -40.8 61.72 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.728 1.611 . . . . 0.0 111.242 175.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 t -84.33 0.85 47.64 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.766 2.427 . . . . 0.0 112.799 -174.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.7 m -128.84 -14.26 4.53 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -166.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 130.51 -18.75 5.15 Favored Glycine 0 CA--C 1.521 0.409 0 CA-C-N 117.992 0.36 . . . . 0.0 113.741 177.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -100.3 -173.06 29.86 Favored Glycine 0 N--CA 1.429 -1.781 0 CA-C-O 123.02 1.345 . . . . 0.0 113.283 -156.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.524 ' HB3' HG22 ' A' ' 122' ' ' VAL . 2.1 m-85 -133.46 153.09 51.91 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.461 1.504 . . . . 0.0 108.256 174.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -145.23 146.98 31.93 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 171.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.58 ' C ' HD23 ' A' ' 89' ' ' LEU . . . -156.02 173.34 16.95 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.039 1.335 . . . . 0.0 111.153 -175.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.58 HD23 ' C ' ' A' ' 88' ' ' ALA . 5.6 mt -121.06 163.78 17.81 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.697 1.199 . . . . 0.0 110.148 -170.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.855 HG21 HD13 ' A' ' 115' ' ' ILE . 42.7 t -141.87 135.0 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 123.963 0.905 . . . . 0.0 111.478 -172.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.6 t 53.0 59.63 13.37 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 128.626 2.77 . . . . 0.0 113.938 175.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -73.11 -51.57 0.16 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.73 1.62 . . . . 0.0 115.808 -169.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 85.01 172.48 0.07 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 128.463 2.705 . . . . 0.0 109.638 -171.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.08 -34.19 42.69 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 125.408 1.483 . . . . 0.0 110.398 169.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.59 -48.12 73.39 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-O 117.883 -1.056 . . . . 0.0 108.619 -173.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 54.8 t -79.82 -52.48 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -176.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -63.92 -9.73 17.06 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.55 1.068 . . . . 0.0 111.23 -176.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.41 -74.53 0.09 Allowed 'General case' 0 CA--C 1.489 -1.4 0 CA-C-O 122.108 0.956 . . . . 0.0 108.547 162.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.661 ' O ' HG22 ' A' ' 103' ' ' THR . 17.7 t -70.93 -29.65 38.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 113.585 -1.643 . . . . 0.0 107.114 -156.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.03 -12.44 3.36 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 117.685 -1.15 . . . . 0.0 109.972 173.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.75 -37.03 8.89 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.1 mp -63.79 -18.53 64.18 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.887 2.475 . . . . 0.0 113.257 172.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.661 HG22 ' O ' ' A' ' 99' ' ' VAL . 12.7 t -128.0 16.48 6.77 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.97 1.308 . . . . 0.0 112.623 -171.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . 0.257 0.1 OUTLIER 40.11 78.95 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.38 1.472 . . . . 0.0 110.661 -173.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.402 ' HB2' HG23 ' A' ' 103' ' ' THR . 0.1 OUTLIER -133.79 -49.02 0.82 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.114 1.366 . . . . 0.0 107.93 -178.291 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.9 p-10 -62.53 -25.32 67.98 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 125.747 1.619 . . . . 0.0 112.072 176.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.5 -11.92 38.78 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.744 1.218 . . . . 0.0 113.895 -178.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.6 mt -105.55 -51.04 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 -173.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.5 t -107.91 142.62 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 121.414 0.626 . . . . 0.0 109.328 -170.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.416 ' HE3' ' HG3' ' A' ' 125' ' ' LYS . 14.4 mtmm -69.52 163.36 25.56 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-N 114.673 -1.149 . . . . 0.0 112.261 173.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -148.87 146.0 17.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 113.312 -1.767 . . . . 0.0 108.887 -169.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -148.57 167.55 25.12 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.544 1.138 . . . . 0.0 110.625 -171.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.7 -40.72 13.06 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -177.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.2 p -127.29 172.08 10.92 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.81 0.814 . . . . 0.0 109.501 -179.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.855 HD13 HG21 ' A' ' 90' ' ' VAL . 23.8 mm -70.04 -40.71 78.79 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.553 170.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 38.8 t -66.35 -33.12 75.0 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 119.288 0.949 . . . . 0.0 109.846 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -64.66 -11.76 38.98 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.872 0.869 . . . . 0.0 111.952 175.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -113.58 -39.08 4.14 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 124.935 1.294 . . . . 0.0 109.829 -175.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 5.9 ttp -58.17 -46.79 85.12 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.865 1.266 . . . . 0.0 112.348 -164.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -90.09 -19.89 23.81 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.869 1.268 . . . . 0.0 111.623 177.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -83.62 -50.39 8.25 Favored 'General case' 0 C--O 1.219 -0.532 0 C-N-CA 123.685 0.794 . . . . 0.0 109.095 -171.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.524 HG22 ' HB3' ' A' ' 86' ' ' PHE . 0.3 OUTLIER -53.36 -16.7 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 127.292 2.237 . . . . 0.0 113.173 177.72 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -47.36 64.07 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.299 2.24 . . . . 0.0 111.746 169.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.22 37.21 1.72 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.559 1.944 . . . . 0.0 113.199 -173.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.416 ' HG3' ' HE3' ' A' ' 110' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.107 0 C-N-CA 130.886 3.675 . . . . 0.0 111.666 157.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 9.2 p90 . . . . . 0 CA--C 1.535 0.383 0 CA-C-O 119.495 -0.288 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.427 ' HG2' ' H ' ' A' ' 18' ' ' ILE . 4.9 ttmt -137.65 173.36 11.74 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.563 1.945 . . . . 0.0 109.452 173.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.427 ' H ' ' HG2' ' A' ' 17' ' ' LYS . 67.0 mt -135.53 134.81 51.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 128.866 2.866 . . . . 0.0 105.973 168.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.2 m -108.1 -169.94 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 128.289 2.635 . . . . 0.0 107.038 164.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -23.05 -75.92 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 128.153 2.581 . . . . 0.0 113.311 -171.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -134.15 36.23 3.24 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.256 0.622 . . . . 0.0 110.291 172.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.758 HG11 ' CE2' ' A' ' 56' ' ' PHE . 6.8 t -142.25 153.55 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.049 0 CA-C-O 122.785 1.278 . . . . 0.0 110.572 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.448 ' C ' HD12 ' A' ' 24' ' ' ILE . 0.9 OUTLIER -113.41 151.96 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.721 0 CA-C-N 112.67 -2.059 . . . . 0.0 107.487 -168.552 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.448 HD12 ' C ' ' A' ' 23' ' ' VAL . 3.9 mp -132.33 88.54 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -179.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.428 ' CD2' HG23 ' A' ' 55' ' ' ILE . 0.5 OUTLIER -67.59 158.26 32.51 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 120.377 1.444 . . . . 0.0 109.811 166.619 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -168.53 73.18 0.82 Allowed Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 123.905 0.882 . . . . 0.0 110.317 -176.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -68.65 120.86 7.76 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.881 2.387 . . . . 0.0 111.407 -168.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -76.16 66.53 2.32 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.4 -0.812 . . . . 0.0 111.749 175.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? 61.31 8.7 2.21 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.538 1.535 . . . . 0.0 113.155 -175.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.04 26.84 0.14 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.835 1.254 . . . . 0.0 112.789 -178.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.97 80.01 7.87 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 123.353 1.549 . . . . 0.0 106.842 175.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -99.63 148.95 23.79 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 127.191 2.196 . . . . 0.0 107.333 163.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.0 tt -54.37 -30.57 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.465 1.506 . . . . 0.0 112.217 174.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.407 ' O ' HD22 ' A' ' 38' ' ' LEU . 46.9 mt-10 -58.93 -63.62 1.23 Allowed 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 175.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -51.7 -46.06 63.75 Favored 'General case' 0 C--O 1.222 -0.356 0 C-N-CA 125.252 1.421 . . . . 0.0 109.574 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.75 -40.57 63.23 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.838 1.255 . . . . 0.0 113.631 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -64.29 -47.72 78.41 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 119.795 1.18 . . . . 0.0 109.599 177.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.407 HD22 ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -72.41 -31.77 65.79 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 118.014 -0.993 . . . . 0.0 111.03 -175.157 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -41.35 -40.3 1.66 Allowed 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 128.075 2.55 . . . . 0.0 110.715 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -55.46 -72.11 0.07 Allowed 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 118.989 0.813 . . . . 0.0 109.41 168.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.53 -35.48 63.24 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.869 0.868 . . . . 0.0 111.132 -172.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 20.7 t90 -59.88 -73.23 0.09 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 117.152 -1.404 . . . . 0.0 111.24 170.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 53.9 t -49.18 -36.33 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-N 120.452 1.478 . . . . 0.0 111.195 -178.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -68.52 -57.48 5.73 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 124.732 1.213 . . . . 0.0 110.538 -178.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -67.72 -31.58 71.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 118.545 0.611 . . . . 0.0 110.636 -177.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -89.24 -20.62 23.92 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 123.334 0.653 . . . . 0.0 111.728 -168.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -133.62 -53.85 0.88 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 118.619 0.645 . . . . 0.0 111.537 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 35.6 mt -64.31 -39.92 94.9 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 119.035 -0.507 . . . . 0.0 110.808 -171.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -72.97 -35.61 66.94 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 126.922 2.089 . . . . 0.0 111.356 173.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.91 -50.62 70.2 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.563 0.745 . . . . 0.0 109.46 175.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 138.21 6.08 1.48 Allowed Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.368 0.985 . . . . 0.0 112.634 -177.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -72.06 155.63 40.09 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 118.464 1.132 . . . . 0.0 109.876 177.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -131.65 15.31 4.89 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.692 1.597 . . . . 0.0 111.187 173.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.469 ' HB3' HG13 ' A' ' 22' ' ' VAL . 0.3 OUTLIER -153.32 105.11 2.83 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 -163.13 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.428 HG23 ' CD2' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -116.09 155.19 17.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 103.801 -2.666 . . . . 0.0 103.801 179.505 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.758 ' CE2' HG11 ' A' ' 22' ' ' VAL . 27.4 m-85 -130.29 160.67 33.23 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 159.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 42.0 tp -126.72 103.98 7.83 Favored 'General case' 0 C--N 1.334 -0.083 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 173.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.2 t -78.88 141.27 15.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 171.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 92' ' ' PRO . 3.4 mp -122.69 12.24 9.88 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.603 0.638 . . . . 0.0 112.304 -178.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.5 t -50.01 -44.72 51.35 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.655 1.582 . . . . 0.0 111.401 178.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -68.56 -36.22 78.48 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 118.684 -0.674 . . . . 0.0 111.234 -175.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 p -103.44 117.71 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 126.579 1.951 . . . . 0.0 107.753 -160.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -76.13 -39.63 54.65 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.22 -0.925 . . . . 0.0 109.17 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 78.9 p -140.29 163.17 33.47 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -175.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.404 HD11 ' HB2' ' A' ' 69' ' ' SER . 20.0 tt -136.7 154.73 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 C-N-CA 126.407 1.883 . . . . 0.0 107.068 175.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.89 160.07 17.37 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.185 1.794 . . . . 0.0 109.847 -175.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.3 t -62.8 -12.89 27.35 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.7 1.2 . . . . 0.0 113.278 174.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -71.37 -68.29 0.46 Allowed 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 168.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.404 ' HB2' HD11 ' A' ' 65' ' ' ILE . 0.6 OUTLIER -70.67 -30.3 66.86 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.674 1.189 . . . . 0.0 112.531 -163.236 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.539 HD22 HD13 ' A' ' 105' ' ' LEU . 11.6 mt -47.42 -42.54 22.44 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.966 0.907 . . . . 0.0 109.759 174.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -71.79 -29.84 66.84 Favored Glycine 0 CA--C 1.528 0.854 0 O-C-N 121.365 -0.834 . . . . 0.0 112.298 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.0 t -67.92 -35.26 71.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 O-C-N 121.583 -0.951 . . . . 0.0 109.314 176.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.8 -47.91 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.6 t -60.88 -39.43 81.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 O-C-N 121.535 -0.728 . . . . 0.0 110.938 174.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.41 -42.76 92.53 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 120.973 -1.08 . . . . 0.0 112.327 -176.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.3 mt -53.64 -43.52 54.83 Favored 'Isoleucine or valine' 0 C--N 1.343 0.308 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 172.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.434 ' C ' HD13 ' A' ' 77' ' ' LEU . 3.1 tm? -66.44 -48.35 70.25 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -173.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 24.6 mttm -55.22 -47.59 75.1 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 122.777 0.431 . . . . 0.0 111.099 178.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.1 m -61.87 -46.55 88.95 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.974 0.91 . . . . 0.0 110.391 -177.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 29.4 mt -65.75 -48.06 83.64 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 C-N-CA 124.051 0.94 . . . . 0.0 111.328 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.52 -39.54 80.38 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 177.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 50.6 m -62.57 -41.54 98.99 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.061 176.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.7 m -61.42 -51.22 69.66 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.362 0.983 . . . . 0.0 109.982 174.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 134.75 24.24 0.6 Allowed Glycine 0 CA--C 1.525 0.671 0 C-N-CA 123.711 0.672 . . . . 0.0 112.396 -171.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -119.67 -173.12 15.23 Favored Glycine 0 N--CA 1.439 -1.131 0 CA-C-N 118.599 1.199 . . . . 0.0 111.942 -176.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.586 ' HB3' HG22 ' A' ' 122' ' ' VAL . 3.4 m-85 -131.6 155.3 47.77 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.843 1.657 . . . . 0.0 109.246 177.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -150.57 135.42 17.5 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.697 0.799 . . . . 0.0 109.595 176.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -139.95 162.24 35.65 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.009 0.433 . . . . 0.0 111.982 -177.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.466 ' N ' HD12 ' A' ' 89' ' ' LEU . 7.5 mp -103.03 151.93 21.93 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.025 1.73 . . . . 0.0 107.405 178.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 70.4 t -145.1 145.43 20.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -168.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 47.1 t 42.37 57.66 10.7 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 124.499 1.119 . . . . 0.0 110.124 -176.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.4 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 30.5 Cg_endo -64.98 -77.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.947 2.431 . . . . 0.0 111.301 -165.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 25.0 p30 142.46 -175.12 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.492 1 C-N-CA 133.337 4.655 . . . . 0.0 106.01 171.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -77.84 -32.91 52.42 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 122.458 1.123 . . . . 0.0 111.849 176.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.74 -51.26 19.9 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 129.921 3.288 . . . . 0.0 110.271 -166.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.824 HG13 HD13 ' A' ' 100' ' ' LEU . 1.2 t -63.94 -48.12 87.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 125.668 1.587 . . . . 0.0 107.75 168.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -61.56 -26.08 67.72 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 122.746 2.521 . . . . 0.0 110.828 -175.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -46.98 85.83 Favored 'General case' 0 C--N 1.344 0.341 0 O-C-N 121.376 -0.827 . . . . 0.0 109.583 175.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.2 p -80.45 -31.31 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -172.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.824 HD13 HG13 ' A' ' 96' ' ' VAL . 3.3 mp -66.06 -17.48 64.72 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 118.037 -0.982 . . . . 0.0 112.462 177.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.6 m -77.86 -58.11 3.44 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 165.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.93 -68.56 0.16 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.019 2.128 . . . . 0.0 111.641 -173.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.628 HG23 HD12 ' A' ' 105' ' ' LEU . 5.7 t -76.92 14.59 0.81 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.671 1.589 . . . . 0.0 112.518 -175.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 42.76 85.05 0.02 OUTLIER 'General case' 0 C--N 1.34 0.194 0 C-N-CA 126.256 1.822 . . . . 0.0 112.014 -169.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.628 HD12 HG23 ' A' ' 103' ' ' THR 0.334 0.1 OUTLIER -126.04 -41.47 1.94 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 125.169 1.388 . . . . 0.0 112.362 178.163 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -67.76 -21.18 65.28 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.95 1.25 . . . . 0.0 111.259 171.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.9 mtm180 -79.51 -1.94 39.94 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 118.805 -0.617 . . . . 0.0 111.227 -178.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.7 mm -127.69 -46.17 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 C-N-CA 124.97 1.308 . . . . 0.0 108.384 -164.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.446 HG11 ' CD1' ' A' ' 89' ' ' LEU . 2.6 t -110.48 149.24 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 -177.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.471 ' HE3' ' H ' ' A' ' 111' ' ' ILE . 0.0 OUTLIER -71.52 160.88 31.93 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.979 173.519 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.471 ' H ' ' HE3' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -145.27 143.29 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -177.249 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -146.55 171.4 15.14 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.349 1.459 . . . . 0.0 110.417 -177.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -87.24 -50.03 6.87 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -177.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 31.8 p -125.55 170.54 11.35 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-O 122.174 0.987 . . . . 0.0 111.141 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 12.4 mm -63.13 -36.76 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 C-N-CA 124.293 1.037 . . . . 0.0 108.379 170.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.79 -43.0 90.04 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 119.869 1.213 . . . . 0.0 110.979 -178.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -71.41 3.87 3.43 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 123.691 0.62 . . . . 0.0 112.169 178.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.466 ' HB1' ' CE1' ' A' ' 56' ' ' PHE . . . -114.39 -33.89 5.46 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 174.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.16 -52.31 62.94 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 120.17 -1.582 . . . . 0.0 111.79 -162.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -89.8 -13.81 35.82 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.48 0.712 . . . . 0.0 112.113 172.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.81 -52.36 6.1 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -168.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.586 HG22 ' HB3' ' A' ' 86' ' ' PHE . 0.3 OUTLIER -53.31 -32.45 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 126.406 1.883 . . . . 0.0 111.322 176.194 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 43.8 mtm180 -62.18 -25.03 67.55 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 124.221 1.008 . . . . 0.0 111.285 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.22 56.33 1.0 Allowed 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 119.158 0.89 . . . . 0.0 109.862 169.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.199 0 CA-C-O 118.196 -0.907 . . . . 0.0 111.437 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 15.2 p90 . . . . . 0 N--CA 1.451 -0.418 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -141.32 173.14 11.78 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 127.309 2.244 . . . . 0.0 108.365 164.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.6 mt -129.8 120.65 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 167.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.3 m -88.09 -151.96 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 124.938 1.295 . . . . 0.0 108.226 172.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -25.03 -72.39 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 128.6 2.76 . . . . 0.0 113.472 -177.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -145.43 28.03 1.21 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.184 1.394 . . . . 0.0 110.49 165.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.735 HG11 ' CE2' ' A' ' 56' ' ' PHE . 24.2 t -122.42 137.22 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 O-C-N 120.824 -1.172 . . . . 0.0 110.444 -177.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.4 t -84.8 135.81 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 177.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.1 mp -117.01 103.39 14.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 173.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.454 HD23 HG23 ' A' ' 55' ' ' ILE . 3.8 mm? -76.66 95.52 3.98 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 128.194 2.598 . . . . 0.0 106.765 171.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 14.8 mtm -94.45 95.8 1.58 Allowed Pre-proline 0 CA--C 1.55 0.966 0 CA-C-N 121.539 1.972 . . . . 0.0 106.54 172.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -67.99 172.25 11.13 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 CA-C-N 122.08 1.778 . . . . 0.0 109.488 171.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.571 HD22 ' H ' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -152.89 -71.99 0.14 Allowed 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 169.661 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.571 ' H ' HD22 ' A' ' 28' ' ' ASN . 0.0 OUTLIER -132.33 17.27 4.47 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.0 1.32 . . . . 0.0 112.488 -176.794 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -89.89 1.13 56.58 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 122.994 0.518 . . . . 0.0 111.13 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 17.9 mt -89.76 89.56 7.83 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -132.68 22.07 4.27 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.499 1.12 . . . . 0.0 113.152 -166.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.255 0.2 OUTLIER 64.12 -43.27 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 129.188 2.995 . . . . 0.0 114.444 -172.795 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -61.39 -19.01 61.42 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 120.765 -1.209 . . . . 0.0 111.061 174.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -115.25 68.77 0.71 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 126.404 1.882 . . . . 0.0 108.288 174.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.582 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . . . -132.34 -62.61 0.83 Allowed 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 167.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -59.05 -35.29 73.07 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.238 0.927 . . . . 0.0 110.306 174.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 36.0 mt -67.11 -28.88 68.52 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 124.244 1.017 . . . . 0.0 112.929 173.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -59.13 -57.75 11.69 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 124.62 1.168 . . . . 0.0 108.745 -172.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.489 ' HE2' ' CE2' ' A' ' 44' ' ' PHE . 3.9 ttpm? -54.24 -49.06 70.37 Favored 'General case' 0 C--O 1.216 -0.682 0 CA-C-O 116.684 -1.627 . . . . 0.0 110.216 172.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -43.99 85.67 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 120.667 1.576 . . . . 0.0 111.367 -176.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -67.81 -60.89 2.17 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-O 116.709 -1.615 . . . . 0.0 109.088 177.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.551 HG12 ' CD1' ' A' ' 48' ' ' LEU . 56.7 t -52.1 -38.7 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 121.538 1.972 . . . . 0.0 109.772 -178.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.517 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 8.0 m-30 -60.26 -69.03 0.24 Allowed 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 124.362 1.065 . . . . 0.0 110.687 176.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.21 -10.13 59.17 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -171.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -90.94 -31.37 16.4 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 116.048 -1.929 . . . . 0.0 110.284 173.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -134.54 -53.42 0.82 Allowed 'General case' 0 C--N 1.357 0.906 0 CA-C-N 122.804 2.547 . . . . 0.0 109.91 -174.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.551 ' CD1' HG12 ' A' ' 43' ' ' VAL . 6.6 mp -55.8 -59.59 4.65 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.818 0.818 . . . . 0.0 110.918 -174.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -75.45 -5.48 45.26 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 124.623 1.169 . . . . 0.0 112.268 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.7 mttm -75.59 -28.8 59.06 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.12 0.873 . . . . 0.0 110.274 163.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 125.0 -6.0 8.29 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 126.143 1.83 . . . . 0.0 112.688 -176.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -71.49 174.79 6.15 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 119.44 1.62 . . . . 0.0 108.928 175.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -172.09 5.72 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.184 1.794 . . . . 0.0 109.598 -169.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.477 ' HB3' HG13 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -131.81 112.49 12.54 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 104.889 -2.263 . . . . 0.0 104.889 -176.513 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.454 HG23 HD23 ' A' ' 25' ' ' LEU . 1.8 mp -122.94 146.38 28.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 178.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.785 ' CE1' HG21 ' A' ' 122' ' ' VAL . 17.1 m-85 -129.34 128.96 44.17 Favored 'General case' 0 C--O 1.228 -0.051 0 C-N-CA 123.958 0.903 . . . . 0.0 109.735 166.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 47.5 tp -95.16 121.48 36.85 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.296 1.039 . . . . 0.0 109.594 -178.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.438 ' HA ' ' HB ' ' A' ' 90' ' ' VAL . 0.8 OUTLIER -89.09 152.94 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 119.59 1.086 . . . . 0.0 111.402 177.902 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.517 ' CD2' HG21 ' A' ' 96' ' ' VAL . 0.9 OUTLIER -134.0 0.8 3.21 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.115 0.966 . . . . 0.0 112.982 175.083 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.44 -8.19 1.7 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 169.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -116.68 -5.66 11.61 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.563 1.145 . . . . 0.0 111.83 -168.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.4 p -143.8 148.43 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 125.012 1.325 . . . . 0.0 107.47 -170.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -78.0 -46.98 19.53 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 176.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.8 p -155.12 168.2 27.82 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.6 tt -94.13 156.43 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 125.977 1.711 . . . . 0.0 108.178 162.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -111.44 174.57 5.8 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.551 -0.718 . . . . 0.0 110.358 -176.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.5 m -57.87 -39.92 78.98 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 121.412 -0.805 . . . . 0.0 112.241 -172.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.582 ' CE1' ' HB2' ' A' ' 36' ' ' ALA . 0.9 OUTLIER -50.36 -53.13 31.36 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.255 1.422 . . . . 0.0 111.232 176.646 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 p -93.51 -20.75 19.97 Favored 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 121.683 -0.635 . . . . 0.0 112.026 -169.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 31.6 tp -56.97 -17.21 8.87 Favored 'General case' 0 CA--C 1.551 0.988 0 O-C-N 120.844 -1.16 . . . . 0.0 111.468 170.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -101.07 -8.51 47.53 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 125.046 1.308 . . . . 0.0 115.216 169.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -89.16 -38.88 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 119.608 1.704 . . . . 0.0 109.157 175.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.4 mm -58.42 -41.17 80.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 O-C-N 121.127 -0.983 . . . . 0.0 110.706 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 65.8 t -61.36 -42.77 94.94 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 CA-C-N 118.264 0.484 . . . . 0.0 110.212 174.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -63.67 -30.64 71.72 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 120.82 -1.175 . . . . 0.0 111.052 -176.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.9 mt -64.17 -40.06 87.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 171.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -67.84 -49.19 63.51 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 123.931 0.892 . . . . 0.0 109.172 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.3 mttm -48.72 -55.64 10.84 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 124.451 1.1 . . . . 0.0 110.418 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 69.2 m -78.41 -26.75 46.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 118.145 -0.931 . . . . 0.0 112.699 -172.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 25.2 mt -59.04 -44.89 92.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 119.85 1.204 . . . . 0.0 109.306 165.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.2 t -74.59 -18.44 60.57 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.34 1.056 . . . . 0.0 112.135 -176.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.1 m -77.89 -43.78 29.08 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.881 0.872 . . . . 0.0 110.279 166.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.0 m -64.38 -50.9 65.84 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 118.418 -0.801 . . . . 0.0 110.741 -176.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 134.2 23.13 0.69 Allowed Glycine 0 CA--C 1.521 0.426 0 CA-C-O 119.157 -0.801 . . . . 0.0 113.565 -175.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -115.82 -171.98 16.64 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 118.84 1.32 . . . . 0.0 111.81 -170.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.16 158.4 43.75 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.466 1.507 . . . . 0.0 110.201 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -150.5 142.2 23.66 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.491 ' C ' HD23 ' A' ' 89' ' ' LEU . . . -144.07 173.22 11.91 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.318 1.447 . . . . 0.0 110.605 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.491 HD23 ' C ' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -118.28 168.14 10.88 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.926 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.438 ' HB ' ' HA ' ' A' ' 58' ' ' VAL . 57.7 t -139.48 129.4 30.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 124.425 1.09 . . . . 0.0 108.153 -164.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.9 t 43.84 69.98 2.12 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 127.122 2.169 . . . . 0.0 110.555 -176.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -71.09 118.82 5.89 Favored 'Trans proline' 0 N--CA 1.445 -1.365 0 N-CA-C 107.597 -1.732 . . . . 0.0 107.597 173.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 49.1 p30 -67.33 165.5 16.26 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 122.863 1.316 . . . . 0.0 109.447 163.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -69.19 -24.49 64.05 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.892 -174.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -46.41 78.79 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 126.624 1.97 . . . . 0.0 110.256 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.517 HG21 ' CD2' ' A' ' 59' ' ' LEU . 6.6 t -77.93 -38.59 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-O 118.263 -0.875 . . . . 0.0 109.982 -178.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -51.25 -39.02 55.78 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 124.744 1.218 . . . . 0.0 110.045 177.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.7 -61.27 1.91 Allowed 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 125.69 1.596 . . . . 0.0 114.222 172.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.569 ' O ' HG22 ' A' ' 103' ' ' THR . 77.9 t -71.21 -47.92 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 C-N-CA 125.889 1.676 . . . . 0.0 107.339 -169.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.39 -21.53 60.05 Favored 'General case' 0 N--CA 1.438 -1.028 0 O-C-N 124.495 1.122 . . . . 0.0 108.6 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.4 m -82.47 -52.01 7.27 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 81.1 mt -57.94 -29.0 64.81 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.578 1.951 . . . . 0.0 113.495 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.569 HG22 ' O ' ' A' ' 99' ' ' VAL . 1.9 t -111.53 -1.81 15.71 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.917 1.287 . . . . 0.0 111.205 -171.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 53.9 78.9 0.14 Allowed 'General case' 0 C--N 1.343 0.283 0 C-N-CA 127.181 2.192 . . . . 0.0 109.931 -176.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.19 -49.39 1.94 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 126.716 2.006 . . . . 0.0 108.064 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -67.17 -12.19 59.36 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.141 1.376 . . . . 0.0 112.465 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.1 mtp180 -90.22 -0.79 57.79 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.867 1.667 . . . . 0.0 111.433 176.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.6 mm -127.46 -45.21 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 125.623 1.569 . . . . 0.0 107.431 -165.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.2 t -99.21 155.08 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 174.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.4 ' HD2' ' HE2' ' A' ' 125' ' ' LYS . 0.1 OUTLIER -76.45 164.78 25.65 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 121.524 -0.735 . . . . 0.0 109.832 170.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.45 141.83 23.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -145.1 164.91 29.8 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 125.981 1.712 . . . . 0.0 110.095 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -94.94 -54.59 3.4 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 46.7 p -106.96 157.56 17.69 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 118.778 0.717 . . . . 0.0 109.365 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 9.1 mm -58.65 -36.55 60.67 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 175.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 45.0 t -60.79 -41.59 95.9 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 118.933 -0.556 . . . . 0.0 110.654 -175.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -71.92 -21.49 61.61 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 124.163 0.915 . . . . 0.0 110.639 -176.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.733 ' O ' HG23 ' A' ' 122' ' ' VAL . . . -79.53 -54.07 6.25 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 104.12 -2.548 . . . . 0.0 104.12 176.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.97 -59.3 3.19 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 125.518 1.527 . . . . 0.0 111.774 -160.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -75.61 -19.21 59.38 Favored 'General case' 0 CA--C 1.521 -0.172 0 O-C-N 123.926 0.766 . . . . 0.0 112.299 -176.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -88.09 -51.49 5.77 Favored 'General case' 0 CA--C 1.495 -1.14 0 CA-C-O 118.568 -0.729 . . . . 0.0 110.134 -172.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.785 HG21 ' CE1' ' A' ' 56' ' ' PHE . 40.3 t -48.65 -39.44 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 126.439 1.896 . . . . 0.0 110.062 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -47.64 -43.11 25.76 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.545 1.138 . . . . 0.0 112.639 171.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -134.06 33.82 3.37 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.377 2.671 . . . . 0.0 112.752 -172.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.4 ' HE2' ' HD2' ' A' ' 110' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.235 0 C-N-CA 126.708 2.003 . . . . 0.0 113.977 -160.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 14.4 p90 . . . . . 0 CA--C 1.541 0.604 0 CA-C-O 121.468 0.651 . . . . 0.0 111.682 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.2 ttmm -136.56 173.17 11.99 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.222 2.209 . . . . 0.0 108.076 161.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 54.2 mt -135.33 144.96 32.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 129.015 2.926 . . . . 0.0 104.223 163.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.1 m -105.76 -130.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 173.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -50.59 -66.87 0.31 Allowed 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 126.917 2.087 . . . . 0.0 111.263 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -144.48 11.87 1.5 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.825 2.05 . . . . 0.0 111.82 178.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.627 HG11 ' CE2' ' A' ' 56' ' ' PHE . 8.9 t -119.26 135.44 59.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -177.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.51 HG13 ' HA ' ' A' ' 55' ' ' ILE . 0.6 OUTLIER -81.55 150.39 4.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 C-N-CA 128.337 2.655 . . . . 0.0 111.798 174.26 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.446 HD12 ' C ' ' A' ' 23' ' ' VAL . 4.1 mp -132.33 88.95 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 175.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.48 HD23 HG23 ' A' ' 55' ' ' ILE . 4.3 mm? -58.36 140.18 54.03 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 168.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 61.6 mtt -139.2 76.54 32.17 Favored Pre-proline 0 C--N 1.328 -0.339 0 C-N-CA 125.04 1.336 . . . . 0.0 108.483 176.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -75.49 68.02 6.22 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.574 2.183 . . . . 0.0 109.02 176.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.2 93.41 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.461 1.504 . . . . 0.0 107.861 176.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.25 -21.32 0.07 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 127.911 2.484 . . . . 0.0 114.8 -170.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.88 59.0 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 129.535 3.134 . . . . 0.0 113.837 -177.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 65.0 mt -127.98 23.41 6.13 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 119.516 -1.99 . . . . 0.0 112.21 175.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -53.3 150.21 6.51 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 164.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.7 mt -58.31 -37.95 66.21 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 CA-C-O 119.33 -0.367 . . . . 0.0 111.629 -174.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -68.33 -34.56 76.34 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 118.725 0.693 . . . . 0.0 109.343 -171.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -72.66 -43.72 62.78 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 171.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.41 -33.18 65.54 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.883 0.765 . . . . 0.0 111.626 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 25.5 t60 -70.06 -47.96 59.79 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 120.495 -1.378 . . . . 0.0 110.262 174.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.468 HD12 ' C ' ' A' ' 38' ' ' LEU . 0.5 OUTLIER -73.0 -17.34 61.46 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 118.968 -0.539 . . . . 0.0 111.727 -178.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -48.83 -55.78 10.62 Favored 'General case' 0 CA--C 1.513 -0.442 0 C-N-CA 127.999 2.52 . . . . 0.0 110.513 -170.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp -66.48 -28.99 69.01 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 117.86 -1.067 . . . . 0.0 111.047 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.7 ttmt -68.26 -51.99 38.97 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 121.157 1.799 . . . . 0.0 109.211 172.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.421 ' CH2' ' CD1' ' A' ' 25' ' ' LEU . 13.7 t90 -59.91 -59.45 5.4 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.229 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.0 t -50.41 -30.04 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 120.262 1.392 . . . . 0.0 112.199 176.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.442 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 3.6 m-85 -72.76 -69.84 0.39 Allowed 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 173.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.41 ' HA ' ' HB2' ' A' ' 49' ' ' ASN . 3.3 t0 -61.61 -35.86 79.06 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 124.289 1.036 . . . . 0.0 112.949 -167.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -75.69 -30.94 59.51 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.247 2.219 . . . . 0.0 111.284 175.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -132.02 -67.21 0.68 Allowed 'General case' 0 C--N 1.352 0.694 0 CA-C-N 120.682 1.583 . . . . 0.0 112.286 -174.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.442 ' HB2' ' HA ' ' A' ' 44' ' ' PHE . 6.5 mt -59.17 -48.76 80.41 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.372 0.987 . . . . 0.0 112.694 -170.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.41 ' HB2' ' HA ' ' A' ' 45' ' ' ASP . 76.4 m-20 -65.56 -34.5 78.39 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 125.428 1.491 . . . . 0.0 109.726 177.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.9 mttm -61.38 -21.64 64.25 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.802 1.241 . . . . 0.0 111.811 171.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.6 14.68 36.94 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.329 0.966 . . . . 0.0 112.485 -178.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -70.38 139.14 51.85 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 118.931 1.365 . . . . 0.0 108.085 166.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -119.42 6.02 11.13 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.592 1.157 . . . . 0.0 110.292 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt -146.87 98.05 2.99 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 120.27 1.395 . . . . 0.0 107.254 -167.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.51 ' HA ' HG13 ' A' ' 23' ' ' VAL . 1.2 mp -102.81 151.92 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.627 ' CE2' HG11 ' A' ' 22' ' ' VAL . 22.4 m-85 -123.2 160.42 26.59 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.965 0.79 . . . . 0.0 111.908 157.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.6 tp -125.3 122.48 37.01 Favored 'General case' 0 C--O 1.223 -0.324 0 C-N-CA 124.887 1.275 . . . . 0.0 109.221 171.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.423 HG12 ' H ' ' A' ' 60' ' ' SER . 15.6 t -95.06 141.74 14.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 173.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.486 HD22 HG11 ' A' ' 96' ' ' VAL . 4.3 mp -123.57 6.46 8.9 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.011 1.324 . . . . 0.0 111.133 -174.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.423 ' H ' HG12 ' A' ' 58' ' ' VAL . 2.4 t -54.66 -36.8 64.99 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.114 1.765 . . . . 0.0 111.737 174.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -104.76 18.71 21.79 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.113 0.965 . . . . 0.0 111.101 -165.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.4 p -151.18 122.84 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 123.551 0.74 . . . . 0.0 109.386 -175.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -73.24 -43.41 61.22 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 117.995 -1.003 . . . . 0.0 108.979 177.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.4 t -150.35 175.82 11.47 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 119.169 0.895 . . . . 0.0 111.962 -171.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.8 tt -140.91 149.85 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 -175.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -81.45 155.75 25.69 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 123.804 0.842 . . . . 0.0 109.743 -174.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.2 p -54.01 -25.8 22.98 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.068 1.347 . . . . 0.0 112.619 175.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -61.94 -63.24 1.32 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.366 1.466 . . . . 0.0 110.478 169.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 26.4 t -82.46 -22.95 34.99 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.591 1.157 . . . . 0.0 111.974 -163.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 40.8 tp -60.91 -16.66 44.63 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 120.549 -1.344 . . . . 0.0 111.609 170.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -91.85 -29.95 11.08 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-O 118.849 -0.973 . . . . 0.0 112.194 167.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -66.67 -37.23 79.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 119.551 1.676 . . . . 0.0 111.23 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.4 mm -59.68 -46.58 93.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 C-N-CA 124.6 1.16 . . . . 0.0 109.826 175.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 50.8 t -60.98 -41.51 89.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 174.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -55.96 -41.01 74.06 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.408 -0.807 . . . . 0.0 111.344 -176.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 71.1 mt -64.03 -39.75 86.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.719 0.808 . . . . 0.0 110.03 174.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.422 ' HG ' HG22 ' A' ' 109' ' ' VAL . 3.0 tm? -62.17 -49.25 76.58 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 119.705 1.139 . . . . 0.0 109.075 178.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -50.12 -55.53 14.63 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 123.475 0.71 . . . . 0.0 109.88 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.71 -39.9 95.45 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 117.569 -1.205 . . . . 0.0 112.365 -178.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 76.4 mt -64.32 -43.98 97.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 121.023 1.738 . . . . 0.0 109.85 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.3 m -56.8 -48.07 78.79 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.393 0.677 . . . . 0.0 110.899 172.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.4 m -71.77 -10.54 59.92 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.09 1.356 . . . . 0.0 113.935 178.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.2 m -99.7 -25.54 14.36 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.687 1.195 . . . . 0.0 111.94 175.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 120.19 2.61 12.22 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 116.435 1.334 . . . . 0.0 116.435 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -99.2 -158.83 29.17 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 119.682 1.741 . . . . 0.0 112.95 -171.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.503 ' CZ ' ' HE2' ' A' ' 125' ' ' LYS . 0.3 OUTLIER -139.93 160.11 40.67 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 127.0 2.12 . . . . 0.0 109.852 170.387 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -149.31 143.82 26.07 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 176.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.27 165.56 28.89 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.09 0.956 . . . . 0.0 112.157 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.405 ' N ' HD12 ' A' ' 89' ' ' LEU . 7.2 mp -113.72 156.39 23.87 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.753 2.021 . . . . 0.0 108.983 -175.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 57.7 t -146.79 149.39 15.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 123.432 0.693 . . . . 0.0 109.934 -159.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.2 t 49.14 54.89 16.83 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 125.029 1.332 . . . . 0.0 111.412 -175.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -82.54 81.7 2.41 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 122.344 2.029 . . . . 0.0 111.69 -164.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.0 156.54 9.13 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 122.044 0.926 . . . . 0.0 110.545 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -62.93 -33.68 75.85 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.803 -1.09 . . . . 0.0 112.241 -163.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.8 -41.59 97.88 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 123.67 0.788 . . . . 0.0 109.264 -174.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.486 HG11 HD22 ' A' ' 59' ' ' LEU . 17.9 t -70.63 -42.37 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-O 117.514 -1.232 . . . . 0.0 110.236 175.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -58.82 -28.65 66.23 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 120.127 1.331 . . . . 0.0 110.804 -172.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -51.08 -60.46 3.07 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-O 125.028 2.347 . . . . 0.0 111.454 173.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.446 ' O ' HG22 ' A' ' 103' ' ' THR . 4.7 t -71.08 -39.01 73.86 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.747 0 CA-C-N 112.508 -2.133 . . . . 0.0 107.454 -172.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.2 mt -61.79 -15.62 42.98 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 118.234 -0.888 . . . . 0.0 110.481 177.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.5 -46.1 10.49 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-O 121.32 0.581 . . . . 0.0 110.164 173.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.73 -62.53 1.8 Allowed 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.703 2.001 . . . . 0.0 108.425 -177.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.446 HG22 ' O ' ' A' ' 99' ' ' VAL . 0.6 OUTLIER -74.0 -5.76 43.33 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 129.129 2.972 . . . . 0.0 111.07 -169.28 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 49.99 77.73 0.11 Allowed 'General case' 0 C--N 1.344 0.361 0 C-N-CA 127.45 2.3 . . . . 0.0 109.437 -168.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.44 -57.08 2.17 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 173.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -65.52 -12.44 52.82 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 127.427 2.291 . . . . 0.0 112.462 175.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.4 mtt-85 -88.96 2.89 53.19 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.082 0.953 . . . . 0.0 113.08 171.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.8 mt -133.15 -43.08 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 125.098 1.359 . . . . 0.0 109.238 -173.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.422 HG22 ' HG ' ' A' ' 77' ' ' LEU . 2.1 t -114.16 141.73 29.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 125.501 1.52 . . . . 0.0 106.941 -177.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.46 159.64 23.9 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.618 0.767 . . . . 0.0 112.21 177.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -123.28 154.93 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 125.65 1.58 . . . . 0.0 106.98 169.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -147.44 162.97 37.94 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.98 1.712 . . . . 0.0 109.569 170.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -81.35 -53.24 6.49 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 119.464 -0.895 . . . . 0.0 109.361 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 67.6 p -129.44 161.58 30.06 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 125.327 1.451 . . . . 0.0 108.502 -169.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 26.7 mm -63.79 -38.89 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -173.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.9 t -74.38 -19.97 60.24 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 118.863 -1.135 . . . . 0.0 111.487 -174.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -70.22 -20.46 63.09 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 118.965 0.802 . . . . 0.0 111.173 170.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.457 ' HB1' ' CZ ' ' A' ' 56' ' ' PHE . . . -105.42 -39.83 6.01 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.997 0.919 . . . . 0.0 109.478 -169.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 5.0 ttm -58.36 -44.12 88.7 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 124.49 1.116 . . . . 0.0 111.972 -162.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -95.16 -10.49 30.39 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.347 1.059 . . . . 0.0 111.726 178.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -93.12 -50.67 5.4 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.041 -172.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.487 HG22 ' HB3' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -47.98 -37.43 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 125.73 1.612 . . . . 0.0 111.059 173.597 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -56.49 -32.78 65.35 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-O 118.494 -0.765 . . . . 0.0 111.684 176.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.73 29.42 2.35 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -175.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.503 ' HE2' ' CZ ' ' A' ' 86' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.175 0 C-N-CA 124.317 1.047 . . . . 0.0 110.059 -171.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.6 p90 . . . . . 0 N--CA 1.442 -0.844 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.6 ttmm -122.44 170.85 9.56 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 126.411 1.885 . . . . 0.0 108.667 167.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.7 mt -129.1 130.52 68.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 157.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.7 m -88.87 -141.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 125.311 1.444 . . . . 0.0 108.185 171.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -40.45 -78.38 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 127.585 2.354 . . . . 0.0 111.001 168.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -135.8 9.17 3.32 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 123.308 0.643 . . . . 0.0 111.87 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.765 HG11 ' CE2' ' A' ' 56' ' ' PHE . 21.7 t -106.25 135.16 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.2 t -84.98 147.52 5.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 171.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.8 mp -130.4 91.85 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 176.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.406 HD12 ' CH2' ' A' ' 42' ' ' TRP . 1.3 mm? -71.25 111.94 6.99 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 121.072 1.76 . . . . 0.0 108.983 171.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 4.1 mtt -106.11 91.39 5.46 Favored Pre-proline 0 CA--C 1.548 0.869 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.33 122.95 4.78 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.187 2.591 . . . . 0.0 111.499 -171.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.417 ' C ' ' HE2' ' A' ' 29' ' ' LYS . 0.4 OUTLIER -90.63 74.87 6.69 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 122.34 1.067 . . . . 0.0 111.746 175.959 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.417 ' HE2' ' C ' ' A' ' 28' ' ' ASN . 0.0 OUTLIER 55.72 16.9 2.16 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 119.891 -1.756 . . . . 0.0 113.137 -174.036 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -99.09 13.41 32.95 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 121.421 -0.799 . . . . 0.0 112.546 -161.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.95 72.25 6.7 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 171.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -92.35 148.5 22.07 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 169.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.571 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 0.5 OUTLIER -58.65 -34.45 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 120.345 1.43 . . . . 0.0 109.617 -177.31 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -64.47 -12.14 40.73 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 120.202 -1.561 . . . . 0.0 112.949 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -110.36 -26.71 9.42 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.452 1.501 . . . . 0.0 112.074 168.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.571 ' HB3' ' HA ' ' A' ' 33' ' ' ILE . . . -68.53 -37.57 80.12 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.099 -1.001 . . . . 0.0 111.194 178.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -55.49 -47.65 75.83 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.003 0.921 . . . . 0.0 109.368 168.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 73.0 mt -70.02 -24.01 63.21 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-O 118.081 -0.961 . . . . 0.0 112.496 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.43 ' HB2' ' HA ' ' A' ' 36' ' ' ALA . 1.0 OUTLIER -55.43 -38.25 68.74 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.805 1.242 . . . . 0.0 112.151 -162.363 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -56.87 -65.3 0.64 Allowed 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 118.384 -0.817 . . . . 0.0 109.107 167.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.2 tmtt? -50.74 -47.16 59.43 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 124.199 1.0 . . . . 0.0 111.029 -175.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.406 ' CH2' HD12 ' A' ' 25' ' ' LEU . 27.1 t90 -61.67 -67.5 0.4 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.809 1.244 . . . . 0.0 109.657 176.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 54.2 t -53.79 -33.22 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 121.411 1.914 . . . . 0.0 111.867 -176.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.442 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 3.8 m-85 -60.56 -75.17 0.07 Allowed 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 124.769 1.228 . . . . 0.0 109.581 171.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -70.75 -14.15 62.33 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.886 1.675 . . . . 0.0 113.871 -169.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.88 -33.43 16.46 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 120.739 -1.226 . . . . 0.0 109.865 175.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -136.67 -60.68 0.7 Allowed 'General case' 0 C--N 1.346 0.439 0 CA-C-N 118.86 0.754 . . . . 0.0 111.921 -169.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.442 ' HB2' ' HA ' ' A' ' 44' ' ' PHE . 10.1 mt -60.19 -55.93 27.72 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.463 1.029 . . . . 0.0 112.673 -173.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -66.41 -9.62 35.6 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.595 1.158 . . . . 0.0 110.973 174.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.13 -2.77 58.67 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.656 1.982 . . . . 0.0 111.81 171.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.85 5.45 59.82 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.913 1.244 . . . . 0.0 114.204 177.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -77.48 146.72 36.28 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 119.745 1.772 . . . . 0.0 110.017 176.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -138.45 14.48 2.77 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.525 1.93 . . . . 0.0 110.027 -172.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.595 ' HB3' HG13 ' A' ' 22' ' ' VAL . 0.9 OUTLIER -149.74 116.7 5.95 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 178.116 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.7 mp -120.8 152.7 23.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 175.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.765 ' CE2' HG11 ' A' ' 22' ' ' VAL . 21.9 m-85 -124.18 158.07 33.26 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.603 1.161 . . . . 0.0 110.082 161.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 54.2 tp -118.09 122.97 44.45 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.963 1.705 . . . . 0.0 107.422 173.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . 0.252 0.7 OUTLIER -95.09 157.48 3.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 119.921 1.237 . . . . 0.0 109.927 174.349 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 24.3 mt -132.24 13.69 4.64 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.226 0.611 . . . . 0.0 111.359 -168.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.1 m -81.53 -46.48 14.43 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -173.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -88.2 -23.12 23.67 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.454 1.025 . . . . 0.0 110.7 -173.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.0 p -78.74 162.66 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 125.538 1.535 . . . . 0.0 109.776 169.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -116.99 -37.51 3.57 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.443 0.697 . . . . 0.0 110.516 170.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.87 176.07 13.04 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 122.438 1.113 . . . . 0.0 110.123 177.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.4 tt -132.6 160.0 42.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 127.361 2.264 . . . . 0.0 108.05 -172.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.453 ' C ' ' H ' ' A' ' 68' ' ' PHE . 35.6 t0 -96.24 168.79 10.37 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 119.625 -1.922 . . . . 0.0 109.79 -168.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.5 m -65.25 31.26 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 128.954 2.902 . . . . 0.0 112.052 165.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.453 ' H ' ' C ' ' A' ' 66' ' ' ASP . 43.5 t80 -132.08 -67.72 0.66 Allowed 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 172.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.28 -25.01 61.43 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.443 -166.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.48 HD11 HG21 ' A' ' 103' ' ' THR . 33.1 tp -55.3 -33.09 62.96 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 120.601 -1.312 . . . . 0.0 110.95 171.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -95.32 1.99 65.0 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 125.111 1.339 . . . . 0.0 114.709 174.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -92.63 -32.79 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 120.181 1.991 . . . . 0.0 109.544 167.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -56.69 -53.02 46.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.339 1.056 . . . . 0.0 109.13 177.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.0 t -59.33 -39.95 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 O-C-N 121.515 -0.741 . . . . 0.0 110.374 176.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -54.94 -38.68 68.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 119.207 0.912 . . . . 0.0 112.231 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 80.5 mt -69.61 -34.21 60.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -63.43 -50.33 70.22 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 119.846 1.203 . . . . 0.0 109.278 175.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -53.31 -48.13 68.67 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.056 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.4 t -58.09 -61.38 2.59 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.395 1.878 . . . . 0.0 111.264 176.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 59.7 mt -54.84 -45.87 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 119.646 1.112 . . . . 0.0 110.798 -177.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.3 t -61.88 -41.04 97.4 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.44 -23.71 65.55 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.133 0.973 . . . . 0.0 113.348 173.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.0 m -79.0 -25.4 43.32 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 118.02 -0.99 . . . . 0.0 112.388 171.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 103.67 15.78 21.69 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.5 -1.167 . . . . 0.0 113.954 -170.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -98.08 -168.28 31.86 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 120.322 2.061 . . . . 0.0 112.586 174.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -133.51 162.65 31.3 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.031 1.333 . . . . 0.0 108.501 168.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -147.88 147.1 29.39 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.298 1.039 . . . . 0.0 108.222 176.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.414 ' C ' HD23 ' A' ' 89' ' ' LEU . . . -152.21 172.64 16.08 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.089 1.356 . . . . 0.0 110.72 178.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.414 HD23 ' C ' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -116.15 171.47 7.79 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 118.588 0.631 . . . . 0.0 109.831 -178.146 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 86.1 t -146.69 144.06 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.821 1.248 . . . . 0.0 109.83 -168.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 44.09 60.07 12.22 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 127.815 2.446 . . . . 0.0 113.942 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -84.51 92.56 0.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 124.545 3.496 . . . . 0.0 110.141 -170.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.65 160.32 14.31 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 121.848 -0.532 . . . . 0.0 110.269 177.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -63.74 -34.89 78.89 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.779 0.832 . . . . 0.0 111.167 -167.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.47 ' HE2' ' O ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -59.34 -29.99 68.06 Favored 'General case' 0 CA--C 1.517 -0.321 0 O-C-N 121.006 -1.059 . . . . 0.0 109.439 178.903 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.2 t -92.57 -37.48 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-O 117.911 -1.042 . . . . 0.0 110.283 177.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -59.55 -33.31 71.25 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 121.806 2.094 . . . . 0.0 109.723 175.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.64 -27.33 67.6 Favored 'General case' 0 C--O 1.222 -0.349 0 O-C-N 121.234 -0.916 . . . . 0.0 112.463 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.621 ' O ' HG22 ' A' ' 103' ' ' THR . 7.3 p -95.39 -39.65 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -178.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.418 HD23 HG13 ' A' ' 99' ' ' VAL . 0.2 OUTLIER -59.41 -15.66 18.34 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.075 1.75 . . . . 0.0 111.955 177.649 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.0 t -93.51 -52.85 4.3 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -53.75 -44.81 70.28 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 128.472 2.709 . . . . 0.0 111.805 -177.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.621 HG22 ' O ' ' A' ' 99' ' ' VAL . 10.1 t -79.52 -17.42 54.1 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 118.843 -0.598 . . . . 0.0 111.299 -178.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.2 m120 63.67 94.21 0.05 Allowed 'General case' 0 C--N 1.34 0.153 0 C-N-CA 127.098 2.159 . . . . 0.0 108.253 -157.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.98 -57.01 1.26 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.502 1.521 . . . . 0.0 108.575 170.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -57.33 -32.56 66.83 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 122.478 1.132 . . . . 0.0 111.098 171.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 60.6 mtt180 -71.36 -1.68 13.79 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 120.499 -1.376 . . . . 0.0 111.922 178.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.7 mt -122.62 -39.06 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 125.874 1.67 . . . . 0.0 108.714 -175.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.4 t -125.7 144.77 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 124.861 1.264 . . . . 0.0 108.775 -175.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.75 160.32 28.4 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.594 0.757 . . . . 0.0 111.328 176.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.94 142.17 34.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -173.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -146.82 176.18 10.07 Favored 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 125.189 1.396 . . . . 0.0 110.98 -176.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -103.56 -43.14 5.46 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 118.365 0.53 . . . . 0.0 111.797 -175.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 30.6 p -109.22 -162.4 0.81 Allowed 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -176.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 27.1 mm -92.01 -39.89 11.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 117.371 -1.299 . . . . 0.0 111.322 160.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.0 t -68.76 -34.77 76.14 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 120.916 1.689 . . . . 0.0 111.052 -168.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -69.06 -15.73 63.52 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 118.934 0.788 . . . . 0.0 111.696 176.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.663 ' O ' HG23 ' A' ' 122' ' ' VAL . . . -91.12 -54.24 4.03 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 176.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 6.6 ttm -54.0 -39.48 66.12 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 124.84 1.256 . . . . 0.0 112.001 -163.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -93.49 -10.61 34.34 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.985 0.914 . . . . 0.0 113.392 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -92.24 -58.24 2.45 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 118.35 -0.833 . . . . 0.0 108.775 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.747 HG21 ' CE1' ' A' ' 56' ' ' PHE . 48.1 t -41.62 -44.39 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 128.456 2.702 . . . . 0.0 110.824 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . 0.251 1.5 ptp180 -53.12 -26.13 15.59 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.09 41.64 0.44 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 127.852 2.461 . . . . 0.0 111.371 -178.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.929 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 172.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 28.2 p90 . . . . . 0 C--O 1.234 0.279 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt -131.97 171.01 14.11 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.733 0.813 . . . . 0.0 110.942 174.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.3 mt -129.61 110.55 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 104.651 -2.351 . . . . 0.0 104.651 176.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.4 m -93.38 -134.93 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 119.562 1.074 . . . . 0.0 109.172 176.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -45.83 -78.72 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 127.827 2.451 . . . . 0.0 111.785 172.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -137.76 15.3 2.9 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.281 1.832 . . . . 0.0 109.678 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.681 HG11 ' CE2' ' A' ' 56' ' ' PHE . 11.9 t -121.6 133.55 67.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -168.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 74.6 t -92.22 131.22 39.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.416 HG13 HD12 ' A' ' 115' ' ' ILE . 1.9 mp -112.48 103.63 15.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 176.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.7 137.35 45.92 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 161.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 13.8 mtt -139.96 79.98 21.62 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.57 -98.81 0.01 OUTLIER 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 121.452 1.435 . . . . 0.0 111.508 -170.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.474 ' ND2' ' H ' ' A' ' 29' ' ' LYS . 18.8 p-10 155.82 -106.18 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 O-C-N 119.38 -2.075 . . . . 0.0 107.688 -163.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.474 ' H ' ' ND2' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -126.94 25.68 6.25 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.205 1.802 . . . . 0.0 108.888 167.25 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -63.19 -16.99 61.9 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.869 1.268 . . . . 0.0 111.711 170.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.6 mp -74.09 67.96 1.37 Allowed 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 169.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -124.59 7.44 8.24 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.775 2.03 . . . . 0.0 113.312 -175.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 94.87 -24.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.563 1 C-N-CA 135.457 5.503 . . . . 0.0 110.113 -176.438 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -71.94 -18.69 61.99 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 120.871 -1.143 . . . . 0.0 111.778 -175.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -98.98 -31.21 11.92 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 173.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.15 -41.74 94.46 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 113.647 0.981 . . . . 0.0 113.647 -159.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -64.3 -43.79 93.66 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.981 1.264 . . . . 0.0 110.146 -177.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.01 -22.33 49.46 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.593 -178.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -41.86 -54.27 3.47 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 127.585 2.354 . . . . 0.0 111.972 -171.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.2 pttt -68.99 -41.22 78.14 Favored 'General case' 0 C--O 1.217 -0.609 0 CA-C-O 118.15 -0.929 . . . . 0.0 111.273 -178.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.72 -44.04 90.3 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 120.31 1.414 . . . . 0.0 110.939 178.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 7.1 t90 -58.13 -66.14 0.53 Allowed 'General case' 0 C--O 1.223 -0.341 0 CA-C-O 117.364 -1.303 . . . . 0.0 108.515 171.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 51.3 t -49.44 -38.28 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 120.049 1.295 . . . . 0.0 112.282 -176.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -60.73 -62.68 1.69 Allowed 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 125.106 1.362 . . . . 0.0 109.294 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -70.61 -44.16 67.83 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 118.852 0.751 . . . . 0.0 111.218 -174.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -61.07 -33.95 74.14 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.914 1.285 . . . . 0.0 110.523 -174.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -136.41 -52.56 0.72 Allowed 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -171.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 39.3 mt -63.46 -37.93 89.18 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.207 0.912 . . . . 0.0 111.075 -173.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -84.67 -9.39 58.3 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.158 1.383 . . . . 0.0 110.549 176.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.3 mttt -82.38 3.83 26.41 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.614 1.566 . . . . 0.0 111.148 156.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.95 4.33 88.52 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 125.374 1.464 . . . . 0.0 114.344 176.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -68.89 112.23 5.43 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 119.541 1.671 . . . . 0.0 109.303 176.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 -107.63 16.65 23.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.889 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.494 ' HB3' HG13 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -132.48 126.05 32.09 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 121.106 -0.996 . . . . 0.0 108.743 164.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.434 HD12 HD11 ' A' ' 80' ' ' ILE . 5.8 mt -128.44 160.19 38.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 126.303 1.841 . . . . 0.0 106.64 172.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.681 ' CE2' HG11 ' A' ' 22' ' ' VAL . 24.3 m-85 -132.42 159.22 39.92 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.016 1.326 . . . . 0.0 111.351 161.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 56.2 tp -127.86 87.19 2.57 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.227 0.611 . . . . 0.0 109.418 171.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.576 HG12 ' H ' ' A' ' 60' ' ' SER . 91.2 t -52.1 151.8 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 126.163 1.785 . . . . 0.0 108.326 167.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.6 mt -135.68 18.68 3.3 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.619 1.968 . . . . 0.0 110.292 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.576 ' H ' HG12 ' A' ' 58' ' ' VAL . 67.3 m -54.1 -54.11 43.95 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 125.071 1.348 . . . . 0.0 111.281 -169.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.41 ' O ' ' HE2' ' A' ' 29' ' ' LYS . 7.0 t0 -97.41 9.61 41.89 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 123.338 0.655 . . . . 0.0 111.339 175.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 17.6 t -98.62 100.56 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 104.312 -2.477 . . . . 0.0 104.312 -176.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -57.82 -49.87 75.19 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.6 t -152.88 164.42 37.92 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 123.1 1.429 . . . . 0.0 112.861 -175.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.4 tt -95.06 -162.77 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 126.877 2.071 . . . . 0.0 106.838 161.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -143.21 166.67 24.06 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.244 1.417 . . . . 0.0 109.737 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.6 t -53.03 -32.73 48.32 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.14 1.776 . . . . 0.0 112.171 176.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -66.14 -60.12 3.11 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 119.376 0.989 . . . . 0.0 109.697 173.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.05 -19.37 47.75 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -163.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 18.7 mt -55.21 -32.66 62.43 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.405 -0.809 . . . . 0.0 110.766 169.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -69.35 -44.23 66.26 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-O 118.832 -0.982 . . . . 0.0 111.474 170.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.57 -32.88 51.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 119.213 1.506 . . . . 0.0 110.759 -169.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -58.51 -53.18 50.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 125.069 1.348 . . . . 0.0 109.391 175.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 38.2 t -60.98 -38.76 80.16 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.618 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 173.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.1 -38.02 81.72 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 120.278 -1.514 . . . . 0.0 112.073 -176.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 70.6 mt -67.43 -36.19 75.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.288 1.035 . . . . 0.0 110.073 172.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.478 HD22 HG22 ' A' ' 109' ' ' VAL . 20.0 tp -60.81 -50.5 73.2 Favored 'General case' 0 C--O 1.219 -0.544 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 175.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 44.2 mttt -62.35 4.48 0.14 Allowed 'General case' 0 C--O 1.234 0.257 0 C-N-CA 126.409 1.884 . . . . 0.0 114.316 178.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.5 t -103.99 -58.8 1.82 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 167.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.434 HD11 HD12 ' A' ' 55' ' ' ILE . 78.3 mt -55.59 -35.82 39.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 125.305 1.442 . . . . 0.0 111.319 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.2 p -53.88 -58.35 7.59 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 126.048 1.739 . . . . 0.0 108.688 -177.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.7 t -61.93 -39.86 93.53 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 127.968 2.507 . . . . 0.0 110.899 -178.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.1 -23.47 67.16 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 175.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.29 17.58 49.63 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-O 118.637 -1.091 . . . . 0.0 112.933 -174.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -89.8 -173.78 45.49 Favored Glycine 0 N--CA 1.438 -1.195 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 172.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.432 ' HB3' HG22 ' A' ' 122' ' ' VAL . 2.5 m-85 -131.75 148.98 52.61 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 125.547 1.539 . . . . 0.0 109.539 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -143.96 149.96 37.58 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.27 1.028 . . . . 0.0 108.425 176.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.555 ' C ' HD23 ' A' ' 89' ' ' LEU . . . -154.18 168.4 26.67 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.972 0.909 . . . . 0.0 111.77 177.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.555 HD23 ' C ' ' A' ' 88' ' ' ALA . 1.5 mt -113.47 171.74 7.38 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 177.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.508 HG13 ' N ' ' A' ' 58' ' ' VAL . 0.5 OUTLIER -152.43 146.65 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 C-N-CA 123.898 0.879 . . . . 0.0 110.227 -166.327 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.7 t 43.92 54.11 11.1 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 126.122 1.769 . . . . 0.0 110.264 177.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.439 ' O ' HG22 ' A' ' 96' ' ' VAL . 25.3 Cg_endo -61.89 -30.96 84.63 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.976 2.451 . . . . 0.0 112.335 -169.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 63.14 165.58 0.12 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 123.962 1.839 . . . . 0.0 110.755 -161.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -54.36 -33.98 60.2 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 112.343 -2.208 . . . . 0.0 110.666 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.63 -41.58 21.26 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 124.439 1.096 . . . . 0.0 112.067 -158.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 92' ' ' PRO . 18.9 m -75.06 -44.33 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.732 0 CA-C-O 118.085 -0.96 . . . . 0.0 110.483 171.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.87 -29.76 63.24 Favored 'General case' 0 N--CA 1.461 0.09 0 C-N-CA 124.334 1.054 . . . . 0.0 108.79 -170.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.34 -62.74 1.14 Allowed 'General case' 0 N--CA 1.428 -1.555 0 C-N-CA 126.153 1.781 . . . . 0.0 112.342 168.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.7 t -72.66 -39.89 61.27 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 CA-C-N 112.365 -2.198 . . . . 0.0 108.295 -173.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.413 ' HB3' ' H ' ' A' ' 106' ' ' ASP . 0.7 OUTLIER -58.67 -17.51 23.11 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.755 1.222 . . . . 0.0 109.236 177.391 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.5 -1.89 43.11 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-O 121.607 0.718 . . . . 0.0 112.467 179.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.8 mt -119.45 -42.78 2.63 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 127.187 2.195 . . . . 0.0 109.854 -174.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.1 t -87.23 0.16 55.78 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.978 2.511 . . . . 0.0 111.341 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 42.94 84.35 0.02 OUTLIER 'General case' 0 C--N 1.344 0.351 0 C-N-CA 126.949 2.1 . . . . 0.0 111.808 -168.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.73 -64.41 1.32 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.937 1.295 . . . . 0.0 108.704 170.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.413 ' H ' ' HB3' ' A' ' 100' ' ' LEU . 3.3 t70 -58.9 -29.03 66.75 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.537 0.735 . . . . 0.0 110.483 172.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 26.3 mtp180 -69.12 1.31 3.7 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.903 -1.123 . . . . 0.0 112.147 176.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.8 mt -130.35 -38.77 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 126.696 1.999 . . . . 0.0 109.663 -176.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.478 HG22 HD22 ' A' ' 77' ' ' LEU . 2.2 t -122.09 153.14 26.33 Favored 'Isoleucine or valine' 0 C--N 1.342 0.242 0 C-N-CA 125.299 1.44 . . . . 0.0 110.149 -169.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.43 155.49 35.3 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.236 1.014 . . . . 0.0 112.511 173.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -147.22 147.78 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 126.43 1.892 . . . . 0.0 107.478 -178.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -144.14 169.89 17.0 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.195 1.398 . . . . 0.0 111.571 -175.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -86.65 -37.7 17.77 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 175.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.3 p -137.3 175.91 9.19 Favored 'General case' 0 C--N 1.334 -0.079 0 C-N-CA 124.168 0.987 . . . . 0.0 111.145 -168.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.472 HD11 ' CG2' ' A' ' 58' ' ' VAL . 10.7 mm -72.74 -40.08 60.81 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 CA-C-O 118.479 -0.772 . . . . 0.0 109.918 176.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.3 t -73.2 -32.33 64.73 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 119.294 0.952 . . . . 0.0 109.965 -171.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -66.65 -10.08 42.47 Favored 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 123.436 0.694 . . . . 0.0 112.036 170.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -102.91 -47.62 4.32 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 -178.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -58.08 -54.39 47.47 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 126.565 1.946 . . . . 0.0 113.676 -160.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -87.47 -12.34 46.3 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.01 1.724 . . . . 0.0 111.25 179.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -91.78 -53.3 4.35 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 124.596 1.158 . . . . 0.0 107.941 -166.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.432 HG22 ' HB3' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -55.06 -23.73 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 128.649 2.78 . . . . 0.0 112.785 176.126 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 78.8 mtt180 -59.66 -28.48 67.29 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 118.46 -0.781 . . . . 0.0 111.718 169.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.34 26.22 3.81 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 126.5 1.92 . . . . 0.0 115.009 -176.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.6 mmtm . . . . . 0 C--O 1.249 1.069 0 C-N-CA 126.236 1.814 . . . . 0.0 106.724 -176.901 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 7.6 p90 . . . . . 0 C--O 1.234 0.288 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -141.85 175.96 9.31 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.437 1.495 . . . . 0.0 108.503 156.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.2 mt -127.77 138.22 55.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 167.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.0 m -114.08 -156.74 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 C-N-CA 126.356 1.862 . . . . 0.0 107.727 168.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -42.21 -63.02 0.81 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 120.978 1.717 . . . . 0.0 114.641 -162.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -133.82 19.23 3.84 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.689 1.596 . . . . 0.0 110.973 170.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.694 HG11 ' CE2' ' A' ' 56' ' ' PHE . 4.2 t -132.59 119.07 37.14 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 123.137 1.446 . . . . 0.0 109.924 -168.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.526 ' O ' HD13 ' A' ' 24' ' ' ILE . 0.6 OUTLIER -67.06 150.3 11.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 127.425 2.29 . . . . 0.0 112.383 169.156 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.673 HD12 HD12 ' A' ' 115' ' ' ILE . 4.4 mm -135.68 96.38 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 174.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.495 HD23 HG23 ' A' ' 55' ' ' ILE . 4.3 mm? -59.99 132.24 53.32 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 164.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 24.8 mmm -127.79 81.32 70.5 Favored Pre-proline 0 C--O 1.234 0.245 0 C-N-CA 126.111 1.764 . . . . 0.0 106.91 178.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -61.69 143.8 96.76 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 122.267 1.978 . . . . 0.0 109.053 170.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.02 -83.11 0.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 179.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.74 1.53 14.18 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.286 1.034 . . . . 0.0 112.035 172.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -67.62 -34.78 77.66 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -171.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 31' ' ' LEU . 1.6 tp -73.22 -81.28 0.06 Allowed 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -153.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 34.24 41.38 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 130.062 3.345 . . . . 0.0 114.361 154.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER 61.31 -31.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 130.54 3.536 . . . . 0.0 115.416 -170.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -54.12 -34.65 60.82 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.505 1.122 . . . . 0.0 112.332 -175.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -122.4 60.37 1.0 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -173.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.45 -65.87 1.14 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 118.769 -0.634 . . . . 0.0 111.512 -177.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -60.32 -28.38 68.09 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.073 1.306 . . . . 0.0 111.887 173.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.71 ' H ' HD22 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -78.95 -31.15 44.97 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 117.65 -1.167 . . . . 0.0 110.206 176.969 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -45.37 -52.66 9.65 Favored 'General case' 0 CA--C 1.508 -0.649 0 O-C-N 124.362 1.039 . . . . 0.0 110.033 178.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.39 -45.98 90.7 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 117.544 -1.217 . . . . 0.0 110.027 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -61.4 -46.95 88.02 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 119.94 1.245 . . . . 0.0 111.38 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.452 ' CH2' ' CD1' ' A' ' 25' ' ' LEU . 15.7 t90 -62.86 -60.79 3.0 Favored 'General case' 0 C--O 1.215 -0.715 0 CA-C-O 117.436 -1.269 . . . . 0.0 108.796 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.7 t -54.16 -30.0 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 CA-C-N 121.468 1.94 . . . . 0.0 111.706 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -66.61 -65.49 0.67 Allowed 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 120.723 -1.236 . . . . 0.0 110.481 170.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -66.63 -37.4 84.77 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.353 1.461 . . . . 0.0 111.781 -171.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -73.14 -31.86 64.54 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 127.941 2.496 . . . . 0.0 111.996 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -129.38 -58.1 1.13 Allowed 'General case' 0 C--N 1.343 0.322 0 CA-C-N 119.596 1.089 . . . . 0.0 111.605 -171.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.0 mt -64.97 -31.54 72.83 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 121.674 -0.641 . . . . 0.0 111.986 -175.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -80.44 -19.44 46.1 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 118.405 -0.807 . . . . 0.0 111.031 176.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.06 -5.22 55.47 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 127.073 2.149 . . . . 0.0 114.128 167.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.03 6.26 79.37 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-O 118.68 -1.067 . . . . 0.0 114.38 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -66.02 143.18 57.52 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 119.29 1.545 . . . . 0.0 109.861 175.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.56 22.99 3.16 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.579 1.551 . . . . 0.0 109.059 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.448 ' HB3' HG13 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -151.84 98.82 2.51 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 174.121 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.495 HG23 HD23 ' A' ' 25' ' ' LEU . 1.3 mp -96.25 152.64 3.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 172.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.695 ' CE1' HG21 ' A' ' 122' ' ' VAL . 12.0 m-30 -125.68 164.35 20.8 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.704 -0.798 . . . . 0.0 112.524 162.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 21.9 tp -129.11 129.1 44.77 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 124.174 0.989 . . . . 0.0 109.364 167.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.8 t -99.91 139.99 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 167.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.49 HD22 HG11 ' A' ' 96' ' ' VAL . 3.8 mp -120.64 54.04 1.08 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.437 1.017 . . . . 0.0 110.122 178.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 26.0 t -109.16 -47.32 3.44 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.879 1.272 . . . . 0.0 110.77 -168.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -72.84 -49.93 27.2 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 1.8 p -68.95 141.58 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 124.581 1.153 . . . . 0.0 109.111 171.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -79.0 -36.81 40.62 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 119.153 -0.451 . . . . 0.0 110.009 167.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.579 ' CB ' ' HE2' ' A' ' 95' ' ' LYS . 10.7 t -165.36 159.73 17.43 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 122.706 1.241 . . . . 0.0 113.168 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.543 HG22 HG21 ' A' ' 96' ' ' VAL . 14.0 tt -79.57 169.94 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 C-N-CA 128.257 2.623 . . . . 0.0 109.219 166.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.0 164.14 12.68 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.124 1.37 . . . . 0.0 109.809 177.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.45 ' HA ' HD12 ' A' ' 70' ' ' LEU . 95.2 p -63.24 -24.22 67.78 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -175.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -60.56 -72.01 0.12 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.799 0.84 . . . . 0.0 108.858 171.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.0 t -70.76 -15.18 62.66 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -173.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 67' ' ' SER . 2.7 mt -46.27 -37.49 7.36 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.699 1.136 . . . . 0.0 110.844 169.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.61 -22.18 51.32 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 123.136 0.398 . . . . 0.0 113.971 -178.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 52.9 t -79.12 -35.45 17.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.515 1.126 . . . . 0.0 109.181 177.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 16.7 mm -56.53 -47.45 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 123.499 0.72 . . . . 0.0 110.667 174.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.9 t -62.43 -40.44 88.06 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.266 0 O-C-N 121.558 -0.714 . . . . 0.0 109.739 176.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -52.02 -46.85 65.13 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.466 1.03 . . . . 0.0 112.309 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.3 mt -56.65 -41.32 73.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.374 1.47 . . . . 0.0 110.097 175.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -66.67 -46.87 74.26 Favored 'General case' 0 CA--C 1.52 -0.209 0 O-C-N 121.494 -0.754 . . . . 0.0 109.621 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -55.72 -50.86 69.2 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 118.757 -0.64 . . . . 0.0 110.472 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 33.1 t -53.14 -52.05 59.97 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 124.845 1.34 . . . . 0.0 109.214 178.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 21.6 mt -63.29 -46.9 94.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 C-N-CA 123.467 0.707 . . . . 0.0 110.69 -174.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -51.45 -55.36 19.23 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.798 0.839 . . . . 0.0 110.461 171.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.6 m -65.3 -17.48 64.54 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.227 1.011 . . . . 0.0 113.504 -178.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.5 m -83.84 -47.26 11.28 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.789 0.836 . . . . 0.0 110.915 178.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 133.32 -1.0 4.42 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 118.295 -1.28 . . . . 0.0 113.75 -166.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -101.73 -169.41 27.56 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-N 120.208 2.004 . . . . 0.0 112.509 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.593 ' CZ ' ' HE2' ' A' ' 125' ' ' LYS . 0.1 OUTLIER -135.41 165.71 24.85 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 126.869 2.068 . . . . 0.0 110.8 171.615 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -155.25 141.76 18.75 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 177.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.79 168.6 23.93 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.268 0.627 . . . . 0.0 112.186 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 mt -116.16 164.17 14.88 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.502 1.121 . . . . 0.0 109.438 -171.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.703 HG21 HD13 ' A' ' 115' ' ' ILE . 79.6 t -146.13 154.87 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 126.049 1.74 . . . . 0.0 109.998 -169.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 t 46.93 58.4 17.07 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 127.772 2.429 . . . . 0.0 112.15 173.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -76.73 97.31 1.13 Allowed 'Trans proline' 0 N--CA 1.445 -1.363 0 C-N-CA 122.148 1.898 . . . . 0.0 111.23 -177.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.43 158.73 5.4 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 119.251 -0.98 . . . . 0.0 109.723 162.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -69.65 -29.45 66.92 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.339 1.056 . . . . 0.0 111.834 -167.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.579 ' HE2' ' CB ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -56.99 -51.93 67.29 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -173.177 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.543 HG21 HG22 ' A' ' 65' ' ' ILE . 0.5 OUTLIER -78.76 -41.03 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 124.057 0.848 . . . . 0.0 110.286 -173.515 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.97 -33.65 18.45 Favored 'General case' 0 CA--C 1.503 -0.827 0 C-N-CA 124.456 1.103 . . . . 0.0 110.836 175.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -53.98 47.13 Favored 'General case' 0 N--CA 1.417 -2.121 0 CA-C-O 123.368 1.556 . . . . 0.0 113.107 178.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.53 ' O ' HG22 ' A' ' 103' ' ' THR . 15.0 t -69.69 -43.52 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.832 0 CA-C-N 111.346 -2.661 . . . . 0.0 106.58 -172.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.412 HD21 HG22 ' A' ' 96' ' ' VAL . 0.4 OUTLIER -55.36 -28.87 56.76 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.933 1.293 . . . . 0.0 108.755 175.264 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.7 m -92.01 4.09 53.81 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.374 1.47 . . . . 0.0 112.729 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 94.1 mt -125.06 -20.76 4.83 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 127.752 2.421 . . . . 0.0 111.769 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.53 HG22 ' O ' ' A' ' 99' ' ' VAL . 7.2 t -111.69 2.24 17.12 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.751 1.62 . . . . 0.0 112.029 -174.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 54.17 87.73 0.04 OUTLIER 'General case' 0 C--N 1.342 0.247 0 C-N-CA 126.541 1.936 . . . . 0.0 109.887 -172.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.73 -57.2 1.45 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 118.544 -0.741 . . . . 0.0 109.702 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.85 -35.29 44.18 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 123.302 1.525 . . . . 0.0 110.585 164.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -72.05 -1.68 15.62 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 120.834 -1.167 . . . . 0.0 111.832 -177.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.7 mt -126.46 -38.63 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 126.34 1.856 . . . . 0.0 109.628 -175.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.2 t -118.21 145.68 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 125.696 1.598 . . . . 0.0 109.332 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -68.14 154.38 41.81 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 123.384 0.673 . . . . 0.0 110.199 174.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -141.98 149.35 19.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -173.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -147.65 165.69 29.67 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.122 1.369 . . . . 0.0 109.434 -172.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -84.66 -46.69 11.24 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 45.3 p -119.35 170.37 9.18 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.232 1.413 . . . . 0.0 108.638 -174.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.703 HD13 HG21 ' A' ' 90' ' ' VAL . 8.9 mm -66.95 -42.02 88.24 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.81 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 167.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 48.2 t -67.98 -37.7 81.81 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.787 1.176 . . . . 0.0 110.712 -165.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -63.51 -28.02 69.66 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 118.184 0.447 . . . . 0.0 110.259 176.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.646 ' O ' HG23 ' A' ' 122' ' ' VAL . . . -80.69 -54.99 5.14 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -54.89 -29.06 54.88 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 126.213 1.805 . . . . 0.0 112.721 -163.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.63 -23.32 14.28 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 126.5 1.92 . . . . 0.0 111.712 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -81.96 -53.73 5.9 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 120.114 1.325 . . . . 0.0 111.887 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.695 HG21 ' CE1' ' A' ' 56' ' ' PHE . 51.4 t -44.05 -39.91 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 129.293 3.037 . . . . 0.0 110.099 -178.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -49.83 -23.26 1.79 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 127.414 2.286 . . . . 0.0 114.265 174.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.69 37.09 0.19 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.306 2.242 . . . . 0.0 113.274 177.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.593 ' HE2' ' CZ ' ' A' ' 86' ' ' PHE . 0.6 OUTLIER . . . . . 0 C--O 1.248 0.99 0 O-C-N 121.436 -0.79 . . . . 0.0 109.514 -174.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 37.4 p90 . . . . . 0 CA--C 1.538 0.508 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.437 ' HE2' ' CG1' ' A' ' 19' ' ' VAL . 0.7 OUTLIER -143.48 164.74 29.49 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.97 2.108 . . . . 0.0 106.823 173.689 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.2 mt -130.36 118.57 43.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 174.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.437 ' CG1' ' HE2' ' A' ' 17' ' ' LYS . 6.4 m -93.34 -162.02 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 125.677 1.591 . . . . 0.0 108.001 168.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -24.6 -70.85 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 129.651 3.181 . . . . 0.0 111.771 171.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -149.96 21.86 0.88 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.734 0.814 . . . . 0.0 110.835 -177.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.616 HG11 ' CE2' ' A' ' 56' ' ' PHE . 20.4 t -127.19 156.62 38.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 95.8 t -116.13 128.52 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mp -101.55 104.95 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 46.8 mt -88.97 128.84 35.71 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 103.551 -2.759 . . . . 0.0 103.551 175.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 30.2 mtm -123.48 95.48 45.1 Favored Pre-proline 0 N--CA 1.465 0.302 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -176.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -69.07 161.44 45.81 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.251 1.967 . . . . 0.0 111.088 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.717 HD22 ' H ' ' A' ' 29' ' ' LYS . 0.5 OUTLIER -151.92 -71.48 0.16 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 121.232 0.539 . . . . 0.0 111.964 -173.003 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.717 ' H ' HD22 ' A' ' 28' ' ' ASN . 0.0 OUTLIER -147.47 6.06 0.83 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.53 1.932 . . . . 0.0 112.132 -176.238 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -79.58 -2.61 43.21 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 128.333 2.653 . . . . 0.0 112.746 177.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.6 mt -101.56 95.23 6.32 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -166.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -164.72 30.76 0.07 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.886 0.874 . . . . 0.0 112.386 -161.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER 73.7 -46.94 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 127.968 2.507 . . . . 0.0 112.287 175.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -68.85 -5.26 19.94 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 126.353 1.861 . . . . 0.0 113.189 -173.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -127.25 0.98 6.41 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 127.345 2.258 . . . . 0.0 109.127 177.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.14 -57.75 3.62 Favored 'General case' 0 C--O 1.224 -0.241 0 O-C-N 120.229 -1.545 . . . . 0.0 110.868 -173.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -65.05 -24.63 67.52 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 120.831 -1.168 . . . . 0.0 110.98 -178.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.447 ' H ' HD22 ' A' ' 38' ' ' LEU . 1.7 mm? -81.54 -33.25 31.85 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 126.219 1.807 . . . . 0.0 110.863 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -42.4 -53.28 4.3 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 126.711 2.004 . . . . 0.0 111.285 176.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.39 -43.26 99.25 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.482 -178.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.13 -49.39 77.14 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.103 0.865 . . . . 0.0 110.639 174.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -58.01 -64.26 0.97 Allowed 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 118.099 -0.953 . . . . 0.0 110.014 177.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 68.8 t -49.56 -37.95 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 120.018 1.281 . . . . 0.0 112.062 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.591 ' CD1' HD12 ' A' ' 48' ' ' LEU . 3.2 m-85 -61.12 -62.21 2.01 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.604 0.762 . . . . 0.0 110.329 175.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.11 -16.66 59.85 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 125.018 1.327 . . . . 0.0 112.867 -170.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -93.62 -31.4 14.51 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.778 1.231 . . . . 0.0 111.732 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -132.01 -54.26 0.98 Allowed 'General case' 0 C--N 1.346 0.42 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -172.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.591 HD12 ' CD1' ' A' ' 44' ' ' PHE . 30.7 mt -60.39 -50.95 71.54 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 118.654 0.661 . . . . 0.0 112.291 -171.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -61.28 -39.43 90.38 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.241 0.616 . . . . 0.0 109.944 177.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -60.09 -1.91 0.37 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 128.318 2.647 . . . . 0.0 114.797 172.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.49 2.75 75.93 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-O 118.304 -1.276 . . . . 0.0 113.02 176.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -72.48 119.09 16.21 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 120.024 1.912 . . . . 0.0 108.791 175.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -114.08 19.2 16.65 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.618 1.167 . . . . 0.0 109.309 -177.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.412 ' HB3' HG13 ' A' ' 22' ' ' VAL . 2.5 mtmt -146.4 130.01 16.96 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.328 1.851 . . . . 0.0 107.353 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.694 HD13 HD11 ' A' ' 80' ' ' ILE . 1.2 mp -138.6 154.26 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 128.062 2.545 . . . . 0.0 105.612 177.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.787 ' CE1' HG21 ' A' ' 122' ' ' VAL . 21.2 m-85 -130.37 156.6 44.44 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 124.633 1.173 . . . . 0.0 113.366 166.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 26.8 tp -121.69 75.83 1.22 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.907 1.283 . . . . 0.0 110.885 177.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.443 ' CG2' HD11 ' A' ' 115' ' ' ILE . 96.1 t -64.56 118.35 6.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 127.791 2.436 . . . . 0.0 107.023 173.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.7 mt -95.85 5.14 52.02 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.563 0.745 . . . . 0.0 110.643 -176.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.3 m -56.73 -23.61 43.72 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 177.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.46 -7.19 56.98 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.516 1.053 . . . . 0.0 111.272 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 p -134.17 157.23 41.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.902 1.681 . . . . 0.0 110.605 -168.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -85.72 -44.6 12.4 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.236 -0.915 . . . . 0.0 108.682 167.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 m -160.29 161.66 33.4 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 123.345 1.545 . . . . 0.0 113.703 -179.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.2 tt -72.47 174.28 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 111.808 -2.451 . . . . 0.0 107.796 163.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -117.88 -144.94 0.38 Allowed 'General case' 0 C--N 1.327 -0.382 0 O-C-N 120.952 -1.093 . . . . 0.0 109.646 -160.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.6 t -50.62 -147.99 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.798 1 C-N-CA 132.111 4.165 . . . . 0.0 112.388 157.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -25.04 -39.91 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.158 1 C-N-CA 132.022 4.129 . . . . 0.0 116.421 177.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.2 t -55.07 -31.55 61.24 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.659 0.784 . . . . 0.0 111.778 -178.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.8 tp -57.49 -18.88 21.06 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.402 1.081 . . . . 0.0 112.73 173.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -98.48 -24.7 10.79 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.559 1.552 . . . . 0.0 113.204 170.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 90.1 t -65.92 -40.86 88.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 119.185 1.493 . . . . 0.0 109.551 173.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.4 mp -51.45 -48.59 34.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.552 1.141 . . . . 0.0 109.628 174.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.8 t -64.92 -46.27 92.26 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.635 0 CA-C-O 117.224 -1.37 . . . . 0.0 109.658 175.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -49.07 -51.29 32.25 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 122.469 2.395 . . . . 0.0 111.814 177.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 77.9 mt -57.85 -37.2 58.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 124.913 1.285 . . . . 0.0 110.143 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.545 HD22 HG22 ' A' ' 109' ' ' VAL . 25.7 tp -63.59 -53.6 49.09 Favored 'General case' 0 CA--C 1.52 -0.201 0 O-C-N 121.012 -1.055 . . . . 0.0 109.265 176.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -57.68 -22.82 48.24 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.388 0.675 . . . . 0.0 110.142 -177.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 67.5 m -81.43 -48.24 12.16 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.44 1.096 . . . . 0.0 111.326 177.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.694 HD11 HD13 ' A' ' 55' ' ' ILE . 21.8 mt -58.61 -43.97 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 119.983 1.265 . . . . 0.0 109.782 172.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.4 t -65.65 -10.87 39.82 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.637 1.575 . . . . 0.0 112.296 175.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.7 t -96.46 -43.21 7.73 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 120.32 1.418 . . . . 0.0 109.552 171.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.6 m -66.91 -28.01 67.96 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -178.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 110.02 38.85 1.63 Allowed Glycine 0 C--N 1.337 0.613 0 CA-C-O 118.702 -1.054 . . . . 0.0 113.428 -174.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -134.77 -175.64 13.97 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 119.93 1.865 . . . . 0.0 111.644 -177.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -127.31 154.13 45.3 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.874 1.67 . . . . 0.0 109.858 179.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -150.41 139.38 20.98 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -145.99 170.38 16.75 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 120.831 0.348 . . . . 0.0 111.477 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.21 167.34 10.63 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -177.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.431 HG13 ' N ' ' A' ' 58' ' ' VAL . 0.5 OUTLIER -148.86 150.06 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 C-N-CA 123.863 0.865 . . . . 0.0 111.541 -170.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 44.2 54.77 12.26 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 126.51 1.924 . . . . 0.0 112.064 171.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.05 167.25 26.62 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.76 2.307 . . . . 0.0 109.714 -178.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -123.06 169.57 11.06 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 173.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -66.69 -34.74 78.52 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 123.686 0.795 . . . . 0.0 110.127 -168.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.433 ' HE3' ' O ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -61.99 -35.94 80.0 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.337 1.455 . . . . 0.0 110.953 177.14 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -81.36 -46.03 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -176.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -57.43 -31.18 65.63 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 125.958 1.703 . . . . 0.0 110.466 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.95 -21.54 66.43 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -175.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.6 t -104.85 -42.55 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.043 0 C-N-CA 125.72 1.608 . . . . 0.0 107.164 -174.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.08 -17.23 24.18 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 116.715 -1.612 . . . . 0.0 108.868 -177.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.8 t -87.18 -50.64 6.48 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 117.62 -1.632 . . . . 0.0 108.569 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.84 -52.78 64.05 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 129.148 2.979 . . . . 0.0 111.047 -172.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -77.07 2.99 13.45 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.157 1.383 . . . . 0.0 110.891 -178.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.6 m120 47.15 75.85 0.12 Allowed 'General case' 0 C--N 1.342 0.249 0 C-N-CA 129.563 3.145 . . . . 0.0 109.816 -171.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.74 -59.86 1.9 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.295 1.438 . . . . 0.0 107.517 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.1 -26.76 67.88 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.776 0.83 . . . . 0.0 111.348 174.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.4 mtp-105 -74.99 -2.2 26.12 Favored 'General case' 0 C--N 1.339 0.112 0 O-C-N 121.751 -0.593 . . . . 0.0 111.75 -178.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.3 mt -128.0 -46.68 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 125.912 1.685 . . . . 0.0 107.272 -171.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.545 HG22 HD22 ' A' ' 77' ' ' LEU . 1.6 t -104.39 148.94 8.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-O 121.898 0.856 . . . . 0.0 109.917 -175.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.07 155.71 39.91 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 123.85 0.86 . . . . 0.0 111.852 173.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -146.42 146.59 18.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -174.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -141.47 163.75 32.1 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.917 0.887 . . . . 0.0 111.178 -171.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.5 -55.01 4.74 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 64.7 p -113.86 175.64 5.38 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.815 0.817 . . . . 0.0 111.048 -177.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.501 HD13 ' HA ' ' A' ' 115' ' ' ILE . 3.4 mm -61.74 -45.87 97.74 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 164.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.2 t -69.34 -33.14 72.66 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 118.774 -0.631 . . . . 0.0 109.855 -164.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -68.85 -24.04 64.3 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.785 0.834 . . . . 0.0 111.155 175.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.678 ' O ' HG23 ' A' ' 122' ' ' VAL . . . -82.74 -52.59 6.63 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 178.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 6.3 tmm? -55.89 -40.1 72.53 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 125.298 1.439 . . . . 0.0 113.502 -157.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -89.39 -21.38 23.09 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 117.935 -1.031 . . . . 0.0 113.151 175.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.431 ' HG2' ' HE2' ' A' ' 125' ' ' LYS . 1.7 tt0 -84.27 -55.64 4.07 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-N 119.046 0.839 . . . . 0.0 109.76 -172.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.787 HG21 ' CE1' ' A' ' 56' ' ' PHE . 41.2 t -42.61 -44.19 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 C-N-CA 127.96 2.504 . . . . 0.0 110.586 178.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 17.9 mtm180 -48.11 -40.93 25.01 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 124.057 0.848 . . . . 0.0 111.083 178.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . 0.321 0.0 OUTLIER -117.83 43.48 2.39 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 125.628 1.571 . . . . 0.0 113.879 176.085 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.431 ' HE2' ' HG2' ' A' ' 121' ' ' GLU . 5.4 mmmt . . . . . 0 C--O 1.251 1.153 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 164.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 11.4 p90 . . . . . 0 N--CA 1.45 -0.474 0 CA-C-O 121.368 0.604 . . . . 0.0 109.649 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.4 173.1 12.1 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.487 2.315 . . . . 0.0 110.031 176.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.3 mt -137.8 135.31 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 127.93 2.492 . . . . 0.0 107.789 166.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.413 HG13 HD13 ' A' ' 24' ' ' ILE . 27.2 m -101.1 -139.36 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 127.085 2.154 . . . . 0.0 108.638 173.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -41.92 -71.19 0.09 Allowed 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 129.227 3.011 . . . . 0.0 110.524 177.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -147.88 20.94 1.13 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.602 1.961 . . . . 0.0 108.222 -173.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.703 HG11 ' CE2' ' A' ' 56' ' ' PHE . 15.3 t -131.51 147.65 32.68 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 C-N-CA 124.437 1.095 . . . . 0.0 108.109 -172.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.473 HG11 ' CZ ' ' A' ' 47' ' ' PHE . 33.7 t -103.84 151.13 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.413 HD13 HG13 ' A' ' 19' ' ' VAL . 5.1 mp -129.89 94.71 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 124.871 1.269 . . . . 0.0 108.426 176.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.675 HD22 HG23 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -65.5 105.51 1.2 Allowed 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 129.677 3.191 . . . . 0.0 109.06 170.036 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.548 ' HA ' HG22 ' A' ' 58' ' ' VAL . 50.8 mtp -113.98 73.68 2.46 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 125.663 1.585 . . . . 0.0 107.943 -172.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -69.75 177.34 5.67 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 123.114 2.542 . . . . 0.0 111.532 -173.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.566 ' ND2' ' H ' ' A' ' 29' ' ' LYS . 2.1 p-10 -156.18 -79.99 0.08 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.982 1.713 . . . . 0.0 109.336 -178.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.566 ' H ' ' ND2' ' A' ' 28' ' ' ASN . 3.9 mppt? -136.58 26.36 3.11 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.972 2.509 . . . . 0.0 109.304 -174.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -91.43 -7.81 49.6 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 125.098 1.359 . . . . 0.0 112.055 177.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.18 75.97 9.9 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 120.977 1.717 . . . . 0.0 108.498 -177.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -105.82 58.51 0.66 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.186 2.195 . . . . 0.0 112.28 -173.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.3 mm 53.85 -75.78 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 127.613 2.365 . . . . 0.0 112.76 -175.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -67.31 -17.99 64.99 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.64 1.176 . . . . 0.0 112.032 -173.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.423 ' O ' HD13 ' A' ' 38' ' ' LEU . 11.6 t-20 -43.7 -39.43 3.65 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.455 163.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.689 ' HB1' HG21 ' A' ' 72' ' ' VAL . . . -61.12 -44.99 96.48 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 175.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 38.5 m170 -67.31 -44.68 78.57 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 118.902 -0.57 . . . . 0.0 109.709 -170.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.483 HD22 ' C ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -79.78 -19.91 47.49 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-O 116.985 -1.483 . . . . 0.0 111.69 173.755 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -44.85 -54.02 6.86 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 125.005 1.322 . . . . 0.0 109.785 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.409 ' HG2' ' CE1' ' A' ' 44' ' ' PHE . 13.2 ttpt -56.83 -53.8 53.71 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.85 -46.95 81.44 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 117.296 -1.335 . . . . 0.0 111.544 -176.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 6.1 t90 -62.44 -66.16 0.58 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 117.329 -1.32 . . . . 0.0 109.05 177.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 87.7 t -50.46 -37.96 15.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 120.003 1.274 . . . . 0.0 111.117 -176.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.409 ' CE1' ' HG2' ' A' ' 40' ' ' LYS . 4.3 m-85 -59.51 -74.04 0.08 Allowed 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 171.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -48.92 -43.02 39.04 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.637 1.975 . . . . 0.0 113.267 -171.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.497 ' HG3' ' CE1' ' A' ' 47' ' ' PHE . 3.0 tp10 -84.7 -28.69 26.16 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 126.846 2.058 . . . . 0.0 109.727 -167.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.497 ' CE1' ' HG3' ' A' ' 46' ' ' GLU . 2.8 m-85 -128.77 -66.76 0.82 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 118.925 0.784 . . . . 0.0 110.606 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.6 mt -61.13 -53.41 57.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 118.865 0.757 . . . . 0.0 112.517 -166.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -67.89 -29.06 68.07 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 127.496 2.318 . . . . 0.0 109.572 176.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -63.49 -24.31 67.76 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 118.028 -0.987 . . . . 0.0 111.605 167.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.8 -4.43 19.07 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 126.533 2.016 . . . . 0.0 113.281 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -66.1 156.38 34.07 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 119.429 1.615 . . . . 0.0 111.085 178.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -134.25 1.09 3.17 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.332 -1.303 . . . . 0.0 111.212 -177.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.567 ' HB3' HG13 ' A' ' 22' ' ' VAL . 8.8 mtmt -138.04 123.18 19.21 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.622 1.101 . . . . 0.0 109.296 -170.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.675 HG23 HD22 ' A' ' 25' ' ' LEU . 1.4 mp -137.45 152.78 27.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 126.701 2.0 . . . . 0.0 106.581 -176.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.703 ' CE2' HG11 ' A' ' 22' ' ' VAL . 21.9 m-85 -141.42 120.12 12.56 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 126.977 2.111 . . . . 0.0 110.216 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 46.2 tp -90.18 119.29 30.38 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 176.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.548 HG22 ' HA ' ' A' ' 26' ' ' MET . 0.8 OUTLIER -87.84 154.81 3.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 118.806 0.73 . . . . 0.0 109.963 173.011 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.565 HD22 HG21 ' A' ' 96' ' ' VAL . 3.9 mp -134.38 8.02 3.64 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.871 0.868 . . . . 0.0 111.482 178.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.03 -36.05 67.56 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.891 -1.131 . . . . 0.0 112.073 -177.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -96.33 -11.38 25.92 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.439 1.096 . . . . 0.0 112.16 178.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.4 t -109.87 113.5 44.38 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -169.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.85 -41.61 43.39 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 -178.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 93.8 p -151.99 168.65 24.53 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -171.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.702 HD11 ' HB2' ' A' ' 69' ' ' SER . 4.5 tt -133.64 151.98 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 C-N-CA 124.504 1.122 . . . . 0.0 109.107 176.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.68 162.85 17.69 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.007 0.923 . . . . 0.0 109.006 179.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 85.8 p -66.76 1.9 1.62 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 171.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.52 ' CE1' ' HB2' ' A' ' 36' ' ' ALA 0.25 0.1 OUTLIER -71.03 -78.63 0.07 Allowed 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 123.955 0.902 . . . . 0.0 110.817 156.028 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.702 ' HB2' HD11 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -75.31 -24.17 57.4 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 118.901 0.773 . . . . 0.0 111.777 -158.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 1.011 HD21 HG21 ' A' ' 103' ' ' THR . 35.0 tp -44.72 -38.88 4.72 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.527 1.531 . . . . 0.0 111.889 176.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.681 ' HA2' HG12 ' A' ' 74' ' ' VAL . . . -108.94 6.36 32.71 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-O 119.82 -0.433 . . . . 0.0 114.154 -174.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.689 HG21 ' HB1' ' A' ' 36' ' ' ALA . 95.0 t -75.99 -46.18 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 158.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.588 HD12 ' O ' ' A' ' 69' ' ' SER . 1.7 mt -59.57 -54.23 37.29 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 CA-C-O 122.694 1.235 . . . . 0.0 111.61 -173.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.681 HG12 ' HA2' ' A' ' 71' ' ' GLY . 9.0 p -45.69 -56.32 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.835 0 O-C-N 120.404 -1.435 . . . . 0.0 113.841 163.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.466 ' N ' HG13 ' A' ' 74' ' ' VAL . 0.9 OUTLIER -49.43 -43.93 45.06 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 121.369 -0.832 . . . . 0.0 110.97 -174.356 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 56.3 mt -58.11 -41.87 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 O-C-N 124.859 1.349 . . . . 0.0 110.569 173.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 21.7 tp -57.99 -54.06 51.26 Favored 'General case' 0 C--O 1.225 -0.196 0 O-C-N 120.278 -1.514 . . . . 0.0 109.695 170.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.497 ' HE3' HG22 ' A' ' 74' ' ' VAL . 72.2 mttt -65.13 3.23 0.63 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.276 1.43 . . . . 0.0 112.419 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 41.4 t -106.2 -51.08 3.03 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 126.631 1.973 . . . . 0.0 107.782 174.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 87.8 mt -59.55 -44.6 93.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.678 0.791 . . . . 0.0 110.367 175.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.58 -19.7 65.29 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.786 0.721 . . . . 0.0 112.638 176.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.9 m -80.64 -33.94 35.31 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.341 0.973 . . . . 0.0 111.405 167.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.4 m -73.12 -62.7 1.37 Allowed 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.339 1.056 . . . . 0.0 110.421 -176.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 148.5 29.03 0.06 OUTLIER Glycine 0 CA--C 1.527 0.819 0 CA-C-O 118.14 -1.367 . . . . 0.0 113.787 -168.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -134.06 -166.4 11.25 Favored Glycine 0 C--N 1.338 0.685 0 CA-C-N 120.245 2.023 . . . . 0.0 113.319 -171.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.513 ' HB3' HG22 ' A' ' 122' ' ' VAL . 5.8 m-85 -135.1 150.18 50.18 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.305 1.442 . . . . 0.0 109.246 178.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -145.9 144.12 30.0 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 170.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.469 ' C ' HD23 ' A' ' 89' ' ' LEU . . . -149.99 176.52 10.7 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 126.165 1.786 . . . . 0.0 111.924 -175.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.469 HD23 ' C ' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -123.14 168.32 12.55 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.702 0.801 . . . . 0.0 111.165 -179.566 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.405 ' HB ' ' HA ' ' A' ' 58' ' ' VAL . 99.4 t -147.35 141.43 19.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 124.722 1.209 . . . . 0.0 109.787 -160.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.2 t 42.98 58.19 11.6 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 124.527 1.131 . . . . 0.0 109.342 -176.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -71.57 -163.2 0.13 Allowed 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 124.275 3.317 . . . . 0.0 110.114 -177.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -155.9 151.42 27.04 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 124.508 1.123 . . . . 0.0 108.07 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -61.5 -21.53 64.3 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.201 1.0 . . . . 0.0 110.998 -176.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.402 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -77.62 -38.19 48.54 Favored 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 126.422 1.889 . . . . 0.0 111.451 176.212 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.872 HG13 HD13 ' A' ' 100' ' ' LEU . 2.3 t -62.18 -46.98 95.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-O 117.102 -1.428 . . . . 0.0 108.216 166.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -57.93 -30.45 65.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 119.982 1.265 . . . . 0.0 109.155 176.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -68.34 -30.46 69.43 Favored 'General case' 0 C--O 1.218 -0.589 0 O-C-N 120.703 -1.248 . . . . 0.0 109.934 -177.574 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.677 ' O ' HG22 ' A' ' 103' ' ' THR . 5.4 p -101.59 -42.63 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -169.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.872 HD13 HG13 ' A' ' 96' ' ' VAL . 5.7 mp -67.0 -19.67 65.75 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 115.95 -1.976 . . . . 0.0 111.152 177.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 12.0 t -79.67 -45.44 19.01 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 121.441 1.928 . . . . 0.0 107.31 172.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -67.6 -51.03 55.1 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 126.337 1.855 . . . . 0.0 110.585 -165.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 1.011 HG21 HD21 ' A' ' 70' ' ' LEU . 9.1 t -81.77 6.32 15.84 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.787 179.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 50.0 88.27 0.02 OUTLIER 'General case' 0 C--O 1.235 0.304 0 C-N-CA 127.162 2.185 . . . . 0.0 110.102 -169.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.476 ' HB3' ' HG ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -133.87 -55.9 0.88 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 127.563 2.345 . . . . 0.0 110.739 -175.992 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.77 -27.05 68.93 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.944 1.247 . . . . 0.0 110.681 173.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 -72.44 -18.18 61.72 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.146 0.498 . . . . 0.0 110.109 -177.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.2 mm -97.54 -56.2 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 103.595 -2.742 . . . . 0.0 103.595 -174.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.561 HG12 ' H ' ' A' ' 110' ' ' LYS . 1.4 t -80.41 -165.0 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 125.518 1.527 . . . . 0.0 110.115 -177.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.561 ' H ' HG12 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -125.66 168.82 13.21 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 128.46 2.704 . . . . 0.0 108.813 169.367 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.36 145.73 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -147.02 171.14 15.73 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 126.334 1.854 . . . . 0.0 110.678 -175.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.28 -53.16 4.34 Favored 'General case' 0 CA--C 1.523 -0.067 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -175.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 71.1 p -130.17 162.88 27.89 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.568 0.747 . . . . 0.0 110.895 -175.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 29.1 mm -65.03 -36.48 77.91 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 CA-C-O 118.168 -0.92 . . . . 0.0 108.582 -172.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.9 t -69.04 -31.74 70.75 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.527 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -68.13 -9.15 44.3 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 119.056 0.844 . . . . 0.0 111.672 173.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -110.37 -38.25 5.29 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 119.529 1.059 . . . . 0.0 109.203 -179.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 2.8 ttm -64.1 -46.45 84.14 Favored 'General case' 0 N--CA 1.446 -0.649 0 O-C-N 120.667 -1.271 . . . . 0.0 113.433 -161.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -91.36 -14.68 30.27 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 117.976 -1.012 . . . . 0.0 111.057 175.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -95.22 -46.85 6.59 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 119.327 0.967 . . . . 0.0 110.574 -167.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.513 HG22 ' HB3' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -49.84 -31.77 7.13 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.18 0 C-N-CA 124.89 1.276 . . . . 0.0 111.002 173.779 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -52.63 -36.21 56.12 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.518 1.127 . . . . 0.0 111.969 174.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.88 35.34 0.76 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.884 1.274 . . . . 0.0 114.251 -174.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.242 0.679 0 C-N-CA 125.5 1.52 . . . . 0.0 112.957 178.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 tpt . . . . . 0 N--CA 1.47 0.561 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 144.82 158.19 7.53 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 124.103 0.859 . . . . 0.0 111.344 171.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.3 m 60.52 148.5 0.02 OUTLIER 'General case' 0 C--O 1.237 0.441 0 C-N-CA 127.082 2.153 . . . . 0.0 112.051 -164.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -80.72 135.11 35.94 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.432 -174.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.76 100.98 5.64 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.7 tp -137.69 98.82 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 37.6 t-80 -153.38 96.01 1.99 Allowed 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -61.38 169.84 2.05 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.774 0.829 . . . . 0.0 111.613 173.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -93.22 92.84 7.92 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -167.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 40.3 t60 -148.32 43.62 1.03 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.732 0.813 . . . . 0.0 109.89 -178.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -63.28 147.67 50.4 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 172.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -88.77 -95.65 0.1 Allowed 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 169.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 13.2 ttt -156.96 96.16 1.58 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 105.318 -2.105 . . . . 0.0 105.318 -167.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -69.51 122.0 84.19 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-O 118.269 -0.872 . . . . 0.0 109.905 -171.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -78.46 101.24 1.44 Allowed 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.494 2.129 . . . . 0.0 110.038 172.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -162.69 175.36 11.42 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 126.474 1.91 . . . . 0.0 109.74 170.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.64 173.26 11.72 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.77 1.228 . . . . 0.0 111.511 165.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.3 mt -119.09 147.4 22.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 174.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 20' ' ' ASP . 46.5 t -125.1 -174.79 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 129.761 3.224 . . . . 0.0 104.849 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.426 ' H ' HG12 ' A' ' 19' ' ' VAL . 2.1 m-20 -51.75 -54.33 29.71 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.869 0.867 . . . . 0.0 113.311 -163.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -127.39 12.37 6.99 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 122.933 0.493 . . . . 0.0 110.367 163.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.828 HG11 ' CE2' ' A' ' 56' ' ' PHE . 22.0 t -119.31 163.77 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 O-C-N 121.114 -0.991 . . . . 0.0 108.585 -166.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.4 t -132.28 125.52 54.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 -170.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.414 HD11 HG21 ' A' ' 19' ' ' VAL . 0.6 OUTLIER -107.69 103.46 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 -176.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.7 mt -90.61 104.77 17.31 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 104.886 -2.264 . . . . 0.0 104.886 -178.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 57.7 mtm -112.89 84.98 7.26 Favored Pre-proline 0 C--N 1.332 -0.172 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -171.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -70.49 156.74 60.82 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.853 1.702 . . . . 0.0 109.871 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -122.61 -92.55 0.53 Allowed 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -178.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.63 59.44 1.63 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 121.784 2.084 . . . . 0.0 111.658 -175.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -144.97 9.69 1.3 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -175.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 25.0 mt -79.26 52.93 1.4 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.429 1.013 . . . . 0.0 110.975 -176.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -85.4 169.63 13.49 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 126.598 1.959 . . . . 0.0 109.116 171.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.9 mt -57.53 -35.38 49.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 C-N-CA 124.272 1.029 . . . . 0.0 112.09 -174.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -71.61 -16.18 62.27 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 120.97 -1.081 . . . . 0.0 111.211 -176.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -120.24 56.28 0.98 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.291 1.437 . . . . 0.0 108.804 175.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -140.45 -64.1 0.47 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.405 1.082 . . . . 0.0 110.592 -177.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 28.2 t60 -58.45 -46.19 87.07 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 120.513 -1.367 . . . . 0.0 109.368 169.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.599 HD12 ' C ' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -65.44 -30.05 70.8 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.792 178.604 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -52.93 -54.05 40.54 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.856 1.262 . . . . 0.0 110.017 -174.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.55 ' HE3' ' CE1' ' A' ' 44' ' ' PHE . 0.8 OUTLIER -57.43 -44.74 84.91 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 124.651 1.181 . . . . 0.0 110.866 172.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.0 -34.24 77.13 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.569 1.548 . . . . 0.0 112.372 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -69.55 -62.48 1.37 Allowed 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 171.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.7 t -47.64 -41.03 7.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 123.916 0.886 . . . . 0.0 112.763 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.55 ' CE1' ' HE3' ' A' ' 40' ' ' LYS . 1.6 m-85 -61.54 -34.76 76.09 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 123.892 0.877 . . . . 0.0 112.121 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -112.41 -12.23 13.55 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.386 1.074 . . . . 0.0 112.712 -170.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -88.38 -34.67 17.49 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.614 1.566 . . . . 0.0 109.889 171.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -130.35 -62.63 0.92 Allowed 'General case' 0 C--N 1.345 0.373 0 C-N-CA 123.095 0.558 . . . . 0.0 111.807 -169.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.6 mt -62.41 -56.08 21.63 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 119.245 -0.407 . . . . 0.0 111.447 -162.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -60.75 -35.29 76.02 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 118.676 -0.678 . . . . 0.0 110.274 175.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.14 -16.21 12.52 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 127.19 2.196 . . . . 0.0 112.965 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 118.23 -10.15 13.35 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 126.046 1.784 . . . . 0.0 111.988 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -73.62 120.26 18.98 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 118.802 1.301 . . . . 0.0 110.837 -172.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -109.72 13.0 23.91 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.83 2.052 . . . . 0.0 112.074 -176.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.43 ' HB3' HG13 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -150.94 107.31 3.48 Favored 'General case' 0 CA--C 1.518 -0.274 0 O-C-N 120.248 -1.533 . . . . 0.0 107.983 -173.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mp -112.02 152.0 13.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 176.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.828 ' CE2' HG11 ' A' ' 22' ' ' VAL . 23.4 m-85 -130.08 150.5 51.32 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.603 1.161 . . . . 0.0 109.492 166.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.5 tp -119.91 110.28 16.54 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.204 1.001 . . . . 0.0 108.535 176.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.3 t -84.31 134.47 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 171.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.3 mp -109.82 6.19 23.23 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.62 0.768 . . . . 0.0 111.963 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 33.4 t -51.98 -48.14 64.52 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.158 0.983 . . . . 0.0 111.458 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -87.99 7.05 32.96 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.341 -0.85 . . . . 0.0 112.195 -168.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.6 p -134.45 126.93 49.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 125.579 1.551 . . . . 0.0 108.099 -173.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -75.34 -42.56 54.06 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 120.675 -1.266 . . . . 0.0 108.944 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.567 ' HB3' ' HE2' ' A' ' 95' ' ' LYS . 1.4 p -162.05 -178.15 6.23 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.992 0.901 . . . . 0.0 111.681 -173.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 21.3 tt -139.66 160.03 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 C-N-CA 125.344 1.458 . . . . 0.0 108.586 -175.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.12 156.18 22.26 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.408 1.083 . . . . 0.0 110.421 172.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.4 m -53.51 -28.77 32.93 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.126 1.37 . . . . 0.0 113.434 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -62.01 -66.6 0.51 Allowed 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.73 1.212 . . . . 0.0 109.309 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.0 t -74.27 -24.23 59.24 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.369 -0.824 . . . . 0.0 111.659 -176.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.414 HD11 HG21 ' A' ' 103' ' ' THR . 55.1 tp -49.98 -30.82 11.26 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.944 1.247 . . . . 0.0 112.407 172.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.65 -24.69 29.84 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-N 118.396 0.544 . . . . 0.0 113.448 175.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.8 t -66.16 -39.52 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 118.194 0.997 . . . . 0.0 108.605 173.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 mp -52.55 -53.25 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 123.8 0.84 . . . . 0.0 108.914 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 73.3 t -58.94 -46.29 91.5 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 175.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -55.57 -43.2 75.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 119.46 1.027 . . . . 0.0 112.501 -174.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.2 mt -59.73 -38.89 78.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 124.114 0.966 . . . . 0.0 109.013 176.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.63 -50.94 71.5 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 119.151 0.887 . . . . 0.0 109.478 172.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -53.94 -47.93 70.75 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 118.077 -0.963 . . . . 0.0 110.331 -176.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.7 m -56.33 -57.49 12.04 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 124.092 0.87 . . . . 0.0 110.358 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 50.3 mt -53.28 -46.79 57.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.859 1.264 . . . . 0.0 110.637 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.2 p -61.78 -31.13 71.32 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.972 1.309 . . . . 0.0 111.978 -175.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.31 -31.68 33.45 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.848 1.659 . . . . 0.0 111.696 175.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 39.4 m -78.69 -21.95 47.43 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 117.64 -1.171 . . . . 0.0 113.991 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 121.02 4.92 10.0 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 119.652 1.115 . . . . 0.0 114.546 -174.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -113.32 -176.28 19.38 Favored Glycine 0 N--CA 1.437 -1.261 0 CA-C-N 119.24 1.52 . . . . 0.0 112.196 -173.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -131.47 157.5 43.33 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.825 1.65 . . . . 0.0 108.68 176.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -148.96 135.45 19.47 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 175.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.59 ' C ' HD23 ' A' ' 89' ' ' LEU . . . -140.11 170.84 15.1 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.36 1.464 . . . . 0.0 110.28 -176.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.59 HD23 ' C ' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -119.27 171.58 8.2 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 122.793 0.437 . . . . 0.0 110.467 -176.573 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.557 HG21 HD13 ' A' ' 115' ' ' ILE . 77.9 t -146.77 143.49 20.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 124.939 1.296 . . . . 0.0 109.723 -172.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 29.1 t 43.61 63.81 7.54 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 125.914 1.685 . . . . 0.0 109.119 -176.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -78.32 91.98 1.16 Allowed 'Trans proline' 0 N--CA 1.444 -1.428 0 N-CA-C 106.168 -2.281 . . . . 0.0 106.168 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -55.39 155.19 5.41 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 122.869 1.319 . . . . 0.0 110.125 -177.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -64.69 -25.26 67.87 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 122.318 1.056 . . . . 0.0 110.99 -165.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.567 ' HE2' ' HB3' ' A' ' 64' ' ' SER . 0.0 OUTLIER -68.82 -35.7 77.29 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 126.069 1.748 . . . . 0.0 111.547 177.428 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.0 m -82.44 -38.15 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.745 0 CA-C-N 120.436 1.471 . . . . 0.0 110.429 172.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.2 -33.42 63.01 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 120.193 1.36 . . . . 0.0 109.85 -176.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.45 -31.38 72.53 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 177.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.1 p -96.54 -32.12 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 C-N-CA 124.974 1.31 . . . . 0.0 108.653 -177.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.98 -18.59 65.41 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.408 1.883 . . . . 0.0 111.341 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.1 m -80.16 -57.01 3.82 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 168.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.41 -5.43 5.26 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 130.257 3.423 . . . . 0.0 114.006 -167.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.414 HG21 HD11 ' A' ' 70' ' ' LEU . 0.8 OUTLIER -130.76 6.93 4.74 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 125.381 1.472 . . . . 0.0 110.659 -177.282 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 46.71 73.95 0.17 Allowed 'General case' 0 C--N 1.342 0.262 0 C-N-CA 127.511 2.325 . . . . 0.0 109.706 -170.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.79 -63.13 1.28 Allowed 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 174.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -57.64 -31.95 66.79 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 123.344 1.545 . . . . 0.0 110.284 174.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -76.43 1.91 15.1 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 120.09 -1.631 . . . . 0.0 111.219 -175.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.4 mt -126.54 -53.12 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 126.06 1.744 . . . . 0.0 107.936 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.2 t -103.11 145.8 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 125.878 1.671 . . . . 0.0 108.186 -174.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -71.09 161.28 31.39 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.5 -0.75 . . . . 0.0 111.164 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.19 143.56 27.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.421 1.488 . . . . 0.0 107.113 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -141.23 168.43 19.8 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 128.902 2.881 . . . . 0.0 109.239 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.2 -46.47 13.71 Favored 'General case' 0 CA--C 1.515 -0.372 0 O-C-N 121.53 -0.731 . . . . 0.0 109.697 177.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 60.1 p -119.45 173.79 6.77 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.045 1.338 . . . . 0.0 108.894 -173.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.557 HD13 HG21 ' A' ' 90' ' ' VAL . 8.8 mm -66.88 -41.9 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-O 117.858 -1.068 . . . . 0.0 108.726 168.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 18.6 t -67.9 -37.85 82.24 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 119.982 1.265 . . . . 0.0 110.87 -167.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -60.82 -28.46 68.81 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 118.4 -0.809 . . . . 0.0 109.802 177.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.727 ' O ' HG23 ' A' ' 122' ' ' VAL . . . -81.27 -54.38 5.54 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.15 -28.76 59.27 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 125.917 1.687 . . . . 0.0 114.061 -160.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -104.79 -0.69 27.0 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 125.22 1.408 . . . . 0.0 114.406 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -123.32 -35.03 3.02 Favored 'General case' 0 C--O 1.213 -0.841 0 C-N-CA 125.162 1.385 . . . . 0.0 112.924 -167.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 118' ' ' ALA . 3.4 t -57.02 -27.23 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 126.036 1.734 . . . . 0.0 109.442 161.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 11.8 mtm180 -54.18 -31.65 53.38 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 121.127 -0.983 . . . . 0.0 113.061 162.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.74 23.66 5.02 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 118.326 2.713 . . . . 0.0 118.326 -177.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 21.6 mttp . . . . . 0 N--CA 1.431 -1.383 0 N-CA-C 102.66 -3.089 . . . . 0.0 102.66 -179.933 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mpt? . . . . . 0 N--CA 1.468 0.458 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 48.6 36.68 18.73 Favored Glycine 0 C--N 1.339 0.726 0 C-N-CA 125.446 1.498 . . . . 0.0 115.087 165.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.2 p -61.44 179.51 0.22 Allowed 'General case' 0 C--O 1.239 0.522 0 CA-C-N 118.003 0.902 . . . . 0.0 109.638 167.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -64.88 171.77 3.27 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 122.995 1.378 . . . . 0.0 111.098 163.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -67.66 129.36 39.67 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 172.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 36.3 mm -90.11 -60.8 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -177.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.2 t60 50.69 102.22 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.007 2.123 . . . . 0.0 111.958 -166.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -59.36 162.16 4.99 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 122.216 1.008 . . . . 0.0 111.809 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -75.22 166.75 23.14 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.805 0.842 . . . . 0.0 111.972 -172.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.73 175.32 5.8 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.695 0.798 . . . . 0.0 111.173 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 3.8 m80 55.31 104.35 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.098 0 C-N-CA 128.201 2.6 . . . . 0.0 112.649 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -142.98 166.26 25.12 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.009 1.324 . . . . 0.0 107.539 174.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.8 mpt? -120.15 175.95 5.69 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 126.71 2.004 . . . . 0.0 107.598 175.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -104.71 96.86 11.24 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 124.088 0.955 . . . . 0.0 109.696 -175.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -77.65 49.22 2.84 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 124.928 3.752 . . . . 0.0 111.198 176.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -160.41 165.11 31.7 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 125.689 1.596 . . . . 0.0 107.909 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -126.66 178.78 5.7 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 163.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.6 mt -126.5 152.23 33.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 163.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 23.3 m -111.19 -141.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 125.612 1.565 . . . . 0.0 107.724 174.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -29.94 -79.21 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 129.043 2.937 . . . . 0.0 112.501 166.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -142.82 14.04 1.91 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.952 2.501 . . . . 0.0 109.252 177.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.642 HG11 ' CE2' ' A' ' 56' ' ' PHE . 21.8 t -115.75 140.07 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 O-C-N 121.092 -1.005 . . . . 0.0 108.712 -173.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.4 t -94.14 130.67 42.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.1 mm -106.94 94.32 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 36.1 mt -77.83 133.69 38.13 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 176.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 70.4 mtm -131.24 92.98 31.15 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 124.21 1.004 . . . . 0.0 109.064 -172.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -78.02 44.62 1.62 Allowed 'Trans proline' 0 CA--C 1.542 0.915 1 C-N-CA 125.461 4.107 . . . . 0.0 113.887 -164.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -49.12 88.77 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 128.763 2.825 . . . . 0.0 114.343 -169.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 36.94 35.41 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 128.95 2.9 . . . . 0.0 115.016 -176.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -122.78 7.43 9.38 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -167.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.0 mp -73.84 63.89 0.93 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 126.027 1.731 . . . . 0.0 109.605 -176.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -78.82 26.88 0.23 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 128.938 2.895 . . . . 0.0 113.868 -166.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.6 mm 72.86 -63.09 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 127.068 2.147 . . . . 0.0 110.643 -177.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -70.3 -18.56 63.11 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 120.916 1.689 . . . . 0.0 111.35 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -47.83 -49.58 28.8 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 123.991 0.916 . . . . 0.0 110.516 162.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.73 -37.33 87.23 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.79 0.436 . . . . 0.0 110.446 -177.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -61.89 -51.19 69.17 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.332 0.653 . . . . 0.0 110.017 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.259 0.0 OUTLIER -81.82 -15.76 53.08 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-O 117.599 -1.191 . . . . 0.0 112.608 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -44.48 -50.74 9.28 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.441 1.896 . . . . 0.0 110.661 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.514 ' HE2' ' CZ ' ' A' ' 44' ' ' PHE . 13.6 tmtt? -60.65 -53.16 60.85 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 123.222 0.609 . . . . 0.0 111.19 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.41 -45.91 87.48 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.039 0.836 . . . . 0.0 109.914 -177.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -60.49 -66.98 0.44 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 117.292 -1.337 . . . . 0.0 109.705 176.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 73.5 t -52.13 -32.32 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 120.537 1.517 . . . . 0.0 111.986 -176.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.514 ' CZ ' ' HE2' ' A' ' 40' ' ' LYS . 3.3 m-85 -58.19 -71.78 0.1 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.91 0.777 . . . . 0.0 109.905 172.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -65.89 -30.83 71.49 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 123.887 0.875 . . . . 0.0 112.885 -170.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -77.32 -31.81 54.85 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.011 1.325 . . . . 0.0 110.962 -175.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -138.13 -62.73 0.58 Allowed 'General case' 0 C--N 1.341 0.22 0 CA-C-N 118.522 0.601 . . . . 0.0 110.991 -170.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 46.6 mt -58.81 -59.43 5.44 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.416 0.553 . . . . 0.0 111.176 -171.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -60.68 -35.26 75.83 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.029 1.332 . . . . 0.0 109.647 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 tttm -56.5 -34.7 67.22 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.952 176.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.41 8.82 5.74 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.991 1.281 . . . . 0.0 114.173 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -77.63 159.77 28.98 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 118.941 1.37 . . . . 0.0 110.426 172.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -143.44 11.06 1.68 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.251 1.82 . . . . 0.0 111.795 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.477 ' HB3' HG13 ' A' ' 22' ' ' VAL . 1.7 mtmt -139.34 114.73 9.79 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 119.93 1.241 . . . . 0.0 107.914 -176.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mp -121.91 152.55 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 127.381 2.272 . . . . 0.0 105.118 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.642 ' CE2' HG11 ' A' ' 22' ' ' VAL . 14.2 m-85 -131.4 160.74 34.18 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.985 1.714 . . . . 0.0 109.37 166.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 26.5 tp -127.6 119.44 25.95 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 118.085 -0.96 . . . . 0.0 108.434 169.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.541 HG12 ' H ' ' A' ' 60' ' ' SER . 46.4 t -81.54 139.35 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 120.389 1.449 . . . . 0.0 107.685 170.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.63 ' CD1' HG11 ' A' ' 96' ' ' VAL . 1.3 mt -112.54 8.82 19.39 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.889 0.768 . . . . 0.0 112.22 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.541 ' H ' HG12 ' A' ' 58' ' ' VAL . 71.9 m -74.79 -34.1 62.36 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.297 -0.877 . . . . 0.0 113.233 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -90.76 30.6 1.15 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 122.889 1.328 . . . . 0.0 110.469 -174.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.9 p -160.8 170.7 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 129.344 3.058 . . . . 0.0 104.853 -174.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -129.94 -47.31 1.13 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 172.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.414 ' CB ' ' HE2' ' A' ' 95' ' ' LYS . 41.7 p -143.23 171.76 13.66 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.707 0.803 . . . . 0.0 110.648 -176.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.6 tt -138.32 157.88 31.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 C-N-CA 124.987 1.315 . . . . 0.0 108.393 -174.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -73.53 153.54 40.24 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.74 0.781 . . . . 0.0 109.808 174.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.6 m -76.21 53.23 0.8 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.629 1.172 . . . . 0.0 110.447 164.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -129.29 -69.45 0.69 Allowed 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 160.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.03 -38.84 77.0 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 128.967 2.907 . . . . 0.0 112.031 -173.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 20.9 tp -46.05 -40.39 10.62 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 125.881 1.673 . . . . 0.0 111.966 171.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.82 -31.1 40.98 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-O 119.404 -0.665 . . . . 0.0 111.762 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.2 t -70.62 -33.75 54.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 118.074 0.937 . . . . 0.0 108.659 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 22.7 mm -55.75 -46.98 79.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 O-C-N 121.367 -0.833 . . . . 0.0 109.722 174.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.4 t -60.48 -36.64 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 O-C-N 121.087 -1.008 . . . . 0.0 111.693 172.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -63.73 -28.09 69.65 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 120.873 1.67 . . . . 0.0 112.121 -178.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.4 mt -70.32 -34.95 60.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 O-C-N 121.289 -0.882 . . . . 0.0 109.091 173.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.18 -40.93 82.14 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.1 mttm -54.65 -46.48 73.98 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 117.92 -1.038 . . . . 0.0 111.607 174.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.6 t -58.23 -58.36 8.83 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.1 mt -62.07 -40.28 86.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 123.828 0.851 . . . . 0.0 111.157 -170.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.0 t -60.52 -40.87 93.03 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.68 1.592 . . . . 0.0 110.909 173.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.7 m -69.97 -35.11 74.2 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.985 -0.447 . . . . 0.0 110.613 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.1 m -73.06 -51.08 19.46 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.472 1.109 . . . . 0.0 112.844 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 132.98 18.8 1.05 Allowed Glycine 0 CA--C 1.531 1.04 0 CA-C-O 118.064 -1.409 . . . . 0.0 115.031 -170.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -116.86 -168.06 14.72 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 120.251 2.026 . . . . 0.0 111.72 -172.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.473 ' HB3' HG22 ' A' ' 122' ' ' VAL . 13.1 m-85 -132.4 153.22 51.03 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.639 1.576 . . . . 0.0 109.901 -178.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -153.16 140.69 19.8 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 174.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.529 ' C ' HD23 ' A' ' 89' ' ' LEU . . . -146.6 172.26 13.85 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.61 1.164 . . . . 0.0 111.469 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.529 HD23 ' C ' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -117.02 165.74 13.0 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.576 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.474 HG21 HD13 ' A' ' 115' ' ' ILE . 53.7 t -142.89 134.85 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 C-N-CA 124.723 1.209 . . . . 0.0 108.034 -165.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.6 t 50.74 54.43 15.4 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 126.201 1.801 . . . . 0.0 111.821 -174.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -73.5 107.7 2.45 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 124.175 3.25 . . . . 0.0 109.154 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 32.6 p-10 -66.47 165.52 14.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 122.393 1.092 . . . . 0.0 110.6 174.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -69.09 -26.35 64.88 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.863 -1.148 . . . . 0.0 112.214 -170.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.414 ' HE2' ' CB ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -62.9 -29.18 70.57 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 126.878 2.071 . . . . 0.0 109.66 177.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.848 HG13 HD13 ' A' ' 100' ' ' LEU . 13.3 t -84.88 -50.32 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-O 116.105 -1.902 . . . . 0.0 108.875 169.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -54.04 -34.74 60.84 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 122.782 2.537 . . . . 0.0 109.844 -177.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.73 -46.09 89.71 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 121.711 -0.618 . . . . 0.0 111.268 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.685 HG13 HD12 ' A' ' 100' ' ' LEU . 8.8 p -83.95 -38.8 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 -169.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.848 HD13 HG13 ' A' ' 96' ' ' VAL . 10.7 mp -61.28 -24.29 66.3 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.776 1.63 . . . . 0.0 112.644 177.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.81 6.86 34.27 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.376 0.989 . . . . 0.0 111.302 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 41.5 mt -108.67 -39.24 5.43 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 126.773 2.029 . . . . 0.0 110.704 171.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.2 t -94.72 0.42 55.0 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.413 1.885 . . . . 0.0 112.021 -168.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 57.96 79.86 0.19 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.296 1.838 . . . . 0.0 109.432 -168.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.406 ' HB3' ' HG ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -128.28 -55.44 1.26 Allowed 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.97 1.308 . . . . 0.0 108.996 175.224 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -59.54 -18.41 40.34 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.642 1.977 . . . . 0.0 112.183 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.92 -9.09 24.59 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.422 1.889 . . . . 0.0 114.535 -178.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.8 mt -107.62 -38.04 3.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 126.926 2.09 . . . . 0.0 107.914 -176.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.5 t -120.78 145.44 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 123.726 0.81 . . . . 0.0 109.117 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.04 161.01 27.67 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.084 0.554 . . . . 0.0 110.742 175.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.09 144.12 25.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -144.67 167.05 23.49 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 127.363 2.265 . . . . 0.0 110.784 -176.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -84.72 -44.52 13.29 Favored 'General case' 0 C--O 1.233 0.189 0 O-C-N 121.835 -0.54 . . . . 0.0 110.008 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.6 p -128.96 177.22 7.27 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.165 0.986 . . . . 0.0 109.48 -171.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.474 HD13 HG21 ' A' ' 90' ' ' VAL . 13.7 mm -74.95 -42.59 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 174.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 10.0 t -70.82 -25.56 62.9 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 119.573 1.079 . . . . 0.0 110.313 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -65.74 -16.22 63.57 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 119.676 1.126 . . . . 0.0 111.399 170.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -107.98 -38.75 5.72 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 123.762 0.825 . . . . 0.0 109.185 -171.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 8.2 ttp -61.7 -42.75 99.36 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.245 1.018 . . . . 0.0 112.571 -160.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -92.72 -23.53 18.89 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 124.586 1.154 . . . . 0.0 111.861 175.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -81.39 -52.14 7.59 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -169.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.473 HG22 ' HB3' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -46.89 -34.8 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 127.182 2.193 . . . . 0.0 112.637 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 11.7 mtm180 -60.68 -32.6 71.81 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 123.595 0.758 . . . . 0.0 111.834 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.8 60.31 0.93 Allowed 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 127.008 2.123 . . . . 0.0 105.624 -178.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.259 1.59 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -174.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.646 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -142.65 174.33 23.54 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 177.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.3 m -161.88 -6.75 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.311 1.844 . . . . 0.0 112.253 168.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 47.99 55.82 8.12 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.886 1.274 . . . . 0.0 113.555 128.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -61.79 -68.8 0.29 Allowed 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.334 -0.853 . . . . 0.0 110.513 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.7 mp 53.31 -96.26 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 125.289 1.435 . . . . 0.0 107.862 -163.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.63 140.36 58.5 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 120.253 1.388 . . . . 0.0 109.749 172.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -123.82 166.47 15.56 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.029 0.932 . . . . 0.0 108.804 170.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 54.73 -178.81 0.03 OUTLIER 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.406 1.098 . . . . 0.0 112.436 -166.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -129.94 139.61 51.07 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 175.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -136.15 73.73 1.47 Allowed 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 -176.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -121.37 -58.46 1.78 Allowed 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 171.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.0 ptt? 53.41 -179.09 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 127.71 2.404 . . . . 0.0 113.205 -172.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -153.5 147.83 19.11 Favored Pre-proline 0 CA--C 1.539 0.525 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 168.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -74.64 132.88 16.46 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.635 2.224 . . . . 0.0 113.014 172.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -153.63 173.62 15.54 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.16 1.384 . . . . 0.0 108.951 177.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -129.48 175.75 8.52 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 157.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.5 mt -125.41 157.54 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 163.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.1 m -117.34 -143.13 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 168.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -47.33 -66.44 0.41 Allowed 'General case' 0 C--O 1.234 0.268 0 C-N-CA 127.058 2.143 . . . . 0.0 112.134 -175.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -141.93 12.15 2.03 Favored 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 123.711 0.804 . . . . 0.0 112.574 170.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.695 HG11 ' CE2' ' A' ' 56' ' ' PHE . 20.5 t -105.77 139.07 28.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.9 t -90.72 149.87 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.239 1.016 . . . . 0.0 108.307 174.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.7 mp -129.88 107.81 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 176.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.49 158.43 24.51 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 120.57 1.532 . . . . 0.0 108.586 170.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 38.8 mtt -133.49 86.14 41.16 Favored Pre-proline 0 N--CA 1.465 0.296 0 C-N-CA 124.951 1.3 . . . . 0.0 107.941 -175.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -65.12 93.0 0.22 Allowed 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.372 2.714 . . . . 0.0 109.967 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.413 ' C ' ' HE2' ' A' ' 29' ' ' LYS . 15.5 p-10 -74.05 52.79 0.46 Allowed 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 125.639 1.576 . . . . 0.0 109.679 165.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.413 ' HE2' ' C ' ' A' ' 28' ' ' ASN . 0.0 OUTLIER 51.85 -2.01 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 130.048 3.339 . . . . 0.0 117.769 173.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -71.84 33.32 0.06 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 128.998 2.919 . . . . 0.0 112.485 176.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.8 mt -84.46 59.7 5.59 Favored 'General case' 0 N--CA 1.457 -0.121 0 O-C-N 120.355 -1.466 . . . . 0.0 108.098 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -73.31 172.35 11.36 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.979 1.712 . . . . 0.0 109.724 169.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.7 mt -71.98 -39.21 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 O-C-N 121.472 -0.767 . . . . 0.0 110.609 -177.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -63.97 -33.81 76.58 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 118.48 0.582 . . . . 0.0 110.117 -170.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -78.47 -21.71 48.64 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 125.267 1.427 . . . . 0.0 111.688 175.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.99 -55.9 6.6 Favored 'General case' 0 CA--C 1.521 -0.17 0 O-C-N 120.639 -1.288 . . . . 0.0 112.294 -171.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -67.11 -30.71 70.8 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 118.717 -1.193 . . . . 0.0 110.191 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.418 ' O ' HD12 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -73.48 -23.36 60.06 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 117.785 -1.102 . . . . 0.0 110.308 176.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -49.87 -41.97 46.6 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.296 1.438 . . . . 0.0 111.295 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -58.79 -63.74 1.18 Allowed 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 172.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -44.79 -50.95 9.9 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.865 2.066 . . . . 0.0 111.447 -177.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -61.78 -65.44 0.69 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 117.304 -1.332 . . . . 0.0 109.959 177.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.7 t -53.1 -34.21 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 120.365 1.439 . . . . 0.0 111.416 -176.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.429 ' CD1' HD12 ' A' ' 48' ' ' LEU . 4.9 m-85 -60.75 -69.43 0.23 Allowed 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 124.41 1.084 . . . . 0.0 109.115 174.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -62.81 -39.84 95.53 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.312 0.645 . . . . 0.0 112.538 -173.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -70.55 -31.42 68.46 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.793 1.237 . . . . 0.0 110.858 -175.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -137.71 -58.59 0.67 Allowed 'General case' 0 C--N 1.343 0.298 0 CA-C-N 119.021 0.828 . . . . 0.0 112.238 -171.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.429 HD12 ' CD1' ' A' ' 44' ' ' PHE . 43.7 mt -59.95 -53.04 62.48 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 120.54 -1.35 . . . . 0.0 111.303 -171.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -69.49 -15.65 63.3 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.553 1.941 . . . . 0.0 111.177 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -74.49 -28.89 61.21 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 118.292 -0.861 . . . . 0.0 111.068 168.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.71 1.82 8.17 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.756 1.646 . . . . 0.0 114.235 -177.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -72.83 159.8 33.17 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 120.066 1.933 . . . . 0.0 110.71 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -139.22 -8.29 1.32 Allowed 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 126.349 1.86 . . . . 0.0 111.423 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.544 ' HB3' HG13 ' A' ' 22' ' ' VAL . 4.7 mtmt -129.25 129.25 44.72 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.029 0.931 . . . . 0.0 109.325 -175.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.5 mt -138.39 155.39 28.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 126.706 2.002 . . . . 0.0 106.433 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.695 ' CE2' HG11 ' A' ' 22' ' ' VAL . 23.8 m-85 -134.43 156.96 47.64 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 125.708 1.603 . . . . 0.0 111.459 166.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 46.5 tp -125.97 114.94 19.14 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 117.289 -1.339 . . . . 0.0 108.584 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.7 t -92.85 119.0 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 121.137 1.789 . . . . 0.0 109.206 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.4 mp -90.78 1.38 56.95 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -173.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 73.4 p -51.26 -44.28 61.73 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.636 1.974 . . . . 0.0 114.242 -171.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -68.88 -27.86 66.18 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 120.942 -1.099 . . . . 0.0 111.098 -175.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -95.13 150.86 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 125.344 1.458 . . . . 0.0 109.103 -165.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -70.2 -59.65 2.76 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 158.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.3 t -164.33 176.83 8.75 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 122.699 1.238 . . . . 0.0 110.677 -168.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.0 tt -109.12 177.95 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 128.288 2.635 . . . . 0.0 107.666 172.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -118.88 173.88 6.62 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.247 0.931 . . . . 0.0 110.381 171.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.8 t -50.5 -41.23 53.17 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 126.583 1.953 . . . . 0.0 111.428 -175.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -65.14 -58.7 5.34 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 118.154 -0.927 . . . . 0.0 111.008 -171.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 66.0 m -69.75 -36.72 76.06 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 120.293 1.406 . . . . 0.0 113.012 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.601 HD21 HG21 ' A' ' 103' ' ' THR . 39.8 tp -49.39 -43.48 44.36 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.867 1.667 . . . . 0.0 112.599 -172.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.532 ' HA2' HG12 ' A' ' 74' ' ' VAL . . . -94.98 11.41 69.55 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 120.739 -0.743 . . . . 0.0 113.797 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.6 t -85.03 -39.69 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 118.376 1.088 . . . . 0.0 108.44 153.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.4 mm -56.19 -62.76 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 119.454 1.024 . . . . 0.0 109.68 -177.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.532 HG12 ' HA2' ' A' ' 71' ' ' GLY . 9.8 p -37.13 -49.83 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 124.908 1.283 . . . . 0.0 114.289 165.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.478 ' N ' HG13 ' A' ' 74' ' ' VAL . 3.1 t-20 -60.61 -42.37 96.67 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 123.598 0.759 . . . . 0.0 109.306 -167.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 75.4 mt -55.85 -41.32 66.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.459 1.104 . . . . 0.0 108.221 176.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -58.89 -51.81 68.44 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 124.074 0.95 . . . . 0.0 110.13 177.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -56.57 -45.18 81.44 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 122.882 0.473 . . . . 0.0 110.331 -175.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -46.94 87.67 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 123.013 0.525 . . . . 0.0 110.711 175.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.6 mt -63.77 -41.24 91.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 123.702 0.801 . . . . 0.0 110.652 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.3 m -58.86 -51.11 71.42 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.713 1.205 . . . . 0.0 110.961 173.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.3 m -63.78 -26.53 68.67 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 176.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.9 m -74.24 -51.59 14.9 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.773 0.829 . . . . 0.0 110.967 174.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.74 37.49 0.62 Allowed Glycine 0 CA--C 1.529 0.965 0 CA-C-O 118.699 -1.056 . . . . 0.0 113.662 -165.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -133.76 -168.7 11.9 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 119.755 1.778 . . . . 0.0 111.602 177.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.443 ' HB3' HG22 ' A' ' 122' ' ' VAL . 11.1 m-85 -142.94 119.48 11.03 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.086 1.754 . . . . 0.0 110.111 -171.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -122.77 146.12 47.8 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.173 0.897 . . . . 0.0 109.143 172.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.629 ' C ' HD23 ' A' ' 89' ' ' LEU . . . -152.72 173.35 15.38 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.342 1.057 . . . . 0.0 111.581 -176.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.629 HD23 ' C ' ' A' ' 88' ' ' ALA . 2.5 mt -120.36 164.6 16.1 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.833 0.853 . . . . 0.0 109.527 -176.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.53 HG21 HD13 ' A' ' 115' ' ' ILE . 55.7 t -140.87 147.19 22.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 124.164 0.986 . . . . 0.0 109.468 -175.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 52.98 57.87 14.46 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.991 1.316 . . . . 0.0 111.332 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -77.15 81.69 2.55 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.202 2.601 . . . . 0.0 110.303 177.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.65 143.82 19.32 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.085 0.554 . . . . 0.0 109.668 172.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -54.77 -36.25 64.67 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.983 1.313 . . . . 0.0 113.643 -156.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.3 -41.17 62.69 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.155 0.982 . . . . 0.0 109.204 178.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -81.2 -29.67 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 118.67 0.668 . . . . 0.0 109.676 -173.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -62.81 -26.87 68.95 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.172 0.896 . . . . 0.0 110.801 172.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.75 -44.16 93.94 Favored 'General case' 0 C--N 1.344 0.33 0 O-C-N 121.465 -0.772 . . . . 0.0 109.47 175.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.679 ' O ' HG22 ' A' ' 103' ' ' THR . 9.9 p -86.3 -43.6 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 -168.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.689 HD13 ' HB3' ' A' ' 105' ' ' LEU . 0.2 OUTLIER -58.4 -24.68 60.71 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.674 1.19 . . . . 0.0 111.296 177.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 26.3 t -77.42 -52.79 8.54 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 120.271 1.396 . . . . 0.0 108.712 172.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 52.0 mt -58.26 -51.46 69.69 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.942 1.297 . . . . 0.0 111.76 -172.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.679 HG22 ' O ' ' A' ' 99' ' ' VAL . 5.5 t -73.79 -5.29 39.96 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.383 0.538 . . . . 0.0 111.197 -178.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 64.24 76.69 0.34 Allowed 'General case' 0 C--N 1.342 0.263 0 C-N-CA 126.832 2.053 . . . . 0.0 107.583 -174.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.689 ' HB3' HD13 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -126.84 -51.86 1.45 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.751 1.22 . . . . 0.0 109.501 -171.467 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.59 -25.54 66.3 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 122.995 1.378 . . . . 0.0 111.436 172.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 4.7 mtm180 -75.28 -8.34 56.38 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.505 1.122 . . . . 0.0 111.34 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.9 mt -130.47 -34.74 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 125.07 1.348 . . . . 0.0 109.006 -165.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.5 t -112.68 149.14 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 126.339 1.856 . . . . 0.0 108.159 175.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.93 160.97 30.63 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.688 0.795 . . . . 0.0 110.782 172.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -146.67 144.36 20.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -176.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -148.18 174.02 12.39 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.017 1.327 . . . . 0.0 112.437 -172.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.75 -44.48 9.43 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.751 0.821 . . . . 0.0 111.526 -177.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 71.1 p -126.43 168.43 14.22 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.811 1.244 . . . . 0.0 109.063 -176.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.53 HD13 HG21 ' A' ' 90' ' ' VAL . 9.0 mm -62.66 -39.89 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 167.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.3 t -70.66 -36.28 73.28 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 119.502 1.046 . . . . 0.0 110.155 -171.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -69.14 -5.65 23.7 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 118.324 -0.846 . . . . 0.0 112.225 174.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -104.42 -44.55 4.9 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 174.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 10.0 ttm -56.7 -51.83 67.27 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 125.377 1.471 . . . . 0.0 112.593 -163.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -104.8 13.75 30.76 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 126.322 1.849 . . . . 0.0 110.933 -176.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -112.98 -58.13 2.2 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.607 1.563 . . . . 0.0 109.309 -177.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.443 HG22 ' HB3' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -48.75 -39.03 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.071 0 C-N-CA 126.736 2.015 . . . . 0.0 110.501 177.612 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 12.0 mtm180 -56.5 -30.42 62.97 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 122.692 0.397 . . . . 0.0 110.668 -176.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.71 38.69 1.36 Allowed 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.745 1.218 . . . . 0.0 111.366 -174.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.875 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 167.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.419 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.28 162.42 35.78 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.684 -0.566 . . . . 0.0 111.684 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.1 p -74.2 100.59 3.73 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.699 1.2 . . . . 0.0 109.225 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 53.9 t0 59.98 -85.58 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.231 1.812 . . . . 0.0 112.707 -175.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 29.1 pttt -139.46 25.45 2.42 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.961 1.704 . . . . 0.0 113.415 -154.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 29.7 mm -57.88 136.99 20.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 123.674 0.79 . . . . 0.0 110.576 -174.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.457 ' CG ' ' H ' ' A' ' 8' ' ' HIS . 13.0 p-80 -164.94 -77.98 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.275 1.83 . . . . 0.0 108.302 161.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.457 ' H ' ' CG ' ' A' ' 7' ' ' HIS . 14.3 m80 -60.21 116.18 4.04 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 124.572 1.149 . . . . 0.0 110.393 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -144.11 17.06 1.74 Allowed 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -177.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -80.23 141.57 35.47 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.585 0.63 . . . . 0.0 110.484 169.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 18.3 m80 31.03 84.09 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 129.511 3.124 . . . . 0.0 113.587 170.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -126.13 21.3 7.43 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.825 1.25 . . . . 0.0 112.296 -176.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.3 tmm? 91.57 144.25 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 130.589 3.555 . . . . 0.0 110.242 -176.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -142.0 86.24 10.53 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 125.493 1.517 . . . . 0.0 108.622 -167.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -80.98 68.32 8.37 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.469 2.78 . . . . 0.0 110.188 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -159.26 164.64 34.77 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 120.773 -1.204 . . . . 0.0 111.088 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.9 173.7 9.39 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.481 1.112 . . . . 0.0 110.209 164.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.493 ' CD1' HG22 ' A' ' 23' ' ' VAL . 9.5 mm -121.82 135.47 61.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 169.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.5 m -115.88 -169.19 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 C-N-CA 126.185 1.794 . . . . 0.0 108.051 168.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -24.08 -61.14 0.05 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 129.397 3.079 . . . . 0.0 113.823 -170.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -145.62 19.91 1.5 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.874 0.369 . . . . 0.0 111.707 161.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.586 HG11 ' CE2' ' A' ' 56' ' ' PHE . 9.4 t -110.11 136.23 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 O-C-N 120.837 -1.165 . . . . 0.0 109.192 -175.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.493 HG22 ' CD1' ' A' ' 18' ' ' ILE . 66.0 t -85.32 125.31 40.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 106.862 -1.532 . . . . 0.0 106.862 172.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.524 HD12 HD12 ' A' ' 115' ' ' ILE . 3.7 mm -103.5 104.2 16.31 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 173.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 25.2 mt -78.24 123.1 26.55 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 172.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 32.9 mtt -125.34 75.94 68.61 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 124.404 1.082 . . . . 0.0 109.295 -168.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -67.0 140.49 54.71 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.298 1.998 . . . . 0.0 110.875 -177.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -130.25 66.43 1.5 Allowed 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 128.731 2.812 . . . . 0.0 109.521 171.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.23 7.33 6.18 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.956 2.102 . . . . 0.0 113.567 167.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -73.19 -3.34 26.06 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.217 1.807 . . . . 0.0 114.435 -177.707 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.6 mt -70.19 31.92 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 128.932 2.893 . . . . 0.0 115.483 -159.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -62.35 151.29 37.2 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 128.641 2.776 . . . . 0.0 112.603 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.7 mt -53.43 -40.31 40.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 124.24 1.016 . . . . 0.0 112.183 -177.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -65.83 -30.47 71.09 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.364 0.666 . . . . 0.0 110.086 -172.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.34 -28.43 14.97 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.27 -34.82 74.28 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 117.924 -1.036 . . . . 0.0 111.831 -176.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -59.71 -64.22 1.02 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 119.569 1.077 . . . . 0.0 109.606 174.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.462 HD22 ' O ' ' A' ' 38' ' ' LEU 0.254 0.0 OUTLIER -74.93 -8.21 55.82 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-O 117.989 -1.005 . . . . 0.0 112.858 -172.922 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -41.65 -42.73 2.59 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.709 2.004 . . . . 0.0 111.993 172.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -53.55 -68.73 0.15 Allowed 'General case' 0 C--N 1.343 0.298 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 170.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -52.62 -42.49 64.64 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 125.54 1.536 . . . . 0.0 111.806 -174.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.411 ' CE3' HG23 ' A' ' 43' ' ' VAL . 15.0 t90 -55.78 -60.63 3.18 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.834 0.854 . . . . 0.0 109.533 172.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.411 HG23 ' CE3' ' A' ' 42' ' ' TRP . 53.9 t -56.37 -35.91 45.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 119.927 1.24 . . . . 0.0 111.716 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -70.06 -37.64 75.57 Favored 'General case' 0 N--CA 1.441 -0.903 0 O-C-N 121.309 -0.87 . . . . 0.0 111.048 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -105.39 -9.2 17.7 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.008 1.323 . . . . 0.0 112.308 -167.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -99.35 -20.24 16.61 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.916 1.234 . . . . 0.0 112.135 165.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -135.67 -49.49 0.71 Allowed 'General case' 0 C--N 1.349 0.577 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -174.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 35.2 mt -67.93 -44.45 76.84 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 120.041 1.291 . . . . 0.0 112.314 -169.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -69.34 -24.56 63.92 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.462 0.705 . . . . 0.0 111.845 173.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.7 mttt -66.26 -6.83 15.16 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.944 1.298 . . . . 0.0 112.676 164.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.3 21.88 72.01 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-O 118.945 -0.92 . . . . 0.0 112.589 178.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -73.08 143.03 47.57 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 119.7 1.75 . . . . 0.0 107.597 163.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -127.82 0.89 6.04 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.601 1.56 . . . . 0.0 112.754 177.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.36 124.59 43.29 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 172.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.482 HD12 HD11 ' A' ' 80' ' ' ILE . 3.3 mt -125.13 147.19 29.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 128.448 2.699 . . . . 0.0 104.362 174.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.586 ' CE2' HG11 ' A' ' 22' ' ' VAL . 18.7 m-30 -126.59 158.29 36.63 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.259 1.423 . . . . 0.0 110.475 166.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 29.5 tp -126.85 111.81 14.61 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 172.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 79.6 t -78.65 135.01 26.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 170.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 mp -117.35 20.02 13.81 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.197 0.999 . . . . 0.0 111.694 176.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.63 -51.5 67.02 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.576 1.151 . . . . 0.0 112.806 172.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -86.83 -9.75 55.08 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.127 -0.983 . . . . 0.0 111.72 -164.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.6 p -108.16 155.01 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 127.212 2.205 . . . . 0.0 108.773 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -101.68 -46.73 4.85 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.792 0.837 . . . . 0.0 109.01 172.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.1 p -155.36 170.58 21.58 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 123.767 1.746 . . . . 0.0 112.643 -166.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.4 tt -137.72 177.52 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 C-N-CA 129.242 3.017 . . . . 0.0 105.592 -176.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -131.28 170.53 14.48 Favored 'General case' 0 C--O 1.238 0.486 0 O-C-N 121.471 -0.768 . . . . 0.0 110.696 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.3 m -67.5 50.63 0.05 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 128.548 2.739 . . . . 0.0 110.994 167.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -133.0 -72.73 0.51 Allowed 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 103.986 -2.598 . . . . 0.0 103.986 155.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 m -65.9 -27.34 68.12 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 124.393 1.077 . . . . 0.0 111.92 -167.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.663 HD22 HG21 ' A' ' 103' ' ' THR . 8.8 mt -51.36 -35.06 36.83 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.218 1.007 . . . . 0.0 112.54 177.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -72.07 -34.17 61.84 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.1 t -75.54 -34.15 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 O-C-N 121.526 -0.985 . . . . 0.0 110.402 -173.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.2 mp -55.89 -45.77 80.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 170.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.7 t -63.78 -45.99 95.69 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 O-C-N 121.048 -1.033 . . . . 0.0 110.04 175.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -50.24 -39.7 45.45 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.883 1.22 . . . . 0.0 113.247 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 65.6 mt -60.88 -47.81 91.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.203 1.001 . . . . 0.0 109.715 174.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.521 ' HG ' HG12 ' A' ' 109' ' ' VAL . 1.1 tm? -59.57 -47.09 86.91 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.7 mttt -56.69 -46.32 81.26 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 119.063 -0.494 . . . . 0.0 110.675 -175.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.8 t -54.39 -58.41 7.55 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 174.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.482 HD11 HD12 ' A' ' 55' ' ' ILE . 81.5 mt -55.58 -48.18 77.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.619 1.167 . . . . 0.0 111.628 -174.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.5 m -69.01 -14.38 63.01 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 117.651 -1.166 . . . . 0.0 112.947 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 51.3 m -87.42 -45.07 10.86 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.474 1.034 . . . . 0.0 110.506 163.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.8 m -66.19 -17.63 64.85 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 126.112 1.765 . . . . 0.0 115.014 -175.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.94 0.2 9.81 Favored Glycine 0 C--N 1.336 0.552 0 CA-C-O 118.116 -1.38 . . . . 0.0 116.307 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -115.85 -165.31 14.36 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-N 119.859 1.829 . . . . 0.0 113.699 -163.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.401 ' HB3' ' CG2' ' A' ' 122' ' ' VAL . 1.0 OUTLIER -131.61 154.41 48.91 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.888 1.675 . . . . 0.0 108.852 173.202 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.494 ' HB3' HD23 ' A' ' 77' ' ' LEU . 13.5 t80 -123.76 141.48 51.99 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 168.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.71 ' C ' HD23 ' A' ' 89' ' ' LEU . . . -144.38 167.18 23.09 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 119.468 -0.893 . . . . 0.0 112.163 167.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.71 HD23 ' C ' ' A' ' 88' ' ' ALA . 1.4 mt -120.86 160.05 24.23 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -175.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.489 HG21 HD13 ' A' ' 115' ' ' ILE . 26.4 t -134.28 138.34 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -171.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.7 m 58.45 60.23 5.7 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 125.034 1.334 . . . . 0.0 111.952 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -82.74 101.02 1.01 Allowed 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.171 2.581 . . . . 0.0 110.001 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -65.72 170.54 5.12 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.896 1.278 . . . . 0.0 108.899 175.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -72.2 -30.04 64.55 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.167 -0.958 . . . . 0.0 111.449 -175.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.402 ' HE3' ' O ' ' A' ' 95' ' ' LYS . 0.2 OUTLIER -58.42 -45.95 87.43 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 120.804 -1.185 . . . . 0.0 108.896 176.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 31.3 m -79.07 -37.24 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.856 0 CA-C-O 117.355 -1.307 . . . . 0.0 111.261 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -56.36 -30.65 62.93 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 121.292 1.86 . . . . 0.0 109.329 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.62 -38.41 90.12 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.689 177.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.53 ' O ' HG22 ' A' ' 103' ' ' THR . 6.4 p -95.81 -28.41 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -170.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.17 -15.37 63.08 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 124.973 1.309 . . . . 0.0 110.231 177.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.52 -55.28 4.97 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 120.05 1.295 . . . . 0.0 107.881 168.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.28 -43.26 86.9 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.966 2.106 . . . . 0.0 112.191 -163.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.663 HG21 HD22 ' A' ' 70' ' ' LEU . 2.1 t -76.45 -6.34 51.31 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.563 0.745 . . . . 0.0 110.964 177.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.7 m120 52.63 83.56 0.06 Allowed 'General case' 0 C--N 1.346 0.425 0 C-N-CA 129.376 3.071 . . . . 0.0 107.875 -163.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.95 -72.96 0.68 Allowed 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 176.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -61.74 -24.47 66.83 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.77 1.228 . . . . 0.0 110.728 174.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -75.15 5.9 4.89 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 120.777 -1.202 . . . . 0.0 111.313 176.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.9 mt -129.45 -43.39 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 C-N-CA 127.795 2.438 . . . . 0.0 107.829 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.521 HG12 ' HG ' ' A' ' 77' ' ' LEU . 3.3 m -98.25 178.69 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 C-N-CA 127.066 2.146 . . . . 0.0 113.137 -172.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.42 ' HB2' ' HB2' ' A' ' 88' ' ' ALA . 24.7 mmtm -99.58 162.95 12.71 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 124.099 0.96 . . . . 0.0 110.086 170.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -151.18 136.47 10.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -171.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -145.03 167.1 23.47 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.41 1.084 . . . . 0.0 112.668 -169.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.14 -38.64 17.53 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.876 -0.515 . . . . 0.0 111.183 -174.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.1 p -134.64 177.21 7.96 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.524 HD12 HD12 ' A' ' 24' ' ' ILE . 15.1 mm -71.19 -40.56 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.278 174.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.4 t -70.3 -32.63 70.49 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 119.424 1.011 . . . . 0.0 110.143 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -70.7 0.57 6.76 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.617 172.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.39 -37.04 3.83 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 119.259 0.936 . . . . 0.0 109.523 175.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 20.7 ttm -63.67 -55.27 24.77 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.984 1.314 . . . . 0.0 111.788 -160.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -81.61 -18.79 43.52 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.064 0.459 . . . . 0.0 110.265 173.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -80.33 -49.02 12.09 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -162.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.401 ' CG2' ' HB3' ' A' ' 86' ' ' PHE . 4.1 p -42.26 -40.48 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 127.856 2.462 . . . . 0.0 111.461 174.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -58.01 -45.83 86.25 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 125.106 1.362 . . . . 0.0 113.423 177.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.09 34.62 3.08 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.364 1.866 . . . . 0.0 110.778 -166.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.417 ' CG ' ' HE2' ' A' ' 110' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.847 0 C-N-CA 127.076 2.151 . . . . 0.0 111.67 -176.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.9 mtm . . . . . 0 N--CA 1.472 0.637 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 141.61 -79.85 0.26 Allowed Glycine 0 C--N 1.337 0.599 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 80.8 p 53.95 -167.11 0.07 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.282 1.833 . . . . 0.0 112.172 -171.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -99.25 150.04 22.5 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 165.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.5 pttt -149.73 174.82 12.18 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.032 0.933 . . . . 0.0 109.631 178.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.5 mt 70.98 -48.41 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 128.078 2.551 . . . . 0.0 111.579 177.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.5 t60 62.89 -77.72 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.625 2.37 . . . . 0.0 111.031 -178.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 28.3 m170 -61.38 140.14 58.07 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.694 1.598 . . . . 0.0 111.235 -176.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -155.87 126.07 6.63 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 172.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -140.47 145.1 36.49 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 126.335 1.854 . . . . 0.0 106.752 154.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 24.7 p-80 176.34 -50.51 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.3 2.24 . . . . 0.0 109.736 167.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -73.21 167.44 21.17 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 169.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 18.0 ttt -125.4 70.27 1.17 Allowed 'General case' 0 C--O 1.231 0.084 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 174.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 34.08 80.03 0.27 Allowed Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 127.691 2.397 . . . . 0.0 112.345 176.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -78.3 48.06 2.59 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 124.913 3.742 . . . . 0.0 112.105 -169.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -155.57 168.38 27.31 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 127.635 2.374 . . . . 0.0 106.02 -171.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -127.62 176.74 7.28 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 120.791 -1.193 . . . . 0.0 108.451 164.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.9 mt -132.32 120.13 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 171.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.6 m -102.33 -175.93 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 166.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -26.74 -55.95 0.08 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 130.199 3.4 . . . . 0.0 113.95 -157.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -143.5 8.97 1.58 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 118.775 -0.631 . . . . 0.0 111.241 164.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.53 HG11 ' CE2' ' A' ' 56' ' ' PHE . 21.3 t -111.32 115.62 50.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 -172.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 38.9 t -68.3 156.4 7.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 173.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.592 HD12 HD12 ' A' ' 115' ' ' ILE . 10.7 mm -130.6 98.4 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 177.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.53 134.49 45.28 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 120.24 1.382 . . . . 0.0 108.25 168.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 51.6 mtm -128.83 72.7 81.53 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 123.644 0.778 . . . . 0.0 109.551 -177.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.59 145.3 57.73 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.31 2.674 . . . . 0.0 112.577 -176.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.602 HD22 ' H ' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -118.87 -77.8 0.58 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 126.056 1.742 . . . . 0.0 110.452 174.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.602 ' H ' HD22 ' A' ' 28' ' ' ASN . 0.0 OUTLIER -135.56 13.85 3.45 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.001 1.321 . . . . 0.0 111.07 -173.571 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -108.78 18.42 20.8 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 120.967 -1.083 . . . . 0.0 112.103 -162.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 19.8 mt -92.62 68.06 4.68 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 124.146 0.978 . . . . 0.0 109.087 -176.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -81.23 144.24 31.73 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.2 tt -52.83 -37.19 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 CA-C-N 119.006 0.821 . . . . 0.0 111.82 170.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -62.62 -52.73 62.2 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.49 -0.756 . . . . 0.0 109.71 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -76.01 -16.38 59.97 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-O 118.228 -0.892 . . . . 0.0 111.96 177.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.73 -40.8 88.5 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.909 1.231 . . . . 0.0 110.518 171.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -60.6 -39.03 86.63 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 120.433 -1.417 . . . . 0.0 109.575 174.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 90.1 mt -73.04 -23.55 60.6 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.783 1.233 . . . . 0.0 113.05 178.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -53.98 -37.67 64.22 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.175 1.39 . . . . 0.0 110.97 -170.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.412 ' HE2' ' CZ ' ' A' ' 44' ' ' PHE . 0.4 OUTLIER -63.35 -52.49 61.53 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.072 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.89 -47.96 73.64 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 124.815 1.246 . . . . 0.0 109.834 178.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.534 ' CE3' HG23 ' A' ' 43' ' ' VAL . 17.6 t90 -58.57 -69.74 0.17 Allowed 'General case' 0 C--O 1.219 -0.549 0 O-C-N 124.593 1.183 . . . . 0.0 109.79 176.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.534 HG23 ' CE3' ' A' ' 42' ' ' TRP . 71.0 t -52.89 -32.21 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 121.153 1.797 . . . . 0.0 111.549 -175.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.483 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 4.0 m-85 -61.43 -77.15 0.05 OUTLIER 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 123.612 0.765 . . . . 0.0 110.051 172.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.468 ' HA ' ' HB2' ' A' ' 49' ' ' ASN . 0.6 OUTLIER -64.95 -28.47 69.54 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -172.183 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.416 ' HG2' ' CZ ' ' A' ' 47' ' ' PHE . 0.7 OUTLIER -74.9 -30.06 61.17 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.347 1.459 . . . . 0.0 110.445 176.695 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.416 ' CZ ' ' HG2' ' A' ' 46' ' ' GLU . 13.6 m-85 -139.83 -66.71 0.45 Allowed 'General case' 0 C--N 1.348 0.508 0 CA-C-N 119.603 1.092 . . . . 0.0 111.609 -172.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.483 ' HB2' ' HA ' ' A' ' 44' ' ' PHE . 18.5 mt -57.37 -54.35 47.78 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 120.878 -1.139 . . . . 0.0 113.081 -169.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.468 ' HB2' ' HA ' ' A' ' 45' ' ' ASP . 78.4 m-20 -67.48 -34.63 77.56 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 125.864 1.665 . . . . 0.0 109.127 177.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.12 -39.07 71.65 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.106 1.362 . . . . 0.0 111.279 176.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 139.65 8.51 0.94 Allowed Glycine 0 CA--C 1.535 1.334 0 C-N-CA 125.123 1.344 . . . . 0.0 113.93 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -92.34 150.3 20.92 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 119.023 1.412 . . . . 0.0 111.392 -177.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.401 ' O ' ' HA3' ' A' ' 85' ' ' GLY . 1.1 m120 -143.22 44.79 1.55 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.287 1.835 . . . . 0.0 108.247 -172.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.462 ' HG3' HG22 ' A' ' 22' ' ' VAL . 0.0 OUTLIER 171.59 149.84 0.05 OUTLIER 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 126.015 1.726 . . . . 0.0 107.829 179.129 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -153.34 163.0 2.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 105.342 -2.095 . . . . 0.0 105.342 -174.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.53 ' CE2' HG11 ' A' ' 22' ' ' VAL . 9.6 m-85 -136.29 148.88 48.18 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.45 1.5 . . . . 0.0 108.615 169.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 50.5 tp -124.27 110.56 14.77 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.251 1.021 . . . . 0.0 109.808 177.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.3 135.57 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 173.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 mp -123.65 43.25 3.02 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.953 0.882 . . . . 0.0 110.288 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.8 t -99.98 -49.58 4.27 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.945 0.898 . . . . 0.0 109.029 -176.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.82 -14.45 58.04 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.126 -0.984 . . . . 0.0 111.159 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.7 p -106.0 118.71 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 125.596 1.559 . . . . 0.0 107.232 174.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -68.83 -51.63 38.6 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 176.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 86.2 p -157.76 166.62 32.27 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.86 -169.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 21.3 tt -135.49 148.99 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 C-N-CA 124.882 1.273 . . . . 0.0 108.333 -168.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -71.49 155.24 40.81 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.2 p -63.97 -14.35 53.24 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 117.902 -1.047 . . . . 0.0 113.77 -174.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -68.53 -71.37 0.22 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.036 1.334 . . . . 0.0 108.934 172.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 41.0 t -63.0 -34.1 76.84 Favored 'General case' 0 C--N 1.339 0.136 0 O-C-N 121.911 -0.493 . . . . 0.0 111.029 -169.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 50.9 tp -40.66 -39.86 1.16 Allowed 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 125.595 1.558 . . . . 0.0 114.041 169.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.401 ' HA2' HG12 ' A' ' 74' ' ' VAL . . . -107.54 0.25 34.63 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 118.44 0.564 . . . . 0.0 113.246 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.0 t -75.28 -30.05 22.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 O-C-N 120.774 -1.427 . . . . 0.0 108.647 161.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.6 mt -66.87 -61.15 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 125.181 1.392 . . . . 0.0 112.542 175.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.401 HG12 ' HA2' ' A' ' 71' ' ' GLY . 7.4 p -41.77 -49.19 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 168.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -45.79 -36.79 5.42 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.567 1.547 . . . . 0.0 112.863 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 90.8 mt -64.52 -46.87 91.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.295 1.038 . . . . 0.0 108.558 175.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -52.9 -48.6 67.08 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.635 0.774 . . . . 0.0 109.728 176.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -56.49 -43.03 79.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 118.955 -0.545 . . . . 0.0 111.067 -174.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.0 m -57.7 -64.79 0.78 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 118.883 -0.58 . . . . 0.0 111.352 166.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 80' ' ' ILE . 51.1 mt -61.52 -42.71 95.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 119.303 0.956 . . . . 0.0 111.502 -166.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.4 m -57.07 -47.55 80.71 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 119.323 0.965 . . . . 0.0 110.179 175.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.5 m -63.54 -34.28 77.44 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.975 0.807 . . . . 0.0 111.689 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 56.6 m -67.57 -38.08 83.56 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 118.604 -0.712 . . . . 0.0 111.941 173.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 105.03 59.37 0.66 Allowed Glycine 0 N--CA 1.448 -0.52 0 CA-C-O 119.162 -0.799 . . . . 0.0 111.136 -166.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 53' ' ' ASN . . . -148.68 -176.45 22.07 Favored Glycine 0 N--CA 1.439 -1.149 0 CA-C-N 118.891 1.345 . . . . 0.0 111.553 177.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.555 ' HB3' HG22 ' A' ' 122' ' ' VAL . 1.8 m-85 -130.9 92.13 3.17 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 122.084 -0.656 . . . . 0.0 112.439 -158.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -104.76 134.75 47.38 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.839 -1.163 . . . . 0.0 110.545 174.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -142.48 167.43 22.11 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.623 1.569 . . . . 0.0 112.472 175.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.438 ' N ' HD12 ' A' ' 89' ' ' LEU . 7.1 mp -113.9 153.13 29.75 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 127.54 2.336 . . . . 0.0 108.299 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 72.8 t -141.09 135.35 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -166.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.7 t 48.46 56.14 17.66 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.691 1.196 . . . . 0.0 110.645 -170.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -72.42 0.09 7.97 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.304 2.669 . . . . 0.0 114.777 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 18.6 p30 47.63 -163.04 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.733 1.613 . . . . 0.0 112.662 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -95.91 -41.54 8.75 Favored 'General case' 0 C--O 1.225 -0.196 0 O-C-N 120.473 -1.392 . . . . 0.0 109.416 174.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.489 ' O ' ' HE3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -53.74 -50.84 65.1 Favored 'General case' 0 C--O 1.227 -0.126 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -175.548 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.3 t -68.84 -47.52 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-O 118.571 -0.728 . . . . 0.0 109.143 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -60.95 -19.74 61.33 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 120.513 1.506 . . . . 0.0 112.273 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.5 -15.52 63.27 Favored 'General case' 0 C--O 1.216 -0.664 0 O-C-N 120.785 -1.197 . . . . 0.0 111.081 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.414 ' O ' HG22 ' A' ' 103' ' ' THR . 2.6 t -118.59 -34.13 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 C-N-CA 125.822 1.649 . . . . 0.0 108.25 -175.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.45 -14.84 31.85 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 117.617 -1.182 . . . . 0.0 109.08 175.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.8 m -79.69 -29.66 40.83 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 117.907 -1.517 . . . . 0.0 109.813 174.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -92.05 -25.33 18.84 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 129.103 2.961 . . . . 0.0 111.421 -159.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.42 HG23 HD23 ' A' ' 105' ' ' LEU . 3.7 t -113.65 35.44 4.05 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.858 1.663 . . . . 0.0 108.296 174.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 35.21 62.38 0.57 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.524 1.93 . . . . 0.0 110.585 176.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.42 HD23 HG23 ' A' ' 103' ' ' THR . 0.0 OUTLIER -114.54 -51.47 2.75 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -166.671 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.5 -24.49 67.84 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 118.616 0.644 . . . . 0.0 111.308 173.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.6 mtt-85 -80.03 -11.25 59.79 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 118.476 -0.773 . . . . 0.0 112.97 -177.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.0 mt -128.1 -37.13 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 C-N-CA 124.49 1.116 . . . . 0.0 109.577 -167.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.6 t -104.26 141.01 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 171.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.52 158.98 34.17 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.882 1.273 . . . . 0.0 111.295 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.1 mp -130.98 146.36 34.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 124.878 1.271 . . . . 0.0 108.077 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -147.02 168.13 22.3 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 127.286 2.234 . . . . 0.0 109.849 175.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.53 -51.77 7.48 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 75.4 p -130.81 171.6 12.95 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 123.165 0.586 . . . . 0.0 109.715 -171.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.592 HD12 HD12 ' A' ' 24' ' ' ILE . 11.8 mm -66.49 -39.3 83.64 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 CA-C-O 118.074 -0.965 . . . . 0.0 108.837 178.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.2 t -67.27 -36.99 82.72 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 118.862 0.756 . . . . 0.0 109.771 -175.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -62.22 -9.31 7.42 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 124.321 1.049 . . . . 0.0 112.256 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.467 ' HB1' ' CZ ' ' A' ' 56' ' ' PHE . . . -116.79 -34.45 4.47 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 124.676 1.19 . . . . 0.0 109.636 -175.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 12.4 ttp -61.8 -46.18 90.67 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 120.593 -1.317 . . . . 0.0 112.549 -161.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.429 ' HA ' ' HG3' ' A' ' 123' ' ' ARG . 14.6 pt-20 -101.52 -2.63 30.18 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.66 1.984 . . . . 0.0 112.112 176.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -91.49 -62.6 1.4 Allowed 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.555 HG22 ' HB3' ' A' ' 86' ' ' PHE . 0.3 OUTLIER -42.43 -37.4 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.307 0 C-N-CA 127.534 2.334 . . . . 0.0 111.553 174.054 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.429 ' HG3' ' HA ' ' A' ' 120' ' ' GLU . 10.1 mmt180 -44.02 -35.45 2.1 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 125.446 1.498 . . . . 0.0 113.32 174.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.09 22.96 2.23 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 172.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.306 0.1 OUTLIER . . . . . 0 C--O 1.249 1.076 0 C-N-CA 129.436 3.094 . . . . 0.0 116.08 -162.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.5 ptt? . . . . . 0 N--CA 1.472 0.65 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 178.47 -169.46 41.1 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.9 t -82.72 -82.88 0.14 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 175.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -147.9 148.98 31.41 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 119.694 1.134 . . . . 0.0 110.499 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -141.73 161.0 39.03 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.917 1.687 . . . . 0.0 108.671 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.46 124.86 55.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -177.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -72.67 96.55 2.02 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.85 1.26 . . . . 0.0 110.456 -175.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -78.77 170.06 17.26 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.341 -0.849 . . . . 0.0 110.454 168.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 8.1 m80 58.0 -176.21 0.07 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.695 1.598 . . . . 0.0 112.076 -175.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 71.3 m80 52.02 88.68 0.03 OUTLIER 'General case' 0 C--O 1.234 0.241 0 C-N-CA 128.539 2.735 . . . . 0.0 113.435 -177.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -40.02 102.83 0.03 OUTLIER 'General case' 0 C--O 1.24 0.598 0 C-N-CA 128.422 2.689 . . . . 0.0 110.811 -175.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 62.3 t60 -71.5 131.49 43.36 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.23 1.412 . . . . 0.0 109.094 -173.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.4 ttt -168.89 97.46 0.37 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.438 1.895 . . . . 0.0 107.285 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -62.6 165.26 9.75 Favored Pre-proline 0 CA--C 1.551 1.012 0 O-C-N 121.54 -0.725 . . . . 0.0 111.134 172.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.401 ' HG3' HD21 ' A' ' 28' ' ' ASN . 92.0 Cg_endo -74.19 89.23 1.06 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 124.807 3.672 . . . . 0.0 109.977 174.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -153.0 169.37 23.05 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.519 ' HE2' HG12 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -135.01 175.31 9.69 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 121.978 -0.451 . . . . 0.0 110.192 168.21 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 67.4 mt -130.45 119.24 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 126.303 1.841 . . . . 0.0 106.944 175.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.519 HG12 ' HE2' ' A' ' 17' ' ' LYS . 33.7 m -100.59 -154.35 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 127.529 2.331 . . . . 0.0 106.792 174.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -25.94 -77.41 0.01 OUTLIER 'General case' 0 C--O 1.241 0.658 0 C-N-CA 129.805 3.242 . . . . 0.0 111.467 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -148.21 28.07 0.92 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 127.961 2.504 . . . . 0.0 109.828 170.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.648 HG11 ' CE2' ' A' ' 56' ' ' PHE . 20.2 t -119.68 148.03 22.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.7 t -103.7 140.29 22.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 177.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.409 HG13 HD12 ' A' ' 115' ' ' ILE . 1.8 mp -118.22 101.54 11.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 177.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.32 146.55 45.18 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 120.416 1.462 . . . . 0.0 108.453 165.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 69.7 mtm -127.98 79.58 73.54 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 124.63 1.172 . . . . 0.0 108.267 178.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -58.05 135.66 70.02 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.813 2.342 . . . . 0.0 110.636 177.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.401 HD21 ' HG3' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -135.22 -105.36 0.22 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.339 1.856 . . . . 0.0 106.312 169.582 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.92 69.4 1.04 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 121.551 1.978 . . . . 0.0 111.247 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -154.9 4.93 0.23 Allowed 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 115.505 1.668 . . . . 0.0 115.505 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.01 37.63 0.55 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 120.576 1.535 . . . . 0.0 109.988 172.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -77.74 157.4 30.06 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.771 1.629 . . . . 0.0 109.599 171.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 61.1 mt -62.15 -35.82 71.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 123.938 0.895 . . . . 0.0 110.704 -174.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -73.33 -8.86 57.67 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.11 -0.994 . . . . 0.0 111.402 -177.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -113.54 28.83 8.47 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.343 1.857 . . . . 0.0 109.754 171.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.68 -54.51 2.6 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 120.733 -1.229 . . . . 0.0 111.7 -175.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 40.7 t60 -62.07 -52.24 64.73 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 120.623 1.556 . . . . 0.0 109.759 175.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.541 HD12 ' C ' ' A' ' 38' ' ' LEU . 0.5 OUTLIER -59.89 -24.73 64.52 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-O 118.748 -0.644 . . . . 0.0 111.167 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -51.86 -44.76 63.81 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 124.88 1.272 . . . . 0.0 110.625 -177.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -64.68 -44.71 89.46 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.82 -41.45 97.87 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 119.038 0.836 . . . . 0.0 112.205 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 15.6 t90 -58.81 -66.28 0.52 Allowed 'General case' 0 C--O 1.221 -0.401 0 CA-C-O 117.23 -1.367 . . . . 0.0 107.479 173.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.5 t -52.93 -36.11 23.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 120.585 1.539 . . . . 0.0 112.193 -177.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -57.76 -67.0 0.38 Allowed 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 124.04 0.936 . . . . 0.0 110.028 173.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.29 -45.43 66.34 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 121.441 -0.787 . . . . 0.0 111.684 -171.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -62.42 -28.75 70.01 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.939 1.696 . . . . 0.0 111.006 -175.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -136.69 -65.85 0.55 Allowed 'General case' 0 C--N 1.346 0.432 0 C-N-CA 123.19 0.596 . . . . 0.0 111.53 -172.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 44.3 mt -55.58 -53.68 53.5 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.147 0.885 . . . . 0.0 111.822 -168.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -71.5 -34.26 69.96 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.513 1.925 . . . . 0.0 109.834 176.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.03 -30.16 65.92 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 118.242 -0.885 . . . . 0.0 112.021 177.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 140.26 -0.49 2.03 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 119.25 -0.75 . . . . 0.0 113.805 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -92.51 154.81 18.23 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 119.803 1.801 . . . . 0.0 110.347 -174.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -134.85 6.72 3.44 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.806 1.242 . . . . 0.0 109.816 172.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.407 ' HB3' HG13 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -135.86 132.21 36.29 Favored 'General case' 0 CA--C 1.518 -0.288 0 O-C-N 120.583 -1.323 . . . . 0.0 107.769 -176.846 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.9 mt -135.71 154.02 33.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 126.094 1.758 . . . . 0.0 106.422 175.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.704 ' CE1' HG21 ' A' ' 122' ' ' VAL . 20.1 m-85 -129.54 152.71 48.78 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.725 1.61 . . . . 0.0 109.702 163.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 54.8 tp -118.97 112.35 19.49 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 118.149 -0.929 . . . . 0.0 110.069 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.505 ' CG2' HD11 ' A' ' 115' ' ' ILE . 47.2 t -90.72 111.18 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 119.175 0.898 . . . . 0.0 109.474 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.539 HD22 HG11 ' A' ' 96' ' ' VAL . 1.8 mp -91.64 5.23 50.48 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.425 0.69 . . . . 0.0 112.514 -177.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 24.3 m -51.59 -42.13 61.69 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.094 0.958 . . . . 0.0 113.221 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -85.23 -29.26 24.8 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.766 0.712 . . . . 0.0 111.09 -174.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.8 p -80.82 173.1 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 O-C-N 121.34 -0.85 . . . . 0.0 109.158 -173.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -121.56 -46.14 2.27 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 120.588 -1.32 . . . . 0.0 109.31 172.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.9 p -150.1 172.63 14.97 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.537 0.684 . . . . 0.0 112.402 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.3 tt -133.48 153.18 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 126.072 1.749 . . . . 0.0 107.323 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -85.16 162.5 19.2 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 122.579 0.352 . . . . 0.0 110.206 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.2 -36.79 66.31 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.598 0.759 . . . . 0.0 111.903 179.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -55.57 -72.93 0.06 Allowed 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.049 1.74 . . . . 0.0 109.59 -178.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 53.5 m -64.27 -30.86 71.9 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 118.249 -0.881 . . . . 0.0 112.662 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.3 tp -59.39 -16.89 25.89 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 120.521 1.509 . . . . 0.0 112.769 -177.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -90.73 -33.97 8.1 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 118.995 0.816 . . . . 0.0 112.843 167.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.6 t -64.2 -36.84 78.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 O-C-N 121.149 -1.206 . . . . 0.0 110.363 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp -52.72 -51.38 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 175.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.4 t -66.02 -35.74 75.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 O-C-N 120.95 -1.094 . . . . 0.0 110.268 177.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.69 -45.05 82.02 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 119.662 1.119 . . . . 0.0 111.268 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 71.7 mt -59.45 -33.72 52.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 123.438 0.695 . . . . 0.0 109.21 175.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -69.8 -44.9 69.1 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 120.269 1.395 . . . . 0.0 108.44 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 48.7 mttm -58.87 -47.31 85.37 Favored 'General case' 0 C--N 1.335 -0.025 0 CA-C-O 118.584 -0.722 . . . . 0.0 110.151 177.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 31.8 m -51.45 -59.55 4.12 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 123.684 0.794 . . . . 0.0 110.272 172.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 21.1 mt -53.96 -43.76 59.28 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 C-N-CA 124.278 1.031 . . . . 0.0 111.406 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 51.6 p -57.35 -48.77 78.14 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.207 0.912 . . . . 0.0 109.974 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.5 -33.87 76.66 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.762 1.625 . . . . 0.0 111.304 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.4 m -67.76 -16.58 64.19 Favored 'General case' 0 C--N 1.335 -0.056 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 170.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.86 1.09 61.79 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-N 119.196 0.907 . . . . 0.0 113.664 -172.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -92.65 -175.99 41.46 Favored Glycine 0 N--CA 1.432 -1.608 0 CA-C-N 118.892 1.346 . . . . 0.0 112.193 -175.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -136.09 155.92 49.48 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.537 1.535 . . . . 0.0 109.517 178.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -152.39 147.17 25.97 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 175.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -148.04 161.04 42.18 Favored 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 124.152 0.908 . . . . 0.0 111.638 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.449 ' CD1' HG11 ' A' ' 109' ' ' VAL . 7.3 mp -106.73 158.17 17.17 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.795 1.638 . . . . 0.0 108.186 -176.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 84.9 t -142.41 135.67 27.55 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -165.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 46.41 57.82 16.62 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 124.904 1.281 . . . . 0.0 109.656 -173.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -72.32 88.75 0.84 Allowed 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.177 2.584 . . . . 0.0 108.604 -178.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -54.46 148.98 11.05 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.657 0.741 . . . . 0.0 110.647 -175.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -54.49 -34.11 61.02 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.671 1.588 . . . . 0.0 111.582 -168.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -49.15 70.23 Favored 'General case' 0 CA--C 1.521 -0.172 0 O-C-N 120.327 -1.483 . . . . 0.0 108.645 177.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.539 HG11 HD22 ' A' ' 59' ' ' LEU . 1.1 t -62.05 -47.9 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 123.774 0.83 . . . . 0.0 110.386 175.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.43 -36.95 64.57 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.827 2.051 . . . . 0.0 109.846 -172.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.84 -59.07 4.18 Favored 'General case' 0 N--CA 1.424 -1.728 0 C-N-CA 126.731 2.012 . . . . 0.0 111.54 177.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.609 ' O ' HG22 ' A' ' 103' ' ' THR . 8.0 t -65.53 -45.58 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 CA-C-N 111.754 -2.476 . . . . 0.0 107.284 -176.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.81 -17.55 16.6 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.965 0.906 . . . . 0.0 110.222 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 65.6 m -117.0 16.7 15.06 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 124.551 1.157 . . . . 0.0 112.314 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 62.2 mt -123.23 -16.25 6.98 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 129.484 3.114 . . . . 0.0 111.435 169.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.609 HG22 ' O ' ' A' ' 99' ' ' VAL . 4.7 t -113.61 1.13 14.84 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.837 2.055 . . . . 0.0 110.632 -177.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 44.99 81.59 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.811 1.644 . . . . 0.0 110.201 -165.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.52 -53.26 2.53 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 173.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.89 -12.04 51.57 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.372 1.069 . . . . 0.0 112.867 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.4 mtt85 -98.66 4.05 47.88 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.848 1.659 . . . . 0.0 111.199 -178.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.3 mt -132.84 -37.24 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 126.031 1.732 . . . . 0.0 110.019 -173.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.449 HG11 ' CD1' ' A' ' 89' ' ' LEU . 2.7 t -111.15 149.78 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 177.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.24 159.01 35.4 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.224 0.61 . . . . 0.0 109.888 174.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -131.99 151.47 35.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 125.041 1.337 . . . . 0.0 108.625 178.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -148.02 173.0 13.35 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 127.055 2.142 . . . . 0.0 110.639 173.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.57 -39.24 14.27 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 123.563 0.745 . . . . 0.0 109.231 177.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 25.2 p -136.86 170.48 16.02 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.043 0.937 . . . . 0.0 110.837 -173.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.505 HD11 ' CG2' ' A' ' 58' ' ' VAL . 19.9 mm -63.94 -45.36 97.1 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 CA-C-O 117.754 -1.117 . . . . 0.0 108.587 172.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.3 t -67.38 -36.72 81.9 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 119.228 0.922 . . . . 0.0 109.134 -169.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -70.87 -15.35 62.62 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 176.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.715 ' O ' HG23 ' A' ' 122' ' ' VAL . . . -86.48 -49.34 7.66 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 174.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.95 -52.24 63.61 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.762 1.225 . . . . 0.0 111.316 -160.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.06 -7.98 54.49 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 127.906 2.482 . . . . 0.0 114.446 176.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -104.28 -53.25 2.76 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 118.795 0.725 . . . . 0.0 109.355 -169.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 118' ' ' ALA . 12.8 t -50.68 -33.63 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 C-N-CA 129.336 3.054 . . . . 0.0 110.39 172.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -43.46 -36.96 2.18 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.006 0.922 . . . . 0.0 113.243 166.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.57 24.08 3.15 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 116.452 2.019 . . . . 0.0 116.452 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 31.5 mmtt . . . . . 0 C--O 1.255 1.383 0 C-N-CA 129.56 3.144 . . . . 0.0 103.174 177.666 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ttp . . . . . 0 N--CA 1.473 0.703 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.91 49.03 0.22 Allowed Glycine 0 CA--C 1.52 0.393 0 CA-C-N 119.086 0.857 . . . . 0.0 111.446 -177.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.7 m 62.3 -22.04 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 128.509 2.723 . . . . 0.0 116.295 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.5 t70 25.01 86.76 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 129.754 3.222 . . . . 0.0 113.806 175.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.2 tttm -151.8 161.8 42.07 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 121.023 -1.048 . . . . 0.0 109.437 176.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.7 tt -83.86 123.27 38.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 166.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -74.57 115.27 13.92 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 169.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -157.88 97.25 1.54 Allowed 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 160.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -151.9 74.88 1.12 Allowed 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.768 -0.583 . . . . 0.0 109.733 174.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -92.83 42.37 1.1 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 122.092 0.949 . . . . 0.0 111.659 178.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -123.07 165.59 16.56 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 154.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 -152.76 56.54 0.8 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 121.287 0.565 . . . . 0.0 110.18 171.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 9.2 ptm -133.96 61.67 1.67 Allowed 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.94 0.896 . . . . 0.0 110.805 -168.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -68.77 154.69 94.46 Favored Pre-proline 0 CA--C 1.544 0.743 0 O-C-N 121.205 -0.935 . . . . 0.0 111.062 170.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -76.29 89.14 1.28 Allowed 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 124.226 3.284 . . . . 0.0 110.993 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -157.14 156.78 33.28 Favored 'General case' 0 C--O 1.239 0.533 0 O-C-N 121.482 -0.761 . . . . 0.0 110.039 175.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.88 170.27 10.28 Favored 'General case' 0 N--CA 1.46 0.069 0 C-N-CA 123.937 0.895 . . . . 0.0 110.286 169.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.1 mt -131.49 150.57 34.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 174.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.4 m -120.27 -133.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 126.408 1.883 . . . . 0.0 107.03 176.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -46.38 -75.41 0.03 OUTLIER 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 127.565 2.346 . . . . 0.0 111.312 -177.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -143.35 27.79 1.54 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.821 1.649 . . . . 0.0 108.434 172.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.749 HG11 ' CE2' ' A' ' 56' ' ' PHE . 11.7 t -121.73 138.94 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 C-N-CA 124.172 0.989 . . . . 0.0 108.451 -175.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 72.5 t -99.21 140.44 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 125.668 1.587 . . . . 0.0 107.546 -178.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mp -119.42 95.98 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 126.402 1.881 . . . . 0.0 105.957 -178.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 31.5 mt -84.8 126.28 33.3 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 177.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 56.1 mtm -125.76 92.02 47.25 Favored Pre-proline 0 N--CA 1.464 0.274 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.76 106.53 1.68 Allowed 'Trans proline' 0 N--CA 1.45 -1.074 0 N-CA-C 108.28 -1.469 . . . . 0.0 108.28 176.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -74.79 55.53 0.68 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.264 1.026 . . . . 0.0 111.549 172.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.99 41.11 3.76 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.447 1.499 . . . . 0.0 112.866 -173.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -105.75 48.85 0.82 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-O 122.222 1.01 . . . . 0.0 110.317 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.61 68.36 8.66 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 123.483 1.611 . . . . 0.0 108.185 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -68.05 3.23 1.67 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 129.577 3.151 . . . . 0.0 114.977 -174.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 mt 65.65 -56.3 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 129.795 3.238 . . . . 0.0 111.378 -167.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -63.81 -31.98 73.34 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 118.258 0.481 . . . . 0.0 109.777 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -59.4 -60.1 4.39 Favored 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 124.147 0.979 . . . . 0.0 109.117 165.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.454 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . . . -51.19 -38.91 54.96 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 120.515 1.507 . . . . 0.0 114.448 -178.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -67.86 -34.04 75.92 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.702 1.137 . . . . 0.0 111.881 178.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.17 -19.0 30.74 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-O 118.154 -0.927 . . . . 0.0 110.883 177.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.454 ' HB2' ' HA ' ' A' ' 36' ' ' ALA . 5.7 t80 -46.62 -49.96 18.26 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 127.917 2.487 . . . . 0.0 110.299 -172.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.0 -57.22 11.07 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 124.6 1.16 . . . . 0.0 109.917 175.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -56.55 -48.98 76.13 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 124.561 1.145 . . . . 0.0 112.07 178.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -56.54 -71.77 0.09 Allowed 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 117.574 -1.203 . . . . 0.0 108.055 178.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.6 t -46.39 -42.72 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.089 0.955 . . . . 0.0 109.373 -177.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 -60.22 -59.97 4.57 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 120.606 1.548 . . . . 0.0 111.643 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -68.63 -4.04 14.09 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.619 1.568 . . . . 0.0 111.991 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -107.17 -33.04 7.56 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 116.413 -1.756 . . . . 0.0 108.956 -177.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.619 ' HB2' HD22 ' A' ' 48' ' ' LEU . 54.4 m-85 -134.57 -49.81 0.78 Allowed 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 123.603 2.91 . . . . 0.0 109.335 -174.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.619 HD22 ' HB2' ' A' ' 47' ' ' PHE . 1.9 mm? -69.49 -57.0 5.79 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 124.039 0.936 . . . . 0.0 110.666 -169.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -62.81 -27.22 69.17 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.571 0.748 . . . . 0.0 109.781 174.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -66.66 -20.14 65.92 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.862 1.665 . . . . 0.0 113.616 171.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.02 6.18 46.02 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.297 1.427 . . . . 0.0 114.787 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -76.57 149.81 36.58 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 119.994 1.897 . . . . 0.0 110.236 172.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -130.02 6.18 5.0 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.216 1.006 . . . . 0.0 112.791 -178.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.512 ' HB3' HG13 ' A' ' 22' ' ' VAL . 1.5 mtmt -133.16 113.09 12.3 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 120.683 1.583 . . . . 0.0 106.856 178.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.0 mp -118.11 151.2 20.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 104.732 -2.321 . . . . 0.0 104.732 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.749 ' CE2' HG11 ' A' ' 22' ' ' VAL . 20.3 m-85 -132.89 160.28 37.45 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 124.525 1.13 . . . . 0.0 110.318 166.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.4 tp -137.72 86.89 2.21 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.866 1.266 . . . . 0.0 108.71 175.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.569 HG12 ' H ' ' A' ' 60' ' ' SER . 95.0 t -60.74 138.57 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 128.428 2.691 . . . . 0.0 107.2 168.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.582 HD22 HG21 ' A' ' 96' ' ' VAL . 2.9 mp -117.81 37.08 4.06 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.29 1.836 . . . . 0.0 109.445 173.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.569 ' H ' HG12 ' A' ' 58' ' ' VAL . 19.9 t -76.42 -38.85 54.98 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.278 1.431 . . . . 0.0 110.688 178.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.97 2.62 51.77 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.917 0.78 . . . . 0.0 111.604 -173.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.3 p -133.24 174.52 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 127.977 2.511 . . . . 0.0 107.464 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -118.4 -31.38 4.95 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.298 0.639 . . . . 0.0 111.64 177.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.1 t -159.01 158.86 34.0 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.746 0.784 . . . . 0.0 112.478 165.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -76.84 166.29 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-N 113.874 -1.512 . . . . 0.0 108.531 160.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -103.8 159.47 15.61 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.206 1.402 . . . . 0.0 110.608 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.34 6.17 0.84 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.615 1.166 . . . . 0.0 113.491 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -76.87 -78.22 0.13 Allowed 'General case' 0 CA--C 1.535 0.376 0 O-C-N 120.956 -1.09 . . . . 0.0 108.766 155.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.8 t -69.93 -13.74 62.39 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -169.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.488 HD21 HG21 ' A' ' 103' ' ' THR . 33.1 tp -47.06 -31.31 3.26 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.054 1.342 . . . . 0.0 111.674 168.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.06 -28.14 31.97 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 121.458 -0.776 . . . . 0.0 114.466 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 45.7 t -75.27 -35.81 34.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 124.45 1.1 . . . . 0.0 109.59 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.6 mm -55.59 -49.79 71.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 123.75 0.82 . . . . 0.0 110.359 175.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 38.7 t -60.34 -41.34 86.84 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.213 0 CA-C-N 118.123 0.419 . . . . 0.0 110.13 177.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -53.25 -44.67 68.34 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.41 1.005 . . . . 0.0 112.413 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.64 -36.17 73.89 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 123.156 0.582 . . . . 0.0 109.593 177.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -64.7 -42.91 94.95 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.289 0.95 . . . . 0.0 109.479 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 55.1 mttt -60.27 -45.27 93.9 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 118.569 0.622 . . . . 0.0 111.309 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 30.0 m -54.95 -52.13 63.99 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.154 0.182 . . . . 0.0 111.434 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 59.4 mt -65.1 -41.62 92.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 122.585 0.354 . . . . 0.0 110.741 -175.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.2 t -48.38 -59.68 3.27 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.168 1.787 . . . . 0.0 108.127 173.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.7 m -64.8 -33.08 75.13 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.3 m -67.45 -20.41 65.49 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 113.834 1.049 . . . . 0.0 113.834 174.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 94.23 9.99 58.78 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-O 119.067 -0.852 . . . . 0.0 113.5 -171.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -88.03 -173.03 47.54 Favored Glycine 0 N--CA 1.434 -1.441 0 CA-C-N 119.449 1.625 . . . . 0.0 111.456 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.527 ' HB3' HG22 ' A' ' 122' ' ' VAL . 2.7 m-85 -130.54 149.99 51.95 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 126.184 1.793 . . . . 0.0 106.692 171.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -141.06 145.34 35.73 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 174.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -149.61 163.06 38.9 Favored 'General case' 0 N--CA 1.441 -0.888 0 O-C-N 123.79 0.681 . . . . 0.0 111.755 176.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.7 mt -97.68 167.78 10.75 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 123.397 0.679 . . . . 0.0 109.429 176.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.514 HG13 ' N ' ' A' ' 58' ' ' VAL . 0.5 OUTLIER -148.59 152.08 12.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 124.702 1.201 . . . . 0.0 111.096 -175.31 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.6 t 39.92 63.64 4.88 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 127.15 2.18 . . . . 0.0 110.825 178.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.14 175.27 7.81 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.252 1.968 . . . . 0.0 110.341 177.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -127.34 166.53 17.65 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 173.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -58.02 -41.71 83.76 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 124.519 1.127 . . . . 0.0 109.305 174.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -26.08 66.77 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 126.513 1.925 . . . . 0.0 110.65 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.618 HG13 HD13 ' A' ' 100' ' ' LEU . 1.5 t -88.62 -49.38 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 CA-C-O 115.777 -2.059 . . . . 0.0 109.071 177.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.38 -34.85 64.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 122.547 2.431 . . . . 0.0 110.297 177.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -31.01 72.04 Favored 'General case' 0 C--O 1.219 -0.511 0 O-C-N 121.395 -0.815 . . . . 0.0 111.479 -178.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.669 HG13 HD12 ' A' ' 100' ' ' LEU . 7.4 p -100.0 -41.31 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -174.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.669 HD12 HG13 ' A' ' 99' ' ' VAL . 6.9 mp -65.84 -14.58 61.71 Favored 'General case' 0 N--CA 1.434 -1.271 0 C-N-CA 125.972 1.709 . . . . 0.0 112.617 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.74 -41.5 10.1 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 117.328 -1.749 . . . . 0.0 108.197 171.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.48 -34.57 78.6 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.747 1.619 . . . . 0.0 112.486 -172.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.575 HG22 ' O ' ' A' ' 99' ' ' VAL . 9.0 t -93.25 -2.05 55.48 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 118.094 -0.955 . . . . 0.0 111.701 177.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.439 ' HB3' ' HD3' ' A' ' 107' ' ' ARG . 48.9 m-80 56.86 83.49 0.1 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.633 1.173 . . . . 0.0 109.201 -163.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.45 ' HB3' ' HG ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -122.55 -58.58 1.68 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 127.876 2.47 . . . . 0.0 109.878 174.717 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.83 -20.14 65.57 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.698 0.799 . . . . 0.0 111.215 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.439 ' HD3' ' HB3' ' A' ' 104' ' ' ASN . 4.5 ptm85 -84.06 -15.35 47.8 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 177.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 13.9 mm -88.85 -36.79 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 C-N-CA 126.358 1.863 . . . . 0.0 106.06 -172.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.48 149.63 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 124.61 1.194 . . . . 0.0 112.297 -172.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -57.25 156.94 6.79 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.357 0.663 . . . . 0.0 110.807 168.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.12 149.22 16.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 -178.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -140.3 165.04 28.47 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 124.845 1.258 . . . . 0.0 113.389 -170.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.82 -52.35 5.16 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.136 0.974 . . . . 0.0 109.753 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 53.3 p -125.12 175.06 7.63 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.549 1.14 . . . . 0.0 109.359 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.435 HD13 ' HA ' ' A' ' 115' ' ' ILE . 5.6 mm -63.84 -45.08 98.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 118.441 -0.79 . . . . 0.0 109.008 167.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.4 t -71.29 -28.18 63.94 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 119.384 -0.927 . . . . 0.0 110.427 -169.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -69.14 -20.56 64.03 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 119.201 0.91 . . . . 0.0 111.181 173.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -92.51 -49.6 6.04 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 -173.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.99 -60.51 2.71 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.924 2.09 . . . . 0.0 111.539 -166.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -86.61 -16.31 37.13 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.553 0.741 . . . . 0.0 111.012 -175.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -77.54 -59.92 2.58 Favored 'General case' 0 C--O 1.216 -0.695 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.527 HG22 ' HB3' ' A' ' 86' ' ' PHE . 0.3 OUTLIER -47.85 -28.7 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 126.949 2.1 . . . . 0.0 112.987 -174.622 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.86 -28.1 65.79 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.484 2.314 . . . . 0.0 113.45 173.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.72 39.51 0.16 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.858 2.063 . . . . 0.0 112.799 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.074 0 C-N-CA 125.776 1.63 . . . . 0.0 110.323 -174.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.7 ttp . . . . . 0 N--CA 1.471 0.616 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.5 -72.44 1.0 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 -170.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.7 t -63.26 165.0 7.96 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 159.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 43.24 68.98 0.44 Allowed 'General case' 0 C--O 1.236 0.351 0 C-N-CA 128.067 2.547 . . . . 0.0 110.632 172.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.85 -36.28 10.24 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.281 -163.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.8 mm 26.93 95.45 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 130.571 3.549 . . . . 0.0 113.037 171.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -60.88 103.93 0.31 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.886 0.875 . . . . 0.0 110.726 175.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -56.48 135.39 54.35 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 172.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 52.7 m170 -138.01 179.94 6.14 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.63 1.172 . . . . 0.0 109.144 176.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 65.31 27.77 11.98 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.896 1.279 . . . . 0.0 114.009 170.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -69.09 89.19 0.43 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.465 1.906 . . . . 0.0 109.903 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -150.82 83.67 1.34 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.077 1.351 . . . . 0.0 109.095 -178.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 13.9 mtm -155.69 130.1 8.95 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.848 1.659 . . . . 0.0 106.993 168.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -110.95 86.39 5.92 Favored Pre-proline 0 N--CA 1.443 -0.796 0 C-N-CA 125.125 1.37 . . . . 0.0 110.864 176.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -76.22 51.09 3.07 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 123.986 3.124 . . . . 0.0 110.685 167.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -159.83 166.96 29.26 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 120.968 -1.082 . . . . 0.0 111.111 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.3 pttt -135.46 170.29 16.17 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 126.073 1.749 . . . . 0.0 109.343 166.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 40.4 mt -120.65 138.28 51.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 C-N-CA 125.296 1.438 . . . . 0.0 107.626 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.492 ' CG2' HD13 ' A' ' 24' ' ' ILE . 76.9 t -131.8 164.67 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 C-N-CA 127.761 2.425 . . . . 0.0 106.769 -177.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -25.07 -63.31 0.06 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 129.553 3.141 . . . . 0.0 113.136 -163.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -145.75 54.01 1.17 Allowed 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 160.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.753 HG11 ' CE2' ' A' ' 56' ' ' PHE . 13.6 t -140.04 152.68 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 124.45 1.1 . . . . 0.0 109.197 170.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.414 ' C ' HD12 ' A' ' 24' ' ' ILE . 13.9 t -111.96 138.47 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.492 HD13 ' CG2' ' A' ' 19' ' ' VAL . 1.8 mp -118.33 106.18 19.2 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.599 HD22 ' CG2' ' A' ' 55' ' ' ILE . 1.9 mp -82.17 63.13 6.23 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.831 2.052 . . . . 0.0 108.271 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.7 mmm -60.05 98.4 0.14 Allowed Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 126.219 1.808 . . . . 0.0 110.805 -175.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -68.26 -47.42 1.64 Allowed 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 122.918 2.412 . . . . 0.0 109.834 -172.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 31.21 54.67 0.22 Allowed 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 120.88 1.673 . . . . 0.0 113.231 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 78.24 22.77 0.75 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.788 2.035 . . . . 0.0 112.527 173.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -118.31 69.78 0.8 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.617 1.567 . . . . 0.0 108.327 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.4 mt -129.72 20.28 5.56 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.832 1.253 . . . . 0.0 111.581 -177.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -49.51 142.48 7.93 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 131.067 3.747 . . . . 0.0 109.533 -177.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 28.9 mt -55.2 -46.66 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 121.049 1.749 . . . . 0.0 111.551 -176.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -80.6 2.96 23.45 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.207 -0.933 . . . . 0.0 112.772 -176.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -89.42 -57.08 3.01 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 153.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.8 -32.28 19.56 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.112 1.765 . . . . 0.0 114.08 -175.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -66.98 -53.17 34.12 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.53 1.059 . . . . 0.0 110.868 175.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.252 0.0 OUTLIER -81.29 -11.27 59.4 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 120.782 -1.199 . . . . 0.0 112.385 -177.492 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -34.83 -57.4 0.54 Allowed 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 129.275 3.03 . . . . 0.0 112.054 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -60.99 -48.95 79.45 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-O 118.542 -0.742 . . . . 0.0 109.34 -176.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -57.91 -46.35 85.09 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 119.494 1.043 . . . . 0.0 110.656 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.464 ' CE3' HG23 ' A' ' 43' ' ' VAL . 5.5 t90 -56.72 -61.05 2.7 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 108.876 -0.786 . . . . 0.0 108.876 174.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.464 HG23 ' CE3' ' A' ' 42' ' ' TRP . 53.0 t -52.23 -33.01 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 124.37 1.068 . . . . 0.0 113.038 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -64.23 -69.57 0.27 Allowed 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 125.19 1.396 . . . . 0.0 108.815 172.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -80.05 -11.33 59.78 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -166.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.427 ' HG2' ' CZ ' ' A' ' 47' ' ' PHE . 1.7 tp10 -88.51 -27.88 21.17 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.27 1.428 . . . . 0.0 110.74 174.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.427 ' CZ ' ' HG2' ' A' ' 46' ' ' GLU . 21.0 m-85 -135.55 -64.18 0.64 Allowed 'General case' 0 C--N 1.347 0.482 0 CA-C-N 119.513 1.051 . . . . 0.0 111.858 -170.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 41.3 mt -48.6 -55.12 12.08 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 118.518 0.599 . . . . 0.0 111.226 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -86.25 1.71 49.86 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.394 0.678 . . . . 0.0 110.963 -173.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.5 3.63 55.12 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 127.599 2.36 . . . . 0.0 112.038 173.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.04 40.23 25.53 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 119.446 1.021 . . . . 0.0 112.564 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -110.45 165.68 11.6 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 160.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -140.81 3.75 1.86 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.557 2.343 . . . . 0.0 112.141 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.581 ' C ' HD12 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -140.42 133.19 28.99 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 121.135 1.789 . . . . 0.0 109.239 -175.806 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.599 ' CG2' HD22 ' A' ' 25' ' ' LEU . 1.9 mp -133.69 149.87 31.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 128.252 2.621 . . . . 0.0 105.206 -172.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.753 ' CE2' HG11 ' A' ' 22' ' ' VAL . 23.5 m-85 -136.23 150.46 48.98 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.087 0.955 . . . . 0.0 112.563 168.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.1 tp -118.35 78.3 1.25 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.475 1.11 . . . . 0.0 110.25 175.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.446 ' N ' HG13 ' A' ' 90' ' ' VAL . 99.5 t -60.11 102.34 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 C-N-CA 126.586 1.955 . . . . 0.0 109.042 172.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.625 HD22 HG21 ' A' ' 96' ' ' VAL . 1.6 mt -86.61 14.25 7.25 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.809 2.444 . . . . 0.0 112.11 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.8 t -63.5 -50.55 69.19 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.802 0.841 . . . . 0.0 112.052 -168.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -83.48 -10.99 58.0 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.342 1.057 . . . . 0.0 110.65 -166.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.5 p -109.61 168.0 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 128.809 2.844 . . . . 0.0 106.712 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.48 -34.53 8.2 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.527 -0.733 . . . . 0.0 110.079 173.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.754 ' HA ' HG23 ' A' ' 96' ' ' VAL . 67.8 p -153.15 167.31 29.69 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 -176.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.4 tt -102.16 151.8 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 162.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -94.89 164.96 12.69 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 124.259 1.023 . . . . 0.0 111.109 -178.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.5 m -76.48 52.65 0.8 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.321 1.848 . . . . 0.0 110.654 176.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -133.44 -68.1 0.59 Allowed 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 158.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.5 t -64.31 -24.46 67.66 Favored 'General case' 0 C--N 1.342 0.267 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 60.6 tp -55.81 -16.54 4.6 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 120.819 -1.176 . . . . 0.0 114.103 177.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -91.5 -34.14 7.61 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 119.946 1.248 . . . . 0.0 112.083 168.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.7 t -64.63 -38.31 82.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 126.295 1.838 . . . . 0.0 110.389 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.3 mm -54.96 -48.93 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 125.292 1.437 . . . . 0.0 110.662 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.9 t -63.89 -45.64 96.4 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.471 0 O-C-N 121.144 -0.972 . . . . 0.0 108.648 176.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.17 -39.26 72.06 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.857 0.753 . . . . 0.0 110.977 -177.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.6 mt -59.62 -44.43 93.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 125.642 1.577 . . . . 0.0 110.628 170.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.419 HD22 HG22 ' A' ' 109' ' ' VAL . 12.5 tp -60.46 -50.67 72.66 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 120.325 -1.484 . . . . 0.0 109.214 177.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 48.3 mttt -59.42 -15.17 15.37 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.52 -0.738 . . . . 0.0 111.217 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.5 t -85.91 -48.56 8.61 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.63 0.772 . . . . 0.0 109.674 172.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 30.6 mt -62.44 -41.93 93.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 O-C-N 120.3 -1.5 . . . . 0.0 110.619 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.6 m -76.53 -5.26 46.81 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 173.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 45.6 t -74.84 -48.07 27.03 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 120.949 -1.094 . . . . 0.0 108.443 159.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.8 m -66.49 -56.03 12.82 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.409 1.084 . . . . 0.0 113.495 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.31 13.49 4.8 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.32 0.962 . . . . 0.0 113.81 -167.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -86.46 -163.58 38.56 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-N 119.141 1.471 . . . . 0.0 111.508 174.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -136.31 162.14 33.84 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.459 1.504 . . . . 0.0 110.023 176.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -158.8 139.53 12.7 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 123.959 0.904 . . . . 0.0 109.192 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.507 ' C ' HD23 ' A' ' 89' ' ' LEU . . . -145.25 171.7 14.19 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 121.171 0.51 . . . . 0.0 112.239 175.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.507 HD23 ' C ' ' A' ' 88' ' ' ALA . 0.7 OUTLIER -111.08 170.04 8.37 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 176.174 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.446 HG13 ' N ' ' A' ' 58' ' ' VAL . 0.5 OUTLIER -151.17 144.46 16.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 124.73 1.212 . . . . 0.0 110.739 -165.688 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.9 t 42.79 58.73 11.24 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 125.861 1.664 . . . . 0.0 111.52 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.57 166.34 26.17 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.489 2.126 . . . . 0.0 109.916 176.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -129.68 170.41 13.85 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 174.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -60.55 -42.56 96.81 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.287 1.035 . . . . 0.0 110.212 -176.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.1 -27.22 68.77 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.692 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.754 HG23 ' HA ' ' A' ' 64' ' ' SER . 0.5 OUTLIER -86.23 -47.12 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-O 118.635 -0.698 . . . . 0.0 109.607 179.261 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -53.63 -44.46 69.56 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 125.581 1.552 . . . . 0.0 108.648 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.19 -23.38 67.29 Favored 'General case' 0 C--O 1.218 -0.592 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.786 -169.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.9 t -95.84 -48.52 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 C-N-CA 126.014 1.726 . . . . 0.0 107.35 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.83 -21.63 57.04 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.108 0.963 . . . . 0.0 109.334 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.7 m -85.05 -11.83 54.45 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.865 0.866 . . . . 0.0 112.874 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 32.6 mt -119.81 -39.7 2.82 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 126.18 1.792 . . . . 0.0 111.033 -166.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.5 t -81.95 1.89 33.29 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.307 1.843 . . . . 0.0 111.095 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 51.18 78.05 0.12 Allowed 'General case' 0 C--N 1.345 0.408 0 C-N-CA 127.386 2.274 . . . . 0.0 111.03 -169.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.78 -57.75 1.61 Allowed 'General case' 0 C--O 1.227 -0.099 0 C-N-CA 123.909 0.883 . . . . 0.0 108.94 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.24 -24.8 66.62 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.548 1.139 . . . . 0.0 111.205 177.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.02 -7.62 59.35 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.6 mt -115.03 -47.63 4.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 125.651 1.58 . . . . 0.0 107.789 -174.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.419 HG22 HD22 ' A' ' 77' ' ' LEU . 0.7 OUTLIER -100.59 143.38 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 123.14 0.576 . . . . 0.0 110.291 178.375 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.9 161.86 12.15 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 124.141 0.976 . . . . 0.0 112.041 176.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.67 146.14 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -177.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -143.46 172.39 12.84 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 125.722 1.609 . . . . 0.0 110.399 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.64 -40.24 10.86 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.781 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 64.0 p -134.27 167.58 20.43 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.765 1.226 . . . . 0.0 108.792 -171.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.417 HD13 ' HA ' ' A' ' 115' ' ' ILE . 4.7 mm -69.75 -40.55 79.28 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.0 t -78.31 -4.74 49.51 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.194 0.907 . . . . 0.0 111.957 -176.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -90.38 -10.51 43.67 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 118.329 -0.843 . . . . 0.0 110.755 166.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.476 ' HB1' ' CE1' ' A' ' 56' ' ' PHE . . . -99.25 -44.5 6.22 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.418 1.087 . . . . 0.0 109.606 177.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -60.26 -40.48 90.48 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 127.801 2.44 . . . . 0.0 115.828 -161.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -112.59 4.31 17.21 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 126.836 2.054 . . . . 0.0 111.31 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -99.64 -63.66 1.11 Allowed 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -46.82 -30.47 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 127.44 2.296 . . . . 0.0 113.04 -176.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 12.1 mtt180 -53.64 -20.51 5.36 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.382 -0.824 . . . . 0.0 112.358 174.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.1 24.34 1.46 Allowed 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 115.151 1.538 . . . . 0.0 115.151 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 116.71 -1.614 . . . . 0.0 110.478 -161.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.475 0.812 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 126.7 136.44 4.38 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 107.909 -2.076 . . . . 0.0 107.909 -168.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.4 m -159.16 161.93 36.3 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 127.48 2.312 . . . . 0.0 106.399 168.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -129.27 -62.85 0.97 Allowed 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -170.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 44.8 mttt 50.2 65.01 1.56 Allowed 'General case' 0 C--O 1.235 0.293 0 C-N-CA 126.324 1.85 . . . . 0.0 110.848 -173.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 89.2 mt -110.61 102.81 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 104.489 -2.411 . . . . 0.0 104.489 173.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -158.47 122.97 4.14 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 167.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -145.79 117.85 8.3 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.458 1.103 . . . . 0.0 108.693 170.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -159.41 164.74 34.35 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.201 1.8 . . . . 0.0 107.455 171.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 60.82 179.36 0.1 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.597 1.159 . . . . 0.0 113.768 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 21.8 t60 58.55 28.68 17.38 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.048 2.139 . . . . 0.0 114.739 175.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -79.54 142.68 35.53 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.572 -0.705 . . . . 0.0 109.395 164.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 13.9 mmm -143.26 104.81 4.31 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 127.069 2.148 . . . . 0.0 108.107 175.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 36.6 62.48 3.04 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 127.32 2.248 . . . . 0.0 112.555 -170.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -74.71 -162.87 0.16 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.961 2.441 . . . . 0.0 110.271 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -57.6 164.11 2.16 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.23 1.012 . . . . 0.0 113.559 -175.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.27 173.51 11.46 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.7 1.2 . . . . 0.0 108.776 174.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 70.7 mt -133.35 104.1 6.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 174.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.452 HG22 HD11 ' A' ' 24' ' ' ILE . 21.7 m -77.74 -171.87 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 166.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -24.59 -68.58 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 128.835 2.854 . . . . 0.0 115.319 -167.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -142.26 19.12 2.08 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 128.279 2.632 . . . . 0.0 109.72 177.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.579 HG11 ' CE2' ' A' ' 56' ' ' PHE . 6.7 t -127.84 133.57 67.13 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 CA-C-O 123.678 1.704 . . . . 0.0 108.783 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.586 ' O ' HD13 ' A' ' 24' ' ' ILE . 1.0 OUTLIER -92.66 153.87 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.686 0 CA-C-N 112.151 -2.295 . . . . 0.0 107.044 -175.374 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.586 HD13 ' O ' ' A' ' 23' ' ' VAL . 2.4 mm -138.17 91.36 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.55 118.86 10.74 Favored 'General case' 0 C--O 1.226 -0.174 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 165.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.476 ' HA ' HG22 ' A' ' 58' ' ' VAL . 4.9 mtm -116.65 80.65 10.75 Favored Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 104.829 -2.286 . . . . 0.0 104.829 -176.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -74.47 168.05 25.72 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.256 2.638 . . . . 0.0 112.051 -168.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.442 HD22 ' H ' ' A' ' 29' ' ' LYS . 0.6 OUTLIER -145.86 -106.73 0.1 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.703 1.201 . . . . 0.0 108.853 -178.883 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.442 ' H ' HD22 ' A' ' 28' ' ' ASN . 1.7 mppt? -103.67 3.56 34.48 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.036 1.335 . . . . 0.0 111.53 174.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -76.18 -1.77 27.91 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.244 1.017 . . . . 0.0 113.275 -174.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 17.7 mt -77.33 21.67 0.25 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.902 1.681 . . . . 0.0 113.662 -176.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -37.24 133.78 0.65 Allowed 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 127.343 2.257 . . . . 0.0 109.343 166.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.1 tt -52.07 -34.42 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 124.309 1.044 . . . . 0.0 111.987 -176.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -70.2 -37.67 75.13 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.147 -0.97 . . . . 0.0 112.081 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -67.09 -46.5 74.06 Favored 'General case' 0 C--O 1.219 -0.521 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 168.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.91 -44.1 66.71 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.97 0.804 . . . . 0.0 112.187 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 14.3 t-160 -65.34 -43.46 90.82 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 119.93 1.241 . . . . 0.0 111.144 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.26 -14.97 59.66 Favored 'General case' 0 C--O 1.218 -0.554 0 O-C-N 121.574 -0.704 . . . . 0.0 110.379 -178.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -50.25 -44.35 53.51 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 127.167 2.187 . . . . 0.0 111.015 -173.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.436 ' HE3' ' CZ ' ' A' ' 44' ' ' PHE . 0.4 OUTLIER -67.35 -41.6 84.9 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-O 117.823 -1.084 . . . . 0.0 111.266 176.061 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -58.65 -48.58 80.57 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 120.324 1.42 . . . . 0.0 110.346 174.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -58.76 -61.64 2.47 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-O 117.738 -1.125 . . . . 0.0 108.186 177.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.4 t -52.78 -37.34 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 119.943 1.247 . . . . 0.0 111.65 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.436 ' CZ ' ' HE3' ' A' ' 40' ' ' LYS . 3.3 m-85 -59.44 -65.43 0.67 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 118.885 0.766 . . . . 0.0 110.371 174.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -60.74 -50.82 71.92 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 126.504 1.922 . . . . 0.0 111.162 -173.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -67.19 -36.4 81.69 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 127.816 2.446 . . . . 0.0 111.179 -174.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -128.91 -60.34 1.09 Allowed 'General case' 0 C--N 1.347 0.498 0 CA-C-N 119.496 1.044 . . . . 0.0 112.254 -174.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 12.1 mt -64.0 -25.26 68.05 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.564 -0.71 . . . . 0.0 112.843 -165.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -99.83 -15.68 18.33 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 127.283 2.233 . . . . 0.0 111.573 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -69.91 -16.75 63.28 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.435 1.094 . . . . 0.0 110.898 164.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.04 1.64 33.88 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.61 1.576 . . . . 0.0 112.935 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -72.57 145.58 47.3 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 119.066 1.433 . . . . 0.0 110.564 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -126.74 4.5 6.7 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.681 1.192 . . . . 0.0 113.285 -177.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.6 mtmt -145.88 95.32 2.62 Favored 'General case' 0 CA--C 1.514 -0.418 0 O-C-N 119.687 -1.883 . . . . 0.0 107.124 -166.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -101.94 154.11 5.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.579 ' CE2' HG11 ' A' ' 22' ' ' VAL . 16.1 m-30 -124.37 156.15 37.56 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 117.922 0.328 . . . . 0.0 111.332 163.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 29.4 tp -130.1 107.65 9.48 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 124.89 1.276 . . . . 0.0 108.438 175.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.476 HG22 ' HA ' ' A' ' 26' ' ' MET . 0.8 OUTLIER -75.81 161.92 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-O 121.37 0.605 . . . . 0.0 110.651 176.111 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 30.1 mt -139.61 12.51 2.52 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.935 1.294 . . . . 0.0 109.678 -174.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.4 ' H ' HG23 ' A' ' 58' ' ' VAL . 68.7 m -66.38 -64.35 0.88 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.918 1.287 . . . . 0.0 110.559 -176.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -69.74 -43.6 71.97 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.972 0.415 . . . . 0.0 111.689 -169.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.3 p -67.94 160.98 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 126.47 1.908 . . . . 0.0 110.691 -177.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -95.24 -56.17 2.81 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.795 0.838 . . . . 0.0 109.314 174.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.5 p -156.36 -165.39 1.89 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.372 0.669 . . . . 0.0 110.693 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.0 tt -139.6 145.02 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 C-N-CA 125.858 1.663 . . . . 0.0 106.914 -177.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -82.86 162.13 21.7 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.308 0.643 . . . . 0.0 109.774 175.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.0 m -54.19 -29.38 45.76 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.947 1.299 . . . . 0.0 112.843 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -56.59 -64.41 0.88 Allowed 'General case' 0 C--N 1.344 0.346 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.7 t -77.24 -22.32 52.39 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 118.839 -0.6 . . . . 0.0 111.582 -176.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.579 HD11 HG21 ' A' ' 103' ' ' THR . 22.1 tp -54.98 -27.17 41.88 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.958 1.254 . . . . 0.0 111.887 173.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -83.93 -35.64 15.26 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.16 0.886 . . . . 0.0 112.87 171.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 45.5 t -67.89 -42.01 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 118.524 1.162 . . . . 0.0 109.462 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 12.0 mm -54.73 -49.68 66.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.206 1.002 . . . . 0.0 109.338 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 38.7 t -62.48 -42.34 95.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 O-C-N 121.397 -0.814 . . . . 0.0 110.417 174.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -52.89 -44.08 66.63 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 120.129 1.331 . . . . 0.0 112.239 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 59.8 mt -60.67 -38.44 78.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 124.06 0.944 . . . . 0.0 108.67 176.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.49 -49.23 64.42 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 120.005 1.275 . . . . 0.0 109.466 178.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -52.57 -48.25 66.3 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 118.607 0.64 . . . . 0.0 110.077 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.0 m -60.02 -54.54 44.81 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.248 1.019 . . . . 0.0 110.711 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 48.6 mt -60.17 -43.74 93.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 124.337 1.055 . . . . 0.0 110.647 -177.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.0 t -70.22 -12.52 61.65 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.397 1.079 . . . . 0.0 111.865 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.5 t -83.82 -46.75 11.84 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 119.208 0.913 . . . . 0.0 108.583 167.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 72.1 m -54.12 -53.65 50.37 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.239 0.616 . . . . 0.0 110.41 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 132.88 18.04 1.12 Allowed Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.213 -0.771 . . . . 0.0 112.589 -168.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -109.48 179.35 20.83 Favored Glycine 0 N--CA 1.44 -1.034 0 CA-C-N 119.827 1.813 . . . . 0.0 112.587 -173.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -141.87 108.49 5.35 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.914 2.086 . . . . 0.0 108.815 -172.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -106.57 139.8 40.45 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.76 1.224 . . . . 0.0 107.802 -176.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.461 ' C ' HD23 ' A' ' 89' ' ' LEU . . . -137.92 172.49 12.86 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.155 0.889 . . . . 0.0 111.861 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.461 HD23 ' C ' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -122.11 167.17 13.47 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.58 0.752 . . . . 0.0 109.903 -179.581 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 92.5 t -142.39 139.13 29.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 C-N-CA 123.36 0.664 . . . . 0.0 110.122 -168.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 t 46.54 54.46 14.82 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 126.304 1.842 . . . . 0.0 111.178 -175.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -69.79 99.89 0.78 Allowed 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 123.149 2.566 . . . . 0.0 108.769 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -62.5 158.3 18.24 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 122.116 0.96 . . . . 0.0 110.954 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 -59.47 -34.77 72.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.216 -171.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.43 -44.93 89.34 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.37 1.468 . . . . 0.0 109.55 175.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.7 t -74.45 -47.22 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-O 117.2 -1.381 . . . . 0.0 109.761 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -54.66 -31.97 58.44 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 121.383 1.901 . . . . 0.0 110.233 -176.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.41 -62.57 1.63 Allowed 'General case' 0 N--CA 1.423 -1.808 0 CA-C-O 123.453 1.597 . . . . 0.0 111.724 175.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.657 ' O ' HG22 ' A' ' 103' ' ' THR . 4.6 p -66.87 -34.58 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 CA-C-N 113.981 -1.463 . . . . 0.0 107.651 -173.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.9 mt -63.26 -23.97 67.66 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.912 0.885 . . . . 0.0 111.36 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.7 m -78.85 -49.59 12.66 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 120.103 1.32 . . . . 0.0 107.829 170.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.71 -15.42 40.37 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.23 2.212 . . . . 0.0 113.582 -174.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.657 HG22 ' O ' ' A' ' 99' ' ' VAL . 7.6 t -120.67 -0.18 10.27 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.914 2.086 . . . . 0.0 111.479 178.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.42 ' HA ' ' HG3' ' A' ' 107' ' ' ARG . 6.5 m-80 48.07 69.01 0.58 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 127.266 2.227 . . . . 0.0 112.967 -168.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.38 -49.44 3.57 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.369 1.867 . . . . 0.0 110.096 166.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -65.57 -12.29 51.69 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 119.56 1.073 . . . . 0.0 112.728 -177.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.42 ' HG3' ' HA ' ' A' ' 104' ' ' ASN . 0.0 OUTLIER -108.0 5.04 25.8 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 127.255 2.222 . . . . 0.0 111.049 -174.133 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.7 mt -125.62 -45.55 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 128.093 2.557 . . . . 0.0 109.579 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.8 t -95.09 166.92 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.678 1.191 . . . . 0.0 107.802 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.517 ' HE2' ' CB ' ' A' ' 125' ' ' LYS . 3.2 mtmp? -95.95 172.64 7.88 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.737 0.815 . . . . 0.0 109.408 168.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -157.98 147.0 9.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 -163.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.504 ' CG ' ' HB2' ' A' ' 118' ' ' ALA . 82.2 m-85 -148.48 162.95 38.58 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.568 1.147 . . . . 0.0 112.489 -169.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.95 -58.37 2.62 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -178.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 69.2 p -102.87 -162.53 0.92 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.416 HD12 HD12 ' A' ' 24' ' ' ILE . 14.6 mm -84.76 -34.17 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-O 118.564 -0.732 . . . . 0.0 111.133 156.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.1 t -70.22 -37.33 75.0 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.373 -156.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -67.14 -39.97 86.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 176.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.504 ' HB2' ' CG ' ' A' ' 112' ' ' TYR . . . -64.63 -41.38 96.21 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -171.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 9.8 ttt -51.39 -43.45 61.93 Favored 'General case' 0 N--CA 1.424 -1.728 0 C-N-CA 127.897 2.479 . . . . 0.0 110.804 -174.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -104.75 -15.48 15.22 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.837 1.255 . . . . 0.0 112.42 -177.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -81.65 -47.21 13.28 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 119.008 0.822 . . . . 0.0 109.096 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -55.24 -19.96 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 124.864 1.265 . . . . 0.0 114.086 176.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 7.7 mtm180 -70.39 -27.94 64.69 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 118.512 -0.756 . . . . 0.0 110.86 173.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.4 47.29 0.11 Allowed 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 120.624 1.556 . . . . 0.0 114.002 -176.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.517 ' CB ' ' HE2' ' A' ' 110' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.069 0 C-N-CA 125.134 1.373 . . . . 0.0 111.444 -172.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.8 mtp . . . . . 0 N--CA 1.469 0.509 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -80.44 179.83 53.18 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 163.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.4 m -77.54 -51.27 10.98 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 121.846 -0.796 . . . . 0.0 110.093 173.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -168.61 129.61 1.25 Allowed 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.644 1.178 . . . . 0.0 110.205 -164.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -164.25 158.01 18.44 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 145.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 42.3 mt -119.67 95.54 3.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 170.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 33.2 p80 -76.62 171.75 14.16 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 163.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.14 136.16 57.86 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.241 0.543 . . . . 0.0 111.108 -177.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 29.2 t60 -101.67 128.35 48.01 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 160.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -149.74 100.15 2.93 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 107.194 -1.409 . . . . 0.0 107.194 -173.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -65.05 103.18 0.71 Allowed 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 175.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 58.3 t60 -151.68 104.58 3.05 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 163.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -53.78 164.33 0.58 Allowed 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.939 1.695 . . . . 0.0 114.38 -172.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -126.88 169.05 12.85 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 128.349 2.66 . . . . 0.0 108.062 174.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -85.16 99.5 0.68 Allowed 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.407 2.071 . . . . 0.0 111.084 -174.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -155.29 165.41 36.73 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 120.898 -1.127 . . . . 0.0 110.284 -178.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -125.94 173.45 9.12 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.181 1.392 . . . . 0.0 108.938 164.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 52.1 mt -132.4 119.6 39.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.9 m -114.72 -166.11 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 170.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -45.66 -43.6 12.63 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 128.492 2.717 . . . . 0.0 115.278 -149.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -150.23 19.37 0.86 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.359 0.664 . . . . 0.0 111.163 156.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.754 HG11 ' CE2' ' A' ' 56' ' ' PHE . 19.3 t -122.15 120.72 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 124.266 1.027 . . . . 0.0 108.532 -173.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.5 t -75.5 143.78 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 176.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.592 HD12 HD12 ' A' ' 115' ' ' ILE . 5.1 mm -119.33 104.03 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 175.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 26.9 mt -85.72 124.64 32.47 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 177.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 65.0 mtm -126.86 76.46 75.36 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -167.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -61.56 148.44 92.99 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.507 2.805 . . . . 0.0 110.934 -170.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.526 HD22 ' H ' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -135.88 -85.27 0.37 Allowed 'General case' 0 C--O 1.225 -0.212 0 CA-C-O 118.931 -0.557 . . . . 0.0 111.123 176.002 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.526 ' H ' HD22 ' A' ' 28' ' ' ASN . 0.0 OUTLIER -126.5 35.13 4.69 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.194 1.397 . . . . 0.0 109.275 -176.72 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.94 -19.36 13.43 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 120.791 -1.193 . . . . 0.0 112.385 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.9 mp -72.77 90.21 1.4 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -132.85 26.04 4.31 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.621 1.168 . . . . 0.0 110.801 -164.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.3 mt 65.24 -54.12 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 129.071 2.948 . . . . 0.0 113.558 -172.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -66.31 -32.4 73.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 120.175 1.352 . . . . 0.0 109.509 -174.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.1 -8.12 46.97 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-O 117.265 -1.35 . . . . 0.0 110.364 175.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.06 -65.99 0.77 Allowed 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 120.869 1.668 . . . . 0.0 111.794 -168.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -67.96 -17.39 64.43 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 121.421 1.919 . . . . 0.0 110.97 177.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 69.3 mt -78.04 -9.19 59.02 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.103 1.761 . . . . 0.0 112.087 170.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -69.01 -60.39 2.39 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -169.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.451 ' HA ' HG22 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -60.65 -33.43 72.79 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 116.609 -1.662 . . . . 0.0 111.253 174.475 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -64.63 -50.16 68.21 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 120.801 1.637 . . . . 0.0 107.904 -175.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -48.58 -62.37 1.54 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 118.134 -0.936 . . . . 0.0 108.704 166.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.451 HG22 ' HA ' ' A' ' 40' ' ' LYS . 9.7 m -57.93 -46.46 87.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 CA-C-O 123.311 1.529 . . . . 0.0 112.671 -166.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.511 ' CD1' HD12 ' A' ' 48' ' ' LEU . 4.7 m-30 -50.01 -44.95 51.45 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 126.771 2.028 . . . . 0.0 108.98 177.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.4 ' HA ' HD22 ' A' ' 49' ' ' ASN . 15.2 t0 -78.96 -9.4 59.51 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 128.063 2.545 . . . . 0.0 114.908 -176.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -123.88 -8.69 7.8 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.385 0.993 . . . . 0.0 112.652 177.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -136.16 -61.68 0.69 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.586 0.754 . . . . 0.0 111.069 -174.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.511 HD12 ' CD1' ' A' ' 44' ' ' PHE . 14.4 mt -67.29 -52.08 44.9 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 118.733 0.697 . . . . 0.0 110.935 -169.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.4 HD22 ' HA ' ' A' ' 45' ' ' ASP . 86.2 m-20 -64.97 -27.16 68.65 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.26 1.024 . . . . 0.0 110.449 173.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.25 -46.81 75.84 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 125.044 1.338 . . . . 0.0 108.74 -178.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 131.0 47.59 0.13 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 125.527 1.537 . . . . 0.0 109.768 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -123.6 133.33 53.96 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 118.32 1.06 . . . . 0.0 110.511 173.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -126.26 22.04 7.23 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 126.097 1.759 . . . . 0.0 111.336 -177.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.688 ' HB3' HG13 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -143.93 142.25 30.67 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.66 1.184 . . . . 0.0 108.321 162.062 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.1 mt -141.76 150.62 19.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 129.238 3.015 . . . . 0.0 104.421 -176.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.754 ' CE2' HG11 ' A' ' 22' ' ' VAL . 11.6 m-85 -133.75 153.84 51.41 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 125.219 1.408 . . . . 0.0 109.969 169.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 29.7 tp -118.95 111.57 18.52 Favored 'General case' 0 C--N 1.339 0.143 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 174.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 87.6 t -86.2 103.47 12.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.462 HD12 HG21 ' A' ' 96' ' ' VAL . 4.2 mm? -78.92 -12.71 60.04 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.091 1.356 . . . . 0.0 111.747 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.75 -38.45 47.77 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.919 1.287 . . . . 0.0 111.115 173.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -84.95 -45.66 11.98 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 120.822 0.344 . . . . 0.0 110.792 -165.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.8 p -76.77 -178.75 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 126.619 1.968 . . . . 0.0 109.663 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -122.89 -41.45 2.35 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.41 1.084 . . . . 0.0 108.821 170.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.5 t -154.23 165.36 36.51 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-O 122.623 1.201 . . . . 0.0 113.766 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.7 tt -135.29 152.7 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 129.805 3.242 . . . . 0.0 105.985 176.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.49 175.13 5.55 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.356 0.662 . . . . 0.0 110.468 -167.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.9 p -62.53 19.0 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 128.244 2.617 . . . . 0.0 114.312 173.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -112.38 -73.02 0.68 Allowed 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 166.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 74.7 m -66.05 -29.44 69.78 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 116.878 -1.534 . . . . 0.0 113.778 -172.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.3 mt -48.55 -46.77 39.38 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.606 1.548 . . . . 0.0 110.192 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.17 -33.07 82.85 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-O 119.71 -0.494 . . . . 0.0 112.025 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.2 t -75.5 -29.6 21.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 118.275 1.038 . . . . 0.0 111.087 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 mp -64.58 -40.21 88.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 174.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.1 t -60.64 -43.46 94.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 O-C-N 120.559 -1.338 . . . . 0.0 110.172 169.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -51.24 -43.33 61.45 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.854 1.262 . . . . 0.0 112.204 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.1 mt -58.56 -45.13 90.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 124.406 1.082 . . . . 0.0 109.353 175.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.01 -49.3 70.78 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -51.4 -49.42 61.62 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.018 0.527 . . . . 0.0 109.615 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 13.6 t -64.28 -47.49 79.33 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -176.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 47.7 mt -60.43 -45.17 97.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 C-N-CA 124.979 1.311 . . . . 0.0 111.747 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.5 m -75.29 -23.32 57.35 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.818 0.735 . . . . 0.0 112.143 176.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.78 -45.59 89.05 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.437 1.017 . . . . 0.0 108.543 167.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 74.8 m -63.94 -71.02 0.19 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.889 1.675 . . . . 0.0 112.008 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 141.23 33.74 0.12 Allowed Glycine 0 CA--C 1.527 0.798 0 C-N-CA 124.195 0.902 . . . . 0.0 111.198 -164.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -126.37 -173.78 13.66 Favored Glycine 0 C--N 1.336 0.578 0 O-C-N 120.517 -1.578 . . . . 0.0 109.592 169.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -131.19 164.15 26.17 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.367 1.067 . . . . 0.0 109.902 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -156.03 141.19 17.43 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.973 1.309 . . . . 0.0 109.03 175.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.565 ' C ' HD23 ' A' ' 89' ' ' LEU . . . -147.08 178.44 8.37 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 123.727 0.811 . . . . 0.0 112.166 174.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.565 HD23 ' C ' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -121.35 163.56 18.46 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 123.453 0.701 . . . . 0.0 109.911 -178.489 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.599 HG21 HD13 ' A' ' 115' ' ' ILE . 40.2 t -144.08 133.51 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 123.847 0.859 . . . . 0.0 108.837 -163.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.9 t 48.95 58.96 17.72 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 127.029 2.131 . . . . 0.0 111.778 -171.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.05 91.96 0.91 Allowed 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 123.748 2.965 . . . . 0.0 108.711 176.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -51.66 153.5 2.34 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 126.536 1.935 . . . . 0.0 112.092 171.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -54.03 -31.2 50.63 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.989 1.716 . . . . 0.0 111.204 -176.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.84 -44.71 84.72 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 126.798 2.039 . . . . 0.0 109.207 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.882 HG13 HD13 ' A' ' 100' ' ' LEU . 1.1 t -74.1 -44.77 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 125.634 1.574 . . . . 0.0 110.488 172.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -58.49 -23.89 59.06 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 120.496 1.498 . . . . 0.0 110.451 -176.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.91 -62.31 1.79 Allowed 'General case' 0 N--CA 1.427 -1.614 0 CA-C-O 124.804 2.24 . . . . 0.0 111.003 175.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.496 ' O ' HG22 ' A' ' 103' ' ' THR . 2.6 t -72.76 -46.16 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.707 0 CA-C-N 111.411 -2.631 . . . . 0.0 104.865 -167.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.882 HD13 HG13 ' A' ' 96' ' ' VAL . 4.5 mp -61.28 -19.83 62.2 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 124.913 1.285 . . . . 0.0 112.568 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.6 m -87.1 -54.89 4.08 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 172.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 68.1 mt -51.37 -51.3 55.82 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.546 1.538 . . . . 0.0 113.08 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 99' ' ' VAL . 1.1 t -91.32 3.66 54.32 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.826 1.65 . . . . 0.0 111.987 -167.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 55.38 77.9 0.21 Allowed 'General case' 0 C--N 1.34 0.175 0 C-N-CA 126.387 1.875 . . . . 0.0 109.678 -173.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.532 ' HB3' HD23 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -123.22 -55.59 1.76 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.327 1.051 . . . . 0.0 108.636 177.541 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -60.18 -31.9 70.56 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.235 1.414 . . . . 0.0 110.306 169.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -74.21 1.21 11.83 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 117.556 -1.211 . . . . 0.0 112.965 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.4 mt -133.94 -39.55 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.547 1.139 . . . . 0.0 110.629 -169.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.4 t -106.12 153.92 7.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 119.647 1.112 . . . . 0.0 108.81 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.71 157.27 38.3 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.291 0.567 . . . . 0.0 111.486 174.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.0 145.29 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -172.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -149.19 169.66 20.23 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 127.093 2.157 . . . . 0.0 110.55 -175.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -88.08 -48.24 7.89 Favored 'General case' 0 CA--C 1.521 -0.173 0 O-C-N 121.763 -0.586 . . . . 0.0 109.419 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 67.5 p -121.56 173.52 7.36 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.921 0.888 . . . . 0.0 109.939 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.599 HD13 HG21 ' A' ' 90' ' ' VAL . 17.9 mm -70.7 -35.92 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.6 t -74.06 -30.11 62.23 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 119.446 1.021 . . . . 0.0 111.246 -173.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -65.19 -20.41 66.43 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 119.462 -0.304 . . . . 0.0 111.355 169.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -101.91 -39.93 7.13 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -170.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 53.1 ttm -48.72 -50.07 35.23 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 127.781 2.432 . . . . 0.0 111.089 -167.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -101.47 -0.42 35.2 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 117.985 -1.007 . . . . 0.0 112.591 -174.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -119.31 -35.49 3.58 Favored 'General case' 0 C--O 1.216 -0.687 0 C-N-CA 123.79 0.836 . . . . 0.0 111.542 -167.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -54.21 -29.02 18.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 O-C-N 121.14 -0.975 . . . . 0.0 109.559 157.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.11 118.02 17.58 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 102.467 -3.16 . . . . 0.0 102.467 163.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . 0.267 0.0 OUTLIER 85.46 23.42 0.08 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 111.968 -2.378 . . . . 0.0 116.193 165.582 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp . . . . . 0 C--O 1.25 1.111 0 C-N-CA 123.854 0.862 . . . . 0.0 111.187 176.487 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.475 0.823 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 172.3 104.27 0.17 Allowed Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 174.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.9 m -145.01 134.37 23.01 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 169.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 67.11 170.47 0.25 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 128.096 2.558 . . . . 0.0 112.826 -177.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.44 95.59 2.95 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 161.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 82.5 mt -127.17 104.45 12.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 -173.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -142.22 58.03 1.46 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.63 0.729 . . . . 0.0 111.729 -173.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -128.95 -0.48 5.29 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -177.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -70.95 150.73 45.41 Favored 'General case' 0 C--O 1.239 0.522 0 O-C-N 121.179 -0.951 . . . . 0.0 110.103 175.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -147.71 116.6 6.78 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 127.261 2.224 . . . . 0.0 105.138 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -52.89 105.62 0.13 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.731 1.212 . . . . 0.0 112.739 -174.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -157.59 162.18 38.74 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.593 1.557 . . . . 0.0 108.515 170.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 35.1 mmm 63.65 107.03 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 127.509 2.324 . . . . 0.0 111.709 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -108.49 85.56 2.96 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 125.713 1.605 . . . . 0.0 109.446 178.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.67 53.45 4.05 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 123.865 3.043 . . . . 0.0 111.436 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -162.14 163.82 28.27 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 120.788 -1.195 . . . . 0.0 109.804 -175.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.5 pttt -129.6 169.43 15.03 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.651 1.58 . . . . 0.0 108.631 168.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.5 mt -137.95 123.71 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 174.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.8 m -99.26 -154.18 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -24.92 -72.5 0.03 OUTLIER 'General case' 0 C--O 1.237 0.414 0 C-N-CA 130.085 3.354 . . . . 0.0 111.623 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.14 12.14 2.19 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.296 1.439 . . . . 0.0 110.646 172.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.656 HG11 ' CE2' ' A' ' 56' ' ' PHE . 5.7 t -112.41 137.45 45.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 O-C-N 120.657 -1.277 . . . . 0.0 108.749 -171.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 65.9 t -88.72 143.3 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 175.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mp -126.84 97.56 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.434 HD12 ' CH2' ' A' ' 42' ' ' TRP . 1.2 mm? -69.03 140.18 54.94 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 162.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 22.8 mtt -131.44 73.25 80.01 Favored Pre-proline 0 C--O 1.236 0.375 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 171.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.53 167.44 24.13 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 121.608 1.539 . . . . 0.0 110.62 174.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -161.16 -107.6 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 126.532 1.933 . . . . 0.0 105.999 -173.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.497 ' H ' ' HD2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -82.68 1.87 36.39 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -171.677 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -90.43 -23.56 20.98 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 120.773 -1.204 . . . . 0.0 113.726 -167.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 16.6 mt -74.9 -76.0 0.15 Allowed 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.155 -153.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . 0.258 0.1 OUTLIER 23.36 60.08 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 129.64 3.176 . . . . 0.0 113.201 153.629 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.8 mt 63.54 -45.29 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 127.908 2.483 . . . . 0.0 114.352 -172.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -63.61 -21.89 66.6 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.226 1.011 . . . . 0.0 112.906 -165.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -127.72 63.22 1.38 Allowed 'General case' 0 C--O 1.232 0.178 0 C-N-CA 125.141 1.376 . . . . 0.0 107.991 170.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.03 -67.94 0.89 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.674 0.79 . . . . 0.0 112.268 -177.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 39.7 t-80 -63.0 -37.1 85.82 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 120.71 1.595 . . . . 0.0 110.188 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.8 -15.3 60.75 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 117.747 -1.12 . . . . 0.0 111.935 173.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -52.59 -48.7 66.09 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 120.581 1.537 . . . . 0.0 110.942 -172.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -67.54 -42.43 82.72 Favored 'General case' 0 C--O 1.211 -0.922 0 CA-C-O 117.428 -1.272 . . . . 0.0 110.381 175.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.5 tttm -55.39 -45.14 76.64 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.937 1.699 . . . . 0.0 111.051 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.512 ' CE3' HG23 ' A' ' 43' ' ' VAL . 8.2 t90 -61.78 -63.04 1.39 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.546 1.138 . . . . 0.0 109.283 176.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.512 HG23 ' CE3' ' A' ' 42' ' ' TRP . 91.2 t -59.55 -32.39 48.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 119.655 1.116 . . . . 0.0 112.305 -176.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -56.54 -60.37 3.64 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 170.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.24 -44.15 72.57 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 -168.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -76.39 -17.26 59.46 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.228 1.811 . . . . 0.0 111.246 -170.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -141.68 -55.5 0.46 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 66.2 mt -64.9 -50.88 64.8 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.687 1.13 . . . . 0.0 111.451 -170.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -65.0 -29.6 70.53 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 127.867 2.467 . . . . 0.0 109.657 175.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.1 mttm -61.02 -46.87 89.0 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 118.638 -0.696 . . . . 0.0 109.14 169.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.97 4.38 2.66 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.193 1.377 . . . . 0.0 113.06 173.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -64.08 150.83 44.63 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 118.936 1.368 . . . . 0.0 109.593 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -122.29 -1.92 9.12 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.05 1.34 . . . . 0.0 114.409 175.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.425 ' HB3' HG13 ' A' ' 22' ' ' VAL . 2.0 mtmt -133.75 121.97 22.65 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 120.908 1.686 . . . . 0.0 108.379 -176.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.4 mt -130.39 157.21 42.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 C-N-CA 125.646 1.579 . . . . 0.0 107.366 176.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.656 ' CE2' HG11 ' A' ' 22' ' ' VAL . 23.2 m-85 -131.92 161.4 33.15 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.389 1.476 . . . . 0.0 111.768 165.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.8 tp -128.46 81.23 2.01 Favored 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 125.068 1.347 . . . . 0.0 108.173 173.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.508 ' N ' HG13 ' A' ' 90' ' ' VAL . 99.1 t -56.25 136.4 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 127.93 2.492 . . . . 0.0 107.563 166.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.59 12.6 12.35 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.182 1.793 . . . . 0.0 110.459 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 68.3 m -43.46 -46.24 6.7 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.68 1.992 . . . . 0.0 112.835 173.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.02 1.42 39.54 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.848 1.259 . . . . 0.0 111.69 -164.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.7 p -132.42 114.46 23.29 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 C-N-CA 126.082 1.753 . . . . 0.0 107.526 -177.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -64.69 -38.55 91.37 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 120.652 -1.28 . . . . 0.0 108.319 176.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 57.2 p -154.52 146.94 23.98 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -174.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 21.3 tt -100.28 151.38 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 113.82 -1.536 . . . . 0.0 107.411 163.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -92.3 168.9 11.0 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 123.083 1.42 . . . . 0.0 110.271 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.0 p -50.75 0.06 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.723 1 C-N-CA 132.565 4.346 . . . . 0.0 115.962 170.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -98.77 -70.52 0.72 Allowed 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.6 t -77.0 -19.88 56.74 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-O 118.552 -0.737 . . . . 0.0 112.082 -172.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 14.3 tp -48.57 -33.94 10.6 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.792 1.178 . . . . 0.0 111.743 170.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -76.4 -37.24 36.67 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 118.114 0.416 . . . . 0.0 113.683 173.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.9 t -65.31 -34.6 71.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 124.176 0.991 . . . . 0.0 109.62 -178.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.58 -48.13 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 123.747 0.819 . . . . 0.0 109.918 175.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.6 t -66.66 -39.85 84.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 O-C-N 121.187 -0.946 . . . . 0.0 109.851 178.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.63 -40.63 72.4 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.643 0.735 . . . . 0.0 110.996 178.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.1 mt -61.88 -39.44 83.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 126.592 1.957 . . . . 0.0 109.641 175.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.423 ' HG ' HG13 ' A' ' 109' ' ' VAL . 3.3 tm? -66.22 -41.5 90.03 Favored 'General case' 0 C--N 1.341 0.215 0 O-C-N 119.922 -1.736 . . . . 0.0 109.487 178.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.8 mttm -54.22 -44.11 71.41 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-O 117.841 -1.076 . . . . 0.0 110.524 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.5 t -53.6 -52.66 59.1 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.822 0.849 . . . . 0.0 110.825 176.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.0 mt -67.66 -39.85 82.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.012 0.525 . . . . 0.0 110.472 -174.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 26.6 t -66.25 -36.22 82.45 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.28 1.432 . . . . 0.0 110.932 176.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 71.8 m -65.39 -40.11 93.07 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 119.386 0.994 . . . . 0.0 109.894 172.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.5 m -73.29 -68.97 0.45 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.733 0.813 . . . . 0.0 111.642 -172.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 146.75 34.43 0.06 OUTLIER Glycine 0 C--N 1.334 0.418 0 CA-C-O 118.798 -1.001 . . . . 0.0 113.354 -166.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -127.6 -163.19 11.33 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 118.948 1.374 . . . . 0.0 111.321 -176.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.546 ' HB3' HG22 ' A' ' 122' ' ' VAL . 1.4 m-85 -137.89 151.85 48.44 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 169.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -147.47 147.53 30.29 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 172.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -153.48 170.73 20.04 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 124.812 1.32 . . . . 0.0 111.211 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.3 mt -108.47 167.4 10.07 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.508 HG13 ' N ' ' A' ' 58' ' ' VAL . 0.5 OUTLIER -145.38 152.85 14.21 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.511 0 C-N-CA 124.89 1.276 . . . . 0.0 111.085 -173.606 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.1 p 41.3 58.88 8.94 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 126.32 1.848 . . . . 0.0 112.812 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -71.35 7.94 1.31 Allowed 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 124.227 3.285 . . . . 0.0 114.498 -170.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 56.26 -160.98 0.2 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.383 1.473 . . . . 0.0 108.993 -176.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -87.9 -15.67 36.01 Favored 'General case' 0 CA--C 1.552 1.044 0 O-C-N 120.706 -1.246 . . . . 0.0 110.892 164.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.62 -33.72 10.85 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 121.062 -1.024 . . . . 0.0 112.606 -160.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.818 HG13 HD13 ' A' ' 100' ' ' LEU 0.268 0.9 OUTLIER -77.28 -37.67 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 116.254 -1.831 . . . . 0.0 107.615 166.421 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -52.96 -35.17 58.57 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 121.685 2.039 . . . . 0.0 110.235 171.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.06 -40.17 87.01 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.424 -175.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.536 HG13 HD12 ' A' ' 100' ' ' LEU . 8.4 p -92.41 -33.31 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -167.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.818 HD13 HG13 ' A' ' 96' ' ' VAL . 7.4 mp -65.55 -12.07 49.6 Favored 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 124.845 1.258 . . . . 0.0 112.5 178.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.7 t -87.29 -50.68 6.42 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 166.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.21 -38.59 87.16 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.261 1.824 . . . . 0.0 113.14 -168.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 99' ' ' VAL . 10.9 t -86.47 -18.44 31.66 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 119.01 -0.519 . . . . 0.0 110.786 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 64.45 93.72 0.06 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.563 1.545 . . . . 0.0 107.215 -151.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.538 ' HB3' ' HG ' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -124.64 -50.94 1.73 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.576 1.551 . . . . 0.0 108.706 168.494 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -29.96 68.18 Favored 'General case' 0 C--N 1.346 0.426 0 N-CA-C 110.002 -0.369 . . . . 0.0 110.002 177.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -77.99 5.65 9.42 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 128.022 2.529 . . . . 0.0 112.353 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.3 mt -124.05 -34.93 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 125.232 1.413 . . . . 0.0 109.006 -177.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.732 HG12 ' H ' ' A' ' 110' ' ' LYS . 1.7 t -123.85 -159.31 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 125.028 1.331 . . . . 0.0 110.546 -177.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.732 ' H ' HG12 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -116.1 158.8 22.63 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 128.837 2.855 . . . . 0.0 108.073 169.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.95 154.03 17.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 -178.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -144.87 167.64 22.12 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.934 0.894 . . . . 0.0 112.7 -171.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.75 -50.52 6.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.944 -177.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 70.4 p -130.29 175.46 8.92 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.92 1.288 . . . . 0.0 107.823 -176.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.439 HD11 ' CG2' ' A' ' 58' ' ' VAL . 6.3 mm -68.25 -41.71 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-O 117.687 -1.149 . . . . 0.0 109.218 170.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.2 t -67.35 -35.62 79.76 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 120.102 1.319 . . . . 0.0 109.43 -175.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.69 -6.51 26.61 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-O 117.554 -1.213 . . . . 0.0 112.797 174.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -110.55 -41.06 4.43 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 119.375 0.989 . . . . 0.0 109.772 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 1.9 ttp -59.61 -53.87 53.03 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.754 1.622 . . . . 0.0 111.94 -163.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -84.88 -13.72 50.03 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.187 1.395 . . . . 0.0 111.215 175.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.8 -52.27 5.39 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -168.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.546 HG22 ' HB3' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -50.31 -25.58 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 128.066 2.547 . . . . 0.0 113.359 177.23 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.17 -41.71 84.45 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 126.72 2.008 . . . . 0.0 111.423 175.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.54 55.84 0.62 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 127.165 2.186 . . . . 0.0 106.272 -170.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.027 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 170.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.467 0.386 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -166.11 159.72 33.05 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 170.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.6 m 61.3 132.24 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.571 1.948 . . . . 0.0 112.303 -173.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -57.56 -55.33 36.22 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 121.875 -0.516 . . . . 0.0 109.857 170.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.3 tttm -149.27 155.53 40.7 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 175.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.62 130.22 35.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 176.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -61.14 -31.59 71.31 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.647 0.779 . . . . 0.0 112.745 -172.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.3 t60 39.76 73.01 0.12 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.124 2.57 . . . . 0.0 113.519 177.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.73 172.91 12.9 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.434 1.494 . . . . 0.0 108.964 173.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 69.24 -33.7 0.26 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 128.912 2.885 . . . . 0.0 115.045 162.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -75.5 151.78 37.93 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 121.265 1.848 . . . . 0.0 107.706 156.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -138.3 96.24 3.15 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 -168.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.7 ttm -155.81 122.91 5.39 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.878 0.871 . . . . 0.0 109.597 -161.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -145.73 83.14 9.01 Favored Pre-proline 0 CA--C 1.539 0.552 0 O-C-N 120.75 -1.219 . . . . 0.0 110.913 174.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -80.63 53.91 4.99 Favored 'Trans proline' 0 C--O 1.238 0.525 0 C-N-CA 124.367 3.378 . . . . 0.0 110.913 175.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -163.58 177.71 8.57 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.538 1.135 . . . . 0.0 109.454 -175.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.7 pttt -151.06 178.51 9.12 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 126.86 2.064 . . . . 0.0 108.787 165.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.8 mp -132.07 136.37 56.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 167.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 20.4 m -99.65 -131.63 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 125.214 1.406 . . . . 0.0 107.704 172.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -44.89 -73.64 0.04 OUTLIER 'General case' 0 C--O 1.235 0.306 0 C-N-CA 127.505 2.322 . . . . 0.0 111.359 178.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -143.59 8.63 1.55 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.477 1.911 . . . . 0.0 110.309 171.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.695 HG11 ' CE2' ' A' ' 56' ' ' PHE . 22.0 t -97.62 132.22 42.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.7 t -83.44 143.64 11.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 170.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.5 mp -121.93 114.4 42.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 174.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.36 147.05 32.55 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 120.41 1.459 . . . . 0.0 108.719 163.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 8.9 mtt -140.43 77.77 23.26 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 127.834 2.453 . . . . 0.0 107.097 -178.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.99 98.62 0.62 Allowed 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 124.881 3.721 . . . . 0.0 112.858 -172.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -76.53 79.26 3.22 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.419 1.087 . . . . 0.0 113.667 -167.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.266 0.0 OUTLIER 40.7 35.61 0.33 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.607 1.963 . . . . 0.0 114.098 -179.494 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -113.43 -11.51 13.1 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 120.63 -1.294 . . . . 0.0 112.732 -164.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.41 83.11 0.26 Allowed 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 125.596 1.558 . . . . 0.0 108.403 -172.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -123.08 38.29 4.22 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.387 1.875 . . . . 0.0 108.127 -177.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.414 HG12 ' CG ' ' A' ' 68' ' ' PHE 0.304 0.3 OUTLIER 68.96 -26.89 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 130.957 3.703 . . . . 0.0 114.556 -177.833 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -40.51 -32.1 0.18 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 129.659 3.184 . . . . 0.0 115.535 -175.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -117.79 -4.34 11.16 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 127.289 2.236 . . . . 0.0 112.089 -164.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.603 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . . . -72.35 -52.0 18.07 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-N 120.114 1.325 . . . . 0.0 111.755 -166.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -60.48 -41.64 94.64 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.74 -0.6 . . . . 0.0 110.123 -178.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.3 -18.53 58.91 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 118.365 -0.826 . . . . 0.0 111.89 178.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -54.49 -42.87 71.26 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.414 1.461 . . . . 0.0 111.824 -172.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -61.76 -52.67 63.28 Favored 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.7 tmtp? -49.11 -46.32 44.68 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.917 1.687 . . . . 0.0 111.255 175.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.554 ' CE3' HG23 ' A' ' 43' ' ' VAL . 10.7 t90 -62.71 -65.55 0.67 Allowed 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 116.973 -1.489 . . . . 0.0 110.178 177.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.554 HG23 ' CE3' ' A' ' 42' ' ' TRP . 58.6 t -54.94 -35.16 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 120.709 1.595 . . . . 0.0 111.284 -175.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -57.59 -67.9 0.29 Allowed 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 123.913 0.885 . . . . 0.0 109.057 173.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.86 -51.56 69.1 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.807 0.843 . . . . 0.0 112.604 -174.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.32 -30.92 70.01 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.617 1.167 . . . . 0.0 111.379 -168.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -133.7 -65.0 0.69 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 122.884 0.474 . . . . 0.0 109.843 -164.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 52.6 mt -56.71 -54.16 49.36 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.835 0.743 . . . . 0.0 111.382 -174.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -67.19 -23.84 65.79 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 126.086 1.754 . . . . 0.0 111.577 175.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.0 tttm -74.68 -6.29 47.92 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.303 1.041 . . . . 0.0 112.194 169.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.68 7.28 53.77 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 124.791 1.186 . . . . 0.0 114.352 175.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -72.32 162.81 28.95 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 120.033 1.916 . . . . 0.0 110.031 176.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -148.34 4.23 0.69 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.502 1.521 . . . . 0.0 111.652 -176.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.488 ' HB3' HG13 ' A' ' 22' ' ' VAL . 1.5 mtmt -141.54 119.02 11.55 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 -177.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.9 mp -119.89 154.97 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 105.14 -2.171 . . . . 0.0 105.14 174.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.695 ' CE2' HG11 ' A' ' 22' ' ' VAL . 24.3 m-85 -130.91 164.19 25.82 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.48 1.512 . . . . 0.0 110.132 160.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.6 tp -128.16 114.6 17.2 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 170.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.573 ' CG2' HD11 ' A' ' 115' ' ' ILE . 53.4 t -82.55 110.42 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 125.991 1.716 . . . . 0.0 108.711 175.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -75.38 -10.89 59.86 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.579 0.752 . . . . 0.0 111.588 170.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.9 m -55.93 -23.52 32.3 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.464 1.029 . . . . 0.0 112.347 172.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.57 -14.16 25.28 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.283 0.947 . . . . 0.0 111.824 177.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.5 p -137.39 101.53 2.19 Favored 'Isoleucine or valine' 0 C--N 1.34 0.152 0 C-N-CA 124.798 1.239 . . . . 0.0 109.643 -173.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -55.05 -48.29 73.67 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.8 m -158.97 170.48 21.99 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.465 HD11 ' CB ' ' A' ' 69' ' ' SER . 8.8 tt -135.83 155.9 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 C-N-CA 127.059 2.144 . . . . 0.0 107.99 -165.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.407 ' HB3' ' CD2' ' A' ' 68' ' ' PHE . 15.8 t70 -91.33 158.47 16.53 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 126.168 1.787 . . . . 0.0 109.774 176.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.7 m -56.07 -24.73 41.83 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 117.594 -1.193 . . . . 0.0 113.337 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.709 ' CE1' ' HB2' ' A' ' 69' ' ' SER 0.278 0.2 OUTLIER -47.59 -64.53 0.76 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 119.686 1.13 . . . . 0.0 111.049 170.766 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.709 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . 30.1 t -92.48 -15.94 26.46 Favored 'General case' 0 CA--C 1.512 -0.486 0 O-C-N 121.52 -0.737 . . . . 0.0 111.642 -168.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.503 HD22 HG21 ' A' ' 103' ' ' THR . 14.2 mt -52.07 -36.22 50.01 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 119.225 -0.99 . . . . 0.0 109.288 170.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -81.27 -25.14 55.64 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-O 118.203 -1.332 . . . . 0.0 114.753 175.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.2 p -72.69 -35.56 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 120.332 2.066 . . . . 0.0 110.048 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 mp -53.34 -49.97 50.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.342 1.457 . . . . 0.0 108.136 173.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 80.7 t -56.61 -52.34 54.84 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 176.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -56.0 -22.46 27.0 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 114.114 1.154 . . . . 0.0 114.114 -174.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 57.8 mt -80.37 -44.34 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.452 1.101 . . . . 0.0 109.481 172.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -54.16 -48.77 70.52 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.452 1.024 . . . . 0.0 109.485 177.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -57.45 -42.75 83.1 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.168 0.587 . . . . 0.0 110.638 -176.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.4 m -60.17 -54.25 48.12 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 118.956 -0.545 . . . . 0.0 110.574 174.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 80.0 mt -57.63 -42.19 80.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.858 0.863 . . . . 0.0 110.803 -176.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -52.07 -40.8 61.72 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.728 1.611 . . . . 0.0 111.242 175.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 t -84.33 0.85 47.64 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.766 2.427 . . . . 0.0 112.799 -174.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.7 m -128.84 -14.26 4.53 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -166.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 130.51 -18.75 5.15 Favored Glycine 0 CA--C 1.521 0.409 0 CA-C-N 117.992 0.36 . . . . 0.0 113.741 177.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -100.3 -173.06 29.86 Favored Glycine 0 N--CA 1.429 -1.781 0 CA-C-O 123.02 1.345 . . . . 0.0 113.283 -156.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.524 ' HB3' HG22 ' A' ' 122' ' ' VAL . 2.1 m-85 -133.46 153.09 51.91 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.461 1.504 . . . . 0.0 108.256 174.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -145.23 146.98 31.93 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 171.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.58 ' C ' HD23 ' A' ' 89' ' ' LEU . . . -156.02 173.34 16.95 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.039 1.335 . . . . 0.0 111.153 -175.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.58 HD23 ' C ' ' A' ' 88' ' ' ALA . 5.6 mt -121.06 163.78 17.81 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.697 1.199 . . . . 0.0 110.148 -170.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.855 HG21 HD13 ' A' ' 115' ' ' ILE . 42.7 t -141.87 135.0 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 123.963 0.905 . . . . 0.0 111.478 -172.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.6 t 53.0 59.63 13.37 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 128.626 2.77 . . . . 0.0 113.938 175.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -73.11 -51.57 0.16 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.73 1.62 . . . . 0.0 115.808 -169.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 85.01 172.48 0.07 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 128.463 2.705 . . . . 0.0 109.638 -171.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.08 -34.19 42.69 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 125.408 1.483 . . . . 0.0 110.398 169.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.59 -48.12 73.39 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-O 117.883 -1.056 . . . . 0.0 108.619 -173.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 54.8 t -79.82 -52.48 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -176.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -63.92 -9.73 17.06 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.55 1.068 . . . . 0.0 111.23 -176.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.41 -74.53 0.09 Allowed 'General case' 0 CA--C 1.489 -1.4 0 CA-C-O 122.108 0.956 . . . . 0.0 108.547 162.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.661 ' O ' HG22 ' A' ' 103' ' ' THR . 17.7 t -70.93 -29.65 38.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 113.585 -1.643 . . . . 0.0 107.114 -156.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.03 -12.44 3.36 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 117.685 -1.15 . . . . 0.0 109.972 173.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.75 -37.03 8.89 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.1 mp -63.79 -18.53 64.18 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.887 2.475 . . . . 0.0 113.257 172.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.661 HG22 ' O ' ' A' ' 99' ' ' VAL . 12.7 t -128.0 16.48 6.77 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.97 1.308 . . . . 0.0 112.623 -171.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . 0.257 0.1 OUTLIER 40.11 78.95 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.38 1.472 . . . . 0.0 110.661 -173.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.402 ' HB2' HG23 ' A' ' 103' ' ' THR . 0.1 OUTLIER -133.79 -49.02 0.82 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.114 1.366 . . . . 0.0 107.93 -178.291 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.9 p-10 -62.53 -25.32 67.98 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 125.747 1.619 . . . . 0.0 112.072 176.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.5 -11.92 38.78 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.744 1.218 . . . . 0.0 113.895 -178.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.6 mt -105.55 -51.04 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 -173.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.5 t -107.91 142.62 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 121.414 0.626 . . . . 0.0 109.328 -170.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.416 ' HE3' ' HG3' ' A' ' 125' ' ' LYS . 14.4 mtmm -69.52 163.36 25.56 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-N 114.673 -1.149 . . . . 0.0 112.261 173.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -148.87 146.0 17.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 113.312 -1.767 . . . . 0.0 108.887 -169.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -148.57 167.55 25.12 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.544 1.138 . . . . 0.0 110.625 -171.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.7 -40.72 13.06 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -177.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.2 p -127.29 172.08 10.92 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.81 0.814 . . . . 0.0 109.501 -179.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.855 HD13 HG21 ' A' ' 90' ' ' VAL . 23.8 mm -70.04 -40.71 78.79 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.553 170.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 38.8 t -66.35 -33.12 75.0 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 119.288 0.949 . . . . 0.0 109.846 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -64.66 -11.76 38.98 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.872 0.869 . . . . 0.0 111.952 175.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -113.58 -39.08 4.14 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 124.935 1.294 . . . . 0.0 109.829 -175.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 5.9 ttp -58.17 -46.79 85.12 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.865 1.266 . . . . 0.0 112.348 -164.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -90.09 -19.89 23.81 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.869 1.268 . . . . 0.0 111.623 177.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -83.62 -50.39 8.25 Favored 'General case' 0 C--O 1.219 -0.532 0 C-N-CA 123.685 0.794 . . . . 0.0 109.095 -171.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.524 HG22 ' HB3' ' A' ' 86' ' ' PHE . 0.3 OUTLIER -53.36 -16.7 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 127.292 2.237 . . . . 0.0 113.173 177.72 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -47.36 64.07 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.299 2.24 . . . . 0.0 111.746 169.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.22 37.21 1.72 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.559 1.944 . . . . 0.0 113.199 -173.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.416 ' HG3' ' HE3' ' A' ' 110' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.107 0 C-N-CA 130.886 3.675 . . . . 0.0 111.666 157.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 ttt . . . . . 0 N--CA 1.47 0.527 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.74 54.29 3.3 Favored Glycine 0 CA--C 1.526 0.746 0 O-C-N 121.155 -0.966 . . . . 0.0 115.131 161.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.0 p -158.12 148.69 20.54 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 150.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -155.99 111.25 2.95 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -175.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.5 tptt 52.85 29.65 7.99 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.522 1.929 . . . . 0.0 113.528 174.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.4 tp -84.83 51.06 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 124.548 1.139 . . . . 0.0 113.061 -164.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 14.4 p-80 -160.53 154.08 22.26 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 120.675 -1.265 . . . . 0.0 110.535 170.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.469 ' CG ' ' H ' ' A' ' 9' ' ' HIS . 81.4 t60 -99.22 -171.56 2.1 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.349 1.86 . . . . 0.0 109.833 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.469 ' H ' ' CG ' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -79.72 101.71 8.58 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 120.063 -1.648 . . . . 0.0 109.949 175.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -132.77 145.41 50.98 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.22 0.608 . . . . 0.0 109.818 177.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -70.02 156.76 38.67 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 123.55 0.74 . . . . 0.0 110.861 173.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -116.18 112.01 21.04 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 126.593 1.957 . . . . 0.0 109.721 -175.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.87 118.27 9.04 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.098 0.959 . . . . 0.0 108.687 173.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -138.98 166.37 25.41 Favored Pre-proline 0 N--CA 1.447 -0.622 0 C-N-CA 126.622 1.969 . . . . 0.0 107.51 172.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -73.55 86.86 1.14 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.836 2.357 . . . . 0.0 109.304 175.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -167.01 172.39 10.21 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.223 1.409 . . . . 0.0 110.839 178.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.427 ' HG2' ' H ' ' A' ' 18' ' ' ILE . 4.9 ttmt -137.65 173.36 11.74 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.563 1.945 . . . . 0.0 109.452 173.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.427 ' H ' ' HG2' ' A' ' 17' ' ' LYS . 67.0 mt -135.53 134.81 51.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 128.866 2.866 . . . . 0.0 105.973 168.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.2 m -108.1 -169.94 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 128.289 2.635 . . . . 0.0 107.038 164.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -23.05 -75.92 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 128.153 2.581 . . . . 0.0 113.311 -171.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -134.15 36.23 3.24 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.256 0.622 . . . . 0.0 110.291 172.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.758 HG11 ' CE2' ' A' ' 56' ' ' PHE . 6.8 t -142.25 153.55 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.049 0 CA-C-O 122.785 1.278 . . . . 0.0 110.572 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.448 ' C ' HD12 ' A' ' 24' ' ' ILE . 0.9 OUTLIER -113.41 151.96 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.721 0 CA-C-N 112.67 -2.059 . . . . 0.0 107.487 -168.552 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.448 HD12 ' C ' ' A' ' 23' ' ' VAL . 3.9 mp -132.33 88.54 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -179.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.428 ' CD2' HG23 ' A' ' 55' ' ' ILE . 0.5 OUTLIER -67.59 158.26 32.51 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 120.377 1.444 . . . . 0.0 109.811 166.619 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -168.53 73.18 0.82 Allowed Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 123.905 0.882 . . . . 0.0 110.317 -176.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -68.65 120.86 7.76 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.881 2.387 . . . . 0.0 111.407 -168.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -76.16 66.53 2.32 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.4 -0.812 . . . . 0.0 111.749 175.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? 61.31 8.7 2.21 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.538 1.535 . . . . 0.0 113.155 -175.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.04 26.84 0.14 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.835 1.254 . . . . 0.0 112.789 -178.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.97 80.01 7.87 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 123.353 1.549 . . . . 0.0 106.842 175.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -99.63 148.95 23.79 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 127.191 2.196 . . . . 0.0 107.333 163.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.0 tt -54.37 -30.57 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.465 1.506 . . . . 0.0 112.217 174.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.407 ' O ' HD22 ' A' ' 38' ' ' LEU . 46.9 mt-10 -58.93 -63.62 1.23 Allowed 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 175.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -51.7 -46.06 63.75 Favored 'General case' 0 C--O 1.222 -0.356 0 C-N-CA 125.252 1.421 . . . . 0.0 109.574 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.75 -40.57 63.23 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.838 1.255 . . . . 0.0 113.631 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -64.29 -47.72 78.41 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 119.795 1.18 . . . . 0.0 109.599 177.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.407 HD22 ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -72.41 -31.77 65.79 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 118.014 -0.993 . . . . 0.0 111.03 -175.157 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -41.35 -40.3 1.66 Allowed 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 128.075 2.55 . . . . 0.0 110.715 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -55.46 -72.11 0.07 Allowed 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 118.989 0.813 . . . . 0.0 109.41 168.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.53 -35.48 63.24 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.869 0.868 . . . . 0.0 111.132 -172.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 20.7 t90 -59.88 -73.23 0.09 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 117.152 -1.404 . . . . 0.0 111.24 170.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 53.9 t -49.18 -36.33 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-N 120.452 1.478 . . . . 0.0 111.195 -178.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -68.52 -57.48 5.73 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 124.732 1.213 . . . . 0.0 110.538 -178.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -67.72 -31.58 71.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 118.545 0.611 . . . . 0.0 110.636 -177.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -89.24 -20.62 23.92 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 123.334 0.653 . . . . 0.0 111.728 -168.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -133.62 -53.85 0.88 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 118.619 0.645 . . . . 0.0 111.537 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 35.6 mt -64.31 -39.92 94.9 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 119.035 -0.507 . . . . 0.0 110.808 -171.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -72.97 -35.61 66.94 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 126.922 2.089 . . . . 0.0 111.356 173.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.91 -50.62 70.2 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.563 0.745 . . . . 0.0 109.46 175.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 138.21 6.08 1.48 Allowed Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.368 0.985 . . . . 0.0 112.634 -177.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -72.06 155.63 40.09 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 118.464 1.132 . . . . 0.0 109.876 177.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -131.65 15.31 4.89 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.692 1.597 . . . . 0.0 111.187 173.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.469 ' HB3' HG13 ' A' ' 22' ' ' VAL . 0.3 OUTLIER -153.32 105.11 2.83 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 -163.13 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.428 HG23 ' CD2' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -116.09 155.19 17.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 103.801 -2.666 . . . . 0.0 103.801 179.505 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.758 ' CE2' HG11 ' A' ' 22' ' ' VAL . 27.4 m-85 -130.29 160.67 33.23 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 159.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 42.0 tp -126.72 103.98 7.83 Favored 'General case' 0 C--N 1.334 -0.083 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 173.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.2 t -78.88 141.27 15.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 171.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 92' ' ' PRO . 3.4 mp -122.69 12.24 9.88 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.603 0.638 . . . . 0.0 112.304 -178.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.5 t -50.01 -44.72 51.35 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.655 1.582 . . . . 0.0 111.401 178.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -68.56 -36.22 78.48 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 118.684 -0.674 . . . . 0.0 111.234 -175.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 p -103.44 117.71 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 126.579 1.951 . . . . 0.0 107.753 -160.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -76.13 -39.63 54.65 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.22 -0.925 . . . . 0.0 109.17 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 78.9 p -140.29 163.17 33.47 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -175.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.404 HD11 ' HB2' ' A' ' 69' ' ' SER . 20.0 tt -136.7 154.73 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 C-N-CA 126.407 1.883 . . . . 0.0 107.068 175.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.89 160.07 17.37 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.185 1.794 . . . . 0.0 109.847 -175.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.3 t -62.8 -12.89 27.35 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.7 1.2 . . . . 0.0 113.278 174.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -71.37 -68.29 0.46 Allowed 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 168.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.404 ' HB2' HD11 ' A' ' 65' ' ' ILE . 0.6 OUTLIER -70.67 -30.3 66.86 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.674 1.189 . . . . 0.0 112.531 -163.236 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.539 HD22 HD13 ' A' ' 105' ' ' LEU . 11.6 mt -47.42 -42.54 22.44 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.966 0.907 . . . . 0.0 109.759 174.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -71.79 -29.84 66.84 Favored Glycine 0 CA--C 1.528 0.854 0 O-C-N 121.365 -0.834 . . . . 0.0 112.298 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.0 t -67.92 -35.26 71.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 O-C-N 121.583 -0.951 . . . . 0.0 109.314 176.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.8 -47.91 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.6 t -60.88 -39.43 81.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 O-C-N 121.535 -0.728 . . . . 0.0 110.938 174.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.41 -42.76 92.53 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 120.973 -1.08 . . . . 0.0 112.327 -176.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.3 mt -53.64 -43.52 54.83 Favored 'Isoleucine or valine' 0 C--N 1.343 0.308 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 172.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.434 HD13 ' C ' ' A' ' 77' ' ' LEU . 3.1 tm? -66.44 -48.35 70.25 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -173.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 24.6 mttm -55.22 -47.59 75.1 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 122.777 0.431 . . . . 0.0 111.099 178.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.1 m -61.87 -46.55 88.95 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.974 0.91 . . . . 0.0 110.391 -177.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 29.4 mt -65.75 -48.06 83.64 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 C-N-CA 124.051 0.94 . . . . 0.0 111.328 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.52 -39.54 80.38 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 177.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 50.6 m -62.57 -41.54 98.99 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.061 176.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.7 m -61.42 -51.22 69.66 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.362 0.983 . . . . 0.0 109.982 174.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 134.75 24.24 0.6 Allowed Glycine 0 CA--C 1.525 0.671 0 C-N-CA 123.711 0.672 . . . . 0.0 112.396 -171.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -119.67 -173.12 15.23 Favored Glycine 0 N--CA 1.439 -1.131 0 CA-C-N 118.599 1.199 . . . . 0.0 111.942 -176.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.586 ' HB3' HG22 ' A' ' 122' ' ' VAL . 3.4 m-85 -131.6 155.3 47.77 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.843 1.657 . . . . 0.0 109.246 177.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -150.57 135.42 17.5 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.697 0.799 . . . . 0.0 109.595 176.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -139.95 162.24 35.65 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.009 0.433 . . . . 0.0 111.982 -177.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.466 HD12 ' N ' ' A' ' 89' ' ' LEU . 7.5 mp -103.03 151.93 21.93 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.025 1.73 . . . . 0.0 107.405 178.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 70.4 t -145.1 145.43 20.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -168.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 47.1 t 42.37 57.66 10.7 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 124.499 1.119 . . . . 0.0 110.124 -176.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.4 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 30.5 Cg_endo -64.98 -77.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.947 2.431 . . . . 0.0 111.301 -165.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 25.0 p30 142.46 -175.12 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.492 1 C-N-CA 133.337 4.655 . . . . 0.0 106.01 171.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -77.84 -32.91 52.42 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 122.458 1.123 . . . . 0.0 111.849 176.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.74 -51.26 19.9 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 129.921 3.288 . . . . 0.0 110.271 -166.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.824 HG13 HD13 ' A' ' 100' ' ' LEU . 1.2 t -63.94 -48.12 87.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 125.668 1.587 . . . . 0.0 107.75 168.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -61.56 -26.08 67.72 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 122.746 2.521 . . . . 0.0 110.828 -175.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -46.98 85.83 Favored 'General case' 0 C--N 1.344 0.341 0 O-C-N 121.376 -0.827 . . . . 0.0 109.583 175.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.2 p -80.45 -31.31 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -172.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.824 HD13 HG13 ' A' ' 96' ' ' VAL . 3.3 mp -66.06 -17.48 64.72 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 118.037 -0.982 . . . . 0.0 112.462 177.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.6 m -77.86 -58.11 3.44 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 165.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.93 -68.56 0.16 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.019 2.128 . . . . 0.0 111.641 -173.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.628 HG23 HD12 ' A' ' 105' ' ' LEU . 5.7 t -76.92 14.59 0.81 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.671 1.589 . . . . 0.0 112.518 -175.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 42.76 85.05 0.02 OUTLIER 'General case' 0 C--N 1.34 0.194 0 C-N-CA 126.256 1.822 . . . . 0.0 112.014 -169.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.628 HD12 HG23 ' A' ' 103' ' ' THR 0.334 0.1 OUTLIER -126.04 -41.47 1.94 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 125.169 1.388 . . . . 0.0 112.362 178.163 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -67.76 -21.18 65.28 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.95 1.25 . . . . 0.0 111.259 171.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.9 mtm180 -79.51 -1.94 39.94 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 118.805 -0.617 . . . . 0.0 111.227 -178.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.7 mm -127.69 -46.17 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 C-N-CA 124.97 1.308 . . . . 0.0 108.384 -164.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.446 HG11 ' CD1' ' A' ' 89' ' ' LEU . 2.6 t -110.48 149.24 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 -177.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.471 ' HE3' ' H ' ' A' ' 111' ' ' ILE . 0.0 OUTLIER -71.52 160.88 31.93 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.979 173.519 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.471 ' H ' ' HE3' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -145.27 143.29 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -177.249 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -146.55 171.4 15.14 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.349 1.459 . . . . 0.0 110.417 -177.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -87.24 -50.03 6.87 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -177.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 31.8 p -125.55 170.54 11.35 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-O 122.174 0.987 . . . . 0.0 111.141 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 12.4 mm -63.13 -36.76 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 C-N-CA 124.293 1.037 . . . . 0.0 108.379 170.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.79 -43.0 90.04 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 119.869 1.213 . . . . 0.0 110.979 -178.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -71.41 3.87 3.43 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 123.691 0.62 . . . . 0.0 112.169 178.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.466 ' HB1' ' CE1' ' A' ' 56' ' ' PHE . . . -114.39 -33.89 5.46 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 174.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.16 -52.31 62.94 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 120.17 -1.582 . . . . 0.0 111.79 -162.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -89.8 -13.81 35.82 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.48 0.712 . . . . 0.0 112.113 172.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.81 -52.36 6.1 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -168.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.586 HG22 ' HB3' ' A' ' 86' ' ' PHE . 0.3 OUTLIER -53.31 -32.45 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 126.406 1.883 . . . . 0.0 111.322 176.194 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 43.8 mtm180 -62.18 -25.03 67.55 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 124.221 1.008 . . . . 0.0 111.285 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.22 56.33 1.0 Allowed 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 119.158 0.89 . . . . 0.0 109.862 169.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.199 0 CA-C-O 118.196 -0.907 . . . . 0.0 111.437 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.913 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.96 -170.06 34.26 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -161.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.5 m 62.4 61.76 1.23 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.278 1.431 . . . . 0.0 111.098 -175.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -52.16 -55.25 22.15 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 127.546 2.338 . . . . 0.0 112.128 -174.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? 48.07 37.47 7.95 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.091 1.756 . . . . 0.0 112.907 171.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.5 tp -91.78 5.41 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 124.597 1.159 . . . . 0.0 112.347 -175.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -99.84 73.15 1.76 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.492 1.517 . . . . 0.0 110.289 -174.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -129.56 -71.24 0.62 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 124.718 1.207 . . . . 0.0 108.799 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -61.3 120.07 9.7 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.702 0.801 . . . . 0.0 110.303 -172.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -125.55 159.6 31.66 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.863 0.865 . . . . 0.0 110.42 -165.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -134.92 39.18 2.98 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.135 1.374 . . . . 0.0 110.803 -162.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 55.62 53.3 9.78 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.258 2.223 . . . . 0.0 113.61 176.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 12.5 ttt -74.99 49.16 0.42 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.649 1.179 . . . . 0.0 110.13 162.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -124.55 72.55 59.99 Favored Pre-proline 0 C--O 1.236 0.367 0 C-N-CA 125.043 1.337 . . . . 0.0 109.039 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -81.23 44.64 1.79 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.544 2.829 . . . . 0.0 109.663 172.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -163.21 169.73 18.8 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 121.029 -1.044 . . . . 0.0 112.305 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -141.32 173.14 11.78 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 127.309 2.244 . . . . 0.0 108.365 164.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.6 mt -129.8 120.65 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 167.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.3 m -88.09 -151.96 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 124.938 1.295 . . . . 0.0 108.226 172.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -25.03 -72.39 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 128.6 2.76 . . . . 0.0 113.472 -177.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -145.43 28.03 1.21 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.184 1.394 . . . . 0.0 110.49 165.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.735 HG11 ' CE2' ' A' ' 56' ' ' PHE . 24.2 t -122.42 137.22 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 O-C-N 120.824 -1.172 . . . . 0.0 110.444 -177.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.4 t -84.8 135.81 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 177.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.1 mp -117.01 103.39 14.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 173.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.454 HD23 HG23 ' A' ' 55' ' ' ILE . 3.8 mm? -76.66 95.52 3.98 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 128.194 2.598 . . . . 0.0 106.765 171.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 14.8 mtm -94.45 95.8 1.58 Allowed Pre-proline 0 CA--C 1.55 0.966 0 CA-C-N 121.539 1.972 . . . . 0.0 106.54 172.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -67.99 172.25 11.13 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 CA-C-N 122.08 1.778 . . . . 0.0 109.488 171.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.571 HD22 ' H ' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -152.89 -71.99 0.14 Allowed 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 169.661 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.571 ' H ' HD22 ' A' ' 28' ' ' ASN . 0.0 OUTLIER -132.33 17.27 4.47 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.0 1.32 . . . . 0.0 112.488 -176.794 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -89.89 1.13 56.58 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 122.994 0.518 . . . . 0.0 111.13 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 17.9 mt -89.76 89.56 7.83 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -132.68 22.07 4.27 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.499 1.12 . . . . 0.0 113.152 -166.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.255 0.2 OUTLIER 64.12 -43.27 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 129.188 2.995 . . . . 0.0 114.444 -172.795 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -61.39 -19.01 61.42 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 120.765 -1.209 . . . . 0.0 111.061 174.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -115.25 68.77 0.71 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 126.404 1.882 . . . . 0.0 108.288 174.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.582 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . . . -132.34 -62.61 0.83 Allowed 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 167.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -59.05 -35.29 73.07 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.238 0.927 . . . . 0.0 110.306 174.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 36.0 mt -67.11 -28.88 68.52 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 124.244 1.017 . . . . 0.0 112.929 173.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -59.13 -57.75 11.69 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 124.62 1.168 . . . . 0.0 108.745 -172.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.489 ' HE2' ' CE2' ' A' ' 44' ' ' PHE . 3.9 ttpm? -54.24 -49.06 70.37 Favored 'General case' 0 C--O 1.216 -0.682 0 CA-C-O 116.684 -1.627 . . . . 0.0 110.216 172.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -43.99 85.67 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 120.667 1.576 . . . . 0.0 111.367 -176.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -67.81 -60.89 2.17 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-O 116.709 -1.615 . . . . 0.0 109.088 177.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.551 HG12 ' CD1' ' A' ' 48' ' ' LEU . 56.7 t -52.1 -38.7 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 121.538 1.972 . . . . 0.0 109.772 -178.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.517 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 8.0 m-30 -60.26 -69.03 0.24 Allowed 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 124.362 1.065 . . . . 0.0 110.687 176.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.21 -10.13 59.17 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -171.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -90.94 -31.37 16.4 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 116.048 -1.929 . . . . 0.0 110.284 173.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -134.54 -53.42 0.82 Allowed 'General case' 0 C--N 1.357 0.906 0 CA-C-N 122.804 2.547 . . . . 0.0 109.91 -174.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.551 ' CD1' HG12 ' A' ' 43' ' ' VAL . 6.6 mp -55.8 -59.59 4.65 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.818 0.818 . . . . 0.0 110.918 -174.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -75.45 -5.48 45.26 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 124.623 1.169 . . . . 0.0 112.268 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.7 mttm -75.59 -28.8 59.06 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.12 0.873 . . . . 0.0 110.274 163.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 125.0 -6.0 8.29 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 126.143 1.83 . . . . 0.0 112.688 -176.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -71.49 174.79 6.15 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 119.44 1.62 . . . . 0.0 108.928 175.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -172.09 5.72 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.184 1.794 . . . . 0.0 109.598 -169.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.477 ' HB3' HG13 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -131.81 112.49 12.54 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 104.889 -2.263 . . . . 0.0 104.889 -176.513 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.454 HG23 HD23 ' A' ' 25' ' ' LEU . 1.8 mp -122.94 146.38 28.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 178.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.785 ' CE1' HG21 ' A' ' 122' ' ' VAL . 17.1 m-85 -129.34 128.96 44.17 Favored 'General case' 0 C--O 1.228 -0.051 0 C-N-CA 123.958 0.903 . . . . 0.0 109.735 166.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 47.5 tp -95.16 121.48 36.85 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.296 1.039 . . . . 0.0 109.594 -178.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.438 ' HA ' ' HB ' ' A' ' 90' ' ' VAL . 0.8 OUTLIER -89.09 152.94 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 119.59 1.086 . . . . 0.0 111.402 177.902 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.517 ' CD2' HG21 ' A' ' 96' ' ' VAL . 0.9 OUTLIER -134.0 0.8 3.21 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.115 0.966 . . . . 0.0 112.982 175.083 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.44 -8.19 1.7 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 169.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -116.68 -5.66 11.61 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.563 1.145 . . . . 0.0 111.83 -168.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.4 p -143.8 148.43 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 125.012 1.325 . . . . 0.0 107.47 -170.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -78.0 -46.98 19.53 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 176.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.8 p -155.12 168.2 27.82 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.6 tt -94.13 156.43 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 125.977 1.711 . . . . 0.0 108.178 162.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -111.44 174.57 5.8 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.551 -0.718 . . . . 0.0 110.358 -176.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.5 m -57.87 -39.92 78.98 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 121.412 -0.805 . . . . 0.0 112.241 -172.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.582 ' CE1' ' HB2' ' A' ' 36' ' ' ALA . 0.9 OUTLIER -50.36 -53.13 31.36 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.255 1.422 . . . . 0.0 111.232 176.646 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 p -93.51 -20.75 19.97 Favored 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 121.683 -0.635 . . . . 0.0 112.026 -169.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 31.6 tp -56.97 -17.21 8.87 Favored 'General case' 0 CA--C 1.551 0.988 0 O-C-N 120.844 -1.16 . . . . 0.0 111.468 170.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -101.07 -8.51 47.53 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 125.046 1.308 . . . . 0.0 115.216 169.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -89.16 -38.88 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 119.608 1.704 . . . . 0.0 109.157 175.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.4 mm -58.42 -41.17 80.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 O-C-N 121.127 -0.983 . . . . 0.0 110.706 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 65.8 t -61.36 -42.77 94.94 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 CA-C-N 118.264 0.484 . . . . 0.0 110.212 174.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -63.67 -30.64 71.72 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 120.82 -1.175 . . . . 0.0 111.052 -176.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.9 mt -64.17 -40.06 87.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 171.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -67.84 -49.19 63.51 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 123.931 0.892 . . . . 0.0 109.172 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.3 mttm -48.72 -55.64 10.84 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 124.451 1.1 . . . . 0.0 110.418 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 69.2 m -78.41 -26.75 46.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 118.145 -0.931 . . . . 0.0 112.699 -172.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 25.2 mt -59.04 -44.89 92.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 119.85 1.204 . . . . 0.0 109.306 165.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.2 t -74.59 -18.44 60.57 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.34 1.056 . . . . 0.0 112.135 -176.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.1 m -77.89 -43.78 29.08 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.881 0.872 . . . . 0.0 110.279 166.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.0 m -64.38 -50.9 65.84 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 118.418 -0.801 . . . . 0.0 110.741 -176.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 134.2 23.13 0.69 Allowed Glycine 0 CA--C 1.521 0.426 0 CA-C-O 119.157 -0.801 . . . . 0.0 113.565 -175.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -115.82 -171.98 16.64 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 118.84 1.32 . . . . 0.0 111.81 -170.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.16 158.4 43.75 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.466 1.507 . . . . 0.0 110.201 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -150.5 142.2 23.66 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.491 ' C ' HD23 ' A' ' 89' ' ' LEU . . . -144.07 173.22 11.91 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.318 1.447 . . . . 0.0 110.605 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.491 HD23 ' C ' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -118.28 168.14 10.88 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.926 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.438 ' HB ' ' HA ' ' A' ' 58' ' ' VAL . 57.7 t -139.48 129.4 30.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 124.425 1.09 . . . . 0.0 108.153 -164.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.9 t 43.84 69.98 2.12 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 127.122 2.169 . . . . 0.0 110.555 -176.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -71.09 118.82 5.89 Favored 'Trans proline' 0 N--CA 1.445 -1.365 0 N-CA-C 107.597 -1.732 . . . . 0.0 107.597 173.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 49.1 p30 -67.33 165.5 16.26 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 122.863 1.316 . . . . 0.0 109.447 163.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -69.19 -24.49 64.05 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.892 -174.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -46.41 78.79 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 126.624 1.97 . . . . 0.0 110.256 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.517 HG21 ' CD2' ' A' ' 59' ' ' LEU . 6.6 t -77.93 -38.59 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-O 118.263 -0.875 . . . . 0.0 109.982 -178.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -51.25 -39.02 55.78 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 124.744 1.218 . . . . 0.0 110.045 177.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.7 -61.27 1.91 Allowed 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 125.69 1.596 . . . . 0.0 114.222 172.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.569 ' O ' HG22 ' A' ' 103' ' ' THR . 77.9 t -71.21 -47.92 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 C-N-CA 125.889 1.676 . . . . 0.0 107.339 -169.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.39 -21.53 60.05 Favored 'General case' 0 N--CA 1.438 -1.028 0 O-C-N 124.495 1.122 . . . . 0.0 108.6 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.4 m -82.47 -52.01 7.27 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 81.1 mt -57.94 -29.0 64.81 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.578 1.951 . . . . 0.0 113.495 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.569 HG22 ' O ' ' A' ' 99' ' ' VAL . 1.9 t -111.53 -1.81 15.71 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.917 1.287 . . . . 0.0 111.205 -171.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 53.9 78.9 0.14 Allowed 'General case' 0 C--N 1.343 0.283 0 C-N-CA 127.181 2.192 . . . . 0.0 109.931 -176.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.19 -49.39 1.94 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 126.716 2.006 . . . . 0.0 108.064 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -67.17 -12.19 59.36 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.141 1.376 . . . . 0.0 112.465 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.1 mtp180 -90.22 -0.79 57.79 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.867 1.667 . . . . 0.0 111.433 176.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.6 mm -127.46 -45.21 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 125.623 1.569 . . . . 0.0 107.431 -165.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.2 t -99.21 155.08 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 174.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.4 ' HD2' ' HE2' ' A' ' 125' ' ' LYS . 0.1 OUTLIER -76.45 164.78 25.65 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 121.524 -0.735 . . . . 0.0 109.832 170.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.45 141.83 23.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -145.1 164.91 29.8 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 125.981 1.712 . . . . 0.0 110.095 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -94.94 -54.59 3.4 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 46.7 p -106.96 157.56 17.69 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 118.778 0.717 . . . . 0.0 109.365 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 9.1 mm -58.65 -36.55 60.67 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 175.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 45.0 t -60.79 -41.59 95.9 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 118.933 -0.556 . . . . 0.0 110.654 -175.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -71.92 -21.49 61.61 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 124.163 0.915 . . . . 0.0 110.639 -176.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.733 ' O ' HG23 ' A' ' 122' ' ' VAL . . . -79.53 -54.07 6.25 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 104.12 -2.548 . . . . 0.0 104.12 176.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.97 -59.3 3.19 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 125.518 1.527 . . . . 0.0 111.774 -160.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -75.61 -19.21 59.38 Favored 'General case' 0 CA--C 1.521 -0.172 0 O-C-N 123.926 0.766 . . . . 0.0 112.299 -176.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -88.09 -51.49 5.77 Favored 'General case' 0 CA--C 1.495 -1.14 0 CA-C-O 118.568 -0.729 . . . . 0.0 110.134 -172.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.785 HG21 ' CE1' ' A' ' 56' ' ' PHE . 40.3 t -48.65 -39.44 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 126.439 1.896 . . . . 0.0 110.062 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -47.64 -43.11 25.76 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.545 1.138 . . . . 0.0 112.639 171.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -134.06 33.82 3.37 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.377 2.671 . . . . 0.0 112.752 -172.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.4 ' HE2' ' HD2' ' A' ' 110' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.235 0 C-N-CA 126.708 2.003 . . . . 0.0 113.977 -160.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.9 mtt . . . . . 0 N--CA 1.473 0.692 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -85.29 178.58 50.63 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 176.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.4 t -159.38 105.06 1.66 Allowed 'General case' 0 C--O 1.235 0.338 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 160.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.1 t0 53.38 177.34 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 128.451 2.701 . . . . 0.0 113.147 -172.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 47.1 mttt -152.41 98.32 2.37 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 125.965 1.706 . . . . 0.0 107.722 165.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 36.0 mm -126.7 134.73 65.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 11.3 p80 -75.33 -44.74 43.71 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 119.047 -0.502 . . . . 0.0 111.293 175.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 36.76 78.63 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 128.495 2.718 . . . . 0.0 112.123 -173.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -59.15 116.9 4.17 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.0 p-80 -153.47 162.21 41.5 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.121 -1.436 . . . . 0.0 107.121 158.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -127.3 88.36 2.79 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 178.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -87.13 -165.5 1.31 Allowed 'General case' 0 C--O 1.241 0.643 0 C-N-CA 124.296 1.038 . . . . 0.0 109.517 -173.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.25 157.22 29.34 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.346 -0.846 . . . . 0.0 109.42 154.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -120.23 94.22 48.55 Favored Pre-proline 0 N--CA 1.448 -0.564 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 170.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -77.25 52.42 3.85 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.727 2.951 . . . . 0.0 109.817 174.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -168.34 174.18 7.18 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.356 1.063 . . . . 0.0 111.682 -179.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.2 ttmm -136.56 173.17 11.99 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.222 2.209 . . . . 0.0 108.076 161.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 54.2 mt -135.33 144.96 32.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 129.015 2.926 . . . . 0.0 104.223 163.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.1 m -105.76 -130.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 173.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -50.59 -66.87 0.31 Allowed 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 126.917 2.087 . . . . 0.0 111.263 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -144.48 11.87 1.5 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.825 2.05 . . . . 0.0 111.82 178.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.627 HG11 ' CE2' ' A' ' 56' ' ' PHE . 8.9 t -119.26 135.44 59.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -177.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.51 HG13 ' HA ' ' A' ' 55' ' ' ILE . 0.6 OUTLIER -81.55 150.39 4.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 C-N-CA 128.337 2.655 . . . . 0.0 111.798 174.26 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.446 HD12 ' C ' ' A' ' 23' ' ' VAL . 4.1 mp -132.33 88.95 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 175.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.48 HD23 HG23 ' A' ' 55' ' ' ILE . 4.3 mm? -58.36 140.18 54.03 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 168.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 61.6 mtt -139.2 76.54 32.17 Favored Pre-proline 0 C--N 1.328 -0.339 0 C-N-CA 125.04 1.336 . . . . 0.0 108.483 176.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -75.49 68.02 6.22 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.574 2.183 . . . . 0.0 109.02 176.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.2 93.41 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.461 1.504 . . . . 0.0 107.861 176.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.25 -21.32 0.07 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 127.911 2.484 . . . . 0.0 114.8 -170.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.88 59.0 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 129.535 3.134 . . . . 0.0 113.837 -177.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 65.0 mt -127.98 23.41 6.13 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 119.516 -1.99 . . . . 0.0 112.21 175.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -53.3 150.21 6.51 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 164.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.7 mt -58.31 -37.95 66.21 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 CA-C-O 119.33 -0.367 . . . . 0.0 111.629 -174.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -68.33 -34.56 76.34 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 118.725 0.693 . . . . 0.0 109.343 -171.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -72.66 -43.72 62.78 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 171.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.41 -33.18 65.54 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.883 0.765 . . . . 0.0 111.626 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 25.5 t60 -70.06 -47.96 59.79 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 120.495 -1.378 . . . . 0.0 110.262 174.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.468 HD12 ' C ' ' A' ' 38' ' ' LEU . 0.5 OUTLIER -73.0 -17.34 61.46 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 118.968 -0.539 . . . . 0.0 111.727 -178.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -48.83 -55.78 10.62 Favored 'General case' 0 CA--C 1.513 -0.442 0 C-N-CA 127.999 2.52 . . . . 0.0 110.513 -170.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp -66.48 -28.99 69.01 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 117.86 -1.067 . . . . 0.0 111.047 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.7 ttmt -68.26 -51.99 38.97 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 121.157 1.799 . . . . 0.0 109.211 172.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.421 ' CH2' ' CD1' ' A' ' 25' ' ' LEU . 13.7 t90 -59.91 -59.45 5.4 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.229 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.0 t -50.41 -30.04 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 120.262 1.392 . . . . 0.0 112.199 176.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.442 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 3.6 m-85 -72.76 -69.84 0.39 Allowed 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 173.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.41 ' HA ' ' HB2' ' A' ' 49' ' ' ASN . 3.3 t0 -61.61 -35.86 79.06 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 124.289 1.036 . . . . 0.0 112.949 -167.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -75.69 -30.94 59.51 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.247 2.219 . . . . 0.0 111.284 175.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -132.02 -67.21 0.68 Allowed 'General case' 0 C--N 1.352 0.694 0 CA-C-N 120.682 1.583 . . . . 0.0 112.286 -174.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.442 ' HB2' ' HA ' ' A' ' 44' ' ' PHE . 6.5 mt -59.17 -48.76 80.41 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.372 0.987 . . . . 0.0 112.694 -170.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.41 ' HB2' ' HA ' ' A' ' 45' ' ' ASP . 76.4 m-20 -65.56 -34.5 78.39 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 125.428 1.491 . . . . 0.0 109.726 177.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.9 mttm -61.38 -21.64 64.25 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.802 1.241 . . . . 0.0 111.811 171.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.6 14.68 36.94 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.329 0.966 . . . . 0.0 112.485 -178.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -70.38 139.14 51.85 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 118.931 1.365 . . . . 0.0 108.085 166.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -119.42 6.02 11.13 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.592 1.157 . . . . 0.0 110.292 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt -146.87 98.05 2.99 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 120.27 1.395 . . . . 0.0 107.254 -167.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.51 ' HA ' HG13 ' A' ' 23' ' ' VAL . 1.2 mp -102.81 151.92 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.627 ' CE2' HG11 ' A' ' 22' ' ' VAL . 22.4 m-85 -123.2 160.42 26.59 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.965 0.79 . . . . 0.0 111.908 157.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.6 tp -125.3 122.48 37.01 Favored 'General case' 0 C--O 1.223 -0.324 0 C-N-CA 124.887 1.275 . . . . 0.0 109.221 171.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.423 HG12 ' H ' ' A' ' 60' ' ' SER . 15.6 t -95.06 141.74 14.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 173.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.486 HD22 HG11 ' A' ' 96' ' ' VAL . 4.3 mp -123.57 6.46 8.9 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.011 1.324 . . . . 0.0 111.133 -174.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.423 ' H ' HG12 ' A' ' 58' ' ' VAL . 2.4 t -54.66 -36.8 64.99 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.114 1.765 . . . . 0.0 111.737 174.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -104.76 18.71 21.79 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.113 0.965 . . . . 0.0 111.101 -165.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.4 p -151.18 122.84 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 123.551 0.74 . . . . 0.0 109.386 -175.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -73.24 -43.41 61.22 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 117.995 -1.003 . . . . 0.0 108.979 177.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.4 t -150.35 175.82 11.47 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 119.169 0.895 . . . . 0.0 111.962 -171.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.8 tt -140.91 149.85 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 -175.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -81.45 155.75 25.69 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 123.804 0.842 . . . . 0.0 109.743 -174.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.2 p -54.01 -25.8 22.98 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.068 1.347 . . . . 0.0 112.619 175.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -61.94 -63.24 1.32 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.366 1.466 . . . . 0.0 110.478 169.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 26.4 t -82.46 -22.95 34.99 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.591 1.157 . . . . 0.0 111.974 -163.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 40.8 tp -60.91 -16.66 44.63 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 120.549 -1.344 . . . . 0.0 111.609 170.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -91.85 -29.95 11.08 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-O 118.849 -0.973 . . . . 0.0 112.194 167.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -66.67 -37.23 79.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 119.551 1.676 . . . . 0.0 111.23 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.4 mm -59.68 -46.58 93.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 C-N-CA 124.6 1.16 . . . . 0.0 109.826 175.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 50.8 t -60.98 -41.51 89.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 174.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -55.96 -41.01 74.06 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.408 -0.807 . . . . 0.0 111.344 -176.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 71.1 mt -64.03 -39.75 86.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.719 0.808 . . . . 0.0 110.03 174.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.422 ' HG ' HG22 ' A' ' 109' ' ' VAL . 3.0 tm? -62.17 -49.25 76.58 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 119.705 1.139 . . . . 0.0 109.075 178.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -50.12 -55.53 14.63 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 123.475 0.71 . . . . 0.0 109.88 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.71 -39.9 95.45 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 117.569 -1.205 . . . . 0.0 112.365 -178.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 76.4 mt -64.32 -43.98 97.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 121.023 1.738 . . . . 0.0 109.85 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.3 m -56.8 -48.07 78.79 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.393 0.677 . . . . 0.0 110.899 172.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.4 m -71.77 -10.54 59.92 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.09 1.356 . . . . 0.0 113.935 178.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.2 m -99.7 -25.54 14.36 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.687 1.195 . . . . 0.0 111.94 175.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 120.19 2.61 12.22 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 116.435 1.334 . . . . 0.0 116.435 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -99.2 -158.83 29.17 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 119.682 1.741 . . . . 0.0 112.95 -171.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.503 ' CZ ' ' HE2' ' A' ' 125' ' ' LYS . 0.3 OUTLIER -139.93 160.11 40.67 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 127.0 2.12 . . . . 0.0 109.852 170.387 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -149.31 143.82 26.07 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 176.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.27 165.56 28.89 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.09 0.956 . . . . 0.0 112.157 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.405 ' N ' HD12 ' A' ' 89' ' ' LEU . 7.2 mp -113.72 156.39 23.87 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.753 2.021 . . . . 0.0 108.983 -175.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 57.7 t -146.79 149.39 15.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 123.432 0.693 . . . . 0.0 109.934 -159.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.2 t 49.14 54.89 16.83 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 125.029 1.332 . . . . 0.0 111.412 -175.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -82.54 81.7 2.41 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 122.344 2.029 . . . . 0.0 111.69 -164.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.0 156.54 9.13 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 122.044 0.926 . . . . 0.0 110.545 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -62.93 -33.68 75.85 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.803 -1.09 . . . . 0.0 112.241 -163.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.8 -41.59 97.88 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 123.67 0.788 . . . . 0.0 109.264 -174.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.486 HG11 HD22 ' A' ' 59' ' ' LEU . 17.9 t -70.63 -42.37 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-O 117.514 -1.232 . . . . 0.0 110.236 175.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -58.82 -28.65 66.23 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 120.127 1.331 . . . . 0.0 110.804 -172.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -51.08 -60.46 3.07 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-O 125.028 2.347 . . . . 0.0 111.454 173.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.446 ' O ' HG22 ' A' ' 103' ' ' THR . 4.7 t -71.08 -39.01 73.86 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.747 0 CA-C-N 112.508 -2.133 . . . . 0.0 107.454 -172.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.2 mt -61.79 -15.62 42.98 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 118.234 -0.888 . . . . 0.0 110.481 177.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.5 -46.1 10.49 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-O 121.32 0.581 . . . . 0.0 110.164 173.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.73 -62.53 1.8 Allowed 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.703 2.001 . . . . 0.0 108.425 -177.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.446 HG22 ' O ' ' A' ' 99' ' ' VAL . 0.6 OUTLIER -74.0 -5.76 43.33 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 129.129 2.972 . . . . 0.0 111.07 -169.28 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 49.99 77.73 0.11 Allowed 'General case' 0 C--N 1.344 0.361 0 C-N-CA 127.45 2.3 . . . . 0.0 109.437 -168.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.44 -57.08 2.17 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 173.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -65.52 -12.44 52.82 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 127.427 2.291 . . . . 0.0 112.462 175.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.4 mtt-85 -88.96 2.89 53.19 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.082 0.953 . . . . 0.0 113.08 171.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.8 mt -133.15 -43.08 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 125.098 1.359 . . . . 0.0 109.238 -173.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.422 HG22 ' HG ' ' A' ' 77' ' ' LEU . 2.1 t -114.16 141.73 29.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 125.501 1.52 . . . . 0.0 106.941 -177.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.46 159.64 23.9 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.618 0.767 . . . . 0.0 112.21 177.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -123.28 154.93 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 125.65 1.58 . . . . 0.0 106.98 169.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -147.44 162.97 37.94 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.98 1.712 . . . . 0.0 109.569 170.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -81.35 -53.24 6.49 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 119.464 -0.895 . . . . 0.0 109.361 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 67.6 p -129.44 161.58 30.06 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 125.327 1.451 . . . . 0.0 108.502 -169.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 26.7 mm -63.79 -38.89 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -173.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.9 t -74.38 -19.97 60.24 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 118.863 -1.135 . . . . 0.0 111.487 -174.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -70.22 -20.46 63.09 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 118.965 0.802 . . . . 0.0 111.173 170.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.457 ' HB1' ' CZ ' ' A' ' 56' ' ' PHE . . . -105.42 -39.83 6.01 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.997 0.919 . . . . 0.0 109.478 -169.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 5.0 ttm -58.36 -44.12 88.7 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 124.49 1.116 . . . . 0.0 111.972 -162.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -95.16 -10.49 30.39 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.347 1.059 . . . . 0.0 111.726 178.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -93.12 -50.67 5.4 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.041 -172.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.487 HG22 ' HB3' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -47.98 -37.43 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 125.73 1.612 . . . . 0.0 111.059 173.597 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -56.49 -32.78 65.35 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-O 118.494 -0.765 . . . . 0.0 111.684 176.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.73 29.42 2.35 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -175.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.503 ' HE2' ' CZ ' ' A' ' 86' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.175 0 C-N-CA 124.317 1.047 . . . . 0.0 110.059 -171.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.6 mtt . . . . . 0 N--CA 1.476 0.828 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 68.48 -166.99 44.88 Favored Glycine 0 CA--C 1.533 1.157 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -170.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.6 m -58.08 95.46 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.255 1.822 . . . . 0.0 113.814 -165.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.44 -43.98 84.37 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.693 1.597 . . . . 0.0 112.139 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.44 ' HE2' ' HA ' ' A' ' 5' ' ' LYS . 8.0 mmpt? 51.56 -170.66 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.426 1.091 . . . . 0.0 111.323 -164.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 37.5 pt -138.87 22.0 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 126.266 1.826 . . . . 0.0 109.88 -175.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -78.99 97.36 6.03 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.453 1.101 . . . . 0.0 108.077 178.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -57.63 111.36 1.1 Allowed 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.47 1.908 . . . . 0.0 109.427 -175.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -146.34 145.47 30.32 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.212 1.805 . . . . 0.0 106.897 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -148.4 171.3 16.25 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.045 0.938 . . . . 0.0 109.531 166.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -99.57 169.13 9.5 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 166.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -146.32 89.67 1.88 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 173.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -120.27 -165.47 1.19 Allowed 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.078 1.351 . . . . 0.0 108.183 169.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -53.3 108.13 1.03 Allowed Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 124.624 1.169 . . . . 0.0 109.934 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -85.68 -167.32 0.39 Allowed 'Trans proline' 0 N--CA 1.445 -1.34 0 C-N-CA 122.369 2.046 . . . . 0.0 110.15 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -48.94 156.48 0.5 Allowed 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 125.498 1.519 . . . . 0.0 114.186 170.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.6 ttmm -122.44 170.85 9.56 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 126.411 1.885 . . . . 0.0 108.667 167.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.7 mt -129.1 130.52 68.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 157.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.7 m -88.87 -141.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 125.311 1.444 . . . . 0.0 108.185 171.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -40.45 -78.38 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 127.585 2.354 . . . . 0.0 111.001 168.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -135.8 9.17 3.32 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 123.308 0.643 . . . . 0.0 111.87 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.765 HG11 ' CE2' ' A' ' 56' ' ' PHE . 21.7 t -106.25 135.16 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.2 t -84.98 147.52 5.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 171.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.8 mp -130.4 91.85 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 176.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.406 HD12 ' CH2' ' A' ' 42' ' ' TRP . 1.3 mm? -71.25 111.94 6.99 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 121.072 1.76 . . . . 0.0 108.983 171.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 4.1 mtt -106.11 91.39 5.46 Favored Pre-proline 0 CA--C 1.548 0.869 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.33 122.95 4.78 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.187 2.591 . . . . 0.0 111.499 -171.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.417 ' C ' ' HE2' ' A' ' 29' ' ' LYS . 0.4 OUTLIER -90.63 74.87 6.69 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 122.34 1.067 . . . . 0.0 111.746 175.959 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.417 ' HE2' ' C ' ' A' ' 28' ' ' ASN . 0.0 OUTLIER 55.72 16.9 2.16 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 119.891 -1.756 . . . . 0.0 113.137 -174.036 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -99.09 13.41 32.95 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 121.421 -0.799 . . . . 0.0 112.546 -161.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.95 72.25 6.7 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 171.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -92.35 148.5 22.07 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 169.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.571 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 0.5 OUTLIER -58.65 -34.45 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 120.345 1.43 . . . . 0.0 109.617 -177.31 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -64.47 -12.14 40.73 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 120.202 -1.561 . . . . 0.0 112.949 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -110.36 -26.71 9.42 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.452 1.501 . . . . 0.0 112.074 168.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.571 ' HB3' ' HA ' ' A' ' 33' ' ' ILE . . . -68.53 -37.57 80.12 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.099 -1.001 . . . . 0.0 111.194 178.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -55.49 -47.65 75.83 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.003 0.921 . . . . 0.0 109.368 168.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 73.0 mt -70.02 -24.01 63.21 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-O 118.081 -0.961 . . . . 0.0 112.496 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.43 ' HB2' ' HA ' ' A' ' 36' ' ' ALA . 1.0 OUTLIER -55.43 -38.25 68.74 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.805 1.242 . . . . 0.0 112.151 -162.363 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -56.87 -65.3 0.64 Allowed 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 118.384 -0.817 . . . . 0.0 109.107 167.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.2 tmtt? -50.74 -47.16 59.43 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 124.199 1.0 . . . . 0.0 111.029 -175.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.406 ' CH2' HD12 ' A' ' 25' ' ' LEU . 27.1 t90 -61.67 -67.5 0.4 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.809 1.244 . . . . 0.0 109.657 176.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 54.2 t -53.79 -33.22 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 121.411 1.914 . . . . 0.0 111.867 -176.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.442 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 3.8 m-85 -60.56 -75.17 0.07 Allowed 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 124.769 1.228 . . . . 0.0 109.581 171.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -70.75 -14.15 62.33 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.886 1.675 . . . . 0.0 113.871 -169.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.88 -33.43 16.46 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 120.739 -1.226 . . . . 0.0 109.865 175.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -136.67 -60.68 0.7 Allowed 'General case' 0 C--N 1.346 0.439 0 CA-C-N 118.86 0.754 . . . . 0.0 111.921 -169.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.442 ' HB2' ' HA ' ' A' ' 44' ' ' PHE . 10.1 mt -60.19 -55.93 27.72 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.463 1.029 . . . . 0.0 112.673 -173.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -66.41 -9.62 35.6 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.595 1.158 . . . . 0.0 110.973 174.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.13 -2.77 58.67 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.656 1.982 . . . . 0.0 111.81 171.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.85 5.45 59.82 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.913 1.244 . . . . 0.0 114.204 177.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -77.48 146.72 36.28 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 119.745 1.772 . . . . 0.0 110.017 176.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -138.45 14.48 2.77 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.525 1.93 . . . . 0.0 110.027 -172.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.595 ' HB3' HG13 ' A' ' 22' ' ' VAL . 0.9 OUTLIER -149.74 116.7 5.95 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 178.116 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.7 mp -120.8 152.7 23.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 175.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.765 ' CE2' HG11 ' A' ' 22' ' ' VAL . 21.9 m-85 -124.18 158.07 33.26 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.603 1.161 . . . . 0.0 110.082 161.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 54.2 tp -118.09 122.97 44.45 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.963 1.705 . . . . 0.0 107.422 173.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . 0.252 0.7 OUTLIER -95.09 157.48 3.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 119.921 1.237 . . . . 0.0 109.927 174.349 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 24.3 mt -132.24 13.69 4.64 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.226 0.611 . . . . 0.0 111.359 -168.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.1 m -81.53 -46.48 14.43 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -173.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -88.2 -23.12 23.67 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.454 1.025 . . . . 0.0 110.7 -173.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.0 p -78.74 162.66 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 125.538 1.535 . . . . 0.0 109.776 169.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -116.99 -37.51 3.57 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.443 0.697 . . . . 0.0 110.516 170.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.87 176.07 13.04 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 122.438 1.113 . . . . 0.0 110.123 177.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.4 tt -132.6 160.0 42.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 127.361 2.264 . . . . 0.0 108.05 -172.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.453 ' C ' ' H ' ' A' ' 68' ' ' PHE . 35.6 t0 -96.24 168.79 10.37 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 119.625 -1.922 . . . . 0.0 109.79 -168.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.5 m -65.25 31.26 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 128.954 2.902 . . . . 0.0 112.052 165.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.453 ' H ' ' C ' ' A' ' 66' ' ' ASP . 43.5 t80 -132.08 -67.72 0.66 Allowed 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 172.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.28 -25.01 61.43 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.443 -166.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.48 HD11 HG21 ' A' ' 103' ' ' THR . 33.1 tp -55.3 -33.09 62.96 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 120.601 -1.312 . . . . 0.0 110.95 171.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -95.32 1.99 65.0 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 125.111 1.339 . . . . 0.0 114.709 174.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -92.63 -32.79 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 120.181 1.991 . . . . 0.0 109.544 167.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -56.69 -53.02 46.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.339 1.056 . . . . 0.0 109.13 177.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.0 t -59.33 -39.95 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 O-C-N 121.515 -0.741 . . . . 0.0 110.374 176.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -54.94 -38.68 68.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 119.207 0.912 . . . . 0.0 112.231 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 80.5 mt -69.61 -34.21 60.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -63.43 -50.33 70.22 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 119.846 1.203 . . . . 0.0 109.278 175.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -53.31 -48.13 68.67 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.056 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.4 t -58.09 -61.38 2.59 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.395 1.878 . . . . 0.0 111.264 176.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 59.7 mt -54.84 -45.87 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 119.646 1.112 . . . . 0.0 110.798 -177.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.3 t -61.88 -41.04 97.4 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.44 -23.71 65.55 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.133 0.973 . . . . 0.0 113.348 173.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.0 m -79.0 -25.4 43.32 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 118.02 -0.99 . . . . 0.0 112.388 171.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 103.67 15.78 21.69 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.5 -1.167 . . . . 0.0 113.954 -170.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -98.08 -168.28 31.86 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 120.322 2.061 . . . . 0.0 112.586 174.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -133.51 162.65 31.3 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.031 1.333 . . . . 0.0 108.501 168.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -147.88 147.1 29.39 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.298 1.039 . . . . 0.0 108.222 176.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.414 ' C ' HD23 ' A' ' 89' ' ' LEU . . . -152.21 172.64 16.08 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.089 1.356 . . . . 0.0 110.72 178.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.414 HD23 ' C ' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -116.15 171.47 7.79 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 118.588 0.631 . . . . 0.0 109.831 -178.146 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 86.1 t -146.69 144.06 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.821 1.248 . . . . 0.0 109.83 -168.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 44.09 60.07 12.22 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 127.815 2.446 . . . . 0.0 113.942 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -84.51 92.56 0.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 124.545 3.496 . . . . 0.0 110.141 -170.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.65 160.32 14.31 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 121.848 -0.532 . . . . 0.0 110.269 177.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -63.74 -34.89 78.89 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.779 0.832 . . . . 0.0 111.167 -167.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.47 ' HE2' ' O ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -59.34 -29.99 68.06 Favored 'General case' 0 CA--C 1.517 -0.321 0 O-C-N 121.006 -1.059 . . . . 0.0 109.439 178.903 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.2 t -92.57 -37.48 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-O 117.911 -1.042 . . . . 0.0 110.283 177.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -59.55 -33.31 71.25 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 121.806 2.094 . . . . 0.0 109.723 175.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.64 -27.33 67.6 Favored 'General case' 0 C--O 1.222 -0.349 0 O-C-N 121.234 -0.916 . . . . 0.0 112.463 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.621 ' O ' HG22 ' A' ' 103' ' ' THR . 7.3 p -95.39 -39.65 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -178.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.418 HD23 HG13 ' A' ' 99' ' ' VAL . 0.2 OUTLIER -59.41 -15.66 18.34 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.075 1.75 . . . . 0.0 111.955 177.649 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.0 t -93.51 -52.85 4.3 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -53.75 -44.81 70.28 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 128.472 2.709 . . . . 0.0 111.805 -177.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.621 HG22 ' O ' ' A' ' 99' ' ' VAL . 10.1 t -79.52 -17.42 54.1 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 118.843 -0.598 . . . . 0.0 111.299 -178.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.2 m120 63.67 94.21 0.05 Allowed 'General case' 0 C--N 1.34 0.153 0 C-N-CA 127.098 2.159 . . . . 0.0 108.253 -157.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.98 -57.01 1.26 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.502 1.521 . . . . 0.0 108.575 170.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -57.33 -32.56 66.83 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 122.478 1.132 . . . . 0.0 111.098 171.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 60.6 mtt180 -71.36 -1.68 13.79 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 120.499 -1.376 . . . . 0.0 111.922 178.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.7 mt -122.62 -39.06 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 125.874 1.67 . . . . 0.0 108.714 -175.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.4 t -125.7 144.77 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 124.861 1.264 . . . . 0.0 108.775 -175.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.75 160.32 28.4 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.594 0.757 . . . . 0.0 111.328 176.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.94 142.17 34.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -173.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -146.82 176.18 10.07 Favored 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 125.189 1.396 . . . . 0.0 110.98 -176.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -103.56 -43.14 5.46 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 118.365 0.53 . . . . 0.0 111.797 -175.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 30.6 p -109.22 -162.4 0.81 Allowed 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -176.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 27.1 mm -92.01 -39.89 11.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 117.371 -1.299 . . . . 0.0 111.322 160.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.0 t -68.76 -34.77 76.14 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 120.916 1.689 . . . . 0.0 111.052 -168.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -69.06 -15.73 63.52 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 118.934 0.788 . . . . 0.0 111.696 176.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.663 ' O ' HG23 ' A' ' 122' ' ' VAL . . . -91.12 -54.24 4.03 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 176.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 6.6 ttm -54.0 -39.48 66.12 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 124.84 1.256 . . . . 0.0 112.001 -163.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -93.49 -10.61 34.34 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.985 0.914 . . . . 0.0 113.392 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -92.24 -58.24 2.45 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 118.35 -0.833 . . . . 0.0 108.775 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.747 HG21 ' CE1' ' A' ' 56' ' ' PHE . 48.1 t -41.62 -44.39 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 128.456 2.702 . . . . 0.0 110.824 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . 0.251 1.5 ptp180 -53.12 -26.13 15.59 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.09 41.64 0.44 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 127.852 2.461 . . . . 0.0 111.371 -178.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.929 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 172.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.1 mtt . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 87.11 -98.9 2.42 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 106.211 -2.755 . . . . 0.0 106.211 -151.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.1 m 63.34 166.74 0.13 Allowed 'General case' 0 C--O 1.233 0.201 0 C-N-CA 126.948 2.099 . . . . 0.0 113.575 -173.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.82 162.57 0.41 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.134 1.774 . . . . 0.0 110.575 156.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? 58.34 15.78 3.65 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.38 1.472 . . . . 0.0 114.012 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.1 tt -47.97 -36.5 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -165.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -138.5 -84.75 0.28 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-N 119.878 1.217 . . . . 0.0 109.134 170.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -139.21 -172.96 3.46 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.633 1.973 . . . . 0.0 106.891 -178.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -132.42 154.02 50.24 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.169 0.988 . . . . 0.0 108.556 173.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -141.49 152.63 44.34 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.093 1.757 . . . . 0.0 106.478 175.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 50.53 76.46 0.15 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.842 1.657 . . . . 0.0 111.184 -172.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -135.99 122.75 21.12 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 173.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -117.48 95.28 4.89 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 105.809 -1.922 . . . . 0.0 105.809 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -55.06 168.26 0.55 Allowed Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 128.345 2.658 . . . . 0.0 111.714 -176.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.35 98.06 0.38 Allowed 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.135 1.89 . . . . 0.0 110.502 169.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -145.84 167.08 24.09 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.993 1.317 . . . . 0.0 110.188 176.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt -131.97 171.01 14.11 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.733 0.813 . . . . 0.0 110.942 174.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.3 mt -129.61 110.55 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 104.651 -2.351 . . . . 0.0 104.651 176.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.4 m -93.38 -134.93 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 119.562 1.074 . . . . 0.0 109.172 176.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -45.83 -78.72 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 127.827 2.451 . . . . 0.0 111.785 172.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -137.76 15.3 2.9 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.281 1.832 . . . . 0.0 109.678 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.681 HG11 ' CE2' ' A' ' 56' ' ' PHE . 11.9 t -121.6 133.55 67.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -168.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 74.6 t -92.22 131.22 39.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.416 HG13 HD12 ' A' ' 115' ' ' ILE . 1.9 mp -112.48 103.63 15.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 176.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.7 137.35 45.92 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 161.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 13.8 mtt -139.96 79.98 21.62 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.57 -98.81 0.01 OUTLIER 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 121.452 1.435 . . . . 0.0 111.508 -170.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.474 ' ND2' ' H ' ' A' ' 29' ' ' LYS . 18.8 p-10 155.82 -106.18 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 O-C-N 119.38 -2.075 . . . . 0.0 107.688 -163.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.474 ' H ' ' ND2' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -126.94 25.68 6.25 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.205 1.802 . . . . 0.0 108.888 167.25 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -63.19 -16.99 61.9 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.869 1.268 . . . . 0.0 111.711 170.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.6 mp -74.09 67.96 1.37 Allowed 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 169.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -124.59 7.44 8.24 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.775 2.03 . . . . 0.0 113.312 -175.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 94.87 -24.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.563 1 C-N-CA 135.457 5.503 . . . . 0.0 110.113 -176.438 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -71.94 -18.69 61.99 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 120.871 -1.143 . . . . 0.0 111.778 -175.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -98.98 -31.21 11.92 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 173.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.15 -41.74 94.46 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 113.647 0.981 . . . . 0.0 113.647 -159.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -64.3 -43.79 93.66 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.981 1.264 . . . . 0.0 110.146 -177.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.01 -22.33 49.46 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.593 -178.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -41.86 -54.27 3.47 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 127.585 2.354 . . . . 0.0 111.972 -171.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.2 pttt -68.99 -41.22 78.14 Favored 'General case' 0 C--O 1.217 -0.609 0 CA-C-O 118.15 -0.929 . . . . 0.0 111.273 -178.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.72 -44.04 90.3 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 120.31 1.414 . . . . 0.0 110.939 178.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 7.1 t90 -58.13 -66.14 0.53 Allowed 'General case' 0 C--O 1.223 -0.341 0 CA-C-O 117.364 -1.303 . . . . 0.0 108.515 171.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 51.3 t -49.44 -38.28 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 120.049 1.295 . . . . 0.0 112.282 -176.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -60.73 -62.68 1.69 Allowed 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 125.106 1.362 . . . . 0.0 109.294 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -70.61 -44.16 67.83 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 118.852 0.751 . . . . 0.0 111.218 -174.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -61.07 -33.95 74.14 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.914 1.285 . . . . 0.0 110.523 -174.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -136.41 -52.56 0.72 Allowed 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -171.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 39.3 mt -63.46 -37.93 89.18 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.207 0.912 . . . . 0.0 111.075 -173.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -84.67 -9.39 58.3 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.158 1.383 . . . . 0.0 110.549 176.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.3 mttt -82.38 3.83 26.41 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.614 1.566 . . . . 0.0 111.148 156.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.95 4.33 88.52 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 125.374 1.464 . . . . 0.0 114.344 176.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -68.89 112.23 5.43 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 119.541 1.671 . . . . 0.0 109.303 176.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 -107.63 16.65 23.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.889 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.494 ' HB3' HG13 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -132.48 126.05 32.09 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 121.106 -0.996 . . . . 0.0 108.743 164.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.434 HD12 HD11 ' A' ' 80' ' ' ILE . 5.8 mt -128.44 160.19 38.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 126.303 1.841 . . . . 0.0 106.64 172.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.681 ' CE2' HG11 ' A' ' 22' ' ' VAL . 24.3 m-85 -132.42 159.22 39.92 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.016 1.326 . . . . 0.0 111.351 161.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 56.2 tp -127.86 87.19 2.57 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.227 0.611 . . . . 0.0 109.418 171.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.576 HG12 ' H ' ' A' ' 60' ' ' SER . 91.2 t -52.1 151.8 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 126.163 1.785 . . . . 0.0 108.326 167.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.6 mt -135.68 18.68 3.3 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.619 1.968 . . . . 0.0 110.292 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.576 ' H ' HG12 ' A' ' 58' ' ' VAL . 67.3 m -54.1 -54.11 43.95 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 125.071 1.348 . . . . 0.0 111.281 -169.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.41 ' O ' ' HE2' ' A' ' 29' ' ' LYS . 7.0 t0 -97.41 9.61 41.89 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 123.338 0.655 . . . . 0.0 111.339 175.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 17.6 t -98.62 100.56 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 104.312 -2.477 . . . . 0.0 104.312 -176.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -57.82 -49.87 75.19 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.6 t -152.88 164.42 37.92 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 123.1 1.429 . . . . 0.0 112.861 -175.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.4 tt -95.06 -162.77 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 126.877 2.071 . . . . 0.0 106.838 161.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -143.21 166.67 24.06 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.244 1.417 . . . . 0.0 109.737 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.6 t -53.03 -32.73 48.32 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.14 1.776 . . . . 0.0 112.171 176.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -66.14 -60.12 3.11 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 119.376 0.989 . . . . 0.0 109.697 173.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.05 -19.37 47.75 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -163.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 18.7 mt -55.21 -32.66 62.43 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.405 -0.809 . . . . 0.0 110.766 169.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -69.35 -44.23 66.26 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-O 118.832 -0.982 . . . . 0.0 111.474 170.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.57 -32.88 51.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 119.213 1.506 . . . . 0.0 110.759 -169.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -58.51 -53.18 50.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 125.069 1.348 . . . . 0.0 109.391 175.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 38.2 t -60.98 -38.76 80.16 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.618 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 173.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.1 -38.02 81.72 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 120.278 -1.514 . . . . 0.0 112.073 -176.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 70.6 mt -67.43 -36.19 75.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.288 1.035 . . . . 0.0 110.073 172.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.478 HD22 HG22 ' A' ' 109' ' ' VAL . 20.0 tp -60.81 -50.5 73.2 Favored 'General case' 0 C--O 1.219 -0.544 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 175.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 44.2 mttt -62.35 4.48 0.14 Allowed 'General case' 0 C--O 1.234 0.257 0 C-N-CA 126.409 1.884 . . . . 0.0 114.316 178.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.5 t -103.99 -58.8 1.82 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 167.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.434 HD11 HD12 ' A' ' 55' ' ' ILE . 78.3 mt -55.59 -35.82 39.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 125.305 1.442 . . . . 0.0 111.319 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.2 p -53.88 -58.35 7.59 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 126.048 1.739 . . . . 0.0 108.688 -177.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.7 t -61.93 -39.86 93.53 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 127.968 2.507 . . . . 0.0 110.899 -178.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.1 -23.47 67.16 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 175.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.29 17.58 49.63 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-O 118.637 -1.091 . . . . 0.0 112.933 -174.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -89.8 -173.78 45.49 Favored Glycine 0 N--CA 1.438 -1.195 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 172.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.432 ' HB3' HG22 ' A' ' 122' ' ' VAL . 2.5 m-85 -131.75 148.98 52.61 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 125.547 1.539 . . . . 0.0 109.539 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -143.96 149.96 37.58 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.27 1.028 . . . . 0.0 108.425 176.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.555 ' C ' HD23 ' A' ' 89' ' ' LEU . . . -154.18 168.4 26.67 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.972 0.909 . . . . 0.0 111.77 177.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.555 HD23 ' C ' ' A' ' 88' ' ' ALA . 1.5 mt -113.47 171.74 7.38 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 177.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.508 HG13 ' N ' ' A' ' 58' ' ' VAL . 0.5 OUTLIER -152.43 146.65 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 C-N-CA 123.898 0.879 . . . . 0.0 110.227 -166.327 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.7 t 43.92 54.11 11.1 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 126.122 1.769 . . . . 0.0 110.264 177.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.439 ' O ' HG22 ' A' ' 96' ' ' VAL . 25.3 Cg_endo -61.89 -30.96 84.63 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.976 2.451 . . . . 0.0 112.335 -169.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 63.14 165.58 0.12 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 123.962 1.839 . . . . 0.0 110.755 -161.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -54.36 -33.98 60.2 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 112.343 -2.208 . . . . 0.0 110.666 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.63 -41.58 21.26 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 124.439 1.096 . . . . 0.0 112.067 -158.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 92' ' ' PRO . 18.9 m -75.06 -44.33 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.732 0 CA-C-O 118.085 -0.96 . . . . 0.0 110.483 171.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.87 -29.76 63.24 Favored 'General case' 0 N--CA 1.461 0.09 0 C-N-CA 124.334 1.054 . . . . 0.0 108.79 -170.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.34 -62.74 1.14 Allowed 'General case' 0 N--CA 1.428 -1.555 0 C-N-CA 126.153 1.781 . . . . 0.0 112.342 168.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.7 t -72.66 -39.89 61.27 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 CA-C-N 112.365 -2.198 . . . . 0.0 108.295 -173.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.413 ' HB3' ' H ' ' A' ' 106' ' ' ASP . 0.7 OUTLIER -58.67 -17.51 23.11 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.755 1.222 . . . . 0.0 109.236 177.391 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.5 -1.89 43.11 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-O 121.607 0.718 . . . . 0.0 112.467 179.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.8 mt -119.45 -42.78 2.63 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 127.187 2.195 . . . . 0.0 109.854 -174.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.1 t -87.23 0.16 55.78 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.978 2.511 . . . . 0.0 111.341 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 42.94 84.35 0.02 OUTLIER 'General case' 0 C--N 1.344 0.351 0 C-N-CA 126.949 2.1 . . . . 0.0 111.808 -168.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.73 -64.41 1.32 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.937 1.295 . . . . 0.0 108.704 170.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.413 ' H ' ' HB3' ' A' ' 100' ' ' LEU . 3.3 t70 -58.9 -29.03 66.75 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.537 0.735 . . . . 0.0 110.483 172.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 26.3 mtp180 -69.12 1.31 3.7 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.903 -1.123 . . . . 0.0 112.147 176.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.8 mt -130.35 -38.77 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 126.696 1.999 . . . . 0.0 109.663 -176.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.478 HG22 HD22 ' A' ' 77' ' ' LEU . 2.2 t -122.09 153.14 26.33 Favored 'Isoleucine or valine' 0 C--N 1.342 0.242 0 C-N-CA 125.299 1.44 . . . . 0.0 110.149 -169.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.43 155.49 35.3 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.236 1.014 . . . . 0.0 112.511 173.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -147.22 147.78 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 126.43 1.892 . . . . 0.0 107.478 -178.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -144.14 169.89 17.0 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.195 1.398 . . . . 0.0 111.571 -175.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -86.65 -37.7 17.77 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 175.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.3 p -137.3 175.91 9.19 Favored 'General case' 0 C--N 1.334 -0.079 0 C-N-CA 124.168 0.987 . . . . 0.0 111.145 -168.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.472 HD11 ' CG2' ' A' ' 58' ' ' VAL . 10.7 mm -72.74 -40.08 60.81 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 CA-C-O 118.479 -0.772 . . . . 0.0 109.918 176.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.3 t -73.2 -32.33 64.73 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 119.294 0.952 . . . . 0.0 109.965 -171.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -66.65 -10.08 42.47 Favored 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 123.436 0.694 . . . . 0.0 112.036 170.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -102.91 -47.62 4.32 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 -178.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -58.08 -54.39 47.47 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 126.565 1.946 . . . . 0.0 113.676 -160.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -87.47 -12.34 46.3 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.01 1.724 . . . . 0.0 111.25 179.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -91.78 -53.3 4.35 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 124.596 1.158 . . . . 0.0 107.941 -166.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.432 HG22 ' HB3' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -55.06 -23.73 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 128.649 2.78 . . . . 0.0 112.785 176.126 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 78.8 mtt180 -59.66 -28.48 67.29 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 118.46 -0.781 . . . . 0.0 111.718 169.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.34 26.22 3.81 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 126.5 1.92 . . . . 0.0 115.009 -176.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.6 mmtm . . . . . 0 C--O 1.249 1.069 0 C-N-CA 126.236 1.814 . . . . 0.0 106.724 -176.901 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.2 mtp . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -62.67 171.37 11.38 Favored Glycine 0 CA--C 1.535 1.301 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 145.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.9 p -150.13 121.04 7.63 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.443 1.097 . . . . 0.0 108.574 -171.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -101.13 -61.66 1.34 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.054 1.742 . . . . 0.0 109.566 173.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.3 ptmm? 43.76 166.21 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 129.423 3.089 . . . . 0.0 114.003 -153.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.0 tp -143.71 152.48 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 171.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -136.71 -64.45 0.58 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.161 0.984 . . . . 0.0 108.588 -175.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 61.78 158.73 0.05 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.427 1.891 . . . . 0.0 112.36 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.07 110.95 5.44 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 171.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 26.3 m170 -133.17 172.67 12.35 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 125.802 1.641 . . . . 0.0 108.318 168.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.467 ' HB2' ' CZ ' ' A' ' 14' ' ' PHE . 2.4 p-80 -156.16 -41.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 126.253 1.821 . . . . 0.0 110.973 174.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 44.7 m-70 58.92 -71.15 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 127.513 2.325 . . . . 0.0 113.084 -174.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.8 mtt -155.39 166.64 32.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 120.573 1.533 . . . . 0.0 108.276 173.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.467 ' CZ ' ' HB2' ' A' ' 11' ' ' HIS . 23.2 m-85 -129.95 86.19 55.46 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 123.459 0.703 . . . . 0.0 109.19 -176.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -77.89 51.68 3.71 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 124.461 3.441 . . . . 0.0 110.769 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -163.95 177.31 8.63 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 120.486 -1.384 . . . . 0.0 108.877 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -141.85 175.96 9.31 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.437 1.495 . . . . 0.0 108.503 156.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.2 mt -127.77 138.22 55.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 167.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.0 m -114.08 -156.74 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 C-N-CA 126.356 1.862 . . . . 0.0 107.727 168.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -42.21 -63.02 0.81 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 120.978 1.717 . . . . 0.0 114.641 -162.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -133.82 19.23 3.84 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.689 1.596 . . . . 0.0 110.973 170.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.694 HG11 ' CE2' ' A' ' 56' ' ' PHE . 4.2 t -132.59 119.07 37.14 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 123.137 1.446 . . . . 0.0 109.924 -168.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.526 ' O ' HD13 ' A' ' 24' ' ' ILE . 0.6 OUTLIER -67.06 150.3 11.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 127.425 2.29 . . . . 0.0 112.383 169.156 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.673 HD12 HD12 ' A' ' 115' ' ' ILE . 4.4 mm -135.68 96.38 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 174.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.495 HD23 HG23 ' A' ' 55' ' ' ILE . 4.3 mm? -59.99 132.24 53.32 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 164.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 24.8 mmm -127.79 81.32 70.5 Favored Pre-proline 0 C--O 1.234 0.245 0 C-N-CA 126.111 1.764 . . . . 0.0 106.91 178.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -61.69 143.8 96.76 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 122.267 1.978 . . . . 0.0 109.053 170.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.02 -83.11 0.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 179.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.74 1.53 14.18 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.286 1.034 . . . . 0.0 112.035 172.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -67.62 -34.78 77.66 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -171.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 31' ' ' LEU . 1.6 tp -73.22 -81.28 0.06 Allowed 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -153.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 34.24 41.38 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 130.062 3.345 . . . . 0.0 114.361 154.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER 61.31 -31.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 130.54 3.536 . . . . 0.0 115.416 -170.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -54.12 -34.65 60.82 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.505 1.122 . . . . 0.0 112.332 -175.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -122.4 60.37 1.0 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -173.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.45 -65.87 1.14 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 118.769 -0.634 . . . . 0.0 111.512 -177.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -60.32 -28.38 68.09 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.073 1.306 . . . . 0.0 111.887 173.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.71 ' H ' HD22 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -78.95 -31.15 44.97 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 117.65 -1.167 . . . . 0.0 110.206 176.969 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -45.37 -52.66 9.65 Favored 'General case' 0 CA--C 1.508 -0.649 0 O-C-N 124.362 1.039 . . . . 0.0 110.033 178.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.39 -45.98 90.7 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 117.544 -1.217 . . . . 0.0 110.027 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -61.4 -46.95 88.02 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 119.94 1.245 . . . . 0.0 111.38 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.452 ' CH2' ' CD1' ' A' ' 25' ' ' LEU . 15.7 t90 -62.86 -60.79 3.0 Favored 'General case' 0 C--O 1.215 -0.715 0 CA-C-O 117.436 -1.269 . . . . 0.0 108.796 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.7 t -54.16 -30.0 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 CA-C-N 121.468 1.94 . . . . 0.0 111.706 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -66.61 -65.49 0.67 Allowed 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 120.723 -1.236 . . . . 0.0 110.481 170.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -66.63 -37.4 84.77 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.353 1.461 . . . . 0.0 111.781 -171.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -73.14 -31.86 64.54 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 127.941 2.496 . . . . 0.0 111.996 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -129.38 -58.1 1.13 Allowed 'General case' 0 C--N 1.343 0.322 0 CA-C-N 119.596 1.089 . . . . 0.0 111.605 -171.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.0 mt -64.97 -31.54 72.83 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 121.674 -0.641 . . . . 0.0 111.986 -175.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -80.44 -19.44 46.1 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 118.405 -0.807 . . . . 0.0 111.031 176.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.06 -5.22 55.47 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 127.073 2.149 . . . . 0.0 114.128 167.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.03 6.26 79.37 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-O 118.68 -1.067 . . . . 0.0 114.38 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -66.02 143.18 57.52 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 119.29 1.545 . . . . 0.0 109.861 175.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.56 22.99 3.16 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.579 1.551 . . . . 0.0 109.059 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.448 ' HB3' HG13 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -151.84 98.82 2.51 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 174.121 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.495 HG23 HD23 ' A' ' 25' ' ' LEU . 1.3 mp -96.25 152.64 3.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 172.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.695 ' CE1' HG21 ' A' ' 122' ' ' VAL . 12.0 m-30 -125.68 164.35 20.8 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.704 -0.798 . . . . 0.0 112.524 162.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 21.9 tp -129.11 129.1 44.77 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 124.174 0.989 . . . . 0.0 109.364 167.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.8 t -99.91 139.99 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 167.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.49 HD22 HG11 ' A' ' 96' ' ' VAL . 3.8 mp -120.64 54.04 1.08 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.437 1.017 . . . . 0.0 110.122 178.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 26.0 t -109.16 -47.32 3.44 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.879 1.272 . . . . 0.0 110.77 -168.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -72.84 -49.93 27.2 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 1.8 p -68.95 141.58 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 124.581 1.153 . . . . 0.0 109.111 171.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -79.0 -36.81 40.62 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 119.153 -0.451 . . . . 0.0 110.009 167.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.579 ' CB ' ' HE2' ' A' ' 95' ' ' LYS . 10.7 t -165.36 159.73 17.43 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 122.706 1.241 . . . . 0.0 113.168 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.543 HG22 HG21 ' A' ' 96' ' ' VAL . 14.0 tt -79.57 169.94 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 C-N-CA 128.257 2.623 . . . . 0.0 109.219 166.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.0 164.14 12.68 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.124 1.37 . . . . 0.0 109.809 177.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.45 ' HA ' HD12 ' A' ' 70' ' ' LEU . 95.2 p -63.24 -24.22 67.78 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -175.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -60.56 -72.01 0.12 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.799 0.84 . . . . 0.0 108.858 171.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.0 t -70.76 -15.18 62.66 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -173.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 67' ' ' SER . 2.7 mt -46.27 -37.49 7.36 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.699 1.136 . . . . 0.0 110.844 169.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.61 -22.18 51.32 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 123.136 0.398 . . . . 0.0 113.971 -178.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 52.9 t -79.12 -35.45 17.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.515 1.126 . . . . 0.0 109.181 177.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 16.7 mm -56.53 -47.45 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 123.499 0.72 . . . . 0.0 110.667 174.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.9 t -62.43 -40.44 88.06 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.266 0 O-C-N 121.558 -0.714 . . . . 0.0 109.739 176.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -52.02 -46.85 65.13 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.466 1.03 . . . . 0.0 112.309 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.3 mt -56.65 -41.32 73.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.374 1.47 . . . . 0.0 110.097 175.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -66.67 -46.87 74.26 Favored 'General case' 0 CA--C 1.52 -0.209 0 O-C-N 121.494 -0.754 . . . . 0.0 109.621 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -55.72 -50.86 69.2 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 118.757 -0.64 . . . . 0.0 110.472 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 33.1 t -53.14 -52.05 59.97 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 124.845 1.34 . . . . 0.0 109.214 178.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 21.6 mt -63.29 -46.9 94.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 C-N-CA 123.467 0.707 . . . . 0.0 110.69 -174.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -51.45 -55.36 19.23 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.798 0.839 . . . . 0.0 110.461 171.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.6 m -65.3 -17.48 64.54 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.227 1.011 . . . . 0.0 113.504 -178.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.5 m -83.84 -47.26 11.28 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.789 0.836 . . . . 0.0 110.915 178.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 133.32 -1.0 4.42 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 118.295 -1.28 . . . . 0.0 113.75 -166.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -101.73 -169.41 27.56 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-N 120.208 2.004 . . . . 0.0 112.509 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.593 ' CZ ' ' HE2' ' A' ' 125' ' ' LYS . 0.1 OUTLIER -135.41 165.71 24.85 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 126.869 2.068 . . . . 0.0 110.8 171.615 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -155.25 141.76 18.75 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 177.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.79 168.6 23.93 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.268 0.627 . . . . 0.0 112.186 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 mt -116.16 164.17 14.88 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.502 1.121 . . . . 0.0 109.438 -171.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.703 HG21 HD13 ' A' ' 115' ' ' ILE . 79.6 t -146.13 154.87 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 126.049 1.74 . . . . 0.0 109.998 -169.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 t 46.93 58.4 17.07 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 127.772 2.429 . . . . 0.0 112.15 173.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -76.73 97.31 1.13 Allowed 'Trans proline' 0 N--CA 1.445 -1.363 0 C-N-CA 122.148 1.898 . . . . 0.0 111.23 -177.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.43 158.73 5.4 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 119.251 -0.98 . . . . 0.0 109.723 162.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -69.65 -29.45 66.92 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.339 1.056 . . . . 0.0 111.834 -167.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.579 ' HE2' ' CB ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -56.99 -51.93 67.29 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -173.177 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.543 HG21 HG22 ' A' ' 65' ' ' ILE . 0.5 OUTLIER -78.76 -41.03 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 124.057 0.848 . . . . 0.0 110.286 -173.515 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.97 -33.65 18.45 Favored 'General case' 0 CA--C 1.503 -0.827 0 C-N-CA 124.456 1.103 . . . . 0.0 110.836 175.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -53.98 47.13 Favored 'General case' 0 N--CA 1.417 -2.121 0 CA-C-O 123.368 1.556 . . . . 0.0 113.107 178.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.53 ' O ' HG22 ' A' ' 103' ' ' THR . 15.0 t -69.69 -43.52 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.832 0 CA-C-N 111.346 -2.661 . . . . 0.0 106.58 -172.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.412 HD21 HG22 ' A' ' 96' ' ' VAL . 0.4 OUTLIER -55.36 -28.87 56.76 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.933 1.293 . . . . 0.0 108.755 175.264 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.7 m -92.01 4.09 53.81 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.374 1.47 . . . . 0.0 112.729 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 94.1 mt -125.06 -20.76 4.83 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 127.752 2.421 . . . . 0.0 111.769 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.53 HG22 ' O ' ' A' ' 99' ' ' VAL . 7.2 t -111.69 2.24 17.12 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.751 1.62 . . . . 0.0 112.029 -174.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 54.17 87.73 0.04 OUTLIER 'General case' 0 C--N 1.342 0.247 0 C-N-CA 126.541 1.936 . . . . 0.0 109.887 -172.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.73 -57.2 1.45 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 118.544 -0.741 . . . . 0.0 109.702 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.85 -35.29 44.18 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 123.302 1.525 . . . . 0.0 110.585 164.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -72.05 -1.68 15.62 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 120.834 -1.167 . . . . 0.0 111.832 -177.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.7 mt -126.46 -38.63 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 126.34 1.856 . . . . 0.0 109.628 -175.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.2 t -118.21 145.68 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 125.696 1.598 . . . . 0.0 109.332 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -68.14 154.38 41.81 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 123.384 0.673 . . . . 0.0 110.199 174.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -141.98 149.35 19.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -173.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -147.65 165.69 29.67 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.122 1.369 . . . . 0.0 109.434 -172.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -84.66 -46.69 11.24 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 45.3 p -119.35 170.37 9.18 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.232 1.413 . . . . 0.0 108.638 -174.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.703 HD13 HG21 ' A' ' 90' ' ' VAL . 8.9 mm -66.95 -42.02 88.24 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.81 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 167.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 48.2 t -67.98 -37.7 81.81 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.787 1.176 . . . . 0.0 110.712 -165.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -63.51 -28.02 69.66 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 118.184 0.447 . . . . 0.0 110.259 176.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.646 ' O ' HG23 ' A' ' 122' ' ' VAL . . . -80.69 -54.99 5.14 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -54.89 -29.06 54.88 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 126.213 1.805 . . . . 0.0 112.721 -163.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.63 -23.32 14.28 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 126.5 1.92 . . . . 0.0 111.712 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -81.96 -53.73 5.9 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 120.114 1.325 . . . . 0.0 111.887 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.695 HG21 ' CE1' ' A' ' 56' ' ' PHE . 51.4 t -44.05 -39.91 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 129.293 3.037 . . . . 0.0 110.099 -178.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -49.83 -23.26 1.79 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 127.414 2.286 . . . . 0.0 114.265 174.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.69 37.09 0.19 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.306 2.242 . . . . 0.0 113.274 177.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.593 ' HE2' ' CZ ' ' A' ' 86' ' ' PHE . 0.6 OUTLIER . . . . . 0 C--O 1.248 0.99 0 O-C-N 121.436 -0.79 . . . . 0.0 109.514 -174.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 78.32 84.63 0.54 Allowed Glycine 0 C--N 1.335 0.499 0 CA-C-N 118.66 0.664 . . . . 0.0 111.711 172.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.9 t -150.09 99.53 2.83 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.92 -178.75 3.8 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.27 1.428 . . . . 0.0 111.456 -167.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 155.34 144.03 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 130.843 3.657 . . . . 0.0 109.164 161.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.6 mp 48.26 92.86 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 127.819 2.448 . . . . 0.0 111.37 176.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -153.82 174.78 14.12 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.898 177.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -153.82 177.93 10.46 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.497 1.519 . . . . 0.0 108.855 171.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 70.58 25.16 4.26 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.901 1.28 . . . . 0.0 113.217 167.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -129.77 101.27 5.81 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 159.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -155.62 113.23 3.32 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 106.193 -1.781 . . . . 0.0 106.193 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -160.99 -177.49 6.15 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.934 1.694 . . . . 0.0 109.735 -175.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 5.5 mmt 54.97 76.31 0.26 Allowed 'General case' 0 C--N 1.339 0.122 0 C-N-CA 125.214 1.406 . . . . 0.0 108.563 176.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -110.51 88.06 7.16 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -81.16 98.76 1.05 Allowed 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.979 3.12 . . . . 0.0 110.509 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -151.0 -177.6 6.11 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.015 -1.053 . . . . 0.0 112.661 -177.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.437 ' HE2' ' CG1' ' A' ' 19' ' ' VAL . 0.7 OUTLIER -143.48 164.74 29.49 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.97 2.108 . . . . 0.0 106.823 173.689 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.2 mt -130.36 118.57 43.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 174.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.437 ' CG1' ' HE2' ' A' ' 17' ' ' LYS . 6.4 m -93.34 -162.02 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 125.677 1.591 . . . . 0.0 108.001 168.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -24.6 -70.85 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 129.651 3.181 . . . . 0.0 111.771 171.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -149.96 21.86 0.88 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.734 0.814 . . . . 0.0 110.835 -177.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.616 HG11 ' CE2' ' A' ' 56' ' ' PHE . 20.4 t -127.19 156.62 38.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 95.8 t -116.13 128.52 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mp -101.55 104.95 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 46.8 mt -88.97 128.84 35.71 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 103.551 -2.759 . . . . 0.0 103.551 175.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 30.2 mtm -123.48 95.48 45.1 Favored Pre-proline 0 N--CA 1.465 0.302 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -176.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -69.07 161.44 45.81 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.251 1.967 . . . . 0.0 111.088 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.717 HD22 ' H ' ' A' ' 29' ' ' LYS . 0.5 OUTLIER -151.92 -71.48 0.16 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 121.232 0.539 . . . . 0.0 111.964 -173.003 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.717 ' H ' HD22 ' A' ' 28' ' ' ASN . 0.0 OUTLIER -147.47 6.06 0.83 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.53 1.932 . . . . 0.0 112.132 -176.238 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -79.58 -2.61 43.21 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 128.333 2.653 . . . . 0.0 112.746 177.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.6 mt -101.56 95.23 6.32 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -166.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -164.72 30.76 0.07 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.886 0.874 . . . . 0.0 112.386 -161.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER 73.7 -46.94 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 127.968 2.507 . . . . 0.0 112.287 175.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -68.85 -5.26 19.94 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 126.353 1.861 . . . . 0.0 113.189 -173.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -127.25 0.98 6.41 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 127.345 2.258 . . . . 0.0 109.127 177.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.14 -57.75 3.62 Favored 'General case' 0 C--O 1.224 -0.241 0 O-C-N 120.229 -1.545 . . . . 0.0 110.868 -173.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -65.05 -24.63 67.52 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 120.831 -1.168 . . . . 0.0 110.98 -178.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.447 ' H ' HD22 ' A' ' 38' ' ' LEU . 1.7 mm? -81.54 -33.25 31.85 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 126.219 1.807 . . . . 0.0 110.863 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -42.4 -53.28 4.3 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 126.711 2.004 . . . . 0.0 111.285 176.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.39 -43.26 99.25 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.482 -178.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.13 -49.39 77.14 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.103 0.865 . . . . 0.0 110.639 174.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -58.01 -64.26 0.97 Allowed 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 118.099 -0.953 . . . . 0.0 110.014 177.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 68.8 t -49.56 -37.95 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 120.018 1.281 . . . . 0.0 112.062 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.591 ' CD1' HD12 ' A' ' 48' ' ' LEU . 3.2 m-85 -61.12 -62.21 2.01 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.604 0.762 . . . . 0.0 110.329 175.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.11 -16.66 59.85 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 125.018 1.327 . . . . 0.0 112.867 -170.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -93.62 -31.4 14.51 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.778 1.231 . . . . 0.0 111.732 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -132.01 -54.26 0.98 Allowed 'General case' 0 C--N 1.346 0.42 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -172.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.591 HD12 ' CD1' ' A' ' 44' ' ' PHE . 30.7 mt -60.39 -50.95 71.54 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 118.654 0.661 . . . . 0.0 112.291 -171.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -61.28 -39.43 90.38 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.241 0.616 . . . . 0.0 109.944 177.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -60.09 -1.91 0.37 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 128.318 2.647 . . . . 0.0 114.797 172.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.49 2.75 75.93 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-O 118.304 -1.276 . . . . 0.0 113.02 176.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -72.48 119.09 16.21 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 120.024 1.912 . . . . 0.0 108.791 175.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -114.08 19.2 16.65 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.618 1.167 . . . . 0.0 109.309 -177.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.412 ' HB3' HG13 ' A' ' 22' ' ' VAL . 2.5 mtmt -146.4 130.01 16.96 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.328 1.851 . . . . 0.0 107.353 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.694 HD13 HD11 ' A' ' 80' ' ' ILE . 1.2 mp -138.6 154.26 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 128.062 2.545 . . . . 0.0 105.612 177.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.787 ' CE1' HG21 ' A' ' 122' ' ' VAL . 21.2 m-85 -130.37 156.6 44.44 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 124.633 1.173 . . . . 0.0 113.366 166.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 26.8 tp -121.69 75.83 1.22 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.907 1.283 . . . . 0.0 110.885 177.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.443 ' CG2' HD11 ' A' ' 115' ' ' ILE . 96.1 t -64.56 118.35 6.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 127.791 2.436 . . . . 0.0 107.023 173.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.7 mt -95.85 5.14 52.02 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.563 0.745 . . . . 0.0 110.643 -176.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.3 m -56.73 -23.61 43.72 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 177.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.46 -7.19 56.98 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.516 1.053 . . . . 0.0 111.272 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 p -134.17 157.23 41.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.902 1.681 . . . . 0.0 110.605 -168.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -85.72 -44.6 12.4 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.236 -0.915 . . . . 0.0 108.682 167.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 m -160.29 161.66 33.4 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 123.345 1.545 . . . . 0.0 113.703 -179.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.2 tt -72.47 174.28 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 111.808 -2.451 . . . . 0.0 107.796 163.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -117.88 -144.94 0.38 Allowed 'General case' 0 C--N 1.327 -0.382 0 O-C-N 120.952 -1.093 . . . . 0.0 109.646 -160.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.6 t -50.62 -147.99 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.798 1 C-N-CA 132.111 4.165 . . . . 0.0 112.388 157.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -25.04 -39.91 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.158 1 C-N-CA 132.022 4.129 . . . . 0.0 116.421 177.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.2 t -55.07 -31.55 61.24 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.659 0.784 . . . . 0.0 111.778 -178.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.8 tp -57.49 -18.88 21.06 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.402 1.081 . . . . 0.0 112.73 173.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -98.48 -24.7 10.79 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.559 1.552 . . . . 0.0 113.204 170.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 90.1 t -65.92 -40.86 88.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 119.185 1.493 . . . . 0.0 109.551 173.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.4 mp -51.45 -48.59 34.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.552 1.141 . . . . 0.0 109.628 174.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.8 t -64.92 -46.27 92.26 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.635 0 CA-C-O 117.224 -1.37 . . . . 0.0 109.658 175.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -49.07 -51.29 32.25 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 122.469 2.395 . . . . 0.0 111.814 177.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 77.9 mt -57.85 -37.2 58.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 124.913 1.285 . . . . 0.0 110.143 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.545 HD22 HG22 ' A' ' 109' ' ' VAL . 25.7 tp -63.59 -53.6 49.09 Favored 'General case' 0 CA--C 1.52 -0.201 0 O-C-N 121.012 -1.055 . . . . 0.0 109.265 176.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -57.68 -22.82 48.24 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.388 0.675 . . . . 0.0 110.142 -177.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 67.5 m -81.43 -48.24 12.16 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.44 1.096 . . . . 0.0 111.326 177.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.694 HD11 HD13 ' A' ' 55' ' ' ILE . 21.8 mt -58.61 -43.97 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 119.983 1.265 . . . . 0.0 109.782 172.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.4 t -65.65 -10.87 39.82 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.637 1.575 . . . . 0.0 112.296 175.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.7 t -96.46 -43.21 7.73 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 120.32 1.418 . . . . 0.0 109.552 171.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.6 m -66.91 -28.01 67.96 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -178.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 110.02 38.85 1.63 Allowed Glycine 0 C--N 1.337 0.613 0 CA-C-O 118.702 -1.054 . . . . 0.0 113.428 -174.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -134.77 -175.64 13.97 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 119.93 1.865 . . . . 0.0 111.644 -177.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -127.31 154.13 45.3 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.874 1.67 . . . . 0.0 109.858 179.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -150.41 139.38 20.98 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -145.99 170.38 16.75 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 120.831 0.348 . . . . 0.0 111.477 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.21 167.34 10.63 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -177.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.431 HG13 ' N ' ' A' ' 58' ' ' VAL . 0.5 OUTLIER -148.86 150.06 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 C-N-CA 123.863 0.865 . . . . 0.0 111.541 -170.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 44.2 54.77 12.26 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 126.51 1.924 . . . . 0.0 112.064 171.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.05 167.25 26.62 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.76 2.307 . . . . 0.0 109.714 -178.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -123.06 169.57 11.06 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 173.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -66.69 -34.74 78.52 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 123.686 0.795 . . . . 0.0 110.127 -168.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.433 ' HE3' ' O ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -61.99 -35.94 80.0 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.337 1.455 . . . . 0.0 110.953 177.14 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -81.36 -46.03 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -176.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -57.43 -31.18 65.63 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 125.958 1.703 . . . . 0.0 110.466 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.95 -21.54 66.43 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -175.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.6 t -104.85 -42.55 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.043 0 C-N-CA 125.72 1.608 . . . . 0.0 107.164 -174.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.08 -17.23 24.18 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 116.715 -1.612 . . . . 0.0 108.868 -177.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.8 t -87.18 -50.64 6.48 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 117.62 -1.632 . . . . 0.0 108.569 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.84 -52.78 64.05 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 129.148 2.979 . . . . 0.0 111.047 -172.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -77.07 2.99 13.45 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.157 1.383 . . . . 0.0 110.891 -178.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.6 m120 47.15 75.85 0.12 Allowed 'General case' 0 C--N 1.342 0.249 0 C-N-CA 129.563 3.145 . . . . 0.0 109.816 -171.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.74 -59.86 1.9 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.295 1.438 . . . . 0.0 107.517 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.1 -26.76 67.88 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.776 0.83 . . . . 0.0 111.348 174.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.4 mtp-105 -74.99 -2.2 26.12 Favored 'General case' 0 C--N 1.339 0.112 0 O-C-N 121.751 -0.593 . . . . 0.0 111.75 -178.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.3 mt -128.0 -46.68 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 125.912 1.685 . . . . 0.0 107.272 -171.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.545 HG22 HD22 ' A' ' 77' ' ' LEU . 1.6 t -104.39 148.94 8.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-O 121.898 0.856 . . . . 0.0 109.917 -175.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.07 155.71 39.91 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 123.85 0.86 . . . . 0.0 111.852 173.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -146.42 146.59 18.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -174.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -141.47 163.75 32.1 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.917 0.887 . . . . 0.0 111.178 -171.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.5 -55.01 4.74 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 64.7 p -113.86 175.64 5.38 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.815 0.817 . . . . 0.0 111.048 -177.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.501 HD13 ' HA ' ' A' ' 115' ' ' ILE . 3.4 mm -61.74 -45.87 97.74 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 164.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.2 t -69.34 -33.14 72.66 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 118.774 -0.631 . . . . 0.0 109.855 -164.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -68.85 -24.04 64.3 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.785 0.834 . . . . 0.0 111.155 175.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.678 ' O ' HG23 ' A' ' 122' ' ' VAL . . . -82.74 -52.59 6.63 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 178.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 6.3 tmm? -55.89 -40.1 72.53 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 125.298 1.439 . . . . 0.0 113.502 -157.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -89.39 -21.38 23.09 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 117.935 -1.031 . . . . 0.0 113.151 175.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.431 ' HG2' ' HE2' ' A' ' 125' ' ' LYS . 1.7 tt0 -84.27 -55.64 4.07 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-N 119.046 0.839 . . . . 0.0 109.76 -172.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.787 HG21 ' CE1' ' A' ' 56' ' ' PHE . 41.2 t -42.61 -44.19 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 C-N-CA 127.96 2.504 . . . . 0.0 110.586 178.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 17.9 mtm180 -48.11 -40.93 25.01 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 124.057 0.848 . . . . 0.0 111.083 178.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . 0.321 0.0 OUTLIER -117.83 43.48 2.39 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 125.628 1.571 . . . . 0.0 113.879 176.085 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.431 ' HE2' ' HG2' ' A' ' 121' ' ' GLU . 5.4 mmmt . . . . . 0 C--O 1.251 1.153 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 164.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.684 0 CA-C-O 117.18 -1.391 . . . . 0.0 107.791 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -90.77 -169.77 42.86 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 174.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m -140.39 -34.81 0.52 Allowed 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 125.335 1.454 . . . . 0.0 110.582 174.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.4 t0 42.64 77.47 0.06 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 128.165 2.586 . . . . 0.0 114.173 174.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -139.43 121.45 15.67 Favored 'General case' 0 CA--C 1.523 -0.08 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 172.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.38 139.26 39.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 -179.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -94.61 158.01 15.72 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.001 0.92 . . . . 0.0 108.855 170.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -173.67 -167.09 0.35 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.164 1.786 . . . . 0.0 108.876 163.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 4.4 m80 66.45 -175.47 0.19 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.789 2.436 . . . . 0.0 111.383 178.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 66.16 19.87 11.12 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.639 1.576 . . . . 0.0 113.675 176.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -129.55 101.95 6.16 Favored 'General case' 0 C--O 1.227 -0.095 0 C-N-CA 124.344 1.058 . . . . 0.0 108.251 168.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 74.7 m-70 -144.32 83.07 1.72 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 165.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 34.7 mtm -121.58 -55.68 1.91 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.716 0.806 . . . . 0.0 109.279 174.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 24.79 81.36 0.19 Allowed Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 128.785 2.834 . . . . 0.0 112.522 172.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.56 98.03 1.01 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.949 2.433 . . . . 0.0 110.847 -175.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -157.27 173.26 17.23 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.062 1.345 . . . . 0.0 109.649 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.4 173.1 12.1 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.487 2.315 . . . . 0.0 110.031 176.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.3 mt -137.8 135.31 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 127.93 2.492 . . . . 0.0 107.789 166.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.413 HG13 HD13 ' A' ' 24' ' ' ILE . 27.2 m -101.1 -139.36 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 127.085 2.154 . . . . 0.0 108.638 173.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -41.92 -71.19 0.09 Allowed 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 129.227 3.011 . . . . 0.0 110.524 177.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -147.88 20.94 1.13 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.602 1.961 . . . . 0.0 108.222 -173.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.703 HG11 ' CE2' ' A' ' 56' ' ' PHE . 15.3 t -131.51 147.65 32.68 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 C-N-CA 124.437 1.095 . . . . 0.0 108.109 -172.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.473 HG11 ' CZ ' ' A' ' 47' ' ' PHE . 33.7 t -103.84 151.13 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.413 HD13 HG13 ' A' ' 19' ' ' VAL . 5.1 mp -129.89 94.71 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 124.871 1.269 . . . . 0.0 108.426 176.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.675 HD22 HG23 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -65.5 105.51 1.2 Allowed 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 129.677 3.191 . . . . 0.0 109.06 170.036 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.548 ' HA ' HG22 ' A' ' 58' ' ' VAL . 50.8 mtp -113.98 73.68 2.46 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 125.663 1.585 . . . . 0.0 107.943 -172.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -69.75 177.34 5.67 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 123.114 2.542 . . . . 0.0 111.532 -173.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.566 ' ND2' ' H ' ' A' ' 29' ' ' LYS . 2.1 p-10 -156.18 -79.99 0.08 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.982 1.713 . . . . 0.0 109.336 -178.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.566 ' H ' ' ND2' ' A' ' 28' ' ' ASN . 3.9 mppt? -136.58 26.36 3.11 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.972 2.509 . . . . 0.0 109.304 -174.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -91.43 -7.81 49.6 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 125.098 1.359 . . . . 0.0 112.055 177.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.18 75.97 9.9 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 120.977 1.717 . . . . 0.0 108.498 -177.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -105.82 58.51 0.66 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.186 2.195 . . . . 0.0 112.28 -173.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.3 mm 53.85 -75.78 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 127.613 2.365 . . . . 0.0 112.76 -175.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -67.31 -17.99 64.99 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.64 1.176 . . . . 0.0 112.032 -173.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.423 ' O ' HD13 ' A' ' 38' ' ' LEU . 11.6 t-20 -43.7 -39.43 3.65 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.455 163.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.689 ' HB1' HG21 ' A' ' 72' ' ' VAL . . . -61.12 -44.99 96.48 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 175.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 38.5 m170 -67.31 -44.68 78.57 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 118.902 -0.57 . . . . 0.0 109.709 -170.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.483 HD22 ' C ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -79.78 -19.91 47.49 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-O 116.985 -1.483 . . . . 0.0 111.69 173.755 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -44.85 -54.02 6.86 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 125.005 1.322 . . . . 0.0 109.785 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.409 ' HG2' ' CE1' ' A' ' 44' ' ' PHE . 13.2 ttpt -56.83 -53.8 53.71 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.85 -46.95 81.44 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 117.296 -1.335 . . . . 0.0 111.544 -176.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 6.1 t90 -62.44 -66.16 0.58 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 117.329 -1.32 . . . . 0.0 109.05 177.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 87.7 t -50.46 -37.96 15.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 120.003 1.274 . . . . 0.0 111.117 -176.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.409 ' CE1' ' HG2' ' A' ' 40' ' ' LYS . 4.3 m-85 -59.51 -74.04 0.08 Allowed 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 171.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -48.92 -43.02 39.04 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.637 1.975 . . . . 0.0 113.267 -171.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.497 ' HG3' ' CE1' ' A' ' 47' ' ' PHE . 3.0 tp10 -84.7 -28.69 26.16 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 126.846 2.058 . . . . 0.0 109.727 -167.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.497 ' CE1' ' HG3' ' A' ' 46' ' ' GLU . 2.8 m-85 -128.77 -66.76 0.82 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 118.925 0.784 . . . . 0.0 110.606 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.6 mt -61.13 -53.41 57.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 118.865 0.757 . . . . 0.0 112.517 -166.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -67.89 -29.06 68.07 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 127.496 2.318 . . . . 0.0 109.572 176.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -63.49 -24.31 67.76 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 118.028 -0.987 . . . . 0.0 111.605 167.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.8 -4.43 19.07 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 126.533 2.016 . . . . 0.0 113.281 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -66.1 156.38 34.07 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 119.429 1.615 . . . . 0.0 111.085 178.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -134.25 1.09 3.17 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.332 -1.303 . . . . 0.0 111.212 -177.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.567 ' HB3' HG13 ' A' ' 22' ' ' VAL . 8.8 mtmt -138.04 123.18 19.21 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.622 1.101 . . . . 0.0 109.296 -170.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.675 HG23 HD22 ' A' ' 25' ' ' LEU . 1.4 mp -137.45 152.78 27.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 126.701 2.0 . . . . 0.0 106.581 -176.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.703 ' CE2' HG11 ' A' ' 22' ' ' VAL . 21.9 m-85 -141.42 120.12 12.56 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 126.977 2.111 . . . . 0.0 110.216 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 46.2 tp -90.18 119.29 30.38 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 176.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.548 HG22 ' HA ' ' A' ' 26' ' ' MET . 0.8 OUTLIER -87.84 154.81 3.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 118.806 0.73 . . . . 0.0 109.963 173.011 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.565 HD22 HG21 ' A' ' 96' ' ' VAL . 3.9 mp -134.38 8.02 3.64 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.871 0.868 . . . . 0.0 111.482 178.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.03 -36.05 67.56 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.891 -1.131 . . . . 0.0 112.073 -177.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -96.33 -11.38 25.92 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.439 1.096 . . . . 0.0 112.16 178.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.4 t -109.87 113.5 44.38 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -169.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.85 -41.61 43.39 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 -178.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 93.8 p -151.99 168.65 24.53 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -171.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.702 HD11 ' HB2' ' A' ' 69' ' ' SER . 4.5 tt -133.64 151.98 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 C-N-CA 124.504 1.122 . . . . 0.0 109.107 176.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.68 162.85 17.69 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.007 0.923 . . . . 0.0 109.006 179.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 85.8 p -66.76 1.9 1.62 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 171.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.52 ' CE1' ' HB2' ' A' ' 36' ' ' ALA 0.25 0.1 OUTLIER -71.03 -78.63 0.07 Allowed 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 123.955 0.902 . . . . 0.0 110.817 156.028 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.702 ' HB2' HD11 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -75.31 -24.17 57.4 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 118.901 0.773 . . . . 0.0 111.777 -158.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 1.011 HD21 HG21 ' A' ' 103' ' ' THR . 35.0 tp -44.72 -38.88 4.72 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.527 1.531 . . . . 0.0 111.889 176.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.681 ' HA2' HG12 ' A' ' 74' ' ' VAL . . . -108.94 6.36 32.71 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-O 119.82 -0.433 . . . . 0.0 114.154 -174.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.689 HG21 ' HB1' ' A' ' 36' ' ' ALA . 95.0 t -75.99 -46.18 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 158.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.588 HD12 ' O ' ' A' ' 69' ' ' SER . 1.7 mt -59.57 -54.23 37.29 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 CA-C-O 122.694 1.235 . . . . 0.0 111.61 -173.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.681 HG12 ' HA2' ' A' ' 71' ' ' GLY . 9.0 p -45.69 -56.32 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.835 0 O-C-N 120.404 -1.435 . . . . 0.0 113.841 163.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.466 ' N ' HG13 ' A' ' 74' ' ' VAL . 0.9 OUTLIER -49.43 -43.93 45.06 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 121.369 -0.832 . . . . 0.0 110.97 -174.356 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 56.3 mt -58.11 -41.87 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 O-C-N 124.859 1.349 . . . . 0.0 110.569 173.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 21.7 tp -57.99 -54.06 51.26 Favored 'General case' 0 C--O 1.225 -0.196 0 O-C-N 120.278 -1.514 . . . . 0.0 109.695 170.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.497 ' HE3' HG22 ' A' ' 74' ' ' VAL . 72.2 mttt -65.13 3.23 0.63 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.276 1.43 . . . . 0.0 112.419 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 41.4 t -106.2 -51.08 3.03 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 126.631 1.973 . . . . 0.0 107.782 174.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 87.8 mt -59.55 -44.6 93.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.678 0.791 . . . . 0.0 110.367 175.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.58 -19.7 65.29 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.786 0.721 . . . . 0.0 112.638 176.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.9 m -80.64 -33.94 35.31 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.341 0.973 . . . . 0.0 111.405 167.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.4 m -73.12 -62.7 1.37 Allowed 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.339 1.056 . . . . 0.0 110.421 -176.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 148.5 29.03 0.06 OUTLIER Glycine 0 CA--C 1.527 0.819 0 CA-C-O 118.14 -1.367 . . . . 0.0 113.787 -168.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -134.06 -166.4 11.25 Favored Glycine 0 C--N 1.338 0.685 0 CA-C-N 120.245 2.023 . . . . 0.0 113.319 -171.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.513 ' HB3' HG22 ' A' ' 122' ' ' VAL . 5.8 m-85 -135.1 150.18 50.18 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.305 1.442 . . . . 0.0 109.246 178.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -145.9 144.12 30.0 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 170.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.469 ' C ' HD23 ' A' ' 89' ' ' LEU . . . -149.99 176.52 10.7 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 126.165 1.786 . . . . 0.0 111.924 -175.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.469 HD23 ' C ' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -123.14 168.32 12.55 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.702 0.801 . . . . 0.0 111.165 -179.566 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.405 ' HB ' ' HA ' ' A' ' 58' ' ' VAL . 99.4 t -147.35 141.43 19.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 124.722 1.209 . . . . 0.0 109.787 -160.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.2 t 42.98 58.19 11.6 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 124.527 1.131 . . . . 0.0 109.342 -176.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -71.57 -163.2 0.13 Allowed 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 124.275 3.317 . . . . 0.0 110.114 -177.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -155.9 151.42 27.04 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 124.508 1.123 . . . . 0.0 108.07 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -61.5 -21.53 64.3 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.201 1.0 . . . . 0.0 110.998 -176.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.402 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -77.62 -38.19 48.54 Favored 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 126.422 1.889 . . . . 0.0 111.451 176.212 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.872 HG13 HD13 ' A' ' 100' ' ' LEU . 2.3 t -62.18 -46.98 95.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-O 117.102 -1.428 . . . . 0.0 108.216 166.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -57.93 -30.45 65.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 119.982 1.265 . . . . 0.0 109.155 176.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -68.34 -30.46 69.43 Favored 'General case' 0 C--O 1.218 -0.589 0 O-C-N 120.703 -1.248 . . . . 0.0 109.934 -177.574 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.677 ' O ' HG22 ' A' ' 103' ' ' THR . 5.4 p -101.59 -42.63 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -169.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.872 HD13 HG13 ' A' ' 96' ' ' VAL . 5.7 mp -67.0 -19.67 65.75 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 115.95 -1.976 . . . . 0.0 111.152 177.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 12.0 t -79.67 -45.44 19.01 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 121.441 1.928 . . . . 0.0 107.31 172.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -67.6 -51.03 55.1 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 126.337 1.855 . . . . 0.0 110.585 -165.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 1.011 HG21 HD21 ' A' ' 70' ' ' LEU . 9.1 t -81.77 6.32 15.84 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.787 179.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 50.0 88.27 0.02 OUTLIER 'General case' 0 C--O 1.235 0.304 0 C-N-CA 127.162 2.185 . . . . 0.0 110.102 -169.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.476 ' HB3' ' HG ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -133.87 -55.9 0.88 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 127.563 2.345 . . . . 0.0 110.739 -175.992 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.77 -27.05 68.93 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.944 1.247 . . . . 0.0 110.681 173.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 -72.44 -18.18 61.72 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.146 0.498 . . . . 0.0 110.109 -177.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.2 mm -97.54 -56.2 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 103.595 -2.742 . . . . 0.0 103.595 -174.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.561 HG12 ' H ' ' A' ' 110' ' ' LYS . 1.4 t -80.41 -165.0 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 125.518 1.527 . . . . 0.0 110.115 -177.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.561 ' H ' HG12 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -125.66 168.82 13.21 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 128.46 2.704 . . . . 0.0 108.813 169.367 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.36 145.73 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -147.02 171.14 15.73 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 126.334 1.854 . . . . 0.0 110.678 -175.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.28 -53.16 4.34 Favored 'General case' 0 CA--C 1.523 -0.067 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -175.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 71.1 p -130.17 162.88 27.89 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.568 0.747 . . . . 0.0 110.895 -175.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 29.1 mm -65.03 -36.48 77.91 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 CA-C-O 118.168 -0.92 . . . . 0.0 108.582 -172.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.9 t -69.04 -31.74 70.75 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.527 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -68.13 -9.15 44.3 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 119.056 0.844 . . . . 0.0 111.672 173.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -110.37 -38.25 5.29 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 119.529 1.059 . . . . 0.0 109.203 -179.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 2.8 ttm -64.1 -46.45 84.14 Favored 'General case' 0 N--CA 1.446 -0.649 0 O-C-N 120.667 -1.271 . . . . 0.0 113.433 -161.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -91.36 -14.68 30.27 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 117.976 -1.012 . . . . 0.0 111.057 175.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -95.22 -46.85 6.59 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 119.327 0.967 . . . . 0.0 110.574 -167.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.513 HG22 ' HB3' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -49.84 -31.77 7.13 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.18 0 C-N-CA 124.89 1.276 . . . . 0.0 111.002 173.779 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -52.63 -36.21 56.12 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.518 1.127 . . . . 0.0 111.969 174.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.88 35.34 0.76 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.884 1.274 . . . . 0.0 114.251 -174.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.242 0.679 0 C-N-CA 125.5 1.52 . . . . 0.0 112.957 178.054 . . . . . . . . 1 1 . 1 stop_ save_